Citrus Sinensis ID: 013258

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------
Protein Sequence
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccccccccccccccccccEEEcccccEEEEEccccccEEEccccHHcccccccEEcccccccccccHHccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccEEEcccccccEEcccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccccccccEEccccccEEEEEcccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEEccEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEccHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEcccccccHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEccccHHHHHHHHHcc
Coil and Loop (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKsklqdpnnslqswdnlpgnlctwfhitcnpegsvtrvdlgnaalsgelapelgqlkNLELLELYGnnlsghipSALGNLiklksldlysnlfngtipDTLANLKQLKYLRLnnnslsgliptslttitslnildlsnnrlsgpvpdngsfsqftpisfennlnlcgpntkkpcsgsppfsppppfgptsspgrnksnaaiPVGVALGAALLFAVPvigfaywrrtrphefffdvpaeddselqlgqlkRFSLRELQVAtdgfsnknilgrggfgkvykgrladgKLVAVKRLKEertsggelqfqTEVKIISMAVHRNLLRLYGFCTTVTEKLLVypymtngsvASRLRerqsslppldwptrkkiALGSARGlsylhehcdpkiihRDVKAANIlldedadqsskTILRRL
Flexible Loop (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAtdgfsnknilgrggfgkvykgrlaDGKLVAVKrlkeertsggelqfqteVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRlrerqsslppldwptrkKIALGSARGLSYLHEHCDPKIIHRDVKAANilldedadqssktilrrl
Low Complexity Region (SEG)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPelgqlknlellelygnnlsgHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNslsgliptslttitslnildlsNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKpcsgsppfsppppfgptsspgRNKSNaaipvgvalgaallfavpvIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered region (IsUnstruct)
****VLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN****************TPISFE*NL************************************AIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV**************DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL***************
Disordered Region (DISOPRED)
*EKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK*****************************IPVGVALGAALLFAVPVIGFAYW**********************GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEER******QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISEMBL)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT************************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISPRO)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGS*****************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Transmembrane Helix (TMHMM)
iiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	447	2.2.26 [Sep-21-2011]
Q94AG2	625	Somatic embryogenesis rec	yes	no	0.973	0.696	0.722	1e-158
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.948	0.689	0.659	1e-152
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.901	0.65	0.661	1e-145
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.870	0.647	0.592	1e-121
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.883	0.622	0.505	1e-109
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.901	0.631	0.5	1e-108
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.923	0.651	0.479	1e-101
Q8VYT3	648	Probable LRR receptor-lik	no	no	0.928	0.640	0.476	6e-99
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.950	0.672	0.496	8e-97
C0LGT1	613	Probable LRR receptor-lik	no	no	0.941	0.686	0.471	2e-95

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  556 bits (1434), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 318/440 (72%), Positives = 352/440 (80%), Gaps = 5/440 (1%)

Query: 1   MEKRVLVFYLVSTIVL--VALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTW 58
           ME   +VF L+S I+L   +L + SAN E DAL+  +  L DPNN LQSWD    N CTW
Sbjct: 1   MESSYVVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTW 60

Query: 59  FHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLK 118
           FH+TCN E SV RVDLGNA LSG L PELG LKNL+ LELY NN++G IPS LGNL  L 
Sbjct: 61  FHVTCNNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLV 120

Query: 119 SLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP 178
           SLDLY N F+G IP++L  L +L++LRLNNNSL+G IP SLT IT+L +LDLSNNRLSG 
Sbjct: 121 SLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGS 180

Query: 179 VPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAI 235
           VPDNGSFS FTPISF NNL+LCGP T  PC GSPPFSPPPPF      S+P       AI
Sbjct: 181 VPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAI 240

Query: 236 PVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATD 295
             GVA GAALLFA P I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D
Sbjct: 241 AGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASD 300

Query: 296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           GFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLL
Sbjct: 301 GFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLL 360

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           RL GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+H
Sbjct: 361 RLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDH 420

Query: 416 CDPKIIHRDVKAANILLDED 435
           CDPKIIHRDVKAANILLDE+
Sbjct: 421 CDPKIIHRDVKAANILLDEE 440

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  537 bits (1384), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 289/438 (65%), Positives = 331/438 (75%), Gaps = 14/438 (3%)

Query: 1   MEKRVLV---FYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCT 57
           ME+R+++   F+L+  +VL  +  +S NAE DAL   K+ L DPN  LQSWD      CT
Sbjct: 1   MERRLMIPCFFWLI--LVLDLVLRVSGNAEGDALSALKNSLADPNKVLQSWDATLVTPCT 58

Query: 58  WFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKL 117
           WFH+TCN + SVTRVDLGNA LSG+L  +LGQL NL+ LELY NN++G IP  LGNL +L
Sbjct: 59  WFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTEL 118

Query: 118 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
            SLDLY N  +G IP TL  LK+L++LRLNNNSLSG IP SLT + +L +LDLSNN L+G
Sbjct: 119 VSLDLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTG 178

Query: 178 PVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPV 237
            +P NGSFS FTPISF N          K         PP    P S  G N+   AI  
Sbjct: 179 DIPVNGSFSLFTPISFANT---------KLTPLPASPPPPISPTPPSPAGSNRITGAIAG 229

Query: 238 GVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGF 297
           GVA GAALLFAVP I  A+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D F
Sbjct: 230 GVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNF 289

Query: 298 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           SNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL
Sbjct: 290 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 349

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCD
Sbjct: 350 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 409

Query: 418 PKIIHRDVKAANILLDED 435
           PKIIHRDVKAANILLDE+
Sbjct: 410 PKIIHRDVKAANILLDEE 427

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  514 bits (1324), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 276/417 (66%), Positives = 314/417 (75%), Gaps = 14/417 (3%)

Query: 22  ISANAEVDALYIFKSKLQ--DP-NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAA 78
           ++ NAE DAL   K+ L   DP NN LQSWD      CTWFH+TCNPE  VTRVDLGNA 
Sbjct: 27  VAGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAK 86

Query: 79  LSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
           LSG+L PELGQL NL+ LELY NN++G IP  LG+L++L SLDLY+N  +G IP +L  L
Sbjct: 87  LSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKL 146

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
            +L++LRLNNNSLSG IP +LT++  L +LD+SNNRLSG +P NGSFS FTPISF NN  
Sbjct: 147 GKLRFLRLNNNSLSGEIPMTLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPISFANN-- 203

Query: 199 LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWR 258
                     +  P   P         P   +  AAI  GVA GAALLFAVP I FA+W 
Sbjct: 204 --------SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAWWL 255

Query: 259 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 318
           R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKVYKGRLAD
Sbjct: 256 RRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLAD 315

Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
           G LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGS
Sbjct: 316 GNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 375

Query: 379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           VAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANILLDE+
Sbjct: 376 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEE 432

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  436 bits (1122), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 247/417 (59%), Positives = 296/417 (70%), Gaps = 28/417 (6%)

Query: 22  ISANAEVDALYIFKSKL---QDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAA 78
           ++   +VDAL   +S L      NN LQSW+      C+WFH+TCN E SVTR+DLG+A 
Sbjct: 22  VTGKTQVDALIALRSSLSSGDHTNNILQSWNATHVTPCSWFHVTCNTENSVTRLDLGSAN 81

Query: 79  LSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
           LSGEL P+L QL NL+ LEL+ NN++G IP  LG+L++L SLDL++N  +G IP +L  L
Sbjct: 82  LSGELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKL 141

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
            +L++LRL NNSLSG IP SLT +  L++LD+SNNRLSG +P NGSFSQFT +SF NN  
Sbjct: 142 GKLRFLRLYNNSLSGEIPRSLTAL-PLDVLDISNNRLSGDIPVNGSFSQFTSMSFANN-- 198

Query: 199 LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWR 258
                               P   + SP  + ++AAI VGVA GAALLFA+         
Sbjct: 199 -----------------KLRPRPASPSPSPSGTSAAIVVGVAAGAALLFALAWW-----L 236

Query: 259 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 318
           R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKGRLAD
Sbjct: 237 RRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLAD 296

Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
             LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGS
Sbjct: 297 DTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 356

Query: 379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           VAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE+
Sbjct: 357 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEE 413

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  395 bits (1016), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 214/423 (50%), Positives = 281/423 (66%), Gaps = 28/423 (6%)

Query: 24  ANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGEL 83
            N EV AL   KS L DP+  L +WD+   + C+W  ITC+ +G V R++  +  LSG L
Sbjct: 39  VNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPSQNLSGTL 97

Query: 84  APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
           +  +G L NL+ + L  N ++G+IP  +G L+KLK+LDL +N F G IP TL+  K L+Y
Sbjct: 98  SSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQY 157

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 203
           LR+NNNSL+G IP+SL  +T L  LDLS N LSGPVP     S     +   N  +C   
Sbjct: 158 LRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTG 213

Query: 204 TKKPCSGSPPFSPPPPFGPTSSPGRNKSN--------AAIPVGVALGAALLFAVPVIGFA 255
           T+K C+G+ P     P   T +  +NKS+         A+  GV+L    L    +IGF 
Sbjct: 214 TEKDCNGTQP----KPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLL---IIGFG 266

Query: 256 Y---WRRTRPHE-FFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 311
           +   WRR    +  FFD+  ++  E+ LG L+RF+ +ELQ AT  FS+KN++G+GGFG V
Sbjct: 267 FLLWWRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNV 326

Query: 312 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
           YKG L DG ++AVKRLK+    GGE+QFQTE+++IS+AVHRNLLRLYGFCTT +E+LLVY
Sbjct: 327 YKGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVY 386

Query: 372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
           PYM+NGSVASRL+ +    P LDW TRK+IALG+ RGL YLHE CDPKIIHRDVKAANIL
Sbjct: 387 PYMSNGSVASRLKAK----PVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANIL 442

Query: 432 LDE 434
           LD+
Sbjct: 443 LDD 445

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  390 bits (1003), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 208/416 (50%), Positives = 267/416 (64%), Gaps = 13/416 (3%)

Query: 24  ANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGEL 83
            N EV AL   K+ L DP+  L +WD    + C+W  +TC+ E  V  +   +  LSG L
Sbjct: 38  VNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTL 97

Query: 84  APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
           +P +  L NL ++ L  NN+ G IP+ +G L +L++LDL  N F+G IP ++  L+ L+Y
Sbjct: 98  SPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQY 157

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 203
           LRLNNNSLSG+ P SL+ +T L  LDLS N LSGPVP    F+  T  S   N  +C   
Sbjct: 158 LRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTG 213

Query: 204 TKKPCSGSPPFSPPPPFGPTSSP----GRNKSNAAIPVGVALGAALLFAVPVIGFAYWRR 259
           T+  C+G+           T  P    G      AI VG ++G   L  + V  F +WR+
Sbjct: 214 TEPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQ 273

Query: 260 TRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 318
                 FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VYKG L D
Sbjct: 274 RHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGD 333

Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
             +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYPYM+NGS
Sbjct: 334 STVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGS 393

Query: 379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           VASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILLD+
Sbjct: 394 VASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  368 bits (944), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 208/434 (47%), Positives = 279/434 (64%), Gaps = 21/434 (4%)

Query: 7   VFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPE 66
           V  L+   V  +L     N EV+AL   K++L DP+   ++WD    + C+W  I+C+ +
Sbjct: 14  VLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSD 73

Query: 67  GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
             V  +   + +LSG L+  +G L NL  + L  NN+SG IP  + +L KL++LDL +N 
Sbjct: 74  NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNR 133

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
           F+G IP ++  L  L+YLRLNNNSLSG  P SL+ I  L+ LDLS N L GPVP      
Sbjct: 134 FSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP------ 187

Query: 187 QFTPISFENNLN--LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAA 244
           +F   +F    N  +C  +  + CSGS   SP       SS GR  +  A+ +GV+LG  
Sbjct: 188 KFPARTFNVAGNPLICKNSLPEICSGSISASPLS-VSLRSSSGRRTNILAVALGVSLG-- 244

Query: 245 LLFAVPVI---GFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNK 300
             FAV VI   GF ++R+ +       +   +++  L LG L+ F+ REL VATDGFS+K
Sbjct: 245 --FAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSK 302

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +ILG GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLLRL G+
Sbjct: 303 SILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGY 362

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
           C + +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE CDPKI
Sbjct: 363 CASSSERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQCDPKI 418

Query: 421 IHRDVKAANILLDE 434
           IHRDVKAANILLDE
Sbjct: 419 IHRDVKAANILLDE 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  361 bits (926), Expect = 6e-99,   Method: Compositional matrix adjust.
 Identities = 206/432 (47%), Positives = 280/432 (64%), Gaps = 17/432 (3%)

Query: 6   LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
            +F   ST+ L + P    N EV+AL   ++ L DP+ +L +WD    + C+W  ITC+P
Sbjct: 19  FLFLCFSTLTLSSEP---RNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSP 75

Query: 66  EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
           +  V  +   + +LSG L+  +G L NL  + L  NN+SG IP  LG L KL++LDL +N
Sbjct: 76  DNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNN 135

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
            F+G IP ++  L  L+YLRLNNNSLSG  P SL+ I  L+ LDLS N LSGPVP     
Sbjct: 136 RFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVP----- 190

Query: 186 SQFTPISFENNLN--LCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGA 243
            +F   +F    N  +C  N  + CSGS   + P     +SS GR  +  AI + V+LG+
Sbjct: 191 -KFPARTFNVAGNPLICRSNPPEICSGSIN-ASPLSVSLSSSSGRRSNRLAIALSVSLGS 248

Query: 244 ALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNI 302
            ++  + +  F ++R+ +      ++  + +  LQ LG L+ F+ REL V TDGFS+KNI
Sbjct: 249 VVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNI 308

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG GGFG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++IS+AVH+NLLRL G+C 
Sbjct: 309 LGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCA 368

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
           T  E+LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIH
Sbjct: 369 TSGERLLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAARGLLYLHEQCDPKIIH 424

Query: 423 RDVKAANILLDE 434
           RDVKAANILLDE
Sbjct: 425 RDVKAANILLDE 436

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  354 bits (909), Expect = 8e-97,   Method: Compositional matrix adjust.
 Identities = 214/431 (49%), Positives = 271/431 (62%), Gaps = 6/431 (1%)

Query: 6   LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
           LVF     I    L     N EV AL   K++L DP   L++WD    + C+W  ++C  
Sbjct: 14  LVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT- 72

Query: 66  EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
           +G V+ +DL + +LSG L+P +G L  L+ + L  N ++G IP  +G L KL+SLDL +N
Sbjct: 73  DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
            F G IP +L  LK L YLRLNNNSL G  P SL+ I  L ++D+S N LSG +P   S 
Sbjct: 133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLP-KVSA 191

Query: 186 SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 245
             F  I    N  +CGP     CS  P     P  GP  S  R   +       A  +A 
Sbjct: 192 RTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAA 248

Query: 246 LFAVPVIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILG 304
            F     G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+ AT+ F++KNILG
Sbjct: 249 FFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILG 308

Query: 305 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV 364
           RGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+HRNLLRL GFC++ 
Sbjct: 309 RGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSN 368

Query: 365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 424
            E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+ARGL YLHE CDPKIIHRD
Sbjct: 369 QERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRD 428

Query: 425 VKAANILLDED 435
           VKAANILLDED
Sbjct: 429 VKAANILLDED 439

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  349 bits (896), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 206/437 (47%), Positives = 268/437 (61%), Gaps = 16/437 (3%)

Query: 1   MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFH 60
           ++K  + F L+    L +   +S +A+ DAL+  +  L+   N L  W+    N CTW  
Sbjct: 6   LQKMAMAFTLLFFACLCSF--VSPDAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQ 63

Query: 61  ITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSL 120
           + C+ +  VT + L +   SG L+  +G L+NL+ L L GN ++G IP   GNL  L SL
Sbjct: 64  VICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSL 123

Query: 121 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           DL  N   G IP T+ NLK+L++L L+ N L+G IP SLT + +L  L L +N LSG +P
Sbjct: 124 DLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIP 183

Query: 181 DNGSFSQFTPISF-ENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGV 239
              S  +    +F  NNLN CG     PC  +   S     G +S P        I   V
Sbjct: 184 Q--SLFEIPKYNFTSNNLN-CGGRQPHPCVSAVAHS-----GDSSKP----KTGIIAGVV 231

Query: 240 ALGAALLFAVPVIGFAYWR-RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFS 298
           A    +LF + +  F   R +    + F DV  E D  +  GQLKRF+ RELQ+ATD FS
Sbjct: 232 AGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFS 291

Query: 299 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
            KN+LG+GGFGKVYKG L D   VAVKRL +  + GG+  FQ EV++IS+AVHRNLLRL 
Sbjct: 292 EKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLI 351

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           GFCTT TE+LLVYP+M N S+A RLRE ++  P LDW TRK+IALG+ARG  YLHEHC+P
Sbjct: 352 GFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNP 411

Query: 419 KIIHRDVKAANILLDED 435
           KIIHRDVKAAN+LLDED
Sbjct: 412 KIIHRDVKAANVLLDED 428

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	447
418204460	624	somatic embryogenesis receptor-like kina	0.973	0.697	0.740	1e-164
115475023	624	Os08g0174700 [Oryza sativa Japonica Grou	0.966	0.692	0.724	1e-163
359480709	624	PREDICTED: somatic embryogenesis recepto	0.973	0.697	0.740	1e-163
218200553	624	hypothetical protein OsI_28003 [Oryza sa	0.966	0.692	0.724	1e-163
400532041	624	somatic embryogenesis receptor-like kina	0.973	0.697	0.733	1e-162
357139703	615	PREDICTED: somatic embryogenesis recepto	0.926	0.673	0.748	1e-162
449462838	626	PREDICTED: somatic embryogenesis recepto	0.926	0.661	0.717	1e-161
38679443	624	benzothiadiazole-induced somatic embryog	0.966	0.692	0.719	1e-161
326497495	622	predicted protein [Hordeum vulgare subsp	0.926	0.665	0.736	1e-160
124303893	622	BRI1-associated receptor kinase 1 [Horde	0.926	0.665	0.736	1e-160

>gi|418204460|gb|AFX61784.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 325/439 (74%), Positives = 355/439 (80%), Gaps = 4/439 (0%)

Query: 1   MEKRVLVFYLVS-TIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWF 59
           M++ + V  L+   +V   L MISAN E DAL+  +S L+DPNN LQSWD    N CTWF
Sbjct: 1   MKREIAVCSLLWLVMVFHPLTMISANMEGDALHNLRSNLEDPNNVLQSWDPTLVNPCTWF 60

Query: 60  HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKS 119
           H+TCN E SV RVDLGNAALSG+L P+LGQLKNL+ LELY NN+SG IPS LGNL  L S
Sbjct: 61  HVTCNNENSVIRVDLGNAALSGQLVPQLGQLKNLQYLELYSNNMSGPIPSDLGNLTNLVS 120

Query: 120 LDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 179
           LDLY N F G IPDTL  L +L++ RLNNNSLSG IP SL  IT+L +LDLSNNRLSGPV
Sbjct: 121 LDLYLNGFTGPIPDTLGKLTKLRFFRLNNNSLSGSIPMSLINITALQVLDLSNNRLSGPV 180

Query: 180 PDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG---PTSSPGRNKSNAAIP 236
           PDNGSFS FTPISF NN NLCGP T KPC GSPPF+PPPPF      SSP  N +  AI 
Sbjct: 181 PDNGSFSLFTPISFANNFNLCGPVTGKPCPGSPPFAPPPPFVPPSTISSPSGNSATGAIA 240

Query: 237 VGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDG 296
            GVA GAALLFA P IGFA+WRR +PHE FFDVPAE+D E+ LGQLKRFSLRELQVATD 
Sbjct: 241 GGVAAGAALLFAAPAIGFAWWRRRKPHEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDT 300

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           L GFC T TE+LLVYPYM NGSVAS LRER  S  PLDWPTRK+IALGSARGLSYLH+HC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSEQPLDWPTRKRIALGSARGLSYLHDHC 420

Query: 417 DPKIIHRDVKAANILLDED 435
           DPKIIHRDVKAANILLDE+
Sbjct: 421 DPKIIHRDVKAANILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115475023|ref|NP_001061108.1| Os08g0174700 [Oryza sativa Japonica Group] gi|40253600|dbj|BAD05545.1| putative somatic embryogenesis receptor kinase 1 [Oryza sativa Japonica Group] gi|57753893|dbj|BAD86793.1| SERK-family receptor-like protein kinase [Oryza sativa Japonica Group] gi|113623077|dbj|BAF23022.1| Os08g0174700 [Oryza sativa Japonica Group] gi|215736920|dbj|BAG95849.1| unnamed protein product [Oryza sativa Japonica Group] gi|222639998|gb|EEE68130.1| hypothetical protein OsJ_26221 [Oryza sativa Japonica Group]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 315/435 (72%), Positives = 350/435 (80%), Gaps = 3/435 (0%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC 63
           R  V+ ++   +LV    + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TC
Sbjct: 5   RWAVWAVLLLRLLVPAARVLANMEGDALHSLRTNLVDPNNVLQSWDPTLVNPCTWFHVTC 64

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
           N + SV RVDLGNAALSG L P+LGQLKNL+ LELY NN+SG IPS LGNL  L SLDLY
Sbjct: 65  NNDNSVIRVDLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLY 124

Query: 124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 183
            N F G IPD+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  G
Sbjct: 125 LNNFTGPIPDSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTG 184

Query: 184 SFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVA 240
           SFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA
Sbjct: 185 SFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVA 244

Query: 241 LGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNK 300
            GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNK
Sbjct: 245 AGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNK 304

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           NILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GF
Sbjct: 305 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 364

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
           C T TE+LLVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKI
Sbjct: 365 CMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKI 424

Query: 421 IHRDVKAANILLDED 435
           IHRDVKAANILLDED
Sbjct: 425 IHRDVKAANILLDED 439

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480709|ref|XP_002276414.2| PREDICTED: somatic embryogenesis receptor kinase 1-like [Vitis vinifera] gi|147769566|emb|CAN65708.1| hypothetical protein VITISV_020732 [Vitis vinifera] gi|296082486|emb|CBI21491.3| unnamed protein product [Vitis vinifera]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 325/439 (74%), Positives = 356/439 (81%), Gaps = 4/439 (0%)

Query: 1   MEKRVLVFYLVSTIVLVA-LPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWF 59
           ME+ +   +LV  I+ V  L MI AN E DAL+  ++ L+DPNN LQSWD    N CTWF
Sbjct: 1   MEREIGASFLVWLILFVRPLTMIYANMEGDALHSLRTNLEDPNNVLQSWDPTLVNPCTWF 60

Query: 60  HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKS 119
           H+TCN E SV RVDLGNAALSG+L P+LGQLKNL+ LELY NN+SG IPS LGNL  L S
Sbjct: 61  HVTCNNENSVIRVDLGNAALSGQLVPQLGQLKNLQYLELYSNNISGQIPSDLGNLTSLVS 120

Query: 120 LDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 179
           LDLY N F G IPDTL  L +L++LRLNNNSLSG IP  LT I++L +LDLSNNRL+GPV
Sbjct: 121 LDLYLNRFTGAIPDTLGKLTKLRFLRLNNNSLSGSIPMFLTNISALQVLDLSNNRLAGPV 180

Query: 180 PDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG---PTSSPGRNKSNAAIP 236
           PDNGSFS FTPISF NNLNLCGP   KPC GSPPFSPPPPF      SSPG N +  AI 
Sbjct: 181 PDNGSFSLFTPISFANNLNLCGPVIGKPCPGSPPFSPPPPFVPPSTVSSPGGNSATGAIA 240

Query: 237 VGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDG 296
            GVA GAALLFA P IGFA+WRR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD 
Sbjct: 241 GGVAAGAALLFAAPAIGFAWWRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDS 300

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           L GFC T TE+LLVYPYM NGSVAS LRER  S PPLDW TRK+IALGSARGLSYLH+HC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSEPPLDWTTRKRIALGSARGLSYLHDHC 420

Query: 417 DPKIIHRDVKAANILLDED 435
           DPKIIHRDVKAANILLDE+
Sbjct: 421 DPKIIHRDVKAANILLDEE 439

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218200553|gb|EEC82980.1| hypothetical protein OsI_28003 [Oryza sativa Indica Group]

 Score =  580 bits (1495), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 315/435 (72%), Positives = 350/435 (80%), Gaps = 3/435 (0%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC 63
           R  V+ ++   +LV    + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TC
Sbjct: 5   RWAVWAVLLLRLLVPAARVLANMEGDALHSLRTNLVDPNNVLQSWDPTLVNPCTWFHVTC 64

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
           N + SV RVDLGNAALSG L P+LGQLKNL+ LELY NN+SG IPS LGNL  L SLDLY
Sbjct: 65  NNDNSVIRVDLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLY 124

Query: 124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 183
            N F G IPD+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP  G
Sbjct: 125 LNNFTGPIPDSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPSTG 184

Query: 184 SFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVA 240
           SFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA
Sbjct: 185 SFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVA 244

Query: 241 LGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNK 300
            GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNK
Sbjct: 245 AGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNK 304

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           NILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GF
Sbjct: 305 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 364

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
           C T TE+LLVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKI
Sbjct: 365 CMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKI 424

Query: 421 IHRDVKAANILLDED 435
           IHRDVKAANILLDED
Sbjct: 425 IHRDVKAANILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|400532041|gb|AFP87140.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  577 bits (1488), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 322/439 (73%), Positives = 353/439 (80%), Gaps = 4/439 (0%)

Query: 1   MEKRVLVFYLVS-TIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWF 59
           M++ + V  L+   +V   L MISAN E DAL+  +S L+DPNN LQSWD    N CTWF
Sbjct: 1   MKREIAVCSLLWLVMVFHPLTMISANMEGDALHNLRSNLEDPNNVLQSWDPTLVNPCTWF 60

Query: 60  HITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKS 119
           H+TCN E SV RVDL NAALSG+L P+LGQLKNL+ LELY NN+SG IPS LGNL  L S
Sbjct: 61  HVTCNNENSVIRVDLENAALSGQLVPQLGQLKNLQYLELYSNNMSGPIPSDLGNLTNLVS 120

Query: 120 LDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 179
           LDLY N F G IPDTL  L +L++ RLNNNSLSG IP SL  IT+L +LDLSNNRLSGPV
Sbjct: 121 LDLYLNGFTGPIPDTLGKLTKLRFFRLNNNSLSGSIPMSLINITALQVLDLSNNRLSGPV 180

Query: 180 PDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG---PTSSPGRNKSNAAIP 236
           PDNGSF+ FTPISF NN NLCGP T KPC GSPPF+PPPPF      SSP  N +  AI 
Sbjct: 181 PDNGSFTLFTPISFANNFNLCGPVTGKPCPGSPPFAPPPPFVPPSTISSPSGNSATGAIA 240

Query: 237 VGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDG 296
            GVA GAALLFA P IGFA+WRR +PHE FFDVPAE+D E+ LGQLKRFSLRELQVATD 
Sbjct: 241 GGVAAGAALLFAAPAIGFAWWRRRKPHEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDT 300

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           FSNKNILGRGGFGKVYKG LADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLR
Sbjct: 301 FSNKNILGRGGFGKVYKGCLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLR 360

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           L GFC T TE+LLVYPYM NGSVAS LRER  S  PLDWPTRK+IALGSARGLSYLH+HC
Sbjct: 361 LRGFCMTPTERLLVYPYMANGSVASCLRERPPSEQPLDWPTRKRIALGSARGLSYLHDHC 420

Query: 417 DPKIIHRDVKAANILLDED 435
           DPKIIHRDVKAANILLDE+
Sbjct: 421 DPKIIHRDVKAANILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357139703|ref|XP_003571417.1| PREDICTED: somatic embryogenesis receptor kinase 1-like, partial [Brachypodium distachyon]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 313/418 (74%), Positives = 341/418 (81%), Gaps = 4/418 (0%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN + SV RVDLGNAALSG
Sbjct: 13  VLANTEGDALHNLRTNLNDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALSG 72

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
            L P+LGQLKNL+ LELY NN+SG IPS LGNL  L SLDLY N F G IPD+L NL +L
Sbjct: 73  TLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIPDSLGNLLKL 132

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
           ++LRLNNNSLSG IP SLT IT+L +LDLSNN+LSG VP  GSFS FTPISF NN  LCG
Sbjct: 133 RFLRLNNNSLSGTIPKSLTAITALQVLDLSNNKLSGEVPSTGSFSSFTPISFGNNPALCG 192

Query: 202 PNTKKPCSGSPPFSPPPPFGP---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYW 257
           P T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFAVP IGFAYW
Sbjct: 193 PGTSKPCPGAPPFSPPPPYNPPTPVQSPGSSSSSTGAIAGGVAAGAALLFAVPAIGFAYW 252

Query: 258 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 317
           RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRL 
Sbjct: 253 RRRKPEEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNKNILGRGGFGKVYKGRLT 312

Query: 318 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 377
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 313 DGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 372

Query: 378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           SVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 373 SVASRLRERGPSEPPLDWQTRRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 430

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449462838|ref|XP_004149147.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus] gi|449521625|ref|XP_004167830.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus]

 Score =  576 bits (1484), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 299/417 (71%), Positives = 332/417 (79%), Gaps = 3/417 (0%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           +SA  E   L+IF+  L+DPNN LQSWD    N CTWFH+TCN E ++ RVDLGNA LSG
Sbjct: 25  VSATVEATVLHIFRLNLEDPNNVLQSWDPTLVNPCTWFHVTCNNENNIIRVDLGNAGLSG 84

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
           +L P+LGQLK+L+ LELYGNN+SG IP  LGNL  L SLDLY N   G IPDT   L QL
Sbjct: 85  KLVPQLGQLKSLQYLELYGNNISGEIPDDLGNLENLVSLDLYLNGLTGPIPDTFGKLTQL 144

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
           ++LRLN+N LSGLIP SL  I++L +LDLSNN LSG VP+NGSFS FTPISF NNL+LCG
Sbjct: 145 RFLRLNDNKLSGLIPISLINISTLQVLDLSNNLLSGKVPNNGSFSLFTPISFANNLDLCG 204

Query: 202 PNTKKPCSGSPPFSPPPPF---GPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWR 258
             T KPC G PPFSPPPPF      SS   N  N AI  GVA GAALLFA P I F YW 
Sbjct: 205 LVTGKPCPGDPPFSPPPPFVPQSTVSSHELNNPNGAIVGGVAAGAALLFATPAIIFVYWH 264

Query: 259 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 318
           R +  E FFDVPAE+DSE+ LGQLKRFSLR+LQVATD F NKNILGRGGFGKVY+GRLAD
Sbjct: 265 RRKSREIFFDVPAEEDSEINLGQLKRFSLRDLQVATDNFCNKNILGRGGFGKVYRGRLAD 324

Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
           G LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL+GFCTT +E+LLVYPYM NGS
Sbjct: 325 GSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLHGFCTTSSERLLVYPYMANGS 384

Query: 379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           VAS LRER  S  PLDWPTRKK+ALGSARGLSYLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 385 VASCLRERPQSEAPLDWPTRKKVALGSARGLSYLHDGCDPKIIHRDVKAANILLDEE 441

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38679443|gb|AAR26543.1| benzothiadiazole-induced somatic embryogenesis receptor kinase 1 [Oryza sativa Indica Group]

 Score =  574 bits (1480), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 313/435 (71%), Positives = 348/435 (80%), Gaps = 3/435 (0%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC 63
           R  V+ ++   +LV    + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TC
Sbjct: 5   RWAVWAVLLLRLLVPAARVLANMEGDALHSLRTNLVDPNNVLQSWDPTLVNPCTWFHVTC 64

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
           N + SV RVDLGNAALSG L P+LGQLKNL+ LELY NN+SG IPS LGNL  L SLDLY
Sbjct: 65  NNDNSVIRVDLGNAALSGTLVPQLGQLKNLQYLELYSNNISGTIPSELGNLTNLVSLDLY 124

Query: 124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG 183
            N F G IPD+L NL +L++LRLNNNSLSG IP SLT IT+L +LDLSNN LSG VP   
Sbjct: 125 LNNFTGPIPDSLGNLLKLRFLRLNNNSLSGSIPKSLTAITALQVLDLSNNNLSGEVPYKH 184

Query: 184 SFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSSPGRNKSNAAIPVGVA 240
            FS FTPISF NN +LCGP T KPC G+PPFSPPPP+ P     SPG + S  AI  GVA
Sbjct: 185 GFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYNPPTPVQSPGSSSSTGAIAGGVA 244

Query: 241 LGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNK 300
            GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSNK
Sbjct: 245 AGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNK 304

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           NILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GF
Sbjct: 305 NILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 364

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
           C T TE+LLVYPYM NGSVASRLRER  S PPLDW TR++IALGSARGLSYLH+HCDPKI
Sbjct: 365 CMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTRRRIALGSARGLSYLHDHCDPKI 424

Query: 421 IHRDVKAANILLDED 435
           IHRDVKAANILLDED
Sbjct: 425 IHRDVKAANILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326497495|dbj|BAK05837.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|332330747|gb|AEE44134.1| BRI1-associated kinase 1 [Hordeum vulgare subsp. vulgare]

 Score =  570 bits (1470), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 308/418 (73%), Positives = 340/418 (81%), Gaps = 4/418 (0%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN + SV RVDLGNAAL G
Sbjct: 20  VLANTEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALFG 79

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
            L P+LGQL+NL+ LELY NN+SG IPS LGNL  L SLDLY N F G IPD+L NL +L
Sbjct: 80  TLVPQLGQLRNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIPDSLGNLLKL 139

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
           ++LRLNNNSLSG IP SLT IT+L +LDLSNN+LSG VP  GSFS FTPISF NN  LCG
Sbjct: 140 RFLRLNNNSLSGTIPKSLTAITALQVLDLSNNKLSGEVPSTGSFSLFTPISFGNNPALCG 199

Query: 202 PNTKKPCSGSPPFSPPPPFGPT---SSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYW 257
           P T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA+P IGFAYW
Sbjct: 200 PGTSKPCPGAPPFSPPPPYNPPTPEQSPGSSSSSTGAIAGGVAAGAALLFAIPAIGFAYW 259

Query: 258 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 317
           RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSN+NILGRGGFGKVYKGRL 
Sbjct: 260 RRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNRNILGRGGFGKVYKGRLT 319

Query: 318 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 377
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 320 DGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 379

Query: 378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           SVASRLRER  + PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 380 SVASRLRERGPAEPPLDWQTRRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 437

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|124303893|gb|ABN05373.1| BRI1-associated receptor kinase 1 [Hordeum vulgare subsp. vulgare]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 308/418 (73%), Positives = 340/418 (81%), Gaps = 4/418 (0%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG 81
           + AN E DAL+  ++ L DPNN LQSWD    N CTWFH+TCN + SV RVDLGNAAL G
Sbjct: 20  VLANTEGDALHSLRTNLNDPNNVLQSWDPTLVNPCTWFHVTCNNDNSVIRVDLGNAALFG 79

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
            L P+LGQL+NL+ LELY NN+SG IPS LGNL  L SLDLY N F G IPD+L NL +L
Sbjct: 80  TLVPQLGQLRNLQYLELYSNNISGTIPSELGNLTNLVSLDLYLNNFTGPIPDSLGNLLKL 139

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
           ++LRLNNNSLSG IP SLT IT+L +LDLSNN+LSG VP  GSFS FTPISF NN  LCG
Sbjct: 140 RFLRLNNNSLSGTIPKSLTAITALQVLDLSNNKLSGEVPSTGSFSLFTPISFGNNPALCG 199

Query: 202 PNTKKPCSGSPPFSPPPPFGPT---SSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYW 257
           P T KPC G+PPFSPPPP+ P     SPG + S   AI  GVA GAALLFA+P IGFAYW
Sbjct: 200 PGTSKPCPGAPPFSPPPPYNPPTPEQSPGSSSSSTGAIAGGVAAGAALLFAIPAIGFAYW 259

Query: 258 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 317
           RR +P E FFDVPAE+D E+ LGQLKRFSLRELQVATD FSN+NILGRGGFGKVYKGRL 
Sbjct: 260 RRRKPQEHFFDVPAEEDPEVHLGQLKRFSLRELQVATDTFSNRNILGRGGFGKVYKGRLT 319

Query: 318 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 377
           DG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 320 DGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 379

Query: 378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           SVASRLRER  + PPLDW TR++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 380 SVASRLRERGPAEPPLDWQTRRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 437

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	447
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.411	0.294	0.847	8.8e-130
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.411	0.292	0.826	5e-125
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.411	0.296	0.798	4.7e-116
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.404	0.301	0.734	3.2e-100
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.950	0.672	0.436	6.4e-83
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.899	0.630	0.426	2e-79
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.384	0.280	0.668	8.4e-79
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.928	0.640	0.404	2.7e-75
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.935	0.659	0.393	2.2e-73
TAIR|locus:2171973	614	AT5G45780 [Arabidopsis thalian	0.894	0.651	0.417	1.2e-72

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 8.8e-130, Sum P(2) = 8.8e-130
 Identities = 156/184 (84%), Positives = 168/184 (91%)

Query:   252 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 311
             I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+DGFSNKNILGRGGFGKV
Sbjct:   257 IAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKV 316

Query:   312 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   317 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 376

Query:   372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
             PYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   377 PYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 436

Query:   432 LDED 435
             LDE+
Sbjct:   437 LDEE 440

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 5.0e-125, Sum P(2) = 5.0e-125
 Identities = 152/184 (82%), Positives = 164/184 (89%)

Query:   252 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 311
             + FA+WRR +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKV
Sbjct:   260 LAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 319

Query:   312 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   320 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 379

Query:   372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
             PYM NGSVAS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   380 PYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANIL 439

Query:   432 LDED 435
             LDE+
Sbjct:   440 LDEE 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 4.7e-116, Sum P(2) = 4.7e-116
 Identities = 147/184 (79%), Positives = 160/184 (86%)

Query:   252 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 311
             I FA+W R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKV
Sbjct:   249 IAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308

Query:   312 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368

Query:   372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
             PYM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANIL
Sbjct:   369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428

Query:   432 LDED 435
             LDE+
Sbjct:   429 LDEE 432

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 3.2e-100, Sum P(2) = 3.2e-100
 Identities = 133/181 (73%), Positives = 148/181 (81%)

Query:   255 AYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG 314
             A+W R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKG
Sbjct:   233 AWWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292

Query:   315 RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM 374
             RLAD  LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM
Sbjct:   293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352

Query:   375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE
Sbjct:   353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412

Query:   435 D 435
             +
Sbjct:   413 E 413

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 831 (297.6 bits), Expect = 6.4e-83, P = 6.4e-83
 Identities = 188/431 (43%), Positives = 235/431 (54%)

Query:     6 LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
             LVF     I    L     N EV AL   K++L DP   L++WD    + C+W  ++C  
Sbjct:    14 LVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT- 72

Query:    66 EGSVTRVDLGNAALSGELAPXXXXXXXXXXXXXXXXXXXXHIPSALGNLIKLKSLDLYSN 125
             +G V+ +DL + +LSG L+P                     IP  +G L KL+SLDL +N
Sbjct:    73 DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132

Query:   126 LFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVPDNGSF 185
              F G IP +L  LK L YLRLNNN                       N LSG +P   S 
Sbjct:   133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLP-KVSA 191

Query:   186 SQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXXXXXXX 245
               F  I    N  +CGP                         R   +             
Sbjct:   192 RTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESGTRTNGHHVALAFAASFSAA 248

Query:   246 XXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILG 304
                    G F +WR  R  + FFDV  + D E+ LG LKR++ +EL+ AT+ F++KNILG
Sbjct:   249 FFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILG 308

Query:   305 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV 364
             RGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ IS+A+HRNLLRL GFC++ 
Sbjct:   309 RGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSN 368

Query:   365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 424
              E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+ARGL YLHE CDPKIIHRD
Sbjct:   369 QERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRD 428

Query:   425 VKAANILLDED 435
             VKAANILLDED
Sbjct:   429 VKAANILLDED 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
 Identities = 177/415 (42%), Positives = 229/415 (55%)

Query:    25 NAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELA 84
             N EV AL   K+ L DP+  L +WD    + C+W  +TC+ E  V  +   +  LSG L+
Sbjct:    39 NFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSSENFVIGLGTPSQNLSGTLS 98

Query:    85 PXXXXXXXXXXXXXXXXXXXXHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             P                     IP+ +G L +L++LDL  N F+G IP ++  L+ L+YL
Sbjct:    99 PSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYL 158

Query:   145 RLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 204
             RLNNN                       N LSGPVP    F+  T  S   N  +C   T
Sbjct:   159 RLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTGT 214

Query:   205 K---KXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXXXXXXXXXXXXXIG-FAYWRRT 260
             +                          ++++                   +G F +WR+ 
Sbjct:   215 EPDCNGTTLIPMSMNLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQR 274

Query:   261 RPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADG 319
                  FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VYKG L D 
Sbjct:   275 HNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDS 334

Query:   320 KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV 379
              +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYPYM+NGSV
Sbjct:   335 TVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSV 394

Query:   380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             ASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILLD+
Sbjct:   395 ASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 8.4e-79, Sum P(2) = 8.4e-79
 Identities = 115/172 (66%), Positives = 136/172 (79%)

Query:   264 EFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVA 323
             + F DV  E D  +  GQLKRF+ RELQ+ATD FS KN+LG+GGFGKVYKG L D   VA
Sbjct:   257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316

Query:   324 VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL 383
             VKRL +  + GG+  FQ EV++IS+AVHRNLLRL GFCTT TE+LLVYP+M N S+A RL
Sbjct:   317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376

Query:   384 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             RE ++  P LDW TRK+IALG+ARG  YLHEHC+PKIIHRDVKAAN+LLDED
Sbjct:   377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDED 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 759 (272.2 bits), Expect = 2.7e-75, P = 2.7e-75
 Identities = 174/430 (40%), Positives = 233/430 (54%)

Query:     7 VFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPE 66
             +F   ST+ L + P    N EV+AL   ++ L DP+ +L +WD    + C+W  ITC+P+
Sbjct:    20 LFLCFSTLTLSSEPR---NPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCSPD 76

Query:    67 GSVTRVDLGNAALSGELAPXXXXXXXXXXXXXXXXXXXXHIPSALGNLIKLKSLDLYSNL 126
               V  +   + +LSG L+                      IP  LG L KL++LDL +N 
Sbjct:    77 NLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSNNR 136

Query:   127 FNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVPDNGSFS 186
             F+G IP ++  L  L+YLRLNNN                       N LSGPVP    F 
Sbjct:   137 FSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVP---KFP 193

Query:   187 QFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXXXXXXXX 246
               T  +   N  +C  N  +                     R  SN              
Sbjct:   194 ART-FNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRR--SNRLAIALSVSLGSVV 250

Query:   247 XXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILG 304
                  +G F ++R+ +      ++  + +  LQ LG L+ F+ REL V TDGFS+KNILG
Sbjct:   251 ILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILG 310

Query:   305 RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV 364
              GGFG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++IS+AVH+NLLRL G+C T 
Sbjct:   311 AGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATS 370

Query:   365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 424
              E+LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRD
Sbjct:   371 GERLLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRD 426

Query:   425 VKAANILLDE 434
             VKAANILLDE
Sbjct:   427 VKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
 Identities = 169/429 (39%), Positives = 232/429 (54%)

Query:     7 VFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPE 66
             V  L+   V  +L     N EV+AL   K++L DP+   ++WD    + C+W  I+C+ +
Sbjct:    14 VLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISCSSD 73

Query:    67 GSVTRVDLGNAALSGELAPXXXXXXXXXXXXXXXXXXXXHIPSALGNLIKLKSLDLYSNL 126
               V  +   + +LSG L+                      IP  + +L KL++LDL +N 
Sbjct:    74 NLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDLSNNR 133

Query:   127 FNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVPDNGSFS 186
             F+G IP ++  L  L+YLRLNNN                       N L GPVP    F 
Sbjct:   134 FSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVP---KFP 190

Query:   187 QFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXXXXXXXX 246
               T  +   N  +C  N+                       R ++N              
Sbjct:   191 ART-FNVAGNPLIC-KNSLPEICSGSISASPLSVSLRSSSGR-RTNILAVALGVSLGFAV 247

Query:   247 XXXXXIGFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGR 305
                  +GF ++R+ +       +   +++  L LG L+ F+ REL VATDGFS+K+ILG 
Sbjct:   248 SVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGA 307

Query:   306 GGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 365
             GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS+AVHRNLLRL G+C + +
Sbjct:   308 GGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSS 367

Query:   366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV 425
             E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+ARGL YLHE CDPKIIHRDV
Sbjct:   368 ERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDV 423

Query:   426 KAANILLDE 434
             KAANILLDE
Sbjct:   424 KAANILLDE 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
 Identities = 171/410 (41%), Positives = 216/410 (52%)

Query:    25 NAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELA 84
             N EV AL   K+K++D    L  WD    + CTW  + C+ EG V  +++ +  LSG L+
Sbjct:    37 NYEVAALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILS 96

Query:    85 PXXXXXXXXXXXXXXXXXXXXHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
                                   IPS LG L +L++LDL  N F+G IP +L  L  L YL
Sbjct:    97 TSIGELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYL 156

Query:   145 RLNNNXXXXXXXXXXXXXXXXXXXXXXNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 204
             RL+ N                       N LSGP P N S   +  +    N  LCGP +
Sbjct:   157 RLSRNLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTP-NISAKDYRIVG---NAFLCGPAS 212

Query:   205 KKXXXXXXXXXXXXXXXXXXXXXRNKSNXXXXXXXXXXXXXXXXXXXIGFAYWRRTRPHE 264
             ++                     ++ S                      +  W R+R   
Sbjct:   213 QELCSDATPVRNATGLSEKDNS-KHHSLVLSFAFGIVVAFIISLMFLFFWVLWHRSRLSR 271

Query:   265 FFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAV 324
                    + D E ++G LKRFS RE+Q AT  FS KNILG+GGFG VYKG L +G +VAV
Sbjct:   272 SH----VQQDYEFEIGHLKRFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAV 327

Query:   325 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 384
             KRLK+   +G E+QFQTEV++I +AVHRNLLRL+GFC T  E++LVYPYM NGSVA RLR
Sbjct:   328 KRLKDPIYTG-EVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLR 386

Query:   385 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             +     P LDW  R  IALG+ARGL YLHE C+PKIIHRDVKAANILLDE
Sbjct:   387 DNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009560 "embryo sac egg cell differentiation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q94AG2	SERK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7227	0.9731	0.696	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	447
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-30
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-30
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-24
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-20
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-16
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-12
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-10
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-10
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.001
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	0.001
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.003
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.004
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.004
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  126 bits (318), Expect = 6e-34
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG GGFG VY  R    GK VA+K +K+E +S    +   E++I+    H N+++LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
                  LV  Y   GS+   L+E +     L      +I L    GL YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 422 HRDVKAANILLDEDADQ 438
           HRD+K  NILLD D  +
Sbjct: 115 HRDLKPENILLDSDNGK 131

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  134 bits (338), Expect = 1e-33
 Identities = 110/372 (29%), Positives = 168/372 (45%), Gaps = 42/372 (11%)

Query: 71  RVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT 130
            +DL     SG +  +LG L  L  L+L  N LSG IP  L +  KL SLDL  N  +G 
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538

Query: 131 IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP 190
           IP + + +  L  L L+ N LSG IP +L  + SL  +++S+N L G +P  G+F     
Sbjct: 539 IPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINA 598

Query: 191 ISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVP 250
            +   N++LCG +T    SG P         P     +  S     +   LGA L+ A+ 
Sbjct: 599 SAVAGNIDLCGGDTT---SGLP---------PCKRVRKTPSWWFY-ITCTLGAFLVLALV 645

Query: 251 VIGFAYWRRTRPHEFFFDVPAEDDS-ELQLGQLKRFSLRELQVATDGFSNKNILGRGGFG 309
             GF + R     E    V  ED + ELQ    K      +         +N++ RG  G
Sbjct: 646 AFGFVFIRGRNNLE-LKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKG 704

Query: 310 KVYKGR-LADGKLVAVKRLKE-------ERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
             YKG+ + +G    VK + +       E    G+LQ            H N+++L G C
Sbjct: 705 ASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ------------HPNIVKLIGLC 752

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            +     L++ Y+   +++  LR        L W  R+KIA+G A+ L +LH  C P ++
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 422 HRDVKAANILLD 433
             ++    I++D
Sbjct: 806 VGNLSPEKIIID 817

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (320), Expect = 1e-33
 Identities = 49/143 (34%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 298 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
           +    LG G FG+VYKG+L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L G CT      +V  YM  G + S LR+ +  L           AL  ARG+ YL
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS---LSDLLSFALQIARGMEYL 118

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                   IHRD+ A N L+ E+
Sbjct: 119 ESK---NFIHRDLAARNCLVGEN 138

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (315), Expect = 5e-33
 Identities = 48/143 (33%), Positives = 67/143 (46%), Gaps = 10/143 (6%)

Query: 298 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
           +    LG G FG+VYKG L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L G CT     ++V  YM  G +   LR+ +     L        AL  ARG+ YL
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYL 119

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                   IHRD+ A N L+ E+
Sbjct: 120 ESK---NFIHRDLAARNCLVGEN 139

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  119 bits (301), Expect = 4e-31
 Identities = 47/140 (33%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +     LG G FGKVY  R    GKLVA+K +K+++      +   E+KI+    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           RLY       +  LV  Y   G +   L++R   L        +         L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSE---DEARFYLRQILSALEYLHSK 116

Query: 416 CDPKIIHRDVKAANILLDED 435
               I+HRD+K  NILLDED
Sbjct: 117 ---GIVHRDLKPENILLDED 133

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 6e-31
 Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 301 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
             LG G FG+VYKG+L         VAVK LKE+ +      F  E +++    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-----PLDWPTRKKIALGSARGLSY 411
           L G CT      LV  YM  G +   LR+ +   P      L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           L      K +HRD+ A N L+ ED
Sbjct: 121 LASK---KFVHRDLAARNCLVGED 141

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  118 bits (299), Expect = 1e-30
 Identities = 47/138 (34%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 303 LGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FG+VYKG L          VAVK LKE  +     +F  E  I+    H N++RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G CT      +V  YM  G +   LR+       L      ++AL  A+G+ YL     
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 418 PKIIHRDVKAANILLDED 435
              +HRD+ A N L+ E+
Sbjct: 122 -NFVHRDLAARNCLVTEN 138

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  117 bits (296), Expect = 2e-30
 Identities = 53/136 (38%), Positives = 66/136 (48%), Gaps = 9/136 (6%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
            LG G FG VYK +    GK+VAVK L K    S  +   + E++I+    H N++RL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
                    LV  Y   G +   L        PL     KKIAL   RGL YLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 420 IIHRDVKAANILLDED 435
           IIHRD+K  NILLDE+
Sbjct: 119 IIHRDLKPENILLDEN 134

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  107 bits (268), Expect = 1e-24
 Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 25/183 (13%)

Query: 21  MISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALS 80
           M+ A  E++ L  FKS + DP   L +W N   ++C W  ITCN    V  +DL    +S
Sbjct: 25  MLHAE-ELELLLSFKSSINDPLKYLSNW-NSSADVCLWQGITCNNSSRVVSIDLSGKNIS 82

Query: 81  GELAPELGQLKNLELLELYGNNLSGHIPSAL-----------------------GNLIKL 117
           G+++  + +L  ++ + L  N LSG IP  +                       G++  L
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNL 142

Query: 118 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
           ++LDL +N+ +G IP+ + +   LK L L  N L G IP SLT +TSL  L L++N+L G
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202

Query: 178 PVP 180
            +P
Sbjct: 203 QIP 205

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  101 bits (255), Expect = 1e-24
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 301 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 358
            +LGRG FG VY     D G+L+AVK ++    S  EL   + E++I+S   H N++R Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 359 GFCTTVTEK-LLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G      +  L ++  Y++ GS++S L ++   LP    P  +K       GL+YLH + 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPE---PVIRKYTRQILEGLAYLHSN- 120

Query: 417 DPKIIHRDVKAANILLDED 435
              I+HRD+K ANIL+D D
Sbjct: 121 --GIVHRDIKGANILVDSD 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (256), Expect = 3e-23
 Identities = 54/119 (45%), Positives = 74/119 (62%), Gaps = 3/119 (2%)

Query: 65  PEGSVT---RVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLD 121
           P GS+     +DL N  LSGE+  ++G   +L++L+L GN L G IP++L NL  L+ L 
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194

Query: 122 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           L SN   G IP  L  +K LK++ L  N+LSG IP  +  +TSLN LDL  N L+GP+P
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 5e-22
 Identities = 57/143 (39%), Positives = 83/143 (58%), Gaps = 2/143 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S+  +DL    L+G +   LG LKNL+ L LY N LSG IP ++ +L KL SLDL  N  
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFS 186
           +G IP+ +  L+ L+ L L +N+ +G IP +LT++  L +L L +N+ SG +P N G  +
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356

Query: 187 QFTPISFENNLNLCGPNTKKPCS 209
             T +    N NL G   +  CS
Sbjct: 357 NLTVLDLSTN-NLTGEIPEGLCS 378

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.0 bits (244), Expect = 1e-21
 Identities = 52/108 (48%), Positives = 68/108 (62%)

Query: 74  LGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD 133
           L +  L G++  ELGQ+K+L+ + L  NNLSG IP  +G L  L  LDL  N   G IP 
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254

Query: 134 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
           +L NLK L+YL L  N LSG IP S+ ++  L  LDLS+N LSG +P+
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 96.4 bits (240), Expect = 2e-21
 Identities = 71/253 (28%), Positives = 106/253 (41%), Gaps = 61/253 (24%)

Query: 27  EVDALYIFKSKLQDPNNSLQSWDNLPGNLCT-----WFHITCNPEGSVTR-----VDLGN 76
           EV AL   KS L  P      W+   G+ C      W    C  + +  +     + L N
Sbjct: 373 EVSALQTLKSSLGLP--LRFGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427

Query: 77  AALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLA 136
             L G +  ++ +L++L+ + L GN++ G+IP +LG++  L+ LDL  N FNG+IP++L 
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487

Query: 137 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
            L  L+ L LN NSLSG +P +L                 G    + +   FT     +N
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRASFNFT-----DN 525

Query: 197 LNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAY 256
             LCG    + C            GP  S           +G+A G ++ F   VI    
Sbjct: 526 AGLCGIPGLRAC------------GPHLS-------VGAKIGIAFGVSVAFLFLVICAMC 566

Query: 257 W--RR---TRPHE 264
           W  RR    R   
Sbjct: 567 WWKRRQNILRAQR 579

Length = 623

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.3 bits (237), Expect = 9e-21
 Identities = 49/107 (45%), Positives = 70/107 (65%)

Query: 74  LGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD 133
           LG   LSGE+  E+G L +L  L+L  NNL+G IPS+LGNL  L+ L LY N  +G IP 
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Query: 134 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           ++ +L++L  L L++NSLSG IP  +  + +L IL L +N  +G +P
Sbjct: 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 16/145 (11%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F     +G+GGFG+VYK R    GK VA+K +K E     E     E++I+    H N++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA---LGSARGLSY 411
           + YG      ++L +V  + + GS+   L+    +L      T  +IA       +GL Y
Sbjct: 61  KYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL------TESQIAYVCKELLKGLEY 113

Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           LH +    IIHRD+KAANILL  D 
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDG 135

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 354
           +   +++GRG FG VYKG  L  G  VA+K++  E+     L+    E+ ++    H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           ++  G   T     ++  Y  NGS+   + ++    P           L   +GL+YLHE
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVL---QGLAYLHE 117

Query: 415 HCDPKIIHRDVKAANILLDED 435
                +IHRD+KAANIL  +D
Sbjct: 118 Q---GVIHRDIKAANILTTKD 135

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 17/146 (11%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNL 354
           +     +G G +G+VYK R    G+LVA+K+++ E    G  +    E+K++    H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 355 LRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
           +RL      VT K      +V+ YM +  +   L   +           K        GL
Sbjct: 61  VRLKE---IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE---SQIKCYMKQLLEGL 113

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YLH +    I+HRD+K +NIL++ D
Sbjct: 114 QYLHSN---GILHRDIKGSNILINND 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 5e-18
 Identities = 47/109 (43%), Positives = 68/109 (62%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI 131
           +DL + +LSGE+   + QL+NLE+L L+ NN +G IP AL +L +L+ L L+SN F+G I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 132 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           P  L     L  L L+ N+L+G IP  L +  +L  L L +N L G +P
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 301 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++G G FG+V +GRL         VA+K LK   +    L F TE  I+    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           L G  T     +++  YM NGS+   LRE               +  G A G+ YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLSEMN 126

Query: 417 DPKIIHRDVKAANILLDED 435
               +HRD+ A NIL++ +
Sbjct: 127 ---YVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 19/152 (12%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+ G     +      LVAVK LKE  ++     F+ E ++++   H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIAL 403
           +++ YG CT     ++V+ YM +G +   LR        L  P             +IA+
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A G+ YL        +HRD+   N L+  D
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              +G+G FG V  G    G+ VAVK LK++  S     F  E  +++   H NL++L G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
                    +V  YM  GS+   LR R  ++  L    +   AL    G+ YL E     
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122

Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F     LG G +G VYK      G++VA+K +          +   E+ I+       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYL 412
           + YG     T+  +V  Y   GSV+  ++    +L      T ++IA     + +GL YL
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLKGLEYL 115

Query: 413 HEHCDPKIIHRDVKAANILLDEDAD 437
           H +   K IHRD+KA NILL+E+  
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQ 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 81.7 bits (200), Expect = 8e-17
 Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 9/146 (6%)

Query: 296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKII-SMAVHR 352
            +     LG G FG+VY  R  D KLVA+K L ++  S  +   +F  E++I+ S+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++LY F        LV  Y+  GS+   L++     P L       I       L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQ 438
           H      IIHRD+K  NILLD D   
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 10/135 (7%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G FG VYKG L     VAVK  +       + +F  E +I+    H N+++L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLHEHCDPKI 420
                 +V   +  GS+ + LR++++ L       +K  +++L +A G+ YL        
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRL-----TVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 421 IHRDVKAANILLDED 435
           IHRD+ A N L+ E+
Sbjct: 115 IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 56/178 (31%), Positives = 81/178 (45%), Gaps = 35/178 (19%)

Query: 293 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKII-SMAV 350
            T  F    ++G G +GKVYK R    G+LVA+K +        E++   E  I+   + 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK--EEYNILRKYSN 61

Query: 351 HRNLLRLYGF-----CTTVTEKL-LVYPYMTNGSV---ASRLRERQSSLPPLDWPTRKKI 401
           H N+   YG           ++L LV      GSV      LR++   L   +W     I
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW-----I 115

Query: 402 AL---GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
           A     + RGL+YLHE+   K+IHRD+K  NILL ++A+          Q   T+ RR
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 81.8 bits (202), Expect = 2e-16
 Identities = 41/99 (41%), Positives = 58/99 (58%)

Query: 79  LSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
            SGE+   LG+  NL +L+L  NNL+G IP  L +   L  L L+SN   G IP +L   
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
           + L+ +RL +NS SG +P+  T +  +  LD+SNN L G
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442

Length = 968

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 17/146 (11%)

Query: 303 LGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           LG+G FG VY+G LA G +       VA+K + E  +    ++F  E  ++      +++
Sbjct: 14  LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKI---ALGSARGL 409
           RL G  +T    L+V   M  G + S LR R+    + P L  PT +K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
           +YL      K +HRD+ A N ++ ED
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 4e-16
 Identities = 45/109 (41%), Positives = 61/109 (55%)

Query: 72  VDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI 131
           +DLG   L G++   L  L +LE L L  N L G IP  LG +  LK + L  N  +G I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228

Query: 132 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           P  +  L  L +L L  N+L+G IP+SL  + +L  L L  N+LSGP+P
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           F+ +  LG G FG+V++G   +   VA+K LK +     +  FQ EV+ +    H++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           L+  C+      ++   M  GS+ + LR  E Q     L   +   +A   A G++YL E
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEGMAYLEE 122

Query: 415 HCDPKIIHRDVKAANILLDED 435
                 IHRD+ A NIL+ ED
Sbjct: 123 Q---NSIHRDLAARNILVGED 140

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 77.1 bits (190), Expect = 8e-16
 Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKG--RLADGKL----VAVKRLKEERTSGGELQFQTEVK 344
           +V  D  +    LG G FG+VY+G  R  DG      VAVK L E  +   E  F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKI 401
           I+S   H+N++RL G       + ++   M  G + S LRE   R      L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           A   A+G  YL E+     IHRD+ A N LL
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 76.9 bits (190), Expect = 8e-16
 Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-F 360
           LG+G  G VYK R    GK+ A+K++  +       Q   E+K +       +++ YG F
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 361 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
                ++   +V  YM  GS+A  L+ +   +P    P    IA    +GL YLH     
Sbjct: 69  YKEGEIS---IVLEYMDGGSLADLLK-KVGKIPE---PVLAYIARQILKGLDYLHT--KR 119

Query: 419 KIIHRDVKAANILL 432
            IIHRD+K +N+L+
Sbjct: 120 HIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 21/143 (14%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 360
           +G+G FGKVY  R  +DGKL  +K +     S  E +    EVKI+    H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 361 CTTVTEKLL--VYPYMTNGSVASRLRERQSSLPP------LDWPTRKKIALGSARGLSYL 412
            +   +  L  V  Y   G ++ ++++++    P      LDW    ++ L     L YL
Sbjct: 67  -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H     KI+HRD+K  NI L  +
Sbjct: 120 HSR---KILHRDIKPQNIFLTSN 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLK---EERTSGGEL-QFQTEVKIISMAVHRNLLRL 357
           LG G FG VY+G  L DG   AVK +    + +T    + Q + E+ ++S   H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 358 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
            G      + L ++   +  GS+A  L++  S   P+     ++I LG    L YLH   
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--- 119

Query: 417 DPKIIHRDVKAANILLDED 435
           D   +HRD+K ANIL+D +
Sbjct: 120 DRNTVHRDIKGANILVDTN 138

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 12/137 (8%)

Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +LG+G FG+V+KG L D   VAVK  KE+     +++F +E +I+    H N+++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLH-EHCDP 418
           T      +V   +  G   S LR+++  L      T++  K AL +A G++YL  ++C  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDEL-----KTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 419 KIIHRDVKAANILLDED 435
             IHRD+ A N L+ E+
Sbjct: 115 --IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+VYK       ++VA+K +  E         Q E++ +S      + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           + YG       KL ++  Y   GS    L+        LD      I      GL YLHE
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 415 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
                 IHRD+KAANILL E+ D          Q + T+ +R
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 74.8 bits (185), Expect = 5e-15
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 15/144 (10%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT----EVKIISMAVH 351
           +     LG G +G VYK R    G++VA+K+++ +    G     +    E+ ++    H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N+++L     T  +  LV+ Y     +   L +R   L P      K I     RGL+Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP---NLIKSIMYQLLRGLAY 113

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
            H H   +I+HRD+K  NIL++ D
Sbjct: 114 CHSH---RILHRDLKPQNILINRD 134

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 8e-15
 Identities = 51/139 (36%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 358
           LG+G FGKV   R    GKL A+K LK+++           TE  I+S   H  +++L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHC 416
            F T   EKL LV  Y   G + S L  ++      +   R   A +  A  L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLS-KEGRFS--EERARFYAAEIVLA--LEYLHSL- 112

Query: 417 DPKIIHRDVKAANILLDED 435
              II+RD+K  NILLD D
Sbjct: 113 --GIIYRDLKPENILLDAD 129

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   + + VA+K ++E   S  E  F  E +++    H  L++LYG CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
             +   LV+ +M +G ++  LR ++         T   + L    G++YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 124 RDLAARNCLVGEN 136

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 13/137 (9%)

Query: 301 NILGRGGFGKVYKG-RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           N +G G FGKVY    L  G+L+AVK  R+++      + +   E+K++ +  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64

Query: 358 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           YG      EK+ ++  Y + G++   L   +     LD    +   L    GL+YLH H 
Sbjct: 65  YGV-EVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH- 118

Query: 417 DPKIIHRDVKAANILLD 433
              I+HRD+K ANI LD
Sbjct: 119 --GIVHRDIKPANIFLD 133

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 19/146 (13%)

Query: 301 NILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQ---FQTEVKIISMAVHR 352
             LG G FGKV   R        G+ VAVK L     SG E     F+ E++I+    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLDHE 66

Query: 353 NLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           N+++  G C     +   L+  Y+ +GS+   L+  +     ++       +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMD 123

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           YL      + IHRD+ A NIL++ + 
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESED 146

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 46/137 (33%), Positives = 64/137 (46%), Gaps = 16/137 (11%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V+ G+      VA+K ++E   S  E  F  E K++    H NL++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA----RGLSYLHEHCDP 418
                 +V  YM NG + + LRER+  L         +  L         + YL  +   
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKL-------GTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 419 KIIHRDVKAANILLDED 435
             IHRD+ A N L+ ED
Sbjct: 121 -FIHRDLAARNCLVGED 136

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 302 ILGRGGFGKVYKGR-LADG---KL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LG G FG VYKG  + +G   K+ VA+K L+EE +     +   E  +++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 413
           L G C +     L+   M  G +   +R  + ++     L+W       +  A+G+SYL 
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 414 EHCDPKIIHRDVKAANILL 432
           E    +++HRD+ A N+L+
Sbjct: 127 EK---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D       LG G  G V K      GK++AVK ++ E     + Q   E+ I+       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           ++  YG      +  +   YM  GS+   L+E Q  +P        KIA+   +GL+YLH
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE---RILGKIAVAVLKGLTYLH 117

Query: 414 EHCDPKIIHRDVKAANILLDE 434
           E    KIIHRDVK +NIL++ 
Sbjct: 118 E--KHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 303 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           +G+G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----QSSL--------------PPLDWPTR 398
           L G C       L++ YM  G +   LR R    Q SL               PL    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
             IA   A G++YL E    K +HRD+   N L+ E+ 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM 167

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 13/138 (9%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-----FQTEVKIISMAVHRNLL 355
            LG G F   Y+ R +  G L+AVK++   R +  E +      + E+++++   H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           R+ G     +   L   +M  GSV+  L    S                  RGLSYLHE+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 416 CDPKIIHRDVKAANILLD 433
              +IIHRDVK AN+L+D
Sbjct: 123 ---QIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY  C+
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 +V  YM+ GS+   L+  +     L  P    +A   A G++YL        IH
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 423 RDVKAANILLDE 434
           RD+ A NIL+ E
Sbjct: 127 RDLAARNILVGE 138

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 9/135 (6%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGF 360
           +G G  G V+K +    G+ VA+K++   R  GG   Q   E+K +    H  +++L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
               +  +LV  YM    ++  LR+ +  LP       K       +G++Y+H +    I
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE---AQVKSYMRMLLKGVAYMHAN---GI 120

Query: 421 IHRDVKAANILLDED 435
           +HRD+K AN+L+  D
Sbjct: 121 MHRDLKPANLLISAD 135

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 49/134 (36%), Positives = 63/134 (47%), Gaps = 10/134 (7%)

Query: 303 LGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G FG V +G    + GK+  VAVK LK ++ S     F  E  I+    H NL+RLY
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G   T     +V      GS+  RLR+    L      T    A+  A G+ YL      
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 419 KIIHRDVKAANILL 432
           + IHRD+ A NILL
Sbjct: 117 RFIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 21/150 (14%)

Query: 303 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FGKV+           D  LVAVK LKE  +      FQ E +++++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE-----------RQSSLPPLDWPTRKKIALGS 405
            YG CT     L+V+ YM +G +   LR               +   L       IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A G+ YL        +HRD+   N L+ + 
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQG 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 300 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G        VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           G CT      ++  +MT G++   LRE  +  +  +       +A   +  + YL +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKK-- 123

Query: 418 PKIIHRDVKAANILLDE 434
              IHRD+ A N L+ E
Sbjct: 124 -NFIHRDLAARNCLVGE 139

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 24/158 (15%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK R +A G+LVA+K +K E     E   Q E+ ++    H N++  +G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 418
               +  +V  Y   GS+    +  +  L  L      +IA     + +GL+YLHE    
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120

Query: 419 KIIHRDVKAANILLDEDAD----------QSSKTILRR 446
             IHRD+K ANILL ED D          Q + TI +R
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 13/142 (9%)

Query: 45  LQSWDN-----LPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELY 99
           LQ W N     +P NL            ++T +DL    L+GE+   L    NL  L L+
Sbjct: 337 LQLWSNKFSGEIPKNL--------GKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388

Query: 100 GNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
            N+L G IP +LG    L+ + L  N F+G +P     L  + +L ++NN+L G I +  
Sbjct: 389 SNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448

Query: 160 TTITSLNILDLSNNRLSGPVPD 181
             + SL +L L+ N+  G +PD
Sbjct: 449 WDMPSLQMLSLARNKFFGGLPD 470

Length = 968

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
            ++G G    VY    L + + VA+KR+  E+      + + EV+ +S   H N+++ Y 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGLSYLHEHCD 417
                 E  LV PY++ GS+   ++   SS P   LD      +     +GL YLH +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 418 PKIIHRDVKAANILLDEDAD 437
              IHRD+KA NILL ED  
Sbjct: 122 -GQIHRDIKAGNILLGEDGS 140

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 16/147 (10%)

Query: 302 ILGRGGFGKVYKGRLA--DGKL--VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 356
           ILG G FG V +G+L+  DG    VAVK +K +  +  E++ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 357 LYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 408
           L G C   +        +++ P+M +G + S L   +    P   P +   K  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           + YL        IHRD+ A N +L ED
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLRED 149

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 +V  YM+NG + + LRE      P       ++      G++YL      + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIH 123

Query: 423 RDVKAANILLDED 435
           RD+ A N L+D+ 
Sbjct: 124 RDLAARNCLVDDQ 136

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +GRG FG+V+ GRL AD   VAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKI 420
           T      +V   +  G   + LR   +  P L      ++   +A G+ YL  +HC    
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115

Query: 421 IHRDVKAANILLDE 434
           IHRD+ A N L+ E
Sbjct: 116 IHRDLAARNCLVTE 129

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 298 SNKNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           + + ++G G FG+V++G L   G+    VA+K LK   T      F +E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           ++RL G  T     +++  YM NG++   LR+              +   G A G+ YL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL- 123

Query: 414 EHCDPKIIHRDVKAANILLD 433
              D   +HRD+ A NIL++
Sbjct: 124 --SDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)

Query: 302 ILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++G G FG+V +GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G  T     +++  +M NG++ S LR+       +       +  G A G+ YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM-- 125

Query: 418 PKIIHRDVKAANILLDED 435
              +HRD+ A NIL++ +
Sbjct: 126 -NYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 27/153 (17%)

Query: 303 LGRGGFGKVYKGRL---ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FGKVYKG L    +      VA+K LKE      + +F+ E +++S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 357 LYGFCTTVTEKLLVYPYMTNGSV---------------ASRLRERQSSLPPLDWPTRKKI 401
           L G CT      +++ Y+ +G +                S     +SSL   D+     I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LHI 129

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           A+  A G+ YL  H     +HRD+ A N L+ E
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 14/138 (10%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLR 356
           +LG+G FG+VY     D G+ +AVK++  +     T       + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 357 LYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            YG C    E L ++  YM  GSV  +L+    +   L     +K       G+ YLH +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 416 CDPKIIHRDVKAANILLD 433
               I+HRD+K ANIL D
Sbjct: 124 ---MIVHRDIKGANILRD 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 10/147 (6%)

Query: 51  LPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSA 110
           +P  LC+         G++ ++ L + +L GE+   LG  ++L  + L  N+ SG +PS 
Sbjct: 372 IPEGLCS--------SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423

Query: 111 LGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL 170
              L  +  LD+ +N   G I     ++  L+ L L  N   G +P S  +   L  LDL
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDL 482

Query: 171 SNNRLSGPVPDN-GSFSQFTPISFENN 196
           S N+ SG VP   GS S+   +    N
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSEN 509

Length = 968

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 42/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V++G   +   VAVK LK       +  F  E +I+    H  L++LY  CT
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 +V   M  GS+   L+        L  P    +A   A G++YL        IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 423 RDVKAANILLDE 434
           RD+ A N+L+ E
Sbjct: 127 RDLAARNVLVGE 138

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKR--LKEERTSGGELQF---QTEVKIISMAVHRNLL 355
            +LG+G +G VY G    G+L+AVK+  L        E ++   Q EV ++    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +  G C       +   ++  GS++S L        PL  P   K       G++YLH +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 416 CDPKIIHRDVKAANILL 432
           C   ++HRD+K  N++L
Sbjct: 122 C---VVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 25/150 (16%)

Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + N   +G G  G+VYK    A GK VA+K+++  + +  +     E+ I+    H N++
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIV 78

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVA-------SRLRERQSSLPPLDWPTRKKIALGSAR 407
             Y     V ++L +V  YM  GS+         R+ E Q +           +     +
Sbjct: 79  DYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA----------YVCREVLQ 127

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           GL YLH      +IHRD+K+ NILL +D  
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGS 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           LG G FGKVYK +  + G   A K ++ E  S  EL+ F  E+ I+S   H N++ LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE- 69

Query: 361 CTTVTE-KLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
                E KL +   +   G++ S + E +     L  P  + +       L++LH H   
Sbjct: 70  -AYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 419 KIIHRDVKAANILLDEDAD 437
           K+IHRD+KA NILL  D D
Sbjct: 123 KVIHRDLKAGNILLTLDGD 141

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 302 ILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNL 354
            LG G FG+V K              VAVK LK++ T        +E++++ M   H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-------LDWPTRKKI------ 401
           + L G CT      +V  Y  +G++   LR R+   PP          P  + +      
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR---PPGEYASPDDPRPPEETLTQKDLV 135

Query: 402 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A   ARG+ +L      K IHRD+ A N+L+ ED
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 302 ILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            LG G FGKV K         A    VAVK LKE  +S       +E  ++    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKIAL 403
           +LYG C+     LL+  Y   GS+ S LRE +   P             LD P  + + +
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 404 GS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           G         +RG+ YL E    K++HRD+ A N+L+ E
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE 162

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 358
           +G G +G V K R  A G++VA+K+ KE      E   +T   EVK++    H N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLK 66

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
                     LV+ Y+   ++   L      LPP      +       + ++Y H H   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSH--- 119

Query: 419 KIIHRDVKAANILLDED 435
            IIHRD+K  NIL+ E 
Sbjct: 120 NIIHRDIKPENILVSES 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 301 NILGRGGFGKVYKGRLAD------GKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           N LG G FG+VY+G   D      G + VAVK L++  T   + +F  E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPP--LDWPTRKKIALGSARGLS 410
           +++L G C     + ++   M  G + S LR+ R     P  L       I L  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 443
           YL        IHRD+ A N L+ E    + + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 302 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            LGRG FG+V+  +           LV VK L++ +    + +F+ E+ +     H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 356 RLYGFCTTVTEKLLVYPYMTNGS-----VASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           RL G C       ++  Y   G       A++ ++ +   PPL    +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           +L      + +HRD+ A N L+
Sbjct: 132 HLSNA---RFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 17/144 (11%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGG---ELQ------FQTEVKIISMAVH 351
           ++G+G +G+VY       G+++AVK+++   T  G     Q       ++E++ +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N+++  GF TT     +   Y+  GS+ S LR         +    +        GL+Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAY 123

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      I+HRD+KA N+L+D D
Sbjct: 124 LHSK---GILHRDLKADNLLVDAD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 35/150 (23%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRL-- 357
           LG G FG+VYK R +  G++VA+K++    E+  G  +    E+KI+    H N++ L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74

Query: 358 --YGFCTTVTEKL----LVYPYM--------TNGSVASRLRERQSSLPPLDWPTRKKIAL 403
                      K     +V PYM         N SV  +L E Q           K   L
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQI----------KCYML 122

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLD 433
               G++YLHE+    I+HRD+KAANIL+D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILID 149

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 16/136 (11%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V+ G+      VA+K + E   S  E  F  E K++    H  L++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDP 418
                 +V  +M NG + + LR+RQ  L        K + L   +    G+ YL  +   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKL-------SKDMLLSMCQDVCEGMEYLERN--- 119

Query: 419 KIIHRDVKAANILLDE 434
             IHRD+ A N L+  
Sbjct: 120 SFIHRDLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 25/163 (15%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 359
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 360 FCTTVT------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                +      +  LV  +   GSV   ++  + +    DW     I     RGL++LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138

Query: 414 EHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
            H   K+IHRD+K  N+LL E+A+          Q  +T+ RR
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 17/142 (11%)

Query: 301 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++G+G FG VY G L D        AVK L          QF  E  I+    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 357 LYGFC-TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 412
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114

Query: 413 HEHCDPKIIHRDVKAANILLDE 434
                 K +HRD+ A N +LDE
Sbjct: 115 ASK---KFVHRDLAARNCMLDE 133

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 5e-11
 Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 15/144 (10%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 359
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 360 FCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    + ++L LV  +   GSV   ++  + +    +W     I     RGLS+LH
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128

Query: 414 EHCDPKIIHRDVKAANILLDEDAD 437
           +H   K+IHRD+K  N+LL E+A+
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAE 149

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +   G+V + + E +    PL  P  + +   +   L+YLHE+   KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 423 RDVKAANILLDEDAD----------QSSKTILRR 446
           RD+KA NIL   D D          ++++TI RR
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 12/135 (8%)

Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           I+G G FG V +G    G+ VAVK +K + T+     F  E  +++   H+NL+RL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-- 66

Query: 362 TTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
             +   L +V   M+ G++ + LR R  +L  +      + +L  A G+ YL      K+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KL 121

Query: 421 IHRDVKAANILLDED 435
           +HRD+ A NIL+ ED
Sbjct: 122 VHRDLAARNILVSED 136

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 302 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM--------AVHR 352
           I+G G F  V   +     K  A+K L + +     L  + +VK + +          H 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-----LIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 353 NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            +++LY +     E L  V  Y  NG +   +R+  S    LD    +  A      L Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEY 117

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      IIHRD+K  NILLD+D
Sbjct: 118 LHSK---GIIHRDLKPENILLDKD 138

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 9/137 (6%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G G +G VYK R    G++VA+K++K    + G       E+K++    H N+++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
                +  LV+ +M +  +   +++RQ  LP       K       +GL++ H H    I
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPE---SLIKSYLYQLLQGLAFCHSH---GI 119

Query: 421 IHRDVKAANILLDEDAD 437
           +HRD+K  N+L++ +  
Sbjct: 120 LHRDLKPENLLINTEGV 136

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 47/135 (34%), Positives = 69/135 (51%), Gaps = 14/135 (10%)

Query: 303 LGRGGFGKVYKG--RLADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G FG V KG   +  GK   VAVK LK+E  + G+ +F  E  +++   H  ++RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           G C    E L LV      G +   L++R+  +P  D    K++A   A G++YL     
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRR-EIPVSDL---KELAHQVAMGMAYLESK-- 114

Query: 418 PKIIHRDVKAANILL 432
              +HRD+ A N+LL
Sbjct: 115 -HFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 18/149 (12%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 352
           +     + LG G  G V K RL +  ++   +         +LQ Q   E++I       
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59

Query: 353 NLLRLYGFCTTVTEKLL--VYPYMTNGSVAS---RLRER--QSSLPPLDWPTRKKIALGS 405
            +++ YG     +   +     Y   GS+ S   ++++R  +     L      KIA   
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESV 114

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
            +GLSYLH     KIIHRD+K +NILL  
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 15/140 (10%)

Query: 303 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV            G++VAVK LK E        ++ E+ I+    H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G C+    K   L+  Y+  GS+   L + + +L  L        A     G++YLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 416 CDPKIIHRDVKAANILLDED 435
                IHRD+ A N+LLD D
Sbjct: 127 ---HYIHRDLAARNVLLDND 143

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 296 GFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRN 353
            F     LG+G +G VYK  RL+D +  A+K +     S  E      E++I++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 354 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  Y        KL +V  Y   G ++  + +R+     +      +I +   RGL  L
Sbjct: 61  IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 413 HEHCDPKIIHRDVKAANILL 432
           HE    KI+HRD+K+ANILL
Sbjct: 120 HEQ---KILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 14/135 (10%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGF 360
           LG G FG VY  R    G+LVA+K++K++  S  E     EVK +  +  H N+++L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 361 CTTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                E      V+ YM  G++   +++R+    P      + I     +GL+++H+H  
Sbjct: 65  -EVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 418 PKIIHRDVKAANILL 432
               HRD+K  N+L+
Sbjct: 119 -GFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 45/138 (32%), Positives = 66/138 (47%), Gaps = 10/138 (7%)

Query: 302 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G  T     ++V  YM NGS+ + LR+       +       +  G A G+ YL    D
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL---SD 124

Query: 418 PKIIHRDVKAANILLDED 435
              +HRD+ A NIL++ +
Sbjct: 125 MGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 10/121 (8%)

Query: 321 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 380
           LVAVK L+ + +      F  EVKI+S     N+ RL G CT      ++  YM NG + 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 381 SRLRERQ-------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
             L++          +   L + T   +A   A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164

Query: 434 E 434
           +
Sbjct: 165 K 165

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)

Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNL 354
           F   N +G+G FG V+K  R AD ++ A+K++   + +  E +    E ++++      +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 355 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD--WPTRKKIALGSARGLSY 411
           +R Y        KL +V  Y  NG +   L+ ++    P D  W    +  +    GL++
Sbjct: 62  IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH     KI+HRD+K+ N+ LD  
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAY 137

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQ---FQT 341
           + ++ D  +  ++L  G FG+++ G L D K      V VK +K+  +   E+Q      
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQ 57

Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP---- 396
           E  ++    H+N+L +   C    E   V YPYM  G++   L+  Q  L   + P    
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQALS 115

Query: 397 TRKKIALGS--ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           T++ + +    A G+SYLH+     +IH+D+ A N ++DE+
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 35/146 (23%), Positives = 58/146 (39%), Gaps = 16/146 (10%)

Query: 301 NILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLY 358
             +G+G FG V K  R +DGK++  K +     +  E  Q  +EV I+    H N++R Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 359 GFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSY 411
                      +Y  M          +  + ++ +  +     W    +I       L  
Sbjct: 66  DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120

Query: 412 LH--EHCDPKIIHRDVKAANILLDED 435
            H        ++HRD+K ANI LD +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 40/138 (28%), Positives = 58/138 (42%), Gaps = 7/138 (5%)

Query: 303 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           +G G FGKV  G    G   A   VK L+   T   +L F  EV+      H N+L+  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIALGSARGLSYLHEHCDP 418
            C      LLV  +   G + + LR  +  +  +      +++A   A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 419 KIIHRDVKAANILLDEDA 436
             IH D+   N  L  D 
Sbjct: 120 DFIHSDLALRNCQLTADL 137

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 303 LGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           +G G FGKV  G +  G     V VK L+   +   +++F  E +      H NLL+  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
            CT VT  LLV  +   G +   LR  R++ L   D  T +++A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 419 KIIHRDVKAANILLDED 435
             IH D+   N LL  D
Sbjct: 120 NFIHSDLALRNCLLTAD 136

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 24/144 (16%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVH 351
           LG G +  VYK R    G++VA+K++K                 E++   E+K      H
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N++ L       +   LV+ +M    +   ++++   L P D    K   L + RGL Y
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH +    I+HRD+K  N+L+  D
Sbjct: 118 LHSN---WILHRDLKPNNLLIASD 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
            +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G  
Sbjct: 13  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG-- 66

Query: 362 TTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
             V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 419 KIIHRDVKAANILLDED 435
             +HRD+ A N+L+ ED
Sbjct: 122 NFVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 9/142 (6%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           R YG     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120

Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              + IHRD+KAAN+LL E  D
Sbjct: 121 ---RKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 12/144 (8%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 352
           F++   +G G FG VY  R +   ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHP 75

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N +   G         LV  Y   GS AS + E      PL       I  G+ +GL+YL
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCL-GS-ASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131

Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H     IHRD+KA NILL E  
Sbjct: 132 HSHE---RIHRDIKAGNILLTEPG 152

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 26/146 (17%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHR 352
             +G G +G VYK R L  G+ VA+K+++   +  G       E+     +K +    H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQLESFEHP 61

Query: 353 NLLRLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGS 405
           N++RL   C            LV+ +     V   L    S  P   L   T K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANIL 431
            RG+ +LH H    I+HRD+K  NIL
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VA+K LK+   S     F  E  ++    H  L+RLY    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE--AFLAEANLMKQLQHPRLVRLYA--- 68

Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            VT++   ++  YM NGS+   L+  +     L       +A   A G++++        
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 421 IHRDVKAANILLDE 434
           IHRD++AANIL+ E
Sbjct: 124 IHRDLRAANILVSE 137

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 358
           LG+GGFG+V   ++   GK+ A K+L ++R     GE     E KI+     R ++ L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
            F  T  +  LV   M  G +  +        P          A     GL +LH+    
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 419 KIIHRDVKAANILLDED 435
           +I++RD+K  N+LLD+ 
Sbjct: 115 RIVYRDLKPENVLLDDH 131

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 303 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 358
           LG G FG V +G+L        VAVK +K    +  E++ F +E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 359 GFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLS 410
           G C    E       +++ P+M +G + S L   +    P   PT+   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL        IHRD+ A N +L+E+
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNEN 148

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNL 354
           F   N +G G +G VY+ R    G++VA+K+++ +    G  +    E+ ++    H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 355 LRLYGFCT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           + L        +    LV  Y     +AS L    +   P      K + L   RGL YL
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQYL 124

Query: 413 HEHCDPKIIHRDVKAANILL 432
           HE+    IIHRD+K +N+LL
Sbjct: 125 HENF---IIHRDLKVSNLLL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 300 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 355
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGS-------- 405
            L G C       L   Y  +G++   LR+ +   + P           L S        
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 406 --ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGEN 160

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LG+G FG+VY    AD G+ +AVK+++       TS      + E++++   +H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 357 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
            YG      E+ L     +M  GS+  +L+    S   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124

Query: 415 HCDPKIIHRDVKAANILLD 433
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM  GS+   L+  +     +  P     +   A G++Y+        IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIERK---NYIH 126

Query: 423 RDVKAANILLDE 434
           RD++AAN+L+ E
Sbjct: 127 RDLRAANVLVSE 138

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 6/134 (4%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G +  VYKGR    G++VA+K +  +   G       E+ ++    H N++RL+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            T  + +LV+ YM       +  +       LD  T K       +G+++ HE+   +++
Sbjct: 68  HTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 422 HRDVKAANILLDED 435
           HRD+K  N+L+++ 
Sbjct: 123 HRDLKPQNLLINKR 136

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRL----KEERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LGRG FG+VY    AD G+ +AVK++      + TS      + E++++    H  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 357 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
            YG      EK L     YM  GS+  +L+    +   L     ++      +G+SYLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 415 HCDPKIIHRDVKAANILLD 433
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 15/138 (10%)

Query: 302 ILGRGGFGKVYK-GRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           ++GRG FG V+   R AD KLV +K++  E+ T    L  Q E +++ +  H N++  Y 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 415
                   ++V  Y   G++A  +++R +SL      L +  +  +AL       ++H  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120

Query: 416 CDPKIIHRDVKAANILLD 433
               I+HRD+K  NILLD
Sbjct: 121 ---LILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 8/139 (5%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRL-Y 358
           LG+GGFG+V   ++ A GKL A K+L ++R     G      E +I++    R ++ L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
            F  T T+  LV   M  G +   +       P    P           GL +LH+    
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 419 KIIHRDVKAANILLDEDAD 437
           +II+RD+K  N+LLD D +
Sbjct: 117 RIIYRDLKPENVLLDNDGN 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 302 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 413
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 414 EHCDPKIIHRDVKAANILL 432
           E    +++HRD+ A N+L+
Sbjct: 127 ER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)

Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 120

Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGE 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 13/144 (9%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           + + YG     T+  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118

Query: 414 EHCDPKIIHRDVKAANILLDEDAD 437
                K IHRD+KAAN+LL E  D
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)

Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 347
           E +   D    + +LG+G +G VY  R L+    +A+K +  ER S        E+ + S
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHS 60

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              HRN+++  G  +      +    +  GS+++ LR +   L   +  T          
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYTKQILE 119

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLD 433
           GL YLH++   +I+HRD+K  N+L++
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T + L+   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL E    +++HRD+ A N+L+
Sbjct: 122 MNYLEER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 30/146 (20%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 359
           +GRG FG V K      G ++AVKR++       + +   ++ ++  +     +++ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 360 --------FC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
                    C        +K   Y Y     + S + E              KIA+ + +
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE---VLKSVIPEEILG----------KIAVATVK 118

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLD 433
            L+YL E  + KIIHRDVK +NILLD
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLD 142

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEV 343
           +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTRKK 400
            ++      +++RL G  +     L++   MT G + S LR  +  +   P    P+ KK
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 401 ---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRL 357
           ++GRG +G VY+G+ +  G++VA+K +  +         Q EV ++S        N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           YG         ++  Y   GSV + ++       P+       I       L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV-- 120

Query: 418 PKIIHRDVKAANILL 432
             +IHRD+KAANIL+
Sbjct: 121 -GVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKR----LKEERTSGGELQFQTEVKIISMA 349
           D +     +G G +GKVYK R    GKLVA+K+    + EE      L+   E+ ++ M 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQML 57

Query: 350 VHRN-LLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 401
                ++RL        E+        LV+ Y+ +          +    PL   T K  
Sbjct: 58  SESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                +G+++ H+H    ++HRD+K  N+L+D+ 
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQ 146

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 24/154 (15%)

Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRN 353
           LG G FG+V         K R      VAVK LK+  T        +E++++  +  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKI 401
           ++ L G CT      ++  Y   G++   LR R+   P             L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      + IHRD+ A N+L+ ED
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
              +  ++  +   G+V + + E    L     P  + I       L YLH     KIIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---KIIH 133

Query: 423 RDVKAANILLDEDAD----------QSSKTILRR 446
           RD+KA N+LL  D D          ++ KT+ RR
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)

Query: 302 ILGRGGFGKVYKG-RLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAV--HRNL 354
           +LG G FG V+KG  + +G      VA+K + ++R+     Q  T+  +++M    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITD-HMLAMGSLDHAYI 71

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSY 411
           +RL G C   + +L V      GS+   +R+ + SL P   L+W       +  A+G+ Y
Sbjct: 72  VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           L EH    ++HR++ A NILL  D
Sbjct: 125 LEEHR---MVHRNLAARNILLKSD 145

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 21/148 (14%)

Query: 303 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKI---ALGSAR 407
           L G  +     L+V   M +G + S LR      E     PP   PT +++   A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
           G++YL+     K +HRD+ A N ++  D
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHD 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 300 KNILGRGGFGKVYKGRLADG----------------KLVAVKRLKEERTSGGELQFQTEV 343
           K  LG G FG+V+    A+G                 LVAVK L+ + T      F  E+
Sbjct: 10  KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--------SSLPPLDW 395
           KI+S   + N++RL G C +     ++  YM NG +   L +R+        +++P +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
                +A+  A G+ YL        +HRD+   N L+ 
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
             +G+G FG+V+K R     ++VA+K+ L E    G  +    E+KI+ +  H N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 359 GFCTTVTEKLLVYPYMTNGSVAS-------------RLRERQSSLPPLDWPTRKKIALGS 405
             C T            N    S              L    +          KK+    
Sbjct: 78  EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLL--SNKNVKFTLSEIKKVMKML 128

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             GL Y+H +   KI+HRD+KAANIL+ +D
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKD 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)

Query: 303 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA---VHRNLLR 356
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 357 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125

Query: 412 LHEHCDPKIIHRDVKAANILL 432
           LH H   +++HRD+K  NIL+
Sbjct: 126 LHSH---RVVHRDLKPQNILV 143

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 287 LRELQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           L  L   TD +     +G+G +GKVYK     DG L AVK L        E++ +  + +
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72

Query: 346 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
            S+  H N+++ YG      + +     LV      GSV   ++        LD      
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           I  G+  GL +LH +   +IIHRDVK  NILL
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILL 161

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 302 ILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LG G FG VYKG    DG+     VA+K L+E  +     +   E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLH 413
           L G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 414 EHCDPKIIHRDVKAANILL 432
           E    +++HRD+ A N+L+
Sbjct: 127 E---VRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 12/142 (8%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 352
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N ++  G         LV  Y   GS +  L   +  L  ++      +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131

Query: 413 HEHCDPKIIHRDVKAANILLDE 434
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 44/145 (30%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 296 GFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQ-FQTEVKIISMAVHR 352
            F    ++G+G FGKV   +  D K + A+K + K++    G ++    E +I+    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 353 NLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
            L+ L Y F     E + LV   +  G     LR   S          K         L 
Sbjct: 61  FLVNLWYSFQDE--ENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YLH      IIHRD+K  NILLDE 
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQ 136

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 303 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG   FGK+YKG L        +LVA+K LK+        +FQ E  +++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRER----------------QSSLPPLDWPTRKKI 401
            G  T      +++ Y+  G +   L  R                +SSL   D+     I
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---LHI 129

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           A+  A G+ YL  H     +H+D+ A NIL+ E
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 22/144 (15%)

Query: 302 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ----------FQTEVKIISMAV 350
           ++G G FG VY G  A  G+L+AVK++  E  S                  E+ ++    
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV--ELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 351 HRNLLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
           H N+++  G  +   + L ++  Y+  GSVA+ L    +    L     ++I     +GL
Sbjct: 65  HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119

Query: 410 SYLHEHCDPKIIHRDVKAANILLD 433
           +YLH      IIHRD+K ANIL+D
Sbjct: 120 NYLHNR---GIIHRDIKGANILVD 140

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 28/156 (17%)

Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK++ T        +E++++ M   H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-----------TRKKI- 401
           ++ L G CT      ++  Y + G++   LR R+   P +D+            T K + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137

Query: 402 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 49.5 bits (119), Expect = 3e-08
 Identities = 23/60 (38%), Positives = 31/60 (51%)

Query: 116 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
            LKSLDL +N            L  LK L L+ N+L+ + P + + + SL  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 41/161 (25%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV------------------- 343
           LG+G F K++KG            ++ E    GEL  +TEV                   
Sbjct: 3   LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49

Query: 344 -KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 402
             ++S   H++L+  YG C    E ++V  Y+  GS+ + L++ ++ +    W       
Sbjct: 50  ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102

Query: 403 LGSARGLSY-LHEHCDPKIIHRDVKAANILLDEDADQSSKT 442
           L  A+ L++ LH   D  + H +V A N+LL  + D+ +  
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 300 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 404
           +++ YG C      ++V+ YM +G +   LR              P +    +   IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            A G+ YL        +HRD+   N L+ E+
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGEN 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 14/139 (10%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 356
           +LG+G FG+VY     D G+ +A K+++       TS      + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 357 LYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
            YG      EK L     YM  GSV  +L+    +   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124

Query: 415 HCDPKIIHRDVKAANILLD 433
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 6/142 (4%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV 350
              F  +  +G+G F  VYK   L DG++VA+K+++  E   +        E+ ++    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++         E  +V      G ++  ++  +     +   T  K  +     L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           ++H     +I+HRD+K AN+ +
Sbjct: 121 HMHSK---RIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.6 bits (128), Expect = 6e-08
 Identities = 52/162 (32%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 280 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG 335
           G LK   + EL    D    F++   +G G FG VY  R     ++VA+K++        
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66

Query: 336 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 392
           E ++Q    EVK +    H N +   G         LV  Y   GS +  L   +    P
Sbjct: 67  E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 121

Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           L       I  G+ +GL+YLH H    +IHRD+KA NILL E
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 68

Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 124 VHRDLRAANILVGEN 138

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 10/138 (7%)

Query: 302 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ILG G FG++ +G L    K    VA+  L+   +      F  E   +    H N++RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G  T     ++V  YM+NG++ S LR+ +  L          +  G A G+ YL E   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYLSEM-- 126

Query: 418 PKIIHRDVKAANILLDED 435
              +H+ + A  +L++ D
Sbjct: 127 -GYVHKGLAAHKVLVNSD 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 27/155 (17%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKIISMAVH 351
           D F     +G G +G+VYK R  D G+LVA+K  RL  E+  G  +    E+KI+    H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65

Query: 352 RNLLRLYGFCTTVTEK-------------LLVYPYMTNGSVASRLRERQSSLPPLDWPTR 398
           RN++ L      VT+K              LV+ YM +  +   L E  S L        
Sbjct: 66  RNIVNL---KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLE--SGLVHFSEDHI 118

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           K        GL+Y H       +HRD+K +NILL+
Sbjct: 119 KSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 14/141 (9%)

Query: 302 ILGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 354
            LG G FGKV +        +D  + VAVK LK    S       +E+KI+S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-H 413
           + L G CT     L++  Y   G + + LR ++ S   L        +   A+G+++L  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLAS 159

Query: 414 EHCDPKIIHRDVKAANILLDE 434
           ++C    IHRD+ A N+LL  
Sbjct: 160 KNC----IHRDLAARNVLLTH 176

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 22/145 (15%)

Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 356
           LG+G FG V   R   L D  G++VAVK+L+        L+ F+ E++I+    H N+++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 357 LYGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSY 411
             G C +   +   LV  Y+  GS+   L   RER      LD       A    +G+ Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEY 123

Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           L      + +HRD+   NIL++ + 
Sbjct: 124 LGSK---RYVHRDLATRNILVESEN 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 12/136 (8%)

Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHRNLLRLY 358
           +G G FG VY    +   ++VAVK++        E ++Q    EVK +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G         LV  Y   GS +  L   +    PL       I  G+ +GL+YLH H   
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 419 KIIHRDVKAANILLDE 434
            +IHRD+KA NILL E
Sbjct: 142 -MIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 354
           +G G +G VYK R    G++VA+K+++ E    G       E+    E+       H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKIALGSARGLSYL 412
           +RL     +  +  LV+ ++        L++   S P   LD P  K       +G++Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD-----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H H   +++HRD+K  N+L+D +
Sbjct: 116 HSH---RVLHRDLKPQNLLIDRE 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 305 RGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFC 361
           RG FGKVY GR   + KL AVK +K+       +  Q Q E   ++++    ++ LY   
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            +     LV  Y+  G V S L          D     K     A  L YLH H    II
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRH---GII 126

Query: 422 HRDVKAANILL 432
           HRD+K  N+L+
Sbjct: 127 HRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 4/107 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
             +DL    LS +L   L  L NL  L+L GN +S  +P  +  L  L+ LDL +N    
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII- 222

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            +  +L+NLK L  L L+NN L   +P S+  +++L  LDLSNN++S
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268

Length = 394

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK R L  G+L AVK +K E      L  Q E+ ++    H N++  +G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            +  +  +   Y   GS    L++      PL       +   + +GL+YLH       +
Sbjct: 76  LSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 422 HRDVKAANILLDEDAD 437
           HRD+K ANILL ++ D
Sbjct: 129 HRDIKGANILLTDNGD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +     LG G +  VYKG+   +GKLVA+K ++ +   G       E  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYL 412
           ++ L+    T     LV+ Y     V + L +     P    P   K+ L    RGLSY+
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 413 HEHCDPKIIHRDVKAANILLDEDAD 437
           H+     I+HRD+K  N+L+ +  +
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGE 141

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 25/125 (20%)

Query: 319 GKLVAVKRL---KEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 375
           G+ VAVK++   K++R    EL F  EV I+    H N++ +Y       E  +V  ++ 
Sbjct: 44  GRQVAVKKMDLRKQQRR---ELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99

Query: 376 NGSV-----ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI 430
            G++      +R+ E Q +           + L   + LS+LH      +IHRD+K+ +I
Sbjct: 100 GGALTDIVTHTRMNEEQIA----------TVCLAVLKALSFLHAQ---GVIHRDIKSDSI 146

Query: 431 LLDED 435
           LL  D
Sbjct: 147 LLTSD 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLP--PLDWPTRKKI 401
           ++ L G CT      ++  Y + G++   LR R+          + +P   + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 358
           LG+G +G VYK      G  +A   +KE R    E +F     E+ I+  AV   ++  Y
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G         +   YM  GS+  +L     +   +     ++I     +GL +L E  + 
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 419 KIIHRDVKAANILLD 433
            IIHRDVK  N+L++
Sbjct: 123 NIIHRDVKPTNVLVN 137

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 359
           LGRG +G V K R +  G ++AVKR++    S  + +   ++ I   +V     +  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 360 --------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
                    C  V +  L   Y        ++ ++  ++P        KIA+   + L Y
Sbjct: 69  LFREGDVWICMEVMDTSLDKFY-------KKVYDKGLTIPE---DILGKIAVSIVKALEY 118

Query: 412 LHEHCDPKIIHRDVKAANILLDE 434
           LH      +IHRDVK +N+L++ 
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINR 139

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 45/149 (30%), Positives = 64/149 (42%), Gaps = 32/149 (21%)

Query: 302 ILGRGGFGKV----YKGRLADGKLVAVKRLKEERTSGGELQFQTEVK----------IIS 347
           +LGRG FGKV    YK     G+L A+K LK+     G++  + EV+            +
Sbjct: 6   VLGRGHFGKVLLAEYKK---TGELYAIKALKK-----GDIIARDEVESLMCEKRIFETAN 57

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-ALGSA 406
              H  L+ L+    T      V  Y   G +   +     S P      R    A    
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVV 111

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
            GL YLHE+   KI++RD+K  N+LLD +
Sbjct: 112 LGLQYLHEN---KIVYRDLKLDNLLLDTE 137

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 12/137 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 359
           + +G +G+V+  +  + G + A+K +K+          Q  TE  I+S A    +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 360 FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           +     + L LV  Y+  G +AS L     ++  LD    +         L YLH +   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 419 KIIHRDVKAANILLDED 435
            IIHRD+K  NIL+D +
Sbjct: 113 GIIHRDLKPDNILIDSN 129

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYA--- 68

Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 123

Query: 421 IHRDVKAANILL 432
           IHRD+++ANIL+
Sbjct: 124 IHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 24/152 (15%)

Query: 300 KNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+           D  LVAVK LK+   +  +  FQ E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-------------RQSSLPPLDWPTRKK 400
           +++ YG C      ++V+ YM +G +   LR              RQ+    L       
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK-GELGLSQMLH 127

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           IA   A G+ YL        +HRD+   N L+
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLV 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 9/137 (6%)

Query: 302 ILGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 358
           +LG+G FG+  +Y+ R  D  LV  K +   R S  E +    E+ I+S+  H N++  Y
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
                    L+   Y   G++  ++  ++  L   +        + SA  +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120

Query: 419 KIIHRDVKAANILLDED 435
            I+HRD+K  NI L + 
Sbjct: 121 GILHRDIKTLNIFLTKA 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 303 LGRGGFGKVYKGRL-------ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRN 353
           LG+G F  +YKG L         G    V  + +   S     L F     ++S   H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           L++LYG C    E ++V  Y+  G +   L  R+ +   L W  +  +A   A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 414 EHCDPKIIHRDVKAANILLDEDADQSS 440
           +    K++H +V   NIL+        
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEG 142

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRN 353
           + N  ++G G +G V K +  + G++VA+K+    E+     ++  + E++++    H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           L+ L           LV+ ++ +    + L + +     LD    +K      RG+ + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 414 EHCDPKIIHRDVKAANILL 432
            H    IIHRD+K  NIL+
Sbjct: 118 SH---NIIHRDIKPENILV 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 33/138 (23%), Positives = 68/138 (49%), Gaps = 11/138 (7%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 360
           +G G +G V+K +  +  ++VA+KR++ +    G       E+ ++    H+N++RLY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSYLHEHCDPK 419
             +  +  LV+ Y         L++   S    +D    K       +GL++ H H    
Sbjct: 68  LHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 420 IIHRDVKAANILLDEDAD 437
           ++HRD+K  N+L++++ +
Sbjct: 120 VLHRDLKPQNLLINKNGE 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 33/184 (17%)

Query: 275 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY--------KGRLADGKLVAVKR 326
           SE +L +  R+     +V  D       LG G FG+V         K +      VAVK 
Sbjct: 3   SEYELPEDPRW-----EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM 57

Query: 327 LKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 385
           LK + T        +E++++ M   H+N++ L G CT      ++  Y + G++   LR 
Sbjct: 58  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 386 RQSSLPPLDW---PTRKKIALGS-----------ARGLSYLHEHCDPKIIHRDVKAANIL 431
           R+   P +++   PT+      S           ARG+ YL      K IHRD+ A N+L
Sbjct: 118 RRP--PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL 172

Query: 432 LDED 435
           + ED
Sbjct: 173 VTED 176

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 21/141 (14%)

Query: 300 KNILGRGGFGKVYKG---RLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
              +G G FG VY+G      + K+ VAVK  K   +     +F  E  I+    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 356 RLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           +L G  T      V E   + P    G + S L+  + SL      +    +   +  L+
Sbjct: 71  KLIGVITENPVWIVME---LAPL---GELRSYLQVNKYSLDLA---SLILYSYQLSTALA 121

Query: 411 YLHEHCDPKIIHRDVKAANIL 431
           YL      + +HRD+ A N+L
Sbjct: 122 YLESK---RFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G +  V+KGR      LVA+K ++ E   G       EV ++    H N++ L+   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 420
            T     LV+ Y+      S L++   +   L      KI +    RGLSY H+    KI
Sbjct: 73  HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 421 IHRDVKAANILLDEDAD 437
           +HRD+K  N+L++E  +
Sbjct: 125 LHRDLKPQNLLINEKGE 141

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 20/142 (14%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEV---KIISMAVHRNLLRL 357
           +G G +G VYK R    G  VA+K ++ +    G  L    EV   K +    H N++RL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 358 YGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARGLS 410
              C T      T+  LV+ +     V   LR     +PP   P  T K +     RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           +LH +C   I+HRD+K  NIL+
Sbjct: 123 FLHANC---IVHRDLKPENILV 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)

Query: 297 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 351
           F+   +LG+G FG V + +L       + VAVK LK +  S  ++ +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 352 RNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSLPPLDWPTRKK 400
            N+++L G       K      +++ P+M +G +      SR+ E   +LP     T  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP---LQTLVR 117

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             +  A G+ YL        IHRD+ A N +L+E+
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN 149

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 45.8 bits (109), Expect = 5e-07
 Identities = 17/42 (40%), Positives = 25/42 (59%), Gaps = 1/42 (2%)

Query: 24 ANAEVDALYIFKSKLQ-DPNNSLQSWDNLPGNLCTWFHITCN 64
           N + DAL  FKS L  DP+ +L SW+    + C+W  +TC+
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 41/171 (23%)

Query: 300 KNILGRGGFGKVY--------------------KGRLADGKLVAVKRLKEERTSGGELQF 339
           K  LG G FG+V+                    KGR     LVAVK L+ +        F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66

Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------ 387
             EVKI+S     N++RL G C       ++  YM NG +   L                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 388 ---SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                LP + + +   +AL  A G+ YL        +HRD+   N L+ E+
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGEN 174

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 19/141 (13%)

Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 360
                    + K +     LVAVK++  +  S  +L+  Q E+       H N+L  Y  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66

Query: 361 CTTVTEKL-LVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIAL---GSARGLSYLH-E 414
              V  +L +V P M  GS    L+      LP L       IA         L Y+H +
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK 120

Query: 415 HCDPKIIHRDVKAANILLDED 435
                 IHR VKA++ILL  D
Sbjct: 121 GF----IHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 50.7 bits (121), Expect = 7e-07
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 302 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 353
           +LG+G FGKV   RL   G+L AVK LK++      LQ        TE +I+S+A  H  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57

Query: 354 LLRLYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           L +LY  C    ++L  V  ++  G +   +++ +      D    +  A      L +L
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFL 112

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H   D  II+RD+K  N+LLD +
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 5/133 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++  +DL    +S +L PE+  L  LE L+L  N++   + S+L NL  L  L+L +N  
Sbjct: 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
              +P+++ NL  L+ L L+NN +S    +SL ++T+L  LDLS N LS  +P       
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 188 FTPISFENNLNLC 200
              +     L L 
Sbjct: 302 LLELLLNLLLTLK 314

Length = 394

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 31/168 (18%)

Query: 280 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ 338
           GQ     L +L+   +       +G G  G+VYK R    G ++AVK+++  RT   E  
Sbjct: 7   GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKE-- 55

Query: 339 FQTEVKIISMAV------HR--NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 390
              E K I M +      H    +++ YG+  T ++  +    M   +   +L +R    
Sbjct: 56  ---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGP 110

Query: 391 PPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD 437
            P D     K+ +   + L YL E H    +IHRDVK +NILLD   +
Sbjct: 111 IPED--ILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGN 153

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 12/137 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H N+++L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHCDP 418
             T  +  LV+ ++        L++   + P    P    K       +GL++ H H   
Sbjct: 68  IHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119

Query: 419 KIIHRDVKAANILLDED 435
           +++HRD+K  N+L++ +
Sbjct: 120 RVLHRDLKPQNLLINTE 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 51/147 (34%), Positives = 69/147 (46%), Gaps = 29/147 (19%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL----- 355
           ++G+G FGKV   +  ADGK  AVK L+++      +  + E K I MA  RN+L     
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKK-----AILKKKEQKHI-MA-ERNVLLKNVK 54

Query: 356 ------RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                   Y F T   +KL  V  Y+  G +   L +R+ S P    P  +  A   A  
Sbjct: 55  HPFLVGLHYSFQTA--DKLYFVLDYVNGGELFFHL-QRERSFPE---PRARFYAAEIASA 108

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           L YLH      II+RD+K  NILLD  
Sbjct: 109 LGYLHSL---NIIYRDLKPENILLDSQ 132

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 17/142 (11%)

Query: 303 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLL 355
           LG G FGKV   R        G+ VAVK LK E  SGG      + E++I+    H N++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIV 69

Query: 356 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           +  G CT        L+  ++ +GS+   L   ++    ++   + K A+   +G+ YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 414 EHCDPKIIHRDVKAANILLDED 435
                + +HRD+ A N+L++ +
Sbjct: 127 SR---QYVHRDLAARNVLVESE 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK          F  E +I+    H  L+ LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYA--- 68

Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  +M  GS+   L+E       L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 421 IHRDVKAANILLDED 435
           IHRD++AANIL+ ++
Sbjct: 124 IHRDLRAANILVGDN 138

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 27/157 (17%)

Query: 300 KNILGRGGFGKVY------------KGRLADGK-----LVAVKRLKEERTSGGELQFQTE 342
           K  LG G FG+V+            K    D       LVAVK L+E+        F  E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV---ASRLRER----QSSLPPLDW 395
           +KI+S     N++RL   C T     ++  YM NG +    SR   +    ++ +  + +
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
            T   +A   A G+ YL        +HRD+   N L+
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 12/144 (8%)

Query: 304 GRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA---VHRNLLRL 357
           GRG +G+VYK +     DGK  A+K+ K ++     +  Q+  + I++     H N++ L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67

Query: 358 YGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
                   +K   L++ Y  +         RQ+    +     K +      G+ YLH +
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 416 CDPKIIHRDVKAANILLDEDADQS 439
               ++HRD+K ANIL+  +  + 
Sbjct: 128 W---VLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 16/138 (11%)

Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 359
           LG GGFG+V   ++    +  A+K +K+        Q    +E +I+    H  +++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 360 FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
              T  +K  +Y    Y   G + + LR+R       D  T +           YLH   
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR- 112

Query: 417 DPKIIHRDVKAANILLDE 434
              II+RD+K  N+LLD 
Sbjct: 113 --GIIYRDLKPENLLLDS 128

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 303 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           LG G +  VYKGR  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
             T     LV+ Y+ +  +   L +  +S   ++    K       RGL+Y H     K+
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 421 IHRDVKAANILLDEDAD 437
           +HRD+K  N+L++E  +
Sbjct: 126 LHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 11/166 (6%)

Query: 11  VSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVT 70
           +S ++ + L   S  + +D      + L  P+  L     L  N+            ++T
Sbjct: 66  LSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLN-RLRSNI-----SELLELTNLT 119

Query: 71  RVDLGNAALSGELAPELGQLK-NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
            +DL N  ++ ++ P +G LK NL+ L+L  N +   +PS L NL  LK+LDL  N  + 
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
            +P  L+NL  L  L L+ N +S  +P  +  +++L  LDLSNN +
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 12/138 (8%)

Query: 303 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           LG G +  V+KGR  L +  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHCDPK 419
             T     LV+ Y+        L++       +      KI L    RGL+Y H     K
Sbjct: 73  VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 420 IIHRDVKAANILLDEDAD 437
           ++HRD+K  N+L++E  +
Sbjct: 125 VLHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.5 bits (114), Expect = 5e-06
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 21/143 (14%)

Query: 300 KNILGRGGFGKVY----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           K I G+  FGKV     K      KL   K +K +  +  E      V  + M  + N +
Sbjct: 23  KLIDGK--FGKVSVLKHKP---TQKLFVQKIIKAKNFNAIEPM----VHQL-MKDNPNFI 72

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +LY   TT+   +L+  Y+ +G +   L++       L     KKI       L+ LH+H
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 416 CDPKIIHRDVKAANILLDEDADQ 438
               IIH D+K  N+L D   D+
Sbjct: 129 ---NIIHNDIKLENVLYDRAKDR 148

Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 10/134 (7%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G +  VYKGR    G+LVA+K ++ E   G       E  ++    H N++ L+   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 420
            T     LV+ Y+      + L++              ++ L    RGL+Y H+    ++
Sbjct: 73  HTKKTLTLVFEYLD-----TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 421 IHRDVKAANILLDE 434
           +HRD+K  N+L+ E
Sbjct: 125 LHRDLKPQNLLISE 138

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 8/98 (8%)

Query: 303 LGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FGKV +       + A  + VAVK LKE  T+       TE+KI I +  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   Y   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 47.6 bits (114), Expect = 6e-06
 Identities = 37/146 (25%), Positives = 71/146 (48%), Gaps = 19/146 (13%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           D +   N +  G +G VY+ R    G++VA+K+LK E+   G  +    E+ I+    H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 353 NLLRL----YGFCTTVTEKLLVYPYMTNG--SVASRLRERQSSLPPLDWPTRKKIALGSA 406
           N++ +     G  + + +  +V  Y+ +   S+   ++       P      K + L   
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMK------QPFLQSEVKCLMLQLL 116

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILL 432
            G+++LH++    I+HRD+K +N+LL
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKIISMA-VHRNLLR 356
           +LG+G FGKV    L    +L AVK LK++   +    E    TE +++++A  H  L +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLTQ 60

Query: 357 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           L       T+  L  V  Y+  G +   ++         D P  +  A     GL +LHE
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHE 114

Query: 415 HCDPKIIHRDVKAANILLDED 435
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDSE 132

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT----EVKIISMAVHRNLLRL 357
           +G G +G V+K R  + G++VA+K+  E   S  +   +     E++++    H NL+ L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                   +  LV+ Y  + +V + L +    +P       KKI   + + +++ H+H  
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEH---LIKKIIWQTLQAVNFCHKH-- 119

Query: 418 PKIIHRDVKAANILL 432
              IHRDVK  NIL+
Sbjct: 120 -NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 7e-06
 Identities = 21/60 (35%), Positives = 29/60 (48%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
           NL+ L+L  N L+     A   L  LK LDL  N      P+  + L  L+ L L+ N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 47.5 bits (114), Expect = 7e-06
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 45/163 (27%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 346
           +     +G G +G V        G+ VA+K++           F           E+K++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53

Query: 347 SMAVHRNLLRLYGFCT-TVTEKL----LVYPYM-TNGSVASRLRERQSSLPPLDWPTRKK 400
               H N++ L         E      +V   M T+  +   ++  Q    PL   T   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQ----PL---TDDH 104

Query: 401 I------ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           I       L   RGL YLH      +IHRD+K +NIL++ + D
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCD 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 29/149 (19%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL---QFQTEVKIISMAVHRNLLRL 357
           ++G+GG G+VY        + VA+K+++E+  S   L   +F  E KI +  +H  ++ +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 358 YGFCTTVTEKLLVY---PYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG--LS 410
           Y  C+   +   VY   PY+   ++ S L+   ++ SL        K++A  ++ G  LS
Sbjct: 68  YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-------KELAEKTSVGAFLS 117

Query: 411 YLHEHC-------DPKIIHRDVKAANILL 432
             H+ C          ++HRD+K  NILL
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 303 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           +G G FGKV    +     VA   VK LK   +S  + +F  +     +  H N+L+  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            C      LLV+ Y   G + S L + Q           +++A   A G++++H+H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 420 IIHRDVKAANILLDED 435
            +H D+   N  L  D
Sbjct: 120 FLHSDLALRNCFLTSD 135

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 29/165 (17%)

Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTSGGELQFQTE 342
           E+ ++T  F  +  LG   FGKVYKG L   A G   + VA+K LK++       +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---------------Q 387
             + S   H N++ L G  T      +++ Y ++  +   L  R               +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 388 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           S+L P D+     I    A G+ +L  H    ++H+D+   N+L+
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 24/141 (17%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 354
           +G G +G VYK R     + +A+K+++ E+   G       E+    E++      H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNI 63

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYL 412
           +RL     +     LV+ Y+        L++   S P      R  K       RG++Y 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 413 HEHCDPKIIHRDVKAANILLD 433
           H H   +++HRD+K  N+L+D
Sbjct: 119 HSH---RVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 300 KNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           + ILG G  G VYK   L   +++AVK +  + T   + Q  +E++I+       ++  Y
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G         +   +M  GS+     +    +P        +IA+   +GL+YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----DVYRKIPE---HVLGRIAVAVVKGLTYL---WSL 114

Query: 419 KIIHRDVKAANILLD 433
           KI+HRDVK +N+L++
Sbjct: 115 KILHRDVKPSNMLVN 129

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 302 ILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 358
            +G G FGK+Y  K + +D +   +K +   +    E +  + EV +++   H N++  +
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHE 414
                     +V  Y   G +  R+  ++  L      L W    +I+LG    L ++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG----LKHIH- 118

Query: 415 HCDPKIIHRDVKAANILLDED 435
             D KI+HRD+K+ NI L ++
Sbjct: 119 --DRKILHRDIKSQNIFLSKN 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 423 RDVKAANILL 432
           RD++AANIL+
Sbjct: 126 RDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   +   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 12/134 (8%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           N +G G  G VYK      G+L A+K +          Q   E++I+    H N+++ + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
                 E  ++  +M  GS+       +  L          +A     G++YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFL--------ADVARQILSGIAYLHRR---H 188

Query: 420 IIHRDVKAANILLD 433
           I+HRD+K +N+L++
Sbjct: 189 IVHRDIKPSNLLIN 202

Length = 353

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)

Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 379 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 106 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152

Query: 434 EDA 436
            D 
Sbjct: 153 SDG 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 301 NILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLR 356
           +++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIALG 404
           L G C       L   Y  +G++   LR+              S+   L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGEN 148

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 353
           F    +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIALGSAR---GL 409
           ++ L     T     LV   M  G +   +    ++           +    +A    GL
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE------EGRAVFYAAEICCGL 115

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
             LH+    +I++RD+K  NILLD+  
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 45.6 bits (109), Expect = 3e-05
 Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYG 359
           LG G FG+V   R    GK  A+K L + +            E +I+    H  L+ LYG
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHEHC 416
                +   LV  Y+  G + S LR  +S   P     R    ++ L     L YLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVLA----LEYLH-SL 120

Query: 417 DPKIIHRDVKAANILLDED 435
           D  I++RD+K  N+LLD D
Sbjct: 121 D--IVYRDLKPENLLLDSD 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 354
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 355 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 410
              Y F T   +KL  +   M  G +   L +           +  ++   +A    GL 
Sbjct: 61  CMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVF-------SEAEMRFYAAEIILGLE 111

Query: 411 YLHEHCDPKIIHRDVKAANILLDE 434
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLKALSVLHAQ- 135

Query: 417 DPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK R +  G+L A+K +K E      +  Q E+ ++    H N++  +G  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
               +  +   +   GS    L++      PL       ++  + +GL YLH       +
Sbjct: 76  LRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---M 128

Query: 422 HRDVKAANILLDEDA 436
           HRD+K ANILL ++ 
Sbjct: 129 HRDIKGANILLTDNG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 302 ILGRGGFGKVY-KGRLADGKLVAVKRLKEE----RTSGGELQFQTEVKIISMAVHRNLLR 356
           ++G+G FGKV    R  DGK  AVK L+++    R     +  +  V ++    H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 357 L-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           L Y F TT  EKL  V  ++  G +   L +R+ S P    P  +  A   A  L YLH 
Sbjct: 61  LHYSFQTT--EKLYFVLDFVNGGELFFHL-QRERSFPE---PRARFYAAEIASALGYLHS 114

Query: 415 HCDPKIIHRDVKAANILLD 433
                I++RD+K  NILLD
Sbjct: 115 ---INIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 12/147 (8%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVH 351
           T+ + +   +G G FG V   R    G+ VA+K++ K   T     +   E+K++    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 352 RNLLRLYG-FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
            N++ L   F + + +   V   +  G+   RL   +    PL+    +       RGL 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR----PLEKQFIQYFLYQILRGLK 122

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD 437
           Y+H      ++HRD+K +NIL++E+ D
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCD 146

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 363 TVTEK--LLVYPYMTNG--SVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHC 416
           + +++   L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 417 DPKIIHRDVKAANILL 432
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 300 KNILGRGGFGKVYKGRLA-DGKLV--AVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 355
           ++++G G FG+V +  +  DG  +  A+K LKE  +      F  E++++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIAL 403
            L G C       +   Y   G++   LR+               +   L      + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A G+ YL    + + IHRD+ A N+L+ E+
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGEN 155

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 303 LGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 358
           +GRG      VY  R    G LV V+    E  +   L+  Q EV +     H N++  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-LDWPTRKKIALGSARGLSYLHEHCD 417
              TT +   ++ P+M  GS  S L+   +  P  +       I  G+ RGL+YLH++  
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLK---TYFPEGMSEALIGNILFGALRGLNYLHQN-- 120

Query: 418 PKIIHRDVKAANILLDED 435
              IHR++KA++IL+  D
Sbjct: 121 -GYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 22/147 (14%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----------LQFQT--EVKII 346
             LG G +GKV K      GK+VA+K++K    S              + F T  E+KI+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +   H N++ L           LV   M     AS L++       L     K I L   
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLD 433
            GL+ LH+      +HRD+  ANI ++
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFIN 153

Length = 335

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 39/124 (31%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 317 ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL---YGFCTTVTEKLLVYPY 373
              K V VK +   +T G E+     +K IS   HR ++ L   Y + +TV   +  Y  
Sbjct: 117 EQRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
                V     +R   LP     T ++  L +   L+YLH      IIHRDVK  NI LD
Sbjct: 171 DLFTYV-----DRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219

Query: 434 EDAD 437
           E  +
Sbjct: 220 EPEN 223

Length = 392

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 17/140 (12%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 360
           +G G F +V K +    GK  A+K +K+   S  ++    E++ +  ++ H N+LRL   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 361 CTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
              + ++      LV+  M + ++   ++ R+  LP       K       + L ++H +
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK---RVKSYMYQLLKSLDHMHRN 119

Query: 416 CDPKIIHRDVKAANILLDED 435
               I HRD+K  NIL+ +D
Sbjct: 120 ---GIFHRDIKPENILIKDD 136

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 354
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 355 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 410
              Y F T   +KL  +   M  G +   L +           + K++   +     GL 
Sbjct: 61  CMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111

Query: 411 YLHEHCDPKIIHRDVKAANILLDE 434
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 14/146 (9%)

Query: 297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 353
           F    +LG+GGFG+V   ++ A GK+ A KRL+++R     GE     E +I+     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 410
           ++ L     T     LV   M  G +   +    +  P  +    ++    +A    GL 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFE---EERALFYAAEILCGLE 116

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
            LH       ++RD+K  NILLD+  
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 30/151 (19%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-------ISMAV----- 350
           LGRG   ++Y G L        K   E+     E + +  +K+       IS+A      
Sbjct: 3   LGRGTRTQIYAGILNY------KDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS 56

Query: 351 ------HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 404
                 H++++ LYG C    E ++V  ++  G +   +  R+S    L  P + K+A  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSD--VLTTPWKFKVAKQ 113

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            A  LSYL    D  ++H +V   NILL  +
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 21/143 (14%)

Query: 302 ILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 353
           +LG+G FGKV         ++ A+K LK++      LQ        TE +I+++A  H  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYL 412
           L  L+    T      V  Y+  G +  ++ R R+      D P  +  A      L +L
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H H    +I+RD+K  NILLD +
Sbjct: 113 HRH---GVIYRDLKLDNILLDAE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 30/153 (19%)

Query: 303 LGRGGFGKVYKGRLADG--KLVAVKRL----------KEERTSGGELQFQTEVKIISMAV 350
           LG G FG VYK R  +    L+A+K +          K ER         +EV II   +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66

Query: 351 -HRNLLRLYGFCTTVTEKLLVYPYM------TNGSVASRLRERQSSLPPLD-WPTRKKIA 402
            H N++R Y    T  E   +Y  M        G   + L+E++        W    ++ 
Sbjct: 67  RHPNIVRYY---KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           L     L YLH+  + +I+HRD+   NI+L ED
Sbjct: 124 LA----LRYLHK--EKRIVHRDLTPNNIMLGED 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLY 358
           +G G +G VYKGR    G++VA+K+++ E  S  E    T ++ IS+     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEH 415
                 +   L++ +++       L++   SLP    +D    K       +G+ + H  
Sbjct: 66  DVLMQESRLYLIFEFLS-----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 416 CDPKIIHRDVKAANILLD 433
              +++HRD+K  N+L+D
Sbjct: 121 ---RVLHRDLKPQNLLID 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)

Query: 302 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLY 358
           ++GRG + KV   RL  + ++ A+K +K+E     E     QTE  +   A     L   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
             C   T +L LV  Y+  G +   + +RQ  LP       +  A      L++LHE   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPE---EHARFYAAEICIALNFLHER-- 115

Query: 418 PKIIHRDVKAANILLDEDA 436
             II+RD+K  N+LLD D 
Sbjct: 116 -GIIYRDLKLDNVLLDADG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 8/141 (5%)

Query: 293 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
           A   + N   LG G +  VYKG    +G+LVA+K +  +   G       E  ++    H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N++ L+    T      V+ YM +  +A  + +    L P +    +       RGL+Y
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLAY 118

Query: 412 LHEHCDPKIIHRDVKAANILL 432
           +H      I+HRD+K  N+L+
Sbjct: 119 IHGQ---HILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 302 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQT--EVKIISMA-VHRNLLRL 357
           +LG+G FGKV+   L    +  A+K LK++     +    T  E +++S+A  H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 358 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           Y  CT  T++ L  V  Y+  G +   ++    S    D P     A     GL +LH  
Sbjct: 62  Y--CTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 416 CDPKIIHRDVKAANILLDED 435
               I++RD+K  NILLD D
Sbjct: 116 ---GIVYRDLKLDNILLDTD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRL- 357
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 358 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           Y F T   ++L  V  Y   G +   L RER  S     +   + ++      L YLH  
Sbjct: 62  YSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS- 113

Query: 416 CDPKIIHRDVKAANILLDED 435
           CD  +++RD+K  N++LD+D
Sbjct: 114 CD--VVYRDLKLENLMLDKD 131

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 302 ILGRGGFGKV--------YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHR 352
           +LG G FGKV         K    +   VAVK LKE  T+       +E+KI I +  H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSELKILIHIGNHL 71

Query: 353 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
           N++ L G CT     L+V   +   G++++ LR ++    P
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-FC 361
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 362 TTVTEKL-LVYPYMTNG--SVASRLRERQSSLPPLDWP--TRKKIALGSARGLSYLHEHC 416
           +    K+ L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 417 DPKIIHRDVKAANILL 432
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 17/140 (12%)

Query: 303 LGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYG 359
           +G G FGK  + K +  DGK   +K +   + S  E +  + EV ++S   H N+++   
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 415
                    +V  Y   G +  ++  ++  L P    LDW  +  +AL         H H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------HVH 118

Query: 416 CDPKIIHRDVKAANILLDED 435
            D KI+HRD+K+ NI L +D
Sbjct: 119 -DRKILHRDIKSQNIFLTKD 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 10/136 (7%)

Query: 303 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF- 360
           +G+G +GKV+K     +G   AVK L        E++ +  + + +++ H N+++ YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84

Query: 361 ----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
                    +  LV      GSV   ++        ++ P    I   +  GL +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 417 DPKIIHRDVKAANILL 432
             K IHRDVK  NILL
Sbjct: 144 --KTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 414
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 114

Query: 415 HCDPKIIHRDVKAANILLDEDA 436
                II+RD+K  N+LLD + 
Sbjct: 115 R---GIIYRDLKLDNVLLDSEG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 48/144 (33%), Positives = 66/144 (45%), Gaps = 24/144 (16%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 359
           LG+G  G+V+  RL   GKL A+K L K+E     ++ +  TE +I++   H  L  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 411
              T T   LV  Y   G +  RL +RQ           K ++   AR         L Y
Sbjct: 69  SFQTETYLCLVMDYCPGGEL-FRLLQRQP---------GKCLSEEVARFYAAEVLLALEY 118

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      I++RD+K  NILL E 
Sbjct: 119 LHLL---GIVYRDLKPENILLHES 139

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 8/141 (5%)

Query: 297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 353
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           ++ L     T     LV   M  G +   +    +  P  D       A     GL  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ 119

Query: 414 EHCDPKIIHRDVKAANILLDE 434
                +I++RD+K  NILLD+
Sbjct: 120 RE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 17/32 (53%), Positives = 20/32 (62%), Gaps = 4/32 (12%)

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 438
            GL YLH     +IIHRDVK  NI ++ D DQ
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFIN-DVDQ 195

Length = 357

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 302 ILGRGGFGKV-----YKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 354
            LG G FGKV     Y    +D  + VAVK LK            +E+K++S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 390
           + L G CT     L++  Y   G + + LR ++ S 
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 11/136 (8%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLY 358
           ++G+G FGKV   R  A+ K  AVK L+++       E    +E  ++   V    L   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 115

Query: 418 PKIIHRDVKAANILLD 433
             I++RD+K  NILLD
Sbjct: 116 -NIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 42/151 (27%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRL-------KEERTSGGELQFQTEVKIISMAVHRN 353
           ++G+G +G+V   R   DGK   +K+L       +E + +  E Q  +++K  ++  +R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 354 --------LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKI 401
                   L  + GFC               G +  +L+E++  L P    ++W  +  +
Sbjct: 67  SWEGEDGLLYIVMGFCE-------------GGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           AL       YLHE     I+HRD+K  N+ L
Sbjct: 114 AL------QYLHEK---HILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 48/140 (34%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 302 ILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAV-HRNLLRL 357
           ++G+G FGKV    R +DG   AVK L+++     + Q     E  ++   + H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 358 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKI-ALGSARGLSYLH 413
            Y F T   EKL  V  Y+  G +   L RER    P      R +  A   A  + YLH
Sbjct: 62  HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEP------RARFYAAEVASAIGYLH 113

Query: 414 EHCDPKIIHRDVKAANILLD 433
                 II+RD+K  NILLD
Sbjct: 114 SL---NIIYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.2 bits (97), Expect = 7e-04
 Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 17/125 (13%)

Query: 68  SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKS 119
           ++ ++ LG   L G     LA  L   ++L+ L L  N +       +   L     L+ 
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 120 LDLYSNLFN----GTIPDTLANLKQLKYLRLNNNSLSG-----LIPTSLTTITSLNILDL 170
           LDL +N         + +TLA+LK L+ L L +N+L+      L    L+   SL  L L
Sbjct: 198 LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSL 257

Query: 171 SNNRL 175
           S N +
Sbjct: 258 SCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.0 bits (96), Expect = 9e-04
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)

Query: 302 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV    L    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHE 414
           +    T +    V  +++ G +   + +RQ  LP  +   R    +I+L     L++LHE
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLP--EEHARFYSAEISLA----LNFLHE 114

Query: 415 HCDPKIIHRDVKAANILLDED 435
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDAE 132

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 302 ILGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 354
            LG G FGKV +      G+  +   VAVK LK    +       +E+KI+S +  H+N+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 387
           + L G CT     L++  Y   G + + LR++ 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRN 353
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSY 411
           ++ L     T     LV   M  G     L+    ++    +   + +  A     GL  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 412 LHEHCDPKIIHRDVKAANILLDE 434
           LH     +I++RD+K  NILLD+
Sbjct: 118 LHRE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 15/136 (11%)

Query: 305 RGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-----IISMAVHRNLLRLY 358
           +G FG VY  +  + G   A+K LK  ++        T VK     ++       + +LY
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
               +     LV  Y+  G  AS L +    LP  DW   K+       G+  LH     
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLP-EDWA--KQYIAEVVLGVEDLH---QR 116

Query: 419 KIIHRDVKAANILLDE 434
            IIHRD+K  N+L+D+
Sbjct: 117 GIIHRDIKPENLLIDQ 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRN 353
           F  +  +GRG F +VY+   L DG  VA+K+++  +   +        E+ ++    H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSY 411
           +++ Y       E  +V      G ++  ++  ++Q  L P     +  + L SA  L +
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEH 121

Query: 412 LHEHCDPKIIHRDVKAANILL 432
           +H     +++HRD+K AN+ +
Sbjct: 122 MHSR---RVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           KI++   RGL+YL E    KI+HRDVK +NIL++   +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGE 138

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 358
           LG+GGFG+V   ++ + GK+ A K+L ++R     GE     E +I+       ++ L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSAR---GLSYL 412
            F  + T   LV   M  G +   +    ER   +        +++   SA+   G+ +L
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--------ERVIHYSAQITCGILHL 111

Query: 413 HEHCDPKIIHRDVKAANILLDE 434
           H      I++RD+K  N+LLD+
Sbjct: 112 HSM---DIVYRDMKPENVLLDD 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS- 347
           DG     ILG G FGKV +G      R      VAVK LK    S  +    +E+KI++ 
Sbjct: 37  DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 390
           +  H N++ L G CT      ++  Y   G + + L + + + 
Sbjct: 97  LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 12/139 (8%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLY 358
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
               T      V  Y+  G +   L RER  S     +   + ++      L YLH    
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114

Query: 418 PKIIHRDVKAANILLDEDA 436
            KI++RD+K  N++LD+D 
Sbjct: 115 -KIVYRDLKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 26/144 (18%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGEL------QFQTEVKIISMAVHRNLL 355
           LG+G FG VY   + D K VA +RLK  +    GEL      Q   E +++S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 356 RLYG-------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
           + +        FC  +TE      Y     +  +L E + +   L      +  +    G
Sbjct: 66  KFHASFLERDAFCI-ITE------YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           + Y+H+    +I+HRD+KA NI L
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 19/155 (12%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQFQTEV 343
            + +L++  + F    ++GRG FG+V   R    K V A+K L K E     +  F  E 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 344 KIISMAVHRN---LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTR 398
           + I MA H N   +++L        +K L  V  YM  G + + +        P  W  R
Sbjct: 94  RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-AR 145

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
              A      L  +H       IHRDVK  N+LLD
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLD 176

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 35/152 (23%)

Query: 302 ILGRGGFGKVY----KGRLADGKLVAVKRLKE----ERTSGGELQFQTEVKIISMAVHRN 353
           +LG G +GKV+     G    GKL A+K LK+    ++    E   +TE +++  AV R 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLE-AVRRC 64

Query: 354 --LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 407
             L+ L+    T T+  L+  Y+  G + + L +R+                   R    
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE------------HFTESEVRVYIA 112

Query: 408 ----GLSYLHEHCDPKIIHRDVKAANILLDED 435
                L +LH+     II+RD+K  NILLD +
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSE 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH 351
           D F    ++GRG FG+V+  R    G++ A+K L++            + E  I++ A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 352 RNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-----ALG 404
             +++LY   +   E+ L  V  YM  G + + L  R+   P  +   R  I     AL 
Sbjct: 61  PWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPE-ET-ARFYIAELVLALD 115

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           S   L +         IHRD+K  NIL+D D
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDAD 137

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMA 349
           ++  D F   + LG G  G V K +     L+  ++L   E       Q   E++++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
               ++  YG   +  E  +   +M  GS+   L+E +  +P        K+++   RGL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPE---EILGKVSIAVLRGL 116

Query: 410 SYLHEHCDPKIIHRDVKAANILLD 433
           +YL E    +I+HRDVK +NIL++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVN 138

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 20/140 (14%)

Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V   R    G+ VAVK +   +    EL F  EV I+    H+N++ +Y   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87

Query: 362 TTVTEKLLVYPYMTNGSVAS-----RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  ++  ++  G++       RL E Q +           +     + L YLH   
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA----------TVCESVLQALCYLHSQ- 136

Query: 417 DPKIIHRDVKAANILLDEDA 436
              +IHRD+K+ +ILL  D 
Sbjct: 137 --GVIHRDIKSDSILLTLDG 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 30/154 (19%)

Query: 303 LGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQ---------------- 338
           LG+G    +Y GRL         + ++     L E   +G EL+                
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 339 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 398
           F     ++S   H +L  ++G C   +E ++V  ++ +G +   LR+ +  + P+ W   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKIT 121

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
               L SA  LSYL    D  ++H +V A NILL
Sbjct: 122 VAQQLASA--LSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 2/90 (2%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  L  L  L+L  N L  +I S L  L  L SLDL +N      P        LK L L
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDL 147

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           ++N +   +P+ L  + +L  LDLS N LS
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS 176

Length = 394

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/93 (31%), Positives = 42/93 (45%), Gaps = 3/93 (3%)

Query: 86  ELGQLKNLELLELYGNNL--SGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
               L  L  L+L   +   S      L NL+ L SLDL  N     I   L  L  L  
Sbjct: 62  LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTS 120

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           L L+NN+++ + P      ++L  LDLS+N++ 
Sbjct: 121 LDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE 153

Length = 394

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 341 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPLDWPTRK 399
           TE  I+    H ++++L G  T      L+ P Y T+  +   L  +++ +   D    +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRN-IAICDILAIE 188

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           +  L   R + YLHE+   +IIHRD+KA NI ++   D
Sbjct: 189 RSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGD 220

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.2 bits (82), Expect = 0.004
 Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 2/61 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
           ++  +DL N  L+  +       L NL++L+L GNNL+   P A   L  L+SLDL  N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 127 F 127
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 42/152 (27%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKIISMAVHRN 353
           +G G FG+V+  R        A+K        RLK+E+          E +++    H  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62

Query: 354 LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 407
           ++RL+   T   ++ L  +  Y+  G + S LR               + +  +      
Sbjct: 63  IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108

Query: 408 ----GLSYLHEHCDPKIIHRDVKAANILLDED 435
                L YLH     +I++RD+K  NILLD++
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKE 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 14/30 (46%), Positives = 21/30 (70%), Gaps = 3/30 (10%)

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
           RGL Y+H      +IHRD+K +N+L++ED 
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDC 144

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 31/148 (20%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKIISMAV-HRNLLRL 357
           +LG+G FGKV    L    +  A+K LK++     +    T  E +++++A  H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 358 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-------- 407
             FCT  T++ L  V  Y+  G +   ++               +     AR        
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------------GRFDEARARFYAAEIIC 107

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
           GL +LH+     II+RD+K  N+LLD+D
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	447
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.96
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.96
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.95
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.95
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.94
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.94
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.93
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.93
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.93
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.93
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.93
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.93
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.93
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.93
KOG0198	313	consensus MEKK and related serine/threonine protei	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.92
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.92
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.92
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
KOG0610	459	consensus Putative serine/threonine protein kinase	99.92
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.92
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.92
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.92
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.92
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.92
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.92
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.91
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.91
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.91
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.91
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.91
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.9
KOG0578	550	consensus p21-activated serine/threonine protein k	99.9
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.9
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.9
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.9
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.9
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.9
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.9
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.9
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.9
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.9
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.9
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.9
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.9
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.9
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
KOG0586	596	consensus Serine/threonine protein kinase [General	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.89
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.89
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.89
PHA02988	283	hypothetical protein; Provisional	99.89
PHA03212	391	serine/threonine kinase US3; Provisional	99.89
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.89
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.89
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.89
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.89
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.89
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.89
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.89
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.89
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.89
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.89
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.89
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.89
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.89
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.89
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.89
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.89
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.89
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.89
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.89
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.89
PTZ00283	496	serine/threonine protein kinase; Provisional	99.88
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.88
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.88
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.88
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.88
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.88
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.88
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.88
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.88
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.88
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.88
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.88
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.88
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.88
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.88
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.88
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.88
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.88
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.88
PHA03209	357	serine/threonine kinase US3; Provisional	99.88
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.88
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.88
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.88
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.88
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.88
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.88
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.88
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.88
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.88
PHA03211	461	serine/threonine kinase US3; Provisional	99.88
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.87
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.87
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.87
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.87
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.87
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.87
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.87
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.87
PTZ00036	440	glycogen synthase kinase; Provisional	99.87
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.87
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.87
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.87
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.87
KOG0589	426	consensus Serine/threonine protein kinase [General	99.87
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.87
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.87
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.87
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.87
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.87
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.87
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.87
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.87
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.87
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.87
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.87
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.87
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.87
PLN03150	623	hypothetical protein; Provisional	99.87
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.87
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.87
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.87
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.87
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.87
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.87
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.87
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.87
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.87
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.87
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.87
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.86
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.86
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.86
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.86
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.86
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.86
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.86
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.86
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.86
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.86
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.86
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.86
PHA03207	392	serine/threonine kinase US3; Provisional	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.86
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.86
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.86
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.86
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.86
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.86
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.86
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.86
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.86
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.85
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.85
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.85
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.85
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.85
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.85
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.85
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.85
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.85
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.85
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.85
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.85
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.85
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.85
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.85
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.85
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.85
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.85
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.85
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.85
KOG0584	632	consensus Serine/threonine protein kinase [General	99.84
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.84
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.84
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.84
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.84
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.84
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.84
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.84
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.84
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.84
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.84
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.84
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.84
PTZ00284	467	protein kinase; Provisional	99.84
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.84
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.84
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.84
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.84
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.83
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.83
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.83
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.83
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.83
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.83
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.83
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.83
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.83
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.83
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.83
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.83
PHA03210	501	serine/threonine kinase US3; Provisional	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.83
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.83
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.82
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.82
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.82
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.82
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.82
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.82
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.82
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.82
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.82
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.81
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.81
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.81
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.81
KOG1152	772	consensus Signal transduction serine/threonine kin	99.81
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.8
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.8
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.8
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.8
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.8
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.8
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.79
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.78
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.78
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.78
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.78
PHA02882	294	putative serine/threonine kinase; Provisional	99.77
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.77
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.77
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.76
smart00090	237	RIO RIO-like kinase.	99.75
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.74
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.73
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.73
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.72
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.7
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.69
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.66
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.63
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.6
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.6
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.55
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.5
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.5
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.34
PLN03150	623	hypothetical protein; Provisional	99.33
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.3
PLN00181	793	protein SPA1-RELATED; Provisional	99.22
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.21
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.16
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.16
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.14
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.12
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.11
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.1
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.09
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.03
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.02
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.01
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.94
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.93
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.85
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.83
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.81
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.78
KOG3087	229	consensus Serine/threonine protein kinase [General	98.78
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.77
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.72
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.71
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.7
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.68
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.67
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.63
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.62
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.6
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.6
KOG1243	690	consensus Protein kinase [General function predict	98.59
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.58
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.57
PRK09902	216	hypothetical protein; Provisional	98.55
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.52
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.48
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.33
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.26
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.23
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
PLN02876	822	acyl-CoA dehydrogenase	98.16
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.16
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.05
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.03
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.99
PF01636	239	APH: Phosphotransferase enzyme family This family	97.93
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.92
PRK10593	297	hypothetical protein; Provisional	97.91
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.91
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.87
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.86

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7e-46  Score=410.27  Aligned_cols=343  Identities=31%  Similarity=0.560  Sum_probs=268.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|||++|+++|.+|..+.++++|+.|+|++|.+.+.+|..+.++++|++|+|++|.++|.+|..+.++++|+.|+|
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            46889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccCCCCC---CCCCCCCCCCCCCCCCCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK---KPCSGSPPFSPPPPFGPT  223 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~---~~C~~~~~~~~~~p~~~~  223 (447)
                      ++|+++|.+|..+..+++|+.+++++|+++|.+|..+.+..+...++.+|+.+|++...   .+|..             
T Consensus       555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~-------------  621 (968)
T PLN00113        555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR-------------  621 (968)
T ss_pred             CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc-------------
Confidence            99999999999999999999999999999999999999999999999999999986422   12210             


Q ss_pred             CCCCCCCCCcccchhhhhhHHHHHhhhhhhheeehhcCCCccccCCCCCC-cccccc---CccccccHHHHHHHhcCCCC
Q 013258          224 SSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAED-DSELQL---GQLKRFSLRELQVATDGFSN  299 (447)
Q Consensus       224 ~~~~~~~~~~~i~i~v~~g~~~lv~~~vi~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~  299 (447)
                         .+......+.+++++++++++++++++++++|++++.+.. ..+... ..+...   .....++++++   ...|..
T Consensus       622 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  694 (968)
T PLN00113        622 ---VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKSITINDI---LSSLKE  694 (968)
T ss_pred             ---ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccc-ccccccccccccccccccchhhhHHHH---HhhCCc
Confidence               0111122233333333333333333333333333221110 000000 000000   01112333333   345778


Q ss_pred             CCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          300 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .++||+|+||.||+|+. .++..||||.++....     ...+|++.+++++|||||+++|+|.+.+..++||||+++|+
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~  769 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN  769 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence            89999999999999996 4789999999864321     12356888999999999999999999999999999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      |.++++.       ++|..+..|+.|+++||+|||+.+.++|+||||||+||+++.++.+++.
T Consensus       770 L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        770 LSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             HHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence            9999953       7899999999999999999997777799999999999999999988765

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=301.71  Aligned_cols=161  Identities=53%  Similarity=0.900  Sum_probs=148.7

Q ss_pred             ccccccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeE
Q 013258          281 QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  360 (447)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~  360 (447)
                      ..+.|++.++..+|++|...+.||+|+||.||+|.+.+|+.||||++....... ..+|.+|++++++++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999989999999886654332 5679999999999999999999999


Q ss_pred             EecCC-ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          361 CTTVT-EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       361 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      |.+.+ +.+||||||++|+|.++|+.....  +++|.+|++||.++|+||+|||+.+.|+||||||||+|||||+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99998 499999999999999999986543  689999999999999999999999999999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       218 lsDFG  222 (361)
T KOG1187|consen  218 LSDFG  222 (361)
T ss_pred             ccCcc
Confidence            99994

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-31  Score=247.83  Aligned_cols=143  Identities=29%  Similarity=0.418  Sum_probs=127.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|...+.||+|+||+||+|+++ ++..||||.+.... .......+..|+++|+.++|||||++++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56777888999999999999965 58999999996553 22233457899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC------Cceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED------ADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~------~~~~i~df~  444 (447)
                      ||.+|||.++++.++.    +++..+..++.|+|.||++||++   +||||||||+||||+..      -..||+||-
T Consensus        90 yC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             eCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999998753    89999999999999999999999   99999999999999975      357999994

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-29  Score=240.77  Aligned_cols=140  Identities=35%  Similarity=0.580  Sum_probs=123.5

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~g  377 (447)
                      .+.+|+|+||+||+|.++....||||++...... ....+|.+|+.+|.+++|||||+++|+|.++. ..++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            4569999999999999975444999999654322 12458999999999999999999999999987 799999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC-eeecCCCCCceeeCCCC-ceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      +|.++++..  ....+++..++.++.|||+||.|||++   + ||||||||+|||++.++ .+||+||-
T Consensus       126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            999999874  223599999999999999999999999   6 99999999999999998 99999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-29  Score=231.59  Aligned_cols=140  Identities=31%  Similarity=0.433  Sum_probs=126.5

Q ss_pred             CCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEeecCCC
Q 013258          299 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYMTN  376 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~e~~~~  376 (447)
                      ..+.||+|..|+||+++++ +++.+|+|.+.........+++.+|++++..++||+||.++|.|.... +..++||||.+
T Consensus        83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg  162 (364)
T KOG0581|consen   83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG  162 (364)
T ss_pred             hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence            3578999999999999975 689999999965555555678999999999999999999999999988 59999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |||+.++...+    .+++...-+|+.+|++||.|||+ +   +||||||||+|||++..|++||+||-.
T Consensus       163 GSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  163 GSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence            99999998653    38899999999999999999996 5   899999999999999999999999965

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.8e-29  Score=233.87  Aligned_cols=143  Identities=27%  Similarity=0.410  Sum_probs=125.8

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccc------cHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      +.|.+.+.||+|+||.|-+|. .++|+.||||++++.....      ......+|+++|++++|||||++++++..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            456777999999999999998 4579999999996543222      122467999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC---Cceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~~i~df~  444 (447)
                      |||||||+||+|.+++-..+.    +.+.....++.|++.|+.|||++   ||+||||||+|||+..+   ...||+||-
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999987653    77788899999999999999999   99999999999999877   678999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.4e-28  Score=235.49  Aligned_cols=143  Identities=29%  Similarity=0.486  Sum_probs=124.8

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv  370 (447)
                      +.|+..++||+|.||.||+|+ ..+|+.||+|+++.+...... ....+||.+|++++||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            345566889999999999998 567999999999766544333 3568999999999999999999998876  689999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|||++ ||..++....   ..++..++..++.|++.||+|+|++   +|+|||||.+|||||.+|..||+||-
T Consensus       197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            999987 8888887532   2389999999999999999999999   99999999999999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=228.38  Aligned_cols=144  Identities=28%  Similarity=0.392  Sum_probs=129.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|+..++||+|+||+||.++.+ +++.+|+|++++.....  .......|..+|..++||.||+++-.|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467899999999999999999854 58999999997654322  244588999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||+.||+|..+|++.+.    +++..+..++..|+.||.|||++   +||||||||+|||||++|.++++||-
T Consensus       104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg  170 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG  170 (357)
T ss_pred             EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence            999999999999986543    88999999999999999999999   99999999999999999999999994

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9e-28  Score=235.26  Aligned_cols=143  Identities=28%  Similarity=0.483  Sum_probs=130.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..|...+.||+|+|+.||+++. .+|..||+|++.+..  .........+||++.+.++|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4578889999999999999996 779999999996533  2334456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+|+|.++++.++    +++++++.++..||+.||.|||+.   +|||||||..|++|++++++||+||-
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            9999999999998543    499999999999999999999999   99999999999999999999999994

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=226.15  Aligned_cols=138  Identities=36%  Similarity=0.531  Sum_probs=119.7

Q ss_pred             CCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHh--cCCCCCccceeeEEecCC----ceEEE
Q 013258          297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTVT----EKLLV  370 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~----~~~lv  370 (447)
                      .+..++||+|+||.||||++. ++.||||+++..    ....|..|-++.+  .++|+||++++++-...+    +.+||
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            344578999999999999984 599999999653    2345777777665  568999999999876655    78999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC------CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH------CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||.+.|+|.++|..+.     .+|....+|+.-+++||+|||+.      ++|+|+|||||++|||+.+|+...|+||-
T Consensus       287 t~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999998763     89999999999999999999974      47899999999999999999999999995

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2.8e-28  Score=227.14  Aligned_cols=142  Identities=23%  Similarity=0.443  Sum_probs=129.1

Q ss_pred             CCCCCCccccCCCceEEEEE-eCCCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +|++.+.||+|.||+|-+|+ ...|+.||||.+++....+.  ...+.+|+++|+.++||||++++++|...+.+.+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            46666889999999999998 46799999999977653332  3358899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |..+|.|++++.+++.    +++..+..++.||.+|+.|+|.+   +++|||||.+|||+|+++++||+||-
T Consensus       134 YaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  134 YASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             ecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            9999999999998764    89999999999999999999999   99999999999999999999999995

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=1.3e-27  Score=211.92  Aligned_cols=143  Identities=27%  Similarity=0.456  Sum_probs=127.8

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|...+.+|+|.||.||+|+ ..+|+.||||+++.....++ .....||+..|+.++|+||+.++++|-..+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            356677899999999999999 45799999999976654433 3468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+. +|+..+++..   ..+...+...++.++++|++|+|++   .|+||||||.|+|++++|..||+||-
T Consensus        82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeeccc
Confidence            9976 9999998753   3578899999999999999999999   99999999999999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=231.39  Aligned_cols=138  Identities=36%  Similarity=0.530  Sum_probs=125.8

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      .+.||+|-||+||.|.+.....||+|.++...  .....|.+|+++|.+++|+|||+++|+|..++.++||||||+.|+|
T Consensus       211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            46799999999999999877799999997753  3345799999999999999999999999998899999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++|+...+  ..+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+||-
T Consensus       289 l~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  289 LDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             HHHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence            999997332  3488899999999999999999999   99999999999999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.95  E-value=6.7e-28  Score=217.24  Aligned_cols=143  Identities=22%  Similarity=0.347  Sum_probs=121.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +.|+....+|+|+||.||+|+.+ +|+.||||++.+...... .+-.+||+++|++++|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            34666788999999999999966 599999999965433222 3347899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+. ++.+.|.....   .++......++.|+++|+.|+|++   +||||||||+|||++.++.+|++||.
T Consensus        82 ~~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             ecch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccch
Confidence            9987 44444444322   278888999999999999999999   99999999999999999999999994

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.1e-28  Score=209.90  Aligned_cols=146  Identities=30%  Similarity=0.432  Sum_probs=129.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|++.+.||+|.||.||.|+. +++-.||+|++-+..  ...-..++.+|+++-+.++||||.++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46788899999999999999995 468899999985433  223345799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||..+|+++..|++...  ..+++.....++.|+|.||.|+|..   +||||||||+|+|++.+++.|++||-
T Consensus       101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence            999999999999986432  3488889999999999999999999   99999999999999999999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.94  E-value=2e-27  Score=229.31  Aligned_cols=147  Identities=27%  Similarity=0.354  Sum_probs=128.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc--cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  368 (447)
                      ...+|...+.||+|+|++|++|+. .+++.||||++.+...-.  ..+-..+|-..|.++ .||.|++|+-.|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346788899999999999999984 469999999985443211  122366788888888 8999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  446 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~~  446 (447)
                      +|+||+++|+|.++|+..+.    +++.....++.+|+.||+|||++   +||||||||+|||||+||.++|.||...
T Consensus       151 FvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999988653    99999999999999999999999   9999999999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-26  Score=208.83  Aligned_cols=143  Identities=27%  Similarity=0.410  Sum_probs=127.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||.|+||+|..++.+ +|..+|+|+++....-  .+.....+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56778899999999999999965 5889999999654321  11224678999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++||.|+++|+..+.    ++++.+..+|.||+.||+|||+.   +|++|||||+|||+|.+|..||.||-
T Consensus       124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence            99999999999998654    99999999999999999999999   99999999999999999999999984

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=5.1e-27  Score=238.32  Aligned_cols=149  Identities=32%  Similarity=0.509  Sum_probs=131.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      ...+....+.||+|+||+||+|+..      +...||||.++.....+..++|++|+++++.++|||||+|+|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3344555688999999999999853      3468999999887766677899999999999999999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCC----------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      .+||+|||..|||.++|+.+...          ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence            99999999999999999864321          22378889999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+||+||.
T Consensus       641 ~VKIsDfG  648 (774)
T KOG1026|consen  641 VVKISDFG  648 (774)
T ss_pred             EEEecccc
Confidence            99999995

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.4e-28  Score=214.25  Aligned_cols=148  Identities=25%  Similarity=0.360  Sum_probs=127.1

Q ss_pred             CCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceee-EEecCCc-eEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYG-FCTTVTE-KLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lv~  371 (447)
                      +|++.+.||+|.||+||++. ..+|..+|.|.++-+.. ....++...|+.+|++++|||||++++ .+.+..+ .++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            46667889999999999998 56899999999973332 223446899999999999999999998 4455555 89999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC--eeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||..|+|...++..+.....+++..+.++..|+++||.++|.. -++  |+||||||.||+||.+|.+|++||.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccch
Confidence            99999999999988766666799999999999999999999994 234  9999999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=2.6e-26  Score=221.73  Aligned_cols=147  Identities=21%  Similarity=0.329  Sum_probs=131.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      ....++|+.+++||+|+||+||.|+.+ +|..+|+|++++...  .....-...|-.+|....+|+||+|+-.|++.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            335578999999999999999999954 599999999976432  22223478899999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||||++|||+..+|...+.    |++..+..++.+++.|++.+|..   |+|||||||+|+|||..|.+|++||.
T Consensus       217 YLiMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence            999999999999999987653    89999999999999999999999   99999999999999999999999995

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=226.10  Aligned_cols=145  Identities=26%  Similarity=0.371  Sum_probs=128.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCC-ceEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT-EKLL  369 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~l  369 (447)
                      ..++|...+.||.|+||.||+|+ ..+|..||||+++..-..-.+..=.||+..|++++ |||||++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34677888999999999999998 45699999999976543333334579999999999 999999999998877 8999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||||+. +|+++++++.   ..+++..+..|+.||.+||+|+|.+   |+.|||+||+|||+.....+||+||.
T Consensus        88 VfE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             eHHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccc
Confidence            9999965 9999998863   3599999999999999999999999   99999999999999999999999995

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=217.60  Aligned_cols=146  Identities=28%  Similarity=0.374  Sum_probs=122.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-------------ccHHHHHHHHHHHhcCCCCCcccee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------------GGELQFQTEVKIISMAVHRNLLRLY  358 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~  358 (447)
                      ..+.|.+.+.||+|.||+|-+|+. .+++.||||++.+....             ....+..+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            346788889999999999999995 46999999999643211             1123688999999999999999999


Q ss_pred             eEEecC--CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          359 GFCTTV--TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       359 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      ++..++  +..|||+|||..|.+...=..    ...+++.++..|..++..||+|||.+   +||||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            998764  578999999999987543222    12288999999999999999999999   999999999999999999


Q ss_pred             ceeeccccc
Q 013258          437 DQSSKTILR  445 (447)
Q Consensus       437 ~~~i~df~~  445 (447)
                      .+||+||-.
T Consensus       248 ~VKIsDFGV  256 (576)
T KOG0585|consen  248 TVKISDFGV  256 (576)
T ss_pred             cEEeeccce
Confidence            999999964

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=227.72  Aligned_cols=148  Identities=30%  Similarity=0.468  Sum_probs=129.3

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCC--C--cE-EEEEEccc--ccccccHHHHHHHHHHHhcCCCCCccceeeEEec
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLAD--G--KL-VAVKRLKE--ERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  363 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  363 (447)
                      +...++....++||+|+||+||+|++..  +  .. ||||..+.  ........+|+.|+++|+.++|||||+++|++..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            4445555666899999999999998642  2  23 89999874  2334445689999999999999999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      ...+++|||+|.||+|.++|+....   .++..++..++.++|+||+|||++   ++|||||.++|+|++.++.+||+||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcc
Confidence            9999999999999999999998654   388999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       307 G  307 (474)
T KOG0194|consen  307 G  307 (474)
T ss_pred             c
Confidence            5

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-26  Score=214.81  Aligned_cols=146  Identities=26%  Similarity=0.397  Sum_probs=133.2

Q ss_pred             hcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||.|..+.||+|+ .+.+..||||++.-+........+.+|+..|+.++||||++++..|..+.++|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4568888999999999999998 467899999999877666566789999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||.+||+.+.++..-..  .+++..+..|.+++++||.|||.+   +.||||||+.|||||+||.+|++||-
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence            99999999999875432  388999999999999999999999   99999999999999999999999994

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=231.76  Aligned_cols=143  Identities=30%  Similarity=0.437  Sum_probs=132.0

Q ss_pred             CCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ...+.++||.|.||+||+|+++-    ...||||.+|...+...+.+|+.|+.+|.++.||||++|.|+.......++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34667999999999999999752    45799999998887777889999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+||+|+.+|+.+.+.   +.+.+...+.++||.||.||-+.   +.|||||.++|||++.+...||+||-
T Consensus       710 EyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG  776 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG  776 (996)
T ss_pred             hhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence            999999999999987643   88999999999999999999998   99999999999999999999999994

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=221.72  Aligned_cols=145  Identities=26%  Similarity=0.382  Sum_probs=128.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc----ccHHHHHHHHHHHhcCC-CCCccceeeEEecCCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  366 (447)
                      ..+.|...+.||+|+||+||.|+. .++..||+|++......    .....+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456788899999999999999985 46899999977553211    22345778999999999 9999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      .++||||+.+|+|++++...+    .+.+..+..++.|+++|++|+|++   +|+||||||+|||+|.+ +++||+||.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            999999999999999998843    388899999999999999999999   99999999999999999 999999995

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.93  E-value=2.6e-26  Score=209.53  Aligned_cols=143  Identities=27%  Similarity=0.411  Sum_probs=124.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeEEec--CCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv  370 (447)
                      ++|+..+.|++|+||.||+|+. ++++.||+|+++.+....+. ..-.+||.+|.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3466678899999999999995 46899999999876544443 257899999999999999999887754  4679999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+. ||..++.....   ++...++..+..|+++|++|||++   .|+|||||++|+|++..|..||+||-
T Consensus       156 Me~~Eh-DLksl~d~m~q---~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG  222 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQ---PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG  222 (419)
T ss_pred             HHHHHh-hHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence            999986 99999987642   488899999999999999999999   89999999999999999999999994

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-26  Score=221.96  Aligned_cols=147  Identities=26%  Similarity=0.384  Sum_probs=132.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..+...+.+.||+|.||+|..|....+..||||.++.+.....+.+|.+|+++|.+++|||||+++|+|..++.+++++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34455667999999999999999877899999999988777777899999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++|+|.+++..+...  ...-....+|+.|||.||+||.+.   ++||||+.++|+|+|.++++||+||-
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence            99999999999876432  234456678999999999999998   99999999999999999999999993

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.93  E-value=1.1e-25  Score=208.73  Aligned_cols=145  Identities=26%  Similarity=0.390  Sum_probs=123.1

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCC-ccceeeEEecCC------c
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRN-LLRLYGFCTTVT------E  366 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~  366 (447)
                      .|+..+.||+|+||+||+|+. .+|+.||+|.++...... ......+|+.+++.++|+| ||++++++.+.+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            344557799999999999994 568999999997654422 2335789999999999999 999999998877      7


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++|+||+.. +|..++.........++-..+..++.|+++||+|||++   +|+||||||+|||++++|..|++||-
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence            8899999964 99999987643212366678999999999999999999   99999999999999999999999995

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-25  Score=210.06  Aligned_cols=143  Identities=31%  Similarity=0.504  Sum_probs=124.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~e  372 (447)
                      ++...+.||+|+||.||.+... +|...|||.+....... ...+.+|+.+|.+++|||||+.+|......  ..++.||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            3555688999999999999964 48999999986542222 446899999999999999999999855554  5899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeeccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTILR  445 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~~  445 (447)
                      |+++|+|.+++...+.   .+++..+..+..||++||+|||++   +||||||||+|||++. ++.+||+||..
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            9999999999987653   389999999999999999999999   9999999999999999 79999999973

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=1.4e-25  Score=219.34  Aligned_cols=150  Identities=30%  Similarity=0.433  Sum_probs=125.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      +..++|++.+.||+|+||.||+|..      .+++.||||.++..........+.+|+.++..+ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3456788899999999999999974      235689999997543333345689999999999 899999999988764


Q ss_pred             C-ceEEEeecCCCCChhhHhhccCCC------------------------------------------------------
Q 013258          365 T-EKLLVYPYMTNGSVASRLRERQSS------------------------------------------------------  389 (447)
Q Consensus       365 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  389 (447)
                      + ..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 578999999999999998753210                                                      


Q ss_pred             ----CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          390 ----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       390 ----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                          ...+++.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG  219 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  219 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecc
Confidence                12477888999999999999999998   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.92  E-value=7.5e-26  Score=218.91  Aligned_cols=142  Identities=26%  Similarity=0.411  Sum_probs=127.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. .....+.+.+|+++++.++|||||.++++|++..+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            45777789999999999999854 58899999985433 33334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+.| +|+++|.....    +++..+..|+.++..||.|||+.   +|+|||+||+|||++..+.+|++||-
T Consensus        82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhh
Confidence            9987 99999987543    89999999999999999999999   99999999999999999999999984

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.92  E-value=4.5e-25  Score=212.55  Aligned_cols=147  Identities=29%  Similarity=0.456  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-----------------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  357 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  357 (447)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|.++.........+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467788999999999999997532                 347999998765433344579999999999999999999


Q ss_pred             eeEEecCCceEEEeecCCCCChhhHhhccCC---------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeee
Q 013258          358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  422 (447)
Q Consensus       358 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  422 (447)
                      ++++...+..++||||+++|+|.+++.....               ....++|.....++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999999865321               112468889999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceeecccc
Q 013258          423 RDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       423 rDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||||+|||+++++.+||+||-
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG  183 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFG  183 (304)
T ss_pred             cCcchhheEEcCCccEEECCCc
Confidence            9999999999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.92  E-value=5.9e-26  Score=221.78  Aligned_cols=149  Identities=30%  Similarity=0.477  Sum_probs=130.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          287 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       287 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      .++..+..+.+...+.||+|+||+||+|+|.  ..||||.++.+.... ..+.|..|+..+++-+|.||+-++|||..+.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3445555556667889999999999999984  369999997654333 3456999999999999999999999999887


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      . .+|+.+|+|-+|+.+++..+.   .++..+...||.|||+|+.|||.+   +|||||||+.||++.+++.+||.||-
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             e-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            7 999999999999999997654   388899999999999999999999   99999999999999999999999994

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9e-25  Score=206.42  Aligned_cols=140  Identities=31%  Similarity=0.440  Sum_probs=119.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHh--cCCCCCccceeeEEecC----CceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTV----TEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~----~~~~  368 (447)
                      ......+.||+|.||+||+|+++ |+.||||++..    .++..+.+|.++.+  .++|+||..+++.-..+    .+++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            34666799999999999999995 78999999953    23446777777775  56999999999876543    3579


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-----CCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      ||.||.++|||+++|...     .++-...++++..+|.||+|||.     +.+|.|.|||||+.|||+..++...|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            999999999999999874     38889999999999999999995     46899999999999999999999999998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       361 G  361 (513)
T KOG2052|consen  361 G  361 (513)
T ss_pred             e
Confidence            5

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=4.8e-25  Score=217.75  Aligned_cols=143  Identities=20%  Similarity=0.314  Sum_probs=126.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++....  ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888899999999999999854 589999999864321  122345788999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            9999999999997643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=8e-25  Score=206.65  Aligned_cols=144  Identities=26%  Similarity=0.377  Sum_probs=127.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+..+.+++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46788899999999999999753    35689999997654433445789999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....   ..++|..+..++.|++.||+|||+.   +++||||||+|||+++++.++++||.
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCc
Confidence            99999999999997643   2488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=3e-25  Score=208.09  Aligned_cols=143  Identities=29%  Similarity=0.311  Sum_probs=126.4

Q ss_pred             CCCCCCccccCCCceEEEEEeCC-CcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .|+..+.||+|.-|+||.+++++ +..+|+|++.+....  ....+.+.|.++|+.++||.++.||+.+++++..+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34556889999999999999765 689999999655422  223367889999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      ||+||+|....+.+..  ..+++..+..++..|+.||+|||..   |||+|||||+||||-+||.+-++||
T Consensus       158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            9999999999887644  3589999999999999999999999   9999999999999999999999998

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.2e-25  Score=218.12  Aligned_cols=143  Identities=19%  Similarity=0.302  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|...+.||+|+||+||+++.. +++.||||.+.....  ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999854 689999999854321  222346888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||.
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999987643    378888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=5.4e-25  Score=217.48  Aligned_cols=143  Identities=22%  Similarity=0.352  Sum_probs=127.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++....  ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888899999999999999964 589999999965321  122335788999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            9999999999987643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.92  E-value=7.3e-26  Score=209.80  Aligned_cols=141  Identities=28%  Similarity=0.435  Sum_probs=116.4

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceEEE
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLV  370 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv  370 (447)
                      |...+++|+|+||.||+|.+. +++.||||+...+..     ---+|.++|+.++|||||+|.-+|....     ...+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            455689999999999999965 479999998854432     2247899999999999999998886532     23589


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTILRR  446 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~~~  446 (447)
                      ||||+. +|.+.++........++.-.+.-+..|+.+||.|||+.   +|+||||||+|+|+|.+ |..||+||...
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            999986 99999986433333477778889999999999999998   99999999999999987 89999999764

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.92  E-value=8.6e-25  Score=217.37  Aligned_cols=142  Identities=23%  Similarity=0.276  Sum_probs=125.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .|...+.||+|+||+||+|+.. +++.||||+++....  ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4777899999999999999854 588999999965322  1223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||.
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCc
Confidence            999999999987643    378888999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.5e-25  Score=210.16  Aligned_cols=143  Identities=24%  Similarity=0.302  Sum_probs=126.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999965 589999999864321  122345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||+++++.+|++||-
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            9999999999997653    378899999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.92  E-value=8.8e-25  Score=212.98  Aligned_cols=143  Identities=22%  Similarity=0.310  Sum_probs=126.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46788899999999999999965 589999999864321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997653    378888999999999999999999   99999999999999999999999985

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.92  E-value=8.4e-25  Score=216.84  Aligned_cols=148  Identities=29%  Similarity=0.383  Sum_probs=127.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      .++|+..+.||+|+||.||+|+.      .++..||||+++..........+.+|++++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45678889999999999999963      235689999997544333445688999999999 89999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCC----------------------------------------------------------
Q 013258          367 KLLVYPYMTNGSVASRLRERQS----------------------------------------------------------  388 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  388 (447)
                      .++||||+++|+|.++++....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999875321                                                          


Q ss_pred             -------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          389 -------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       389 -------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                                   ....++|..+..++.|+++||+|||+.   +|+||||||+|||+++++.+|++||-
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG  259 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFG  259 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCc
Confidence                         012478889999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.92  E-value=1.8e-24  Score=206.79  Aligned_cols=143  Identities=27%  Similarity=0.436  Sum_probs=125.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999865 68999999986544333344678999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. |+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+|++||.
T Consensus        85 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG  148 (288)
T cd07871          85 LD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFG  148 (288)
T ss_pred             CC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            97 499988865432   368889999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=1e-24  Score=215.76  Aligned_cols=147  Identities=24%  Similarity=0.311  Sum_probs=128.6

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      +....++|+..+.||+|+||.||+++.. +++.+|+|.++....  ......+.+|+.+++.++||||+++++++...+.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445578999999999999999999965 588999999864321  1223457899999999999999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999999998653     278888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.91  E-value=2e-24  Score=209.90  Aligned_cols=137  Identities=26%  Similarity=0.320  Sum_probs=121.4

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.||+|+||.||+++.. +|+.||+|+++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 689999999865422  122345788999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||.
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            9999987643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=6.6e-25  Score=216.30  Aligned_cols=142  Identities=26%  Similarity=0.376  Sum_probs=128.0

Q ss_pred             CCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      -|+..+.||+|+.|.|..|+ ..+|+.+|||++.....  ......+++|+.+|+.+.||||+++++++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            35667889999999999998 45799999999965522  2223368999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|.|++++..++.    +.+.++.+++.||+.|+.|+|..   +|+|||+||+|+|||...++||+||.
T Consensus        93 yv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             ecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence            9999999999987654    89999999999999999999999   99999999999999999999999995

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=1.8e-24  Score=214.72  Aligned_cols=142  Identities=23%  Similarity=0.295  Sum_probs=125.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +|++.+.||+|+||.||+++.. +++.||||.+.....  ......+.+|++++..++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888899999999999999854 589999999864321  1223458899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||.
T Consensus        82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999997643    378888899999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.91  E-value=1.5e-24  Score=215.79  Aligned_cols=142  Identities=24%  Similarity=0.297  Sum_probs=125.3

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .|...+.||+|+||+||+|+.. +++.||+|.+.....  ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4778899999999999999854 588999999864321  1223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||.
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECC
Confidence            999999999987643    378888899999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=2.7e-24  Score=209.01  Aligned_cols=137  Identities=25%  Similarity=0.326  Sum_probs=121.1

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.||+|+||.||+++.. +|+.||+|.++....  ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999854 689999999865422  222345788999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence            9998887543    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.91  E-value=1.9e-24  Score=211.36  Aligned_cols=144  Identities=24%  Similarity=0.291  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC--CcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|+..+.||+|+||.||+|+...  +..||+|.+.....  ......+.+|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568888999999999999998543  36899999854321  2223468899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||-
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCC
Confidence            999999999999997653    388899999999999999999999   99999999999999999999999995

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.91  E-value=3.8e-24  Score=206.03  Aligned_cols=144  Identities=26%  Similarity=0.448  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|+.. +++.||||.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888999999999999999965 6899999998654333334467899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+. ++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCC
Confidence            995 688888765432   378889999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.3e-24  Score=210.37  Aligned_cols=143  Identities=23%  Similarity=0.304  Sum_probs=127.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++....  ......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36788899999999999999965 589999999965432  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            9999999999997543    378899999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=3.9e-24  Score=208.29  Aligned_cols=137  Identities=28%  Similarity=0.338  Sum_probs=121.4

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.||+|+||.||+++.. +++.||+|+++....  ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999854 589999999965432  222346889999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence            9998886543    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=3.5e-24  Score=204.48  Aligned_cols=143  Identities=29%  Similarity=0.392  Sum_probs=124.6

Q ss_pred             CCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.....  ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999985 4689999999864321  12234578999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+.+.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||-
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999988865322  2488999999999999999999999   99999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.91  E-value=2.8e-24  Score=212.99  Aligned_cols=149  Identities=30%  Similarity=0.412  Sum_probs=126.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  365 (447)
                      ..++|++.+.||+|+||.||+|+..      ++..||||.++..........+.+|+++++.+ +|+|||+++++|...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3457888999999999999998742      24579999997544333345688999999999 8999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCC---------------------------------------------------------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQS---------------------------------------------------------  388 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  388 (447)
                      ..++||||+++|+|.++++....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999864311                                                         


Q ss_pred             ---------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          389 ---------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       389 ---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                               ....+++.....++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfG  257 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFG  257 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeece
Confidence                     012478888999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=8.1e-24  Score=205.83  Aligned_cols=137  Identities=26%  Similarity=0.325  Sum_probs=120.4

Q ss_pred             CccccCCCceEEEEEe-CCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.||+|+||.||+++. .+++.||+|.++....  ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 4689999999965432  122345788999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|..++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||+++++.+||+||.
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence            9998886543    38899999999999999999997 6   89999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.91  E-value=1.9e-24  Score=213.97  Aligned_cols=145  Identities=22%  Similarity=0.273  Sum_probs=126.6

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ...++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567888999999999999999864 588999999864321  122335788999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG  187 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecc
Confidence            999999999999998653     267788889999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.5e-24  Score=205.81  Aligned_cols=135  Identities=21%  Similarity=0.295  Sum_probs=119.9

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||.||+|+.. +++.||+|.++...  .......+.+|+.++..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 58899999986432  122234678999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++|+||.
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg  138 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFG  138 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECc
Confidence            99997643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=7.7e-24  Score=206.51  Aligned_cols=145  Identities=26%  Similarity=0.345  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||.||+++.. ++..||+|.++.........++.+|++++..++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467888999999999999999965 5889999998654333334569999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.++|+||-
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCc
Confidence            999999999997643    3788999999999999999999852  59999999999999999999999995

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.91  E-value=4.7e-24  Score=210.51  Aligned_cols=143  Identities=20%  Similarity=0.335  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+++.. +++.||+|+++...  .......+.+|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999865 58999999986432  1222346788999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||-
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999997643    378899999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.91  E-value=6.8e-24  Score=205.52  Aligned_cols=143  Identities=27%  Similarity=0.469  Sum_probs=123.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++.........++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888899999999999999853 333    48999987544334455789999999999999999999998764 5789


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccc
Confidence            9999999999999986532   378899999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.91  E-value=7.1e-24  Score=206.94  Aligned_cols=145  Identities=26%  Similarity=0.349  Sum_probs=127.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467899999999999999999965 5889999988654333334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+..  +|+||||||+|||+++++.+|++||-
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCC
Confidence            999999999997643    3788889999999999999999742  69999999999999999999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.7e-24  Score=207.44  Aligned_cols=144  Identities=22%  Similarity=0.299  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+++.. +++.||+|.++...  .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888899999999999999964 58999999986422  1222345889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||.
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            99999999999976322   378889999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=4.3e-24  Score=211.42  Aligned_cols=150  Identities=23%  Similarity=0.313  Sum_probs=130.4

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEec
Q 013258          287 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  363 (447)
Q Consensus       287 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  363 (447)
                      +.+.....++|+..+.||+|+||.||+++.. +++.+|+|.++....  ......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4445566688999999999999999999965 588999999854221  1223357889999999999999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      .+..++||||+++|+|.+++...     .++...+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998653     267888899999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       187 G  187 (371)
T cd05622         187 G  187 (371)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.91  E-value=5.9e-24  Score=207.21  Aligned_cols=144  Identities=23%  Similarity=0.294  Sum_probs=127.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+++.. +++.||+|.++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888899999999999999864 689999999975432  223346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            99999999999976522   388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.91  E-value=6.6e-24  Score=211.56  Aligned_cols=149  Identities=28%  Similarity=0.381  Sum_probs=127.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  365 (447)
                      ..++|.+.+.||+|+||.||+|+..      .+..||||+++..........+.+|+++++.+. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4567888899999999999999852      134799999975543333457999999999996 999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCC---------------------------------------------------------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQS---------------------------------------------------------  388 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  388 (447)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998875321                                                         


Q ss_pred             -----------------------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC
Q 013258          389 -----------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  433 (447)
Q Consensus       389 -----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~  433 (447)
                                                         ....+++..+..++.|+++||+|||+.   +|+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                               012477888899999999999999998   999999999999999


Q ss_pred             CCCceeecccc
Q 013258          434 EDADQSSKTIL  444 (447)
Q Consensus       434 ~~~~~~i~df~  444 (447)
                      +++.+|++||-
T Consensus       272 ~~~~~kL~DfG  282 (400)
T cd05105         272 QGKIVKICDFG  282 (400)
T ss_pred             CCCEEEEEeCC
Confidence            99999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=6.7e-24  Score=206.93  Aligned_cols=144  Identities=20%  Similarity=0.264  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+++.. +++.||+|.+....  .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999965 58899999986432  1122335788999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            99999999999976422   378889999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-24  Score=225.40  Aligned_cols=148  Identities=32%  Similarity=0.497  Sum_probs=130.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC--Cc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD--GK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .+..+..+.||+|+||+||+|...+  +.    .||||.++...+.....+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445567889999999999998653  33    49999998776666677899999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCC---CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|||++|+|..+|++.+.   ....+...+.+.++.|||+|+.||+++   ++|||||.++|+||++...+||+||-
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999998621   234578889999999999999999999   99999999999999999999999994

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=1.9e-23  Score=197.15  Aligned_cols=144  Identities=31%  Similarity=0.453  Sum_probs=127.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..+.||+|+||.||+|++..    ...||||.++.........+|.+|+.++..++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999998642    4579999987654444455789999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg  151 (266)
T cd05033          84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (266)
T ss_pred             EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence            999999999999976432   488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.3e-24  Score=209.18  Aligned_cols=143  Identities=26%  Similarity=0.357  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++....  ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999965 689999999865432  123446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|++||.
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            9999999999997652    388899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=5.9e-24  Score=209.21  Aligned_cols=138  Identities=24%  Similarity=0.342  Sum_probs=119.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|+||.||+|+.. +++.||||.+...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455688999999999999864 689999999865433333456899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|....        ..++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus       155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccc
Confidence            999986432        245677889999999999999999   99999999999999999999999995

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-24  Score=211.76  Aligned_cols=146  Identities=28%  Similarity=0.421  Sum_probs=126.6

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      ....++|...++||+|+||+|+.+..+ +++.+|||.++++..  .+.....+.|.+++... +||.+++++..+++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345578999999999999999999965 588999999987642  23334577888888766 59999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .|+||||+.||++..+.+..     .++++.+..+++.|+.||+|||++   +|||||||.+|||||.+|.+||+||-
T Consensus       444 l~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             EEEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence            99999999999965554432     389999999999999999999999   99999999999999999999999995

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=1.8e-23  Score=196.10  Aligned_cols=142  Identities=29%  Similarity=0.429  Sum_probs=126.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|+..+.||+|+||.||++++.++..+|+|.++...  ....++.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            3577788999999999999998888899999886432  23457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.++++....   .++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCC
Confidence            99999999876432   378999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.90  E-value=1.3e-23  Score=200.04  Aligned_cols=139  Identities=29%  Similarity=0.400  Sum_probs=120.6

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||+||++... +++.||+|.+......  .....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 6889999998643222  1224578899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...+.........+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  142 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLG  142 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence            988865433334589999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=1.3e-23  Score=203.72  Aligned_cols=137  Identities=28%  Similarity=0.359  Sum_probs=120.8

Q ss_pred             CccccCCCceEEEEEe----CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          301 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      +.||+|+||.||+++.    .+|+.||+|+++..... .....+.+|++++.+++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    35789999999654322 223457889999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeecc
Confidence            999999986543    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.6e-24  Score=207.72  Aligned_cols=141  Identities=25%  Similarity=0.385  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ..|...+.||+|+.|.||.++ ..+++.||||++.... ...+.-+.+|+.+|+..+|+|||.+++.|...+++|.||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            346777899999999999998 5568999999995443 23334588999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++|+|.+.+....     +++.+...|+.++++||+|||.+   +|+|||||++|||++.++++||.||.
T Consensus       352 m~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFG  414 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFG  414 (550)
T ss_pred             cCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeee
Confidence            99999999987653     89999999999999999999999   99999999999999999999999994

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.90  E-value=1.4e-23  Score=203.88  Aligned_cols=137  Identities=27%  Similarity=0.352  Sum_probs=119.9

Q ss_pred             CccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          301 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.||+|+||.||+++.    .+++.||||.++....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    2578999999864321   12233578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++....    .+.+..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  145 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFG  145 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCc
Confidence            99999999987643    377888889999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.90  E-value=2.6e-23  Score=194.53  Aligned_cols=138  Identities=31%  Similarity=0.486  Sum_probs=122.6

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      +.||+|+||.||+|+.. +++.||+|.+...........+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 68999999886543333345799999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++||.
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccc
Confidence            99987543   2478999999999999999999999   99999999999999999999999994

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=1.5e-23  Score=203.96  Aligned_cols=142  Identities=25%  Similarity=0.337  Sum_probs=122.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~  371 (447)
                      +|+..+.||+|+||.||+|+.. +++.||||+++....  ......+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4777899999999999999865 578999999865421  22334678899999999765 5888999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||.
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            9999999999987643    378999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.90  E-value=2.1e-23  Score=201.38  Aligned_cols=143  Identities=25%  Similarity=0.426  Sum_probs=125.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.++..........+.+|+++++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46788899999999999999865 58899999987554444444688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++ +|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+||.
T Consensus        86 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          86 LDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             CCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            975 88888765432   378889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=2.1e-23  Score=202.55  Aligned_cols=137  Identities=28%  Similarity=0.404  Sum_probs=119.3

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||+|+++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 588999999865432  22233577888888765 799999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|...+....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            99999887643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=2.3e-23  Score=202.97  Aligned_cols=137  Identities=25%  Similarity=0.342  Sum_probs=120.3

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      ++||+|+||.||+++.. +++.||+|+++.....  .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999864 5889999999754322  2233578899999888 799999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            99998886543    389999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=1.7e-23  Score=204.27  Aligned_cols=144  Identities=21%  Similarity=0.276  Sum_probs=125.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+++.+ +++.+|+|.+....  .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888899999999999999965 47889999985432  1122334888999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            99999999999976422   378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=1.9e-23  Score=203.91  Aligned_cols=142  Identities=25%  Similarity=0.308  Sum_probs=123.4

Q ss_pred             CCCCCCccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          296 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      +|++.+.||+|+||.||+++.    .+++.||+|+++....   ......+.+|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477789999999999999875    2578999999864321   11233578899999999 599999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999987643    388899999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=3e-23  Score=196.08  Aligned_cols=140  Identities=28%  Similarity=0.353  Sum_probs=119.3

Q ss_pred             ccccCCCceEEEEEeCC---CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          302 ILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .||+|+||+||+|+..+   ...+|+|.+...........+.+|++.++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   457888887654333334568899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCC-CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          379 VASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.+++...... ....++.....++.|++.||+|||+.   +|+||||||+|||+++++.+|++||-
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccc
Confidence            99999765321 12356778899999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=1.8e-23  Score=203.30  Aligned_cols=140  Identities=29%  Similarity=0.402  Sum_probs=119.9

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHH---hcCCCCCccceeeEEecCCceEEE
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      |++.+.||+|+||.||+|+.. +++.||||+++....  ......+.+|++++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556789999999999999864 589999999964421  12223466666654   567899999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|...++..     .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||-
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCccc
Confidence            9999999999887642     389999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.90  E-value=2.7e-23  Score=197.98  Aligned_cols=147  Identities=29%  Similarity=0.441  Sum_probs=126.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||+||+|..     .++..||+|.++.........++.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999974     24678999999754433334578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCC-------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          370 VYPYMTNGSVASRLRERQS-------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      +|||+++|+|.+++.....             ....+++.....++.|++.||+|||++   +|+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999864321             122478889999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+|++||-
T Consensus       162 ~~kl~dfg  169 (283)
T cd05090         162 HVKISDLG  169 (283)
T ss_pred             cEEecccc
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.90  E-value=2.4e-23  Score=198.92  Aligned_cols=150  Identities=27%  Similarity=0.422  Sum_probs=127.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      +..++|++.+.||+|+||.||+|..+      .+..||+|.++..........+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678899999999999999999743      245899998865433333446889999999999999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCC------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          366 EKLLVYPYMTNGSVASRLRERQS------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      ..++||||+++|+|.++++....      .....++.....++.|++.||.|||++   +|+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975321      123356778889999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      ++||-
T Consensus       160 L~Dfg  164 (288)
T cd05061         160 IGDFG  164 (288)
T ss_pred             ECcCC
Confidence            99984

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2e-23  Score=199.26  Aligned_cols=144  Identities=28%  Similarity=0.386  Sum_probs=125.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +|+..+.||+|+||+||++... +++.||+|.+......  .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999864 6899999998643221  123357889999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            9999999988865322  3488999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.90  E-value=1.2e-23  Score=197.86  Aligned_cols=140  Identities=35%  Similarity=0.577  Sum_probs=120.7

Q ss_pred             CCccccCCCceEEEEEeC-----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          300 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .+.||+|.||.||+|.+.     .+..|+||.++.........+|.+|++.+.+++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999875     257899999966444334568999999999999999999999999888899999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.++|....  ...+++..+..|+.|+++||+|||++   +++|+||+++||++++++.+||+||.
T Consensus        84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            9999999998862  22489999999999999999999999   99999999999999999999999984

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.90  E-value=3.4e-23  Score=195.53  Aligned_cols=144  Identities=29%  Similarity=0.426  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-C---CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|++.+.||+|+||.||+|+.. +   +..+|+|.++..........+.+|+.++.+++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999853 2   3479999986544333345789999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.+++.....   .+++.+...++.|++.||+|||+.   +++||||||+|||+++++.++++||-
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFG  151 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCC
Confidence            999999999999976432   378999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.90  E-value=2.3e-23  Score=207.61  Aligned_cols=149  Identities=26%  Similarity=0.375  Sum_probs=126.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  365 (447)
                      ..++|.+.+.||+|+||.||+|++.      .++.||||+++..........+.+|++++.++. |||||++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3445777899999999999999853      246899999975433333446889999999997 999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCC---------------------------------------------------------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQS---------------------------------------------------------  388 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  388 (447)
                      ..++|+||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999975321                                                         


Q ss_pred             -------------------------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          389 -------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       389 -------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                                                           ....++|.....++.|++.||+|||+.   +|+||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                                 112467888899999999999999998   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      +++++.+|++||-
T Consensus       272 l~~~~~~kL~DfG  284 (401)
T cd05107         272 ICEGKLVKICDFG  284 (401)
T ss_pred             EeCCCEEEEEecC
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.90  E-value=2.7e-23  Score=197.30  Aligned_cols=149  Identities=26%  Similarity=0.407  Sum_probs=127.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      ..++|+..+.||+|+||.||+|...      ++..||+|.++.........++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567888999999999999998753      2467999998654333334568899999999999999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCC------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceee
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                      .++||||+++|+|.++++.....      ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998763221      22467888999999999999999998   9999999999999999999999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||.
T Consensus       161 ~dfg  164 (277)
T cd05062         161 GDFG  164 (277)
T ss_pred             CCCC
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=3e-23  Score=202.17  Aligned_cols=137  Identities=27%  Similarity=0.360  Sum_probs=119.2

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+++.. +++.||+|+++.....  .....+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 5889999999754221  2233577888888766 899999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            99998886543    388999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=6.8e-24  Score=216.52  Aligned_cols=147  Identities=26%  Similarity=0.379  Sum_probs=125.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCC-cEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeE-Eec------CC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGF-CTT------VT  365 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~------~~  365 (447)
                      .++++.++|.+|||+.||.|+...+ ..||+|++-.. .......+.+||.+|+.|+ |+|||.+++. ...      .-
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            3456678999999999999997654 99999998443 2334556899999999997 9999999993 321      23


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      +.+|.||||.+|+|-+++..+...  .|.+.++++|+.|+++|+++||.. .|+|||||||-|||||+.+++.|++||-.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            678999999999999999876443  399999999999999999999996 78899999999999999999999999964

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.90  E-value=3.1e-23  Score=201.39  Aligned_cols=137  Identities=27%  Similarity=0.373  Sum_probs=116.5

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      ++||+|+||.||+|+.. +++.||+|++.....  ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 588999999864321  122234555554 57889999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|...+....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            99998886543    377888899999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.90  E-value=5.3e-24  Score=178.55  Aligned_cols=142  Identities=23%  Similarity=0.425  Sum_probs=122.9

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|.||+||+|+. .+++.||+|+++-+...++. ....+|+-+++.++|.|||++++...++...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            345567899999999999994 46899999999765443332 3578999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.. +|..+.....+   .++......++.|+++||.|+|++   ++.|||+||+|.||+.+|+.|++||-
T Consensus        83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfg  146 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFG  146 (292)
T ss_pred             hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccc
Confidence            954 88888765433   378888999999999999999999   99999999999999999999999995

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.90  E-value=3.8e-23  Score=199.53  Aligned_cols=144  Identities=28%  Similarity=0.337  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||.||+++.. ++..+|+|.++.........++.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999854 58889999886543333344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....    .+++.....++.|+++||.|||+.+  +++||||||+|||+++++.++++||-
T Consensus        81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCC
Confidence            99999999997653    3788999999999999999999732  79999999999999999999999984

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=3.6e-23  Score=200.45  Aligned_cols=137  Identities=26%  Similarity=0.395  Sum_probs=116.9

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 588999999965421  1223345566666654 4899999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            99999987643    378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.3e-23  Score=194.12  Aligned_cols=145  Identities=29%  Similarity=0.403  Sum_probs=129.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..++|+..+.||+|++|.||+|...+++.||+|.++...  ....++.+|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            345688889999999999999998778899999986542  234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++....  ...+++.....++.|++.|+.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  148 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFG  148 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcc
Confidence            999999999997643  23488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.90  E-value=2.9e-23  Score=201.44  Aligned_cols=137  Identities=31%  Similarity=0.445  Sum_probs=119.3

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||||.++...  .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 58899999986532  122334577888888766 699999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            99999887653    388999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=2.5e-23  Score=198.58  Aligned_cols=143  Identities=18%  Similarity=0.288  Sum_probs=123.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|+++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999975 588999999865432 2223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++++.+..+....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            99987766554322    2378899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=3.7e-23  Score=198.31  Aligned_cols=147  Identities=28%  Similarity=0.424  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC---------------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD---------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG  359 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~  359 (447)
                      ++|++.+.||+|+||.||+++...               ...||+|.++..........+.+|++++.+++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987532               23589999876543334456999999999999999999999


Q ss_pred             EEecCCceEEEeecCCCCChhhHhhccCC--------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          360 FCTTVTEKLLVYPYMTNGSVASRLRERQS--------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       360 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                      ++...+..++||||+++++|.+++.....        ....++|..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999865321        112468899999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      +++++.+|++||.
T Consensus       162 l~~~~~~kl~dfg  174 (295)
T cd05097         162 VGNHYTIKIADFG  174 (295)
T ss_pred             EcCCCcEEecccc
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.90  E-value=3.4e-23  Score=201.31  Aligned_cols=142  Identities=25%  Similarity=0.342  Sum_probs=122.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +|...+.||+|+||+||+|+.. +++.||+|.++....  ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777899999999999999865 578999999865432  12223467788887776 5899999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            9999999999987643    388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.90  E-value=3.7e-23  Score=201.00  Aligned_cols=137  Identities=28%  Similarity=0.403  Sum_probs=117.0

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +|+.||+|++.....  .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 689999999864321  112234455544 56789999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|..++....    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||.
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            99999987643    378899999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.90  E-value=3.9e-23  Score=198.99  Aligned_cols=147  Identities=29%  Similarity=0.477  Sum_probs=125.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|++.+.||+|+||.||+|+.+ ++.  .+|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46788899999999999999864 344  46888776443333445788999999999 899999999999999999999


Q ss_pred             eecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          371 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      +||+++|+|.++++....            ....+++.++..++.|++.|++|||+.   +|+||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999976421            123478999999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      |++||-
T Consensus       164 kl~dfg  169 (303)
T cd05088         164 KIADFG  169 (303)
T ss_pred             EeCccc
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=3.5e-23  Score=202.89  Aligned_cols=148  Identities=30%  Similarity=0.412  Sum_probs=124.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC-C
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-T  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~  365 (447)
                      .++|++.+.||+|+||.||+|..      .+++.||||.++..........+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45788899999999999999973      246789999997544333345688999999999 689999999988654 4


Q ss_pred             ceEEEeecCCCCChhhHhhccCCC--------------------------------------------------------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSS--------------------------------------------------------  389 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  389 (447)
                      ..+++|||+++|+|.++++.....                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            678999999999999998753210                                                        


Q ss_pred             -------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          390 -------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       390 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                             ...++|..+..++.|+++||+|||++   +|+||||||+|||+++++.+|++||.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecc
Confidence                   12367888899999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=1.9e-23  Score=205.11  Aligned_cols=145  Identities=25%  Similarity=0.369  Sum_probs=129.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ....|.+.+.||+|.|++|..|+.. ++..||+|.+.+...... ...+.+|+++|..++|||||+++.+.......|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3456888899999999999999854 699999999976543322 34589999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+.+|.+++++.....    .....+..+..|+.+|++|+|++   .|||||||++|||||.++++||+||.
T Consensus       134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg  200 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG  200 (596)
T ss_pred             EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence            999999999999988653    55688889999999999999999   99999999999999999999999995

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=4.5e-23  Score=199.76  Aligned_cols=137  Identities=28%  Similarity=0.434  Sum_probs=118.5

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||||.++....  ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 578999999865421  2223346677777775 5899999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            99999987643    378999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=5.5e-23  Score=192.95  Aligned_cols=142  Identities=30%  Similarity=0.446  Sum_probs=126.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|...+.||+|+||.||+|+..++..+|+|.++...  ....++.+|+.++.+++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            3567778999999999999998777789999986432  23456899999999999999999999999888899999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....   .+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+|++||.
T Consensus        82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCc
Confidence            99999999876432   488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.89  E-value=6.3e-23  Score=193.93  Aligned_cols=140  Identities=26%  Similarity=0.350  Sum_probs=118.6

Q ss_pred             ccccCCCceEEEEEeCCC---cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          302 ILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .||+|+||.||+|+..++   ..+++|.++..........+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   34567766544333344579999999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.++++.........++.....++.|+++||+|||+.   +++||||||+|||++.++.++++||-
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg  144 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYG  144 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccc
Confidence            9999986533333466777889999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=6.7e-23  Score=193.75  Aligned_cols=141  Identities=31%  Similarity=0.394  Sum_probs=120.9

Q ss_pred             CccccCCCceEEEEEeCC---CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.||+|+||.||+|...+   +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   46799998865543333457889999999999999999999999999999999999999


Q ss_pred             ChhhHhhccCC-CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|.++++.... .....++..+..++.|++.|++|||+.   +++||||||+||++++++.++++||-
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcc
Confidence            99999976432 122467778889999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.89  E-value=4.8e-23  Score=199.62  Aligned_cols=137  Identities=26%  Similarity=0.399  Sum_probs=118.4

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhc-CCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||.||+|+.. +|+.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 588999999965421  1223346677777765 4899999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.++|+||-
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            99999987643    378899999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=3e-23  Score=202.78  Aligned_cols=141  Identities=18%  Similarity=0.357  Sum_probs=120.6

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC-----CceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~  368 (447)
                      +|++.+.||+|+||.||+|+.. +++.||||.++.... .....++.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            3677889999999999999954 689999999864322 22234688999999999999999999988643     2479


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+. ++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg  148 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFG  148 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCc
Confidence            9999995 68998887543    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=5e-23  Score=193.58  Aligned_cols=144  Identities=27%  Similarity=0.415  Sum_probs=127.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|...++..||+|.+....  .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            35688889999999999999998788899999886432  2345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.++++....  ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++||-
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  148 (261)
T cd05072          83 MAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFG  148 (261)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCc
Confidence            999999999976422  2478899999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.89  E-value=8.4e-23  Score=190.72  Aligned_cols=138  Identities=33%  Similarity=0.526  Sum_probs=123.2

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChh
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  380 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  380 (447)
                      ++||+|+||.||+|...+++.+|+|.++..........+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999987889999999875543333446889999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          381 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       381 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++.....   .+++.....++.|++.||.|+|+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  138 (250)
T cd05085          81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (250)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCc
Confidence            99875432   378999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.89  E-value=4.4e-23  Score=200.67  Aligned_cols=137  Identities=27%  Similarity=0.380  Sum_probs=117.1

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +|+.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999854 689999999864321  122234555554 46789999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|...+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            99998886543    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=2.8e-23  Score=212.27  Aligned_cols=144  Identities=17%  Similarity=0.223  Sum_probs=124.4

Q ss_pred             CCCCCccccCCCceEEEEEeC-C-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-D-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++|||||++++++...+..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            777899999999999999843 4 6788888764332 222335788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++........++++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCc
Confidence            99999998876433334588889999999999999999998   99999999999999999999999995

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.89  E-value=6.6e-23  Score=192.32  Aligned_cols=141  Identities=31%  Similarity=0.437  Sum_probs=125.8

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      +|+..+.||+|+||.||++.++++..+|+|.++...  ....++.+|+++++.++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            467778999999999999998777789999985432  234468899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|.+++.....   .++|.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||-
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcc
Confidence            9999999976432   478999999999999999999999   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=3.7e-23  Score=200.99  Aligned_cols=142  Identities=25%  Similarity=0.338  Sum_probs=122.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +|+..+.||+|+||+||+|+.. +++.||+|+++....  ......+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999864 589999999865421  222345778888888875 567888999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            9999999999987643    388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.89  E-value=6.8e-23  Score=193.26  Aligned_cols=147  Identities=18%  Similarity=0.277  Sum_probs=127.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||||.++....  ......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888899999999999999854 689999998754322  222346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.........+++.....++.|+++||+|||+.   +++||||||+||+++.++.++++||-
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            99999999998865433333478888999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA02988 hypothetical protein; Provisional

Probab=99.89  E-value=1.1e-22  Score=193.99  Aligned_cols=151  Identities=18%  Similarity=0.278  Sum_probs=124.8

Q ss_pred             cccccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceee
Q 013258          282 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYG  359 (447)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~  359 (447)
                      .+.++.++++     ......||+|++|.||+|.+ +|+.||||.++.......  ...|.+|+.++.+++||||++++|
T Consensus        12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            4445555552     22236799999999999998 688999999975432221  246889999999999999999999


Q ss_pred             EEec----CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          360 FCTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       360 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                      ++.+    ....++||||+++|+|.+++....    .++|.....++.|++.||.|||+..  +++||||||+|||++++
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~  159 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN  159 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence            9876    346789999999999999997643    3889999999999999999999732  68899999999999999


Q ss_pred             Cceeecccc
Q 013258          436 ADQSSKTIL  444 (447)
Q Consensus       436 ~~~~i~df~  444 (447)
                      +.+|++||-
T Consensus       160 ~~~kl~dfg  168 (283)
T PHA02988        160 YKLKIICHG  168 (283)
T ss_pred             CcEEEcccc
Confidence            999999984

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=4.1e-23  Score=205.57  Aligned_cols=136  Identities=24%  Similarity=0.291  Sum_probs=121.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|....       ..+.+|+++++.++||||+++++++......++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            35799999999999999999985 4689999996532       247899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+. ++|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCC
Confidence            995 68888886543    378999999999999999999999   99999999999999999999999995

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.89  E-value=5.9e-23  Score=195.08  Aligned_cols=147  Identities=31%  Similarity=0.511  Sum_probs=127.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.++..........+.+|++++..++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778999999999999998532      47899999875543334567999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCC----------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          369 LVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      +||||+++|+|.++++....          ....+++.....++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999976421          223478899999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      +++||-
T Consensus       162 kl~d~g  167 (280)
T cd05049         162 KIGDFG  167 (280)
T ss_pred             EECCcc
Confidence            999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.89  E-value=8.3e-23  Score=194.73  Aligned_cols=143  Identities=27%  Similarity=0.432  Sum_probs=124.5

Q ss_pred             CCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  368 (447)
                      .|++.+.||+|+||.||+++.     .++..||+|.++..........+.+|+++++.++||||+++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            367788999999999999974     247889999987554333445799999999999999999999998775  5689


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++++|.+++....   ..++|..+..++.|++.||+|||++   +|+||||||+||++++++.++++||.
T Consensus        85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCc
Confidence            9999999999999986542   2479999999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-23  Score=190.41  Aligned_cols=145  Identities=25%  Similarity=0.386  Sum_probs=127.9

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      +++|+-.-|+     +.||+|+|+.|--+. ..+|..||||++.+. ....+.+..+|++++..+ .|+||++|+++|.+
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            4566666666     789999999999998 678999999999654 334456789999999888 59999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceee
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSS  440 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i  440 (447)
                      +...|||||-|.||.|.+++++++.    +++.++.++..+|+.||.|||.+   +|.|||+||+|||..+-.   -+||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence            9999999999999999999998765    89999999999999999999999   999999999999987644   5799


Q ss_pred             ccc
Q 013258          441 KTI  443 (447)
Q Consensus       441 ~df  443 (447)
                      +||
T Consensus       221 CDf  223 (463)
T KOG0607|consen  221 CDF  223 (463)
T ss_pred             ecc
Confidence            998

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.89  E-value=5e-23  Score=197.06  Aligned_cols=150  Identities=30%  Similarity=0.453  Sum_probs=128.5

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      ...++|+..+.||+|+||.||++...+      ...+|+|.++.........++.+|+.++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345568888999999999999998532      3689999987543333345688999999999 899999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccC------------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..+++|||+++|+|.++++...            .....+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            99999999999999999997532            1234588999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.+|++||-
T Consensus       166 ~~~~~~kL~Dfg  177 (293)
T cd05053         166 TEDHVMKIADFG  177 (293)
T ss_pred             cCCCeEEeCccc
Confidence            999999999995

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.89  E-value=8.2e-23  Score=196.02  Aligned_cols=147  Identities=27%  Similarity=0.412  Sum_probs=126.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-----------------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-----------------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  357 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  357 (447)
                      ++|++.+.||+|+||.||+++..                 ++..||+|.++.........++.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998532                 2346899998754333344579999999999999999999


Q ss_pred             eeEEecCCceEEEeecCCCCChhhHhhccCCC-------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCce
Q 013258          358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  430 (447)
Q Consensus       358 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI  430 (447)
                      ++++...+..+++|||+++|+|.+++......       ...+++.....++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998764321       12377889999999999999999999   999999999999


Q ss_pred             eeCCCCceeecccc
Q 013258          431 LLDEDADQSSKTIL  444 (447)
Q Consensus       431 Ll~~~~~~~i~df~  444 (447)
                      |+++++.++++||.
T Consensus       162 li~~~~~~~l~dfg  175 (296)
T cd05095         162 LVGKNYTIKIADFG  175 (296)
T ss_pred             EEcCCCCEEeccCc
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.89  E-value=6.2e-23  Score=217.07  Aligned_cols=147  Identities=22%  Similarity=0.340  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++......  ...++.+|+++++.++||||+++++++...+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999965 58999999996543222  2346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCC-------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....       .....++..+..++.|+++||+|||+.   +|+||||||+|||++.++.++++||-
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211       112356778899999999999999999   99999999999999999999999985

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.89  E-value=8.9e-23  Score=195.89  Aligned_cols=147  Identities=25%  Similarity=0.431  Sum_probs=125.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-Cc--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|++.+.||+|+||+||+|...+ +.  .+++|.++..........+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998653 33  47899887543333445689999999999 799999999999999999999


Q ss_pred             eecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          371 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      +||+++|+|.++++....            ....+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999976421            112478899999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      |++||-
T Consensus       159 kl~dfg  164 (297)
T cd05089         159 KIADFG  164 (297)
T ss_pred             EECCcC
Confidence            999995

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=1.1e-22  Score=193.58  Aligned_cols=147  Identities=31%  Similarity=0.493  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-C-----cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|+..+.||+|+||.||+|.... +     ..||+|.++.........++.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357778999999999999998533 2     5799999875543333456899999999999999999999999988999


Q ss_pred             EEeecCCCCChhhHhhccCCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          369 LVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      ++|||+++|+|.+++......            ...+++.....++.|++.||+|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999764211            13478889999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .++|+||.
T Consensus       162 ~~~L~dfg  169 (283)
T cd05048         162 TVKISDFG  169 (283)
T ss_pred             cEEECCCc
Confidence            99999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.89  E-value=8e-23  Score=198.83  Aligned_cols=137  Identities=28%  Similarity=0.368  Sum_probs=115.8

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHH-HHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEV-KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||+|++.....  ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 578899999864321  11223444444 456788999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+.+.....++.|+++||+|||+.   +|+||||||+|||+++++.+||+||.
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            99999987643    267888889999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=6.8e-23  Score=199.49  Aligned_cols=137  Identities=28%  Similarity=0.362  Sum_probs=119.9

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|+.. +++.||+|+++.....  .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 5789999999754322  2233578899998887 699999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            99998886543    389999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.89  E-value=9.2e-23  Score=196.43  Aligned_cols=149  Identities=28%  Similarity=0.438  Sum_probs=127.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      ..++|.+.+.||+|+||.||+|+..        ++..||+|.++.........++.+|+.++..+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3566788899999999999999741        24579999986543333445789999999999 89999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                      ....+++|||+++|+|.+++......            ...++|..+..++.|+++||+|||++   +|+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            99999999999999999999764221            12478889999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      +++++.+|++||-
T Consensus       170 i~~~~~~kl~D~g  182 (304)
T cd05101         170 VTENNVMKIADFG  182 (304)
T ss_pred             EcCCCcEEECCCc
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=1.1e-22  Score=193.74  Aligned_cols=143  Identities=27%  Similarity=0.438  Sum_probs=123.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  367 (447)
                      .+|++.+.||+|+||.||++...     +++.||+|.++... ......+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46778899999999999999742     47899999986442 2234468999999999999999999998754  3467


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+||+++|+|.+++.....   .++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg  153 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFG  153 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCc
Confidence            899999999999999975432   388999999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.89  E-value=9e-23  Score=197.87  Aligned_cols=137  Identities=30%  Similarity=0.425  Sum_probs=119.9

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+++.. +++.||||+++....  ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 588999999975421  22234577888888877 799999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|...+....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.++|+||.
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            99998887643    389999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.89  E-value=1.1e-22  Score=194.39  Aligned_cols=146  Identities=32%  Similarity=0.442  Sum_probs=124.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +|++.+.||+|+||.||+|+..      ....+|+|.++.........++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999852      2357899988655433334578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCC--------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          370 VYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      ++||+.+|+|.+++.....                    ....+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999865321                    113478899999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 013258          430 ILLDEDADQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~~~~i~df~  444 (447)
                      ||+++++.+|++||-
T Consensus       158 ill~~~~~~kl~dfg  172 (290)
T cd05045         158 VLVAEGRKMKISDFG  172 (290)
T ss_pred             EEEcCCCcEEecccc
Confidence            999999999999984

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=6.2e-23  Score=192.88  Aligned_cols=145  Identities=30%  Similarity=0.445  Sum_probs=129.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ..+|+..+.||+|+||.||+|...+++.+|+|.++.... ....++.+|+.+++.++|+||+++++++...+..++||||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            456778899999999999999987789999999865432 2344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.++++....  ..+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||.
T Consensus        84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcccc
Confidence            999999999976432  3478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.89  E-value=1.4e-22  Score=191.06  Aligned_cols=147  Identities=20%  Similarity=0.301  Sum_probs=129.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++....  ......+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999975 789999998864322  222456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.........+++..+..++.|+++||.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            99999999999876433334588999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.89  E-value=9.5e-23  Score=192.65  Aligned_cols=143  Identities=29%  Similarity=0.450  Sum_probs=125.3

Q ss_pred             CCCCCCccccCCCceEEEEEeCC-C---cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +|+..+.||+|+||.||+|+... +   ..||||.++.........+|..|+.+++.++||||+++++++......++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46677899999999999998643 3   3699999875433334457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||-
T Consensus        85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg  151 (269)
T cd05065          85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG  151 (269)
T ss_pred             ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence            99999999999876432   378999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.89  E-value=8.4e-23  Score=197.02  Aligned_cols=148  Identities=30%  Similarity=0.429  Sum_probs=127.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      .++|.+.+.||+|+||.||+++..        +...+|+|.++.........++.+|++++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888899999999999999742        23579999997543333345688899999999 799999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..++||||+++|+|.+++.....            ....++|..+..++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999976432            112488999999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.++++||.
T Consensus       174 ~~~~~~kL~dfg  185 (307)
T cd05098         174 TEDNVMKIADFG  185 (307)
T ss_pred             cCCCcEEECCCc
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.89  E-value=5.5e-23  Score=200.94  Aligned_cols=149  Identities=32%  Similarity=0.441  Sum_probs=124.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC-
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-  364 (447)
                      ..++|++.+.||+|+||.||+|+..      +++.||+|.++..........+.+|+.++.++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457888999999999999999632      24789999987543333344688899999999 899999999988654 


Q ss_pred             CceEEEeecCCCCChhhHhhccCCC-------------------------------------------------------
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSS-------------------------------------------------------  389 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  389 (447)
                      ...++++||+++|+|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5678999999999999998643210                                                       


Q ss_pred             --CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          390 --LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       390 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                        ...++|..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||-
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG  218 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFG  218 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccc
Confidence              12578999999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.89  E-value=8.9e-23  Score=202.29  Aligned_cols=141  Identities=26%  Similarity=0.331  Sum_probs=121.9

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  368 (447)
                      +|+..+.||+|+||.||+++. .+++.||||.+..... .....++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999996 4689999999864321 123346889999999999999999999998776     789


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+||+. ++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        81 lv~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  148 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFG  148 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccc
Confidence            9999996 57888775432    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.89  E-value=1.1e-22  Score=195.48  Aligned_cols=143  Identities=27%  Similarity=0.450  Sum_probs=125.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46788899999999999999865 58899999986544333445678999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. ++|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCc
Confidence            97 589888876432   378899999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=1.4e-22  Score=192.82  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=120.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||+||+|.+. +++    .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            45777899999999999999863 344    4788877543322233467888889999999999999998754 45789


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++|+|.+++.....   .++|.....++.|++.||+|||+.   +++||||||+|||+++++.+|++||.
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999976432   488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=8e-23  Score=195.19  Aligned_cols=148  Identities=30%  Similarity=0.488  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|+..+.||+|+||.||+++..      ++..||+|.++.........++.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888899999999999999853      46789999987544333345699999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCC------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          368 LLVYPYMTNGSVASRLRERQS------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      ++++||+++|+|.+++.....                  ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  112478889999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 013258          430 ILLDEDADQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~~~~i~df~  444 (447)
                      |++++++.++++||-
T Consensus       161 il~~~~~~~~l~dfg  175 (288)
T cd05050         161 CLVGENMVVKIADFG  175 (288)
T ss_pred             eEecCCCceEECccc
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.89  E-value=1.5e-22  Score=192.46  Aligned_cols=144  Identities=28%  Similarity=0.455  Sum_probs=124.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      .++|+..+.||+|+||+||+|++ .+++    .||+|.++.........++.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35678889999999999999985 3444    4899998755444445578899999999999999999999875 4578


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++||+++|+|.++++....   .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+|++||.
T Consensus        85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCC
Confidence            99999999999999976432   388999999999999999999999   99999999999999999999999995

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.89  E-value=1.3e-22  Score=197.63  Aligned_cols=141  Identities=23%  Similarity=0.300  Sum_probs=121.7

Q ss_pred             CCCccccC--CCceEEEEEe-CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          299 NKNILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       299 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ..++||+|  +|++||+++. .+|+.||+|+++...... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  6789999985 468999999996543322 2335778999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+++.||.
T Consensus        82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccc
Confidence            99999999875422  2378999999999999999999998   99999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.89  E-value=1.2e-22  Score=192.44  Aligned_cols=147  Identities=25%  Similarity=0.473  Sum_probs=126.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|+..+.||+|+||+||+|+.+      +.+.|++|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788899999999999999853      246799998854332223457899999999999999999999999989999


Q ss_pred             EEeecCCCCChhhHhhccCCCC-----CCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSL-----PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      +||||+++|+|.+++.......     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654211     2489999999999999999999998   9999999999999999999999987


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       162 ~  162 (275)
T cd05046         162 S  162 (275)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-23  Score=191.79  Aligned_cols=142  Identities=24%  Similarity=0.378  Sum_probs=122.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcc-cccccccHHHHHHHHHHHhcCCCCCccceeeEEec-----CCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~  367 (447)
                      ..|...+.||+|+||.|+.+.. .+|+.||||.+. ........++..+|+++++.++|+||+.+.+.+..     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            3455568899999999999985 468999999985 33333445578899999999999999999998765     3568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|+|+|+ -+|...++....    ++......+..|+++||.|+|+.   +|+||||||+|+|++.+.+.||+||.
T Consensus       102 YiV~elMe-tDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            99999994 589999876543    88899999999999999999999   99999999999999999999999995

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.89  E-value=9.9e-23  Score=193.24  Aligned_cols=148  Identities=28%  Similarity=0.429  Sum_probs=127.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...........+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4568888999999999999998542      3689999986543333345688999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCC------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          368 LLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      ++||||+++|+|.+++......      ...++|..+..++.|++.||.|||+.   +|+||||||+||++++++.+|++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999999754321      12478899999999999999999998   99999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       162 dfg  164 (277)
T cd05032         162 DFG  164 (277)
T ss_pred             Ccc
Confidence            984

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=2.1e-22  Score=189.21  Aligned_cols=135  Identities=24%  Similarity=0.368  Sum_probs=117.6

Q ss_pred             cccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||.||+|.+.   ++..||+|.++..........+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   355799999876543333456899999999999999999999875 4578999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++....   ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+|++||-
T Consensus        82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCC
Confidence            99987543   2488999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.89  E-value=1.9e-22  Score=191.65  Aligned_cols=137  Identities=26%  Similarity=0.350  Sum_probs=118.7

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||+||+++.+ +|+.||+|.+......  .....+..|++++.+++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 5899999998643221  1233466799999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+||-
T Consensus        81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg  140 (277)
T cd05607          81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLG  140 (277)
T ss_pred             HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeece
Confidence            988865432  2378999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.89  E-value=1.9e-22  Score=190.24  Aligned_cols=142  Identities=27%  Similarity=0.410  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++||||+++++++...+..++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4688889999999999999996 468899999986432 22334578999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.++++...    .+++..+..++.|++.||.|||+.   +|+|||+||+||++++++.++++||-
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  151 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFG  151 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCc
Confidence            99999999987543    378999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.89  E-value=1.8e-22  Score=190.15  Aligned_cols=143  Identities=29%  Similarity=0.411  Sum_probs=126.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|...+.||+|+||.||+|... +++.||+|.++..  .....++.+|++++..++||||+++++++...+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            34677789999999999999864 5889999998643  22345689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|++||-
T Consensus        84 ~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          84 MTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             CCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCc
Confidence            999999999876432  3488999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5e-23  Score=210.76  Aligned_cols=149  Identities=20%  Similarity=0.229  Sum_probs=126.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  365 (447)
                      ..++|.+.+.||+|+||+||+|+. .+++.||||.+..... ......+.+|+..+..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            346788899999999999999985 4689999999865432 223346889999999999999999987765432     


Q ss_pred             ---ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          366 ---EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       366 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999976544445688999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       187 FG  188 (496)
T PTZ00283        187 FG  188 (496)
T ss_pred             cc
Confidence            95

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.88  E-value=2e-22  Score=193.14  Aligned_cols=148  Identities=28%  Similarity=0.398  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-----------------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  356 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~  356 (447)
                      .++|++.+.||+|+||.||+|+...                 +..||+|.+...........+.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3568888999999999999987532                 24689999875544344557899999999999999999


Q ss_pred             eeeEEecCCceEEEeecCCCCChhhHhhccCC-------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       357 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      +++++...+..++++||+++++|.+++.....       ....+++.....++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999976531       112488999999999999999999998   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 013258          430 ILLDEDADQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~~~~i~df~  444 (447)
                      |++++++.++++||-
T Consensus       161 ili~~~~~~~l~dfg  175 (296)
T cd05051         161 CLVGKNYTIKIADFG  175 (296)
T ss_pred             eeecCCCceEEcccc
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.1e-22  Score=188.80  Aligned_cols=143  Identities=30%  Similarity=0.487  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|... |+.||+|.++....  ...++.+|+.+++.++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            356788899999999999999874 78999999965532  355789999999999999999999999988999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++.....++.|++.||.|||+.   +++||||||+||++++++.++++||-
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g  147 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFG  147 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccc
Confidence            999999999976532  2489999999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.88  E-value=1.8e-22  Score=190.57  Aligned_cols=145  Identities=28%  Similarity=0.493  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CC---cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|+..+.||+|+||.||+|+.. ++   ..+|+|.++.........++..|++++..++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346777899999999999999864 23   37999998654333334578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++++|.+++....   ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++||.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence            999999999999987643   2388999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=2.1e-22  Score=192.42  Aligned_cols=143  Identities=29%  Similarity=0.492  Sum_probs=118.0

Q ss_pred             CCCCCCccccCCCceEEEEEe-C-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeEEec-----C
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-A-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----V  364 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~  364 (447)
                      +|++.+.||+|+||+||+|+. . +++.||+|.++...... ....+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            688889999999999999986 3 46889999986443222 233566777777655   69999999998852     3


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|++||-
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            46899999996 689999875432  2478999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.88  E-value=2.1e-23  Score=185.74  Aligned_cols=145  Identities=26%  Similarity=0.350  Sum_probs=125.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc---c----HHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG---G----ELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~----~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      ..+.|...+.+|+|..+.|.++.. .+|+.+|+|++.......   .    ...-.+|+.+|+++ .||+|+++.++|++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            445678889999999999999874 568999999985432211   1    12356799999887 69999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      +...++|+|.|+.|.|+++|.+..    .+++....+|+.|+..|++|||.+   +||||||||+|||+|++.+++|+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            999999999999999999998754    388999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      .
T Consensus       168 G  168 (411)
T KOG0599|consen  168 G  168 (411)
T ss_pred             c
Confidence            4

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=2e-22  Score=191.54  Aligned_cols=143  Identities=27%  Similarity=0.484  Sum_probs=124.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||.||+|... +|+    .+|+|.++.........++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45777899999999999999864 233    6899988665443344578899999999999999999999887 78899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||-
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCc
Confidence            9999999999999976432   388999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.1e-22  Score=189.33  Aligned_cols=145  Identities=30%  Similarity=0.450  Sum_probs=129.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..++|.+.+.||+|+||.||+|...+++.+|||.++...  ....++.+|+.+++.++|+||+++++++......+++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            456788889999999999999998778899999986532  234578999999999999999999999998889999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++.....  ..+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++++||-
T Consensus        82 ~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          82 YMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             ccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccc
Confidence            9999999999976432  2488999999999999999999999   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=1.5e-22  Score=192.52  Aligned_cols=149  Identities=26%  Similarity=0.412  Sum_probs=128.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC-----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  366 (447)
                      ..++|+..+.||+|+||.||+|...+     +..|++|.++..........+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45678888999999999999998654     688999998754433344568899999999999999999998876 567


Q ss_pred             eEEEeecCCCCChhhHhhccCCC----CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      .++++||+++|+|.+++......    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999999764322    13588999999999999999999998   999999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       161 ~g  162 (280)
T cd05043         161 NA  162 (280)
T ss_pred             CC
Confidence            85

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=2.1e-22  Score=189.33  Aligned_cols=144  Identities=28%  Similarity=0.406  Sum_probs=126.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..++|+..+.||+|+||.||+|..++++.||+|.+....  ....++.+|+.+++.++|+||+++++++ ..+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence            346788889999999999999998888999999986543  2345789999999999999999999986 4567899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  147 (260)
T cd05067          81 YMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFG  147 (260)
T ss_pred             cCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCc
Confidence            9999999999875432  2478999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=1.7e-22  Score=192.40  Aligned_cols=139  Identities=30%  Similarity=0.459  Sum_probs=121.0

Q ss_pred             CCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 013258          298 SNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  370 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv  370 (447)
                      +..+.||+|+||+||++..     .+++.||+|.++..........+.+|+++++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7789999999999988652     357889999987553333445788999999999999999999988653  357899


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||-
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            9999999999998753     289999999999999999999999   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.88  E-value=1.9e-22  Score=191.80  Aligned_cols=138  Identities=25%  Similarity=0.356  Sum_probs=122.1

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|+||.||+|+. .+++.||+|.+..........++.+|++++.+++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            577789999999999999985 4688999999865433333456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|..+.        .+++.....++.|++.||+|||+.   +|+|+||||+|||++.++.++++||-
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg  140 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFG  140 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCC
Confidence            999986542        267888899999999999999999   99999999999999999999999995

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=1.4e-22  Score=192.25  Aligned_cols=136  Identities=26%  Similarity=0.346  Sum_probs=114.2

Q ss_pred             ccccCCCceEEEEEeCC-------------------------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc
Q 013258          302 ILGRGGFGKVYKGRLAD-------------------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  356 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~  356 (447)
                      .||+|+||.||+|....                         ...||+|.+..... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997421                         13588998864322 22346888999999999999999


Q ss_pred             eeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       357 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      +++++.+....++||||+++|+|..++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            99999999999999999999999999875322   378999999999999999999998   999999999999998654


Q ss_pred             c-------eeecccc
Q 013258          437 D-------QSSKTIL  444 (447)
Q Consensus       437 ~-------~~i~df~  444 (447)
                      .       .|++||-
T Consensus       155 ~~~~~~~~~kl~d~g  169 (274)
T cd05076         155 LAEGTSPFIKLSDPG  169 (274)
T ss_pred             cccCccceeeecCCc
Confidence            3       6888874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-22  Score=198.33  Aligned_cols=144  Identities=25%  Similarity=0.344  Sum_probs=127.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l  369 (447)
                      .+.|+..+.||+|.||.||+++.+ +|+.+|+|.+++.....  ....+.+|+.+|+.+. |||||.+++++.+.+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456777899999999999999965 49999999997654332  2357899999999998 9999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC----Cceeeccccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSKTILR  445 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~~i~df~~  445 (447)
                      |||++.||.|++.+...     .+++..+..++.|++.++.|||+.   +|+|||+||+|+|+...    +..|++||.-
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999876     288999999999999999999998   99999999999999864    3689999964

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=2.7e-22  Score=188.95  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=124.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|.+.+.||+|+||.||+|+..++..||+|.++...  ....++.+|+++++.++||||+++++++. .+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            34688889999999999999998776789999986532  23457899999999999999999999874 4568999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.++++....  ..+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.++++||-
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg  147 (262)
T cd05071          82 MSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  147 (262)
T ss_pred             CCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCC
Confidence            999999999976422  2478999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.88  E-value=2.6e-23  Score=182.94  Aligned_cols=151  Identities=27%  Similarity=0.336  Sum_probs=132.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-----CCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~  366 (447)
                      ..++|.+.+.+|+|||+.||.++ ..+++.||+|++.... .++....++|++..++++||||++++++...     ..+
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34578888999999999999998 6679999999996543 3445578999999999999999999988753     345


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .|++++|...|+|.+.+.....+...+++.+.+.|+.++.+||++||+. .|+.+||||||.|||+.+++.+.+.||-.
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            8999999999999999988766666799999999999999999999998 55799999999999999999999999964

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=1.8e-22  Score=192.70  Aligned_cols=143  Identities=27%  Similarity=0.360  Sum_probs=124.0

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||+|+||+||++... +++.||+|.+......  .....+.+|++++..++|+||+++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556688999999999999864 6889999998643221  1233578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++++||-
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999988865432  2489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=1.8e-22  Score=194.30  Aligned_cols=147  Identities=29%  Similarity=0.380  Sum_probs=126.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  365 (447)
                      ..++|...+.||+|+||.||++..      .++..||||.++..........+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345688889999999999999974      124589999987543333344689999999999 7999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..+++|||+++|+|.++++....  ..+++.+...++.|++.||+|||+.   +|+|+||||+|||+++++.++++||.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999976432  2379999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.88  E-value=3.9e-22  Score=188.69  Aligned_cols=141  Identities=29%  Similarity=0.483  Sum_probs=120.7

Q ss_pred             CccccCCCceEEEEEeCC-Cc--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||.||+|+..+ +.  .+|+|.++..........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999653 43  56889886543333445788999999999 799999999999999999999999999


Q ss_pred             CChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++.....            ....+++.....++.|++.|++|||+.   +++||||||+||++++++.+|++||-
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999976431            122478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=3.1e-22  Score=189.26  Aligned_cols=144  Identities=28%  Similarity=0.413  Sum_probs=118.7

Q ss_pred             CCCCccccCCCceEEEEEeCC-Cc--EEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC------Cce
Q 013258          298 SNKNILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  367 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~  367 (447)
                      .+.+.||+|+||.||+|+..+ +.  .+|+|.++..... .....+.+|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999654 33  6899988654322 2234688999999999999999999987532      246


Q ss_pred             EEEeecCCCCChhhHhhccC--CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+++|+|.+++....  .....+++.....++.|++.||+|||++   +|+||||||+|||+++++.+|++||-
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            89999999999998875422  1223478999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.88  E-value=2e-22  Score=195.11  Aligned_cols=149  Identities=28%  Similarity=0.438  Sum_probs=126.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      .++|.+.+.||+|+||.||+++..        ....+|+|.++.........++..|++++..+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356778899999999999999742        24579999987543333345688999999999 699999999999998


Q ss_pred             CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..+++|||+++|+|.+++.....            ....++|.....++.|++.||+|||+.   +|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            899999999999999999976421            123488999999999999999999998   99999999999999


Q ss_pred             CCCCceeeccccc
Q 013258          433 DEDADQSSKTILR  445 (447)
Q Consensus       433 ~~~~~~~i~df~~  445 (447)
                      ++++.+|++||.-
T Consensus       168 ~~~~~~kL~Dfg~  180 (314)
T cd05099         168 TEDNVMKIADFGL  180 (314)
T ss_pred             cCCCcEEEccccc
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.88  E-value=1.7e-22  Score=190.54  Aligned_cols=147  Identities=20%  Similarity=0.304  Sum_probs=127.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+++. .+++.+|||.++.....  ....++.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4577789999999999999995 47899999987543221  22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++.........+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||.
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            99999999999875333334588999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.88  E-value=2.1e-22  Score=192.49  Aligned_cols=143  Identities=25%  Similarity=0.466  Sum_probs=125.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|++|.||+|+.+ +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999965 58999999986543333334577899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +.+ +|.+++.....   .+++.....++.|+++||.|||+.   +|+||||||+||++++++.++++||.
T Consensus        85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccc
Confidence            984 99998876432   478899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.88  E-value=2e-22  Score=196.78  Aligned_cols=148  Identities=29%  Similarity=0.432  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      ..+|.+.+.||+|+||.||+++..        .+..||+|.++.........++.+|++++.++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            346788899999999999999742        12368999887543333445789999999999 799999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..++++||+++|+|.+++.....            ....++|..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            999999999999999999976421            123478899999999999999999998   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.+||+||-
T Consensus       168 ~~~~~~kL~Dfg  179 (334)
T cd05100         168 TEDNVMKIADFG  179 (334)
T ss_pred             cCCCcEEECCcc
Confidence            999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.88  E-value=2e-22  Score=191.32  Aligned_cols=149  Identities=31%  Similarity=0.400  Sum_probs=127.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.++..........|.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3467888899999999999999864      3568999988654433334568999999999999999999999999899


Q ss_pred             eEEEeecCCCCChhhHhhccCCC---CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceee
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSS  440 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i  440 (447)
                      .++||||+++|+|.+++......   ...++|..+..++.|++.||+|||+.   +++||||||+||++++++   .+|+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            99999999999999999765321   12488999999999999999999999   999999999999998765   5899


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||.
T Consensus       161 ~dfg  164 (277)
T cd05036         161 ADFG  164 (277)
T ss_pred             ccCc
Confidence            9984

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.88  E-value=2.6e-22  Score=189.16  Aligned_cols=142  Identities=26%  Similarity=0.458  Sum_probs=125.4

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      +|...+.||+|+||+||+|...+++.+|+|.++.....     .....+.+|+++++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            46778999999999999999878999999988643221     1123588999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence            99999999999997643    378899999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.88  E-value=3.3e-22  Score=188.00  Aligned_cols=143  Identities=28%  Similarity=0.443  Sum_probs=125.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|++.+.||+|+||.||+|...++..+|+|.++....  ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            356788899999999999999988888899999865432  3456899999999999999999999875 4568999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          82 MSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCce
Confidence            999999999976422  2478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.9e-22  Score=196.56  Aligned_cols=135  Identities=24%  Similarity=0.271  Sum_probs=115.1

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcC---CCCCccceeeEEecCCceEEEeecCCC
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA---VHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      ||+|+||+||+|+.. +++.||||++......  .....+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999864 5899999998543211  1122455666666655   699999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.++|+||.
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            99999987643    388999999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.88  E-value=1.7e-22  Score=213.80  Aligned_cols=143  Identities=31%  Similarity=0.399  Sum_probs=126.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++.....  .....+.+|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888899999999999999965 5899999998653221  12346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+.+++|.+++....    .+++..+..|+.|++.||+|||..   +||||||||+|||++.++.+||+||-
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            9999999999997643    378889999999999999999998   99999999999999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.88  E-value=5.4e-23  Score=204.72  Aligned_cols=143  Identities=29%  Similarity=0.426  Sum_probs=122.2

Q ss_pred             CCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC------CceEEEe
Q 013258          299 NKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKLLVY  371 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lv~  371 (447)
                      ..+.||+|+||.||+|+. .+|+.||||.++............+|+++|++++|+|||+++++-.+.      +...+||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            347799999999999994 569999999998776666666799999999999999999999875543      3568999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC--CCC--ceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDA--DQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~~i~df~~  445 (447)
                      |||.+|||...|++... ...+++...+.+..++..||.|||++   +||||||||.||++-  ++|  --|++||..
T Consensus        97 EyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999987532 33589999999999999999999999   999999999999975  344  359999864

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=3.3e-22  Score=191.08  Aligned_cols=146  Identities=28%  Similarity=0.461  Sum_probs=125.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|.+.+.||+|+||+||++...      ++..+|+|.++... ......+.+|++++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46788899999999999999742      34568999886432 223446899999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCC---------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          369 LVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      +||||+++++|.+++.....         ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            99999999999999975421         223489999999999999999999998   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      ++||-
T Consensus       161 l~dfg  165 (288)
T cd05093         161 IGDFG  165 (288)
T ss_pred             eccCC
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.9e-22  Score=202.65  Aligned_cols=139  Identities=30%  Similarity=0.468  Sum_probs=124.9

Q ss_pred             CCccccCCCceEEEEEe-CCC----cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          300 KNILGRGGFGKVYKGRL-ADG----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .++||+|+||+||+|.+ +.|    .+||+|++..........++.+|+-+|.+++|||+++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            48899999999999974 433    4799999987766666778999999999999999999999998876 88999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      +.|.|.++++.++..   +--...+.+..|||+||.|||.+   ++|||||..+|||+.+-..+||.||.-
T Consensus       780 P~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             ccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecch
Confidence            999999999987653   56678899999999999999999   999999999999999999999999974

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=3.1e-22  Score=187.68  Aligned_cols=136  Identities=26%  Similarity=0.422  Sum_probs=117.3

Q ss_pred             CccccCCCceEEEEEeCC-C----------cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          301 NILGRGGFGKVYKGRLAD-G----------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +.||+|+||.||+|...+ +          ..+++|.++.....  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            468999999999999754 3          25788877544322  5678999999999999999999999988 77899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-------ceeecc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-------DQSSKT  442 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~~i~d  442 (447)
                      ||||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++       .++++|
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999999986532   488999999999999999999998   999999999999999888       789999


Q ss_pred             ccc
Q 013258          443 ILR  445 (447)
Q Consensus       443 f~~  445 (447)
                      |.-
T Consensus       152 fg~  154 (259)
T cd05037         152 PGI  154 (259)
T ss_pred             CCc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.88  E-value=2.3e-22  Score=191.33  Aligned_cols=147  Identities=24%  Similarity=0.331  Sum_probs=123.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHH-HhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+++.. +|+.||+|+++.........++..|+.. ++..+||||+++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999965 5899999998654333334456666665 566789999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++ |+|.+++.........+++..+..++.|++.||+|||+++  +++||||||+||++++++.+||+||-
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            996 6888888764333346899999999999999999999852  79999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=2.7e-22  Score=191.41  Aligned_cols=143  Identities=27%  Similarity=0.371  Sum_probs=124.0

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||+|+||.||++... +++.||||.+.......  ....+..|+.++..++|+||+++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566788999999999999864 68999999986433222  123577899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++++||-
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999998865422  2488899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.88  E-value=1.7e-22  Score=192.35  Aligned_cols=146  Identities=25%  Similarity=0.372  Sum_probs=123.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +|...+.||+|+||.||+|+..      +++.||+|.++..........+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            3555688999999999999853      2478999999754332233468899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccC------------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          370 VYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      ++||+.+++|.+++....            .....+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123478888999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +|++||.
T Consensus       163 ~kl~Dfg  169 (283)
T cd05091         163 VKISDLG  169 (283)
T ss_pred             eEecccc
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.88  E-value=4.3e-22  Score=186.58  Aligned_cols=144  Identities=17%  Similarity=0.296  Sum_probs=126.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|+||.||+++.. +++.+|+|.++..........+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999864 588999999864433334456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....  ..+++.....++.|++.||.|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg  145 (255)
T cd08219          81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFG  145 (255)
T ss_pred             CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccC
Confidence            99999998865322  2478888999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.88  E-value=6e-22  Score=187.30  Aligned_cols=146  Identities=29%  Similarity=0.414  Sum_probs=122.3

Q ss_pred             CCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----
Q 013258          297 FSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  366 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----  366 (447)
                      |++.+.||+|+||.||+|....    +..||+|.++...... ....+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    3679999987543222 23468999999999999999999998876554     


Q ss_pred             -eEEEeecCCCCChhhHhhccCC--CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          367 -KLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       367 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                       .++++||+++|+|.+++.....  ....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7899999999999999865321  123588999999999999999999998   9999999999999999999999998


Q ss_pred             cc
Q 013258          444 LR  445 (447)
Q Consensus       444 ~~  445 (447)
                      -.
T Consensus       158 g~  159 (273)
T cd05035         158 GL  159 (273)
T ss_pred             cc
Confidence            53

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.88  E-value=1.9e-22  Score=192.22  Aligned_cols=154  Identities=26%  Similarity=0.341  Sum_probs=129.0

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEe-
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT-  362 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~-  362 (447)
                      .++.+....++|++.+.||+|+||.||+++.. +++.+|+|.++...  ....++.+|+.++..+ +||||+++++++. 
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34455567788999999999999999999864 58899999875432  2234688899999998 6999999999874 


Q ss_pred             ----cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          363 ----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       363 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                          ..+..++||||+++++|.+++.........+++..+..++.|+++||.|||+.   +|+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34568999999999999998865332233578899999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      +++||-
T Consensus       164 kl~dfg  169 (286)
T cd06638         164 KLVDFG  169 (286)
T ss_pred             EEccCC
Confidence            999984

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=3.8e-22  Score=196.60  Aligned_cols=139  Identities=24%  Similarity=0.327  Sum_probs=122.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ....+|.+.+.||+|+||.||+|+.. +++.||+|.....       ....|+.++++++||||+++++++......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34567999999999999999999965 4788999975322       235689999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||+. ++|.+++....   ..++|..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            99995 68888886543   2489999999999999999999999   99999999999999999999999995

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=2.4e-22  Score=191.59  Aligned_cols=147  Identities=25%  Similarity=0.364  Sum_probs=127.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||++... +++.||+|.++.........++.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35778899999999999999975 68999999886543333345788999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.... ....+++..+..++.|+++||.|||+.+  +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecC
Confidence            99999999887632 1234899999999999999999999632  89999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-23  Score=216.25  Aligned_cols=153  Identities=24%  Similarity=0.296  Sum_probs=135.4

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEe
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  362 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  362 (447)
                      ...+++...++|.+.++||+|+||+|..++++ +++.||+|++.+...  .....-|.+|-.+|...+.+-|++++-.|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34566777789999999999999999999965 589999999976432  223345899999999999999999999999


Q ss_pred             cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       363 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      +..++|+|||||+||+|..++....    .+++..+..++..|..||.-+|+.   |.|||||||+|||||.+|.+|++|
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999998764    388999999999999999999999   999999999999999999999999


Q ss_pred             ccc
Q 013258          443 ILR  445 (447)
Q Consensus       443 f~~  445 (447)
                      |..
T Consensus       219 FGs  221 (1317)
T KOG0612|consen  219 FGS  221 (1317)
T ss_pred             chh
Confidence            963

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.88  E-value=3.1e-22  Score=191.39  Aligned_cols=144  Identities=25%  Similarity=0.380  Sum_probs=124.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467888999999999999999864 5889999998654433334467899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+. +++.+.+....   ..+.+..+..++.|++.||+|||+.   +|+||||||+||+++.+++++++||.
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence            995 67877765432   2367888899999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=5.2e-22  Score=186.71  Aligned_cols=143  Identities=27%  Similarity=0.433  Sum_probs=125.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc----cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|++|.||+|... +++.||+|.++......    ....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999854 58999999986432211    12358899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++++|.+.+....    .+++.....++.|++.||.|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999999987643    378888999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.88  E-value=6.7e-22  Score=185.93  Aligned_cols=142  Identities=28%  Similarity=0.405  Sum_probs=123.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|.+.+.||+|+||.||+|...++..+|+|.+....  .....+.+|+++++.++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4577788999999999999998777789999886432  23456889999999999999999998875 45689999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.++++....  ..++|..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg  147 (260)
T cd05069          83 GKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFG  147 (260)
T ss_pred             CCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCc
Confidence            99999999976422  2478999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.88  E-value=5.5e-22  Score=185.68  Aligned_cols=144  Identities=24%  Similarity=0.357  Sum_probs=126.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|++|.||+|... +++.|++|.+.... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677789999999999999864 58999999986432 223345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.++++....  ..+++.....++.|++.||.|||+.   +++||||||+||++++++.++++||-
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~  146 (256)
T cd08529          81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLG  146 (256)
T ss_pred             CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccc
Confidence            999999999986422  3488899999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-23  Score=201.35  Aligned_cols=145  Identities=28%  Similarity=0.402  Sum_probs=128.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ...+.....+||-|-||+||.|.|+. .-.||||.++++..  ...+|+.|+.+|+.++|||+|+|+|+|......|+|+
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            33455667899999999999999865 67899999987643  3457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||.+|+|.++|+++....  ++--..++++.||+.||+||..+   ++|||||.++|+|+.++-.+||+||-
T Consensus       343 EfM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             ecccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            9999999999999975432  55566789999999999999999   99999999999999999999999994

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.88  E-value=1.3e-22  Score=190.39  Aligned_cols=142  Identities=32%  Similarity=0.472  Sum_probs=123.2

Q ss_pred             CCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccH-HHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |+..+.||+|+||+||+++... ++.||+|.+......... ....+|+.++..++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            3456889999999999999654 678999999655332222 23456999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++++++++++||-.
T Consensus        81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             ccccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            9999999998332    389999999999999999999999   999999999999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.88  E-value=7.5e-22  Score=185.00  Aligned_cols=141  Identities=34%  Similarity=0.531  Sum_probs=124.7

Q ss_pred             CccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||.||+|....    +..||+|.++..........+.+|++.+..++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998643    7899999997654433356789999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCC-----CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSS-----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|.+++......     ...+++..+..++.|+++||+|||++   +++||||||+||++++++.++++||-
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccc
Confidence            9999999875211     24589999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.88  E-value=3.8e-22  Score=190.83  Aligned_cols=143  Identities=30%  Similarity=0.399  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.++....  ......+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36778899999999999999865 589999999864321  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+|++||-
T Consensus        81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            9999999999987653    388899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=3.3e-22  Score=201.96  Aligned_cols=136  Identities=24%  Similarity=0.271  Sum_probs=120.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|.+.+.||+|+||.||+|+.. +++.||||....       ..+.+|++++++++|+|||++++++...+..++||||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46888899999999999999965 488999995421       2367899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. ++|.+++.....   .++|..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       242 ~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFG  305 (461)
T PHA03211        242 YR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFG  305 (461)
T ss_pred             cC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccC
Confidence            95 789888865422   489999999999999999999999   99999999999999999999999995

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=6.8e-22  Score=188.32  Aligned_cols=143  Identities=23%  Similarity=0.359  Sum_probs=124.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++..... ......+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999975 589999999864332 2223457899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++++.|..++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccc
Confidence            999988887765432    388999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=3.5e-22  Score=190.47  Aligned_cols=144  Identities=24%  Similarity=0.331  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||+||++... +++.||+|.+...........+.+|++++..++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45667789999999999999854 58899999886543333455789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...+    .+++.....++.+++.||.|||+..  +++||||||+||++++++.++++||-
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCC
Confidence            99999999887643    3889999999999999999999732  79999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.87  E-value=5.7e-22  Score=191.06  Aligned_cols=143  Identities=21%  Similarity=0.325  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+.....  ......+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888899999999999999965 478999999865432  122346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++||.
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence            9999999999997643    378999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.87  E-value=6.6e-23  Score=198.63  Aligned_cols=130  Identities=31%  Similarity=0.474  Sum_probs=117.0

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ++-||.|+-|.||+|++. ++.||||+++..        -+.+|+.|++++|||||.+.|+|......++|||||+.|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            466999999999999985 688999988542        24678899999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ++.|+..+.    +.......+..+||.||.|||.+   .|||||||+-||||..+..+||+||--
T Consensus       200 ~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  200 YEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             HHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence            999987643    66677889999999999999999   999999999999999999999999953

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=6.4e-22  Score=188.19  Aligned_cols=144  Identities=26%  Similarity=0.416  Sum_probs=125.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  367 (447)
                      ++|+..+.||+|+||.||++++.     +++.+|||.++..........+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35667789999999999999853     3678999998754332234579999999999999999999999877  5578


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|||+++++|.+++.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            999999999999999976532   389999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=7.8e-22  Score=184.85  Aligned_cols=144  Identities=22%  Similarity=0.316  Sum_probs=126.4

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||.++. .+++.+++|.+.... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999885 458899999885432 223345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++....  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|++||-
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~  146 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFG  146 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCc
Confidence            99999999997642  23478999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=6e-22  Score=186.26  Aligned_cols=143  Identities=23%  Similarity=0.370  Sum_probs=125.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||++...++..+|+|.++...  .....+.+|+++++.++|+||+++++++.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            46788889999999999999997777889999886432  233468999999999999999999999877 778999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||-
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  147 (260)
T cd05073          82 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  147 (260)
T ss_pred             CCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCc
Confidence            999999999976432  3478899999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.87  E-value=4.9e-22  Score=187.66  Aligned_cols=149  Identities=23%  Similarity=0.316  Sum_probs=125.9

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +.+++++.....||+|+||.||+|+.. ++..||+|.+..... .....+.+|+++++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            445666766788999999999999854 578899998864432 234468999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      ++||+++++|.++++..... ...++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++++||.
T Consensus        83 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence            99999999999999764221 1127788889999999999999998   9999999999999987 6789999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.87  E-value=7.4e-22  Score=188.03  Aligned_cols=144  Identities=21%  Similarity=0.361  Sum_probs=124.6

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|++|.||+|+.. +++.||+|.++...... ....+.+|+.++..++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999965 68999999986443222 234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++ ++|.+++..... ...+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++|+||.
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  146 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFG  146 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccc
Confidence            97 688888865332 23588999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.87  E-value=9.8e-22  Score=184.12  Aligned_cols=142  Identities=27%  Similarity=0.430  Sum_probs=125.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      +|+..+.||+|+||+||+|... +++.|++|.+.....    ......+.+|+++++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999965 689999998854321    12334689999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.+||+||-
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~  147 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG  147 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999997643    378999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=4.2e-22  Score=189.38  Aligned_cols=144  Identities=31%  Similarity=0.430  Sum_probs=127.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||++... ++..+|+|.++... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356788899999999999999964 58899999986432 2233468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++..+++||-
T Consensus        83 ~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          83 FCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             ccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCc
Confidence            9999999999876432   488999999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.87  E-value=4e-24  Score=187.53  Aligned_cols=146  Identities=23%  Similarity=0.308  Sum_probs=125.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++.|++.+.||+|.|+.||++.. ++|+.+|+|++.... ...+..++.+|+++.+.++||||++|.+.+.+....++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            345677778999999999999974 579999999885332 223456799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeeccccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  445 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~~  445 (447)
                      +|+|.||+|..-+-.+.    ..++..+-.++.||+++|.|+|.+   +|||||+||+|+|+.+..   -+|++||-.
T Consensus        89 Fe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             EecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence            99999999988876652    367888999999999999999999   999999999999997533   579999964

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.87  E-value=3.6e-22  Score=201.89  Aligned_cols=142  Identities=23%  Similarity=0.323  Sum_probs=117.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  364 (447)
                      ..+|+..+.||+|+||.||+|+.. +++.||||.+....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            457888999999999999999864 58899999885321     2345799999999999999999876432        


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeeccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  443 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df  443 (447)
                      ...++||||+++ ++.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999975 77777764333334588999999999999999999999   999999999999999765 6999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       216 G  216 (440)
T PTZ00036        216 G  216 (440)
T ss_pred             c
Confidence            5

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=9.2e-22  Score=185.37  Aligned_cols=137  Identities=26%  Similarity=0.380  Sum_probs=115.6

Q ss_pred             CccccCCCceEEEEEeCC-------------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          301 NILGRGGFGKVYKGRLAD-------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      +.||+|+||.||+|...+             ...|++|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998532             2258889875432 22334688899999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc-------eee
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-------QSS  440 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~~i  440 (447)
                      +++|||+++|+|..++....   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999998886543   2388999999999999999999998   9999999999999987764       788


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||.
T Consensus       154 ~d~g  157 (262)
T cd05077         154 SDPG  157 (262)
T ss_pred             CCCC
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.87  E-value=1.1e-21  Score=184.03  Aligned_cols=141  Identities=28%  Similarity=0.442  Sum_probs=123.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEe-cCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-TVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||++... +..||+|.++...   ....+.+|+.++++++|+|++++++++. ..+..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46788899999999999999874 7889999886432   3456899999999999999999999765 45678999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.++++....  ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+|++||-
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg  147 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFG  147 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCc
Confidence            999999999976432  2478999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.87  E-value=7.2e-22  Score=189.63  Aligned_cols=141  Identities=23%  Similarity=0.353  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|+..+.||+|+||.||+++. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            5688889999999999999995 4689999999864332 2334688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.+.     .+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.++++||-
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCc
Confidence            9999999998653     278889999999999999999998   99999999999999999999999994

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=7.4e-22  Score=186.10  Aligned_cols=143  Identities=27%  Similarity=0.419  Sum_probs=122.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  367 (447)
                      .+|+..+.||+|+||.||+|+.. +++.||+|.+......    .....+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46788899999999999999864 5899999988533211    1123688899999999999999999988764  457


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+|+||||+||++++++.++++||.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence            89999999999999987543    278888999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.87  E-value=1e-21  Score=183.55  Aligned_cols=138  Identities=29%  Similarity=0.466  Sum_probs=123.1

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChh
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  380 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  380 (447)
                      ++||+|+||.||++...+++.||+|.++..........+.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999976699999999865443334457899999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          381 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       381 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++.....   .+++.....++.+++.||+|||++   +++||||||+||++++++.++++||.
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecc
Confidence            99876432   378889999999999999999999   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.87  E-value=8.1e-22  Score=189.15  Aligned_cols=142  Identities=27%  Similarity=0.436  Sum_probs=124.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      +|+..+.||+|+||.||+|... +++.||||.++.....    .....+..|+++++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677789999999999999964 5899999999654322    1233577899999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+ +|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+||++++++.++|+||-
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg  147 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG  147 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccce
Confidence            9999 899999997643   2489999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.87  E-value=1.4e-22  Score=195.91  Aligned_cols=146  Identities=24%  Similarity=0.349  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeEEecCCc-eEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-KLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lv~  371 (447)
                      ++|...+++|+|+||.++..+.+ +++.+++|.+........ +.....|+.++++++|||||.+.+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999988854 578999999975543333 3368899999999999999999999998888 99999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      +|++||++.+.+.+.+.  ..+++.....++.|++.|+.|||++   +|+|||||+.||+++.+..+|++||.-
T Consensus        84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence            99999999999988653  3478889999999999999999988   999999999999999999999999963

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=5.5e-22  Score=194.42  Aligned_cols=143  Identities=24%  Similarity=0.334  Sum_probs=121.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  364 (447)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.++..... .....+.+|+++++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457899999999999999999985 46889999998643221 2234577899999999999999999887542      


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...++++|++ +++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            4568999988 78998877542     388999999999999999999999   99999999999999999999999994

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.87  E-value=5.3e-22  Score=187.74  Aligned_cols=145  Identities=31%  Similarity=0.481  Sum_probs=124.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC------
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV------  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------  364 (447)
                      +++.|+..+.||+|+||+||+|... +++.||+|.+....  .....+.+|+.++.++ +|+||+++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4566778889999999999999864 58899999985432  3345688999999988 799999999998753      


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...+++|||+.+|+|.+++.....  ..++|..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            457899999999999999876432  2478999999999999999999998   99999999999999999999999995

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.87  E-value=1.2e-21  Score=183.80  Aligned_cols=135  Identities=25%  Similarity=0.380  Sum_probs=116.9

Q ss_pred             ccccCCCceEEEEEe---CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          302 ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      .||+|+||.||+|.+   .++..+|+|+++..... ....++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   35788999998644322 22346899999999999999999999875 45678999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+|++||-
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg  140 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG  140 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCc
Confidence            9999997543    378999999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.87  E-value=8.8e-22  Score=184.61  Aligned_cols=138  Identities=35%  Similarity=0.450  Sum_probs=121.1

Q ss_pred             CccccCCCceEEEEEeCC--C--cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLAD--G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|++|.||+|.+.+  +  ..||+|.++..........+.+|++++++++||||+++++++.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  36999999765443344579999999999999999999999888 889999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++.....  ..++|.....++.|++.||+|||+.   +++||||||+||+++.++.+|++||.
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg  142 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG  142 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccc
Confidence            999999987532  3489999999999999999999999   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.87  E-value=4.7e-22  Score=187.61  Aligned_cols=142  Identities=26%  Similarity=0.403  Sum_probs=125.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            3566678899999999999985 4588999999865422 2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....    .+++.+...++.|++.||.|||+.   +|+||||||+||+++.++.++++||-
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg  151 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFG  151 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcce
Confidence            99999999987543    388999999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=9e-22  Score=186.21  Aligned_cols=142  Identities=27%  Similarity=0.416  Sum_probs=123.3

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc---------cHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG---------GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      +|...+.||+|+||.||+|... +++.||+|.++......         ....+.+|+.++..++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566789999999999999854 68999999885321111         1124778999999999999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..++||||+++|+|.++++...    .+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence            9999999999999999997652    388899999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.87  E-value=9.2e-22  Score=189.44  Aligned_cols=143  Identities=28%  Similarity=0.481  Sum_probs=121.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||.||+|... ++.    .+|+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45777899999999999999853 444    57899886543333344688999999999999999999998754 4679


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+|++||-
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence            9999999999999876432   378899999999999999999999   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.87  E-value=4.1e-22  Score=189.20  Aligned_cols=140  Identities=31%  Similarity=0.481  Sum_probs=123.3

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |+..+.||+|+||.||+|... +++.||+|.++..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            444577999999999999864 5789999998654333334568999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|.+++...     .+++..+..++.|+++|+.|||+.   +++|+||||+||++++++.++++||-
T Consensus        86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccc
Confidence            99999988642     378899999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.87  E-value=1.1e-22  Score=184.32  Aligned_cols=147  Identities=24%  Similarity=0.354  Sum_probs=123.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-----CcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEec-CCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  366 (447)
                      ...|+....||+|.||.||+|.-.+     .+.+|+|.++.+.... -.....+|+.+++.++||||++|..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3468888999999999999996322     3479999997654322 24568999999999999999999998877 778


Q ss_pred             eEEEeecCCCCChhhHhhccCCC-CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC----Cceeec
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSK  441 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~~i~  441 (447)
                      .+|++||.+. +|.+.++-++.. ...++-..+..|..||+.|+.|||++   -|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            8999999987 899998764322 23577888999999999999999999   89999999999999988    889999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      |+-
T Consensus       179 DlG  181 (438)
T KOG0666|consen  179 DLG  181 (438)
T ss_pred             ccc
Confidence            983

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=9.2e-22  Score=190.50  Aligned_cols=145  Identities=30%  Similarity=0.335  Sum_probs=127.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.......  ....+.+|++++..++|+||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999965 48999999986543222  3346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+.+++|.+++....  ...+++.....++.|+++||+|||+.   +++||||||+||+++.++.++++||-
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence            9999999999987532  23488999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=1.2e-21  Score=187.53  Aligned_cols=143  Identities=29%  Similarity=0.409  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|++.+.||+|+||.||+|+.. +++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56788899999999999999965 48899999986432 22345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|..++.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||-
T Consensus        91 ~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  155 (292)
T cd06644          91 CPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFG  155 (292)
T ss_pred             CCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCc
Confidence            999999888765332   388999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.3e-23  Score=195.05  Aligned_cols=143  Identities=33%  Similarity=0.439  Sum_probs=128.9

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .|...+.||+|+||.||+|.. .+++.||+|++.-+...+...++++|+.++..++++||.+++|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            466678899999999999995 4689999999987766666667999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .+|++.+.|....    .+++....-|.+++..||.|||++   +.+|||||+.|||+.++|++|++||..
T Consensus        94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecce
Confidence            9999999997653    247777888999999999999999   999999999999999999999999964

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.87  E-value=8.3e-22  Score=186.30  Aligned_cols=143  Identities=24%  Similarity=0.338  Sum_probs=122.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|...+.||+|+||.||+|...+    ...||||.............+.+|+.+++.++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457778999999999999998543    246899988654433344578999999999999999999998865 557899


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||-
T Consensus        85 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          85 MELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence            999999999999976432   378999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.87  E-value=4.6e-22  Score=189.57  Aligned_cols=143  Identities=24%  Similarity=0.397  Sum_probs=125.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....... ....+.+|+++++.++||||+++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35778899999999999999975 58999999986433222 23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.++.....    .++|.....++.|+++||+|||+.   +|+||||+|+||++++++.++++||.
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeee
Confidence            999998887765432    388999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.87  E-value=1.1e-21  Score=187.74  Aligned_cols=145  Identities=28%  Similarity=0.453  Sum_probs=124.4

Q ss_pred             CCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +|...+.||+|+||.||+|+..      ++..+++|.++... ......+.+|++++++++|+||+++++++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4677789999999999999742      34568999886432 2223468999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          370 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      ||||+++++|.+++.....            ....++|..+..++.|++.||+|||++   +|+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999975421            122478999999999999999999999   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      ++++||-
T Consensus       162 ~~l~dfg  168 (291)
T cd05094         162 VKIGDFG  168 (291)
T ss_pred             EEECCCC
Confidence            9999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.87  E-value=1.1e-21  Score=186.74  Aligned_cols=144  Identities=26%  Similarity=0.460  Sum_probs=126.0

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|++|.||+|+.. +|+.||||.++..........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 588999999876543334456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++ +|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||-
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecc
Confidence            85 88888865432 23589999999999999999999998   99999999999999999999999983

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN03150 hypothetical protein; Provisional

Probab=99.87  E-value=1.1e-21  Score=205.00  Aligned_cols=160  Identities=34%  Similarity=0.619  Sum_probs=131.5

Q ss_pred             ccCchHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC-----ccceeEeCCC-----CCEEEEEcCCCCccccccccccCC
Q 013258           21 MISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLC-----TWFHITCNPE-----GSVTRVDLGNAALSGELAPELGQL   90 (447)
Q Consensus        21 ~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~v~~l~L~~~~l~g~~~~~l~~l   90 (447)
                      ..+...|+.||+.+|..+.++..  .+|++   ++|     .|.||.|...     ..|+.|+|++|.+.|.+|+.++.|
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L  441 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL  441 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence            34567799999999999876542  48964   566     6999999521     248999999999999999999999


Q ss_pred             CCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcc-cccccc
Q 013258           91 KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT-SLNILD  169 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~l~  169 (447)
                      ++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|+.|+|++|+++|.+|..+.... ++.   
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~---  518 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA---  518 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc---
Confidence            9999999999999999999999999999999999999999999999999999999999999999998876531 122   


Q ss_pred             cccccccccCCCCCCCCccccccccccccccCCCCCCCC
Q 013258          170 LSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC  208 (447)
Q Consensus       170 ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~C  208 (447)
                                          ..++.+|..+|+.+....|
T Consensus       519 --------------------~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        519 --------------------SFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             --------------------eEEecCCccccCCCCCCCC
Confidence                                2346677778876554556

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.1e-23  Score=199.61  Aligned_cols=142  Identities=31%  Similarity=0.445  Sum_probs=121.8

Q ss_pred             CCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||.|+||.||-|+. .+...||||.+.-......  -.++..|+..|..++|||+|.+.|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999995 5688999999853322222  23689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |- ||-.+++.-.+.   ++.+-.+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.+|++||..
T Consensus       108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence            96 577777765433   477888999999999999999999   999999999999999999999999965

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.87  E-value=8.2e-22  Score=189.17  Aligned_cols=141  Identities=22%  Similarity=0.352  Sum_probs=125.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|+..+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4677888999999999999985 4688999998865432 2345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...     .+++.+...++.|++.||+|||+.   +|+||||||+||++++++.++|+||-
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccc
Confidence            9999999998643     278899999999999999999999   99999999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.87  E-value=1.4e-21  Score=183.16  Aligned_cols=142  Identities=27%  Similarity=0.479  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .+|+..+.||+|+||.||++.+.+++.+|+|.++...  ....++.+|+++++.++|||++++++++......+++|||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            3567778999999999999998778899999886432  23457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|.+++.....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++||-
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          82 EHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCc
Confidence            99999999876432   378899999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.87  E-value=4.6e-22  Score=190.23  Aligned_cols=154  Identities=31%  Similarity=0.414  Sum_probs=129.7

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      .++++...+++|+..+.||+|+||.||++.. .+++.+|+|.+....  ....++.+|+.++.++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3445555678899999999999999999986 468899999985432  2234678899999988 89999999999875


Q ss_pred             C-----CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          364 V-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       364 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      .     +..++|+||+++|+|.++++........+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999998875332333588999999999999999999998   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      |++||.
T Consensus       168 kl~dfg  173 (291)
T cd06639         168 KLVDFG  173 (291)
T ss_pred             EEeecc
Confidence            999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.5e-21  Score=183.24  Aligned_cols=136  Identities=30%  Similarity=0.459  Sum_probs=118.7

Q ss_pred             CccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||.||+|....    +..+|+|.++.........++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997532    26899999876544334557899999999999999999999876 4568999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+|++||-
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~  140 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFG  140 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccc
Confidence            99999997653    388999999999999999999998   99999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.87  E-value=1.4e-21  Score=183.71  Aligned_cols=138  Identities=31%  Similarity=0.458  Sum_probs=116.2

Q ss_pred             CccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEeecCC
Q 013258          301 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYMT  375 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~~  375 (447)
                      +.||+|+||.||+|...    +...+|+|.+...........+.+|+.+++.++||||+++++++.. .+..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999988543322334568899999999999999999998764 556789999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+|.+++.....   ..++.....++.|+++||+|||+.   +++||||||+|||+++++.+|++||-
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            9999999976432   257788899999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.87  E-value=6.6e-22  Score=195.10  Aligned_cols=142  Identities=23%  Similarity=0.278  Sum_probs=120.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  365 (447)
                      ..++|+..+.||+|+||.||+++.. +|+.||||.++.... ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3467999999999999999999864 589999999864322 223446889999999999999999999886543     


Q ss_pred             -ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                       ..++||||+.+ ++.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46999999975 56666543      277888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.87  E-value=1.2e-21  Score=184.66  Aligned_cols=143  Identities=29%  Similarity=0.423  Sum_probs=124.6

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +|+..+.||+|+||.||++.. .+++.||+|.++......     ....+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 568999999986432111     13468899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeeccccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  445 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~~  445 (447)
                      |+||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++ .++++||..
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999997643    378999999999999999999999   999999999999999876 589999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.7e-21  Score=183.81  Aligned_cols=141  Identities=28%  Similarity=0.457  Sum_probs=123.5

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc--------HHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      |...+.||+|+||.||+|... +++.+|+|.+........        ...+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            566789999999999999864 588999998864332211        13578999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+++++|.+++....    .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||-
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence            99999999999999997643    378889999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.87  E-value=2e-21  Score=181.89  Aligned_cols=143  Identities=34%  Similarity=0.513  Sum_probs=125.5

Q ss_pred             CCCCCccccCCCceEEEEEeCC-----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          297 FSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      |++.+.||+|+||.||+++..+     +..||+|.++..........+..|++.+..++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456889999999999998653     38899999976543334567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++......  .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||-
T Consensus        81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            999999999998764321  178999999999999999999999   99999999999999999999999984

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.87  E-value=1.7e-21  Score=216.01  Aligned_cols=190  Identities=32%  Similarity=0.557  Sum_probs=131.9

Q ss_pred             hHHHHHHHHHHHHHhcccCchHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCccceeEeCCCCCEEEEEcCCCCcccccc
Q 013258            5 VLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELA   84 (447)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~v~~l~L~~~~l~g~~~   84 (447)
                      |-|++|++.+ +......+...|..||+.||.++.+|...+.+|+. ..++|.|.||+|+..++|+.|||++|.++|.++
T Consensus         9 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~   86 (968)
T PLN00113          9 CPYLIFMLFF-LFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKIS   86 (968)
T ss_pred             CChHHHHHHH-HHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCC
Confidence            4454444332 33344445678999999999999988888999964 468999999999977899999999999999999


Q ss_pred             ccccCCCCCCEEECCCCccCCCCChhhc-CCCCCcEEEccCCcccccCC----------------------ccccCCCCC
Q 013258           85 PELGQLKNLELLELYGNNLSGHIPSALG-NLIKLKSLDLYSNLFNGTIP----------------------DTLANLKQL  141 (447)
Q Consensus        85 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p----------------------~~~~~l~~L  141 (447)
                      +.+..+++|+.|+|++|.++|.+|..+. .+++|++|+|++|+++|.+|                      ..++++++|
T Consensus        87 ~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L  166 (968)
T PLN00113         87 SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL  166 (968)
T ss_pred             hHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCC
Confidence            9999999999999999999988888765 77777777777777665554                      444445555


Q ss_pred             CeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       142 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                      ++|+|++|.+.+.+|..++++++|+.|++++|.+++.+|.. +.+..++.+.+.+|
T Consensus       167 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n  222 (968)
T PLN00113        167 KVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN  222 (968)
T ss_pred             CEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCC
Confidence            55555555555555555555555555555555555544432 22333444444433

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.87  E-value=6.1e-22  Score=185.85  Aligned_cols=142  Identities=26%  Similarity=0.350  Sum_probs=126.3

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +|+..+.||+|+||.||+|+.. +++.||+|.+......  .....+.+|++++++++||||+++++++...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4777899999999999999965 5899999998654321  234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+.+++|.+++...    ..+++.....++.|+++||.|||+.   +++|+||||+||++++++.++++||-
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999998764    2488899999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.87  E-value=4e-22  Score=195.04  Aligned_cols=145  Identities=28%  Similarity=0.423  Sum_probs=128.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC---C--cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD---G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      ..+.....+.||+|-||.||+|.+.+   |  -.||||..+.+...+....|+.|..+|+.++|||||+++|+|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            33445556889999999999998532   2  35899999888777777789999999999999999999999876 458


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|||.++-|.|.++|+..+..   ++......++.|+..||+|||+.   ++|||||..+|||+.+...+|++||.
T Consensus       466 WivmEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eEEEecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            9999999999999999987653   78888999999999999999999   99999999999999999999999995

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.87  E-value=1.5e-21  Score=185.46  Aligned_cols=141  Identities=30%  Similarity=0.454  Sum_probs=125.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4666788999999999999864 588999999865433333456899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++...     .+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++++||.
T Consensus        85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccc
Confidence            999999998643     378888999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.87  E-value=1.6e-21  Score=185.19  Aligned_cols=140  Identities=31%  Similarity=0.473  Sum_probs=124.2

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            666788999999999999864 6889999988644333334568899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|.+++...     .+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++++||-
T Consensus        86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecc
Confidence            99999998642     378999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=1e-21  Score=187.63  Aligned_cols=147  Identities=27%  Similarity=0.349  Sum_probs=125.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  371 (447)
                      ++|...+.||.|++|.||++... +++.+|+|.+..........++.+|+++++.++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777889999999999999974 58899999986543333455789999999999999999999988653  4689999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++.........+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++++||-
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence            99999999988765333334578889999999999999999998   99999999999999999999999984

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.86  E-value=1.7e-21  Score=185.46  Aligned_cols=141  Identities=30%  Similarity=0.454  Sum_probs=123.1

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |++.+.||+|+||.||+|+.. ++..+++|.+.... ......+.+|+++++.++||||+++++++...+..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            455678999999999999965 47888999885432 2233468899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|..++....   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            999998876532   2489999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.2e-21  Score=182.33  Aligned_cols=143  Identities=31%  Similarity=0.454  Sum_probs=127.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+++++.++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            56888899999999999999864 5789999998654322 445789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.++++||-
T Consensus        82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccc
Confidence            99999999887642   2388899999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.86  E-value=1.8e-21  Score=182.35  Aligned_cols=140  Identities=30%  Similarity=0.474  Sum_probs=122.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...   ....+.+|+.++..++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4577889999999999999975 57889999886432   234688999999999999999999988654 579999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||-
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCc
Confidence            99999999976432  2478899999999999999999998   99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.86  E-value=3.6e-23  Score=186.42  Aligned_cols=140  Identities=28%  Similarity=0.457  Sum_probs=126.2

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |++.+.||+|+||.||++.++ .|+.+|+|.+..+   .+.+++..|+.+|++++.|++|++||.|.....+|+|||||-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            455688999999999999865 5999999998654   345679999999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .|+..+.++.+.   .++.+.....+....++||+|||..   .-||||||+.|||++-+|.+|++||-.
T Consensus       112 AGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  112 AGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             CCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccc
Confidence            999999998754   3589999999999999999999998   789999999999999999999999964

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.86  E-value=2.5e-21  Score=181.22  Aligned_cols=141  Identities=30%  Similarity=0.457  Sum_probs=127.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.++....   ..++.+|+++++.++||||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578888999999999999999764 78999999865422   45799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....   ..+++.....++.|++.||.|||+.   +|+||||+|+||++++++.++++||-
T Consensus        80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccc
Confidence            99999999987543   2489999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.8e-21  Score=184.49  Aligned_cols=142  Identities=30%  Similarity=0.411  Sum_probs=127.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+...........+.+|+++++.++|+||+++++++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35777889999999999999965 58899999986544333445688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++||.
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            9999999998754     488999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.86  E-value=2e-21  Score=184.88  Aligned_cols=146  Identities=31%  Similarity=0.465  Sum_probs=125.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      .+|...+.||+|+||.||++...      ++..+|+|.++... ......+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            35677899999999999999642      35689999886432 233457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCC-----------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          369 LVYPYMTNGSVASRLRERQSS-----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      ++|||+++|+|.++++.....           ...+++..+..++.|++.|++|||+.   +++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            999999999999998764311           12478999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      ++++||.
T Consensus       161 ~kL~dfg  167 (280)
T cd05092         161 VKIGDFG  167 (280)
T ss_pred             EEECCCC
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.86  E-value=1.4e-21  Score=183.98  Aligned_cols=143  Identities=31%  Similarity=0.404  Sum_probs=127.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|+||.||++... +++.+|+|.+..........++.+|+++++.++||||+++++++...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677789999999999999975 589999999876543444557899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|.+++....   ..+++.....++.|++.||+|||+ .   +++||||||+||++++++.++++||-
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            9999999997643   347888999999999999999999 7   99999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.86  E-value=9.3e-22  Score=193.75  Aligned_cols=142  Identities=23%  Similarity=0.289  Sum_probs=120.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  364 (447)
                      ..++|+..+.||+|+||.||+++.. +++.||||.+..... ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999854 588999999865332 22234678899999999999999999988643      


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...++||||+++ ++.+.+..      .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346999999965 67666643      278888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.86  E-value=2.4e-21  Score=182.06  Aligned_cols=143  Identities=29%  Similarity=0.437  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|++|.||+|+.. +++.|+||.+...........+.+|+..+..++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999976 48999999986554333455799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....    .+++.....++.|+++|++|||+ .   +++||||+|+||+++.++.++++||-
T Consensus        81 ~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          81 MDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999997642    48899999999999999999999 8   99999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=2.2e-21  Score=182.47  Aligned_cols=142  Identities=30%  Similarity=0.479  Sum_probs=126.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999864 6899999998654332 2345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....    .+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+|++||.
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g  144 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG  144 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccc
Confidence            99999999987642    378889999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.86  E-value=1.8e-21  Score=185.78  Aligned_cols=143  Identities=29%  Similarity=0.438  Sum_probs=117.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeEEec-----CC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----VT  365 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~  365 (447)
                      +|++.+.||+|+||+||+|+.. +++.||+|.++...... ....+.+|++++..+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777899999999999999865 68999999986543222 223466777777655   79999999998764     24


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..+++|||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|++||-
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence            5789999997 488888875432  2378999999999999999999999   99999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.86  E-value=1.2e-21  Score=184.88  Aligned_cols=141  Identities=32%  Similarity=0.492  Sum_probs=120.7

Q ss_pred             CccccCCCceEEEEEeCC-------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          301 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.||+|+||.||+|+..+       ++.+|+|.+..........++.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2579999886543333455789999999999999999999999998999999999


Q ss_pred             CCCCChhhHhhccCC---CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-----ceeecccc
Q 013258          374 MTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~~i~df~  444 (447)
                      +++|+|.+++.....   ....++|..+..++.|++.||+|||+.   +++|+||||+||++++++     .++++||.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999976422   123478899999999999999999998   999999999999999887     89999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.5e-21  Score=183.71  Aligned_cols=141  Identities=26%  Similarity=0.439  Sum_probs=125.2

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .|+..+.||+|+||.||+|.. .+++.||+|.++.........++.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            366778999999999999996 4689999999865443344456889999999987   999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.++++..     .+++.....++.|++.||.|||+.   +|+||||+|+||++++++.++++||-
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            999999999988653     388999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.86  E-value=5.9e-22  Score=196.52  Aligned_cols=142  Identities=27%  Similarity=0.403  Sum_probs=124.2

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-C-----CCccceeeEEecCCceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H-----RNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~  368 (447)
                      +|.+.++||+|+||+|-+|.. .+++.||||+++...  .-..+-..|+.+|..++ |     -|+|++++++...++.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            678899999999999999984 569999999997653  23446788999999887 4     48999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC--ceeeccccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTILR  445 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--~~~i~df~~  445 (447)
                      +|+|.+. -+|+++|+.....  .++......|+.||+.||.+||..   +|||+|||||||||.+-.  .+||.||-.
T Consensus       265 iVfELL~-~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999885 4999999987543  488899999999999999999999   999999999999998754  789999964

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.86  E-value=3.9e-21  Score=181.32  Aligned_cols=142  Identities=27%  Similarity=0.448  Sum_probs=122.4

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc----ccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~  368 (447)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....    .....+.+|+.+++.++||||+++++++..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6888899999999999999864 5899999988543211    122358889999999999999999998865  35678


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++||+++++|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        83 l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence            9999999999999987643    378899999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=1.3e-21  Score=195.27  Aligned_cols=137  Identities=25%  Similarity=0.283  Sum_probs=120.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...      ....+|+++++.++||||+++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            356888999999999999999753   3578999987532      2356899999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+. ++|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+||.
T Consensus       165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            99995 6888888433    2489999999999999999999999   99999999999999999999999995

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=2.5e-21  Score=185.04  Aligned_cols=142  Identities=27%  Similarity=0.332  Sum_probs=123.2

Q ss_pred             CCCCCCccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          296 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      +|++.+.||+|+||.||+++.    .+|+.||+|+++....   ......+.+|++++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999985    3688999999864321   12234678899999999 599999999999988899


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+||+++++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+|||+++++.++++||.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence            99999999999999987643    378888999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=9.2e-22  Score=184.84  Aligned_cols=137  Identities=26%  Similarity=0.406  Sum_probs=115.8

Q ss_pred             CccccCCCceEEEEEeCC-C-------cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          301 NILGRGGFGKVYKGRLAD-G-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +.||+|+||.||+|.... +       ..+|+|.+.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            469999999999998532 2       348888775332 2223468899999999999999999999999899999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc--------eeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------QSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~~i~df~  444 (447)
                      |+++|+|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.+++        ++++||.
T Consensus        80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999976532   478999999999999999999999   9999999999999998876        4788874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.86  E-value=3.9e-21  Score=181.01  Aligned_cols=146  Identities=29%  Similarity=0.421  Sum_probs=128.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||+||+|... ++..+|+|++...........+.+|++.++.++|+||+++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888899999999999999854 58899999986544333455799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.++++.... ...+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~  147 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFG  147 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence            999999999976422 12478999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.86  E-value=2.7e-21  Score=181.17  Aligned_cols=144  Identities=20%  Similarity=0.300  Sum_probs=125.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.+|+++.. +++.||+|.+..... .....++.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4777899999999999999854 689999999864322 22334789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+.+.....  ..+++.....++.|++.|++|||+.   +++|+||+|+||++++++.++++||.
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~  146 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG  146 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999876432  2378899999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.86  E-value=2.7e-21  Score=184.22  Aligned_cols=142  Identities=26%  Similarity=0.392  Sum_probs=125.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++..... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999964 689999999865432 22244689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      + +++|.+++....   ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg  144 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFG  144 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeee
Confidence            9 999999987643   3489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.86  E-value=2e-21  Score=192.06  Aligned_cols=141  Identities=22%  Similarity=0.284  Sum_probs=119.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC------C
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  365 (447)
                      .++|+..+.||+|+||.||+++.. +++.||||.+..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467899999999999999999854 588999999865322 22334688999999999999999999987543      3


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..++||||+++ +|.+.+..      .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            46999999965 77777643      277888999999999999999999   99999999999999999999999995

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.86  E-value=2.2e-21  Score=184.80  Aligned_cols=143  Identities=22%  Similarity=0.441  Sum_probs=124.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|++|.||+|+.. +++.||||.++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999864 5899999998654322 2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++||.
T Consensus        81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg  145 (284)
T cd07860          81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  145 (284)
T ss_pred             cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            95 689888865432  3488999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.1e-21  Score=188.45  Aligned_cols=135  Identities=21%  Similarity=0.233  Sum_probs=108.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC--CCcEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccc-eeeEEecC
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLR-LYGFCTTV  364 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~  364 (447)
                      ...++|...+.||+|+||+||+|+..  +++.||||++.....    ......|.+|++++..++|+|+++ +++    .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence            44577999999999999999999864  477789998753211    112346899999999999999985 443    2


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCC-CCCceeeCCCCceeeccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  443 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~~i~df  443 (447)
                      +..++||||+++++|... ..       ..   ...++.|+++||+|||+.   +|+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            457999999999999632 11       01   146788999999999999   9999999 999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       157 G  157 (365)
T PRK09188        157 Q  157 (365)
T ss_pred             c
Confidence            5

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.86  E-value=1.5e-21  Score=185.92  Aligned_cols=142  Identities=22%  Similarity=0.428  Sum_probs=122.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||+|+.. +|+.||+|.++..... .....+.+|+++++.++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3677789999999999999965 5899999998643222 2234578899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. ++|.+++....   ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.++++||.
T Consensus        81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg  144 (284)
T cd07839          81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFG  144 (284)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccc
Confidence            97 58888776532   2389999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=1.1e-21  Score=208.49  Aligned_cols=153  Identities=16%  Similarity=0.263  Sum_probs=124.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec--CCce
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  367 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~  367 (447)
                      ...++|.+.+.||+|+||+||+|+.. ++..+|+|.+...... .....+..|+.++..++|||||++++++..  ....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34567888999999999999999965 5788999998643322 223468999999999999999999998854  3568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCC----CCeeecCCCCCceeeCCC--------
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD----PKIIHRDVKAANILLDED--------  435 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivHrDlkp~NILl~~~--------  435 (447)
                      ++||||+++|+|.++|.........+++..+..|+.||+.||+|||+...    .+||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999997643333458999999999999999999998521    259999999999999753        


Q ss_pred             ---------Cceeecccc
Q 013258          436 ---------ADQSSKTIL  444 (447)
Q Consensus       436 ---------~~~~i~df~  444 (447)
                               ..+||+||-
T Consensus       170 ~~~~n~ng~~iVKLsDFG  187 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFG  187 (1021)
T ss_pred             ccccccCCCCceEEccCC
Confidence                     348999985

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.86  E-value=2.6e-21  Score=185.74  Aligned_cols=141  Identities=21%  Similarity=0.363  Sum_probs=125.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3578889999999999999985 468999999886432 22345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...     .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++++||.
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999988653     378999999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.86  E-value=2.6e-21  Score=185.27  Aligned_cols=143  Identities=24%  Similarity=0.373  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv  370 (447)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46778899999999999999975 58899999996543222 233577899999999999999999998877  889999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+. ++|.+.+.....   .+++.....++.|+++||+|||+.   +++||||||+||++++++.++++||-
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence            99997 599888876432   489999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.86  E-value=3.7e-21  Score=180.76  Aligned_cols=149  Identities=23%  Similarity=0.333  Sum_probs=124.2

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~  371 (447)
                      +|+..+.||+|+||.||++.. .+++.+|+|.++.... .....++..|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477789999999999999985 4688999999864332 2223468899999999999999999998764  34578999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC--CCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++.........+++..+..++.|++.||+|||..+  ..+++|+||||+||++++++.+|++||.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999765333446899999999999999999999221  2299999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4e-22  Score=188.82  Aligned_cols=148  Identities=28%  Similarity=0.395  Sum_probs=129.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      +..+.|..-++||+|+||+||-++.+ +|+.||.|.+.+..  ...++.-.+.|-.++.+++.+.||.+--.|.+.+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            33456888899999999999999854 69999999885432  2233445788999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+..|.||+|.-+|...+.  +.+++..+..++.+|+.||++||..   +||.||+||+|||+|++|+++|+|+-
T Consensus       262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccc
Confidence            99999999999998877653  4599999999999999999999999   99999999999999999999999974

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=4.7e-21  Score=180.60  Aligned_cols=143  Identities=27%  Similarity=0.433  Sum_probs=122.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc----cccHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  367 (447)
                      .+|...+.||+|+||.||+|+.. +++.||+|.+.....    ......+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            36788899999999999999864 589999998743211    12234688999999999999999999988764  457


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+++++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||++++++.++++||.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence            89999999999999987543    278889999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.85  E-value=4.2e-21  Score=183.84  Aligned_cols=146  Identities=26%  Similarity=0.404  Sum_probs=122.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCC-CCCccceeeEEecCCc-----
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE-----  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----  366 (447)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999965 5899999988654322 22346888999999995 6999999999887665     


Q ss_pred             eEEEeecCCCCChhhHhhccCCC-CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      .+++|||+++ +|.+++...... ...+++..+..++.|+++||+|||+.   +|+||||||+||+++. ++.++++||-
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 888888654322 23579999999999999999999999   9999999999999999 8899999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.85  E-value=5.1e-21  Score=185.34  Aligned_cols=138  Identities=22%  Similarity=0.339  Sum_probs=113.4

Q ss_pred             CCccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEeecC
Q 013258          300 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  374 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~  374 (447)
                      .+.||+|+||+||+|+..   +++.||+|.++...   ....+.+|+++++.++||||+++++++..  ....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            367999999999999854   46789999986432   23457899999999999999999998854  45678999998


Q ss_pred             CCCChhhHhhccCC-----CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee----CCCCceeecccc
Q 013258          375 TNGSVASRLRERQS-----SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~~i~df~  444 (447)
                      . ++|.+++.....     ....+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+||.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            6 588887754321     122478888999999999999999999   99999999999999    456789999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.85  E-value=4.8e-21  Score=181.90  Aligned_cols=137  Identities=28%  Similarity=0.395  Sum_probs=119.7

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||+||++... +|+.||+|.+.....  ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 589999999864321  22234577899999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++||-
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg  140 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLG  140 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence            999876532  2488999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.85  E-value=7e-21  Score=180.11  Aligned_cols=145  Identities=27%  Similarity=0.400  Sum_probs=119.4

Q ss_pred             CCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 013258          297 FSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  365 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  365 (447)
                      |.+.+.||+|+||.||+|.+.    +++.||||.++.... .....++.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999853    368899999865432 223446889999999999999999999886532      


Q ss_pred             ceEEEeecCCCCChhhHhhccC--CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      ..++++||+.+|+|.+++....  .....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875422  1122478889999999999999999998   9999999999999999999999998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       158 g  158 (273)
T cd05074         158 G  158 (273)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.85  E-value=2.6e-21  Score=186.03  Aligned_cols=139  Identities=27%  Similarity=0.360  Sum_probs=118.1

Q ss_pred             CCccccCCCceEEEEEe-CCCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      .++||+|-||+||-|.. ++|+.||||++.+.. ....+.++.+|+++|..++||.||.+.--|++++..+.|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            38899999999999985 469999999996544 33445679999999999999999999999999999999999995 5


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~  444 (447)
                      +..+.+-...  ...+++..-..++.||+.||.|||.+   +|+|+||||+|||+.+..   ++|++||-
T Consensus       648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            6666554432  23488888889999999999999999   999999999999998653   78999994

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=5.8e-21  Score=180.51  Aligned_cols=147  Identities=32%  Similarity=0.440  Sum_probs=127.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCC-----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT-----  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-----  365 (447)
                      .+++|+..+.||+|+||.||+|... +++.+++|.++...  ....++.+|+.+++++ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999975 57899999986442  2345689999999998 7999999999987644     


Q ss_pred             -ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                       ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++||-
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999876432234588999999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.85  E-value=5.1e-21  Score=182.04  Aligned_cols=136  Identities=29%  Similarity=0.361  Sum_probs=113.8

Q ss_pred             ccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHH---hcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          302 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      .||+|+||.||++... +++.+|+|.+.......  ....+.+|..++   ...+||||+++++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 58999999886543221  122344454433   34479999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||.
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCC
Confidence            999999987643    389999999999999999999999   99999999999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.85  E-value=2.6e-21  Score=185.32  Aligned_cols=136  Identities=26%  Similarity=0.362  Sum_probs=120.3

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      ...||+|+||.||++... ++..||||.+.... ......+.+|+..++.++|+||+++++.+...+..++||||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            466999999999999864 58899999885432 2234468899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.+++...     .+++.....++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus       106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658         106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence            99987542     278899999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.85  E-value=6e-21  Score=178.84  Aligned_cols=144  Identities=22%  Similarity=0.322  Sum_probs=123.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC-CceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e  372 (447)
                      +|+..+.||+|++|.||++... +++.||+|.+..... ......+.+|++++++++|+|++++++.+... ...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999864 578999999864332 22334688999999999999999999887644 45789999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++.....  ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEeccc
Confidence            9999999999976422  2478999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.85  E-value=4.5e-21  Score=186.75  Aligned_cols=139  Identities=29%  Similarity=0.408  Sum_probs=119.7

Q ss_pred             CccccC--CCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|  +||+||+++.. +|+.||+|.+...... .....+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  89999999864 6999999998654322 2234688999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++..++.||.
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence            999999876432  2378889999999999999999998   99999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.7e-22  Score=181.73  Aligned_cols=145  Identities=28%  Similarity=0.344  Sum_probs=126.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ..++|+..++||+|.||+|..++ ..+++.+|+|+++++..-..  ..--..|-++|...+||.+..|.-.++..+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            34678888999999999999998 45799999999987643221  1235678999999999999999988999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||..||.|+-+|...+    .+++.....+...|..||.|||++   +||.||+|.+|.|+|.||.+||+||-
T Consensus       246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG  313 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG  313 (516)
T ss_pred             EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence            999999999999887643    388888889999999999999999   99999999999999999999999994

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=6.4e-21  Score=180.06  Aligned_cols=147  Identities=24%  Similarity=0.340  Sum_probs=122.6

Q ss_pred             CCCCCCccccCCCceEEEEEeCC--CcEEEEEEcccccc---------cccHHHHHHHHHHHhc-CCCCCccceeeEEec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT---------SGGELQFQTEVKIISM-AVHRNLLRLYGFCTT  363 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  363 (447)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+.....         .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778999999999999999654  68899998853221         1122357778888764 799999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      .+..+++|||+++++|.+++.........+++..+..++.|++.||.|||+ .   +++||||||+||++++++.++++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886532233358888999999999999999996 5   799999999999999999999999


Q ss_pred             ccc
Q 013258          443 ILR  445 (447)
Q Consensus       443 f~~  445 (447)
                      |..
T Consensus       158 fg~  160 (269)
T cd08528         158 FGL  160 (269)
T ss_pred             ccc
Confidence            963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.85  E-value=5.5e-21  Score=183.65  Aligned_cols=146  Identities=28%  Similarity=0.436  Sum_probs=124.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC----
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  365 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  365 (447)
                      ...++|++.+.||+|+||.||+|... +++.||+|.++.... ......+.+|+++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34577889999999999999999975 588999999865432 222346788999999999999999999987654    


Q ss_pred             ------ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          366 ------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       366 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                            ..++|+||+++ ++...+....   ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 7777766532   2489999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      ++||-
T Consensus       157 l~dfg  161 (302)
T cd07864         157 LADFG  161 (302)
T ss_pred             eCccc
Confidence            99984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.1e-21  Score=172.17  Aligned_cols=136  Identities=16%  Similarity=0.225  Sum_probs=104.6

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccH--------HH-----------------HHHHHHHHhcCCCCCc
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--------LQ-----------------FQTEVKIISMAVHRNL  354 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------~~-----------------~~~E~~~l~~l~H~ni  354 (447)
                      ...||+|+||.||+|...+|+.||||+++........        .+                 ...|++.+..+.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999999878999999999754321100        11                 2349999999988887


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhh-hcCCCCCeeecCCCCCceeeC
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLD  433 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlkp~NILl~  433 (447)
                      .....+..  ...++||||++++++.......    ..+++.....++.|++.+|.|+ |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            54433322  2348999999988776543222    1378889999999999999999 677   999999999999998


Q ss_pred             CCCceeeccccc
Q 013258          434 EDADQSSKTILR  445 (447)
Q Consensus       434 ~~~~~~i~df~~  445 (447)
                       ++.+++.||-.
T Consensus       153 -~~~v~LiDFG~  163 (190)
T cd05147         153 -DGKLYIIDVSQ  163 (190)
T ss_pred             -CCcEEEEEccc
Confidence             47899999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.85  E-value=8.7e-21  Score=180.95  Aligned_cols=144  Identities=27%  Similarity=0.433  Sum_probs=128.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++.|+..+.||+|+||.||+|... +++.+++|.++....  ....+.+|++.++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4456777889999999999999976 588999999865432  3456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+||.
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence            9999999999998754   2489999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.85  E-value=4.1e-21  Score=180.45  Aligned_cols=135  Identities=28%  Similarity=0.401  Sum_probs=120.2

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||.||+++.. +++.+++|.++.....  .....+.+|++++.+++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 4899999998654321  2344688999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++....    .+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++||-
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg  138 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFG  138 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecc
Confidence            99997643    388999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.85  E-value=6e-21  Score=182.89  Aligned_cols=141  Identities=23%  Similarity=0.364  Sum_probs=125.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5788889999999999999985 468899999985432 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+||-
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg  160 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  160 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCc
Confidence            9999999998653     278899999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.85  E-value=3.8e-21  Score=187.93  Aligned_cols=142  Identities=21%  Similarity=0.336  Sum_probs=121.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  367 (447)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|.++..........+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46788999999999999999985 468999999986543333345688999999999999999999987654     357


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+. +++.+.+...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence            99999997 4888777543     388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.85  E-value=5e-21  Score=183.84  Aligned_cols=136  Identities=24%  Similarity=0.333  Sum_probs=120.6

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      ...||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++++||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            357999999999999864 68999999985432 2334568899999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.+++...     .+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+||.
T Consensus       105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659         105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence            99887542     378999999999999999999999   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.85  E-value=5.4e-21  Score=181.92  Aligned_cols=152  Identities=30%  Similarity=0.463  Sum_probs=128.4

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      ++.++....+.|+..+.||+|+||.||+|+. .+++.+|+|.+....  ....++..|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4555556678899999999999999999996 458899999875432  2334688899999888 69999999998853


Q ss_pred             ------CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          364 ------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       364 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                            .+..+++|||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  4567999999999999999876432  2377888899999999999999999   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      ++++||.
T Consensus       160 ~~l~dfg  166 (282)
T cd06636         160 VKLVDFG  166 (282)
T ss_pred             EEEeeCc
Confidence            9999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=9.2e-21  Score=183.24  Aligned_cols=145  Identities=23%  Similarity=0.372  Sum_probs=121.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC---CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~  368 (447)
                      +|+..+.||+|+||.||+|+..   +++.||+|.+....  .......+.+|+.++..++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677788999999999999964   47899999987532  122234678899999999999999999999887  7899


Q ss_pred             EEeecCCCCChhhHhhccCCC-CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC----CCceeeccc
Q 013258          369 LVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE----DADQSSKTI  443 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~~~i~df  443 (447)
                      +||||+++ ++.+.+...... ...+++.....++.|++.||+|||+.   +|+||||||+||++++    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 777776543222 22578889999999999999999999   9999999999999999    899999998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       157 g  157 (316)
T cd07842         157 G  157 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.85  E-value=5e-21  Score=182.50  Aligned_cols=142  Identities=25%  Similarity=0.341  Sum_probs=123.4

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||+|... +++.||+|.++.... ......+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5778899999999999999965 588999999865432 22345689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++.+..+.....    .+++.....++.|++.||+|||+.   +++||||||+||++++++.+|++||.
T Consensus        82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          82 VERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeee
Confidence            99877766554322    378899999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.85  E-value=9e-21  Score=177.47  Aligned_cols=144  Identities=28%  Similarity=0.398  Sum_probs=124.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999864 58899999986432 222344688999999999999999999999989999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||++   +++||||||+||++++++ .+|++||-
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCC
Confidence            999999999976432  3478899999999999999999999   999999999999998654 57999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.85  E-value=1e-20  Score=182.49  Aligned_cols=143  Identities=30%  Similarity=0.431  Sum_probs=123.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +.|+..+.||+|+||.||+|+.. +++.||+|.+......  ....++.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777899999999999999864 5899999988543222  22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+. |++.+.+.....   .+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.++++||.
T Consensus        95 e~~~-g~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          95 EYCL-GSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             HhhC-CCHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            9997 577777654322   388999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.85  E-value=9.5e-21  Score=178.18  Aligned_cols=135  Identities=26%  Similarity=0.360  Sum_probs=119.9

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||.||+++.. +++.+|+|.+......  .....+.+|+++++.++||||+++++++..++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 4899999998643322  2345689999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++....    .+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~  138 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFG  138 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCC
Confidence            99997643    278889999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.85  E-value=1.4e-20  Score=175.92  Aligned_cols=146  Identities=26%  Similarity=0.393  Sum_probs=128.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||++... +++.+++|.+...... ....++.+|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999965 5889999998654322 3345688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+.+.........+++.....++.+++.||+|||+.   +++|+||+|+||++++++.++++||-
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence            999999999987532234589999999999999999999999   99999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.84  E-value=1.8e-21  Score=191.63  Aligned_cols=140  Identities=26%  Similarity=0.432  Sum_probs=119.3

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEccc---ccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc--eEEEeec
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKE---ERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE--KLLVYPY  373 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lv~e~  373 (447)
                      .++||+|+|-+||||... +|..||.-.++.   ........+|..|+++|+.|+|||||+++.++.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            478999999999999864 477887554432   2223334679999999999999999999999987665  7799999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      |..|+|..++.+.+.    ++......+++||++||.|||++ .|+|||||||-+||+|+.+ |++||+|+.
T Consensus       125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence            999999999988754    77888999999999999999998 8899999999999999965 799999973

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.84  E-value=1.1e-20  Score=179.45  Aligned_cols=140  Identities=24%  Similarity=0.322  Sum_probs=119.3

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecC--CceEEEee
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLVYP  372 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lv~e  372 (447)
                      |+..+.||+|+||.||+|+.. +++.||+|.++............+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999854 689999999875433333334567888888885 99999999999887  88999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++ |++.+.+....   ..++|..+..++.|++.||+|||+.   +|+||||||+||++++ +.+||+||-
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecc
Confidence            997 58888887543   2489999999999999999999999   9999999999999999 999999984

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.84  E-value=8.5e-21  Score=177.75  Aligned_cols=144  Identities=19%  Similarity=0.350  Sum_probs=124.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|+||.||++... +|..+|+|.+...... .....+.+|+++++.++|+||+++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677789999999999999965 5889999998653221 2334688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++ .++++||-
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccc
Confidence            999999999876432  2478999999999999999999998   999999999999999886 46999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2e-20  Score=174.74  Aligned_cols=142  Identities=29%  Similarity=0.472  Sum_probs=125.9

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|+..+.||+|++|.||+++.. +++.||+|.+...... .....+.+|++++.+++|||++++++++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999865 5789999998654322 2334689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~  144 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFG  144 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccc
Confidence            99999999987652    489999999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.84  E-value=1.1e-20  Score=182.35  Aligned_cols=144  Identities=28%  Similarity=0.433  Sum_probs=122.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  369 (447)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++...... ....+.+|++++.+++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357888999999999999999964 58999999986443222 223567899999999999999999998754  46899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+. ++|.+++....   ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.+|++||-
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            999997 48888886542   2489999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.84  E-value=9.1e-21  Score=180.31  Aligned_cols=142  Identities=28%  Similarity=0.432  Sum_probs=123.4

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |++.+.||+|++|+||+|+.. +++.|+||++.............+|+..+.+++ |+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            556788999999999999975 478999999865433333334667999999999 999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                       +|+|.+.+.....  ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++++||-
T Consensus        81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecc
Confidence             8899998876531  2479999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1e-20  Score=185.65  Aligned_cols=151  Identities=23%  Similarity=0.304  Sum_probs=126.4

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEe
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCT  362 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  362 (447)
                      ...+++...+++|+..+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|+.++.+++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            34556677889999999999999999999985 4689999999864321 222346788999999999999999999875


Q ss_pred             cC------CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          363 TV------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       363 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      ..      ...+++++++ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            43      3467888876 78998887543     288999999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+|++||-
T Consensus       158 ~~kl~dfg  165 (345)
T cd07877         158 ELKILDFG  165 (345)
T ss_pred             CEEEeccc
Confidence            99999984

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.84  E-value=1.2e-20  Score=181.93  Aligned_cols=144  Identities=29%  Similarity=0.471  Sum_probs=121.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  365 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+...... .....+.+|++++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356888899999999999999965 5899999988643322 22335678999999999999999999987654      


Q ss_pred             --ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          366 --EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       366 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                        ..++||||+. ++|.+.+....   ..+++.....++.|++.||+|||+.   +++||||||+||++++++.+|++||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              3499999996 48888876542   2488999999999999999999999   9999999999999999999999998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      .
T Consensus       164 g  164 (310)
T cd07865         164 G  164 (310)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1.1e-20  Score=185.31  Aligned_cols=143  Identities=23%  Similarity=0.360  Sum_probs=121.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----  365 (447)
                      ..++|+..+.||+|+||.||++.. .+++.||||++..... ......+.+|+++++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456799999999999999999985 4689999999854322 222345889999999999999999999887543     


Q ss_pred             -ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                       ..++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999999 77898887542     388999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.84  E-value=7.6e-21  Score=180.31  Aligned_cols=143  Identities=27%  Similarity=0.371  Sum_probs=126.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|...+.||+|+||.||+++.. +++.||+|++.....  ......+.+|++++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999965 689999999865321  122346889999999998 99999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.+++....    .+++.....++.|++.||.|||+.   +++|+||||+||++++++.++++||-
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence            99999999999997653    489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=1.5e-20  Score=178.90  Aligned_cols=141  Identities=28%  Similarity=0.467  Sum_probs=122.6

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEee
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  372 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~e  372 (447)
                      |++.+.||+|+||.||+|+.. +++.+|+|.++... .......+.+|+++++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999965 48899999997553 222334688999999999999999999999887  78999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++ +|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++++||-
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccc
Confidence            9974 8888886542   2488999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.84  E-value=9.7e-21  Score=177.14  Aligned_cols=146  Identities=25%  Similarity=0.348  Sum_probs=127.0

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|++.+.||+|+||.||+++.. +++.+|+|.+..... .....++.+|+++++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999854 688999999865332 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+|++||-
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence            999999999877433334588999999999999999999999   99999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=1.8e-21  Score=203.56  Aligned_cols=145  Identities=26%  Similarity=0.385  Sum_probs=117.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  364 (447)
                      ..+|+..++||+||||.||+++.+ ||+.||||+|+-.........+.+|+.++++++|||||+++..+.+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356888899999999999999954 89999999997654344445689999999999999999998654210        


Q ss_pred             --------------------------------------------------------------------------------
Q 013258          365 --------------------------------------------------------------------------------  364 (447)
Q Consensus       365 --------------------------------------------------------------------------------  364 (447)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh
Q 013258          365 -------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH  413 (447)
Q Consensus       365 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  413 (447)
                                                     ..+|+-||||+.-.+.++++......   .-....+++++|++||.|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence                                           01367788888877777776543210   23457789999999999999


Q ss_pred             cCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          414 EHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       414 ~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++   +||||||||.||++|+++++||+||-
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFG  742 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFG  742 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccc
Confidence            99   99999999999999999999999994

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.84  E-value=2e-20  Score=181.06  Aligned_cols=137  Identities=23%  Similarity=0.352  Sum_probs=112.5

Q ss_pred             CccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEEeecCC
Q 013258          301 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYMT  375 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv~e~~~  375 (447)
                      ..||+|+||+||+|+..   ++..||+|.++...   ....+.+|+++++.++||||+++++++..  ....++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            57999999999999864   35789999886432   23467899999999999999999998854  456789999987


Q ss_pred             CCChhhHhhccC-----CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee----CCCCceeecccc
Q 013258          376 NGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~~i~df~  444 (447)
                      + +|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    ++++.+||+||.
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            4 7877775321     1122478888999999999999999999   99999999999999    566789999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.84  E-value=2.4e-20  Score=177.30  Aligned_cols=136  Identities=29%  Similarity=0.364  Sum_probs=113.3

Q ss_pred             ccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHH---HHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          302 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVK---IISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      +||+|+||.||+++.. +++.||+|.+.......  ....+..|..   .++...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 58899999986432221  1122334433   4445679999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCc
Confidence            999998886542    489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00284 protein kinase; Provisional

Probab=99.84  E-value=5.9e-21  Score=194.86  Aligned_cols=145  Identities=19%  Similarity=0.314  Sum_probs=116.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCC------CCccceeeEEe
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH------RNLLRLYGFCT  362 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~  362 (447)
                      +...+++|++.+.||+|+||+||+|+.. +++.||||+++...  ....++..|++++..++|      .+++++++++.
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445678999999999999999999864 58899999986432  122345566666666554      45888888887


Q ss_pred             cC-CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCC----
Q 013258          363 TV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDA----  436 (447)
Q Consensus       363 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~----  436 (447)
                      .. ...++|||++ +++|.+++....    .+++..+..|+.|++.||+|||+ .   +||||||||+|||++.++    
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            64 4678999988 778988887643    38899999999999999999997 5   899999999999999776    


Q ss_pred             ------------ceeecccc
Q 013258          437 ------------DQSSKTIL  444 (447)
Q Consensus       437 ------------~~~i~df~  444 (447)
                                  .+||+||.
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG  293 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLG  293 (467)
T ss_pred             cccccccCCCCceEEECCCC
Confidence                        48999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-21  Score=191.88  Aligned_cols=139  Identities=29%  Similarity=0.427  Sum_probs=122.9

Q ss_pred             CCccccCCCceEEEEEeCC--Cc--EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          300 KNILGRGGFGKVYKGRLAD--GK--LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      .+.||+|.||.|++|.|..  |+  .||||.++.+.......+|.+|+.+|.+++|||+|+|||+..+ ....||+|.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            4789999999999999753  44  6899999877655456689999999999999999999999887 67899999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .|||.+.|++..  ...+-......++.|||.||.||.++   ++|||||..+|+|+-....+||+||-
T Consensus       194 lGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  194 LGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             cchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence            999999999832  23477788889999999999999999   99999999999999999999999994

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.84  E-value=9.6e-21  Score=184.92  Aligned_cols=142  Identities=23%  Similarity=0.367  Sum_probs=121.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEec----CCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~  368 (447)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999854 589999999865432 2233467889999999999999999998753    34679


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+. |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||-
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence            9999995 68988886542    388999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=2.5e-20  Score=178.44  Aligned_cols=144  Identities=23%  Similarity=0.402  Sum_probs=121.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|++|.||+|+.. +++.||+|.++..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788899999999999999965 6889999998644322 223468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      |++ ++|.+.+.....  ..+++.....++.|++.||+|||++   +++||||||+||++++ ++.+|++||-
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            996 588887765332  2357788889999999999999998   9999999999999986 4568999984

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.84  E-value=2.1e-20  Score=177.93  Aligned_cols=142  Identities=24%  Similarity=0.434  Sum_probs=123.5

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |+..+.||+|++|.||+|... +|+.||+|+++...... ....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999864 69999999986543222 2346889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++++||-
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            5 689998876432  2489999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.84  E-value=1.6e-20  Score=181.53  Aligned_cols=137  Identities=24%  Similarity=0.232  Sum_probs=114.5

Q ss_pred             ccccCCCceEEEEEeCCCcEEEEEEcccc-cccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChh
Q 013258          302 ILGRGGFGKVYKGRLADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  380 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~  380 (447)
                      .+|.|+++.||++.. +++.||||+++.. ........+.+|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344444444444444 6899999998654 22333457999999999999999999999999999999999999999999


Q ss_pred             hHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          381 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       381 ~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++.....  ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~  146 (314)
T cd08216          88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLR  146 (314)
T ss_pred             HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCc
Confidence            99986422  2378888999999999999999999   99999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.84  E-value=4.1e-20  Score=171.98  Aligned_cols=142  Identities=33%  Similarity=0.504  Sum_probs=126.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|+..+.||+|++|.||++... +++.+++|+++.... .....+.+|++.++.++|+|++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4677789999999999999975 688999999865433 24457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|.+++....   ..+++..+..++.|++.||.|||..   +++||||+|+||++++++.++|.||-
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence            9999999987642   2489999999999999999999998   99999999999999999999999984

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.84  E-value=3.1e-20  Score=180.02  Aligned_cols=141  Identities=31%  Similarity=0.457  Sum_probs=121.1

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||+|+||.||+++.. ++..+|+|.+......  .....+.+|+++++.++|||++++++++...+..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            556688999999999999964 5889999998643222  2234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. |++.+.+....   ..++|..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++||.
T Consensus       107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCC
Confidence            97 57877775432   2488999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.83  E-value=3.4e-20  Score=176.89  Aligned_cols=139  Identities=24%  Similarity=0.361  Sum_probs=122.4

Q ss_pred             CCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |...+.||+|++|.||++.. .+++.+++|.++... ......+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            44457899999999999985 468899999885432 2233468899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||.
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence            99999998762     378899999999999999999999   99999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=2.8e-20  Score=174.81  Aligned_cols=137  Identities=25%  Similarity=0.343  Sum_probs=115.1

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHH-hcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||.||+|... +++.||+|.++....  ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999864 588999999864321  11122344554443 456899999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|.+++....    .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++||.
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            99999997643    378899999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.83  E-value=1.6e-20  Score=179.22  Aligned_cols=142  Identities=27%  Similarity=0.332  Sum_probs=122.2

Q ss_pred             CCCCCCccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          296 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      +|+..+.||+|+||.||+++.    .+++.||||.++....   ......+.+|++++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999999999874    2468899999864321   12234588999999999 599999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++....    .+++.....++.|+++||+|||+.   +++||||||+||++++++.++++||-
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence            99999999999999987543    378899999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.5e-21  Score=188.11  Aligned_cols=138  Identities=28%  Similarity=0.419  Sum_probs=120.2

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      -+||+|.||+||.|+.. +...+|||.+....+ ...+-+.+|+.+.+.++|.|||+++|.+.+.+...+.||.++||||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            46999999999999954 466789999966543 2334588999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCC--ChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeeccccc
Q 013258          380 ASRLRERQSSLPPL--DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTILR  445 (447)
Q Consensus       380 ~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~~  445 (447)
                      .++|+..-+   ++  .+.+.-.+..||++||.|||++   .|||||||-+|||++- .|..||+||.-
T Consensus       660 SsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGT  722 (1226)
T KOG4279|consen  660 SSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGT  722 (1226)
T ss_pred             HHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccccc
Confidence            999987532   35  6778889999999999999999   9999999999999985 78999999963

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.83  E-value=3.4e-20  Score=173.26  Aligned_cols=142  Identities=32%  Similarity=0.485  Sum_probs=126.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  371 (447)
                      +|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+|+..+++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999975 689999999865432 12345689999999999999999999999888  8899999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+||-
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccc
Confidence            9999999999987653    489999999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=6.5e-21  Score=182.94  Aligned_cols=143  Identities=24%  Similarity=0.331  Sum_probs=124.6

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      -|+..+.||+|.|+.|-.|++ -+|..||||++.+..... ....+..|++.|+.++|||||+||++......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            466678899999999999984 379999999996654322 233588999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      -.+|+|++++-++..+   +.+..+.+++.||..|+.|+|..   .+|||||||+||.+-+ -|-+|+.||-
T Consensus        99 GD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            9999999999876543   88899999999999999999998   8999999999997654 6789999984

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=4.8e-21  Score=187.81  Aligned_cols=142  Identities=23%  Similarity=0.302  Sum_probs=123.3

Q ss_pred             CCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      -|..++.||-|+||+|..++ .++...||+|.+++...  .....-...|-.+|.....+-||+|+-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47778899999999999987 44577899999865421  1112236789999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++||++..+|...+    .+.+..+..++..++.|+++.|..   ++|||||||+|||||.||.+|+.||.
T Consensus       710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence            999999999997654    378888889999999999999999   99999999999999999999999994

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.83  E-value=2.7e-20  Score=178.59  Aligned_cols=145  Identities=24%  Similarity=0.426  Sum_probs=120.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|+..+.||+|+||+||+|...+ ++.||||.++.........++.+|+.++.+.. ||||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567788999999999999999764 89999999965433333445777887776665 999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+. +++.+++.....   .+++..+..++.|+++||+|||+..  +|+||||||+||++++++.++|+||-
T Consensus        94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            9985 477766654322   4889999999999999999999731  89999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.83  E-value=1.9e-20  Score=182.33  Aligned_cols=145  Identities=24%  Similarity=0.367  Sum_probs=123.8

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEec-CCce
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  367 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~  367 (447)
                      ...+++|+..+.||+|+||.||+++.. +++.||+|++..... ......+.+|++++..++||||+++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999854 689999998854322 2234568899999999999999999998865 5578


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+ +++|.+++...     .+++.....++.|+++||.|||+.   +|+||||||+||++++++.++++||-
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccc
Confidence            9999998 56898887642     267888889999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=8.2e-22  Score=193.03  Aligned_cols=141  Identities=26%  Similarity=0.337  Sum_probs=121.9

Q ss_pred             CCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          298 SNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      .+...||.|+||+||+|..++ +-..|-|.+... +.....+|.-||++|+.+.||+||+|++.|...+.+++..|||.|
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            344568999999999998654 455677777432 233445799999999999999999999999999999999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |.....+-+-..   .+.+.++..+++|++.||.|||++   +|||||||+.|||++-||+++++||..
T Consensus       114 GAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  114 GAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             chHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccc
Confidence            999988876543   489999999999999999999999   999999999999999999999999964

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.7e-20  Score=189.72  Aligned_cols=149  Identities=21%  Similarity=0.333  Sum_probs=115.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-----------------CCCcEEEEEEcccccccc-------------cHHHHHHH
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-----------------ADGKLVAVKRLKEERTSG-------------GELQFQTE  342 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E  342 (447)
                      ..++|++.++||+|+||.||+|..                 ..++.||||+++......             .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 235679999986432110             11123457


Q ss_pred             HHHHhcCCCCCc-----cceeeEEec--------CCceEEEeecCCCCChhhHhhccCCC--------------------
Q 013258          343 VKIISMAVHRNL-----LRLYGFCTT--------VTEKLLVYPYMTNGSVASRLRERQSS--------------------  389 (447)
Q Consensus       343 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------  389 (447)
                      +..+.+++|.++     ++++++|..        .++.++||||+++|+|.++++.....                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     677777753        35689999999999999998753210                    


Q ss_pred             CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          390 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       390 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFG  354 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFG  354 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCc
Confidence            12356788899999999999999998   99999999999999999999999994

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=2.8e-20  Score=183.06  Aligned_cols=142  Identities=23%  Similarity=0.314  Sum_probs=120.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecC------
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------  364 (447)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......++.+|+.++..++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3467999999999999999999854 68999999986432 222234677899999999999999999988643      


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...++||||+. ++|.+.+...      +++.....++.|++.||+|||+.   +|+||||||+||++++++.+|++||-
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            34699999996 5888877542      77888999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=3.8e-20  Score=165.56  Aligned_cols=134  Identities=18%  Similarity=0.218  Sum_probs=105.5

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccc--------------------c-----HHHHHHHHHHHhcCCCCCc
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG--------------------G-----ELQFQTEVKIISMAVHRNL  354 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~H~ni  354 (447)
                      ...||+|+||+||+|+..+|+.||||+++......                    .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999997789999999987542110                    0     1124678999999999998


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhH-hhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceee
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  432 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl  432 (447)
                      .....+...  ..++||||++++++... +...     .++......++.|++.++.|+|+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            655444333  34899999998865433 3221     26778889999999999999999 8   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      + ++.++++||-
T Consensus       152 ~-~~~~~liDFG  162 (190)
T cd05145         152 H-DGKPYIIDVS  162 (190)
T ss_pred             E-CCCEEEEEcc
Confidence            9 8899999985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.83  E-value=2.3e-20  Score=182.44  Aligned_cols=142  Identities=23%  Similarity=0.380  Sum_probs=121.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcC-CCCCccceeeEEecC--CceE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV--TEKL  368 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~  368 (447)
                      .++|+..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+.++.++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            457888899999999999999965 58899999885421 122234577899999999 999999999988653  3679


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+. ++|..++...     .++|..+..++.|++.||+|||+.   +|+||||||+||++++++.+|++||-
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence            9999997 5998888653     378999999999999999999998   99999999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.83  E-value=6.1e-20  Score=173.47  Aligned_cols=144  Identities=26%  Similarity=0.308  Sum_probs=118.3

Q ss_pred             HHHHHHhcCCCCCCcc--ccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhc-CCCCCccceeeEEec
Q 013258          288 RELQVATDGFSNKNIL--GRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTT  363 (447)
Q Consensus       288 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  363 (447)
                      .+.....++|++.+.+  |+|+||.||+++. .++..+|+|.++......    .  |+..... .+||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEec
Confidence            3444455677777776  9999999999985 468899999986432111    1  2222221 279999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKT  442 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~d  442 (447)
                      .+..++||||+++|+|.+++....    .++|..+..++.|+++||.|||+.   +++||||||+||+++.++ .++++|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999997653    489999999999999999999999   999999999999999998 999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |.
T Consensus       154 fg  155 (267)
T PHA03390        154 YG  155 (267)
T ss_pred             Cc
Confidence            85

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=1.2e-20  Score=193.60  Aligned_cols=148  Identities=19%  Similarity=0.240  Sum_probs=113.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC--CcEEEEEEc--------------ccc--cccccHHHHHHHHHHHhcCCCCCc
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRL--------------KEE--RTSGGELQFQTEVKIISMAVHRNL  354 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~~--~~~~~~~~~~~E~~~l~~l~H~ni  354 (447)
                      ..++|++.+.||+|+||+||+|..+.  +..++.|.+              ...  ........+.+|+.++..++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987532  222222211              000  011123358899999999999999


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhHhhccCCC-CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  433 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~  433 (447)
                      +++++++...+..++++|++. ++|.+++...... ...........|+.|++.||+|||++   +||||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 5777776543211 11123456778999999999999999   999999999999999


Q ss_pred             CCCceeecccc
Q 013258          434 EDADQSSKTIL  444 (447)
Q Consensus       434 ~~~~~~i~df~  444 (447)
                      .++.+||+||-
T Consensus       302 ~~~~vkL~DFG  312 (501)
T PHA03210        302 CDGKIVLGDFG  312 (501)
T ss_pred             CCCCEEEEeCC
Confidence            99999999995

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=4.3e-20  Score=180.37  Aligned_cols=141  Identities=26%  Similarity=0.311  Sum_probs=120.5

Q ss_pred             CCC-CCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-------------cHHHHHHHHHHHhcCCCCCccceeeE
Q 013258          296 GFS-NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------------GELQFQTEVKIISMAVHRNLLRLYGF  360 (447)
Q Consensus       296 ~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~H~niv~l~~~  360 (447)
                      +|. ..+.||+|+||+||+|+.. +++.||||.++......             ....+.+|++++..++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            443 3477999999999999964 58999999986432221             01247789999999999999999999


Q ss_pred             EecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceee
Q 013258          361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       361 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                      +...+..+++|||+. |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+++
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            999999999999997 68998886532    378899999999999999999998   9999999999999999999999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||-
T Consensus       161 ~dfg  164 (335)
T PTZ00024        161 ADFG  164 (335)
T ss_pred             CCcc
Confidence            9985

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.83  E-value=3.2e-20  Score=177.82  Aligned_cols=135  Identities=25%  Similarity=0.374  Sum_probs=119.8

Q ss_pred             CccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ..||+|+||.||++... +++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            57999999999999864 68999999885432 22344688999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++...     .+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||-
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg  161 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  161 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccc
Confidence            9887542     278899999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.83  E-value=2.6e-20  Score=177.83  Aligned_cols=146  Identities=25%  Similarity=0.358  Sum_probs=118.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeec
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +|...+.||+|+||.||+++.. +++.+|+|.+...........+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999864 589999999865433334456889999999996 99999999999999999999999


Q ss_pred             CCCCChhhHhhcc-CCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRER-QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +.. ++.++.... ......+++.....++.|++.||+|||+..  +|+||||||+||++++++.++++||.
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecc
Confidence            864 555443211 011134889999999999999999999632  89999999999999999999999994

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.82  E-value=2.7e-20  Score=174.87  Aligned_cols=145  Identities=21%  Similarity=0.274  Sum_probs=120.4

Q ss_pred             CCCCCCccccCCCceEEEEEeCC-CcEEEEEEccccc----ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      +|.+.+.||+|+||.||+++... +..+++|.++...    ......++.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999998643 4556666654322    122234577899999999999999999999998999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.++++........+++..+..++.|+++||.|||+.   +++|+||||+||++++ +.++++||-
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence            999999999999876433344689999999999999999999998   9999999999999985 558999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.82  E-value=3.5e-20  Score=181.17  Aligned_cols=142  Identities=22%  Similarity=0.364  Sum_probs=121.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  367 (447)
                      ++|.+.+.||+|+||.||+|+. .+++.||||.++... .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4688889999999999999985 468999999986432 222334678899999999999999999987643     347


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++||+. ++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.+||+||-
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            99999996 68888886542    388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.82  E-value=3.6e-21  Score=202.27  Aligned_cols=145  Identities=33%  Similarity=0.446  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      -+++....||.|.||.||.|. ..+|...|||.++-... ....+...+|+.++..++|||+|+++|+-.+++..++.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            456677899999999999998 56799999998864322 2234468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  446 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~~  446 (447)
                      ||++|+|.+.++..+.    .++..-..+..|++.|++|||+.   +||||||||+||+||.+|..|.+||...
T Consensus      1315 yC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccce
Confidence            9999999999976532    56666778889999999999999   9999999999999999999999999754

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.82  E-value=4e-20  Score=180.12  Aligned_cols=141  Identities=23%  Similarity=0.360  Sum_probs=122.9

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~  368 (447)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777899999999999999965 489999999865432 233456899999999999999999999988765     789


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|||++ ++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.++++||-
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg  148 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFG  148 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccC
Confidence            9999998 58888886543    489999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.82  E-value=1.3e-19  Score=175.23  Aligned_cols=141  Identities=31%  Similarity=0.446  Sum_probs=120.6

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |...+.||+|+||+||+|+.. +++.|++|.+......  .....+.+|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455678999999999999864 5889999998543221  2224688899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. |++.+.+....   ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++++||-
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg  166 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG  166 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence            96 57877776532   2488999999999999999999998   99999999999999999999999984

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.82  E-value=6.2e-20  Score=179.85  Aligned_cols=141  Identities=24%  Similarity=0.387  Sum_probs=118.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  365 (447)
                      .++|...+.||+|+||.||+|+.. +++.||||.++.... ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            367888999999999999999854 689999999864322 222346889999999999999999999886542      


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..++|+||+.. +|......      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++||.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             eEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence            46899999964 67665421      378899999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.82  E-value=7.5e-20  Score=173.84  Aligned_cols=141  Identities=26%  Similarity=0.436  Sum_probs=123.0

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |+..+.||+|++|.||+|... +++.+++|.++..... .....+.+|+++++.++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456688999999999999864 6889999998654322 23446889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++ ++.+.+....   ..+++..+..++.|+++||.|||+.   +|+|+||||+||++++++.++++||.
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeee
Confidence            75 8888887643   2488999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.82  E-value=1e-19  Score=169.74  Aligned_cols=135  Identities=33%  Similarity=0.364  Sum_probs=120.2

Q ss_pred             cccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          303 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      ||+|+||.||++... +++.+|+|.++......  ....+.+|+.+++.++||||+++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999965 48999999986543222  334688999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++....    .+++.....++.|+++||.|+|+.   +++|+||||+||++++++.++++||-
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~  138 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFG  138 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecC
Confidence            99997653    388999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.82  E-value=1.7e-20  Score=161.03  Aligned_cols=152  Identities=26%  Similarity=0.347  Sum_probs=124.6

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHh-cCCCCCccceeeEEecCCce
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~  367 (447)
                      +++..++......||+|++|.|-+-++ .+|+..|||+++.........+..+|+.+.. ....|.+|+++|.+......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344445555567899999999988774 4699999999987655555567888888764 45799999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++.||.|.- ||..+-++--......++...-+|+..+..||.|||++.  .+||||+||+|||+|.+|++|++||-
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            999999964 887776654333345788888899999999999999974  89999999999999999999999995

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.82  E-value=5.4e-20  Score=177.40  Aligned_cols=144  Identities=30%  Similarity=0.446  Sum_probs=120.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  365 (447)
                      .++|++.+.||+|+||.||+|+.. +++.+|+|.+....... ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999965 58899999986443222 2335788999999999999999999875433      


Q ss_pred             --ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          366 --EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       366 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                        ..++|+||+.+ ++...+....   ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46999999975 6777765432   2489999999999999999999999   9999999999999999999999998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       160 g  160 (311)
T cd07866         160 G  160 (311)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.81  E-value=1.1e-19  Score=175.36  Aligned_cols=141  Identities=31%  Similarity=0.458  Sum_probs=120.5

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |+..+.||+|+||.||+|+.. +++.+|+|.+....  ......++.+|+++++.++|+|++++.+++...+..++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555678999999999999964 57899999885422  122234688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +. |++.+.+....   ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++||.
T Consensus        97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            96 68887775432   2378899999999999999999998   99999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=9.5e-20  Score=173.04  Aligned_cols=141  Identities=30%  Similarity=0.476  Sum_probs=123.3

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |+..+.||+|+||.||+|+.. +++.+|+|.++.... ......+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455688999999999999965 589999999875432 222346788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      + ++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.++++||.
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCC
Confidence            8 59999997653   2388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.81  E-value=1.6e-19  Score=171.86  Aligned_cols=142  Identities=28%  Similarity=0.473  Sum_probs=118.6

Q ss_pred             CCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeEEecCCc-----
Q 013258          297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTTVTE-----  366 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----  366 (447)
                      |++.+.||+|+||.||+|+.++ ++.||+|.++...... ....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5567889999999999999764 8999999996443222 223466787776655   69999999999988776     


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++|||+. ++|.+++.....  ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++.++++||.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999997 489888866432  2489999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.81  E-value=1.1e-19  Score=177.29  Aligned_cols=141  Identities=24%  Similarity=0.343  Sum_probs=117.2

Q ss_pred             CCCCCCccccCCCceEEEEEeC-C--CcEEEEEEccccccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEecC----Cc
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-D--GKLVAVKRLKEERTS-GGELQFQTEVKIISMA-VHRNLLRLYGFCTTV----TE  366 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~  366 (447)
                      +|...+.||+|+||.||+++.. +  +..||+|.++..... .....+.+|++++.++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3667789999999999999964 4  778999998643222 2234678899999999 599999999875432    45


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++++||+. ++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+||-
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg  150 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG  150 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence            788889886 68988886543    388999999999999999999999   99999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.81  E-value=4.1e-20  Score=179.80  Aligned_cols=144  Identities=22%  Similarity=0.295  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc----cccH---HHHHHHHHHHhcCC---CCCccceeeEEec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGE---LQFQTEVKIISMAV---HRNLLRLYGFCTT  363 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~---~~~~~E~~~l~~l~---H~niv~l~~~~~~  363 (447)
                      .+|.....+|+|+||+|+.|.++ +...|.||.+.++..    +.+.   -..-.|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35788899999999999999965 467899999865431    1111   13567999999998   9999999999999


Q ss_pred             CCceEEEeecC-CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          364 VTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       364 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      .+..|++||-. ++-+|++++..+.    .++++.+..|..||+.|.++||++   +|||||||-+||.+|.+|-+|+.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999965 5678999987653    389999999999999999999999   999999999999999999999999


Q ss_pred             ccc
Q 013258          443 ILR  445 (447)
Q Consensus       443 f~~  445 (447)
                      |-.
T Consensus       714 fgs  716 (772)
T KOG1152|consen  714 FGS  716 (772)
T ss_pred             ccc
Confidence            964

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.81  E-value=7.3e-20  Score=185.98  Aligned_cols=151  Identities=30%  Similarity=0.431  Sum_probs=129.7

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec--
Q 013258          288 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT--  363 (447)
Q Consensus       288 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~--  363 (447)
                      +.+...++-|.+.+.||.|.+|+||+++ .++++.+|+|++.....  ...+.+.|.++++.. .|||++.++|++.-  
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3344456778888999999999999998 45689999999866533  344678888888766 69999999999863  


Q ss_pred             ---CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceee
Q 013258          364 ---VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       364 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                         ++++|||||||.+||..++.....  ...++|....+|++.++.||.+||..   .++|||+|-.|||++.++.+|+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence               678999999999999999988765  34589999999999999999999999   9999999999999999999999


Q ss_pred             ccccc
Q 013258          441 KTILR  445 (447)
Q Consensus       441 ~df~~  445 (447)
                      .||-.
T Consensus       165 vDFGv  169 (953)
T KOG0587|consen  165 VDFGV  169 (953)
T ss_pred             eeeee
Confidence            99965

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.1e-19  Score=161.97  Aligned_cols=133  Identities=18%  Similarity=0.230  Sum_probs=103.4

Q ss_pred             CCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-----CCCCccceeeEEecCC---ceE
Q 013258          298 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-----VHRNLLRLYGFCTTVT---EKL  368 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~  368 (447)
                      ...+.||+|+||.||.  ++ ++.. +||++.... .....++.+|+.++..+     .||||++++|++.+..   ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3457899999999996  43 3444 689875532 22345799999999999     5799999999998864   333


Q ss_pred             -EEeec--CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHH-hhhhcCCCCCeeecCCCCCceeeCCC----Cceee
Q 013258          369 -LVYPY--MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL-SYLHEHCDPKIIHRDVKAANILLDED----ADQSS  440 (447)
Q Consensus       369 -lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlkp~NILl~~~----~~~~i  440 (447)
                       +|+||  +.+|+|.+++.+..     +++.  ..++.|++.++ +|||++   +|+||||||+|||++..    ..++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence             78999  66899999996531     4444  35677888887 999999   99999999999999743    37999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||+
T Consensus       151 iDg~  154 (210)
T PRK10345        151 CDNI  154 (210)
T ss_pred             EECC
Confidence            9964

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.80  E-value=1.8e-19  Score=167.22  Aligned_cols=126  Identities=21%  Similarity=0.207  Sum_probs=110.1

Q ss_pred             CCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChhhHhh
Q 013258          306 GGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR  384 (447)
Q Consensus       306 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  384 (447)
                      |.||.||+++.. +++.||+|.++...      .+.+|...+....||||+++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            889999999964 68999999986532      23445555556679999999999999999999999999999999987


Q ss_pred             ccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          385 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       385 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...    .+++.....++.|+++||+|||+.   +|+||||||+||++++++.++++||.
T Consensus        78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~  130 (237)
T cd05576          78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS  130 (237)
T ss_pred             Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeccc
Confidence            643    388999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=1.1e-21  Score=172.99  Aligned_cols=142  Identities=32%  Similarity=0.531  Sum_probs=118.2

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc-HHHHHHHHHHHhcCCCCCccceeeEEecC--------Cc
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--------TE  366 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~  366 (447)
                      |.....||+|.||+||+|+.+ +|+.||+|++-.+....+ .....+|+.++..++|+|++.+++.|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            344577999999999999955 588899987643332222 23578999999999999999999988642        24


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .++|+++|+. +|..+|.....   .++..+..+++.++..||.|+|+.   .|+|||+||+|+||+.|+..|++||-.
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            7999999986 89998876532   378899999999999999999999   999999999999999999999999964

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.80  E-value=1.7e-19  Score=176.82  Aligned_cols=140  Identities=26%  Similarity=0.366  Sum_probs=118.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC---------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV---------  364 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------  364 (447)
                      .+|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            56888899999999999999864 589999999855432 3345688999999999999999999876543         


Q ss_pred             -----CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCce
Q 013258          365 -----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQ  438 (447)
Q Consensus       365 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~  438 (447)
                           ...++|+||++ ++|.+++...     .+++.....++.|+++||.|||+.   +|+||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 5888887542     378899999999999999999998   9999999999999985 5578


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      +++||-
T Consensus       155 kl~dfg  160 (342)
T cd07854         155 KIGDFG  160 (342)
T ss_pred             EECCcc
Confidence            999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.80  E-value=1.2e-19  Score=177.81  Aligned_cols=143  Identities=24%  Similarity=0.364  Sum_probs=122.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCc----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----  366 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  366 (447)
                      ..++|+..+.||+|+||.||+|+.. +++.||||.+..... ......+.+|+.+++.++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567888899999999999999965 588999999864321 2223457789999999999999999998766554    


Q ss_pred             --eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 --KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                        .++|+||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.++++||-
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 67999888652     389999999999999999999998   99999999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3.8e-20  Score=174.79  Aligned_cols=145  Identities=27%  Similarity=0.389  Sum_probs=121.4

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccH------HHHHHHHHHHhcCCCCCccceeeEEec-CCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~  366 (447)
                      ++|-...+||+|+|++||+|. +...+.||||+-.....+.++      +-..+|.++.+.+.||.||++|+|+.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            345567889999999999998 445789999985433222222      236889999999999999999999875 456


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeeccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  443 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df  443 (447)
                      .+-|+|||+|.+|.-+|...+.    +++..+..|+.||..||.||.+. .|+|||-||||.|||+-+   -|++||.||
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            7899999999999999987653    78999999999999999999987 789999999999999965   468999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      .
T Consensus       618 G  618 (775)
T KOG1151|consen  618 G  618 (775)
T ss_pred             c
Confidence            5

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.80  E-value=3e-20  Score=167.78  Aligned_cols=140  Identities=25%  Similarity=0.313  Sum_probs=117.0

Q ss_pred             hcCCCC-CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec----CCc
Q 013258          294 TDGFSN-KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT----VTE  366 (447)
Q Consensus       294 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~  366 (447)
                      +++|++ ..+||-|-.|+|..+..+ +++.+|+|++..      .....+|+++.-+. .|||||+++++|..    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            445544 367999999999999854 689999998843      23467888876655 69999999999864    456


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeeccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  443 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df  443 (447)
                      +.+|||+|+||.|++.+++++.  ..+.+.++..|+.||..|+.|||+.   +|.||||||+|+|...   |...|++||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999998754  3589999999999999999999999   9999999999999975   446799998


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       209 G  209 (400)
T KOG0604|consen  209 G  209 (400)
T ss_pred             c
Confidence            5

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.79  E-value=4.8e-19  Score=185.03  Aligned_cols=152  Identities=26%  Similarity=0.380  Sum_probs=130.5

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC----C----CcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeE
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLA----D----GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF  360 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~  360 (447)
                      .+...++..+.+.+|+|.||+|++|...    .    ...||||.++..........+..|+++|..+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444455566679999999999999742    1    3579999998776665667899999999988 59999999999


Q ss_pred             EecCCceEEEeecCCCCChhhHhhccC---CC-------C--CCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCC
Q 013258          361 CTTVTEKLLVYPYMTNGSVASRLRERQ---SS-------L--PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  428 (447)
Q Consensus       361 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~  428 (447)
                      |..+...++|+||+..|+|.++|+..+   .-       .  ..+...+.+.++.|||.|++||++.   ++|||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999999876   00       0  1377889999999999999999999   9999999999


Q ss_pred             ceeeCCCCceeecccc
Q 013258          429 NILLDEDADQSSKTIL  444 (447)
Q Consensus       429 NILl~~~~~~~i~df~  444 (447)
                      |||+.++..+||+||.
T Consensus       448 NVLi~~~~~~kIaDFG  463 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFG  463 (609)
T ss_pred             hEEecCCCEEEEcccc
Confidence            9999999999999995

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=6.1e-20  Score=172.09  Aligned_cols=145  Identities=24%  Similarity=0.363  Sum_probs=123.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc-HHH-HHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQ-FQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~-~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  368 (447)
                      ...+|....+||+|+||+|..|..+ +.+.+|||+++++..-+. ..+ -+.|-++|+.. +-|.++++..++++.+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3456888999999999999999855 478899999987643221 112 34566777666 5788999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+.||+|.-.+++.+.    +.++.+..+|..||-||=|||++   +||.||||..|||+|.+|.+||+||-
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG  495 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  495 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence            99999999999999987654    88899999999999999999999   99999999999999999999999995

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.78  E-value=1.8e-20  Score=166.60  Aligned_cols=142  Identities=27%  Similarity=0.355  Sum_probs=114.1

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHh-cCCCCCccceeeEEecCCceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      ...||.|+||+|+|-.++ .|+.+|||+++.........++..|.+... .-+.||||+++|.+...+..|+-||.|. -
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            466999999999998754 699999999987655445567888887654 4479999999999999999999999995 4


Q ss_pred             ChhhHhhcc-CCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRER-QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+..+...- .-....+++.-.-.|......||.||-+..  .|||||+||+|||+|..|++|++||-
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence            665543321 011123777777788888999999998864  89999999999999999999999994

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.78  E-value=4.3e-19  Score=158.44  Aligned_cols=148  Identities=24%  Similarity=0.410  Sum_probs=119.3

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEE
Q 013258          284 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFC  361 (447)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~  361 (447)
                      ..++.|++..       ..||.|+.|.|++++.+ +|..+|||.+.........+++...+.++.+.+ .|.||+.+|||
T Consensus        88 ~~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF  160 (391)
T KOG0983|consen   88 QADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF  160 (391)
T ss_pred             ccChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence            3455555543       45999999999999965 589999999977655555567777788776665 89999999999


Q ss_pred             ecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       362 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      ......++-||.|.. -+..+++...   .++++...-++...+.+||.||.+++  +|||||+||+|||+|+.|++|++
T Consensus       161 i~n~dV~IcMelMs~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  161 ITNTDVFICMELMST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             eeCchHHHHHHHHHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            999999999998843 3444444432   24777777788999999999999876  89999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       235 DFG  237 (391)
T KOG0983|consen  235 DFG  237 (391)
T ss_pred             ccc
Confidence            995

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.78  E-value=9.6e-20  Score=158.66  Aligned_cols=136  Identities=21%  Similarity=0.373  Sum_probs=114.8

Q ss_pred             hcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCC--ceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~l  369 (447)
                      .++|++.+.+|+|.|++|+.|. ..+.+.+.||++++..    .+.+.+|+.+|..+. ||||+++++...++.  ...|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4578888999999999999998 5568899999997653    346899999999997 999999999987654  4679


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeeccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  443 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df  443 (447)
                      ++||+.+-+...+...       ++..+...+..++++||.|+|+.   ||+|||+||.|+|+|... ..++.|.
T Consensus       113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence            9999999887665432       66778899999999999999999   999999999999999754 5666664

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.77  E-value=1.8e-18  Score=165.88  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=105.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC----CcEEEEEEccccccccc----------HHHHHHHHHHHhcCCCCCccceee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVHRNLLRLYG  359 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~niv~l~~  359 (447)
                      .++|++.+.||+|+||+||+|+..+    +..+|+|..........          ......+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3578889999999999999998654    34567765432211100          011223344556778999999999


Q ss_pred             EEecCC----ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          360 FCTTVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       360 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                      ++....    ..++++|++.. ++.+.+....    ..++.....++.|+++||+|||+.   +|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            766543    34677887643 5666654432    256788899999999999999998   99999999999999999


Q ss_pred             Cceeecccc
Q 013258          436 ADQSSKTIL  444 (447)
Q Consensus       436 ~~~~i~df~  444 (447)
                      +.++++||-
T Consensus       163 ~~~~l~DFG  171 (294)
T PHA02882        163 NRGYIIDYG  171 (294)
T ss_pred             CcEEEEEcC
Confidence            999999994

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.77  E-value=6.7e-20  Score=181.06  Aligned_cols=144  Identities=28%  Similarity=0.410  Sum_probs=127.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|.....+|.|.||.|||++. +.++..|||.++-+.. +...-...|+-+++.++|||||.++|.|...+..++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            35677788899999999999995 4689999999976643 334457889999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ||.+|+|++.-+-.+    ++++.+..++++...+||.|||+.   +-+|||||-.|||+++.+++|++||-.
T Consensus        93 ycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgv  158 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGV  158 (829)
T ss_pred             ecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCc
Confidence            999999998876543    488899999999999999999999   889999999999999999999999953

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.77  E-value=4.8e-18  Score=155.36  Aligned_cols=142  Identities=34%  Similarity=0.483  Sum_probs=124.8

Q ss_pred             CCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+..++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556889999999999999764 889999998654332134578899999999999999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|.+++......   +++.....++.+++.++.|||..   +++|+|++|+||+++.++.++++||.
T Consensus        81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            99999998764321   78899999999999999999998   99999999999999999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.76  E-value=1.2e-17  Score=150.32  Aligned_cols=136  Identities=37%  Similarity=0.541  Sum_probs=120.4

Q ss_pred             cccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChhh
Q 013258          303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS  381 (447)
Q Consensus       303 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  381 (447)
                      ||+|.+|.||++...+ ++.+++|.+...........+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998654332224579999999999999999999999999899999999999999999


Q ss_pred             HhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          382 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       382 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      ++....   ..+++..+..++.++++++.|||+.   +++|+||+|.||+++. ++.++++||-
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~  138 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFG  138 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCC
Confidence            987642   2378899999999999999999999   9999999999999999 8999999984

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=5.8e-18  Score=156.21  Aligned_cols=137  Identities=14%  Similarity=0.115  Sum_probs=105.4

Q ss_pred             CCCCCCccccCCCceEEEEE--eCCCcEEEEEEcccccccc-----------------------cHHHHHHHHHHHhcCC
Q 013258          296 GFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  350 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~  350 (447)
                      .|++.+.||+|+||.||+|.  ..+|+.||+|.++......                       ....+.+|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998  5679999999986432100                       0123568999999997


Q ss_pred             CCC--ccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC-eeecCCCC
Q 013258          351 HRN--LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKA  427 (447)
Q Consensus       351 H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlkp  427 (447)
                      +..  +.+.+++    ...++||||++++++........    .........++.|++.+++|||..   + |+||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            643  3334432    23589999999988876542221    245556788999999999999999   8 99999999


Q ss_pred             CceeeCCCCceeecccc
Q 013258          428 ANILLDEDADQSSKTIL  444 (447)
Q Consensus       428 ~NILl~~~~~~~i~df~  444 (447)
                      +||+++ ++.+++.||-
T Consensus       178 ~NIli~-~~~i~LiDFg  193 (237)
T smart00090      178 YNILVH-DGKVVIIDVS  193 (237)
T ss_pred             hhEEEE-CCCEEEEECh
Confidence            999999 8899999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=2.7e-19  Score=159.60  Aligned_cols=138  Identities=25%  Similarity=0.337  Sum_probs=114.8

Q ss_pred             CCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCC-----ceEEEe
Q 013258          299 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLVY  371 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lv~  371 (447)
                      ..+.||-|+||.||....+ +|+.||.|++.... .-...+++.+|++++..++|.|+...++...-..     ++|.++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            3488999999999999864 69999999885432 1123457899999999999999999998876543     568889


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.|. .+|...+-...    .++-.....+..||++||.|||+.   +|.||||||.|.|++++...||+||.
T Consensus       137 ELmQ-SDLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHH-hhhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccc
Confidence            9885 47777775433    377778889999999999999999   99999999999999999999999994

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.6e-17  Score=151.13  Aligned_cols=131  Identities=17%  Similarity=0.220  Sum_probs=110.1

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEccccccccc-------HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.||+|++|.||+|+. +|..+++|..........       ...+.+|++++..++|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998654322111       23578899999999999998888777777888999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|++|.+.+...       .+ .+..++.+++.+|.++|..   +++|||++|+|||++ ++.+++.||.
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECC
Confidence            9999999988642       12 7889999999999999999   999999999999999 7889999995

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=3.7e-19  Score=170.81  Aligned_cols=144  Identities=24%  Similarity=0.287  Sum_probs=124.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..+++....||-|+||.|-...... ...+|+|++++...-+  +..-...|-.+|..++.|.||++|-.|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            3445556779999999999888654 3358999987654322  223477899999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||-|-||.+...|++++.    ++..+...++..+.+|++|||++   +||+|||||+|.|+|.+|-+|+.||-
T Consensus       499 mEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             HHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence            999999999999998764    89999999999999999999999   99999999999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.73  E-value=2.3e-17  Score=152.35  Aligned_cols=132  Identities=35%  Similarity=0.484  Sum_probs=117.2

Q ss_pred             CCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChhhHhhc
Q 013258          307 GFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE  385 (447)
Q Consensus       307 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  385 (447)
                      +||.||+|+.. +++.+|+|++...........+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999986554332256799999999999999999999999999999999999999999999876


Q ss_pred             cCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       386 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ...    +++.....++.++++++.|||+.   +++|+||+|+||++++++.++++||-.
T Consensus        81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~  133 (244)
T smart00220       81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGL  133 (244)
T ss_pred             ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccc
Confidence            432    78899999999999999999998   999999999999999999999999853

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.73  E-value=5.6e-18  Score=175.38  Aligned_cols=144  Identities=23%  Similarity=0.242  Sum_probs=101.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-C----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeE------E
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF------C  361 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~  361 (447)
                      ..++|+..+.||+|+||.||+|++. +    +..||||.++....   ...+..|  .+....+.+++.+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999964 4    68999998754221   1111111  1122223333322221      2


Q ss_pred             ecCCceEEEeecCCCCChhhHhhccCCC----------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCC
Q 013258          362 TTVTEKLLVYPYMTNGSVASRLRERQSS----------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  425 (447)
Q Consensus       362 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  425 (447)
                      ....+.++||||+.+++|.+++......                .....+..+..++.|++.||+|||++   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            4566789999999999999998754210                00011233557899999999999998   9999999


Q ss_pred             CCCceeeCC-CCceeecccc
Q 013258          426 KAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       426 kp~NILl~~-~~~~~i~df~  444 (447)
                      ||+|||+++ ++.+||+||-
T Consensus       282 KP~NILl~~~~~~~KL~DFG  301 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLG  301 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCC
Confidence            999999996 5789999995

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.2e-18  Score=156.75  Aligned_cols=145  Identities=25%  Similarity=0.330  Sum_probs=124.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccccc--HHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  368 (447)
                      ...+|...++||+|+|++|-.+++ ++.+.||+|+++++-..++  ..-.+.|-.+.... +||.+|-+..++++....+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            346789999999999999999985 4689999999986543322  22355666666554 7999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|.||+++|+|.-+++..+.    +++..+..+...|..||.|||++   +||.||||..|||+|.+|.+|+.|+-
T Consensus       328 fvieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence            99999999999888876543    89999999999999999999999   99999999999999999999999974

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=2.2e-17  Score=148.86  Aligned_cols=133  Identities=22%  Similarity=0.164  Sum_probs=104.5

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc---------------------ccHHHHHHHHHHHhcCCCCC-
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------------------GGELQFQTEVKIISMAVHRN-  353 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~H~n-  353 (447)
                      -|...+.||+|+||.||++..++|+.||||+++.....                     .....+..|..++..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            37778999999999999999888999999987543210                     00113677888898888874 


Q ss_pred             -ccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          354 -LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       354 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                       +++.++    ....++||||+++++|......          .....++.++++++.++|+.   +|+||||||+||++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill  158 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV  158 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence             444443    2456899999999998765321          23467889999999999998   99999999999999


Q ss_pred             CCCCceeeccccc
Q 013258          433 DEDADQSSKTILR  445 (447)
Q Consensus       433 ~~~~~~~i~df~~  445 (447)
                      ++++.++++||.-
T Consensus       159 ~~~~~~~liDfg~  171 (198)
T cd05144         159 DDDEKIYIIDWPQ  171 (198)
T ss_pred             cCCCcEEEEECCc
Confidence            9999999999964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.72  E-value=7e-18  Score=150.59  Aligned_cols=141  Identities=21%  Similarity=0.330  Sum_probs=116.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeE-EecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF-CTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lv~  371 (447)
                      +.|.+.+.+|+|.||++-.++++ +.+.+++|.++....  ...+|.+|...--.+ .|.||+.-++. +++.+..++++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            45778899999999999999976 477899999865533  345799998765555 48999988764 56677888999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCC-ceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDA-DQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~-~~~i~df~~  445 (447)
                      ||++.|+|.+-+...+     +.+.....++.|+++|++|||++   ++||||||.+||||- .|+ .+|++||..
T Consensus       102 E~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             ccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence            9999999998876532     67788899999999999999999   999999999999984 343 789999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.6e-17  Score=159.14  Aligned_cols=135  Identities=22%  Similarity=0.332  Sum_probs=113.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-----C---CCccceeeEEec-
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----H---RNLLRLYGFCTT-  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~-  363 (447)
                      ..+|.+.++||=|.|++||.|.. .+.+.||+|+.+...  .-....+.||++|++++     |   .+||+|+++|.. 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            36788889999999999999985 457899999986542  22345788999998874     3   369999999875 


Q ss_pred             ---CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          364 ---VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       364 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                         +.+.+||+|++ |-+|..+|.....+.  ++...+..|+.||+.||.|||+.|  +|||-||||+|||+...
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence               45789999998 668999998765543  888999999999999999999998  99999999999999765

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.4e-17  Score=146.91  Aligned_cols=127  Identities=17%  Similarity=0.235  Sum_probs=103.3

Q ss_pred             ccccCCCceEEEEEeCCCcEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .||+|+||.||+|.+ ++..+++|.........       ...++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 57889999864322111       1235778999999999988766666666677789999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|.+.+....           ..++.+++++|.++|+.   +++|||+||+||+++ ++.+++.||.
T Consensus        80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg  134 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFG  134 (199)
T ss_pred             CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECC
Confidence            9999998875421           07899999999999999   999999999999999 8899999985

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=6.6e-17  Score=143.28  Aligned_cols=129  Identities=18%  Similarity=0.136  Sum_probs=101.3

Q ss_pred             CCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc---HHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeec
Q 013258          298 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .....|++|+||+||.+.. .+..++.+.+........   ...+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997665 577788777754432111   224789999999995 5889999886    457999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCC-CCCceeeCCCCceeeccccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTILR  445 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~~i~df~~  445 (447)
                      ++|.+|.+.+..           ....+..|++++|+|+|++   +|+|||| ||+|||+++++.++|+||-.
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~  138 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL  138 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence            999988654321           1135678999999999999   9999999 79999999999999999964

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=4.1e-17  Score=147.65  Aligned_cols=135  Identities=10%  Similarity=0.087  Sum_probs=109.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccH--H------HHHHHHHHHhcCCCCCccceeeEEecC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--L------QFQTEVKIISMAVHRNLLRLYGFCTTV  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~------~~~~E~~~l~~l~H~niv~l~~~~~~~  364 (447)
                      ..++|...+++|.|+||.||.... +++.+|||.+++.......  .      .+.+|++.+.+++|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            457899999999999999999765 5778999999755432221  1      168999999999999999998886532


Q ss_pred             --------CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          365 --------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       365 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                              ...+++|||++|.+|.+...        ++.    ....+++.++..+|..   +++|||+||+||++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999977631        221    3456899999999999   999999999999999998


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                       +++.||-
T Consensus       173 -i~liDfg  179 (232)
T PRK10359        173 -LRIIDLS  179 (232)
T ss_pred             -EEEEECC
Confidence             9999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.71  E-value=1.2e-17  Score=169.21  Aligned_cols=140  Identities=29%  Similarity=0.339  Sum_probs=111.1

Q ss_pred             CCCCCccccCCCce-EEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecC
Q 013258          297 FSNKNILGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       297 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      |...+++|.|+-|+ ||+|.+ +|+.||||++-.+.    ..-..+|+..+..- +|||||++++.-.++...|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45567899999886 799998 57899999985432    22467899999877 5999999998888888999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---C--Cceeeccccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---D--ADQSSKTILR  445 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~~i~df~~  445 (447)
                      . .+|.+++...........-.....+..|+++||++||+.   +||||||||.||||+.   +  ..++|+||-.
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccc
Confidence            6 599999977411111111134577889999999999998   9999999999999987   3  4789999964

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=6.6e-17  Score=167.33  Aligned_cols=133  Identities=15%  Similarity=0.201  Sum_probs=106.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEE-ccccccc------ccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTS------GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      ..|...+.||+|+||.||+|.+.+.. +++|+ .......      ....++.+|++++..++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            44566789999999999999875443 33443 2211111      1123588999999999999999888888777788


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++++|.+++.            ....++.+++++|.|||+.   +|+|||+||+|||+ +++.++++||-
T Consensus       412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence            99999999999998875            3467899999999999999   99999999999999 67889999984

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=3.3e-17  Score=159.17  Aligned_cols=142  Identities=21%  Similarity=0.279  Sum_probs=120.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc-HHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..|++.++||+||.++||++...+.+.||+|++.....+.. ...|..|+..|.+++ |.+||+|++|-..++.+|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            45888899999999999999988888999998765433322 346999999999995 9999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |=+ -+|.++|+.....  ..+| .+..+..|++.++.++|.+   +|||.||||.|+|+- .|..|+.||.
T Consensus       441 ~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFG  504 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFG  504 (677)
T ss_pred             ccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeec
Confidence            774 5999999886542  2335 7788999999999999999   999999999999986 5779999985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.69  E-value=3.1e-17  Score=162.55  Aligned_cols=140  Identities=24%  Similarity=0.316  Sum_probs=116.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++.|.....+|.|+|+.|-++.. .+++..+||++....     .+-.+|+.++... +||||+++.+.+....+.++|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            356677778899999999999985 468899999996541     1234566555544 799999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee-CCCCceeeccccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-DEDADQSSKTILR  445 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~~i~df~~  445 (447)
                      ||++.+|-+.+.+.....    .. ..+..|+.+++.|+.|||++   +||||||||+|||+ ++.++.+++||-.
T Consensus       395 ~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~  462 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGF  462 (612)
T ss_pred             ehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEech
Confidence            999999988888765432    22 67778999999999999999   99999999999999 5889999999964

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.66  E-value=2.7e-16  Score=147.04  Aligned_cols=153  Identities=24%  Similarity=0.330  Sum_probs=128.3

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeE
Q 013258          287 LRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  360 (447)
Q Consensus       287 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~  360 (447)
                      ..++.+..++++...++-+|.||+||+|.+++      .+.|-||.++...+..+...+..|...+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45667777788888999999999999996543      356778888777666666678999999999999999999999


Q ss_pred             Eec-CCceEEEeecCCCCChhhHhhccCCC----CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          361 CTT-VTEKLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       361 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                      +.+ .+..+..|.++.-|+|..+|+.++..    ...+.-.+...++.|++.|++|||.+   +|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            876 45678999999999999999854321    23456667889999999999999999   99999999999999999


Q ss_pred             Cceeecc
Q 013258          436 ADQSSKT  442 (447)
Q Consensus       436 ~~~~i~d  442 (447)
                      .++|++|
T Consensus       433 LqVkltD  439 (563)
T KOG1024|consen  433 LQVKLTD  439 (563)
T ss_pred             eeEEecc
Confidence            9999987

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.63  E-value=6.1e-16  Score=136.10  Aligned_cols=142  Identities=20%  Similarity=0.252  Sum_probs=118.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv  370 (447)
                      ....|...+.||.|+||.+|.|. ..+|..||||.-+..   ....++..|..+...++| ..|..+..|..+.+.-.+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            34578889999999999999998 667999999975433   233467889999988875 5688888888899999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~  444 (447)
                      ||.+ |.||+++..-+..   .++..+.+-++-|++.-++|+|.+   ++|||||||+|.|..-+.   ...+.||-
T Consensus        90 MdLL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             eecc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEecc
Confidence            9988 7799998876543   378889999999999999999999   999999999999987543   46777774

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=1.9e-15  Score=129.17  Aligned_cols=130  Identities=17%  Similarity=0.123  Sum_probs=109.3

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      .+.||+|.++.||++...+ ..+++|..+....   ...+.+|+..+..++|  .++++++++....+..++++||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999999754 7899998855432   3468899999999977  58999998888878899999999987


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+...           +......++.+++++++++|.....+++|+|+||+||++++++.+++.||.
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~  134 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE  134 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence            76543           345667889999999999998654579999999999999998999999985

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.63  E-value=2.7e-16  Score=143.71  Aligned_cols=138  Identities=25%  Similarity=0.320  Sum_probs=112.6

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccc-cccccHHHHHHHHHHHhcCCCCCccceeeEEecC------Cce
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  367 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~  367 (447)
                      +|.....+|.|.- .|..+... .++.||+|.+... ......++..+|..++..++|+||++++.++.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4556677888876 55555432 4889999987432 2233345678999999999999999999998643      357


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|||||. ++|...++..      ++-.+..+|..|+..|+.|||+.   +|+||||||+||++..++..||.||.
T Consensus        97 y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            99999995 5899888743      67788899999999999999999   99999999999999999999999996

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.63  E-value=7e-16  Score=145.90  Aligned_cols=141  Identities=21%  Similarity=0.348  Sum_probs=119.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  365 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  365 (447)
                      ......|...++||+|.|+.||++.+.    .++.||+|.+......   .+...|++.|..+ .+.||+++.+++...+
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            334466888999999999999999743    3678999998665433   2588999999988 5999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc-eeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-~~i~df~  444 (447)
                      ...+|+||++.-+..+++..       ++......+.+.+..||.|+|.+   +||||||||+|+|.+.... -.+.||-
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            99999999999988888764       66788999999999999999999   9999999999999997654 4666774

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=8.4e-16  Score=137.09  Aligned_cols=131  Identities=20%  Similarity=0.241  Sum_probs=93.0

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEccccccccc-HHH----------------------HHHHHHHHhcCCCCC--c
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQ----------------------FQTEVKIISMAVHRN--L  354 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~----------------------~~~E~~~l~~l~H~n--i  354 (447)
                      .+.||+|+||+||+|...+++.||||+++....... ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999987899999999865321111 111                      134555555554433  3


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhH-hhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceee
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  432 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl  432 (447)
                      .+.+++    ...++||||++++.+... +....     .. .....++.+++.++.++|. .   +|+||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            334332    346899999999654321 22111     11 4567899999999999999 7   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      + ++.+++.||-
T Consensus       149 ~-~~~~~liDfg  159 (187)
T cd05119         149 D-DGKVYIIDVP  159 (187)
T ss_pred             E-CCcEEEEECc
Confidence            9 8999999985

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.60  E-value=4e-15  Score=136.66  Aligned_cols=140  Identities=20%  Similarity=0.270  Sum_probs=117.7

Q ss_pred             cCCCCCCccccCCCceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      -.|.+.+.||+|+||+.+.|+ +-++++||||.-+...   ...++..|.+..+.+. .++|...+-|..++.+-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            368889999999999999998 5679999999754322   2346778888888774 6899999988888889999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-----ceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~~i~df~  444 (447)
                      .+ |-||+++..-++.   .++..++..||.|++.-++|+|++   .+|.|||||+|+||..-+     .+.+.||-
T Consensus       105 LL-GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hh-CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEecc
Confidence            88 7799988876654   388899999999999999999999   999999999999998644     46788885

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.60  E-value=4.4e-15  Score=144.08  Aligned_cols=142  Identities=21%  Similarity=0.261  Sum_probs=115.3

Q ss_pred             CCCCCCccccCCCceEEEEEeCCC--cEEEEEEcccccccccHHHHHHHHHHHhcCCC----CCccceeeEE-ecCCceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVH----RNLLRLYGFC-TTVTEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~  368 (447)
                      +|.+.+.||+|+||.||.+.....  ..+|+|........... .+..|+.++..+..    +++.++++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            788899999999999999996543  57899987554333322 57788888888863    5888999888 4777889


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-----Cceeeccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-----ADQSSKTI  443 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~~i~df  443 (447)
                      +||+.+ |.+|.++.....  ...++-.+...|+.|++.+|+++|+.   +++||||||+|+++...     ....+.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999977 779999775543  23488899999999999999999999   99999999999999865     35788888


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       172 G  172 (322)
T KOG1164|consen  172 G  172 (322)
T ss_pred             C
Confidence            3

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.59  E-value=2e-15  Score=141.11  Aligned_cols=134  Identities=20%  Similarity=0.293  Sum_probs=112.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCC--C----CccceeeEEecCCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--R----NLLRLYGFCTTVTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~  366 (447)
                      +.+|.+...+|+|.||+|-++... ++..||||+++....  -....+-|++++.++.+  |    -+|++.+++.-.++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            678889999999999999999854 478999999976432  23346778999998842  2    37888899999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                      .++|+|.+ |-|+++++.....  .+++...+..|+.|++++++|||+.   +++|-||||+|||+-+.
T Consensus       166 iCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss  228 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS  228 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence            99999988 5699999988644  3578889999999999999999999   99999999999998543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.6e-14  Score=133.51  Aligned_cols=132  Identities=17%  Similarity=0.197  Sum_probs=100.8

Q ss_pred             Cccc-cCCCceEEEEEeCCCcEEEEEEccccc------------ccccHHHHHHHHHHHhcCCCCCc--cceeeEEecCC
Q 013258          301 NILG-RGGFGKVYKGRLADGKLVAVKRLKEER------------TSGGELQFQTEVKIISMAVHRNL--LRLYGFCTTVT  365 (447)
Q Consensus       301 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~  365 (447)
                      ..|| .|+.|+||..+.. +..++||.+....            .......+.+|++++..++|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999874 6788999874311            01122458899999999998885  66776644322


Q ss_pred             ----ceEEEeecCCC-CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceee
Q 013258          366 ----EKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       366 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                          ..++|+||+++ .+|.+++...     .++.    ....+++.++.+||+.   +|+||||||+|||++.++.+++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence                23599999997 6898887542     1333    2367899999999999   9999999999999999999999


Q ss_pred             ccccc
Q 013258          441 KTILR  445 (447)
Q Consensus       441 ~df~~  445 (447)
                      +||-.
T Consensus       184 IDfg~  188 (239)
T PRK01723        184 IDFDR  188 (239)
T ss_pred             EECCC
Confidence            99964

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.55  E-value=4.9e-14  Score=135.42  Aligned_cols=143  Identities=34%  Similarity=0.459  Sum_probs=121.8

Q ss_pred             CCCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEeec
Q 013258          297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~e~  373 (447)
                      |...+.||.|+||.||++...  ..+++|.+........  ...+.+|+.++..+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999976  7899999976554432  55799999999999988 799999999777778999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeeccccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  445 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~~  445 (447)
                      +.++++.+++...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .+++.||.-
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence            9999999777654311 2477889999999999999999999   899999999999999998 799999964

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.50  E-value=3e-14  Score=137.76  Aligned_cols=146  Identities=19%  Similarity=0.218  Sum_probs=121.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC------CCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~  365 (447)
                      ...+|.+....|+|-|+.|.+|... .|..||||+|+....  ..+.=+.|+++|.+++      --|+++++..|...+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            4467888888999999999999864 488999999975432  1234568999999886      347899999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      ++|||+|-+. -+|.++|...+. ...|....+..++.|+.-||..|-..   +|+|.||||.|||+++.- ..||+||.
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence            9999999874 589999988643 34578889999999999999999987   999999999999999876 56999996


Q ss_pred             c
Q 013258          445 R  445 (447)
Q Consensus       445 ~  445 (447)
                      .
T Consensus       583 S  583 (752)
T KOG0670|consen  583 S  583 (752)
T ss_pred             c
Confidence            5

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.50  E-value=2e-15  Score=126.35  Aligned_cols=131  Identities=29%  Similarity=0.495  Sum_probs=120.3

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|.|++|.++ .+||.|..|.+|+.|++++|++. .+|..++++++|+.|+++-|++. .+|..|++++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            57899999999998 78999999999999999999999 69999999999999999999998 89999999999999999


Q ss_pred             cCccccc-cCchHHhhcccccccccccccccccCCCCCCCCcccccccccccccc
Q 013258          147 NNNSLSG-LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC  200 (447)
Q Consensus       147 ~~N~l~~-~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc  200 (447)
                      .+|++.. .+|..|.-+..|+.|+++.|.|.-.+|+.+.+..+..++...|..+.
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~  164 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLS  164 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhh
Confidence            9999964 57999999999999999999999999999999998888887775543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=4.1e-14  Score=149.83  Aligned_cols=146  Identities=21%  Similarity=0.254  Sum_probs=113.3

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeEEecCCc
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTE  366 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~  366 (447)
                      .++..+.|.+.+.||+|+||+||+|...+|+.||+|+=+....++-    ---.+++.+++   -+-|..+...+.-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            4455567888899999999999999987899999998776554432    11122334444   2344555555566778


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-------CCcee
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------DADQS  439 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~~~~~  439 (447)
                      .++|+||.+.|+|.+++...+    ..+|.-.+.++.|+++-+++||..   +|||+||||+|.||..       ..-.+
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             ceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence            899999999999999998433    489999999999999999999999   9999999999999853       22478


Q ss_pred             ecccccc
Q 013258          440 SKTILRR  446 (447)
Q Consensus       440 i~df~~~  446 (447)
                      |.||-..
T Consensus       842 lIDfG~s  848 (974)
T KOG1166|consen  842 LIDFGRS  848 (974)
T ss_pred             EEecccc
Confidence            8898654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=2.3e-13  Score=136.60  Aligned_cols=136  Identities=22%  Similarity=0.231  Sum_probs=96.2

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccc---------------------------------------cHHHHH
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG---------------------------------------GELQFQ  340 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~  340 (447)
                      .+.||+|++|+||+|++++|+.||||+.++.....                                       .+.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            37899999999999999999999999986542100                                       011255


Q ss_pred             HHHHHHhcCC----CCCccceeeEEe-cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHH-HHhhhhc
Q 013258          341 TEVKIISMAV----HRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-GLSYLHE  414 (447)
Q Consensus       341 ~E~~~l~~l~----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~  414 (447)
                      +|++.+.+++    |.+-+.+-.++. .....++||||++|++|.+........   .   .+..++.+++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence            5666665552    333333333332 244579999999999998876542111   2   23456666665 4678888


Q ss_pred             CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          415 HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       415 ~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .   +++|+|+||.||++++++.+++.||-
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG  302 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFG  302 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCC
Confidence            8   99999999999999999999999985

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.2e-13  Score=121.98  Aligned_cols=137  Identities=25%  Similarity=0.414  Sum_probs=113.6

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccc-cccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      .+|.+...|+.|+|+++.+ .+.+|+++.. .+....++|.+|.-.++-+.||||..++|.|.++.+..++..||+.|||
T Consensus       196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            4578889999999999754 4555776432 2233345799999999999999999999999999999999999999999


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      +..|++...  ...+-.++.+++.++|+|++|||+. .|-|.---|.+..|++|+|..++|+
T Consensus       275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            999998643  3478889999999999999999997 4445555789999999999988875

>PLN03150 hypothetical protein; Provisional

Probab=99.33  E-value=1.7e-12  Score=136.17  Aligned_cols=91  Identities=41%  Similarity=0.635  Sum_probs=88.2

Q ss_pred             CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccc
Q 013258           92 NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS  171 (447)
Q Consensus        92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls  171 (447)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|.+.|.+|+.++.+++|+.|+|++|+++|.+|..++++++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCCCC
Q 013258          172 NNRLSGPVPDN  182 (447)
Q Consensus       172 ~N~l~g~~p~~  182 (447)
                      +|+++|.+|..
T Consensus       499 ~N~l~g~iP~~  509 (623)
T PLN03150        499 GNSLSGRVPAA  509 (623)
T ss_pred             CCcccccCChH
Confidence            99999999975

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=1.3e-12  Score=132.75  Aligned_cols=139  Identities=21%  Similarity=0.215  Sum_probs=89.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-CcEEEEEEccccccc---------------------c------------------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTS---------------------G------------------  334 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------~------------------  334 (447)
                      ..|+. +.||+|++|+||+|++++ |+.||||+.++....                     .                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34665 789999999999999877 999999999754210                     0                  


Q ss_pred             cHHHHHHHHHHHhcCC----CCCccceeeEEec-CCceEEEeecCCCCChhhH--hhccCCCCCCCChHHHHHHHHHHHH
Q 013258          335 GELQFQTEVKIISMAV----HRNLLRLYGFCTT-VTEKLLVYPYMTNGSVASR--LRERQSSLPPLDWPTRKKIALGSAR  407 (447)
Q Consensus       335 ~~~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia~  407 (447)
                      .+.++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.+.  +...+.....+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence            0112455665555443    4444444444433 4567899999999999764  22221100011122222233333  


Q ss_pred             HHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeecccc
Q 013258          408 GLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  444 (447)
Q Consensus       408 gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df~  444 (447)
                           +..   +++|+|+||.||+++.++    ..++.||-
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFG  309 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFG  309 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecc
Confidence                 345   899999999999999988    89999984

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.30  E-value=1e-11  Score=108.65  Aligned_cols=126  Identities=20%  Similarity=0.179  Sum_probs=92.6

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCcc-ceeeEEecCCceEEEeecCCCCCh
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      +.++.|.++.||+++.. ++.|++|.......  ....+..|++.+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56889999999999875 77899998754421  123467899999888765554 455443  3346899999999887


Q ss_pred             hhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC--CCCeeecCCCCCceeeCCCCceeecccc
Q 013258          380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       380 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ...  .       .   ....+..+++++|+.||...  ...++|+|++|.||+++ ++.+++.||.
T Consensus        79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~  132 (170)
T cd05151          79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE  132 (170)
T ss_pred             ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence            543  0       0   11345678999999999972  12369999999999999 6678999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.22  E-value=5.6e-12  Score=136.97  Aligned_cols=89  Identities=11%  Similarity=0.019  Sum_probs=69.8

Q ss_pred             cCCC-CCccceeeEEe-------cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC
Q 013258          348 MAVH-RNLLRLYGFCT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK  419 (447)
Q Consensus       348 ~l~H-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  419 (447)
                      .++| +||.++++++.       ..+..+.++||+ +++|.++|....   ..+++.++..++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3456 58888888772       234567888887 569999997532   2489999999999999999999999   9


Q ss_pred             eeecCCCCCceeeCCCCceeeccc
Q 013258          420 IIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       420 ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      |+||||||+||||+..+..|++||
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeec
Confidence            999999999999966555444444

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.21  E-value=4.2e-13  Score=112.56  Aligned_cols=129  Identities=25%  Similarity=0.452  Sum_probs=103.1

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccc-ccCCccccCCCCCCeeeC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN-GTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-g~~p~~~~~l~~L~~L~l  146 (447)
                      ++..|++.+|++. .+|..++.|+.|+.|+++-|++. ..|..|+.++.|+.|||+.|++. ..+|..|..++.|+.|+|
T Consensus        57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl  134 (264)
T KOG0617|consen   57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL  134 (264)
T ss_pred             hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence            5777889999987 68888999999999999999998 78999999999999999998885 347777777777888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL  199 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l  199 (447)
                      ++|.+. .+|..++.+++|+.|.+..|.+-..+-+.+.+.+++.+.++||...
T Consensus       135 ~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             cCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence            888886 5677778888888888888777655555666777777777777543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=1.8e-10  Score=105.29  Aligned_cols=140  Identities=16%  Similarity=0.217  Sum_probs=105.6

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC--CccceeeEEecCC---ceEEEeecCC
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTTVT---EKLLVYPYMT  375 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~---~~~lv~e~~~  375 (447)
                      +.++.|.++.||++...+|+.+++|............++..|++++..+++.  ++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            6689999999999988667889999875443222334688999999998764  4577777766532   5689999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC---------------------------------------
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------  416 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------  416 (447)
                      +.++.+.+..     ..++......++.+++++|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888766531     12566777788888888888888521                                       


Q ss_pred             --------------CCCeeecCCCCCceeeCC--CCceeeccccc
Q 013258          417 --------------DPKIIHRDVKAANILLDE--DADQSSKTILR  445 (447)
Q Consensus       417 --------------~~~ivHrDlkp~NILl~~--~~~~~i~df~~  445 (447)
                                    ...++|+|++|.||++++  ++.+.+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~  203 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWEL  203 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccc
Confidence                          245799999999999998  56678899853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.16  E-value=4.7e-12  Score=124.42  Aligned_cols=130  Identities=27%  Similarity=0.276  Sum_probs=110.4

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .+..|+|+.|+++..-...+..|+.|+.|+||+|.+....++.|...++|++|+|++|+++..-+..|..|..|+.|+|+
T Consensus       270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs  349 (873)
T KOG4194|consen  270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS  349 (873)
T ss_pred             ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence            57889999999987777788999999999999999999999999999999999999999997777788899999999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCC----CCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG----SFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~----~~~~~~~~~~~~n~  197 (447)
                      .|.+...-..+|..+++|+.|||++|.+++.|-+..    .+..++.+.+.||+
T Consensus       350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ  403 (873)
T ss_pred             ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence            999987777788889999999999999988776531    24445555555554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=1.6e-11  Score=127.45  Aligned_cols=140  Identities=21%  Similarity=0.244  Sum_probs=106.3

Q ss_pred             CCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHH----HHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          298 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGEL----QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~----~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ...+++|.|++|.|+..... .....+.|..+... ......    .+..|..+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34678999999977777633 34444444332100 111111    2556777778899999988888777776666669


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |||++ +|+..+....    .+.-.++..+..|+..|+.|+|+.   +|.|||+|++|++++.++..||.||..
T Consensus       401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~  466 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGA  466 (601)
T ss_pred             hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCc
Confidence            99999 9999987642    266778889999999999999999   999999999999999999999999964

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.14  E-value=4.1e-10  Score=99.88  Aligned_cols=133  Identities=14%  Similarity=0.157  Sum_probs=94.8

Q ss_pred             CccccCCCceEEEEEeCC-------CcEEEEEEcccccc-----------c----------ccHHH----HHHHHHHHhc
Q 013258          301 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERT-----------S----------GGELQ----FQTEVKIISM  348 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~----------~~~~~----~~~E~~~l~~  348 (447)
                      ..||.|.=+.||.|...+       +..+|||+.+....           .          .....    .++|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       47899998753210           0          00112    2379999988


Q ss_pred             CCC--CCccceeeEEecCCceEEEeecCCCCChhh-HhhccCCCCCCCChHHHHHHHHHHHHHHhhh-hcCCCCCeeecC
Q 013258          349 AVH--RNLLRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRD  424 (447)
Q Consensus       349 l~H--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD  424 (447)
                      +..  -++.+.+++    ...++||||+.+..+.. .+++.     .++......+..+++.+|.++ |..   +|||+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            864  456666654    56789999997654422 23221     134455667789999999999 777   999999


Q ss_pred             CCCCceeeCCCCceeecccccc
Q 013258          425 VKAANILLDEDADQSSKTILRR  446 (447)
Q Consensus       425 lkp~NILl~~~~~~~i~df~~~  446 (447)
                      |++.|||++ ++.+.+.||-+.
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qa  171 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQS  171 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCc
Confidence            999999997 467999999764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.12  E-value=1.1e-11  Score=129.78  Aligned_cols=140  Identities=25%  Similarity=0.258  Sum_probs=112.4

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHH---HHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++...+.||++.|=+|.+|+.+.|. |.||++-+.........|.   +|++ ....+|||.+++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4566788999999999999987776 8889874433233333343   4444 556689999998877777777899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |..+ +|++.|..+    +.+...+.+-|+.|++.|+.-+|..   +|+|+|||.+||||++-..+.++||..
T Consensus       102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence            9965 888888654    2366777888999999999999999   999999999999999999999999964

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.11  E-value=4.7e-12  Score=119.33  Aligned_cols=124  Identities=31%  Similarity=0.446  Sum_probs=99.4

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCcccc-CCCCCCeeeCc
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLA-NLKQLKYLRLN  147 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~-~l~~L~~L~l~  147 (447)
                      +..||...|-+ +++|++++.|..|.-|+|..|.+. .+| +|.++..|+.|.++.|++. .+|.... +++++..|||.
T Consensus       185 L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLR  260 (565)
T KOG0472|consen  185 LKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLR  260 (565)
T ss_pred             HHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeecc
Confidence            34445444444 467777777777777778777777 566 6777777888888888876 6777665 89999999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  198 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~  198 (447)
                      +|+++ ..|..+.-+++|+.||+|+|.+++.++.-|.+ .+..+.+.||+.
T Consensus       261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             ccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            99998 68999999999999999999999999988877 777888888873

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.10  E-value=1.6e-11  Score=122.32  Aligned_cols=138  Identities=25%  Similarity=0.260  Sum_probs=113.5

Q ss_pred             ccccCCCceEEEEE----eCCCcEEEEEEccccccccc-HHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeecCC
Q 013258          302 ILGRGGFGKVYKGR----LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      ++|+|+||.|+.++    ...|..+|+|.++....... ......|..++..++ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998764    23478899998865432221 113556777888887 9999999999999999999999999


Q ss_pred             CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccccc
Q 013258          376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRR  446 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~~  446 (447)
                      +|++...+.....    ++......+...++-+++++|..   +|+|||+|++||+++.+|.+++.||..+
T Consensus        81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgls  144 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLS  144 (612)
T ss_pred             cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhh
Confidence            9999988876533    66777778888899999999999   9999999999999999999999999765

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=6.3e-11  Score=111.79  Aligned_cols=87  Identities=25%  Similarity=0.332  Sum_probs=67.0

Q ss_pred             CCCCCccceeeEEec---------------------------CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHH
Q 013258          349 AVHRNLLRLYGFCTT---------------------------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI  401 (447)
Q Consensus       349 l~H~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  401 (447)
                      -+|||||++.++|.+                           +..+|+||.-+. .+|.+++..+.     .+...+.-|
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-----~s~r~~~~~  346 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-----RSYRTGRVI  346 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-----CchHHHHHH
Confidence            369999999987743                           124578887664 38888887653     455667788


Q ss_pred             HHHHHHHHhhhhcCCCCCeeecCCCCCceeeC--CCC--ceeecccc
Q 013258          402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDA--DQSSKTIL  444 (447)
Q Consensus       402 ~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~~i~df~  444 (447)
                      ..|+++|+.|||.+   +|.|||+|++|||+.  +|.  ..-|+||-
T Consensus       347 laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             HHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccc
Confidence            89999999999999   999999999999985  333  34677874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.03  E-value=1.1e-09  Score=102.44  Aligned_cols=141  Identities=23%  Similarity=0.342  Sum_probs=88.6

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCC----------CCccceeeEEe----
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVH----------RNLLRLYGFCT----  362 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~----  362 (447)
                      .+.||.|+++.||.++.. +++.+|||+.....  ......++.+|.-....+.+          -.++--++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            478999999999999975 48999999874332  22233456666655544332          12221222211    


Q ss_pred             -----cCC--------ceEEEeecCCCCChhhHhhc---cCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCC
Q 013258          363 -----TVT--------EKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  426 (447)
Q Consensus       363 -----~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  426 (447)
                           ...        ..+++|+-+ .+||.+++..   .......+....++.+..|+.+.+++||+.   ++||+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                 111        235677766 4688877543   222111233445667779999999999999   99999999


Q ss_pred             CCceeeCCCCceeecccc
Q 013258          427 AANILLDEDADQSSKTIL  444 (447)
Q Consensus       427 p~NILl~~~~~~~i~df~  444 (447)
                      |+|++++++|.+.++||.
T Consensus       173 ~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             GGGEEE-TTS-EEE--GG
T ss_pred             eeeEEEcCCCCEEEcChH
Confidence            999999999999999985

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.02  E-value=2.1e-11  Score=114.98  Aligned_cols=129  Identities=31%  Similarity=0.509  Sum_probs=101.0

Q ss_pred             CEEEEEcCCCCcc-----------------------ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           68 SVTRVDLGNAALS-----------------------GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        68 ~v~~l~L~~~~l~-----------------------g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      .|+.++++.|++.                       +.+|..++.+++|+.|+|++|.+. .+|.+++.+..|+.||+|.
T Consensus       389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~  467 (565)
T KOG0472|consen  389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSF  467 (565)
T ss_pred             ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccc
Confidence            4888888877654                       345667788888888888888887 6888888888888888888


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccc
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  198 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~  198 (447)
                      |+|. .+|..+..+..++.+-.++|++....|+.+.++.+|..||+.+|.+...+|..|.+.+++.+.+.||+.
T Consensus       468 NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  468 NRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             cccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            8887 677777777777777667777776666668888888888888888888888778888888887777753

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.01  E-value=4e-11  Score=118.03  Aligned_cols=134  Identities=25%  Similarity=0.340  Sum_probs=84.5

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCc---cccCCCCCCee
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD---TLANLKQLKYL  144 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~---~~~~l~~L~~L  144 (447)
                      ++..|||++|+++..-+.++..|..|+.|+|+.|+++..--..|..+++|+.|||++|.+++.+.+   .|..|++|+.|
T Consensus       318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL  397 (873)
T KOG4194|consen  318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL  397 (873)
T ss_pred             cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence            456666666666655555666666666666666666654445566667777777777777666554   35567777777


Q ss_pred             eCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccC
Q 013258          145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       145 ~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +|.+|++..+.-.+|..+.+|+.|||.+|.+...-|+...--.+..+.++....+|.
T Consensus       398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCD  454 (873)
T KOG4194|consen  398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCD  454 (873)
T ss_pred             eecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEe
Confidence            777777776555677777778888888877765544432111344444444555554

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.96  E-value=8e-11  Score=116.73  Aligned_cols=106  Identities=31%  Similarity=0.502  Sum_probs=84.4

Q ss_pred             CEEEEEcCCCCcc-ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCcc-ccCCCCCCeee
Q 013258           68 SVTRVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT-LANLKQLKYLR  145 (447)
Q Consensus        68 ~v~~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~  145 (447)
                      ++.++++..|++. ..||+.|..|..|+.||||.|++. ..|..+.+-+++-+|+||+|++. .||.. +.+|+.|-+||
T Consensus        79 ~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD  156 (1255)
T KOG0444|consen   79 RLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD  156 (1255)
T ss_pred             hhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence            4556667767665 357888888888888888888888 68888888888888888888887 67765 46888888888


Q ss_pred             CcCccccccCchHHhhccccccccccccccc
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      ||+|++. .+|+.+..+..|+.|++|+|.+.
T Consensus       157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~  186 (1255)
T KOG0444|consen  157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN  186 (1255)
T ss_pred             cccchhh-hcCHHHHHHhhhhhhhcCCChhh
Confidence            8888887 46667788888888888888875

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.94  E-value=9.3e-11  Score=121.12  Aligned_cols=127  Identities=33%  Similarity=0.459  Sum_probs=107.8

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .+..|.|.+|.++...-|-+.++.+|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|+.+.++..|++|...
T Consensus       360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah  438 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH  438 (1081)
T ss_pred             HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence            4677889999999988888999999999999999998544556788999999999999998 799999999999999999


Q ss_pred             CccccccCchHHhhccccccccccccccc-ccCCCCCCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLS-GPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~-g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      +|++. ..| .+..++.|+.+|+|.|+++ +.+|.......++.+++.||.
T Consensus       439 sN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  439 SNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             CCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            99997 466 7889999999999999998 445554444667777788876

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.93  E-value=1.2e-10  Score=115.41  Aligned_cols=126  Identities=27%  Similarity=0.406  Sum_probs=92.9

Q ss_pred             EEEEEcCCCCcc-ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           69 VTRVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        69 v~~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +..|++++.+-+ ..+|.++..|.+|..+|||.|++. ..|+.+.++++|+.|+||+|+++ .+-...+.+.+|++|+||
T Consensus       199 L~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlS  276 (1255)
T KOG0444|consen  199 LSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLS  276 (1255)
T ss_pred             hhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccc
Confidence            344444443322 457888888888888888888888 68888888888888888888887 566666777888888888


Q ss_pred             CccccccCchHHhhccccccccccccccc--ccCCCCCCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLS--GPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~--g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      .|+++ .+|+++..++.|+.|.+.+|+++  |.+...|.+.++.....++|.
T Consensus       277 rNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~  327 (1255)
T KOG0444|consen  277 RNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK  327 (1255)
T ss_pred             cchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence            88887 57888888888888888888775  544445666666655555553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.90  E-value=1.4e-09  Score=94.69  Aligned_cols=105  Identities=32%  Similarity=0.519  Sum_probs=37.7

Q ss_pred             CEEEEEcCCCCcccccccccc-CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccc-cCCCCCCeee
Q 013258           68 SVTRVDLGNAALSGELAPELG-QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLR  145 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~  145 (447)
                      +++.|+|.+|.++- + +.++ .+.+|+.|+|++|.++. ++ .+..++.|+.|++++|+++ .+++.+ ..+++|+.|+
T Consensus        20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~   94 (175)
T PF14580_consen   20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY   94 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred             cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence            46778888888764 2 3455 47788888888888874 43 4677888888888888887 455444 3578888888


Q ss_pred             CcCccccccC-chHHhhcccccccccccccccc
Q 013258          146 LNNNSLSGLI-PTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       146 l~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      |++|++...- -..+..+++|+.|++.+|+++.
T Consensus        95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            8888886421 1456677778888888887763

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.85  E-value=1.9e-09  Score=77.10  Aligned_cols=60  Identities=43%  Similarity=0.661  Sum_probs=32.9

Q ss_pred             CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccc
Q 013258           92 NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL  151 (447)
Q Consensus        92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  151 (447)
                      +|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|++
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555543334555555555555555555544444555555555555555543

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.84  E-value=3.1e-08  Score=92.77  Aligned_cols=139  Identities=16%  Similarity=0.110  Sum_probs=96.7

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEccccccc----------ccHHHHHHHHHHHhcCCCCCc--cceeeEEec-----
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------GGELQFQTEVKIISMAVHRNL--LRLYGFCTT-----  363 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~-----  363 (447)
                      +.+-+.....|++..+ +|+.|.||........          .....+.+|...+..+...+|  ++.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444445777766 5778999976432210          111247889998888854444  445556543     


Q ss_pred             CCceEEEeecCCCC-ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-------C
Q 013258          364 VTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------D  435 (447)
Q Consensus       364 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~  435 (447)
                      ....++|+|++++- +|.+++.....  ...+......++.+++..+.-||..   +|+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23478999999876 78888864321  1244566778999999999999999   9999999999999985       4


Q ss_pred             Cceeeccccc
Q 013258          436 ADQSSKTILR  445 (447)
Q Consensus       436 ~~~~i~df~~  445 (447)
                      ..+.+.||-+
T Consensus       182 ~~~~LIDl~r  191 (268)
T PRK15123        182 LKLSVIDLHR  191 (268)
T ss_pred             ceEEEEECCc
Confidence            5788888863

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.83  E-value=1.9e-09  Score=77.16  Aligned_cols=61  Identities=41%  Similarity=0.633  Sum_probs=56.3

Q ss_pred             CCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccc
Q 013258          115 IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL  175 (447)
Q Consensus       115 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l  175 (447)
                      ++|+.|++++|+++...+..|..+++|++|++++|+++...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999999999966567899999999999999999988889999999999999999986

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=3.2e-08  Score=87.45  Aligned_cols=123  Identities=21%  Similarity=0.271  Sum_probs=79.6

Q ss_pred             eEEEEEeCCCcEEEEEEccccccc------------c---------c----HHHHHHHHHHHhcCCCC--CccceeeEEe
Q 013258          310 KVYKGRLADGKLVAVKRLKEERTS------------G---------G----ELQFQTEVKIISMAVHR--NLLRLYGFCT  362 (447)
Q Consensus       310 ~Vy~~~~~~~~~vavK~~~~~~~~------------~---------~----~~~~~~E~~~l~~l~H~--niv~l~~~~~  362 (447)
                      .||.|...+|..+|||+.+.....            .         .    .....+|.+.|.++...  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            389999888999999987642110            0         0    12367899999999766  46666654  


Q ss_pred             cCCceEEEeecCC--CCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhh-hcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          363 TVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       363 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                        ....+||||++  +..+.. +....     ++......+..+++..+..+ |..   +|+|+|+.+.|||++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  544443 33321     12334566777777766664 677   99999999999999988 899


Q ss_pred             ecccccc
Q 013258          440 SKTILRR  446 (447)
Q Consensus       440 i~df~~~  446 (447)
                      +.||-+.
T Consensus       147 iIDf~qa  153 (188)
T PF01163_consen  147 IIDFGQA  153 (188)
T ss_dssp             E--GTTE
T ss_pred             EEecCcc
Confidence            9999764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=6.5e-08  Score=83.31  Aligned_cols=128  Identities=18%  Similarity=0.222  Sum_probs=93.7

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEc-ccccccc------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRL-KEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ..+++|+=+.+|.+.+. |..+.+|.- ++.....      ...+..+|++++.+++--.|..-.=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999764 444666643 2221111      122467899999988766665555566788889999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|-.|.+.+...           +..++..+-.-+.-||..   +|||+||.++||++..+. +.+.||-
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence            9998888888653           244566666677789999   999999999999998776 7777773

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.78  E-value=8e-08  Score=82.43  Aligned_cols=140  Identities=14%  Similarity=0.168  Sum_probs=98.5

Q ss_pred             CCCccccCCCceEEEEEeCCCcEEEEEEc-ccccc------cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          299 NKNILGRGGFGKVYKGRLADGKLVAVKRL-KEERT------SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ....+-+|+-+.|+++.+. |+...||.- .+...      .....+..+|++.+.+++--.|.--.=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4577889999999999984 677667643 22111      111335788999999887655554444556666678999


Q ss_pred             ecCCC-CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecccc
Q 013258          372 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  444 (447)
Q Consensus       372 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~df~  444 (447)
                      ||+++ -++.+++.......  -.......++..|-+.+.-||.+   +|||+||..+||++.++++   +.+.||.
T Consensus        90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence            99976 36777777643211  11222267788888899999999   9999999999999988774   4577774

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.77  E-value=1.5e-09  Score=98.99  Aligned_cols=123  Identities=25%  Similarity=0.344  Sum_probs=87.1

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      ++.|||++|.++ .+.+++.-++.++.|++|+|.+.. +. .+..|.+|+.||||+|.++ .+-.+-..+.+.+.|.|+.
T Consensus       286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence            567888888776 566777777888888888888872 33 3777888888888888886 4444445567778888888


Q ss_pred             ccccccCchHHhhcccccccccccccccc--cCCCCCCCCccccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSG--PVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g--~~p~~~~~~~~~~~~~~~n~  197 (447)
                      |.+..  -+.+..+-+|..||+++|++..  .+-..|.+..+..+.+.+|+
T Consensus       362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP  410 (490)
T KOG1259|consen  362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP  410 (490)
T ss_pred             hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence            88753  2557777888888888888863  23344556666666666665

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.76  E-value=1e-08  Score=67.44  Aligned_cols=40  Identities=38%  Similarity=0.844  Sum_probs=30.9

Q ss_pred             hHHHHHHHHHHHHCC-CCCCCCCCCCCCC-CCCCccceeEeC
Q 013258           25 NAEVDALYIFKSKLQ-DPNNSLQSWDNLP-GNLCTWFHITCN   64 (447)
Q Consensus        25 ~~~~~~l~~~~~~~~-~~~~~l~~w~~~~-~~~c~w~gv~c~   64 (447)
                      ++|++||+.||+++. +|.+.+.+|+..+ .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            579999999999998 5778999998764 799999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.72  E-value=1.7e-08  Score=100.70  Aligned_cols=93  Identities=24%  Similarity=0.334  Sum_probs=84.7

Q ss_pred             HhcCCCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCe-eecC
Q 013258          346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI-IHRD  424 (447)
Q Consensus       346 l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vHrD  424 (447)
                      |+.+.|.|+.+++|.+..+...+.|.+||..|+|.+.+....   ..++|.-...++.+++.||+|+|.-   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            356789999999999999999999999999999999998743   2489999999999999999999986   55 9999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 013258          425 VKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       425 lkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|+++|.....|++||.
T Consensus        75 l~s~nClvd~~w~lklt~~G   94 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFG   94 (484)
T ss_pred             eccccceeeeeEEEEechhh
Confidence            99999999999999999985

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.71  E-value=8e-09  Score=89.91  Aligned_cols=106  Identities=36%  Similarity=0.471  Sum_probs=36.4

Q ss_pred             ccCCCCCCEEECCCCccCCCCChhhc-CCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHH-hhccc
Q 013258           87 LGQLKNLELLELYGNNLSGHIPSALG-NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-TTITS  164 (447)
Q Consensus        87 l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~  164 (447)
                      +.+...++.|+|++|.++. | +.++ .+.+|+.|+|++|.++ .++ .+..++.|+.|++++|.++. ++..+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred             ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence            4556678999999999984 4 3566 5889999999999998 454 57889999999999999985 44445 46899


Q ss_pred             cccccccccccccc--CCCCCCCCccccccccccc
Q 013258          165 LNILDLSNNRLSGP--VPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       165 L~~l~ls~N~l~g~--~p~~~~~~~~~~~~~~~n~  197 (447)
                      |+.|++++|++...  +-.-..+..+..+++.+|+
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence            99999999999742  1111234556666777775

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.70  E-value=2.5e-09  Score=101.04  Aligned_cols=135  Identities=24%  Similarity=0.334  Sum_probs=110.3

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC-CcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS-NLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      ...+.|+|..|+++...+..|+.+.+|+.||||+|+|+.+-|.+|..+.+|..|-+.+ |+++..--..|++|.+|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3678999999999977777899999999999999999999999999999998887766 999955456799999999999


Q ss_pred             CcCccccccCchHHhhcccccccccccccccccCC-CCCCCCccccccccccccccC
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP-DNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +.-|++.-.....|..+++|..|.+-.|.+....- ....+...+....+.|++.|.
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            99999998889999999999999999999874321 111223444555666776554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.68  E-value=1.7e-09  Score=106.60  Aligned_cols=106  Identities=30%  Similarity=0.537  Sum_probs=90.5

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      +..|-+++|+++ .+|++++.+..|..||.+.|.+. .+|+.++++.+|+.|++..|++. .+|+.+..|+ |..||+|.
T Consensus       145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfSc  220 (722)
T KOG0532|consen  145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSC  220 (722)
T ss_pred             ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeeccc
Confidence            566667777776 68888888888999999999888 68888999999999999999988 6888888665 88999999


Q ss_pred             ccccccCchHHhhcccccccccccccccccC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPV  179 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~  179 (447)
                      |+++ .||-.|.+++.|++|-|.+|.+..+.
T Consensus       221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  221 NKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             Ccee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            9997 68999999999999999999998654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.67  E-value=2e-08  Score=106.16  Aligned_cols=113  Identities=25%  Similarity=0.339  Sum_probs=50.1

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|++++ +|+..   .+|+.|++++|.|++ +|..   ..+|+.|+|++|+|+ .+|...   ++|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMVS  410 (788)
T ss_pred             ccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCcc---cCCCEEEcc
Confidence            45555666655553 33211   223333344443332 3321   134556666666665 244322   345555555


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      +|++++ +|...   .+|+.|++++|+++ .+|+ .+.+..+..+.+.+|+
T Consensus       411 ~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~  456 (788)
T PRK15387        411 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  456 (788)
T ss_pred             CCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence            555553 34321   23455555555555 2332 2223344444444443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.65  E-value=3.1e-07  Score=97.65  Aligned_cols=96  Identities=28%  Similarity=0.421  Sum_probs=56.6

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      .+.|+|+++.++ .+|..+.  .+|+.|+|++|.++ .+|..+.  .+|+.|++++|+|+ .+|..+.  .+|+.|+|++
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~  250 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI  250 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence            456777777776 3555443  36777777777777 4565443  46777777777766 4555442  3456666666


Q ss_pred             ccccccCchHHhhccccccccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      |++. .+|..+.  .+|+.|++++|+++
T Consensus       251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~  275 (754)
T PRK15370        251 NRIT-ELPERLP--SALQSLDLFHNKIS  275 (754)
T ss_pred             CccC-cCChhHh--CCCCEEECcCCccC
Confidence            6655 3454443  34555555555555

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.63  E-value=2e-07  Score=85.08  Aligned_cols=133  Identities=21%  Similarity=0.199  Sum_probs=92.4

Q ss_pred             CCCCccccCCCceEEEEEeCCCcEEEEEEccccccc---------------------ccHHHHHHHHHHHhcCCCC--Cc
Q 013258          298 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------------------GGELQFQTEVKIISMAVHR--NL  354 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~H~--ni  354 (447)
                      .+.+.||-|.=+.||.|..+.|.++|||.=+...++                     ......++|.+.|.++...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            445889999999999999988999999965432110                     0122467899999988654  66


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  434 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~  434 (447)
                      .+.+++    +...+||||+++-.|...-         ++-.....+...|++-+.-.-..   +|||+|+.+=||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            666654    5568999999886554331         11122233333344433333344   8999999999999999


Q ss_pred             CCceeecccccc
Q 013258          435 DADQSSKTILRR  446 (447)
Q Consensus       435 ~~~~~i~df~~~  446 (447)
                      ||++.+.||=+.
T Consensus       238 dg~~~vIDwPQ~  249 (304)
T COG0478         238 DGDIVVIDWPQA  249 (304)
T ss_pred             CCCEEEEeCccc
Confidence            999999998653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.63  E-value=1.3e-08  Score=105.77  Aligned_cols=143  Identities=22%  Similarity=0.296  Sum_probs=112.7

Q ss_pred             CCCCCCccccCCCceEEEEEeC--CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .|...+.||+|+|+.|-.....  ....+|+|.+.... ..........|..+-..+. |+|++++++...+.+..++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4556677999999999877643  24567777775432 1112223445777767776 999999999999999999999


Q ss_pred             ecCCCCChhhHh-hccCCCCCCCChHHHHHHHHHHHHHHhhhh-cCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          372 PYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      ||..+|++.+.+ ....   ...+......+..|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++||.
T Consensus       101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            999999999988 3322   12556778889999999999999 76   999999999999999999 99999985

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.62  E-value=5.2e-08  Score=103.14  Aligned_cols=52  Identities=31%  Similarity=0.347  Sum_probs=34.6

Q ss_pred             CCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       139 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      .+|+.|+|++|++++ +|..   .++|+.|++++|++++ +|..  ...+..+.+.+|.
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~Nq  433 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQ  433 (788)
T ss_pred             cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCc
Confidence            367888888888875 5543   3578899999999986 5542  2334445555554

>PLN03210 Resistant to P

Probab=98.61  E-value=1.1e-07  Score=107.29  Aligned_cols=57  Identities=16%  Similarity=0.229  Sum_probs=34.7

Q ss_pred             CCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          140 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       140 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      +|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|....+..+..+.+.++
T Consensus       779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c  835 (1153)
T PLN03210        779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC  835 (1153)
T ss_pred             cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence            455556666655556677777777777777777655555665544555555555443

syringae 6; Provisional

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.60  E-value=3.3e-08  Score=98.81  Aligned_cols=146  Identities=18%  Similarity=0.173  Sum_probs=113.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC--CCcEEEEEEcccccccccHH-HHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGGEL-QFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      .-+.+|.....||.|.|+.|+....+  ++..|++|.+.........+ .-..|+-+...+ .|.++++....+...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888999999999999998743  57899999886544322222 234555555555 599999988888888888


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      ++--||++++++...+...    ..++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-++.||.
T Consensus       342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            9999999999887665322    2367788899999999999999988   99999999999999986 666666654

>PLN03210 Resistant to P

Probab=98.60  E-value=1.1e-07  Score=107.22  Aligned_cols=124  Identities=25%  Similarity=0.342  Sum_probs=97.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|...+.+|..+++|++|+.|++++|..-+.+|..+ ++++|+.|++++|..-..+|..   .++|+.|+|
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            368889999998888899999999999999999876555788776 7899999999987655566654   367889999


Q ss_pred             cCccccccCchHHhhccccccccccc-ccccccCCCCCCCCccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSN-NRLSGPVPDNGSFSQFTPISFEN  195 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~-N~l~g~~p~~~~~~~~~~~~~~~  195 (447)
                      ++|.++ .+|..+..+++|+.|++++ |++.+..+....+..+..+.+.+
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCC
Confidence            999997 5788999999999999988 56665444444455555555544

syringae 6; Provisional

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.59  E-value=1.9e-07  Score=94.44  Aligned_cols=117  Identities=19%  Similarity=0.187  Sum_probs=95.1

Q ss_pred             eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCCh
Q 013258          316 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW  395 (447)
Q Consensus       316 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  395 (447)
                      ..++.+|.|...+.... .......+.++.|+.++||||+++++.+...+..|+|+|-+.  -|..++.+..       .
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------K  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------H
Confidence            45688899888865433 223346788889999999999999999999999999999885  3666665532       3


Q ss_pred             HHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       396 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ......+.||+.||.|||..|  +++|++|.-.-|++++.|+-|++.|.
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle  150 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLE  150 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeE
Confidence            455667889999999999765  89999999999999999999999875

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.58  E-value=8e-09  Score=107.12  Aligned_cols=104  Identities=38%  Similarity=0.515  Sum_probs=90.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|+++.-....+.++..|+.|+||+|.|+ .+|..+.++..|++|...+|++. .+| .+..++.|+.+|+
T Consensus       383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl  459 (1081)
T KOG0618|consen  383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL  459 (1081)
T ss_pred             cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence            47899999999998555556889999999999999999 79999999999999999999998 678 8899999999999


Q ss_pred             cCccccc-cCchHHhhccccccccccccc
Q 013258          147 NNNSLSG-LIPTSLTTITSLNILDLSNNR  174 (447)
Q Consensus       147 ~~N~l~~-~~p~~~~~l~~L~~l~ls~N~  174 (447)
                      |.|+|+- .+|..... ++|++||+++|.
T Consensus       460 S~N~L~~~~l~~~~p~-p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  460 SCNNLSEVTLPEALPS-PNLKYLDLSGNT  487 (1081)
T ss_pred             ccchhhhhhhhhhCCC-cccceeeccCCc
Confidence            9999974 34444433 789999999997

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.57  E-value=8.2e-08  Score=102.04  Aligned_cols=98  Identities=28%  Similarity=0.433  Sum_probs=62.1

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.|+|++|.++ .+|..+.  .+|+.|++++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  .+|+.|+++
T Consensus       200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF  270 (754)
T ss_pred             CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence            5788888888887 4666554  47888888888777 4565443  35666667666666 5565543  356666666


Q ss_pred             CccccccCchHHhhcccccccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      +|+++. +|..+.  ++|+.|++++|+|++
T Consensus       271 ~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~  297 (754)
T PRK15370        271 HNKISC-LPENLP--EELRYLSVYDNSIRT  297 (754)
T ss_pred             CCccCc-cccccC--CCCcEEECCCCcccc
Confidence            666653 454432  356666666666654

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1.4e-06  Score=77.60  Aligned_cols=136  Identities=18%  Similarity=0.179  Sum_probs=99.0

Q ss_pred             ccCCCceEEEEEeCCCcEEEEEEccccc--c---cccHHHHHHHHHHHhcCCCCC--ccceeeEEe-cC----CceEEEe
Q 013258          304 GRGGFGKVYKGRLADGKLVAVKRLKEER--T---SGGELQFQTEVKIISMAVHRN--LLRLYGFCT-TV----TEKLLVY  371 (447)
Q Consensus       304 g~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~-~~----~~~~lv~  371 (447)
                      |+||-+-|++-.+. |+.+-+|+-....  +   +.+...|.+|...+..+...+  +.+.. ++. ..    -..+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            56888889987764 4568888764111  1   335668999999999886433  44444 332 21    2357999


Q ss_pred             ecCCC-CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc--eeecccccc
Q 013258          372 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTILRR  446 (447)
Q Consensus       372 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~~i~df~~~  446 (447)
                      |-+.+ -+|.+++.+...  ...+...+..+..++++.+.-||..   ++.|+|+.+.||+++.++.  +++.||++.
T Consensus       105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            97753 588888865421  2345667789999999999999999   9999999999999986666  899999873

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.52  E-value=5.8e-08  Score=91.98  Aligned_cols=90  Identities=27%  Similarity=0.345  Sum_probs=81.7

Q ss_pred             ccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccc
Q 013258           87 LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN  166 (447)
Q Consensus        87 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  166 (447)
                      |..|++|+.|+|++|.+++.-+.+|..+..++.|.|..|++.-.--..|.++..|+.|+|.+|+++..-|.+|..+.+|.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            77899999999999999998999999999999999999999755556788999999999999999999999999999999


Q ss_pred             cccccccccc
Q 013258          167 ILDLSNNRLS  176 (447)
Q Consensus       167 ~l~ls~N~l~  176 (447)
                      .|++-.|.+.
T Consensus       350 ~l~l~~Np~~  359 (498)
T KOG4237|consen  350 TLNLLSNPFN  359 (498)
T ss_pred             eeehccCccc
Confidence            9999888874

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.51  E-value=3.9e-08  Score=95.11  Aligned_cols=111  Identities=30%  Similarity=0.407  Sum_probs=76.8

Q ss_pred             CCEEEEEcCCCCccccccccccCCCC---CCEEECCCCccCC----CCChhhcCC-CCCcEEEccCCccccc----CCcc
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKN---LELLELYGNNLSG----HIPSALGNL-IKLKSLDLYSNLFNGT----IPDT  134 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~ls~N~l~g~----~p~~  134 (447)
                      ..++.|+|++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    ++..
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            46888888888887666666655555   8888888888773    334455666 7888888888887732    3345


Q ss_pred             ccCCCCCCeeeCcCcccccc----CchHHhhcccccccccccccccc
Q 013258          135 LANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      +..+++|+.|++++|.+++.    ++..+...++|+.|++++|.+++
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  207 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD  207 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence            56667788888888888742    33445555678888888887763

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=6.5e-07  Score=80.98  Aligned_cols=102  Identities=19%  Similarity=0.218  Sum_probs=79.8

Q ss_pred             HHHHHHHHHHhcCCCCC--ccceeeEEecCC----ceEEEeecCCCC-ChhhHhhccCCCCCCCChHHHHHHHHHHHHHH
Q 013258          337 LQFQTEVKIISMAVHRN--LLRLYGFCTTVT----EKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGL  409 (447)
Q Consensus       337 ~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL  409 (447)
                      ....+|...+..+....  +.+.+++.....    ..++|+|++++- +|.+++.....    .+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            35788888887775443  456666665532    358999999874 78988876322    45567788999999999


Q ss_pred             hhhhcCCCCCeeecCCCCCceeeCCCC---ceeeccccc
Q 013258          410 SYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTILR  445 (447)
Q Consensus       410 ~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~~  445 (447)
                      +-||..   +|+|+|+++.|||++.+.   .+.+.||-+
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~  167 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDR  167 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence            999999   999999999999999987   788888853

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.49  E-value=4.9e-08  Score=94.44  Aligned_cols=110  Identities=34%  Similarity=0.422  Sum_probs=86.9

Q ss_pred             CEEEEEcCCCCccc----cccccccCC-CCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCccccc----CCcc
Q 013258           68 SVTRVDLGNAALSG----ELAPELGQL-KNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IPDT  134 (447)
Q Consensus        68 ~v~~l~L~~~~l~g----~~~~~l~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~  134 (447)
                      +++.|+|++|.+++    .+...+..+ .+|+.|+|++|.+++.    ++..+..+++|+.|++++|.+++.    ++..
T Consensus       109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~  188 (319)
T cd00116         109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG  188 (319)
T ss_pred             cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence            49999999999884    344556777 8999999999999843    445677788999999999999842    4455


Q ss_pred             ccCCCCCCeeeCcCccccccC----chHHhhcccccccccccccccc
Q 013258          135 LANLKQLKYLRLNNNSLSGLI----PTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      +..+++|++|++++|.+++..    +..+..+++|+.|++++|.+++
T Consensus       189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence            666789999999999987543    3445567789999999999875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.48  E-value=2.1e-08  Score=99.01  Aligned_cols=125  Identities=30%  Similarity=0.427  Sum_probs=87.8

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .+++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|+.++.+.+|+.|++.
T Consensus       122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr  197 (722)
T KOG0532|consen  122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR  197 (722)
T ss_pred             HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence            4677777777776 5666666654 677777788777 57777777777788888888776 677777788888888888


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  198 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~  198 (447)
                      .|++. .+|..+..+ .|..||+|+|+++..+-+...+.++..+-+++|+.
T Consensus       198 Rn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL  246 (722)
T KOG0532|consen  198 RNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL  246 (722)
T ss_pred             hhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence            88776 456666655 37778888888775444444455555555666653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.46  E-value=2.4e-08  Score=91.29  Aligned_cols=129  Identities=27%  Similarity=0.315  Sum_probs=100.5

Q ss_pred             CCCCCCCCCCCccceeEeCCC-----CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEE
Q 013258           46 QSWDNLPGNLCTWFHITCNPE-----GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSL  120 (447)
Q Consensus        46 ~~w~~~~~~~c~w~gv~c~~~-----~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  120 (447)
                      ..|+.......+.+-++|-..     ..|..|+++.|.+...  .++..|.+|+.||||+|.++ .+-.+-..|-+.+.|
T Consensus       281 dTWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             chHhhhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            356655445556677777532     4689999999999742  23888999999999999998 455555678899999


Q ss_pred             EccCCcccccCCccccCCCCCCeeeCcCcccccc-CchHHhhcccccccccccccccccC
Q 013258          121 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPV  179 (447)
Q Consensus       121 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~g~~  179 (447)
                      .|+.|.+..  -+.++.+=+|..||+++|++... --..+++++.|+.+.+-+|.+.+.+
T Consensus       358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            999999862  34577788999999999999632 1246789999999999999998754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=1e-06  Score=89.50  Aligned_cols=134  Identities=19%  Similarity=0.219  Sum_probs=88.0

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEccccccc---------------------c------------------cHHHHHH
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------------------G------------------GELQFQT  341 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~------------------~~~~~~~  341 (447)
                      +.|+.++-|+||+|++++|+.||||+.++.-..                     .                  .+.++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999998753211                     0                  0112445


Q ss_pred             HHHHHhcCC-----CCCccceeeEEe-cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHH-Hhhhhc
Q 013258          342 EVKIISMAV-----HRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG-LSYLHE  414 (447)
Q Consensus       342 E~~~l~~l~-----H~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~  414 (447)
                      |...+.+++     .+++ ++-.+|. -.....|+|||++|-.+.+.......   ..+   +..++..++++ +.-+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence            666655442     3333 3333333 35678999999999888877432211   134   23333333332 222222


Q ss_pred             CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          415 HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       415 ~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .   +++|.|..|.||+++.++..-..||-
T Consensus       284 d---gffHaDpHpGNi~v~~~g~i~~lDfG  310 (517)
T COG0661         284 D---GFFHADPHPGNILVRSDGRIVLLDFG  310 (517)
T ss_pred             c---CccccCCCccceEEecCCcEEEEcCc
Confidence            3   89999999999999999998888874

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=2.3e-07  Score=86.16  Aligned_cols=95  Identities=25%  Similarity=0.383  Sum_probs=80.8

Q ss_pred             HhcCCCCCccceeeEEecC-----CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCe
Q 013258          346 ISMAVHRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI  420 (447)
Q Consensus       346 l~~l~H~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  420 (447)
                      +-.+.|.|||+++.|+.+.     ....++.|||..|++.++|++.+.....+....-.+++-||..||.|||+. .|+|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            3455699999999988653     346899999999999999998655555677777789999999999999995 8999


Q ss_pred             eecCCCCCceeeCCCCceeec
Q 013258          421 IHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       421 vHrDlkp~NILl~~~~~~~i~  441 (447)
                      +|+++.-+-|.+..++-+|+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             ccCCcchhheeecCCceEEec
Confidence            999999999999999988875

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=6.5e-06  Score=75.48  Aligned_cols=73  Identities=12%  Similarity=0.105  Sum_probs=53.1

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeEEecCCceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      ...||+|..+.||+.   .+..+++|..+...   ......+|.+++..+..-.  +.+.+++....+...+|||+++|.
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            367999999999984   24457788875432   2335788999998886443  466777777777778999999886


Q ss_pred             C
Q 013258          378 S  378 (447)
Q Consensus       378 s  378 (447)
                      .
T Consensus        80 ~   80 (226)
T TIGR02172        80 R   80 (226)
T ss_pred             c
Confidence            3

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.33  E-value=3.6e-07  Score=91.31  Aligned_cols=104  Identities=39%  Similarity=0.633  Sum_probs=68.9

Q ss_pred             CEEEEEcCCCCccccccccccCCC-CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLK-NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .++.|++.+|.++ .+++....+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.|++
T Consensus       117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence            4666777777666 4555556664 7777777777776 45556677777777777777776 56665556677777777


Q ss_pred             cCccccccCchHHhhcccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRL  175 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l  175 (447)
                      ++|+++ .+|.....+..|+.+.+++|.+
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~  221 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNSI  221 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCcc
Confidence            777776 4555555555577777777743

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.26  E-value=1.7e-07  Score=76.34  Aligned_cols=104  Identities=24%  Similarity=0.367  Sum_probs=67.3

Q ss_pred             EEEEEcCCCCcccccc---ccccCCCCCCEEECCCCccCCCCChhhc-CCCCCcEEEccCCcccccCCccccCCCCCCee
Q 013258           69 VTRVDLGNAALSGELA---PELGQLKNLELLELYGNNLSGHIPSALG-NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL  144 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L  144 (447)
                      .-.+||+++.+. .++   ..+.....|+..+|++|.|.. .|+.|. .++.++.|+|++|.++ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            345566666553 233   234445566666777777773 455554 3457777777777777 677777777777777


Q ss_pred             eCcCccccccCchHHhhccccccccccccccc
Q 013258          145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       145 ~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      +++.|.+.. .|..+..+.+|..||..+|.+.
T Consensus       106 Nl~~N~l~~-~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  106 NLRFNPLNA-EPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccccCcccc-chHHHHHHHhHHHhcCCCCccc
Confidence            777777763 4666666777777777666654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.23  E-value=6.7e-08  Score=78.61  Aligned_cols=111  Identities=23%  Similarity=0.331  Sum_probs=87.8

Q ss_pred             CCEEEEEcCCCCcccccccccc-CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      -.++.++|++|.+.. +|+.+. ..+.++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|.+||
T Consensus        53 ~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            468899999999984 555554 4568999999999999 69999999999999999999998 6788888899999999


Q ss_pred             CcCccccccCchHHhhcccccccccccccccccCCC
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ..+|.+. .+|-.+...+..-..++.++.+.+..|.
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~  164 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK  164 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence            9999886 5666654444445556666666665554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.23  E-value=6.3e-06  Score=81.35  Aligned_cols=129  Identities=16%  Similarity=0.121  Sum_probs=96.1

Q ss_pred             ceEEEEE-eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEeecCCC-CChhhH
Q 013258          309 GKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTN-GSVASR  382 (447)
Q Consensus       309 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~  382 (447)
                      .+.||+. ..||..|..|++........ .....-++.++++.|+|+|++.+++..    +..+++||+|.++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            5679997 45799999999954332111 123345678899999999999998873    4467899999986 567666


Q ss_pred             hhccCC-----------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          383 LRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       383 l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      ......           .....++...+.++.|++.||.++|+.   |..-+-|.+.+||++.+..++|+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEe
Confidence            543211           112356678889999999999999998   88889999999999998766654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.22  E-value=1e-06  Score=93.26  Aligned_cols=106  Identities=24%  Similarity=0.363  Sum_probs=73.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|..++.|..|+||.||..+++. .+.+|+|+-+..       .+.+-  ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCccee------------------
Confidence            578888999999999999998764 677888532221       11111  23333334333                  


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                         ||-...+...+.    ++-        +.+.+++|+|+.   +|+|||+||+|.+|+.-|.+|+.||-.
T Consensus       136 ---gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ---chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence               565555554322    221        126889999999   999999999999999999999999964

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.18  E-value=2.4e-06  Score=85.67  Aligned_cols=142  Identities=21%  Similarity=0.103  Sum_probs=107.6

Q ss_pred             CCCCCCcccc--CCCceEEEEEe--C-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceE
Q 013258          296 GFSNKNILGR--GGFGKVYKGRL--A-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  368 (447)
                      .|.....+|.  |.+|.||.+..  + ++..+|+|.-+.... ......-.+|......++ |+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3555678999  99999999986  3 578899997432211 122223345666666664 999999889999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHH----HHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeeccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  443 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df  443 (447)
                      +-+|++. .+|.++.+....   .++......+..+..+    ||.++|+.   +|+|-|+||.||....+ ...+..||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999885 688877765432   2555666777777777    99999999   99999999999999999 77777777


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       268 ~  268 (524)
T KOG0601|consen  268 G  268 (524)
T ss_pred             c
Confidence            3

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=6.9e-06  Score=83.32  Aligned_cols=134  Identities=17%  Similarity=0.155  Sum_probs=82.2

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccc------------------------------------cHHHHHHHH
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG------------------------------------GELQFQTEV  343 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~~~~E~  343 (447)
                      .+.||.-+.|+||+|++++|+.||||+-++.-...                                    .+.+|..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            37899999999999999999999999876532110                                    111355566


Q ss_pred             HHHhcC----CCCC------ccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh
Q 013258          344 KIISMA----VHRN------LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH  413 (447)
Q Consensus       344 ~~l~~l----~H~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH  413 (447)
                      +...++    +|-+      |.+++..  -.....|+||||+|..+.+.-.-...+   ++-.....-+.++..-+-+ +
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qIf-~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQIF-K  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHHH-h
Confidence            554433    3555      3333322  234689999999998776653322221   3333333222222111112 2


Q ss_pred             cCCCCCeeecCCCCCceeeCC----CCceeeccc
Q 013258          414 EHCDPKIIHRDVKAANILLDE----DADQSSKTI  443 (447)
Q Consensus       414 ~~~~~~ivHrDlkp~NILl~~----~~~~~i~df  443 (447)
                       .   |++|+|-.|.||+++.    ++++.+.||
T Consensus       320 -~---GffHaDPHPGNilv~~~~~~~~~ivllDh  349 (538)
T KOG1235|consen  320 -T---GFFHADPHPGNILVRPNPEGDEEIVLLDH  349 (538)
T ss_pred             -c---CCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence             2   7999999999999995    456666665

>PLN02876 acyl-CoA dehydrogenase

Probab=98.16  E-value=2.2e-05  Score=85.77  Aligned_cols=79  Identities=13%  Similarity=0.296  Sum_probs=56.9

Q ss_pred             CCccccCCCceEEEEEeCCC---cEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCc--cceeeEEecC---CceEEE
Q 013258          300 KNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL--LRLYGFCTTV---TEKLLV  370 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lv  370 (447)
                      .+.++.|.+..+|+....++   ..+++|+............+.+|.++++.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            36688899999999876553   3677777644332223346889999999985 6665  7777877654   357899


Q ss_pred             eecCCCCC
Q 013258          371 YPYMTNGS  378 (447)
Q Consensus       371 ~e~~~~gs  378 (447)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.16  E-value=9.8e-08  Score=96.79  Aligned_cols=121  Identities=32%  Similarity=0.377  Sum_probs=58.0

Q ss_pred             cCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCcc-ccCCCCCCeeeCcCcccc
Q 013258           74 LGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT-LANLKQLKYLRLNNNSLS  152 (447)
Q Consensus        74 L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~  152 (447)
                      .+.|.+. .+..++.-++.|++|||+.|+++..  ..+..|+.|+.|||+.|+|. .+|.. ...+ .|+.|++++|.++
T Consensus       171 fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~  245 (1096)
T KOG1859|consen  171 FSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALT  245 (1096)
T ss_pred             cchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHHH
Confidence            3344443 2334445555556666666665522  14555556666666666655 34432 1122 2556666666554


Q ss_pred             ccCchHHhhccccccccccccccccc--CCCCCCCCccccccccccccccC
Q 013258          153 GLIPTSLTTITSLNILDLSNNRLSGP--VPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       153 ~~~p~~~~~l~~L~~l~ls~N~l~g~--~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      ..  ..+.++.+|+.||+|+|-+.+-  +--.+.+..+..+.++||+.-|.
T Consensus       246 tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  246 TL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            32  2345555566666666655431  10011233344444555555444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.13  E-value=1.1e-06  Score=87.83  Aligned_cols=126  Identities=33%  Similarity=0.494  Sum_probs=97.0

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.|++++|++. .+|..+..+..|++|+++
T Consensus       141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~  217 (394)
T COG4886         141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS  217 (394)
T ss_pred             hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence            6899999999997 55567899999999999999999 57877778999999999999998 788876667779999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      +|.+. .++..+.++.++..+.+++|++...+-..+.+..+..+++.+|.
T Consensus       218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~  266 (394)
T COG4886         218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ  266 (394)
T ss_pred             CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccc
Confidence            99543 35667788888888888888876532222233344555555543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.3e-05  Score=71.11  Aligned_cols=99  Identities=22%  Similarity=0.264  Sum_probs=77.4

Q ss_pred             HHHHHHHhcCCC-CCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCC
Q 013258          340 QTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP  418 (447)
Q Consensus       340 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  418 (447)
                      ..|.-++..+.+ +++++++|+|-    .+++.||...+++...-.. ......-+|..|.+||.++++.++++++...-
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357778888876 69999999984    4789999988776532100 00111268999999999999999999985433


Q ss_pred             CeeecCCCCCceeeCCCCceeeccc
Q 013258          419 KIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       419 ~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      .+.-.|++++|+-+++++.+|+.|.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDl  106 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDL  106 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEec
Confidence            6889999999999999999999985

Proteins in this uncharacterised family are described as transmembrane proteins.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.05  E-value=6.9e-06  Score=72.01  Aligned_cols=52  Identities=33%  Similarity=0.301  Sum_probs=45.3

Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceee
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                      |+|.++++..+.   .++|..+..++.|+++||+|||++   +      ||+|||+++++.+++
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~   52 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL   52 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee
Confidence            789999976432   489999999999999999999998   4      999999999987765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.03  E-value=4.5e-06  Score=54.93  Aligned_cols=36  Identities=39%  Similarity=0.625  Sum_probs=17.6

Q ss_pred             CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccc
Q 013258           92 NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN  128 (447)
Q Consensus        92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  128 (447)
                      +|++|++++|+++ .+|+.+++|++|+.|++++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            4555555555555 34444555555555555555544

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.99  E-value=5.3e-06  Score=54.60  Aligned_cols=38  Identities=39%  Similarity=0.594  Sum_probs=27.0

Q ss_pred             CCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccc
Q 013258          115 IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG  153 (447)
Q Consensus       115 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~  153 (447)
                      ++|++|++++|+++ .+|+.+++|++|+.|++++|+++.
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            46777888888887 567667778888888888887763

...

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.93  E-value=4.5e-05  Score=69.94  Aligned_cols=77  Identities=16%  Similarity=0.213  Sum_probs=54.3

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC--CccceeeEEec---CCceEEEeecCC
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTT---VTEKLLVYPYMT  375 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lv~e~~~  375 (447)
                      +.++.|..+.||+....+ +.+++|.....   .....+.+|..++..+...  .+.+++.+...   ....+++|+|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568899999999999876 68999987543   2334677888888877533  35566664432   234689999999


Q ss_pred             CCChhh
Q 013258          376 NGSVAS  381 (447)
Q Consensus       376 ~gsL~~  381 (447)
                      +..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.92  E-value=0.00012  Score=66.42  Aligned_cols=151  Identities=19%  Similarity=0.262  Sum_probs=93.8

Q ss_pred             ccHHHHHHHhcCCCCCCccc---cCCCceEEEEEeCCCcEEEEEEcccccccc------------------cHH-----H
Q 013258          285 FSLRELQVATDGFSNKNILG---RGGFGKVYKGRLADGKLVAVKRLKEERTSG------------------GEL-----Q  338 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~-----~  338 (447)
                      .+.+.+....++..+.+..|   +|.-+.||+|.-.++..+|||+.+.....-                  ...     -
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            44555555555555555555   555566999997789999999986432110                  000     1


Q ss_pred             HHHHHHHHhcCC--CCCccceeeEEecCCceEEEeecCCCC-ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC
Q 013258          339 FQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH  415 (447)
Q Consensus       339 ~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~  415 (447)
                      ...|...|.++.  +-.+.+-+++    ..-.|||||+... .-.-.|.+-     .+.......+..++++.+.-|-..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence            234565565553  2333334433    2347999999543 222222221     122225667777788888777762


Q ss_pred             CCCCeeecCCCCCceeeCCCCceeeccccccC
Q 013258          416 CDPKIIHRDVKAANILLDEDADQSSKTILRRL  447 (447)
Q Consensus       416 ~~~~ivHrDlkp~NILl~~~~~~~i~df~~~~  447 (447)
                      +  ++||+||..=|||+. ++.+.|.|+-+.+
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV  214 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAV  214 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECcccc
Confidence            2  899999999999999 8899999987653

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00016  Score=69.26  Aligned_cols=76  Identities=14%  Similarity=0.102  Sum_probs=55.0

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCC---CCccceeeEEec---CCceEEEeec
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRLYGFCTT---VTEKLLVYPY  373 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~---~~~~~lv~e~  373 (447)
                      .+.||.|..+.||+....+++ +.+|..+..   .....+..|.+.++.+.-   -.+.+++++|..   .+..++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSF---STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEeccc---ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            467999999999998765554 666764331   122368899999988753   357788887754   3568999999


Q ss_pred             CCCCCh
Q 013258          374 MTNGSV  379 (447)
Q Consensus       374 ~~~gsL  379 (447)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.91  E-value=0.00012  Score=67.87  Aligned_cols=76  Identities=9%  Similarity=0.047  Sum_probs=52.0

Q ss_pred             ccccCCC-ceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeecCCCCCh
Q 013258          302 ILGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSV  379 (447)
Q Consensus       302 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~gsL  379 (447)
                      .|..|.. ..||+.... +..+.||+.....    ..+..+|++++..+. +--+.+++++....+..++||||++|.++
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455555 779998764 4678888775432    234678888887774 33455777777666678999999998776


Q ss_pred             hhH
Q 013258          380 ASR  382 (447)
Q Consensus       380 ~~~  382 (447)
                      .+.
T Consensus        80 ~~~   82 (244)
T cd05150          80 AAL   82 (244)
T ss_pred             hHh
Confidence            543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.87  E-value=0.00021  Score=63.80  Aligned_cols=130  Identities=21%  Similarity=0.314  Sum_probs=88.9

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEccccc---------------ccccHHHHHHHHHHHhcCC------CCCcccee
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---------------TSGGELQFQTEVKIISMAV------HRNLLRLY  358 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------H~niv~l~  358 (447)
                      ...||+|+.-.||.  +++.....||+.+...               ......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999988885  4455566788886544               1112345677777665555      88999999


Q ss_pred             eEEecCCceEEEeecCCC--C----ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          359 GFCTTVTEKLLVYPYMTN--G----SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       359 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      |+..+.....+|+|.+.+  |    +|.+++.+..     ++.    .+...+-+-..||-..   +|+.+|++|+||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence            999999999999998743  2    4667764432     333    2333333445677777   89999999999999


Q ss_pred             CCCC----ceeeccc
Q 013258          433 DEDA----DQSSKTI  443 (447)
Q Consensus       433 ~~~~----~~~i~df  443 (447)
                      ....    ...+.|-
T Consensus       152 ~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDG  166 (199)
T ss_pred             EecCCCceEEEEEeC
Confidence            7544    3445553

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.86  E-value=6.5e-05  Score=67.39  Aligned_cols=134  Identities=15%  Similarity=0.174  Sum_probs=83.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHH---------HHHHHHHHhcCCCCCc---cceeeE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ---------FQTEVKIISMAVHRNL---LRLYGF  360 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~E~~~l~~l~H~ni---v~l~~~  360 (447)
                      ...+|...+++-......|.+-.. +|+.+.+|..+..... ..+.         ..+++..+..++...+   ..++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            345677777776666666665555 5788899987654321 1111         2334444444432222   222222


Q ss_pred             Ee-----cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC
Q 013258          361 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  435 (447)
Q Consensus       361 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  435 (447)
                      ..     -....+++|||++|..|.+...        ++.    .++..+.+++.-+|..   |++|+|..|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            22     1234578999999988765532        221    2455677788999999   99999999999999965


Q ss_pred             Cceeecccc
Q 013258          436 ADQSSKTIL  444 (447)
Q Consensus       436 ~~~~i~df~  444 (447)
                      + .++.||-
T Consensus       172 ~-i~iID~~  179 (229)
T PF06176_consen  172 G-IRIIDTQ  179 (229)
T ss_pred             c-EEEEECc
Confidence            5 7888873

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	447
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-84
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-82
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		8e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-08
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		8e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-04
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  310 bits (793), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 147/178 (82%), Positives = 160/178 (89%)
Query: 258 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 317
           RR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLA
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 318 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 377
           DG LVAVKRLKEER  GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           SVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 178

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  302 bits (774), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 144/170 (84%), Positives = 155/170 (91%)
Query: 266 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 325
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D F NKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 326 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 385
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 284 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 343
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 284 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 343
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 276 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 328
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 329 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 386
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 387 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/168 (41%), Positives = 96/168 (57%), Gaps = 14/168 (8%)
Query: 276 ELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK- 328
           E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 329 --EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER 386
             +  T   + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 387 QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 125 DGT-PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 285 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 335
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 336 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 395
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 126
Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 162

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/159 (42%), Positives = 90/159 (56%), Gaps = 14/159 (8%)
Query: 285 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 335
           FS  EL+  T+ F  +      N  G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 336 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 395
           + QF  E+K+ +   H NL+ L GF +   +  LVY Y  NGS+  RL     + PPL W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPLSW 123
Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 159

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 355
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 416 CDPKIIHRDVKAANIL---LDEDADQSSKT 442
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 355
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 416 CDPKIIHRDVKAANIL---LDEDADQSSKT 442
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 303 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 355
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 416 CDPKIIHRDVKAANIL---LDEDADQSSKT 442
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 422 HRDVKAANILLDE 434
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 422 HRDVKAANILLDE 434
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGGELQFQTEVKII 346
           L++     + + I+G GGFGKVY+     G  VAVK  +   +E  S      + E K+ 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIAL 403
           +M  H N++ L G C       LV  +   G +   L  ++  +PP   ++W      A+
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNW------AV 112
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI 443
             ARG++YLH+     IIHRD+K++NIL+    E+ D S+K +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 167
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 168 --ASKKFVHRDLAARNCMLDE 186

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 168
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 169 --ASKKFVHRDLAARNCMLDE 187

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 301 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 357 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 412
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 144
Query: 413 HEHCDPKIIHRDVKAANILLDE 434
                 K +HRD+ A N +LDE
Sbjct: 145 ---ASKKFVHRDLAARNCMLDE 163

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 301 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 357 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 412
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 146
Query: 413 HEHCDPKIIHRDVKAANILLDE 434
                 K +HRD+ A N +LDE
Sbjct: 147 ---ASKKFVHRDLAARNCMLDE 165

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 301 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 357 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 412
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 147
Query: 413 HEHCDPKIIHRDVKAANILLDE 434
                 K +HRD+ A N +LDE
Sbjct: 148 ---ASKKFVHRDLAARNCMLDE 166

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 301 NILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 357 LYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 412
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL 141
Query: 413 HEHCDPKIIHRDVKAANILLDE 434
                 K +HRD+ A N +LDE
Sbjct: 142 ---ASKKFVHRDLAARNCMLDE 160

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 298 SNKNILGRGGFGKVYKGRL--ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
           + + ++G G FG+VYKG L  + GK    VA+K LK   T    + F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N++RL G  +     +++  YM NG++   LRE+      L      +   G A G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL 163
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
               +   +HRD+ A NIL++ +
Sbjct: 164 ---ANMNYVHRDLAARNILVNSN 183

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R  + K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     K+IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLL 141

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 136
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLL 158

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K +KE   S  E  F  E +++    H  L++LYG C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 147 RDLAARNCLVGEN 159

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 147
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 154
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 155 --ASKKFVHRDLAARNCMLDE 173

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLL 167

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 303 LGRGGFGKVYKGRLADG-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +G G FG+V++ R A G        +VAVK LKEE ++  +  FQ E  +++   + N++
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNG--------------------SVASRLRERQSSLPPLDW 395
           +L G C       L++ YM  G                     +++R R      PPL  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLL 167

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 302 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 358 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 413
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 208
Query: 414 EHCDPKIIHRDVKAANILLDE 434
                K +HRD+ A N +LDE
Sbjct: 209 --ASKKFVHRDLAARNCMLDE 227

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 118
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLL 140

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 125 RDLAARNCLVGEN 137

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 130 RDLAARNCLVGEN 142

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 358
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 419 KIIHRDVKAANILLDE 434
            I+HRD+K+ N+L+D+
Sbjct: 159 PIVHRDLKSPNLLVDK 174

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 123
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLL 145

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 31/182 (17%)
Query: 268 DVPAEDDSELQLGQLKR----FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLV 322
           D PA    E+ L  L+     F L EL            +G G +G+VYKGR +  G+L 
Sbjct: 5   DSPARSLDEIDLSALRDPAGIFELVEL------------VGNGTYGQVYKGRHVKTGQLA 52
Query: 323 AVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT-----VTEKL-LVYPYMT 375
           A+K +  + T   E + + E+ ++   + HRN+   YG         + ++L LV  +  
Sbjct: 53  AIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            GSV   ++  + +    +W     I     RGLS+LH+H   K+IHRD+K  N+LL E+
Sbjct: 111 AGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN 165
Query: 436 AD 437
           A+
Sbjct: 166 AE 167

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 116
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            LSY H     ++IHRD+K  N+LL
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLL 138

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 275 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 311
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 28  SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87
Query: 312 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 365
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 88  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147
Query: 366 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 201
Query: 420 IIHRDVKAANILL 432
            IHRD+ A N LL
Sbjct: 202 FIHRDIAARNCLL 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 358
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 419 KIIHRDVKAANILLDE 434
            I+HR++K+ N+L+D+
Sbjct: 159 PIVHRNLKSPNLLVDK 174

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 275 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 311
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 5   SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 64
Query: 312 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 365
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 65  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 124
Query: 366 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 125 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 178
Query: 420 IIHRDVKAANILL 432
            IHRD+ A N LL
Sbjct: 179 FIHRDIAARNCLL 191

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 347
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV  +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 128 RDLAARNCLVGEN 140

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 300 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 135
Query: 414 EHCDPKIIHRDVKAANILLDED 435
           E      +HRD+ A NIL++ +
Sbjct: 136 EM---SYVHRDLAARNILVNSN 154

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 147 YLEEN---HFIHRDIAARNCLL 165

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 162 YLEEN---HFIHRDIAARNCLL 180

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 172 YLEEN---HFIHRDIAARNCLL 190

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 300 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 133
Query: 414 EHCDPKIIHRDVKAANILLDED 435
           E      +HRD+ A NIL++ +
Sbjct: 134 EM---SYVHRDLAARNILVNSN 152

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 303 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 410
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 411 YLHEHCDPKIIHRDVKAANILL 432
           YL E+     IHRD+ A N LL
Sbjct: 182 YLEEN---HFIHRDIAARNCLL 200

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYG 359
           ++GRG +G VYKG L D + VAVK      +      F  E  I  + +  H N+ R   
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 360 FCTTVT-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH- 413
               VT     E LLV  Y  NGS+   L     SL   DW +  ++A    RGL+YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                +H  P I HRD+ + N+L+  D 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDG 157

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 +V  Y++NG + + LR     L P       ++      G+++L  H   + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 423 RDVKAANILLDED 435
           RD+ A N L+D D
Sbjct: 128 RDLAARNCLVDRD 140

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 LV+ +M +G ++  LR ++         T   + L    G++YL E     +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 423 RDVKAANILLDED 435
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 300 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L G  T  T  +++  +M NGS+ S LR+       +      +   G A G+ YL   
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 151
Query: 416 CDPKIIHRDVKAANILLDED 435
            D   +HRD+ A NIL++ +
Sbjct: 152 ADMNYVHRDLAARNILVNSN 171

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 280 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF 339
           G L     +E++V       + ++GRG FG V K +    K VA+K+++ E        F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---F 49
Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
             E++ +S   H N+++LYG C  +    LV  Y   GS+ + L   +  LP        
Sbjct: 50  IVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAM 106
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
              L  ++G++YLH      +IHRD+K  N+LL
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSN 183

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 423 RDVKAANILLDEDAD----------QSSKTILRR 446
           RD+KA NIL   D D          ++++TI RR
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 45  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 158
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSN 181

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 35  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 148
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSN 171

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 297 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 344
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 392
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 393 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 297 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 344
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 392
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 393 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           +T  +  +V  +    S+   L    +S    +      IA  +ARG+ YLH      II
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 423 RDVKAANILLDEDAD 437
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 423 RDVKAANILLDEDAD 437
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 78  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 131 HRDLKSNNIFLHED 144

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 303 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 405
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           A G+ YL        +HRD+   N L+ +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQ 170

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 303 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 107
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 405
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           A G+ YL        +HRD+   N L+ +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQ 193

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 303 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 405
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           A G+ YL        +HRD+   N L+ +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQ 164

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            C  +    LV  Y   GS+ + L   +  LP           L  ++G++YLH      
Sbjct: 69  AC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 420 IIHRDVKAANILL 432
           +IHRD+K  N+LL
Sbjct: 126 LIHRDLKPPNLLL 138

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 90  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 301 NILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 412
           RL G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 133
Query: 413 HEHCDPKIIHRDVKAANILL 432
            E    +++HRD+ A N+L+
Sbjct: 134 EER---RLVHRDLAARNVLV 150

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 297 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 344
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 392
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 393 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           LD P  + + +G         ++G+ YL E     ++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 286 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 339
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 18  AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 77
Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           +   G   G+ YL    D   +HRD+ A NIL++
Sbjct: 138 R---GIGSGMKYLS---DMSAVHRDLAARNILVN 165

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 18/140 (12%)
Query: 301 NILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 412
           RL G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 156
Query: 413 HEHCDPKIIHRDVKAANILL 432
            E    +++HRD+ A N+L+
Sbjct: 157 EER---RLVHRDLAARNVLV 173

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 343
            SL + ++     + K+ LG G FG+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 401
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 402 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 435
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 286 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 339
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 123 R---GIGSGMKYLS---DMSYVHRDLAARNILVNSN 152

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+  + +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           R +G     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 135
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              + IHRD+KAAN+LL E  D
Sbjct: 136 ---RKIHRDIKAANVLLSEQGD 154

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 300 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L G  T     +++  YM NGS+ + LR+       +      +   G   G+ YL   
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS-- 127
Query: 416 CDPKIIHRDVKAANILLDED 435
            D   +HRD+ A NIL++ +
Sbjct: 128 -DMSYVHRDLAARNILVNSN 146

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 300 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L G  T  T  +++  +M NGS+ S LR+       +      +   G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 125
Query: 416 CDPKIIHRDVKAANILLDED 435
            D   +HR + A NIL++ +
Sbjct: 126 ADMNYVHRALAARNILVNSN 145

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 164

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 406
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDE 434
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSE 179

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 344
           SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 402
           ++    H NL++L G CT      ++  +MT G++   LRE  RQ             + 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVL 111
Query: 403 LGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 435
           L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 112 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 159

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 144
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPD 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 132
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 160

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 406
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDE 434
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSE 179

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGEL 337
           F   E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    +
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 338 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLD 394
           +F  E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 395 WPTRKK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            P+  K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 165

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 150
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPD 177

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%)
Query: 106 HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXX 165
           +IP  +G++  L  L+L  N  +G+IPD + +L+ L  L L++N                
Sbjct: 644 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 703
Query: 166 XXXXXXNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
                 NN LSGP+P+ G F  F P  F NN  LCG
Sbjct: 704 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 139
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPD 166

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 196

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP--------TRKKIALGS- 405
            L G CT     L+V   +   G++++ LR +++   P   P        T + +   S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 406 --ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             A+G+ +L      K IHRD+ A NILL E
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 143
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  +
Sbjct: 144 ---KKIHRDIKAANVLLSEHGE 162

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 47/96 (48%)
Query: 106 HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNXXXXXXXXXXXXXXXX 165
           +IP  +G++  L  L+L  N  +G+IPD + +L+ L  L L++N                
Sbjct: 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 166 XXXXXXNNRLSGPVPDNGSFSQFTPISFENNLNLCG 201
                 NN LSGP+P+ G F  F P  F NN  LCG
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 80
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 137
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 138 RSLAYIHSF---GICHRDIKPQNLLLDPD 163

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCN 102
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 159
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPD 186

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 161

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 79
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 136
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 137 RSLAYIHSF---GICHRDIKPQNLLLDPD 162

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 343
            SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 401
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 402 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 435
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 280 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG 335
           G LK   + EL    D    FS+   +G G FG VY  R + + ++VA+K++        
Sbjct: 36  GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 336 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 392
           E ++Q    EV+ +    H N ++  G         LV  Y   GS +  L   +    P
Sbjct: 96  E-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 150
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
           L       +  G+ +GL+YLH H    +IHRDVKA NILL E
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE 189

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSN 183

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 353
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 354 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 109
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 166
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 349
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 138
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  +
Sbjct: 139 ---KKIHRDIKAANVLLSEHGE 157

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           +T  +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 109
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 166
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 111
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 168
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPD 194

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ      I+    H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ------IMRKLDHCNI 113
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 170
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPD 196

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE 123
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  +
Sbjct: 124 ---KKIHRDIKAANVLLSEHGE 142

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 126 LHRDLAARNCLVNDQG 141

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 21/150 (14%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-------DWPTRKKIALGS-- 405
            L G CT     L+V   +   G++++ LR +++   P        D+ T + +   S  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 406 -ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
            A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSE 183

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 267 FDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLV-- 322
           +D+P  ++   Q  G+    +L  +   T+ F    +LG G FG VYKG  + +G+ V  
Sbjct: 12  YDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 323 --AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 380
             A+K L+E  +     +   E  +++   + ++ RL G C T T +L+    M  G + 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLL 129
Query: 381 SRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
             +RE + ++     L+W       +  A+G++YL    D +++HRD+ A N+L+
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLV 175

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 154
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 211
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPD 237

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 421 IHRDVKAANILLDE 434
           +HRD+ A N L+++
Sbjct: 122 LHRDLAARNCLVND 135

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 127 LHRDLAARNCLVNDQG 142

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSE 185

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 142 LHRDLAARNCLVNDQG 157

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 256 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 315
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 316 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 432 LDED 435
           +D +
Sbjct: 184 VDSN 187

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 356 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 142 LHRDLAARNCLVNDQG 157

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 256 YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 315
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 316 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 371
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 431
            YM NGS+ + LR        +       +  G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQL---VGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 432 LDED 435
           +D +
Sbjct: 184 VDSN 187

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 352
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N ++  G         LV  Y   GS +  L   +    PL       +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYL 131
Query: 413 HEHCDPKIIHRDVKAANILLDE 434
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 356 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSE 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 356 RLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 405
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 406 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 79
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 131
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 132 EKKNFIHRDLAARNCLVGEN 151

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 420
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+ A N L+++  
Sbjct: 133 LHRDLAARNCLVNDQG 148

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 12/136 (8%)
Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           LG G +G VYK      G++VA+K++  E     +LQ    E+ I+      ++++ YG 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
               T+  +V  Y   GSV+  +R R  +L   +  T   I   + +GL YLH     + 
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLEYLHFM---RK 146
Query: 421 IHRDVKAANILLDEDA 436
           IHRD+KA NILL+ + 
Sbjct: 147 IHRDIKAGNILLNTEG 162

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 88
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 140
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 141 EKKNFIHRDLAARNCLVGEN 160

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 9/142 (6%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      ++VA+K +  E         Q E+ ++S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           + YG     ++  ++  Y+  GS    LR       P D      +     +GL YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE 139
Query: 416 CDPKIIHRDVKAANILLDEDAD 437
              K IHRD+KAAN+LL E  D
Sbjct: 140 ---KKIHRDIKAANVLLSEQGD 158

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLV 144

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 69/140 (49%), Gaps = 18/140 (12%)
Query: 301 NILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            +LG G FG VYKG  + DG+     VA+K L+E  +     +   E  +++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYL 412
           RL G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYL 135
Query: 413 HEHCDPKIIHRDVKAANILL 432
               D +++HRD+ A N+L+
Sbjct: 136 E---DVRLVHRDLAARNVLV 152

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 341
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 398
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 399 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            K   +A   A G++YL+ +   K +HRD+ A N  + ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAED 161

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLV 160

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLV 156

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 128
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 129 HRDLKSNNIFLHED 142

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 132
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 131
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 146
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 147 HRDLKSNNIFLHED 160

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 153
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 154 HRDLKSNNIFLHED 167

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 295 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 407
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 132
Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDA 436
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDG 158

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 154
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 295 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 407
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 127
Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDA 436
           GL YLH++     IHRDVKA NILL ED 
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDG 153

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L           W  ++K A    R +    ++C  K 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH-------GW-MKEKEARAKFRQIVSAVQYCHQKF 126
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 127 IVHRDLKAENLLLDADMN 144

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI---DIARQTAQGMDYLHAKS---II 154
Query: 422 HRDVKAANILLDED 435
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 296 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 300 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 403
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGEN 168

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 300 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 403
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGEN 178

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 133
Query: 423 RDVKAANILLDE 434
           RD++AAN+L+ E
Sbjct: 134 RDLRAANVLVSE 145

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A G
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLV 147

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 338
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 339 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 392
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKL---VAVKRLKEERTSGGELQFQTEVKII 346
           ++     + + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
               H N++ L G  T     ++V  YM NGS+ + L++       +         +G  
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ-------LVGML 130
Query: 407 RGLSYLHEH-CDPKIIHRDVKAANILLD 433
           RG+S   ++  D   +HRD+ A NIL++
Sbjct: 131 RGISAGMKYLSDMGYVHRDLAARNILIN 158

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 342
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 396
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 338
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 339 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 392
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 163

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 301 NILGRGGFGKVYKGRL--ADGK--LVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLL 355
            ILG G FG V +G L   DG    VAVK +K + +S  E+ +F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 356 RLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARG 408
           RL G C  ++ +     +++ P+M  G + + L   +    P   P  T  K  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           + YL        +HRD+ A N +L +D
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDD 183

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 338
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 339 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 392
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 15/163 (9%)
Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQ 338
           F   E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 339 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 392
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 344
           S+ + ++     + K+ LG G +G+VY G      L VAVK LKE+     E  F  E  
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 345 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 404
           ++    H NL++L G CT      +V  YM  G++   LRE               + L 
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLY 134
Query: 405 SARGLSYLHEHCDPK-IIHRDVKAANILLDED 435
            A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 135 MATQISSAMEYLEKKNFIHRDLAARNCLVGEN 166

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 19/157 (12%)
Query: 284 RFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE---RTSGGELQF 339
           ++SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E   R    E   
Sbjct: 2   KYSLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HT 53
Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
             E  ++S+  H  ++R++G      +  ++  Y+  G + S LR+ Q   P    P  K
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPN---PVAK 109
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
             A      L YLH      II+RD+K  NILLD++ 
Sbjct: 110 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNG 143

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 300 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L G  T     ++V  +M NG++ + LR+       +      +   G A G+ YL   
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYL--- 161
Query: 416 CDPKIIHRDVKAANILLD 433
            D   +HRD+ A NIL++
Sbjct: 162 ADMGYVHRDLAARNILVN 179

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 19/151 (12%)
Query: 300 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 76
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 404
           +++ YG C      ++V+ YM +G +   LR             PP +    +   IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            A G+ YL        +HRD+   N L+ E+
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGEN 164

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 64/141 (45%), Gaps = 9/141 (6%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 351
           + F   N+LG+G F  VY+   +  G  VA+K + K+     G +Q  Q EVKI     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            ++L LY +        LV     NG +   L+ R   + P      +        G+ Y
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLY 127
Query: 412 LHEHCDPKIIHRDVKAANILL 432
           LH H    I+HRD+  +N+LL
Sbjct: 128 LHSH---GILHRDLTLSNLLL 145

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 303 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 356
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 417 DPKIIHRDVKAANILL 432
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 67
Query: 363 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +M  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 132
Query: 423 RDVKAANILLDE 434
           RD++AAN+L+ E
Sbjct: 133 RDLRAANVLVSE 144

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +LG G FG VYKG  + +G+     VA+  L+E  +     +   E  +++   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLV 184

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 282
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 334
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHR++ A N L+ E+
Sbjct: 335 EKKNFIHRNLAARNCLVGEN 354

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 15/145 (10%)
Query: 303 LGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG+G FG VY+G   D         VAVK + E  +    ++F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSARGLS 410
           L G  +     L+V   M +G + S LR      E     PP       ++A   A G++
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL+     K +HRD+ A N ++  D
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHD 165

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 82
Query: 363 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+ ED
Sbjct: 138 FVHRDLAARNVLVSED 153

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 73
Query: 363 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+ ED
Sbjct: 129 FVHRDLAARNVLVSED 144

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRLKEER--TSGGELQFQTEVKIIS 347
           +   D F     LG+G FG VY  R    K + A+K L + +    G E Q + E++I S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 126
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            L Y HE    K+IHRD+K  N+L+
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLM 148

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 254
Query: 363 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+ ED
Sbjct: 310 FVHRDLAARNVLVSED 325

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+      VAVK LK    +  + Q F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
           T      +V  +    S+   L  +++            IA  +A+G+ YLH      II
Sbjct: 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI---DIARQTAQGMDYLHA---KNII 154
Query: 422 HRDVKAANILLDE 434
           HRD+K+ NI L E
Sbjct: 155 HRDMKSNNIFLHE 167

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRLKEER--TSGGELQFQTEVKIIS 347
           +   D F     LG+G FG VY  R    K + A+K L + +    G E Q + E++I S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            L Y HE    K+IHRD+K  N+L+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLM 147

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 321
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 373
Query: 417 DPK-IIHRDVKAANILLDED 435
           + K  IHR++ A N L+ E+
Sbjct: 374 EKKNFIHRNLAARNCLVGEN 393

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 74  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 128 RDLRAANILVSD 139

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 348
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 81  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 134
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 135 RDLRAANILVSD 146

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 73
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H+ L+RLY   T      ++  YM NGS+   L  +  S   L       +A   A G
Sbjct: 74  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEG 130
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDE 434
           ++++ E      IHRD++AANIL+ +
Sbjct: 131 MAFIEER---NYIHRDLRAANILVSD 153

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 348
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 80  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 133
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 134 RDLRAANILVSD 145

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 84  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 137
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 138 RDLRAANILVSD 149

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 297 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 351
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 408
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 348
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAV--KRLKEERTSGGELQFQTEVKIISM 348
           +  D F +  +LGRGGFG+V+  ++ A GKL A      K  +   G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           E +V  +       LG G FG+V+ G       VAVK LK+   S     F  E  ++  
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQ 64
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H+ L+RLY   T      ++  YM NGS+   L  +  S   L       +A   A G
Sbjct: 65  LQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEG 121
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDE 434
           ++++ E      IHRD++AANIL+ +
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSD 144

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I  +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGR--------XKEKEARAKFRQIVSAVQYCHQKF 133
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADXN 151

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 293 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGL 409
            N++RLY    T  +  LV+ +M N  +   +  R     P  L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 410 SYLHEHCDPKIIHRDVKAANILLDE 434
           ++ HE+   KI+HRD+K  N+L+++
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINK 143

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 87  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 140
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 141 RDLRAANILVSD 152

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 89  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 142
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 143 RDLRAANILVSD 154

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAV 350
           + + + N  ++G G +G V K R  D G++VA+K+  E        +    E+K++    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H NL+ L   C       LV+ ++ +    + L + +     LD+   +K       G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 411 YLHEHCDPKIIHRDVKAANILLDE 434
           + H H    IIHRD+K  NIL+ +
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQ 159

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 300 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 403
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             ARG+ YL +    + IHR++ A NIL+ E+
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGEN 175

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 361 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 411
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 361 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 411
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 361 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 411
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 85  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 140 IHRN---KILHRDMKAANVLITRDG 161

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 303 LGRGGFGKVYKGRLAD--GKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 356
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 357 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 409
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 287 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKI 345
           L+E  +  +      ++G+G FG+VY GR      VA++ +  ER +  +L+ F+ EV  
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
                H N++   G C +     ++       ++ S +R+ +     LD    ++IA   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEI 139
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLD 433
            +G+ YLH      I+H+D+K+ N+  D
Sbjct: 140 VKGMGYLHA---KGILHKDLKSKNVFYD 164

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 342
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 396
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 166

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTE 342
           E +V+ +  +    LG+G FG VY+G   D         VAVK + E  +    ++F  E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 396
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 131
Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 132 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 167

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 69
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 70  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 125 VHRDLRAANILVGEN 139

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 247
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 303 VHRDLRAANILVGEN 317

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKIRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 303 LGRGGFGKVYKGRLAD--GKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 356
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 357 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 409
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 303 LGRGGFGKVYKGRLAD--GKLVAVKRLK-EERTSGGELQFQTEVKII---SMAVHRNLLR 356
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 357 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGL 409
           L+  CT       T+  LV+ +     V   L      +P    PT   K +     RGL
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
            +LH H   +++HRD+K  NIL+
Sbjct: 134 DFLHSH---RVVHRDLKPQNILV 153

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 71
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 127 VHRDLRAANILVGEN 141

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 357
           + LG G FGKV  G+    G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 358 YGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           Y   +T ++  +V  Y++ G +        RL E++S          +++      G+ Y
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----------RRLFQQILSGVDY 131
Query: 412 LHEHCDPKIIHRDVKAANILLD 433
            H H    ++HRD+K  N+LLD
Sbjct: 132 CHRHM---VVHRDLKPENVLLD 150

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVCEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 73
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 74  VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 129 VHRDLRAANILVGEN 143

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 185

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTEN 180

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 70
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 71  VVSEEPIXIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 126 VHRDLRAANILVGEN 140

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 329
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 385 VHRDLRAANILVGEN 399

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 404
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 405 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 182

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVH 351
           +   + LG G F  VYK R  +  ++VA+K++K     E   G       E+K++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N++ L       +   LV+ +M    +   +++    L P      K   L + +GL Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGLEY 127
Query: 412 LHEHCDPKIIHRDVKAANILLDEDA 436
           LH+H    I+HRD+K  N+LLDE+ 
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENG 149

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 63
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 118
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNG 146

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 28/171 (16%)
Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVK--- 325
           P+E  +++     K   LR+L+V          LG G FG V+KG  + +G+ + +    
Sbjct: 16  PSEKANKVLARIFKETELRKLKV----------LGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 326 RLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 384
           ++ E+++     Q  T+  + I    H +++RL G C   + + LV  Y+  GS+   +R
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVR 124
Query: 385 ERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           + + +L P   L+W       +  A+G+ YL EH    ++HR++ A N+LL
Sbjct: 125 QHRGALGPQLLLNW------GVQIAKGMYYLEEH---GMVHRNLAARNVLL 166

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 62
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 117
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNG 145

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVGEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 65
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 120
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNG 148

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 101
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 156
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNG 184

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 88
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 143
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNG 171

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 423 RDVKAANILLDEDAD 437
           RD+KA N+L+  + D
Sbjct: 133 RDLKAGNVLMTLEGD 147

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
           +  +G+G F KV   R +  G+ VAVK + + + +   LQ    EV+I+ +  H N+++L
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           +    T     LV  Y + G V   L              ++K A    R +    ++C 
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCH 131
Query: 418 PK-IIHRDVKAANILLDED 435
            K I+HRD+KA N+LLD D
Sbjct: 132 QKYIVHRDLKAENLLLDGD 150

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 346
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 404
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILL 432
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 68
Query: 361 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 123
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNG 151

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 346
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 404
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILL 432
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 75  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 423 RDVKAANILLDE 434
           R+++AANIL+ +
Sbjct: 129 RNLRAANILVSD 140

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKII 346
           +AT  +     +G G +G VYK R    G  VA+K ++    EE      ++    ++ +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALG 404
               H N++RL   C T      +   +    V   LR      PP   P  T K +   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILL 432
             RGL +LH +C   I+HRD+K  NIL+
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 361 CTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           C T             LV+ +  +  +A  L    + L        K++      GL Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H +   KI+HRD+KAAN+L+  D 
Sbjct: 142 HRN---KILHRDMKAANVLITRDG 162

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 22/151 (14%)
Query: 300 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+           D  LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRK-----------KI 401
           +++ YG C      ++V+ YM +G +   LR     ++  +D   R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           A   A G+ YL        +HRD+   N L+
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLV 166

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 12/140 (8%)
Query: 301 NILGRGGFGKVYK-GRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRNLLRL 357
            +LG+G FG+  K      G+++ +K L   +E T   +  F  EVK++    H N+L+ 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEHPNVLKF 72
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G          +  Y+  G++   ++   S  P   W  R   A   A G++YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSM-- 127
Query: 418 PKIIHRDVKAANILLDEDAD 437
             IIHRD+ + N L+ E+ +
Sbjct: 128 -NIIHRDLNSHNCLVRENKN 146

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD+ AANIL+ E+
Sbjct: 136 VHRDLAAANILVGEN 150

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 423 RDVKAANILLDEDAD 437
           RD+KA N+L+  + D
Sbjct: 141 RDLKAGNVLMTLEGD 155

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 301 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 412
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 413 HEHCDPKIIHRDVKAANILL 432
            EH    ++HR++ A N+LL
Sbjct: 132 EEH---GMVHRNLAARNVLL 148

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 175

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVMEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 401
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 179

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+ G       VA+K LK    S     F  E +I+    H  L++LY    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLKHDKLVQLYA--- 71
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM  GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 421 IHRDVKAANILL 432
           IHRD+++ANIL+
Sbjct: 127 IHRDLRSANILV 138

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 279 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERT 332
           + Q K+  L+E+ ++   F  +  LG   FGKVYKG L   A G   + VA+K LK++  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 333 SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--------- 383
                +F+ E  + +   H N++ L G  T      +++ Y ++G +   L         
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 384 ------RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
                 R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 130 GSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 134
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDADMN 152

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 419
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 131
Query: 420 IIHRDVKAANILLDEDAD 437
           I+HRD+KA N+LLD D +
Sbjct: 132 IVHRDLKAENLLLDADMN 149

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW-------PTRK------- 399
           ++ L G CT      ++  Y + G++   L+ R+   P L++       P  +       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSHNPEEQLSSKDLV 138
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 171

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 31/158 (19%)
Query: 302 ILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 354
           +LG G FGKV         +      VAVK LKE+  S       +E+K+++ +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKI----------- 401
           + L G CT      L++ Y   G + + LR ++   S   +++  +K++           
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 402 ------ALGSARGLSYLH-EHCDPKIIHRDVKAANILL 432
                 A   A+G+ +L  + C    +HRD+ A N+L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLV 205

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 303 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 353
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW-------PTRK------- 399
           ++ L G CT      ++  Y + G++   L+ R+   P L++       P  +       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSHNPEEQLSSKDLV 153
Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 7/142 (4%)
Query: 298 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           S   ILG G FG+V+K       L    ++ + R    + + + E+ +++   H NL++L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           Y    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+   
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI---CEGIRHMHQMY- 207
Query: 418 PKIIHRDVKAANIL-LDEDADQ 438
             I+H D+K  NIL ++ DA Q
Sbjct: 208 --ILHLDLKPENILCVNRDAKQ 227

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 363 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 421 IHRDVKAANILLDED 435
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 295 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTS--GGELQFQTEVKIISMAVH 351
           D F     LG+G FG VY  R      +VA+K L + +    G E Q + E++I +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N+LRLY +        L+  Y   G +   L++  +     D      I    A  L Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTATIMEELADALMY 138
Query: 412 LHEHCDPKIIHRDVKAAN 429
            H     K+IHRD+K  N
Sbjct: 139 CH---GKKVIHRDIKPEN 153

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 420
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 303 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 356 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 128
Query: 414 EHCDPKIIHRDVKAANILLDED 435
                  IHR + A N+LLD D
Sbjct: 129 AQ---HYIHRALAARNVLLDND 147

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 303 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 356 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 129
Query: 414 EHCDPKIIHRDVKAANILLDED 435
                  IHR + A N+LLD D
Sbjct: 130 AQ---HYIHRALAARNVLLDND 148

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER------QSSLPPLDWPTRKKIALGSARGL 409
            L G CT     L++  Y   G + + LR +      +    PL+       +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
           ++L        IHRDV A N+LL
Sbjct: 166 AFL---ASKNCIHRDVAARNVLL 185

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 420
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 421 IHRDVKAANILLDEDA 436
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G  G+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  YM NGS+   L+    S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 423 RDVKAANILLDE 434
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER------QSSLPPLDWPTRKKIALGSARGL 409
            L G CT     L++  Y   G + + LR +      +    PL+       +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
           ++L        IHRDV A N+LL
Sbjct: 174 AFL---ASKNCIHRDVAARNVLL 193

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 303 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 133
Query: 416 CDPKIIHRDVKAANILLDED 435
              + +HRD+ A N+L++ +
Sbjct: 134 ---QYVHRDLAARNVLVESE 150

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 299 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ----FQTEVKIISMAVHRNL 354
           +  ++G+G FG VY G   D     ++   +  +   E+Q    F  E  ++    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 355 LRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGL 409
           L L G      E L  ++ PYM +G +   +R  Q +      PT K +    L  ARG+
Sbjct: 85  LALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQRN------PTVKDLISFGLQVARGM 137
Query: 410 SYLHEHCDPKIIHRDVKAANILLDE 434
            YL E    K +HRD+ A N +LDE
Sbjct: 138 EYLAEQ---KFVHRDLAARNCMLDE 159

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEG 143

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQT--EVKII 346
           +AT  +     +G G +G VYK R    G  VA+K  R+      GG L   T  EV ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 347 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 401
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILV 153

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEG 141

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 303 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 416 CDPKIIHRDVKAANILLDED 435
              + +HRD+ A N+L++ +
Sbjct: 146 ---QYVHRDLAARNVLVESE 162

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 287 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           L E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +
Sbjct: 14  LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIAL 72
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTR 398
                H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T+
Sbjct: 73  HKHLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           + +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 130 QIL-----EGLKYLH---DNQIVHRDIKGDNVLIN 156

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLPPLDWPTRKKIALGS 405
            L G CT     L++  Y   G + + LR ++          S  P     +R  +   S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 406 --ARGLSYLHEHCDPKIIHRDVKAANILL 432
             A+G+++L        IHRDV A N+LL
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLL 199

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 287 LRELQVATDGFSNKNILGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ-FQT 341
           L ++ +    F+   +LG+G FG V + +L   DG  V  AVK LK +  +  +++ F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSL 390
           E   +    H ++ +L G       K      +++ P+M +G +     ASR+ E   +L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 391 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           P     T  +  +  A G+ YL        IHRD+ A N +L ED
Sbjct: 135 P---LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKII 346
           ++  D F    +LG+G FGKV   R+ + G L AVK LK++   +    E    TE +I+
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-MTEKRIL 77
Query: 347 SMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           S+A +   L     C    ++L  V  ++  G +   +++ +      D    +  A   
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEI 133
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
              L +LH   D  II+RD+K  N+LLD + 
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEG 161

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 422 HRDVKAANILLDEDAD 437
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 303 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ 136
Query: 416 CDPKIIHRDVKAANILLDED 435
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 422 HRDVKAANILLDEDAD 437
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD---------WPTRKKIALGS- 405
            L G CT     L++  Y   G + + LR R+S +   D           TR  +   S 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 406 -ARGLSYLHEHCDPKIIHRDVKAANILL 432
            A+G+++L        IHRDV A N+LL
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 361
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 422 HRDVKAANILLDEDAD 437
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 22/148 (14%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD---------WPTRKKIALGS- 405
            L G CT     L++  Y   G + + LR R+S +   D           TR  +   S 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 406 -ARGLSYLHEHCDPKIIHRDVKAANILL 432
            A+G+++L        IHRDV A N+LL
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 280 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTS 333
           G+LK  SL  ++   +       LG   FGKVYKG L   A G   + VA+K LK++   
Sbjct: 1   GKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 334 GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL---------- 383
               +F+ E  + +   H N++ L G  T      +++ Y ++G +   L          
Sbjct: 54  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 384 -----RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
                R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 114 STDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 161

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 347
           E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +  
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHK 60
Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTRKK 400
              H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T++ 
Sbjct: 61  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 118 L-----EGLKYLH---DNQIVHRDIKGDNVLIN 142

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 303 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 136
Query: 416 CDPKIIHRDVKAANILLDED 435
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 303 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEE 131
Query: 415 HCDPKIIHRDVKAANILLDEDADQSS 440
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 81  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 423 RDVKAANILL 432
           RD++AANIL+
Sbjct: 135 RDLRAANILV 144

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 25/146 (17%)
Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISM--AVHRNLLRL 357
            +  RG FG V+K +L + + VAVK    +++ S     +Q E ++ S+    H N+L+ 
Sbjct: 30  EVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-----WQNEYEVYSLPGMKHENILQF 83
Query: 358 YGF---CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
            G     T+V   L L+  +   GS++  L+    S     W     IA   ARGL+YLH
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNELCHIAETMARGLAYLH 138
Query: 414 EHC-------DPKIIHRDVKAANILL 432
           E          P I HRD+K+ N+LL
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLL 164

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GLS+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 303 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           LG G +  VYKG+  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
             T     LV+ Y+ +  +   L +  +    ++    K       RGL+Y H     K+
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 421 IHRDVKAANILLDE 434
           +HRD+K  N+L++E
Sbjct: 122 LHRDLKPQNLLINE 135

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 292 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 85
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 403
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 139
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 444
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 177

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 292 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 403
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLD 433
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLE 160

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 248 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 301
Query: 423 RDVKAANILL 432
           RD++AANIL+
Sbjct: 302 RDLRAANILV 311

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 59/140 (42%), Gaps = 15/140 (10%)
Query: 303 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 358 YGFC--TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            G C         LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 416 CDPKIIHRDVKAANILLDED 435
                IHRD+ A N+LLD D
Sbjct: 154 ---HYIHRDLAARNVLLDND 170

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 346
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 347 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 392
           +   H+ ++R Y             T V +K  ++    Y  NG++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 8/147 (5%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA 349
           V  + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++   
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
           ++ H H   +++HRD+K  N+L++ + 
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 347
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 348 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 118
Query: 406 ARGLSYLHE-HCDPKIIHRDVKAANILL 432
            + ++YL   +C    +HRD+   NIL+
Sbjct: 119 CKAMAYLESINC----VHRDIAVRNILV 142

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           + +L  GGF  VY+ + +  G+  A+KRL            Q    +  ++ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 359 GFCTTVT----------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
            FC+  +           + L+   +  G +   L++ +S   PL   T  KI   + R 
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRA 148
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           + ++H    P IIHRD+K  N+LL
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLL 171

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 422
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 254 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 423 RDVKAANILL 432
           RD++AANIL+
Sbjct: 308 RDLRAANILV 317

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 129
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 130 ---GTKRYIHRDLATRNILVENE 149

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 345
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 346 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 72  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 126
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 127 EIILGLQFLH---SKGIVYRDLKLDNILLDKDG 156

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 303 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEE 131
Query: 415 HCDPKIIHRDVKAANILLDEDADQSS 440
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 408
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDA 436
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTEG 140

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 134
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 135 ---GTKRYIHRDLATRNILVENE 154

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 347
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 348 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 134
Query: 406 ARGLSYLHE-HCDPKIIHRDVKAANILL 432
            + ++YL   +C    +HRD+   NIL+
Sbjct: 135 CKAMAYLESINC----VHRDIAVRNILV 158

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 137
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 138 ---GTKRYIHRDLATRNILVENE 157

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 292 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 102
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 403
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 156
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLD 433
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLE 183

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 135
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 136 ---GTKRYIHRDLATRNILVENE 155

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 292 VATDGFSNKNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 347
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 348 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 122
Query: 406 ARGLSYLHE-HCDPKIIHRDVKAANILL 432
            + ++YL   +C    +HRD+   NIL+
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILV 146

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 136
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 137 ---GTKRYIHRDLATRNILVENE 156

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 300 KNILGRGGFGKV-----YKGRLADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAVHR 352
           +  LG G FGKV     YK +    + VA+K +  +  + S   ++ + E+  + +  H 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++++LY   TT T+ ++V  Y   G +   + E++     +     ++        + Y 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYC 124
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H H   KI+HRD+K  N+LLD++
Sbjct: 125 HRH---KIVHRDLKPENLLLDDN 144

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 161
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 162 ---GTKRYIHRDLATRNILVENE 181

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 144
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 145 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 182

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           +G+G +G+V+ G+   G+ VAVK      T       +TE+    +  H N+L   GF  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 363 -------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
                  + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 416 C-----DPKIIHRDVKAANILLDEDA 436
                  P I HRD+K+ NIL+ ++ 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEG 140

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I +M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 135
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 128
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 129 ---GTKRYIHRDLATRNILVENE 148

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 292 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 103
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 403
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 157
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLD 433
               G++Y+H++   KI+HRD+K  N+LL+
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLE 184

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEG 142

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEG 141

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 139
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 140 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 177

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEG 141

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEG 142

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 21/147 (14%)
Query: 296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 354
            ++N  ++G G FG V++ +L +   VA+K+ L+++R    ELQ    VK      H N+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNV 94
Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           + L  F  +  +K        +L Y   T    +    + + ++P L     K       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML---LIKLYMYQLL 151
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLD 433
           R L+Y+H      I HRD+K  N+LLD
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLD 175

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
           + H H   +++HRD+K  N+L++ + 
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 146
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 147 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 184

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L+   ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEG 141

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 291 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 349
           Q   +   N   +G G  G+V+K R    G ++AVK++   R SG + + +  +  + + 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVV 77
Query: 350 VHRN----LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           +  +    +++ +G   T T+  +    M  G+ A +L++R     P+      K+ +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQG--PIPERILGKMTVAI 133
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDE 434
            + L YL E     +IHRDVK +NILLDE
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDE 160

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------------------PPLDWP 396
            L G CT     L++  Y   G + + LR +  ++                    PL+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
                +   A+G+++L        IHRDV A N+LL
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 267
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 362 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQG 190
Query: 417 DPKIIHRDVKAANILLDEDA----------DQSSKTILRR 446
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKI 345
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T  E ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 346 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 71  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 125
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 350
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 408
           H N+++L     T  +  LV+ +     V   L++    S+L  +  P  K       +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEH-----VDQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDA 436
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 287 LRELQVATDGFSNKN-------ILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQ 338
           + EL+    G SN          +GRG F  VYKG   +  + VA   L++ + +  E Q
Sbjct: 11  IEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 339 -FQTEVKIISMAVHRNLLRLY-GFCTTVTEK---LLVYPYMTNGSVASRL-RERQSSLPP 392
            F+ E + +    H N++R Y  + +TV  K   +LV    T+G++ + L R +   +  
Sbjct: 71  RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV 130
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           L    R+ +     +GL +LH    P IIHRD+K  NI +
Sbjct: 131 LRSWCRQIL-----KGLQFLHTRT-PPIIHRDLKCDNIFI 164

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 122
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 123 GITHRDIKPENLLLDE 138

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 123
Query: 420 IIHRDVKAANILLDE 434
           I+HRD+K  N+LLDE
Sbjct: 124 IVHRDLKPENLLLDE 138

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 132
Query: 420 IIHRDVKAANILLDE 434
           I+HRD+K  N+LLDE
Sbjct: 133 IVHRDLKPENLLLDE 147

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 133
Query: 420 IIHRDVKAANILLDE 434
           I+HRD+K  N+LLDE
Sbjct: 134 IVHRDLKPENLLLDE 148

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 272 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 330
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 331 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 385
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 272 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 330
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 331 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 385
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 127
Query: 420 IIHRDVKAANILLDE 434
           I+HRD+K  N+LLDE
Sbjct: 128 IVHRDLKPENLLLDE 142

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  ++  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 279 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 334
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 335 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 394
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 395 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 436
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 272 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 330
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 166 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 331 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 385
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 225 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 282
Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 283 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 326

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 297 FSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           F    +LG G F +V+  K RL  GKL A+K +K+   +  +   + E+ ++    H N+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENI 68
Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS---Y 411
           + L     + T   LV   ++ G +  R+ ER          T K  +L   + LS   Y
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-------TEKDASLVIQQVLSAVKY 121
Query: 412 LHEHCDPKIIHRDVKAANIL 431
           LHE+    I+HRD+K  N+L
Sbjct: 122 LHEN---GIVHRDLKPENLL 138

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 272 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 330
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 331 R--TSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 385
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L  
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-- 283
Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             S          +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 284 --SQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 279 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 334
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 335 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 394
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 395 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 436
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 279 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 334
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 335 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 394
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 395 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 436
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 356 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 135
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
            YLHE+   +IIHRD+K  NI+L
Sbjct: 136 RYLHEN---RIIHRDLKPENIVL 155

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 294 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 350
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 351 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 356 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 134
Query: 410 SYLHEHCDPKIIHRDVKAANILL 432
            YLHE+   +IIHRD+K  NI+L
Sbjct: 135 RYLHEN---RIIHRDLKPENIVL 154

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 294 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 350
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 351 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIH---SMSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 294 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 350
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 67
Query: 351 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           L Y+H      ++H D+K +NI +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 294 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 350
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 63
Query: 351 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 409 LSYLHEHCDPKIIHRDVKAANILL 432
           L Y+H      ++H D+K +NI +
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 28/151 (18%)
Query: 301 NILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM--AVHRNLLR 356
            I  RG FG V+K +L +   VAVK   L+++++      +Q+E +I S     H NLL+
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQ 73
Query: 357 LYGF----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
                        E  L+  +   GS+   L+        + W     +A   +RGLSYL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYL 128
Query: 413 HEHC--------DPKIIHRDVKAANILLDED 435
           HE           P I HRD K+ N+LL  D
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSD 159

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 303 LGRGGFGKV--YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           LG GGF  V   +G L DG   A+KR+        E + Q E  +  +  H N+LRL  +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 361 CT----TVTEKLLVYPYMTNGSV---ASRLRERQSSLPPLDWPTRKKIA---LGSARGLS 410
           C        E  L+ P+   G++     RL+++ + L      T  +I    LG  RGL 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL------TEDQILWLLLGICRGLE 148
Query: 411 YLHEHCDPKIIHRDVKAANILLDEDA 436
            +H        HRD+K  NILL ++ 
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEG 171

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 19/123 (15%)
Query: 319 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 378
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 379 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           +      +R+ E Q +           + L   R LSYLH   +  +IHRD+K+ +ILL 
Sbjct: 129 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLH---NQGVIHRDIKSDSILLT 175
Query: 434 EDA 436
            D 
Sbjct: 176 SDG 178

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 357
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 358 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 412 LHEHCDPKIIHRDVKAANILLD 433
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 131
Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHR++   NIL++ +
Sbjct: 132 ---GTKRYIHRNLATRNILVENE 151

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 301 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 357
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 358 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 412 LHEHCDPKIIHRDVKAANILLD 433
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRHM---VVHRDLKPENVLLD 145

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 292 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 345
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 403
           +    H N+ +LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLD 433
               G++Y H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLE 160

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 361 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEG 140

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 413 HEHCDPKIIHRDVKAANILLDEDA 436
           H H   +++HRD+K  N+L++ + 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEG 139

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 96
Query: 361 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 151
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 361 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 414 -----EHCDPKIIHRDVKAANILLDEDA 436
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 125
Query: 418 PKIIHRDVKAANILLDEDA 436
             II+RD+K  N+LLD + 
Sbjct: 126 -GIIYRDLKLDNVLLDSEG 143

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 129
Query: 418 PKIIHRDVKAANILLDEDA 436
             II+RD+K  N+LLD + 
Sbjct: 130 -GIIYRDLKLDNVLLDSEG 147

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVH 351
           + F    ILG G F  V   R LA  +  A+K L K       ++ + T E  ++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 352 RNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
              ++LY FC    EKL     Y  NG +   +R+  S     D    +         L 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALE 151
Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YLH      IIHRD+K  NILL+ED
Sbjct: 152 YLH---GKGIIHRDLKPENILLNED 173

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 309 GKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VT 365
           G+++KGR   G  + VK LK  + ++     F  E   + +  H N+L + G C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV 425
              L+  +M  GS+ + L E  + +  +D     K AL  ARG+++LH   +P I    +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-LEPLIPRHAL 139
Query: 426 KAANILLDED 435
            + ++++DED
Sbjct: 140 NSRSVMIDED 149

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 140
Query: 418 PKIIHRDVKAANILLDEDA 436
             II+RD+K  N+LLD + 
Sbjct: 141 -GIIYRDLKLDNVLLDSEG 158

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 346
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 347 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 392
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 26/147 (17%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 70
Query: 356 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 409
             Y    +     E  LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 124
Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
            YL      + +HRD+ A NIL++ +A
Sbjct: 125 EYLGSR---RCVHRDLAARNILVESEA 148

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 27/144 (18%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G +G+V++G L  G+ VAVK    ++E++   E    TE+    +  H N+L   GF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE----TEIYNTVLLRHDNIL---GF 67
Query: 361 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
             +        T+  L+  Y  +GS+   L +RQ+  P L      ++A+ +A GL++LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHL----ALRLAVSAACGLAHLH 122
Query: 414 -----EHCDPKIIHRDVKAANILL 432
                    P I HRD K+ N+L+
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLV 146

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 303 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G  G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 419 KIIHRDVKAANILLDE 434
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F  K  LG G F +V      A GKL AVK + ++   G E   + E+ ++    H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L     +     LV   ++ G +  R+ E+       D  T  +  L +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDA---VYYLHRM 139
Query: 416 CDPKIIHRDVKAANILLDEDADQSSKTIL 444
               I+HRD+K  N+L     D+ SK ++
Sbjct: 140 ---GIVHRDLKPENLLY-YSQDEESKIMI 164

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 401
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 402 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 432
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 167 SYQVAKGMAFLASKNC----IHRDLAARNILL 194

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 401
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           +   A+G+++L        IHRD+ A NILL
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILL 178

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 392
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 125

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 401
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 402 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 432
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 169 SYQVAKGMAFLASKNC----IHRDLAARNILL 196

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 303 LGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G G FGK +      DG+   +K +   R S  E +  + EV +++   H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHEHC 416
                   +V  Y   G +  R+  ++  L      LDW  +  +AL         H H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------HVH- 142
Query: 417 DPKIIHRDVKAANILLDEDA 436
           D KI+HRD+K+ NI L +D 
Sbjct: 143 DRKILHRDIKSQNIFLTKDG 162

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 401
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           +   A+G+++L        IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILL 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 9/132 (6%)
Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 360
           +G G +G V+K R  D G++VA+K+  E        +    E++++    H NL+ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
                   LV+ Y  + +V   L   Q  +P       K I   + + +++ H+H     
Sbjct: 71  FRRKRRLHLVFEY-CDHTVLHELDRYQRGVPE---HLVKSITWQTLQAVNFCHKH---NC 123
Query: 421 IHRDVKAANILL 432
           IHRDVK  NIL+
Sbjct: 124 IHRDVKPENILI 135

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 303 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 401
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           +   A+G+++L        IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILL 201

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 294 TDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKIISMA 349
           +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV ++   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N+++LY F        LV      G +   +  RQ     +D     K  L    G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS---GT 117
Query: 410 SYLHEHCDPKIIHRDVKAANILLD 433
           +YLH+H    I+HRD+K  N+LL+
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLE 138

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 290 LQVATDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKI 345
            Q  +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           +    H N+++LY F        LV      G +   +  RQ     +D     K  L  
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS- 132
Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLD 433
             G +YLH+H    I+HRD+K  N+LL+
Sbjct: 133 --GTTYLHKH---NIVHRDLKPENLLLE 155

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 303 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 361 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 417
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 418 -PKIIHRDVKAANILLD 433
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 10/105 (9%)
Query: 338 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLP 391
            F+ E++II+   +   L   G  T   E  ++Y YM N S+         L +  +   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 392 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 436
           P+     K I        SY+H   +  I HRDVK +NIL+D++ 
Sbjct: 149 PI--QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A++ +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 172
Query: 418 PKIIHRDVKAANILLDEDA 436
             II+RD+K  N+LLD + 
Sbjct: 173 -GIIYRDLKLDNVLLDSEG 190

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 303 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 361 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 417
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 418 -PKIIHRDVKAANILLD 433
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 303 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 360
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 361 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 417
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 418 -PKIIHRDVKAANILLD 433
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 295 DGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAV 350
           D +  +++LG G F +V    LA+ K    LVA+K + ++   G E   + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N++ L     +     L+   ++ G +  R+ E+             ++       + 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----RDASRLIFQVLDAVK 130
Query: 411 YLHEHCDPKIIHRDVKAANIL---LDEDA 436
           YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRL-----KEERTSGGELQFQTEVKIISMAVHRNLLRL 357
           LG G +G+V    L   K+  V+R      K   ++    +   EV ++ +  H N+++L
Sbjct: 45  LGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           Y F        LV      G +   +  R      +D     K  L    G++YLH+H  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLS---GVTYLHKH-- 155
Query: 418 PKIIHRDVKAANILLD 433
             I+HRD+K  N+LL+
Sbjct: 156 -NIVHRDLKPENLLLE 170

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 4/151 (2%)
Query: 295 DGFSNKNILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D F  K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           +++++          +V      G +  R+   Q+    L      ++       L+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 414 EHCDPKIIHRDVKAANILLDEDADQSSKTIL 444
                 ++H+D+K  NIL  + +  S   I+
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKII 169

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 65/154 (42%), Gaps = 44/154 (28%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---------- 352
           LGRG FG+V+             R+++++T      FQ  VK + + V R          
Sbjct: 82  LGRGSFGEVH-------------RMEDKQTG-----FQCAVKKVRLEVFRAEELMACAGL 123
Query: 353 ---NLLRLYGFCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA- 406
               ++ LYG    V E   V  +M    G    +L + Q  LP      R    LG A 
Sbjct: 124 TSPRIVPLYG---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQAL 176
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
            GL YLH     +I+H DVKA N+LL  D   ++
Sbjct: 177 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAA 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 409 LSYLHEHCDPKIIHRDVKAANILLD 433
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 409 LSYLHEHCDPKIIHRDVKAANILLD 433
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 409 LSYLHEHCDPKIIHRDVKAANILLD 433
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 65/154 (42%), Gaps = 44/154 (28%)
Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---------- 352
           LGRG FG+V+             R+++++T      FQ  VK + + V R          
Sbjct: 101 LGRGSFGEVH-------------RMEDKQTG-----FQCAVKKVRLEVFRAEELMACAGL 142
Query: 353 ---NLLRLYGFCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA- 406
               ++ LYG    V E   V  +M    G    +L + Q  LP      R    LG A 
Sbjct: 143 TSPRIVPLYG---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQAL 195
Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
            GL YLH     +I+H DVKA N+LL  D   ++
Sbjct: 196 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAA 226

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 346
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVXLL 56
Query: 347 SMAVHRNLLRLYGFC----------TTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 392
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 434
             W   ++I       LSY+H      IIHR++K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDE 151

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 409 LSYLHEHCDPKIIHRDVKAANILLD 433
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 290 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 409 LSYLHEHCDPKIIHRDVKAANILLD 433
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 74
Query: 356 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 409
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 128
Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
            YL      + +HRD+ A NIL++ +A
Sbjct: 129 EYLGSR---RCVHRDLAARNILVESEA 152

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 73
Query: 356 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 409
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 127
Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
            YL      + +HRD+ A NIL++ +A
Sbjct: 128 EYLGSR---RCVHRDLAARNILVESEA 151

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 303 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 86
Query: 356 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 409
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 140
Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDA 436
            YL      + +HRD+ A NIL++ +A
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEA 164

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 44/160 (27%)
Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---- 352
            +++  LGRG FG+V+             R+K+++T      FQ  VK + + V R    
Sbjct: 74  MTHQPRLGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRLEVFRVEEL 115
Query: 353 ---------NLLRLYGFCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKI 401
                     ++ LYG    V E   V  +M    G    +L ++   LP      R   
Sbjct: 116 VACAGLSSPRIVPLYG---AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE----DRALY 168
Query: 402 ALGSA-RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
            LG A  GL YLH     +I+H DVKA N+LL  D  +++
Sbjct: 169 YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA 205

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 303 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 355
           LGRG FGKV +       +    + VAVK LKE  T+       TE+KI++ +  H N++
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 356 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQ 387
            L G CT     L+V   Y   G++++ L+ ++
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR 127

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 10/162 (6%)
Query: 276 ELQLGQLKRFSLRELQVAT---DGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEER 331
           E Q  +L+ F  ++ +V     D F   + LG G  G V+K      G ++A K +  E 
Sbjct: 46  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 105
Query: 332 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 391
                 Q   E++++       ++  YG   +  E  +   +M  GS+   L+ +   +P
Sbjct: 106 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIP 164
Query: 392 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
                   K+++   +GL+YL E    KI+HRDVK +NIL++
Sbjct: 165 ---EQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVN 201

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 350
           +D +    ILG GG  +V+  R L D + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 351 HRNLLRLY--GFCTTVTEKLLVYPYMTNGSV-ASRLRERQSSLPPLDWPTRKKIALGSAR 407
           H  ++ +Y  G   T    L   PY+    V    LR+   +  P+      ++   + +
Sbjct: 71  HPAIVAVYDTGEAETPAGPL---PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 408 GLSYLHEHCDPKIIHRDVKAANILL 432
            L++ H++    IIHRDVK ANIL+
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILI 149

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	447
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-113
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-74
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-47
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-46
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-43
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-07
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-04
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-34
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-28
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-27
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-24
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-23
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-22
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-22
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-22
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-13
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-21
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-16
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-08
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-17
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-12
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-04
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-07
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-06
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-07
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-14
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-06
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-13
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-06
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-13
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-08
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-04
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-12
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-11
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-11
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-10
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-10
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-06
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-04
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	3e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (857), Expect = e-113
 Identities = 145/170 (85%), Positives = 156/170 (91%)

Query: 266 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 325
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 326 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 385
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 386 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  248 bits (635), Expect = 1e-79
 Identities = 68/173 (39%), Positives = 94/173 (54%), Gaps = 14/173 (8%)

Query: 272 EDDSELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVK 325
               E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 326 RLKEERTSG---GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASR 382
           +L           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  R
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 383 LRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           L     + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE 
Sbjct: 121 LSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  235 bits (602), Expect = 2e-74
 Identities = 71/167 (42%), Positives = 96/167 (57%), Gaps = 6/167 (3%)

Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE 329
            A   S L   +  R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 330 ERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS 388
           E  S  G  +F+TE++ +S   H +L+ L GFC    E +L+Y YM NG++   L     
Sbjct: 74  E--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 389 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               + W  R +I +G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  164 bits (417), Expect = 2e-47
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 19/162 (11%)

Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 344
                L   +       +  RG FG V+K +L   + VAVK    +       Q + EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVY 70

Query: 345 IISMAVHRNLLRLYGFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
            +    H N+L+  G          +  L+  +   GS++  L+        + W     
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 401 IALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDED 435
           IA   ARGL+YLHE          P I HRD+K+ N+LL  +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  161 bits (409), Expect = 4e-46
 Identities = 61/185 (32%), Positives = 89/185 (48%), Gaps = 11/185 (5%)

Query: 27  EVDALYIFKSKLQDPNNSLQSW-DNLPGNLCTWFHITCNPEGSVTRV---DLGNAALSGE 82
           +  AL   K  L +P  +L SW         TW  + C+ +    RV   DL    L   
Sbjct: 7   DKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 83  LA--PELGQLKNLELLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLK 139
                 L  L  L  L + G NNL G IP A+  L +L  L +     +G IPD L+ +K
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 140 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQ-FTPISFENNL 197
            L  L  + N+LSG +P S++++ +L  +    NR+SG +PD+ GSFS+ FT ++   N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN- 184

Query: 198 NLCGP 202
            L G 
Sbjct: 185 RLTGK 189

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  154 bits (392), Expect = 1e-43
 Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 3/137 (2%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
            +    L+G++ P    L NL  ++L  N L G      G+    + + L  N     + 
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 133 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
             +   K L  L L NN + G +P  LT +  L+ L++S N L G +P  G+  +F   +
Sbjct: 239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSA 297

Query: 193 FENNLNLCGPNTKKPCS 209
           + NN  LCG      C+
Sbjct: 298 YANNKCLCGSPL-PACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 21/58 (36%), Positives = 28/58 (48%), Gaps = 1/58 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
           ++  +DL N  + G L   L QLK L  L +  NNL G IP   GNL +       +N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  163 bits (416), Expect = 3e-44
 Identities = 49/150 (32%), Positives = 79/150 (52%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           +    ++ +    G  +P      ++  L++  N LSG+IP  +G++  L  L+L  N  
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
           +G+IPD + +L+ L  L L++N L G IP +++ +T L  +DLSNN LSGP+P+ G F  
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFET 728

Query: 188 FTPISFENNLNLCGPNTKKPCSGSPPFSPP 217
           F P  F NN  LCG    +    +      
Sbjct: 729 FPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (344), Expect = 1e-34
 Identities = 46/136 (33%), Positives = 64/136 (47%), Gaps = 2/136 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            +  + L    LSG +   LG L  L  L+L+ N L G IP  L  +  L++L L  N  
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFS 186
            G IP  L+N   L ++ L+NN L+G IP  +  + +L IL LSNN  SG +P   G   
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538

Query: 187 QFTPISFENNLNLCGP 202
               +    N    G 
Sbjct: 539 SLIWLDLNTN-LFNGT 553

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  132 bits (335), Expect = 2e-33
 Identities = 46/131 (35%), Positives = 65/131 (49%), Gaps = 2/131 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            +  + L    L GE+  EL  +K LE L L  N+L+G IPS L N   L  + L +N  
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
            G IP  +  L+ L  L+L+NNS SG IP  L    SL  LDL+ N  +G +P   +  +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA--AMFK 560

Query: 188 FTPISFENNLN 198
            +     N + 
Sbjct: 561 QSGKIAANFIA 571

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  132 bits (335), Expect = 2e-33
 Identities = 57/156 (36%), Positives = 83/156 (53%), Gaps = 9/156 (5%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           +N+      +  NLC       NP+ ++  + L N   +G++ P L     L  L L  N
Sbjct: 377 SNNFSG--PILPNLCQ------NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
            LSG IPS+LG+L KL+ L L+ N+  G IP  L  +K L+ L L+ N L+G IP+ L+ 
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 162 ITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN 196
            T+LN + LSNNRL+G +P   G       +   NN
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  126 bits (319), Expect = 2e-31
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 7/139 (5%)

Query: 70  TRVDLGNAALSGELAPEL-GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             + L     +GE+   L G    L  L+L GN+  G +P   G+   L+SL L SN F+
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331

Query: 129 GTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTIT-SLNILDLSNNRLSGPVPD---NG 183
           G +P DTL  ++ LK L L+ N  SG +P SLT ++ SL  LDLS+N  SGP+       
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391

Query: 184 SFSQFTPISFENNLNLCGP 202
             +    +  +NN    G 
Sbjct: 392 PKNTLQELYLQNN-GFTGK 409

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  123 bits (312), Expect = 2e-30
 Identities = 48/137 (35%), Positives = 68/137 (49%), Gaps = 6/137 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++  +D+ +   S  + P LG    L+ L++ GN LSG    A+    +LK L++ SN F
Sbjct: 201 NLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT-ITSLNILDLSNNRLSGPVPDN-GSF 185
            G IP     LK L+YL L  N  +G IP  L+    +L  LDLS N   G VP   GS 
Sbjct: 260 VGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317

Query: 186 SQFTPISFENNLNLCGP 202
           S    ++  +N N  G 
Sbjct: 318 SLLESLALSSN-NFSGE 333

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  123 bits (311), Expect = 2e-30
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 6/140 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIP-SALGNLIKLKSLDLYSNL 126
           ++T +DL      G + P  G    LE L L  NN SG +P   L  +  LK LDL  N 
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354

Query: 127 FNGTIPDTLANLK-QLKYLRLNNNSLSGLIPTSL--TTITSLNILDLSNNRLSGPVPDN- 182
           F+G +P++L NL   L  L L++N+ SG I  +L      +L  L L NN  +G +P   
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414

Query: 183 GSFSQFTPISFENNLNLCGP 202
            + S+   +    N  L G 
Sbjct: 415 SNCSELVSLHLSFN-YLSGT 433

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (304), Expect = 2e-29
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 8/138 (5%)

Query: 68  SVTRVDLGNAALSGELAPEL---GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS 124
           S+  +DL   ++SG              L+ L + GN +SG +   +   + L+ LD+ S
Sbjct: 152 SLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSS 209

Query: 125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 184
           N F+  IP  L +   L++L ++ N LSG    +++T T L +L++S+N+  GP+P    
Sbjct: 210 NNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LP 267

Query: 185 FSQFTPISFENNLNLCGP 202
                 +S   N    G 
Sbjct: 268 LKSLQYLSLAEN-KFTGE 284

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  114 bits (287), Expect = 3e-27
 Identities = 36/127 (28%), Positives = 54/127 (42%), Gaps = 5/127 (3%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
            L    L+GE+   L    NL  + L  N L+G IP  +G L  L  L L +N F+G IP
Sbjct: 472 ILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531

Query: 133 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPI 191
             L + + L +L LN N  +G IP ++          ++ N ++G       +       
Sbjct: 532 AELGDCRSLIWLDLNTNLFNGTIPAAM----FKQSGKIAANFIAGKRYVYIKNDGMKKEC 587

Query: 192 SFENNLN 198
               NL 
Sbjct: 588 HGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  112 bits (282), Expect = 1e-26
 Identities = 32/135 (23%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 73  DLGNAALSGEL-APELGQLKNLELLELYGNNLSGHIPSAL---GNLIKLKSLDLYSNLFN 128
           ++ +  L          +L +LE+L+L  N++SG             +LK L +  N  +
Sbjct: 132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQ 187
           G +   ++    L++L +++N+ S  IP  L   ++L  LD+S N+LSG       + ++
Sbjct: 192 GDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTE 248

Query: 188 FTPISFENNLNLCGP 202
              ++  +N    GP
Sbjct: 249 LKLLNISSN-QFVGP 262

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (280), Expect = 2e-26
 Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 27/166 (16%)

Query: 23  SANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGE 82
           S   E+  L  FK  L D N  L  W +   N CT+  +TC     VT +DL +  L+  
Sbjct: 9   SLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCRD-DKVTSIDLSSKPLNVG 65

Query: 83  LAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLK 142
                                   + S+L +L  L+SL L ++  NG++         L 
Sbjct: 66  F---------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLT 103

Query: 143 YLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFS 186
            L L+ NSLSG + T  SL + + L  L++S+N L  P   +G   
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.1 bits (240), Expect = 2e-21
 Identities = 29/142 (20%), Positives = 47/142 (33%), Gaps = 16/142 (11%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           NNS     N+P  L     +          +DL     +G +   + +        +  N
Sbjct: 523 NNSFS--GNIPAELGDCRSLI--------WLDLNTNLFNGTIPAAMFKQSGK----IAAN 568

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNL--FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
            ++G     + N    K      NL  F G   + L  L       + +    G    + 
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628

Query: 160 TTITSLNILDLSNNRLSGPVPD 181
               S+  LD+S N LSG +P 
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPK 650

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 4/62 (6%)

Query: 144 LRLNNNSLS---GLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
           + L++  L+     + +SL ++T L  L LSN+ ++G V      +  T +    N +L 
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN-SLS 113

Query: 201 GP 202
           GP
Sbjct: 114 GP 115

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (372), Expect = 4e-41
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 271 AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 329
           A   SE    +L   +  E++        +  +G+GGFG V+KGR + D  +VA+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 330 ERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTNGSV 379
             + G         +FQ EV I+S   H N+++LYG        V E      ++  G +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME------FVPCGDL 108

Query: 380 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 439
             RL ++     P+ W  + ++ L  A G+ Y+  + +P I+HRD+++ NI L    + +
Sbjct: 109 YHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 440 SKTI 443
               
Sbjct: 165 PVCA 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  147 bits (372), Expect = 9e-41
 Identities = 50/164 (30%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 344
            +  E  +  D      ++GRG +G VYKG L D + VAVK             F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS----FANRQNFINEKN 57

Query: 345 IISMAV--HRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 397
           I  + +  H N+ R       V      E LLV  Y  NGS+   L          DW +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVS 112

Query: 398 RKKIALGSARGLSYLHE------HCDPKIIHRDVKAANILLDED 435
             ++A    RGL+YLH       H  P I HRD+ + N+L+  D
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (361), Expect = 3e-39
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 358
           K  +G G FG V++     G  VAVK L E+      +  F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 359 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           G  T       VTE      Y++ GS+   L  +  +   LD   R  +A   A+G++YL
Sbjct: 101 GAVTQPPNLSIVTE------YLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H + +P I+HR++K+ N+L+D+ 
Sbjct: 154 H-NRNPPIVHRNLKSPNLLVDKK 175

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  142 bits (360), Expect = 4e-39
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 15/140 (10%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68

Query: 360 FCTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            C      V E      Y   GS+ + L   +  LP           L  ++G++YLH  
Sbjct: 69  ACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 416 CDPKIIHRDVKAANILLDED 435
               +IHRD+K  N+LL   
Sbjct: 122 QPKALIHRDLKPPNLLLVAG 141

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  138 bits (349), Expect = 6e-38
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLR 356
           + I+G GGFGKVY+     G  VAVK  + +     S      + E K+ +M  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 357 LYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           L G C        V E      +   G +   L  ++     +        A+  ARG++
Sbjct: 71  LRGVCLKEPNLCLVME------FARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMN 119

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDADQSSKT 442
           YLH+     IIHRD+K++NIL+ +  +    +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  137 bits (347), Expect = 1e-37
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 19/145 (13%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 358
              L     G+++KGR   G  + VK LK    S  + + F  E   + +  H N+L + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 359 GFCTT--------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           G C +        +T       +M  GS+ + L E  +    +D     K AL  ARG++
Sbjct: 74  GACQSPPAPHPTLITH------WMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMA 125

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           +LH   +P I    + + ++++DED
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDED 149

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  130 bits (328), Expect = 1e-34
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 20/143 (13%)

Query: 300 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
             +LG+G FG+  K      G+++ +K L        +  F  EVK++    H N+L+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 359 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           G          +TE      Y+  G++   ++   S      W  R   A   A G++YL
Sbjct: 74  GVLYKDKRLNFITE------YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H      IIHRD+ + N L+ E+
Sbjct: 125 HSM---NIIHRDLNSHNCLVREN 144

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (324), Expect = 3e-34
 Identities = 47/139 (33%), Positives = 65/139 (46%), Gaps = 20/139 (14%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG VYKG+   G  VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 362 T-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           T      VT+      +    S+   L   +      +      IA  +ARG+ YLH   
Sbjct: 90  TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139

Query: 417 DPKIIHRDVKAANILLDED 435
              IIHRD+K+ NI L ED
Sbjct: 140 --SIIHRDLKSNNIFLHED 156

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (326), Expect = 3e-34
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 21/143 (14%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 358
             ++G+G FG+VY GR   G+ VA++ +  ER +  +L+ F+ EV       H N++   
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 359 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           G C +      +T            ++ S +R+ +     LD    ++IA    +G+ YL
Sbjct: 96  GACMSPPHLAIITS------LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYL 146

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H      I+H+D+K+ N+  D  
Sbjct: 147 HAK---GILHKDLKSKNVFYDNG 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (317), Expect = 3e-33
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 28/165 (16%)

Query: 282 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT 341
           ++R   R++ +          +G+G +G+V++G    G+ VAVK          E  +  
Sbjct: 2   MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFR 49

Query: 342 EVKIISMAV--HRNLLRLYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDW 395
           E ++ +  +  H N+L       T         L+  Y   GS+   L+        LD 
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDT 104

Query: 396 PTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDED 435
            +  +I L  A GL++LH         P I HRD+K+ NIL+ ++
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  126 bits (317), Expect = 7e-33
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 358
             +G+G +G+V+ G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97

Query: 359 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
                   + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 415 -----HCDPKIIHRDVKAANILLDED 435
                   P I HRD+K+ NIL+ ++
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (303), Expect = 7e-31
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 21/146 (14%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 358
             +G+G FG+V++G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 359 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
                   T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 157

Query: 415 -----HCDPKIIHRDVKAANILLDED 435
                   P I HRD+K+ NIL+ ++
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKN 183

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  117 bits (295), Expect = 2e-29
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 19/143 (13%)

Query: 300 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
              +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 359 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           G CT       V E       +  G   + LR   + L      T  ++   +A G+ YL
Sbjct: 179 GVCTQKQPIYIVME------LVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYL 229

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                   IHRD+ A N L+ E 
Sbjct: 230 ESK---CCIHRDLAARNCLVTEK 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (281), Expect = 5e-28
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 354
             ILG G FG V +G L         VAVK +K + +S  E++ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 355 LRLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSAR 407
           +RL G C       + + +++ P+M  G + + L   +    P   P +   K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
           G+ YL        +HRD+ A N +L +D
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDD 183

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (278), Expect = 9e-28
 Identities = 48/140 (34%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 301 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 357 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           L G C       L V PYM +G + + +R    +    D        L  A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASK 147

Query: 416 CDPKIIHRDVKAANILLDED 435
              K +HRD+ A N +LDE 
Sbjct: 148 ---KFVHRDLAARNCMLDEK 164

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (278), Expect = 1e-27
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)

Query: 300 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
              LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 355 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  G CT        L+  ++ +GS+   L + ++ +       + K A+   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKGMDYL 142

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + +HRD+ A N+L++ +
Sbjct: 143 GSR---QYVHRDLAARNVLVESE 162

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  110 bits (276), Expect = 3e-27
 Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 15/143 (10%)

Query: 300 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
              LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 355 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  G C         LV  Y+  GS+   L      L  L        A     G++YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H       IHRD+ A N+LLD D
Sbjct: 151 HAQ---HYIHRDLAARNVLLDND 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 4e-27
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 301 NILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 356 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (273), Expect = 5e-27
 Identities = 40/141 (28%), Positives = 57/141 (40%), Gaps = 11/141 (7%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
             ++G+G FG VY G   D        A+K L           F  E  ++    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 356 RLYGFCTTVTE-KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
            L G          ++ PYM +G +   +R  Q +             L  ARG+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLAE 142

Query: 415 HCDPKIIHRDVKAANILLDED 435
               K +HRD+ A N +LDE 
Sbjct: 143 Q---KFVHRDLAARNCMLDES 160

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  108 bits (273), Expect = 7e-27
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              LG+G FG VY+G             VA+K + E  +    ++F  E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRK---KIALGSAR 407
           ++RL G  +     L++   MT G + S LR      ++ P L  P+     ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
           G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAED 174

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (272), Expect = 1e-26
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 354
             +LG+G FG V + +L         VAVK LK +  +  +++ F  E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 355 LRLYGFCT------TVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSA 406
            +L G          +   +++ P+M +G + + L   +    P  L   T  +  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
            G+ YL        IHRD+ A N +L ED
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAED 173

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (268), Expect = 2e-26
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            C       LV  +M +G ++  LR ++         T   + L    G++YL E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---C 124

Query: 420 IIHRDVKAANILLDED 435
           +IHRD+ A N L+ E+
Sbjct: 125 VIHRDLAARNCLVGEN 140

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (273), Expect = 2e-26
 Identities = 47/140 (33%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 301 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 357 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           L G C       L V PYM +G + + +R    +    D        L  A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASK 211

Query: 416 CDPKIIHRDVKAANILLDED 435
              K +HRD+ A N +LDE 
Sbjct: 212 ---KFVHRDLAARNCMLDEK 228

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 2e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 300 KNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
             ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 356 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           +L G         + E          G +   L   ++SL      T    +L   + ++
Sbjct: 77  KLIGIIEEEPTWIIME------LYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMA 127

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL        +HRD+   NIL+   
Sbjct: 128 YLESI---NCVHRDIAVRNILVASP 149

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (267), Expect = 2e-26
 Identities = 34/143 (23%), Positives = 59/143 (41%), Gaps = 21/143 (14%)

Query: 302 ILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
            +G G FG V++G     +     VA+K  K   +     +F  E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 358 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G  T      + E        T G + S L+ R+ SL      +    A   +  L+YL
Sbjct: 82  IGVITENPVWIIME------LCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTALAYL 132

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + +HRD+ A N+L+  +
Sbjct: 133 ESK---RFVHRDIAARNVLVSSN 152

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  106 bits (267), Expect = 5e-26
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 22/146 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
             +LG G FG V+KG            V +K ++++            +  I    H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 355 LRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
           +RL G C       VT+      Y+  GS+   +R+ + +L P          +  A+G+
Sbjct: 78  VRLLGLCPGSSLQLVTQ------YLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGM 128

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YL EH    ++HR++ A N+LL   
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSP 151

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  110 bits (275), Expect = 5e-26
 Identities = 52/269 (19%), Positives = 86/269 (31%), Gaps = 31/269 (11%)

Query: 179 VPDNGSFSQFTPISFENNLNLCGPNTK--KPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 236
           +P+   F     +     L   G      + C  S   +      PT     +       
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 237 VGVALGAALLFAVP--VIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAT 294
               L +      P  +      R        F+ P  D  EL+    K+  L+   +  
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD---KKLFLKRDNLLI 339

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
                   LG G FG V +G     K    VA+K LK+        +   E +I+    +
Sbjct: 340 A----DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395

Query: 352 RNLLRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
             ++RL G C       V E          G +   L  ++  +P        ++    +
Sbjct: 396 PYIVRLIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVS 446

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
            G+ YL E      +HR++ A N+LL   
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNR 472

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (265), Expect = 5e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 300 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73

Query: 355 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 130

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 131 GTK---RYIHRDLATRNILVENE 150

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (267), Expect = 6e-26
 Identities = 47/147 (31%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLS 410
           ++R  G       + ++   M  G + S LRE     S    L       +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD 437
           YL E+     IHRD+ A N LL     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGP 178

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (265), Expect = 6e-26
 Identities = 35/144 (24%), Positives = 55/144 (38%), Gaps = 20/144 (13%)

Query: 300 KNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
              LG G FG V +G     K    VA+K LK+        +   E +I+    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 357 LYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           L G C       V E          G +   L  ++  +P        ++    + G+ Y
Sbjct: 75  LIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVSMGMKY 125

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           L E      +HRD+ A N+LL   
Sbjct: 126 LEEK---NFVHRDLAARNVLLVNR 146

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 6e-26
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 300 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104

Query: 355 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 161

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + IHRD+   NIL++ +
Sbjct: 162 GTK---RYIHRDLATRNILVENE 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (264), Expect = 6e-26
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            CT      ++  YM NG + + LRE +            ++       + YL      +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---Q 140

Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N L+++ 
Sbjct: 141 FLHRDLAARNCLVNDQ 156

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (263), Expect = 7e-26
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            C+      +V  Y++NG + + LR     L P       ++      G+++L  H   +
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---Q 124

Query: 420 IIHRDVKAANILLDED 435
            IHRD+ A N L+D D
Sbjct: 125 FIHRDLAARNCLVDRD 140

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  109 bits (274), Expect = 7e-26
 Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 1/122 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S   +DL    L    +        L++L+L    +      A  +L  L +L L  N  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
                   + L  L+ L     +L+ L    +  + +L  L++++N +         FS 
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSN 147

Query: 188 FT 189
            T
Sbjct: 148 LT 149

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (251), Expect = 6e-23
 Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 1/115 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHI-PSALGNLIKLKSLDLYSNL 126
           ++  +D+ +             L +LE+L++ GN+   +  P     L  L  LDL    
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
                P    +L  L+ L +++N+   L       + SL +LD S N +      
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 24/107 (22%), Positives = 42/107 (39%), Gaps = 2/107 (1%)

Query: 73  DLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI 131
            +   +      P+   +L+NL  L+L    L    P+A  +L  L+ L++  N F    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510

Query: 132 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNRLSG 177
                 L  L+ L  + N +       L    +SL  L+L+ N  + 
Sbjct: 511 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 6/120 (5%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNL-SGHIPSALGNLIKLKSLDLYSNL 126
           S+ ++      L+      +G LK L+ L +  N + S  +P    NL  L+ LDL SN 
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 127 FNGTIPDTLANLKQLKY----LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
                   L  L Q+      L L+ N ++ + P +   I  L+ L L NN  S  V   
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 27/144 (18%), Positives = 51/144 (35%), Gaps = 5/144 (3%)

Query: 41  PNNSLQSWDNLPGNLCTWFHITCNPE-GSVTRVDLGNAALS--GELAPELGQLKNLELLE 97
           P   L+S   L        +     +  S+  +DL    LS  G  +       +L+ L+
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 98  LYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIP 156
           L  N +   + S    L +L+ LD   +            +L+ L YL +++        
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 157 TSLTTITSLNILDLSNNRLSGPVP 180
                ++SL +L ++ N       
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 31/174 (17%), Positives = 53/174 (30%), Gaps = 26/174 (14%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPE-LGQLKNLE 94
            ++   N SL    +L  N   +       E  + ++ L N   S  +    +  L  LE
Sbjct: 173 HQMPLLNLSL----DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228

Query: 95  LLELYGNNLSGH------IPSALGNLIKLKSLDL---YSNLFNGTIPDTLANLKQLKYLR 145
           +  L                SAL  L  L   +    Y + +   I D    L  +    
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
           L + ++  +   S         L+L N            F QF  +  ++   L
Sbjct: 289 LVSVTIERVKDFSYN--FGWQHLELVNC----------KFGQFPTLKLKSLKRL 330

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 35/163 (21%), Positives = 54/163 (33%), Gaps = 13/163 (7%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLEL 95
             L      L   D    ++   F    N   +V+   L +  +      +       + 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLF----NCLTNVSSFSLVSVTIER--VKDFSYNFGWQH 308

Query: 96  LELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS--G 153
           LEL            L +L   K L   SN           +L  L++L L+ N LS  G
Sbjct: 309 LELVNCKFGQFPTLKLKSL---KRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKG 363

Query: 154 LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
               S    TSL  LDLS N +     +     Q   + F+++
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIK-LKSLDLYSNL 126
           S+  +++ +             L +L++L+   N++       L +    L  L+L  N 
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

Query: 127 FNGTIP--DTLANLKQLKYLRLNNNSLSGLIPTSL--TTITSLNI 167
           F  T      L  +K  + L +    +    P+      + SLNI
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (263), Expect = 9e-26
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 359
            +GRG F  VYKG        VA   L++ + +  E  +F+ E +++    H N++R Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 360 -FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            + +TV  K  +      MT+G++ + L+        +     +       +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 416 CDPKIIHRDVKAANILLD 433
             P IIHRD+K  NI + 
Sbjct: 149 -TPPIIHRDLKCDNIFIT 165

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (262), Expect = 2e-25
 Identities = 52/145 (35%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 302 ILGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 355
            LG G FG V +G      GK   VAVK LK +  S  E    F  EV  +    HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 356 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           RLYG   T     VTE          GS+  RLR+ Q         T  + A+  A G+ 
Sbjct: 85  RLYGVVLTPPMKMVTE------LAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMG 135

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL      + IHRD+ A N+LL   
Sbjct: 136 YLESK---RFIHRDLAARNLLLATR 157

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (265), Expect = 2e-25
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK---KIALGSARGLS 410
           ++R  G       + ++   M  G + S LRE +                +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD 437
           YL E+     IHRD+ A N LL     
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGP 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  104 bits (262), Expect = 2e-25
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 8/134 (5%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +LG+G +G VY GR L++   +A+K + E  +   +     E+ +     H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87

Query: 361 CTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            +     + ++   +  GS+++ LR +   L   +  T          GL YLH++   +
Sbjct: 88  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIGFYTKQILEGLKYLHDN---Q 142

Query: 420 IIHRDVKAANILLD 433
           I+HRD+K  N+L++
Sbjct: 143 IVHRDIKGDNVLIN 156

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  104 bits (261), Expect = 2e-25
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 18/141 (12%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75

Query: 360 FCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
             T      +TE      YM NGS+   L+        L       +A   A G++++ E
Sbjct: 76  VVTQEPIYIITE------YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 415 HCDPKIIHRDVKAANILLDED 435
                 IHRD++AANIL+ + 
Sbjct: 128 R---NYIHRDLRAANILVSDT 145

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (263), Expect = 2e-25
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           + I+G G  G+V  GRL         VA+K LK   T      F +E  I+    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           RL G  T     ++V  YM NGS+ + LR                +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGMLRGVGAGMRYLSDL 170

Query: 416 CDPKIIHRDVKAANILLDED 435
                +HRD+ A N+L+D +
Sbjct: 171 ---GYVHRDLAARNVLVDSN 187

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  104 bits (262), Expect = 3e-25
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 301 NILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 356 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (259), Expect = 4e-25
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 15/149 (10%)

Query: 300 KNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
              LG+G F K++KG               V +K L +   +  E  F     ++S   H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSH 71

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           ++L+  YG C    E +LV  ++  GS+ + L++ ++ +       + ++A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI---LWKLEVAKQLAAAMHF 128

Query: 412 LHEHCDPKIIHRDVKAANILLDEDADQSS 440
           L E+    +IH +V A NILL  + D+ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKT 154

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  103 bits (258), Expect = 5e-25
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)

Query: 300 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
           G CT      ++  +MT G++   LRE       +       +A   +  + YL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 419 KIIHRDVKAANILLDED 435
             IHRD+ A N L+ E+
Sbjct: 131 NFIHRDLAARNCLVGEN 147

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (257), Expect = 6e-25
 Identities = 37/143 (25%), Positives = 60/143 (41%), Gaps = 8/143 (5%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIIS-MAVHRN 353
           F     +G G FG V+K     DG + A+KR K     S  E     EV   + +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 354 LLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++R +       + +L+   Y   GS+A  + E    +        K + L   RGL Y+
Sbjct: 73  VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H      ++H D+K +NI +   
Sbjct: 132 HSM---SLVHMDIKPSNIFISRT 151

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (257), Expect = 6e-25
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 360 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 82  VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 133

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
             +     +HRD+ A N+L+ ED
Sbjct: 134 EGN---NFVHRDLAARNVLVSED 153

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  103 bits (259), Expect = 7e-25
 Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 14/143 (9%)

Query: 300 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
            + LG+G FG V   R        G LVAVK+L+       +  FQ E++I+       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 355 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           ++  G       +   LV  Y+ +G +   L+  ++ L           +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEYL 143

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
                 + +HRD+ A NIL++ +
Sbjct: 144 GSR---RCVHRDLAARNILVESE 163

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (256), Expect = 9e-25
 Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 22/143 (15%)

Query: 302 ILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
            LG G FG V KG     K+   VAVK LK E            E  ++    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 358 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
            G C       V E          G +   L++ +     +      ++    + G+ YL
Sbjct: 84  IGICEAESWMLVME------MAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 133

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
            E      +HRD+ A N+LL   
Sbjct: 134 EES---NFVHRDLAARNVLLVTQ 153

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  103 bits (258), Expect = 9e-25
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 300 KNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           + ++G G FG+VYKG L          VA+K LK   T    + F  E  I+    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           +RL G  +     +++  YM NG++   LRE+              +  G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV---LQLVGMLRGIAAGMKYLAN 165

Query: 415 HCDPKIIHRDVKAANILLDED 435
                 +HRD+ A NIL++ +
Sbjct: 166 M---NYVHRDLAARNILVNSN 183

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (265), Expect = 1e-24
 Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 249 VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 308
           V V     +      E  + +P+  D E+Q  +++                   +G G F
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL---------------GRCIGEGQF 403

Query: 309 GKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT- 363
           G V++G     +     VA+K  K   +     +F  E   +    H ++++L G  T  
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 364 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
               + E        T G + S L+ R+ SL      +    A   +  L+YL      +
Sbjct: 464 PVWIIME------LCTLGELRSFLQVRKFSLDL---ASLILYAYQLSTALAYLESK---R 511

Query: 420 IIHRDVKAANILLDED 435
            +HRD+ A N+L+  +
Sbjct: 512 FVHRDIAARNVLVSSN 527

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (256), Expect = 1e-24
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              LG   FGKVYKG L           VA+K LK++       +F+ E  + +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 401
           ++ L G  T      +++ Y ++G +   L  R            ++    L+ P    +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               A G+ YL  H    ++H+D+   N+L+ + 
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 164

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (258), Expect = 2e-24
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
             ++G G FG+V  GRL         VA+K LK   T      F  E  I+    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           RL G  T     ++V  YM NGS+ S LR+  +            +  G A G+ YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---IQLVGMLRGIASGMKYLSDM 166

Query: 416 CDPKIIHRDVKAANILLDED 435
                +HRD+ A NIL++ +
Sbjct: 167 ---GYVHRDLAARNILINSN 183

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 2e-24
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 361 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 248 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 299

Query: 416 CDPKIIHRDVKAANILLDED 435
                +HRD++AANIL+ E+
Sbjct: 300 ---NYVHRDLRAANILVGEN 316

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (254), Expect = 2e-24
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 22/154 (14%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+     +        LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 401
           +++ YG C      ++V+ YM +G +   LR              + +   L       I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   A G+ YL        +HRD+   N L+  +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 169

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (254), Expect = 3e-24
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 300 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLL 355
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++     H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK------------KIAL 403
            L G C       L   Y  +G++   LR+ +       +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (254), Expect = 3e-24
 Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 20/153 (13%)

Query: 300 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 352
              LG G FGKV +              VAVK LK    +  +    +E+KI+S    H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIA 402
           N++ L G CT     L++  Y   G + + LR +   L                     +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              A+G+++L        IHRDV A N+LL   
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (259), Expect = 3e-24
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 360 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 254 VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 305

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
             +     +HRD+ A N+L+ ED
Sbjct: 306 EGN---NFVHRDLAARNVLVSED 325

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 4e-24
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 10/149 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +  + ++G G    V         + VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 354 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIAL---GSARG 408
           ++  Y     V ++L LV   ++ GSV   ++   +             IA        G
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L YLH++     IHRDVKA NILL ED  
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGS 159

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (257), Expect = 5e-24
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 18/140 (12%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
             LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 361 CTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            T      +TE      +M  GS+   L+  + S  PL  P     +   A G++++ + 
Sbjct: 252 VTKEPIYIITE------FMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303

Query: 416 CDPKIIHRDVKAANILLDED 435
                IHRD++AANIL+   
Sbjct: 304 ---NYIHRDLRAANILVSAS 320

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  103 bits (260), Expect = 6e-24
 Identities = 32/122 (26%), Positives = 49/122 (40%), Gaps = 2/122 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++T ++L +  L    A    +   L  L++  N +S   P     L  LK L+L  N  
Sbjct: 26  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
           +     T A    L  L L +NS+  +         +L  LDLS+N LS      G+  Q
Sbjct: 86  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL--GTQVQ 143

Query: 188 FT 189
             
Sbjct: 144 LE 145

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 2/117 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++T + L + ++         + KNL  L+L  N LS         L  L+ L L +N  
Sbjct: 98  NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157

Query: 128 NGTIPDTLANLK--QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
                + L       LK L L++N +    P     I  L  L L+N +L   + + 
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 32/119 (26%), Positives = 48/119 (40%), Gaps = 4/119 (3%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
           +L +  LS           NL  L L  N++     +       L +LDL  N  + T  
Sbjct: 79  NLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL 138

Query: 133 DTLANLKQLKYLRLNNNSLSGLIPTSLTTI--TSLNILDLSNNRLSGPVPDNGSFSQFT 189
            T   L+ L+ L L+NN +  L    L     +SL  L+LS+N++    P  G F    
Sbjct: 139 GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP--GCFHAIG 195

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.1 bits (237), Expect = 5e-21
 Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 16/148 (10%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
             +L++ D+ P            P  ++T +DL N  ++      L  L+ LE+L+L  N
Sbjct: 463 RVALKNVDSSPSPFQ--------PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514

Query: 102 NLS--------GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG 153
           NL+        G     L  L  L  L+L SN F+    +   +L +LK + L  N+L+ 
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574

Query: 154 LIPTSLTTITSLNILDLSNNRLSGPVPD 181
           L  +      SL  L+L  N ++     
Sbjct: 575 LPASVFNNQVSLKSLNLQKNLITSVEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 94.3 bits (235), Expect = 8e-21
 Identities = 33/137 (24%), Positives = 52/137 (37%), Gaps = 6/137 (4%)

Query: 68  SVTRVDLGNAALSGELAPELG---QLKNLELLELYGNNLSGHIPSALGNL--IKLKSLDL 122
            +  + L N  L   L  +L       ++  L L  + LS    +    L    L  LDL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 123 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
             N  N    D+ A L QL+Y  L  N++  L   SL  + ++  L+L  +     +   
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 183 GSFSQFTPISFENNLNL 199
            S  +    SF+    L
Sbjct: 316 -SLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 9e-21
 Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 9/134 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++T +DL    L+         L  LE   L  NN+      +L  L  ++ L+L  +  
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 128 NGTI---------PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP 178
             +I           +   LK L++L + +N + G+     T + +L  L LSN+  S  
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368

Query: 179 VPDNGSFSQFTPIS 192
              N +F       
Sbjct: 369 TLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 5/130 (3%)

Query: 73  DLGNAALSGELAP-ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-- 129
           DLG   +  EL   E   L+N+  + L  N       ++   +  L+ L L         
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVD 470

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           + P     L+ L  L L+NN+++ +    L  +  L ILDL +N L+       +     
Sbjct: 471 SSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA--RLWKHANPGGP 528

Query: 190 PISFENNLNL 199
               +   +L
Sbjct: 529 IYFLKGLSHL 538

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 5/127 (3%)

Query: 67  GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
            S T+  +  A+L          LK LE L +  N++ G   +    LI LK L L ++ 
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 127 FNGT--IPDTLANLKQ--LKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
            +      +T  +L    L  L L  N +S +   + + +  L +LDL  N +   +   
Sbjct: 365 TSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-G 423

Query: 183 GSFSQFT 189
             +    
Sbjct: 424 QEWRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 23/101 (22%), Positives = 32/101 (31%), Gaps = 1/101 (0%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNN 148
              L +L L  N +S     A   L  L+ LDL  N     +       L+ +  + L+ 
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           N    L   S   + SL  L L    L         F    
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 9/129 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKN--LELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
           ++  + L N  +    + EL    N  L+ LEL  N +    P     + +L  L L + 
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 126 LFNGTIPDTLA---NLKQLKYLRLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGPVP 180
               ++ + L        ++ L L+N+ LS    T+      T+L +LDLS N L+    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 181 DNGSFSQFT 189
           D  SF+   
Sbjct: 266 D--SFAWLP 272

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 28/124 (22%), Positives = 47/124 (37%), Gaps = 10/124 (8%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG--HIPSALGNLIKLKSLDLYSN 125
           ++  + L               + +L+ L L    L      PS    L  L  LDL +N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLS--------GLIPTSLTTITSLNILDLSNNRLSG 177
                  D L  L++L+ L L +N+L+        G     L  ++ L+IL+L +N    
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

Query: 178 PVPD 181
              +
Sbjct: 551 IPVE 554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 3/90 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
           + E+ +     L+  +P  L     +  L+L  N              QL  L +  N++
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
           S L P     +  L +L+L +N LS     
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDK 91

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 20/111 (18%), Positives = 40/111 (36%), Gaps = 4/111 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            +  ++L +             L  L++++L  NNL+    S   N + LKSL+L  NL 
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596

Query: 128 NGTIPDTLA-NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
                       + L  L +  N       +       +N ++ ++  +  
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA---WFVNWINETHTNIPE 644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (251), Expect = 6e-24
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           + YG       KL ++  Y+  GS    L        PLD      I     +GL YLH 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS 137

Query: 415 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
               K IHRD+KAAN+LL E  +          Q + T ++R
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (251), Expect = 8e-24
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 23/156 (14%)

Query: 300 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 352
              LGRG FG+V +            + VAVK LKE  T        +E+KI+     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 353 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRK------------ 399
           N++ L G CT     L+V   +   G++++ LR +++   P                   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  103 bits (258), Expect = 9e-24
 Identities = 31/160 (19%), Positives = 62/160 (38%), Gaps = 8/160 (5%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDL-GNAALSGELAPELGQLKNLELLELYG 100
            N   S + L  +              +  + +  N   +  +   L ++K L +LE   
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGE--KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT-SL 159
           N L G +P+  G+ IKL SL+L  N       +     +Q++ L   +N L  +      
Sbjct: 340 NQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398

Query: 160 TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
            +++ ++ +D S N +     D  +F      +    +N+
Sbjct: 399 KSVSVMSAIDFSYNEIGS--VDGKNFDPL-DPTPFKGINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (256), Expect = 2e-23
 Identities = 27/144 (18%), Positives = 46/144 (31%), Gaps = 13/144 (9%)

Query: 40  DPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELY 99
           + N  L  W   PG       ++ N  G VT + L     SG +   +GQL  LE+L L 
Sbjct: 61  NFNKELDMWGAQPG-------VSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113

Query: 100 GNNLSG----HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLK--QLKYLRLNNNSLSG 153
            +          P  +   +  +        +  T  D         L    +N++    
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

Query: 154 LIPTSLTTITSLNILDLSNNRLSG 177
            I  S         +   +N ++ 
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF 197

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (252), Expect = 5e-23
 Identities = 22/126 (17%), Positives = 50/126 (39%), Gaps = 9/126 (7%)

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
           N   +    +   A        +   LK+L  +E+Y       +P+ L  L +++ +++ 
Sbjct: 222 NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 124 SNLF--------NGTIPDTLANLKQLKYLRLNNNSLSGL-IPTSLTTITSLNILDLSNNR 174
            N          +          ++++ + +  N+L    + TSL  +  L +L+   N+
Sbjct: 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341

Query: 175 LSGPVP 180
           L G +P
Sbjct: 342 LEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 97.4 bits (243), Expect = 7e-22
 Identities = 27/131 (20%), Positives = 41/131 (31%), Gaps = 8/131 (6%)

Query: 81  GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-------TIPD 133
             L P   +  N+  + L  N +S            L S++L  N+             +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 134 TLANLKQLKYLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
              N   L  + L  N L+ L      TT+  L  +DLS N  S       + S      
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542

Query: 193 FENNLNLCGPN 203
             N  +  G  
Sbjct: 543 IRNQRDAQGNR 553

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 15/118 (12%), Positives = 39/118 (33%), Gaps = 15/118 (12%)

Query: 86  ELGQLKNLELLELYGNNLSG-------HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
           +   +  +  ++   N +          +       I + S++L +N  +    +  +  
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456

Query: 139 KQLKYLRLNNNSLSGL-------IPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
             L  + L  N L+ +          +      L  +DL  N+L+  + D+   +   
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 18/149 (12%), Positives = 44/149 (29%), Gaps = 20/149 (13%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            + +  + +      +            +    NN++  +  A+  L KL+   + ++ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 128 NG-------------------TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL 168
                                T      NLK L  + + N      +PT L  +  + ++
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278

Query: 169 DLSNNRLSGPVPDNGSFSQFTPISFENNL 197
           +++ NR          +           +
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEKI 307

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 24/166 (14%), Positives = 51/166 (30%), Gaps = 8/166 (4%)

Query: 22  ISANAEVDALYIFKSKLQDPNNSLQS-WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALS 80
           ++ +A V       ++      +L+  WD L G   +         G+    +       
Sbjct: 12  LTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGT-QPGANWNFNKELDMWG 70

Query: 81  GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG----TIPDTLA 136
            +    L     +  L L G   SG +P A+G L +L+ L L S+          P  ++
Sbjct: 71  AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130

Query: 137 NLKQLKYLRLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGPVP 180
                +  +                   + L    ++++     + 
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 16/102 (15%), Positives = 35/102 (34%), Gaps = 10/102 (9%)

Query: 86  ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL------FNGTIPDTLANLK 139
               L  L  ++L  N+ S   P+   N   LK   + +             P+ +    
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566

Query: 140 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
            L  L++ +N +  +         ++++LD+ +N        
Sbjct: 567 SLTQLQIGSNDIRKVNEKIT---PNISVLDIKDNPNISIDLS 605

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (250), Expect = 9e-24
 Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 17/157 (10%)

Query: 288 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL----KEERTSGGELQFQTE 342
             + +    +     LG GGF  V     L DG   A+KR+    +++R      + Q E
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76

Query: 343 VKIISMAVHRNLLRLYGFC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 398
             +  +  H N+LRL  +C        E  L+ P+   G++ + +   +     L     
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             + LG  RGL  +H        HRD+K  NILL ++
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDE 170

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (250), Expect = 1e-23
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 350
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 398
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  102 bits (255), Expect = 1e-23
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 361 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 331 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 382

Query: 416 CDPKIIHRDVKAANILLDED 435
                +HRD++AANIL+ E+
Sbjct: 383 ---NYVHRDLRAANILVGEN 399

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           K  LG G FGKV+     +        LVAVK LKE  +      FQ E ++++M  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------QSSLPPLDWPTRKKIA 402
           ++R +G CT     L+V+ YM +G +   LR               +  PL       +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              A G+ YL        +HRD+   N L+ + 
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 354
           +     LG G FGKVYK +    G L A K ++ +  S  EL+ +  E++I++   H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78

Query: 355 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 410
           ++L G       KL ++  +   G+V + + E    L      T  +I +        L+
Sbjct: 79  VKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL------TEPQIQVVCRQMLEALN 131

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
           +LH     +IIHRD+KA N+L+  + D          ++ KT+ +R
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 2e-23
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 350
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 398
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 29/162 (17%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              LG G FGKV K      K       VAVK LKE  +        +E  ++    H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------------QSSLPPLDWP 396
           +++LYG C+     LL+  Y   GS+   LRE                      P     
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 397 TRK---KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           T       A   ++G+ YL E    K++HRD+ A NIL+ E 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEG 186

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =   99 bits (249), Expect = 3e-23
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 11/149 (7%)

Query: 294 TDGFSNKNILGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMA 349
              +    ++G+G      V   R    G+ V V+R+  E  S   + F Q E+ +  + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 350 VHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
            H N++           +L +V  +M  GS    +         ++      I  G  + 
Sbjct: 84  NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKA 140

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           L Y+H       +HR VKA++IL+  D  
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGK 166

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (252), Expect = 3e-23
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 301 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           + LG G +G+VY+G        VAVK LKE+       +F  E  ++    H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
            CT      ++  +MT G++   LRE       +       +A   +  + YL +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 420 IIHRDVKAANILLDED 435
            IHR++ A N L+ E+
Sbjct: 339 FIHRNLAARNCLVGEN 354

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
              +G G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER--------------------QSSLPPL 393
           +++L G C       L++ YM  G +   LR                          PPL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 394 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.3 bits (245), Expect = 6e-23
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 14/180 (7%)

Query: 257 WRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR- 315
           W              ED+  + L +  +    E +      +++  +GRG FG+V++ + 
Sbjct: 20  WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79

Query: 316 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 375
              G   AVK+++ E           E+   +      ++ LYG         +    + 
Sbjct: 80  KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            GS+   +++       L           +  GL YLH     +I+H DVKA N+LL  D
Sbjct: 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 350
              LG G FG+V                  VAVK LK + T        +E++++ M   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------- 399
           H+N++ L G CT      ++  Y + G++   L+ R+       +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 400 -KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 29/162 (17%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 352
             +LG G FGKV                VAVK LKE+  S       +E+K+++    H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS------- 405
           N++ L G CT      L++ Y   G + + LR ++      +     +  L         
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 406 ------------ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                       A+G+ +L        +HRD+ A N+L+   
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 208

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 24/157 (15%)

Query: 300 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 352
              LG G FGKV +              VAVK LK            +E+K++S    H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK----------- 400
           N++ L G CT     L++  Y   G + + LR  R S +     P   +           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 401 --IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              +   A+G+++L        IHRD+ A NILL   
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 25/122 (20%), Positives = 43/122 (35%), Gaps = 1/122 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S   +DL    L    +        L+ L+L    +      A   L  L +L L  N  
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
               P + + L  L+ L      L+ L    +  + +L  L++++N +         FS 
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

Query: 188 FT 189
            T
Sbjct: 152 LT 153

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 21/102 (20%), Positives = 34/102 (33%)

Query: 75  GNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT 134
           GN+     L+       NL  L+L    L          L +L+ L++  N         
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

Query: 135 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              L  L  L  + N +            SL   +L+NN ++
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 6/124 (4%)

Query: 82  ELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-TIPDTLANLK 139
             +P     L +LE L      L+      +G LI LK L++  N  +   +P   +NL 
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 140 QLKYLRLNNNSLSGLIPTSLTTITSLNI----LDLSNNRLSGPVPDNGSFSQFTPISFEN 195
            L ++ L+ N +  +    L  +         LD+S N +           +   ++   
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213

Query: 196 NLNL 199
           N N 
Sbjct: 214 NFNS 217

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 26/118 (22%), Positives = 46/118 (38%), Gaps = 4/118 (3%)

Query: 68  SVTRVDLGNAALS--GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
           S++ +DL   ALS  G  +       +L  L+L  N     + +    L +L+ LD   +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409

Query: 126 LFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
                       +L++L YL ++  +           +TSLN L ++ N        N
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 25/120 (20%), Positives = 46/120 (38%), Gaps = 6/120 (5%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG-HIPSALGNLIKLKSLDLYSNL 126
           S+  +      L+   +  +GQL  L+ L +  N +    +P+   NL  L  +DL  N 
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164

Query: 127 FNGTIPDTLANLKQLK----YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
                 + L  L++       L ++ N +  +   +   I  L+ L L  N  S  +   
Sbjct: 165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 23/139 (16%), Positives = 48/139 (34%), Gaps = 11/139 (7%)

Query: 68  SVTRVDLGNAALSG-ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLK----SLDL 122
           ++ ++++ +  +   +L      L NL  ++L  N +     + L  L +      SLD+
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 123 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP-TSLTTITSLNILDLSNNRLSG---- 177
             N  +         +K L  L L  N  S  I  T L  +  L++  L           
Sbjct: 189 SLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247

Query: 178 PVPDNGSFSQFTPISFENN 196
            + +         ++ +  
Sbjct: 248 EIFEPSIMEGLCDVTIDEF 266

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 22/80 (27%), Positives = 29/80 (36%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
           DL    L          L  L+LL +  NNL     S    L  L +LD   N    +  
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

Query: 133 DTLANLKQLKYLRLNNNSLS 152
                 K L +  L NNS++
Sbjct: 539 ILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 22/136 (16%), Positives = 36/136 (26%), Gaps = 18/136 (13%)

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTI------PDT 134
            +  +  Q   L  L L GN  S +I    L NL  L    L    F          P  
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 135 LANLKQLKY--LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS------ 186
           +  L  +     RL   +           + +++ + L+   +         F       
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314

Query: 187 ---QFTPISFENNLNL 199
              Q       +   L
Sbjct: 315 IRCQLKQFPTLDLPFL 330

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 28/96 (29%), Positives = 39/96 (40%), Gaps = 7/96 (7%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
            ++ +    + L +    L    P+   +L  LKSL L  N   G+I      L  L YL
Sbjct: 301 EDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMN--KGSISFKKVALPSLSYL 355

Query: 145 RLNNNSLSGLIPTSLT--TITSLNILDLSNNRLSGP 178
            L+ N+LS     S +     SL  LDLS N     
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM 391

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 30/148 (20%), Positives = 50/148 (33%), Gaps = 9/148 (6%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
               +   NL     +     C+   ++    L       +   +   L N+  + L G 
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDV--TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
           ++  ++   +    K +SL +         P    +L  LK L L  N  S  I      
Sbjct: 296 SIK-YLED-VPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVA 348

Query: 162 ITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           + SL+ LDLS N LS     + S     
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTN 376

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 15/106 (14%), Positives = 39/106 (36%), Gaps = 1/106 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            +  +++ +  L    +    QL +L  L+   N +             L   +L +N  
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
              I +    L+ +K  +    ++  +   +   + +  +LD +N+
Sbjct: 558 A-CICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 43/199 (21%)

Query: 275 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 333
           S+     L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +      
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--- 60

Query: 334 GGELQ-FQTEVKIIS-MAVHRNLLRLYG-----FCTTVTEKL-LVYPYMTNGSVA----- 380
           G E +  + E+ ++   + HRN+   YG         + ++L LV  +   GSV      
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 381 ---SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
              + L+E   +           I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 121 TKGNTLKEEWIAY----------ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

Query: 438 ----------QSSKTILRR 446
                     Q  +T+ RR
Sbjct: 168 VKLVDFGVSAQLDRTVGRR 186

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.3 bits (238), Expect = 2e-22
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRL-KEE-RTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           LG+G F  VY+   +  G  VA+K + K+    +G   + Q EVKI     H ++L LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 418
           +        LV     NG +   L+ R       +   R  +  +    G+ YLH H   
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQI--ITGMLYLHSH--- 131

Query: 419 KIIHRDVKAANILLDED 435
            I+HRD+  +N+LL  +
Sbjct: 132 GILHRDLTLSNLLLTRN 148

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 24/156 (15%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F    +LG+G FG+V K R   D +  A+K+++   T        +EV +++   H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 356 RLYGF------------CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD-WPTRKKI 401
           R Y                     L +   Y  NG++   +     +    + W   ++I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
                  LSY+H      IIHRD+K  NI +DE  +
Sbjct: 126 LEA----LSYIHSQ---GIIHRDLKPMNIFIDESRN 154

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 33/156 (21%), Positives = 66/156 (42%), Gaps = 11/156 (7%)

Query: 283 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT 341
           +    + + V    +S    +G GG  KV++      ++ A+K +  E      L  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 342 EVKIISMAVHRNL--LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
           E+  ++     +   +RLY +  T     +V     N  + S L++++S    +D   RK
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERK 130

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                    +  +H+H    I+H D+K AN L+ + 
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 163

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 30/144 (20%), Positives = 61/144 (42%), Gaps = 6/144 (4%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQF-QTEVKIISMAVH 351
             F  +  +GRG F +VY+   L DG  VA+K+++  +            E+ ++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N+++ Y       E  +V      G ++  ++  +     +   T  K  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           +H     +++HRD+K AN+ +   
Sbjct: 152 MHSR---RVMHRDIKPANVFITAT 172

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 15/140 (10%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 357
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 358 YGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           Y +  T      +Y  M   N  + S L++++S    +D   RK         +  +H+H
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127

Query: 416 CDPKIIHRDVKAANILLDED 435
               I+H D+K AN L+ + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG 144

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 97.3 bits (242), Expect = 9e-22
 Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 10/125 (8%)

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
           N        +   A            LK+L  +ELY       +P  L +L +L+SL++ 
Sbjct: 464 NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523

Query: 124 SNLFNG---------TIPDTLANLKQLKYLRLNNNSLSGL-IPTSLTTITSLNILDLSNN 173
            N              + D      +++   +  N+L       SL  +  L +LD  +N
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583

Query: 174 RLSGP 178
           ++   
Sbjct: 584 KVRHL 588

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 29/166 (17%), Positives = 55/166 (33%), Gaps = 17/166 (10%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPEL--GQLKNLELLELY 99
           NN + S   +P N              +T +DL    L+  L+ +     L  L  +++ 
Sbjct: 706 NNLMTS---IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVS 761

Query: 100 GNNLSGHIPSALGNLIKLKSLDLYSNL------FNGTIPDTLANLKQLKYLRLNNNSLSG 153
            N  S   P+   N  +LK+  +               P  +     L  L++ +N +  
Sbjct: 762 YNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820

Query: 154 LIPTSLTTITSLNILDLSNNRL-SGPVPDNGSFSQFTPISFENNLN 198
           +          L ILD+++N   S  V     + +        +  
Sbjct: 821 VDEKLT---PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 88.4 bits (219), Expect = 8e-19
 Identities = 14/115 (12%), Positives = 38/115 (33%), Gaps = 6/115 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             + +L  L+++    +  +    +     +  +  +            + +NLK L  +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDV 496

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
            L N      +P  L  +  L  L+++ NR          +++      +    +
Sbjct: 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL-ADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 85.7 bits (212), Expect = 6e-18
 Identities = 20/110 (18%), Positives = 41/110 (37%), Gaps = 4/110 (3%)

Query: 81  GELAPELGQLKNLELLELYGNNLSG-HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLK 139
             LA +      +++  +  NNL      ++L  ++KL  LD   N       +      
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNV 595

Query: 140 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           +L  L+L+ N +  +          +  L  S+N+L   +P+  +     
Sbjct: 596 KLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVY 644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 33/192 (17%), Positives = 57/192 (29%), Gaps = 24/192 (12%)

Query: 12  STIVLVALPMISANA-EVDALYIFKSKLQDPNNSLQSWDNLP-GNLCTW-FHITCNPEGS 68
              V + L   +    +  AL      L   N    S       +   W F+   +  G 
Sbjct: 254 DANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGD 313

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
              VDL N                +  L L G    G +P A+G L +LK L   ++   
Sbjct: 314 QPGVDLDN-------------NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLI-PTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
            +                  + +        L     LN+ DL  + ++          +
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-------RNPE 413

Query: 188 FTPISFENNLNL 199
             PI  ++ ++L
Sbjct: 414 MKPIKKDSRISL 425

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 23/138 (16%), Positives = 49/138 (35%), Gaps = 13/138 (9%)

Query: 70  TRVDLGNAALSGELAPELGQ-LKNLELLELYGNNLSGHIPSA--LGNLIKLKSLDLYSNL 126
           T + L    +  E+  +       +E L    N L   IP+     ++  + S+D   N 
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNK 655

Query: 127 FNGTIPDTLA-----NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
                 +               + L+ N +         T + ++ + LSNN ++  +P+
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPE 714

Query: 182 NGSFSQFTPISFENNLNL 199
           N    +    +++N   L
Sbjct: 715 NSLKPK--DGNYKNTYLL 730

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 79.5 bits (196), Expect = 6e-16
 Identities = 24/164 (14%), Positives = 47/164 (28%), Gaps = 26/164 (15%)

Query: 42  NNSLQS-WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYG 100
            N + S   N+  ++  +  I      + + V L    +             +  + L  
Sbjct: 653 YNKIGSEGRNISCSMDDYKGI------NASTVTLSYNEIQKFPTELFATGSPISTIILSN 706

Query: 101 NNLS-------GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLA--NLKQLKYLRLNNNSL 151
           N ++               N   L ++DL  N    ++ D      L  L  + ++ N  
Sbjct: 707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765

Query: 152 SGLIPTSLTTITSLNILDL------SNNRLSGPVPDNGSFSQFT 189
           S   PT     + L    +        NR+    P     +   
Sbjct: 766 SS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT--GITTCP 806

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 17/154 (11%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
             F     LGRGGFG V++ +   D    A+KR++         +   EVK ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 354 LLRLYGF---------CTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKI 401
           ++R +               + K+ +Y         ++   +  R +     +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            L  A  + +LH      ++HRD+K +NI    D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 349
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 350 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 44/187 (23%), Positives = 65/187 (34%), Gaps = 18/187 (9%)

Query: 254 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYK 313
           F    + +P    F   A +  +       R      Q     F   + LG G +G+V+K
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFK 75

Query: 314 GR-LADGKLVAVKRL-KEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLV 370
            R   DG+L AVKR     R      +   EV     +  H   +RL        E  ++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ---AWEEGGIL 132

Query: 371 YPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 428
           Y        S+        +SLP             +   L++LH      ++H DVK A
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPE---AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 429 NILLDED 435
           NI L   
Sbjct: 187 NIFLGPR 193

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 6/166 (3%)

Query: 275 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 333
           S    G+LK    +      +   +   +GRG +G V K      G+++AVKR++     
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 334 GGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP- 391
             + Q   ++ ++   +    +++ YG      +  +    M + S     +   S L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 392 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
            +      KI L + + L++L E  + KIIHRD+K +NILLD   +
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGN 164

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 357
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           Y +  T  + + +     N  + S L++++S    +D   RK         +  +H+H  
Sbjct: 122 YDYEIT-DQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 418 PKIIHRDVKAANILLDE 434
             I+H D+K AN L+ +
Sbjct: 175 -GIVHSDLKPANFLIVD 190

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 32/199 (16%)

Query: 260 TRPHEFFFDVPAEDDSELQ-----------LGQLKRFSLRELQVATD---GFSNKNILGR 305
              H   +D+P  ++   Q            G LK   + EL    D    FS+   +G 
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64

Query: 306 GGFGKVYKGR-LADGKLVAVKR--LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 362
           G FG VY  R + + ++VA+K+     ++++        EV+ +    H N ++  G C 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CY 123

Query: 363 TVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 418
                  LV  Y   GS +  L   +  L         +IA    G+ +GL+YLH H   
Sbjct: 124 LREHTAWLVMEYC-LGSASDLLEVHKKPL------QEVEIAAVTHGALQGLAYLHSH--- 173

Query: 419 KIIHRDVKAANILLDEDAD 437
            +IHRDVKA NILL E   
Sbjct: 174 NMIHRDVKAGNILLSEPGL 192

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 23/122 (18%), Positives = 39/122 (31%), Gaps = 2/122 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S   ++     L         +L NL  L+L    +         +  +L +L L +N  
Sbjct: 34  STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
                  L+  K LK+L      +S +    L    +L  L L +N +S           
Sbjct: 94  IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS--IKLPKGFP 151

Query: 188 FT 189
             
Sbjct: 152 TE 153

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 30/123 (24%), Positives = 50/123 (40%), Gaps = 2/123 (1%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           SV  ++L         +        L+ L+L   +LS  +PS L  L  LK L L +N F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFS 186
                 + +N   L +L +  N+    + T  L  + +L  LDLS++ +      N    
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373

Query: 187 QFT 189
             +
Sbjct: 374 NLS 376

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 26/108 (24%), Positives = 37/108 (34%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
           T +DL    +             L+ L L  N L     +AL     LK L       + 
Sbjct: 60  TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
                L N K L+ L L +N +S +          L +LD  NN +  
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.1 bits (219), Expect = 8e-19
 Identities = 27/125 (21%), Positives = 42/125 (33%), Gaps = 4/125 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNL 126
           ++ ++ L                 +L  L + GN     + +  L NL  L+ LDL  + 
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 127 FN--GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 184
                     L NL  L+ L L+ N    L   +      L +LDL+  RL         
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSP 420

Query: 185 FSQFT 189
           F    
Sbjct: 421 FQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 2/129 (1%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
            L    L       L   K L+ L      +S      L N   L+SL L SN  +    
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146

Query: 133 DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI--LDLSNNRLSGPVPDNGSFSQFTP 190
                 ++LK L   NN++  L    ++++       L+L+ N ++G  P     + F  
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS 206

Query: 191 ISFENNLNL 199
           ++F    NL
Sbjct: 207 LNFGGTQNL 215

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 24/117 (20%), Positives = 52/117 (44%), Gaps = 4/117 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHI---PSALGNLIKLKSLDLYS 124
            +  ++L ++ L          L  L+ L L GN+         ++L  L +L+ L L  
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
              +        +LK + ++ L++N L+     +L+ +  +  L+L++N +S  +P 
Sbjct: 486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 1/99 (1%)

Query: 79  LSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
            + +    L  L  LE+L L   +LS     A  +L  +  +DL  N    +  + L++L
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
           K + YL L +N +S ++P+ L  ++    ++L  N L  
Sbjct: 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 30/114 (26%), Positives = 42/114 (36%), Gaps = 4/114 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIP-SALGNLIKLKSLDLYSNL 126
            +  ++L              +   LELL+L    L      S   NL  LK L+L  +L
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLI---PTSLTTITSLNILDLSNNRLSG 177
            + +       L  L++L L  N           SL T+  L IL LS   LS 
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 3/134 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++  +      +S      L   K LE L L  N++S           KLK LD  +N  
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI 165

Query: 128 NGTIPDTLANLKQLK--YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
           +    + +++L+Q     L LN N ++G I            L+    +    +      
Sbjct: 166 HYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224

Query: 186 SQFTPISFENNLNL 199
           S    +      ++
Sbjct: 225 STIQSLWLGTFEDM 238

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 23/135 (17%), Positives = 48/135 (35%), Gaps = 6/135 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLY-SNL 126
           ++  + LG+  +S    P+    + L++L+   N +       + +L +  +L L  +  
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL--TTITSLNILDLSNNRLSGPVPDNGS 184
               I     +    + L         +I   L  +TI SL +    +            
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED--ISPAV 247

Query: 185 FSQFTPISFENNLNL 199
           F     +S E ++NL
Sbjct: 248 FEGLCEMSVE-SINL 261

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 27/156 (17%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           F    ++G GGFG+V+K +   DGK   +KR+K         + + EVK ++   H N++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67

Query: 356 RLYGF-------------CTTVTEKLLVYPYM---TNGSVASRLRERQSSLPPLDWPTRK 399
              G               ++ ++   ++  M     G++   + +R+     LD     
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLAL 125

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           ++     +G+ Y+H     K+I+RD+K +NI L + 
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 32/139 (23%), Positives = 56/139 (40%), Gaps = 16/139 (11%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG+GGF K ++       ++ A K      L +        +   E+ I     H++++ 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
            +GF        +V       S+    + R+     L  P  +        G  YLH + 
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN- 134

Query: 417 DPKIIHRDVKAANILLDED 435
             ++IHRD+K  N+ L+ED
Sbjct: 135 --RVIHRDLKLGNLFLNED 151

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 349
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 350 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 9e-21
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 10/136 (7%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 359
           LG+G FG VY  R      ++A+K L + +   +G E Q + EV+I S   H N+LRLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
           +    T   L+  Y   G+V   L++        D           A  LSY H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---R 129

Query: 420 IIHRDVKAANILLDED 435
           +IHRD+K  N+LL   
Sbjct: 130 VIHRDIKPENLLLGSA 145

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 352
           + +     +G G FGK    +   DG+   +K +   R S  E +  + EV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARG 408
           N+++            +V  Y   G +  R+  ++  L      LDW    +I L     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           L ++H+    KI+HRD+K+ NI L +D
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKD 161

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 22/162 (13%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           ++    +G+G  G VY    +A G+ VA++++  ++    EL    E+ ++    + N++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
                   V ++L +V  Y+  GS+   + E       +D      +     + L +LH 
Sbjct: 81  NYLD-SYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS 134

Query: 415 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
           +   ++IHRD+K+ NILL  D            Q +    +R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 32/139 (23%), Positives = 56/139 (40%), Gaps = 16/139 (11%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           LG+GGF K ++       ++ A K      L +        +   E+ I     H++++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
            +GF        +V       S+    + R+     L  P  +        G  YLH + 
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN- 160

Query: 417 DPKIIHRDVKAANILLDED 435
             ++IHRD+K  N+ L+ED
Sbjct: 161 --RVIHRDLKLGNLFLNED 177

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 32/167 (19%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
             +   +G G  G V   R    G+ VAVK +   +    EL    EV I+    H N++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVV 105

Query: 356 RLYGFCTTVTEKL-LVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGL 409
            +Y     V E+L ++  ++  G++       RL E Q +           +     + L
Sbjct: 106 EMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----------VCEAVLQAL 154

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
           +YLH      +IHRD+K+ +ILL  D            Q SK + +R
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 30/166 (18%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNL 354
           F     LG G +G VYK      G++VA+K++  E        +   E+ I+      ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDSPHV 86

Query: 355 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 410
           ++ YG        L +V  Y   GSV+  +R R  +L      T  +IA     + +GL 
Sbjct: 87  VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL------TEDEIATILQSTLKGLE 139

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 446
           YLH     + IHRD+KA NILL+ +            Q + T+ +R
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 6/147 (4%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 352
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 353 NLLRLYG-FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           N++R Y          L +V  Y   G +AS + +       LD     ++       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 411 YLHEHCDP--KIIHRDVKAANILLDED 435
             H   D    ++HRD+K AN+ LD  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK 152

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 290 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-S 347
           ++V  D       LGRG +G V K R +  G+++AVKR++    S  + +   ++ I   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
                  +  YG      +  +    M + S+    ++       +      KIA+   +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
            L +LH      +IHRDVK +N+L++    
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQ 148

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 12/149 (8%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
           F  K++LG G  G +    + D + VAVKR+  E  S        EV++      H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVI 81

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           R +        + +        ++   + ++  +   L+      +   +  GL++LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137

Query: 416 CDPKIIHRDVKAANILLDEDADQSSKTIL 444
               I+HRD+K  NIL+           +
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAM 163

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 12/137 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 359
           LG+G FG VY  R   +  ++A+K L + +    G E Q + E++I S   H N+LR+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 418
           +        L+  +   G +   L+ +       +  +   +  L  A  L Y HE    
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFD--EQRSATFMEELADA--LHYCHER--- 133

Query: 419 KIIHRDVKAANILLDED 435
           K+IHRD+K  N+L+   
Sbjct: 134 KVIHRDIKPENLLMGYK 150

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 88.6 bits (219), Expect = 6e-19
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K  LG GGFG V +      G+ VA+K+ ++E +     ++  E++I+    H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 359 ------GFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIA-LGSARGL 409
                          LL   Y   G +   L   E    L       R  ++ + SA  L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IRTLLSDISSA--L 134

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDADQS 439
            YLHE+   +IIHRD+K  NI+L     + 
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRL 161

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 15/176 (8%)

Query: 271 AEDDSELQLGQLKRFSLREL--------QVATDGFSNKNILGRGGFGKVYKGRL-ADGKL 321
            +   EL+L + +R  L           ++  D F   + LG G  G V+K      G +
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 322 VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS 381
           +A K +  E       Q   E++++       ++  YG   +  E  +   +M  GS+  
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 382 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
            L++       +      K+++   +GL+YL E    KI+HRDVK +NIL++   +
Sbjct: 121 VLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKRLK----------------EERTSGGELQFQTEVKII 346
           L +G F K+      D K  A+K+ +                +         F+ E++II
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----SSLPPLDWPTRKKIA 402
           +   +   L   G  T   E  ++Y YM N S+            +    +     K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  SY+H   +  I HRDVK +NIL+D++
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 18/165 (10%), Positives = 36/165 (21%), Gaps = 34/165 (20%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
            L  G    V+  R +   +  A+K   +  E +     +        +  +  +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 359 GFC--------------------------TTVTEKLLVYPYM--TNGSVASRLRERQSSL 390
                                          V   LL+ P        + S L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 391 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                     +     R  + L       ++H      N+ +  D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPD 230

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 24/122 (19%), Positives = 44/122 (36%), Gaps = 1/122 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S   +DL    L    +        L++L+L    +      A  +L  L +L L  N  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
                   + L  L+ L     +L+ L    +  + +L  L++++N +         FS 
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSN 147

Query: 188 FT 189
            T
Sbjct: 148 LT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 1/91 (1%)

Query: 87  LGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
              L +LE+L++ GN+   +        L  L  LDL         P    +L  L+ L 
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           + +N L  +       +TSL  + L  N   
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 18/107 (16%), Positives = 39/107 (36%), Gaps = 3/107 (2%)

Query: 84  APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLK 142
           +       +L+ L+L  N +   + S    L +L+ LD   +            +L+ L 
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424

Query: 143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           YL +++             ++SL +L ++ N           F++  
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 28/117 (23%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLR 145
              L +L+ L     NL+      +G+L  LK L++  N + +  +P+  +NL  L++L 
Sbjct: 96  FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 146 LNNNSLSGLIPTSLTTITSLNI----LDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
           L++N +  +  T L  +  + +    LDLS N ++   P      +   ++  NN +
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFD 212

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 29/173 (16%), Positives = 54/173 (31%), Gaps = 25/173 (14%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG-ELAPELGQLKNLE 94
             L      L   D    ++   F+   N    V+   L +  +   +        ++LE
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTN----VSSFSLVSVTIERVKDFSYNFGWQHLE 310

Query: 95  LLELYGNNLSGHIPSAL----------------GNLIKLKSLDLYSNLFN--GTIPDTLA 136
           L+             +L                 +L  L+ LDL  N  +  G    +  
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 137 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
               LKYL L+ N +   + ++   +  L  LD  ++ L   + +   F    
Sbjct: 371 GTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLR 421

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 29/139 (20%), Positives = 52/139 (37%), Gaps = 11/139 (7%)

Query: 68  SVTRVDLGNAAL-SGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLK----SLDL 122
           ++  +++ +  + S +L      L NLE L+L  N +     + L  L ++     SLDL
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184

Query: 123 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSG-LIPTSLTTITSLNILDLSNNRLSG---- 177
             N  N   P     ++ L  L L NN  S  ++ T +  +  L +  L           
Sbjct: 185 SLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243

Query: 178 PVPDNGSFSQFTPISFENN 196
              D  +      ++ E  
Sbjct: 244 EKFDKSALEGLCNLTIEEF 262

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 20/93 (21%), Positives = 29/93 (31%), Gaps = 8/93 (8%)

Query: 87  LGQLKNLELLELYGNNLSG---HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
           L  L NL + E     L      I      L  + S  L S      + D  +     ++
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQH 308

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           L L N          L    SL  L  ++N+  
Sbjct: 309 LELVNCKFGQFPTLKL---KSLKRLTFTSNKGG 338

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L NL  L L  +N+S    S L NL K+ SL+L +N  N +    L+N+  L YL
Sbjct: 104 SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYL 160

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
            +  + +  + P  +  +T L  L L+ N++  
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED 191

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 4/92 (4%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             +  L  L++L +  N +S    S L NL +L SL L +N       + +  L  L  L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L+ N ++ + P  L +++ ++  D +N  + 
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 4/93 (4%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L  L  LE+  N +S    +A+ +L KLK L++ SN    +    L NL QL  L
Sbjct: 237 SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSL 292

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
            LNNN L       +  +T+L  L LS N ++ 
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 6/112 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             +  L NLE L L GN ++   P  L NL+KL +L + +N    T    L NL  L+ L
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLREL 115

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
            LN +++S + P  L  +T +  L+L  N     +    + +    ++   +
Sbjct: 116 YLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 25/93 (26%), Positives = 40/93 (43%), Gaps = 5/93 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L  +  L L  N+    + S L N+  L  L +  +      P  +ANL  L  L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
            LN N +  + P  L ++TSL+      N+++ 
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 6/93 (6%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  +  L  L +  + +     + + NL  L SL L  N      P  LA+L  L Y 
Sbjct: 149 SPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYF 204

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
               N ++ + P  +  +T LN L + NN+++ 
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 74.5 bits (184), Expect = 7e-15
 Identities = 24/110 (21%), Positives = 49/110 (44%), Gaps = 8/110 (7%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
              R  L  A+++        +L+++  L + G  ++      +  L  L+ L+L  N  
Sbjct: 23  EGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQI 78

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
               P  L+NL +L  L +  N ++    ++L  +T+L  L L+ + +S 
Sbjct: 79  TDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 69.1 bits (170), Expect = 5e-13
 Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 6/94 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
              L       L   +++         L  +  L +       +I   +  L  L+YL L
Sbjct: 18  DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           N N ++ + P  L+ +  L  L +  N+++    
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKITDISA 105

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 58.3 bits (142), Expect = 1e-09
 Identities = 14/108 (12%), Positives = 36/108 (33%), Gaps = 10/108 (9%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
              L  L    N +         +L +     L        +      L+ +  L +   
Sbjct: 2   AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL 197
            ++ +    +  +T+L  L+L+ N+++  +    +  + T +    N 
Sbjct: 55  KVASI--QGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNK 99

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.5 bits (202), Expect = 3e-18
 Identities = 24/108 (22%), Positives = 44/108 (40%), Gaps = 3/108 (2%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
            R+ +    ++ +  P L  L +L LL++  +     I + +  L K+ S+DL  N    
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
            I   L  L +LK L +  + +       +     LN L   +  + G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.4 bits (199), Expect = 8e-18
 Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 1/90 (1%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           +  L NLE L + G +++      L  L  L  LD+  +  + +I   +  L ++  + L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           + N     I   L T+  L  L++  + + 
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 5e-16
 Identities = 17/87 (19%), Positives = 37/87 (42%), Gaps = 2/87 (2%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           +    N++ L +   + +    + +  L  L+ L +            L+ L  L  L +
Sbjct: 62  IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNN 173
           ++++    I T + T+  +N +DLS N
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.8 bits (169), Expect = 8e-14
 Identities = 18/95 (18%), Positives = 43/95 (45%), Gaps = 4/95 (4%)

Query: 88  GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 147
            Q+ +L  + L   N++  + + +     +K L + +       P  ++ L  L+ LR+ 
Sbjct: 41  AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
              ++     +L+ +TSL +LD+S++     +   
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
           T +D+ ++A    +  ++  L  +  ++L  N     I   L  L +LKSL++  +  + 
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD 173

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGL 154
                + +  +L  L   + ++ G 
Sbjct: 174 YRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.5 bits (124), Expect = 8e-08
 Identities = 15/94 (15%), Positives = 33/94 (35%), Gaps = 7/94 (7%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
             K      L G + + +I  A   +  L  + L +          +     +K L +NN
Sbjct: 21  TFKAYLNGLL-GQSSTANITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
              +   P  ++ +++L  L +    ++     N
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPN 107

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 24/160 (15%), Positives = 58/160 (36%), Gaps = 11/160 (6%)

Query: 288 RELQVATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQT 341
            E Q+ +      ++LG G F +VY+          + +   +K  K        +  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK 400
            ++ +  ++    ++ Y         +LV    + G++ + +   + +    +       
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
            A+     +  +H+    +IIH D+K  N +L     +  
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 12/150 (8%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 355
             ++ ILG G  G V       G+ VAVKR+  +           E+K+      H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVI 72

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYL 412
           R Y   TT     +      N ++   +  +  S   L          +    A G+++L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQSSKT 442
           H     KIIHRD+K  NIL+   +  ++  
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQ 158

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK 344
             +  Q   +   N   +G G  G+V+K R    G ++AVK+++         +   ++ 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 345 IISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           ++  +     +++ +G   T T+  +    M   +   + R +     P+      K+ +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
              + L YL E     +IHRDVK +NILLDE   
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 34/158 (21%), Positives = 56/158 (35%), Gaps = 7/158 (4%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPE-GSVTRVDLGNAALSGELAPELGQLKNLELLELYG 100
              L     LP  L +      +    ++  + L    +   L   +  L+NL+ L++  
Sbjct: 160 CPELTE---LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 160
           + LS  +  A+ +L KL+ LDL         P        LK L L + S    +P  + 
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274

Query: 161 TITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL 197
            +T L  LDL        +P           I    +L
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 29/118 (24%), Positives = 46/118 (38%), Gaps = 12/118 (10%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGN---------LIKLKSLDLY 123
            L    L   L   +  L  L  L +        +P  L +         L+ L+SL L 
Sbjct: 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191

Query: 124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD 181
                 ++P ++ANL+ LK L++ N+ LS L   ++  +  L  LDL         P 
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPP 247

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 20/97 (20%), Positives = 33/97 (34%), Gaps = 5/97 (5%)

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNL--IKLKSLDLYSNLFNGTIPDTLANLK 139
             A       N ++    G  L       L +       +L+L S       PD    L 
Sbjct: 47  HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104

Query: 140 QLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L+++ ++   L  L P ++     L  L L+ N L 
Sbjct: 105 HLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR 140

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 17/96 (17%), Positives = 32/96 (33%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
             +DL          P  G    L+ L L   +    +P  +  L +L+ LDL   +   
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL 165
            +P  +A L     + +  +  + L         + 
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 13/94 (13%), Positives = 20/94 (21%), Gaps = 7/94 (7%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
                    E L   G+         L    +  + D              AN    +  
Sbjct: 6   HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIE 61

Query: 145 RLNNNSLSGLIPTSLTTITSLN--ILDLSNNRLS 176
                +L       L   T      L+L +  L 
Sbjct: 62  TRTGRALKAT-ADLLEDATQPGRVALELRSVPLP 94

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 360
           L  GGF  VY+ + +  G+  A+KRL              EV  +  ++ H N+++    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 361 CTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
            +   E+        L+   +  G +   L++ +S   PL   T  KI   + R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH 153

Query: 414 EHCDPKIIHRDVKAANILLDED 435
               P IIHRD+K  N+LL   
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQ 174

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 27/166 (16%), Positives = 55/166 (33%), Gaps = 35/166 (21%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVK--------------RLKEERTSGGELQ-------- 338
           +LG+       +      G+   V               ++KEE      L+        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 339 -----FQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM--TNGSVASRLRERQSS 389
                F     ++     + ++R+        V  +  +YP M     +    L    S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 390 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 242

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 35/166 (21%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKII------------ 346
           +LG+       +      G+   V      E   S    Q + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 347 ----SMAVHRNLLRLYGFCT-----------TVTEKLLVYPYM--TNGSVASRLRERQSS 389
                     +L++                  V  +  +YP M     +    L    S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 390 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 247

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 34/150 (22%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK---RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           LG G +GKV +          AVK   + K  R   GE   + E++++    H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 359 GFCTTVTEK--LLVYPYMTNGS-------VASRLRERQSSLPPLDWPTRKK----IALGS 405
                  ++   +V  Y   G           R    Q+                I    
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA---------HGYFCQLID--- 120

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             GL YLH      I+H+D+K  N+LL   
Sbjct: 121 --GLEYLHSQ---GIVHKDIKPGNLLLTTG 145

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 6/120 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             +  LKNL  L LY NN+S   P  + +L KL+ L  Y+N    +   +LANL  + +L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWL 358

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT 204
              +N +S L P  L  +T +  L L++   +    +  +              L  P T
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPAT 416

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 37/112 (33%), Positives = 48/112 (42%), Gaps = 7/112 (6%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L +L NLE L    N +S   P  LG L  L  L L  N        TLA+L  L  L
Sbjct: 193 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDL 248

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
            L NN +S L P  L+ +T L  L L  N++S  +      +  T +    N
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNEN 297

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 33/96 (34%), Positives = 43/96 (44%), Gaps = 6/96 (6%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L NL  L+L  N +S   P  L  L KL  L L +N  +   P  LA L  L  L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
            LN N L  + P  ++ + +L  L L  N +S   P
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 24/113 (21%), Positives = 45/113 (39%), Gaps = 8/113 (7%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
              +  LG   ++         L  +  L+     +       +  L  L  ++  +N  
Sbjct: 25  EKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQL 80

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
               P  L NL +L  + +NNN ++ + P  L  +T+L  L L NN+++   P
Sbjct: 81  TDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L +L+ L   GN ++   P  L NL  L+ LD+ SN    +    LA L  L+ L
Sbjct: 150 SALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESL 204

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
              NN +S + P  L  +T+L+ L L+ N+L     
Sbjct: 205 IATNNQISDITP--LGILTNLDELSLNGNQLKDIGT 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 6/89 (6%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L  L  + +  N ++    + L NL  L  L L++N      P  L NL  L  L
Sbjct: 84  TPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNN 173
            L++N++S +    L+ +TSL  L   N 
Sbjct: 140 ELSSNTISDISA--LSGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L NL  L L+ N ++      L NL  L  L+L SN  +      L+ L  L+ L
Sbjct: 106 TPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
              N  ++ L P  L  +T+L  LD+S+N++S    
Sbjct: 162 SFGNQ-VTDLKP--LANLTTLERLDISSNKVSDISV 194

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
              L       L   N++  +     +L ++ +L            D +  L  L  +  
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINF 75

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
           +NN L+ + P  L  +T L  + ++NN+++   P
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 6/111 (5%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++T + L    +S      +  L  L+ L  Y N +S    S+L NL  +  L    N  
Sbjct: 310 NLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP 178
           +   P  LANL ++  L LN+ + +         ++  N +      L  P
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 4/112 (3%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L N+  L    N +S   P  L NL ++  L L    +     +  AN+     +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
           +    +L  + P +++   S    D++ N  S     + +FSQ   I     
Sbjct: 405 KNVTGAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTT 454

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 3e-16
 Identities = 28/98 (28%), Positives = 41/98 (41%), Gaps = 1/98 (1%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI-PDTLANLKQLKYLRLNN 148
           L   E L L  N +     S+   L +L+ L+L S     TI  +   NL  L+ L L +
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
           + +  L P +   +  L  L L    LS  V  +G F 
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 27/109 (24%), Positives = 48/109 (44%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           SV  +DL +  +    +     LK+L++L L  N ++     A   L  L+ L+L  NL 
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                     L ++ Y+ L  N ++ +   +   +  L  LDL +N L+
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 36/168 (21%), Positives = 67/168 (39%), Gaps = 15/168 (8%)

Query: 42  NNSLQSWDNLPGNLCTWF----HITCNPEG--SVTRVDLGNAALSG-ELAPELGQLKNLE 94
           +N+L +   +P ++   F     +   P+   +   + L    L   ++   L ++ +L+
Sbjct: 371 DNALTTIHFIP-SIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQ 429

Query: 95  LLELYGNNLSGHIPSAL-GNLIKLKSLDLYSNLFNGTI-----PDTLANLKQLKYLRLNN 148
           +L L  N  S             L+ L L  N+           D    L  L+ L LN+
Sbjct: 430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
           N L+ L P   + +T+L  L L++NRL+  +  N   +    +    N
Sbjct: 490 NYLNSLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 26/114 (22%), Positives = 42/114 (36%), Gaps = 7/114 (6%)

Query: 90  LKNLELLELYGNNLSGHI--PSALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLRL 146
           L +L  L LY   LS  +       NL  L  LDL  N      +  +   L  LK +  
Sbjct: 96  LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155

Query: 147 NNNSLSGLIPTSLTTIT--SLNILDLSNNRLSGPVPDN--GSFSQFTPISFENN 196
           ++N +  +    L  +   +L+   L+ N L   V  +     + F  +  E  
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 5/109 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
            +  ++L    ++         L NL++L L  N L     S    L K+  +DL  N  
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                 T   L++L+ L L +N+L     T++  I S+  + LS N+L 
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV 394

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 44/207 (21%), Positives = 73/207 (35%), Gaps = 15/207 (7%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPEL-----GQLKNLELLELYGNNLSGHIPSALGNLIK 116
           T +   S+ ++ LG   L      EL       L +L++L L  N L+   P    +L  
Sbjct: 446 TPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505

Query: 117 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           L+ L L SN       + L     L+ L ++ N L    P       SL++LD+++N+  
Sbjct: 506 LRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFI 560

Query: 177 GPVPDNGSFSQF---TPISFENNLNLCGPNTKKPCSGSPPFS-PPPPFGPTSSPGRNKSN 232
               +  +F  +   T ++                SG   FS               K +
Sbjct: 561 CEC-ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619

Query: 233 AAIPVGVALGAALLFAVPVIGFAYWRR 259
             I   V L   L+  + V  F  +  
Sbjct: 620 LFIVCTVTLTLFLMTILTVTKFRGFCF 646

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 29/153 (18%), Positives = 52/153 (33%), Gaps = 24/153 (15%)

Query: 68  SVTRVDL-GNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNL--IKLKSLDLYS 124
           ++TR+DL  N   S  L P  G+L +L+ ++   N +       L  L    L    L +
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 125 NLFNGTIPDTLANLKQ------LKYLRLNNN------------SLSGLIPTSLTTITSLN 166
           N     +               L+ L ++ N            ++S     SL     + 
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 167 ILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
                 + +    PD  +F+     S   +L+L
Sbjct: 244 GAGFGFHNIK--DPDQNTFAGLARSSVR-HLDL 273

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 17/108 (15%), Positives = 34/108 (31%), Gaps = 20/108 (18%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNL------IKLKSLDLYSNLFNGTIPDTLAN----- 137
           Q K L    L  N+L   +    G        + L+ LD+  N +   I    +N     
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231

Query: 138 -------LKQLKYLRLNNNSLSGLIPTSLTTITSLNI--LDLSNNRLS 176
                     +       +++      +   +   ++  LDLS+  + 
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 34/151 (22%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHR--NL 354
           LG GGFG VY G  ++D   VA+K     R+ +        +   EV ++         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 355 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 404
           +RL  +       +L+              +    L+E  +         R     +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---------RSFFWQVL-- 159

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               + + H      ++HRD+K  NIL+D +
Sbjct: 160 --EAVRHCHNC---GVLHRDIKDENILIDLN 185

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 28/144 (19%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 362 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 411
                + L   Y + G +         + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.8 bits (190), Expect = 9e-16
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 19/156 (12%)

Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKI-- 345
           AT  +     +G G +G VYK R    G  VA+K ++     GG      +   EV +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 346 -ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
            +    H N++RL   C T          LV+ ++    + + L +     P L   T K
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIK 123

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            +     RGL +LH +    I+HRD+K  NIL+   
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 21/87 (24%), Positives = 42/87 (48%), Gaps = 2/87 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
               ++ ++  ++L   + S   +   +K LDL  N  +      LA   +L+ L L++N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLS 176
            L   +   L ++++L  LDL+NN + 
Sbjct: 69  VLYETLD--LESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 7/109 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
                 + +++L   LA       N++ L+L GN LS    + L    KL+ L+L SN+ 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                D L +L  L+ L LNNN +       L    S+  L  +NN +S
Sbjct: 71  Y-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 24/95 (25%), Positives = 34/95 (35%), Gaps = 4/95 (4%)

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
             A        LE L L  N +   +        KLK+LDL SN     +     +   +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            ++ L NN L   I  +L    +L   DL  N   
Sbjct: 217 TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 9/105 (8%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
            +L  L  L  L+L  N +       L     +++L   +N  +  +    +  +  K +
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS--CSRGQGKKNI 125

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
            L NN ++ L        + +  LDL  N +   V      +   
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 17/70 (24%), Positives = 28/70 (40%)

Query: 107 IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 166
           I     N  + K   +  +     +     +   +K L L+ N LS +    L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 167 ILDLSNNRLS 176
           +L+LS+N L 
Sbjct: 62  LLNLSSNVLY 71

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 28/144 (19%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 362 TTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 411
                + L   Y + G           + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 35/153 (22%), Positives = 54/153 (35%), Gaps = 36/153 (23%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISM----AVHR 352
           LG+GGFG V+ G  L D   VA+K     R+         +    EV ++        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IA 402
            ++RL  +  T    +LV              +    L E  S         R     + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---------RCFFGQVV 149

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                 + + H      ++HRD+K  NIL+D  
Sbjct: 150 ----AAIQHCHSR---GVVHRDIKDENILIDLR 175

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 16/140 (11%)

Query: 303 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +  GG G +Y       +G+ V +K L     +  +     E + ++  VH ++++++ F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 361 CTTVTEKLLVYPYM-----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
                       Y+        S+     +       L         L     LSYLH  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI 201

Query: 416 CDPKIIHRDVKAANILLDED 435
               +++ D+K  NI+L E+
Sbjct: 202 ---GLVYNDLKPENIMLTEE 218

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 352
           + +     +G G +G VYK + + G++VA+KR++ +    G +      E+ ++    H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N++ L     +     LV+ +M    +   L E ++ L        K       RG+++ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHC 135

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H+H   +I+HRD+K  N+L++ D
Sbjct: 136 HQH---RILHRDLKPQNLLINSD 155

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 49/267 (18%), Positives = 84/267 (31%), Gaps = 47/267 (17%)

Query: 186 SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 245
                   +N  N      ++     P  +         S   + S +A  +  A     
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 246 LFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGR 305
                       +       +F     +D        K F           +  K+++GR
Sbjct: 64  A-----------QPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGR 104

Query: 306 GGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKII-SMAVHRNLLR 356
           G    V +    A G   AVK       RL  E+        + E  I+  +A H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 357 LYGFCTTVTEKLLVYPYMTNGS-----VAS-RLRERQSSLPPLDWPTRKKIALGSARGLS 410
           L     + +   LV+  M  G           L E+++            I       +S
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVS 214

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDAD 437
           +LH +    I+HRD+K  NILLD++  
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQ 238

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 21/87 (24%), Positives = 42/87 (48%), Gaps = 2/87 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
               ++ ++  ++L   + S   +   +K LDL  N  +      LA   +L+ L L++N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLS 176
            L   +   L ++++L  LDL+NN + 
Sbjct: 69  VLYETLD--LESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 7/109 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
                 + +++L   LA       N++ L+L GN LS    + L    KL+ L+L SN+ 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                D L +L  L+ L LNNN +       L    S+  L  +NN +S
Sbjct: 71  Y-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 23/90 (25%), Positives = 34/90 (37%), Gaps = 4/90 (4%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
                 LE L L  N +   +   +    KLK+LDL SN     +     +   + ++ L
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            NN L   I  +L    +L   DL  N   
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 19/105 (18%), Positives = 34/105 (32%), Gaps = 9/105 (8%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
            +L  L  L  L+L  N +       L     +++L   +N  +          K +   
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI--- 125

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
            L NN ++ L        + +  LDL  N +   V      +   
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 3/92 (3%)

Query: 86  ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYL 144
              + +  + + L  N ++       G   +++ LDL  N  +     +  A+   L++L
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L  N +  +          L  LDLS+N+L+
Sbjct: 175 NLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA 204

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 17/71 (23%), Positives = 28/71 (39%)

Query: 107 IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 166
           I     N  + K   +  +     +     +   +K L L+ N LS +    L   T L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 167 ILDLSNNRLSG 177
           +L+LS+N L  
Sbjct: 62  LLNLSSNVLYE 72

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 26/115 (22%), Positives = 43/115 (37%), Gaps = 4/115 (3%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN- 128
             +DL +  L+  + PE      +  + L  N L   I  AL     L+  DL  N F+ 
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

Query: 129 GTIPDTLANLKQLKYLRLN-NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
           GT+ D  +  ++++ +       L+G      T  T  +        L  P  D 
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 17/160 (10%), Positives = 36/160 (22%), Gaps = 6/160 (3%)

Query: 33  IFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKN 92
            F    +    + Q+   L G       +           +   A  +  L     + K 
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL--IALKRKE 314

Query: 93  LELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS 152
             LL   G+     +     N  + + +D     +   I       +    L     +L 
Sbjct: 315 HALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

Query: 153 GLIPTSLTTITSLN---ILDLSNNRLSGPVPDNGSFSQFT 189
             +         L+      +    L     +        
Sbjct: 374 EQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLR 413

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 24/108 (22%), Positives = 51/108 (47%), Gaps = 2/108 (1%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFN 128
             +++ +      + P      NL  L +   NL+  +P  A+ +L+ L+ L+L  N  +
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                 L  L +L+ ++L    L+ + P +   +  L +L++S N+L+
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 3/124 (2%)

Query: 56  CTWFHITCNPEG---SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALG 112
           C        PEG       +DLG   +      E     +LE LEL  N +S   P A  
Sbjct: 18  CHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN 77

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
           NL  L++L L SN            L  L  L ++ N +  L+      + +L  L++ +
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 173 NRLS 176
           N L 
Sbjct: 138 NDLV 141

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 2/88 (2%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           L NL  L L  N L   IP      L  L  LD+  N     +     +L  LK L + +
Sbjct: 79  LFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N L  +   + + + SL  L L    L+
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT 165

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 25/110 (22%), Positives = 48/110 (43%), Gaps = 2/110 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
           ++T + + +  L+  +    +  L  L  L L  N +S    S L  L++L+ + L    
Sbjct: 225 NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                P     L  L+ L ++ N L+ L  +   ++ +L  L L +N L+
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 20/103 (19%), Positives = 41/103 (39%), Gaps = 2/103 (1%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  L  L +L L   N++     +   L +LK L++    +  T+         L  L +
Sbjct: 172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI 231

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
            + +L+ +   ++  +  L  L+LS N +S    +     +  
Sbjct: 232 THCNLTAVPYLAVRHLVYLRFLNLSYNPIS--TIEGSMLHELL 272

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 12/147 (8%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 351
           D +     LG G +G+VYK       + VA+KR++ E    G +      EV ++    H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-VPGTAIREVSLLKELQH 92

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           RN++ L           L++ Y       + L++     P +     K        G+++
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 412 LHEHCDPKIIHRDVKAANILLDEDADQ 438
            H     + +HRD+K  N+LL      
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDAS 171

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 360
           +G+G F KV   R +  G+ VA+K + K +       +   EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 361 CTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLH 413
             T     L+  Y + G V        R++E+++         R K   + SA  + Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA---------RSKFRQIVSA--VQYCH 131

Query: 414 EHCDPKIIHRDVKAANILLDED 435
           +     I+HRD+KA N+LLD D
Sbjct: 132 QKR---IVHRDLKAENLLLDAD 150

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 8e-15
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 349
             +     +G+G FG+V+K R    G+ VA+K++  E    G   F  T   E+KI+ + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 350 VHRNLLRLYGFCTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 401
            H N++ L   C T             LV+ +  +  +A  L               K++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL---SEIKRV 129

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                 GL Y+H +   KI+HRD+KAAN+L+  D
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 32/185 (17%), Positives = 50/185 (27%), Gaps = 44/185 (23%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVK----RLKEERTSGGELQFQTEVKIISMAVHRNL 354
           K  +G+G +G V          + A+K        +       + +TEV+++    H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR------- 407
            RLY          LV      G +  +L                K  +           
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 408 -----------------------------GLSYLHEHCDPKIIHRDVKAANILLDEDADQ 438
                                         L YLH      I HRD+K  N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207

Query: 439 SSKTI 443
             K +
Sbjct: 208 EIKLV 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 1/88 (1%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           L +LE+L++ GN+   +        L  L  LDL         P    +L  L+ L +++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N+   L       + SL +LD S N + 
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 1/88 (1%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI-PDTLANLKQLKYLRLNN 148
           L+NL  L++   +           L  L+ L +  N F     PD    L+ L +L L+ 
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLS 176
             L  L PT+  +++SL +L++S+N   
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 17/95 (17%), Positives = 38/95 (40%), Gaps = 4/95 (4%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYLRLN 147
             +L+ L+L  N +   + S    L +L+ LD   +     + +     +L+ L YL ++
Sbjct: 77  TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDIS 134

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
           +             ++SL +L ++ N        +
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 3/104 (2%)

Query: 75  GNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPD 133
           GN+     L     +L+NL  L+L    L   +   A  +L  L+ L++  N F      
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217

Query: 134 TLANLKQLKYLRLNNNSLSGLIPTSLTTI-TSLNILDLSNNRLS 176
               L  L+ L  + N +       L    +SL  L+L+ N  +
Sbjct: 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 3/69 (4%)

Query: 118 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG 177
             +   S     ++P  +        L L +N L  L       +T L  L LS+N LS 
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 178 PVPDNGSFS 186
               + S  
Sbjct: 67  KGCCSQSDF 75

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 36/183 (19%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 324
            + +         K++  + +++  D   +       LG G FG V++    A G   A 
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 325 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 384
           K +     S  E   + E++ +S+  H  L+ L+       E +++Y +M+ G +  ++ 
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 385 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
           +  + +   +       A+   R    GL ++HE+     +H D+K  NI+         
Sbjct: 247 DEHNKMSEDE-------AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296

Query: 441 KTI 443
           K I
Sbjct: 297 KLI 299

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 73.7 bits (182), Expect = 1e-14
 Identities = 35/146 (23%), Positives = 72/146 (49%), Gaps = 14/146 (9%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 351
           + F     +G G +G VYK R    G++VA+K+++ +  + G +      E+ ++    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNH 61

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGL 409
            N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +GL
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
           ++ H H   +++HRD+K  N+L++ +
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTE 139

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 352
           + +     +G G +G VYK +   G+  A+K+++ E+   G +   T  E+ I+    H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++LY    T    +LV+ ++    +   L   +  L      T K   L    G++Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES---VTAKSFLLQLLNGIAYC 116

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H+    +++HRD+K  N+L++ +
Sbjct: 117 HDR---RVLHRDLKPQNLLINRE 136

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 24/88 (27%), Positives = 35/88 (39%), Gaps = 2/88 (2%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           L  L+ L L  N L   +P     +L  L  L L+ N  +         L  L  L L+ 
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N ++ + P +   +  L  L L  N LS
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 1/110 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           +  R+ L    +S   A      +NL +L L+ N L+    +A   L  L+ LDL  N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 128 NGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             ++   T   L +L  L L+   L  L P     + +L  L L +N L 
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 28/84 (33%), Positives = 39/84 (46%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L NL  L L+GN +S     A   L  L  L L+ N      P    +L +L  L L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 150 SLSGLIPTSLTTITSLNILDLSNN 173
           +LS L   +L  + +L  L L++N
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 18/87 (20%), Positives = 34/87 (39%), Gaps = 4/87 (4%)

Query: 100 GNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
              L   +P  +      + + L+ N  +     +    + L  L L++N L+ +   + 
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 160 TTITSLNILDLSNNRLSGPVPDNGSFS 186
           T +  L  LDLS+N     V    +F 
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDP-ATFH 102

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 22/62 (35%), Positives = 37/62 (59%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L +L+ L L+ N ++   P A  +L +L +L L++N  +    + LA L+ L+YLRLN+N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

Query: 150 SL 151
             
Sbjct: 236 PW 237

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 2/87 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L NL  L L   NL   IP  L  LIKL  LDL  N  +   P +   L  L+ L +  +
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLS 176
            +  +   +   + SL  ++L++N L+
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 2/90 (2%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
           P L  L  L+ L+L GN+LS  I   +   L+ L+ L +  +       +   NL+ L  
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
           + L +N+L+ L     T +  L  + L +N
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 21/85 (24%), Positives = 34/85 (40%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
           N  LL L+ N +     ++  +L  L+ L L  N            L  L  L L +N L
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
           + +   +   ++ L  L L NN + 
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE 149

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 1/110 (0%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           +   ++L    +          L++LE+L+L  N++      A   L  L +L+L+ N  
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS-NNRLS 176
                     L +LK L L NN +  +   +   I SL  LDL    RLS
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 35/102 (34%), Positives = 43/102 (42%), Gaps = 7/102 (6%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLN 147
           L  L+ L L  N +   IPS A   +  L+ LDL        I       L  L+YL L 
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
             +L   IP  LT +  L+ LDLS N LS      GSF    
Sbjct: 194 MCNLRE-IPN-LTPLIKLDELDLSGNHLS--AIRPGSFQGLM 231

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 18/85 (21%), Positives = 39/85 (45%), Gaps = 3/85 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
               +     NL   +P  +      + L+L+ N       ++  +L+ L+ L+L+ N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
             +   +   + +LN L+L +NRL+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT 125

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 14/62 (22%), Positives = 26/62 (41%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L +L+ L +  + +     +A  NL  L  ++L  N       D    L  L+ + L++N
Sbjct: 230 LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

Query: 150 SL 151
             
Sbjct: 290 PW 291

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 1/98 (1%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
            ++ L+L  N ++      L     L+ L L S+  N    D   +L  L++L L++N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           S L  +    ++SL  L+L  N     +     F   T
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQT-LGVTSLFPNLT 123

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 23/138 (16%), Positives = 49/138 (35%), Gaps = 4/138 (2%)

Query: 68  SVTRVDL-GNAALSGELAPELGQLKNLELLELYGNNLSGHIP-SALGNLIKLKSLDLYSN 125
           S+  ++L GN   +  +      L NL+ L +        I       L  L  L++ + 
Sbjct: 99  SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
                   +L +++ + +L L+ +  + L+      ++S+  L+L +  L+         
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR--FQFSPL 216

Query: 186 SQFTPISFENNLNLCGPN 203
                 S    L   G  
Sbjct: 217 PVDEVSSPMKKLAFRGSV 234

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 6/114 (5%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLS---GHIPSALGNLIKLKSLDLYS 124
            V R+ + N+ +          LK+LE L+L  N +        +  G    L++L L  
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370

Query: 125 NLFN--GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N         + L  LK L  L ++ N+    +P S      +  L+LS+  + 
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 28/149 (18%), Positives = 53/149 (35%), Gaps = 6/149 (4%)

Query: 47  SWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSG-ELAPELGQLKNLELLELY--GNNL 103
           S++ L   L     ++       T   LG+   S  ++  ELG+++ + +  L+     L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298

Query: 104 SGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI---PTSLT 160
              + +    L K+K + + ++           +LK L++L L+ N +            
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 161 TITSLNILDLSNNRLSGPVPDNGSFSQFT 189
              SL  L LS N L              
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 24/134 (17%), Positives = 52/134 (38%), Gaps = 4/134 (2%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
           ++  + +GN     E+       L +L  LE+   +L  +   +L ++  +  L L+ + 
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
               +      L  ++YL L + +L+    + L      + +     R S  V  + SF+
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS--VLTDESFN 241

Query: 187 QFTPISFENNLNLC 200
           +   +     L L 
Sbjct: 242 ELLKL-LRYILELS 254

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 30/118 (25%), Positives = 48/118 (40%), Gaps = 22/118 (18%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN---LFNGTIPDTL---------- 135
            LKNL  L++  N     +P +     K++ L+L S    +    IP TL          
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443

Query: 136 ----ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
                 L +L+ L ++ N L  L   SL     L ++ +S N+L      +G F + T
Sbjct: 444 DSFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLK--SVPDGIFDRLT 497

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 24/126 (19%), Positives = 50/126 (39%), Gaps = 9/126 (7%)

Query: 50  NLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS 109
           ++  N       +C     +  ++L +  +   +   +   + LE+L++  NNL      
Sbjct: 393 DISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL 448

Query: 110 ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILD 169
               L +L+ L +  N    T+PD  +    L  ++++ N L  +       +TSL  + 
Sbjct: 449 ---FLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW 503

Query: 170 LSNNRL 175
           L  N  
Sbjct: 504 LHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 20/117 (17%), Positives = 43/117 (36%), Gaps = 8/117 (6%)

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALG--------NLIKLKSLDLYSNLFNGTIPD 133
           +L   + +L  +E  +   N L    PS             + ++ L +        +  
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304

Query: 134 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTP 190
             + L+++K + + N+ +  +  +    + SL  LDLS N +      N +     P
Sbjct: 305 VYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 14/121 (11%), Positives = 39/121 (32%), Gaps = 8/121 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  ++++  L L+ +  +  +      L  ++ L+L            L   +    ++ 
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 147 NNNSLSGL-------IPTSLTTITSLNILDLSNNRLSG-PVPDNGSFSQFTPISFENNLN 198
                S L       +   L  I  L+ ++  +  L+G    +       + +     + 
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 199 L 199
           +
Sbjct: 288 I 288

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 27/188 (14%)

Query: 272 EDDSELQLGQLKRF-------SLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADG 319
            ++SE+ L   +         ++ +  V      ++      LG G  G+V         
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160

Query: 320 KLVAVK-------RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 372
           K VA++        +   R +   L  +TE++I+    H  ++++  F     +  +V  
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219

Query: 373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
            M  G +  ++   +     L   T K         + YLHE+    IIHRD+K  N+LL
Sbjct: 220 LMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272

Query: 433 DEDADQSS 440
               +   
Sbjct: 273 SSQEEDCL 280

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 349
             +   + LG G F  VYK R     ++VA+K++K    S  +    +T   E+K++   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N++ L       +   LV+ +M    +   +++    L P      K   L + +GL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGL 125

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            YLH+H    I+HRD+K  N+LLDE+
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           + +   + LG G +  VYKG+      LVA+K ++ E   G       EV ++    H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           ++ L+    T     LV+ Y+    +   L +  + +        K       RGL+Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQLLRGLAYCH 117

Query: 414 EHCDPKIIHRDVKAANILLDED 435
                K++HRD+K  N+L++E 
Sbjct: 118 RQ---KVLHRDLKPQNLLINER 136

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 34/151 (22%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEER-------TSGGELQFQTEVKIISMAVHRNL 354
           LG G FG V+        K V VK +K+E+             +   E+ I+S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 355 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 404
           +++           LV     +G           RL E  +               +   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA---------SYIFRQLV-- 140

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               + YL       IIHRD+K  NI++ ED
Sbjct: 141 --SAVGYLRLK---DIIHRDIKDENIVIAED 166

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 37/135 (27%), Positives = 57/135 (42%), Gaps = 7/135 (5%)

Query: 68  SVTRVDLGNAALSGELAPE--LGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYS 124
               +DL +  LS  L  E    +L NL  L L  N+L+  I S A   +  L+ LDL S
Sbjct: 40  YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGS 184
           N  +       ++L+ L+ L L NN +  +   +   +  L  L LS N++S   P    
Sbjct: 98  NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPV-EL 155

Query: 185 FSQFTPISFENNLNL 199
                 +     L+L
Sbjct: 156 IKDGNKLPKLMLLDL 170

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 9/93 (9%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIP----DTLANLKQLKYL 144
           L+ LE+L LY N++   +   A  ++ +L+ L L  N  +   P         L +L  L
Sbjct: 111 LQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168

Query: 145 RLNNNSLSGLIPTSLTTITSL--NILDLSNNRL 175
            L++N L  L  T L  + +   N L L NN L
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 2/87 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L NL+ L L   N+   +P  L  L+ L+ L++  N F    P +   L  LK L + N+
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLS 176
            +S +   +   + SL  L+L++N LS
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 27/89 (30%), Positives = 39/89 (43%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
           P L  L  LE LE+ GN+     P +   L  LK L + ++  +    +    L  L  L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNN 173
            L +N+LS L     T +  L  L L +N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 21/85 (24%), Positives = 31/85 (36%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
           N   L L  NN+         +L  L+ L L  N            L  L  L L +N L
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
           + +   +   ++ L  L L NN + 
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE 160

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 30/126 (23%), Positives = 53/126 (42%), Gaps = 4/126 (3%)

Query: 55  LCTWFHITCNPEG---SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSAL 111
           +CT   ++  P+G   +   ++L    +    A     L +LE+L+L  N++      A 
Sbjct: 60  VCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119

Query: 112 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 171
             L  L +L+L+ N            L +L+ L L NN +  +   +   + SL  LDL 
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179

Query: 172 -NNRLS 176
              +L 
Sbjct: 180 ELKKLE 185

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 21/85 (24%), Positives = 36/85 (42%), Gaps = 3/85 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
               +      LS  +P  +      + L+L  N       DT  +L  L+ L+L  NS+
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
             +   +   + SLN L+L +N L+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT 136

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 16/62 (25%), Positives = 27/62 (43%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L +L+ L +  + +S    +A   L  L  L+L  N  +    D    L+ L  L L++N
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

Query: 150 SL 151
             
Sbjct: 301 PW 302

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 351
           + + N  ++G G +G V K R    G++VA+K+  E       ++     E+K++    H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            NL+ L   C       LV+ ++ + ++   L    + L        +K       G+ +
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDY---QVVQKYLFQIINGIGF 139

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
            H H    IIHRD+K  NIL+ + 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQS 160

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 30/144 (20%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           +G G FG     R     +LVAVK +  ER +  +   Q E+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 362 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 411
            T T   ++  Y + G +      A R  E ++         R      ++     G+SY
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEA---------RFFFQQLLS-----GVSY 131

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
            H     +I HRD+K  N LLD  
Sbjct: 132 CHSM---QICHRDLKLENTLLDGS 152

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)

Query: 303 LGRGGFGKVYKGR---LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           +GRG +G VYK +     D K  A+K+++     G  +    E+ ++    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85

Query: 360 FCTTVTEKL--LVYPYM----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
              +  ++   L++ Y      +     R  +       L     K +      G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 414 EHCDPKIIHRDVKAANILLDEDAD 437
            +    ++HRD+K ANIL+  +  
Sbjct: 146 AN---WVLHRDLKPANILVMGEGP 166

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 20/183 (10%)

Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 324
              D  +      K++  + ++V      +       LG G FG V++    A G++   
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 325 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 384
           K +            + E+ I++   H  L+ L+       E +L+  +++ G +  R+ 
Sbjct: 82  KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 385 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
                +   +        +   R    GL ++HEH    I+H D+K  NI+ +     S 
Sbjct: 141 AEDYKMSEAE-------VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190

Query: 441 KTI 443
           K I
Sbjct: 191 KII 193

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 29/144 (20%), Positives = 62/144 (43%), Gaps = 11/144 (7%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 351
             +     +G G +G V+K +     ++VA+KR++ +    G +      E+ ++    H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           +N++RL+    +  +  LV+ +     +          L P      K       +GL +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
            H      ++HRD+K  N+L++ +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRN 137

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 14/155 (9%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 351
           ++ +     LG G +G+V   R        A+K +++   S         EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGL 409
            N+++LY F        LV      G +   +  R        +       I      G+
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGV 149

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 443
           +YLH+H    I+HRD+K  N+LL+     +  K +
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 42/148 (28%), Positives = 60/148 (40%), Gaps = 17/148 (11%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKII-SMA 349
           K ILGRG    V +       K  AVK            E           EV I+  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            H N+++L     T T   LV+  M  G +   L E+ +    L     +KI       +
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVI 137

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDAD 437
             LH+     I+HRD+K  NILLD+D +
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMN 162

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 31/146 (21%), Positives = 61/146 (41%), Gaps = 5/146 (3%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N+++++
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
                     +V      G +  R+   Q+    L      ++       L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 419 KIIHRDVKAANILLDEDADQSS-KTI 443
            ++H+D+K  NIL  + +  S  K I
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKII 169

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 71.4 bits (176), Expect = 6e-14
 Identities = 36/145 (24%), Positives = 63/145 (43%), Gaps = 13/145 (8%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAV 350
           + +     +G G +G V+K R    G++VA+K+  E        +      E++++    
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H NL+ L           LV+ Y  + +V   L   Q  +P       K I   + + ++
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPE---HLVKSITWQTLQAVN 116

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           + H+H     IHRDVK  NIL+ + 
Sbjct: 117 FCHKH---NCIHRDVKPENILITKH 138

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 7e-14
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 30/146 (20%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 360 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 409
             +T T+  +V  Y++ G +        R+ E ++         R+     ++      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA---------RRLFQQILS-----AV 124

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            Y H H    ++HRD+K  N+LLD  
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAH 147

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
           ++N  ++G G FG V++ +L +   VA+K++ +++          E++I+ +  H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVD 96

Query: 357 LYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           L  F  +  +K       LV  Y+   +V    R        +     K       R L+
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 411 YLHEHCDPKIIHRDVKAANILLDEDADQ 438
           Y+H      I HRD+K  N+LLD  +  
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGV 180

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 24/186 (12%)

Query: 259 RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 318
              P + F D         +  Q K    +   +  D F +  +LGRGGFG+V+  ++  
Sbjct: 155 GQAPFQEFLDSLYFL----RFLQWKWLEAQ--PMGEDWFLDFRVLGRGGFGEVFACQMKA 208

Query: 319 -GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPY 373
            GKL A K+L ++R     G      E KI++    R ++ L Y F T     L LV   
Sbjct: 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMTI 266

Query: 374 MTNGSVASRLRERQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAAN 429
           M  G +   +       P    P       +I  G    L +LH+     II+RD+K  N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319

Query: 430 ILLDED 435
           +LLD+D
Sbjct: 320 VLLDDD 325

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 8/148 (5%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
            S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           +LY    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206

Query: 416 CDPKIIHRDVKAANILLDEDADQSSKTI 443
               I+H D+K  NIL      +  K I
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKII 231

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 27/160 (16%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL 96
            L   NN+L++  +LP  L                + + N  L  +L PEL     L+++
Sbjct: 115 SLLVDNNNLKALSDLPPLL--------------EYLGVSNNQLE-KL-PELQNSSFLKII 158

Query: 97  ELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 156
           ++  N+L   +P    +   L+ +   +N     +P+ L NL  L  +  +NNSL  L  
Sbjct: 159 DVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPD 212

Query: 157 TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
                  SL  +   NN L    P+  +    T I  +NN
Sbjct: 213 ----LPLSLESIVAGNNILEEL-PELQNLPFLTTIYADNN 247

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 38/149 (25%), Positives = 57/149 (38%), Gaps = 36/149 (24%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           NNSL+   +LP +L                +  GN  L  EL PEL  L  L  +    N
Sbjct: 204 NNSLKKLPDLPLSL--------------ESIVAGNNILE-EL-PELQNLPFLTTIYADNN 247

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
            L   +P    +   L++L++  N     +P+   +L  L       + LS L P +L  
Sbjct: 248 LLK-TLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSEL-PPNLYY 301

Query: 162 --------------ITSLNILDLSNNRLS 176
                           SL  L++SNN+L 
Sbjct: 302 LNASSNEIRSLCDLPPSLEELNVSNNKLI 330

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 40/153 (26%), Positives = 59/153 (38%), Gaps = 40/153 (26%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           NNSL+   +LP +L                +  GN  L  EL PEL  L  L  +    N
Sbjct: 162 NNSLKKLPDLPPSL--------------EFIAAGNNQLE-EL-PELQNLPFLTAIYADNN 205

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
           +L   +P    +L   +S+   +N+        L NL  L  +  +NN L  L P    +
Sbjct: 206 SLK-KLPDLPLSL---ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKTL-PDLPPS 258

Query: 162 ITSLNI-----------------LDLSNNRLSG 177
           + +LN+                 LD+S N  SG
Sbjct: 259 LEALNVRDNYLTDLPELPQSLTFLDVSENIFSG 291

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 15/157 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQL--KNLELLELY 99
           +++L        N+ +                 GN          L     +    LEL 
Sbjct: 20  SSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELN 79

Query: 100 GNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
              LS  +P    +L   +SL    N     +P+   +LK L     N  +LS L P   
Sbjct: 80  NLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--- 131

Query: 160 TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
                L  L +SNN+L   +P+  + S    I  +NN
Sbjct: 132 ----LLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNN 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 26/142 (18%), Positives = 49/142 (34%), Gaps = 21/142 (14%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCN-----PE--GSVTRVDLGNAALSGELAPELGQLKNLE 94
           NN L     LP  L      + N     PE   ++ ++ +    L  E       +++L 
Sbjct: 326 NNKLIELPALPPRL-ERLIASFNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 383

Query: 95  LLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL 154
           +     N+    +P    NL   K L + +N      PD     + ++ LR+N+  +   
Sbjct: 384 M-----NSHLAEVPELPQNL---KQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDP 431

Query: 155 IPTSLTTITSLNILDLSNNRLS 176
              +  T   L      ++   
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 21/107 (19%), Positives = 32/107 (29%), Gaps = 18/107 (16%)

Query: 83  LAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL---- 138
           + P       L+    + +NL+  +P    N+          + +    P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 139 ---------KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                    +Q   L LNN  LS L P        L  L  S N L+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSL-PEL---PPHLESLVASCNSLT 104

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 31/162 (19%), Positives = 52/162 (32%), Gaps = 33/162 (20%)

Query: 36  SKLQDPNNSLQSWDNLPGNL----CTWFHITCNPE--GSVTRVDLGNAALSGELAPELGQ 89
             L   +N L     LP +L     +    +   E   ++  ++  +  +   L      
Sbjct: 260 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SL---CDL 315

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
             +LE L +  N L   +P+       L+ L    N     +P+   N   LK L +  N
Sbjct: 316 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQN---LKQLHVEYN 367

Query: 150 SLSGL--IPTSLT-------------TITSLNILDLSNNRLS 176
            L     IP S+                 +L  L +  N L 
Sbjct: 368 PLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 31/135 (22%), Positives = 54/135 (40%), Gaps = 30/135 (22%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           NN L++  +LP +L                +++ +  L+ +L      L  L++ E   +
Sbjct: 246 NNLLKTLPDLPPSL--------------EALNVRDNYLT-DLPELPQSLTFLDVSENIFS 290

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
            LS   P+       L  L+  SN    ++ D   +L++L    ++NN L  L P     
Sbjct: 291 GLSELPPN-------LYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLIEL-PAL--- 335

Query: 162 ITSLNILDLSNNRLS 176
              L  L  S N L+
Sbjct: 336 PPRLERLIASFNHLA 350

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 2/110 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
            V  ++L +  +  E+          ++ L +  N +    P    N+  L  L L  N 
Sbjct: 70  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            +        N  +L  L ++NN+L  +   +    TSL  L LS+NRL+
Sbjct: 129 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 26/110 (23%), Positives = 38/110 (34%), Gaps = 2/110 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
           +   V   N+ +  +L    L   + +ELL L    +      A      ++ L +  N 
Sbjct: 46  NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                P    N+  L  L L  N LS L          L  L +SNN L 
Sbjct: 105 IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 7/108 (6%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             VDL    L  ++      +++ LE L +  N L   +      +  LK LDL  N   
Sbjct: 251 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             +        +L+ L L++NS+  L    L+T  +L  L LS+N   
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 3/90 (3%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
              +  L +L L  N+LS        N  KL +L + +N       DT      L+ L+L
Sbjct: 113 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 172

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           ++N L+ +    L+ I SL   ++S N LS
Sbjct: 173 SSNRLTHV---DLSLIPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 10/109 (9%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S+   ++    LS      L     +E L+   N+++  +       ++L  L L  N  
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             T    L N   L  + L+ N L  ++      +  L  L +SNNRL 
Sbjct: 239 --TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 10/91 (10%)

Query: 87  LGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
                 L  L +  NNL   I          L++L L SN     +   L+ +  L +  
Sbjct: 137 FHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHAN 192

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           ++ N L     ++L    ++  LD S+N ++
Sbjct: 193 VSYNLL-----STLAIPIAVEELDASHNSIN 218

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 9/89 (10%), Positives = 31/89 (34%), Gaps = 2/89 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSAL--GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 147
             +    +++ +  +  +        L   K +   ++         L + +Q++ L LN
Sbjct: 18  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           +  +  +   +     ++  L +  N + 
Sbjct: 78  DLQIEEIDTYAFAYAHTIQKLYMGFNAIR 106

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 10/70 (14%), Positives = 25/70 (35%)

Query: 107 IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 166
           I S L        + +     +         L   K +   N+++  L    L +   + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 167 ILDLSNNRLS 176
           +L+L++ ++ 
Sbjct: 73  LLNLNDLQIE 82

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 7/146 (4%)

Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 351
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTN--GSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
            N++RLY    T  +  LV+ +M N             +    L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP-RGLELNLVKYFQWQLLQGL 121

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
           ++ HE+   KI+HRD+K  N+L+++ 
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKR 144

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 22/159 (13%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 351
            + ++   +LG+G FG+V K +     +  AVK + +      +      EV+++    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGS 405
            N+++L+      +   +V    T G +   +       E  ++          +I    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQV 130

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 443
             G++Y+H+H    I+HRD+K  NILL+        K I
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 29/146 (19%), Positives = 54/146 (36%), Gaps = 11/146 (7%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL----QFQTEVKIISMAVHRNL 354
             ++G+G F  V +      G+  AVK +   + +          + E  I  M  H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           + L    ++     +V+ +M    +   + +R  +                   L Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 415 HCDPKIIHRDVKAANILL---DEDAD 437
           +    IIHRDVK   +LL   +  A 
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAP 171

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 14/138 (10%)

Query: 303 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 357
           LG GG   VY     D  L   VA+K +        E    F+ EV   S   H+N++ +
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                      LV  Y+   +++  +        PL   T          G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 418 PKIIHRDVKAANILLDED 435
            +I+HRD+K  NIL+D +
Sbjct: 131 -RIVHRDIKPQNILIDSN 147

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 28/130 (21%), Positives = 48/130 (36%), Gaps = 4/130 (3%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
            V  ++L +  +  E+          ++ L +  N +    P    N+  L  L L  N 
Sbjct: 76  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
            +        N  +L  L ++NN+L  +   +    TSL  L LS+NRL+  V       
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDL-SLIP 192

Query: 187 QFTPISFENN 196
                +   N
Sbjct: 193 SLFHANVSYN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 7/108 (6%)

Query: 70  TRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             VDL    L  ++      +++ LE L +  N L   +      +  LK LDL  N   
Sbjct: 257 VEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             +        +L+ L L++NS+  L    L+T  +L  L LS+N   
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 26/110 (23%), Positives = 38/110 (34%), Gaps = 2/110 (1%)

Query: 68  SVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
           +   V   N+ +  +L    L   + +ELL L    +      A      ++ L +  N 
Sbjct: 52  NQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                P    N+  L  L L  N LS L          L  L +SNN L 
Sbjct: 111 IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 7/111 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSN 125
           ++ ++ +G  A+   L P + Q +  L +L L  N+LS  +P     N  KL +L + +N
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 157

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                  DT      L+ L+L++N L+ +    L+ I SL   ++S N LS
Sbjct: 158 NLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 10/109 (9%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S+   ++    LS      L     +E L+   N+++  +       ++L  L L  N  
Sbjct: 193 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 244

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             T    L N   L  + L+ N L  ++      +  L  L +SNNRL 
Sbjct: 245 --TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 9/89 (10%), Positives = 31/89 (34%), Gaps = 2/89 (2%)

Query: 90  LKNLELLELYGNNLSGHIPSAL--GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 147
             +    +++ +  +  +        L   K +   ++         L + +Q++ L LN
Sbjct: 24  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 83

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           +  +  +   +     ++  L +  N + 
Sbjct: 84  DLQIEEIDTYAFAYAHTIQKLYMGFNAIR 112

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 10/70 (14%), Positives = 25/70 (35%)

Query: 107 IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 166
           I S L        + +     +         L   K +   N+++  L    L +   + 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 167 ILDLSNNRLS 176
           +L+L++ ++ 
Sbjct: 79  LLNLNDLQIE 88

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 52/169 (30%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVK-------------------------RLKEERTSGGE 336
           +G+G +G V       D    A+K                              +  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 337 LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLD 394
            Q   E+ I+    H N+++L        E  L  V+  +  G V             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 395 WPTRKKIALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 435
            PT K ++   AR        G+ YLH     KIIHRD+K +N+L+ ED
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIV 110

Query: 356 RLYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
           RL  F  +  EK       LV  Y+   +V    R    +   L     K       R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDADQ 438
           +Y+H      I HRD+K  N+LLD D   
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAV 195

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKIISMAVH 351
              LG G  G+V         K VA+K        +   R +   L  +TE++I+    H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGS 405
             ++++  F     +  +V   M  G          RL+E    L         ++ L  
Sbjct: 75  PCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL------YFYQMLL-- 125

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
              + YLHE+    IIHRD+K  N+LL    +   
Sbjct: 126 --AVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 1/107 (0%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
            ++ L+L  N ++    S L   + L++L L SN  N    D+ ++L  L++L L+ N L
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
           S L  +    ++SL  L+L  N     + +   FS  T +      N
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGN 158

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 8/115 (6%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L  LE LE+  ++L  + P +L ++  +  L L+       +   +     ++ L L + 
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232

Query: 150 SLSGLIPTSLTTI--------TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
            L     + L+T          +   + +++  L   +      S    + F  N
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 18/114 (15%), Positives = 44/114 (38%), Gaps = 6/114 (5%)

Query: 87  LGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
              L  L++L +   +    I       L  L+ L++ ++      P +L +++ + +L 
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
           L+      L+   +   +S+  L+L +  L         FS+ +     + +  
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTF-----HFSELSTGETNSLIKK 253

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 26/113 (23%), Positives = 38/113 (33%), Gaps = 26/113 (23%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN----------------------LF 127
           L +LE L+L  N LS    S    L  L  L+L  N                        
Sbjct: 99  LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158

Query: 128 NGTI----PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             T         A L  L+ L ++ + L    P SL +I +++ L L   +  
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 3/117 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNL 126
           +V  +DL N  ++     +L +  NL+ L L  N ++  I   +  +L  L+ LDL  N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDN 182
            +         L  L +L L  N    L  TSL + +T L IL + N      +   
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 16/92 (17%), Positives = 32/92 (34%), Gaps = 9/92 (9%)

Query: 90  LKNLELLELYGNNLSG----HIPS----ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
             ++E LEL   +L       + +    +L      +++ +        +   L  +  L
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGL 279

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
             L  + N L  +       +TSL  + L  N
Sbjct: 280 LELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 22/112 (19%), Positives = 44/112 (39%), Gaps = 13/112 (11%)

Query: 87  LGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGT--------IPDTLAN 137
           L  ++N+  L L+       +    +     ++ L+L     +            ++L  
Sbjct: 194 LKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252

Query: 138 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
               + +++ + SL   +   L  I+ L  L+ S N+L   VPD G F + T
Sbjct: 253 KFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPD-GIFDRLT 301

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 25/70 (35%), Positives = 35/70 (50%), Gaps = 2/70 (2%)

Query: 107 IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN 166
           IPS L     +KSLDL +N         L     L+ L L +N ++ +   S +++ SL 
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103

Query: 167 ILDLSNNRLS 176
            LDLS N LS
Sbjct: 104 HLDLSYNYLS 113

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 10/65 (15%), Positives = 21/65 (32%), Gaps = 1/65 (1%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L +      +++   +L   +   L  +  L  L+   N            L  L+ + L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308

Query: 147 NNNSL 151
           + N  
Sbjct: 309 HTNPW 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 26/87 (29%), Positives = 37/87 (42%), Gaps = 3/87 (3%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           +K L  + +   N++  IP  L     L  L L  N        +L  L  L  L L+ N
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLS 176
           S+S +   SL     L  L L+NN+L 
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV 253

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 3/119 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
               +DL N  ++     +   LKNL  L L  N +S   P A   L+KL+ L L  N  
Sbjct: 53  DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
              +P+ +   K L+ LR++ N ++ +  +    +  + +++L  N L     +NG+F 
Sbjct: 113 K-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 7/109 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  L NL  L L  N++S     +L N   L+ L L +N     +P  LA+ K ++ + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 147 NNNSLSGL------IPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           +NN++S +       P   T   S + + L +N +        +F    
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 22/91 (24%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 88  GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-LFNGTIPD-TLANLKQLKYLR 145
              K L+ L ++ N ++    S    L ++  ++L +N L +  I +     +K+L Y+R
Sbjct: 118 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           + + +++  IP  L    SL  L L  N+++
Sbjct: 178 IADTNITT-IPQGL--PPSLTELHLDGNKIT 205

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 15/94 (15%), Positives = 33/94 (35%), Gaps = 11/94 (11%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT-------LANLKQLK 142
             +L  L L  N L   +P  L +   ++ + L++N  +  I                  
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296

Query: 143 YLRLNNNSL--SGLIPTSLTTITSLNILDLSNNR 174
            + L +N +    + P++   +     + L N +
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 37/156 (23%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAV 350
           +D +  + +LG+G FG+V   +    G+  AVK + + +            EV+++    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 408
           H N+++LY F        LV    T G +   +  R+       +      +I      G
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSG 138

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 443
           ++Y+H++   KI+HRD+K  N+LL+  +  ++ + I
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 30/146 (20%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 359
           LG G FGKV  G+    G  VAVK L  ++  +     + + E++ + +  H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 360 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 409
             +T ++  +V  Y++ G +        RL E++S         R+     ++     G+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES---------RRLFQQILS-----GV 129

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            Y H H    ++HRD+K  N+LLD  
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAH 152

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 347
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 408 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 30/92 (32%), Positives = 37/92 (40%), Gaps = 1/92 (1%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
              G L  L  L+L  N L   +P     L  L  LD+  N         L  L +L+ L
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L  N L  L P  LT    L  L L+NN L+
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 1/107 (0%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
             +DL +  L   L      L  L +L++  N L+     AL  L +L+ L L  N    
Sbjct: 80  GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             P  L    +L+ L L NN+L+ L    L  + +L+ L L  N L 
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 27/157 (17%)

Query: 295 DGFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQF-QT---EVKI--- 345
             +     +G G +GKV+K R     G+ VA+KR++ +    G      +   EV +   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRH 67

Query: 346 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 398
           +    H N++RL+  CT           LV+ ++        L     +   P +   T 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           K +     RGL +LH H   +++HRD+K  NIL+   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             +  L++++ L+L    ++    + L  L  L+ L L  N      P  LA L  L+YL
Sbjct: 101 SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            + N  +S L P  L  ++ L  L   +N++S
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 18/131 (13%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L NL+ L +    +S  + + L NL KL +L    N  +  I   LA+L  L  +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEV 200

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP------------DNGSFSQFTPIS 192
            L NN +S + P  L   ++L I+ L+N  ++                   S +   P +
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258

Query: 193 FENNLNLCGPN 203
             +N     PN
Sbjct: 259 ISDNGTYASPN 269

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 22/109 (20%), Positives = 46/109 (42%), Gaps = 8/109 (7%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           +  ++  G + ++         L  +  L  +G  ++  I   +  L  L  L+L  N  
Sbjct: 20  NAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
               P  L NL ++  L L+ N L  +    +  + S+  LDL++ +++
Sbjct: 76  TDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 21/90 (23%), Positives = 36/90 (40%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
              L N   +    +N++        +L  + +L  +      TI   +  L  L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            +N ++ L P  L  +T +  L+LS N L 
Sbjct: 71  KDNQITDLAP--LKNLTKITELELSGNPLK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 21/108 (19%), Positives = 37/108 (34%), Gaps = 4/108 (3%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L NL  + L  N +S    S L N   L  + L +            NL      
Sbjct: 189 SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP--N 244

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
            +   S + + P +++   +    +L+ N  S     + +F+Q     
Sbjct: 245 VVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFK 292

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 347
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 408 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 33/151 (21%), Positives = 60/151 (39%), Gaps = 25/151 (16%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
           K  LG+G F  V +      G   A K +  ++ S  + Q  + E +I     H N++RL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GL 409
           +      +   LV+  +T G +   +  R+         +        A          +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-------SEAD-----ASHCIQQILESI 118

Query: 410 SYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
           +Y H +    I+HR++K  N+LL   A  ++
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAA 146

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 21/99 (21%), Positives = 40/99 (40%), Gaps = 1/99 (1%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLNNNS 150
           ++  ++L  N+++    ++   L  L+ L +        I  +T   L  L  L+L+ N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 151 LSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
              L   +   + +L +L L+   L G V     F   T
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT 129

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 38/153 (24%), Positives = 59/153 (38%), Gaps = 12/153 (7%)

Query: 41  PNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYG 100
            + + +  DN      T+  +  +    V   DL  + +   L        +LE L L  
Sbjct: 257 GHTNFKDPDN-----FTFKGLEAS---GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQ 308

Query: 101 NNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
           N ++  I   A   L  L  L+L  N           NL +L+ L L+ N +  L   S 
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF 367

Query: 160 TTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
             + +L  L L  N+L   VPD G F + T + 
Sbjct: 368 LGLPNLKELALDTNQLKS-VPD-GIFDRLTSLQ 398

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 26/85 (30%), Positives = 33/85 (38%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
            L +L  L L  N L         NL KL+ LDL  N        +   L  LK L L+ 
Sbjct: 321 GLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380

Query: 149 NSLSGLIPTSLTTITSLNILDLSNN 173
           N L  +       +TSL  + L  N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 3/114 (2%)

Query: 90  LKNLELLELYGNNL-SGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRL 146
           L NLE+L L   NL    +       L  L+ L L  N      P +   N+++   L L
Sbjct: 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL 161

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
             N +  +    L      +   L  + ++    +          +   N ++ 
Sbjct: 162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 18/65 (27%), Positives = 30/65 (46%), Gaps = 4/65 (6%)

Query: 89  QLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRL 146
            L  LE+L+L  N++   +   +   L  LK L L +N    ++PD     L  L+ + L
Sbjct: 345 NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402

Query: 147 NNNSL 151
           + N  
Sbjct: 403 HTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 21/115 (18%), Positives = 40/115 (34%), Gaps = 17/115 (14%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP---DTLANLKQLKYLRL 146
           L ++ L ++    L             + +LDL  N F  ++           +++ L L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 147 NN--NSLSGLIPTSLTTI----------TSLNILDLSNNRLSGPVPDNGSFSQFT 189
           +N  N  S    T+              + +   DLS +++   +     FS FT
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LL-KSVFSHFT 299

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 19/119 (15%), Positives = 33/119 (27%), Gaps = 13/119 (10%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIK--LKSLDLYSN--------LFNGTIPDTLANLK 139
           ++   +L+L  N +       L N        L L S                       
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212

Query: 140 QLKYLRLNNNSLSGLIP---TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFEN 195
            +  L L+ N     +          T +  L LSN+   G    + +F      +F+ 
Sbjct: 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 4/99 (4%)

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
           +   +L +  N +S    S + +L KL+ L +  N             ++L+YL L++N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 151 LSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           L  +         +L  LDLS N     +P    F   +
Sbjct: 81  LVKISCHPT---VNLKHLDLSFNAFDA-LPICKEFGNMS 115

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 27/141 (19%), Positives = 47/141 (33%), Gaps = 9/141 (6%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
             T +++    +S     ++  L  L +L +  N +     S      +L+ LDL  N  
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDNGSFS 186
              I         LK+L L+ N+   L        ++ L  L LS   L        S  
Sbjct: 82  V-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-----KSSVL 133

Query: 187 QFTPISFENNLNLCGPNTKKP 207
               ++    L + G    + 
Sbjct: 134 PIAHLNISKVLLVLGETYGEK 154

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 21/119 (17%), Positives = 46/119 (38%), Gaps = 5/119 (4%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++   +   +           ++     L+   N L+  +    G+L +L++L L  N  
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360

Query: 128 NGTIPDT---LANLKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDN 182
              +         +K L+ L ++ NS+S        +   SL  L++S+N L+  +   
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 33/146 (22%), Positives = 53/146 (36%), Gaps = 26/146 (17%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLS--GHIPSALGNLIKLKSLDLYSN 125
               +D  N  L+  +    G L  LE L L  N L     I      +  L+ LD+  N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384

Query: 126 LFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSLTT---------------------IT 163
             +        +  K L  L +++N L+  I   L                       + 
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLE 444

Query: 164 SLNILDLSNNRLSGPVPDNGSFSQFT 189
           +L  L++++N+L   VPD G F + T
Sbjct: 445 ALQELNVASNQLKS-VPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 23/101 (22%), Positives = 37/101 (36%), Gaps = 3/101 (2%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
              N+ +     +            +     LD  +NL   T+ +   +L +L+ L L  
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357

Query: 149 NSLSGLIPTSLTT--ITSLNILDLSNNRLSGPVPDNGSFSQ 187
           N L  L   +  T  + SL  LD+S N +S      G  S 
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK-GDCSW 397

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 12/133 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPEL-GQLKNLELLELYG 100
            N L+    +                S+ ++D+   ++S +         K+L  L +  
Sbjct: 357 MNQLKELSKIAEMTTQM--------KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 160
           N L+  I   L    ++K LDL+SN    +IP  +  L+ L+ L + +N L  +      
Sbjct: 409 NILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFD 465

Query: 161 TITSLNILDLSNN 173
            +TSL  + L  N
Sbjct: 466 RLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 30/196 (15%), Positives = 58/196 (29%), Gaps = 10/196 (5%)

Query: 4   RVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWD-NLPGNLCTWFHIT 62
             ++   V T+  + L  I    E +    F S L     + +  +  L     TW    
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238

Query: 63  ----CNPEGSVTRVDLGNAALSGELAPELG-----QLKNLELLELYGNNLSGHIPSALGN 113
                    +V    + N  L G+L           LK L + ++  +            
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 114 LIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
              +   +   +          + +    +L  +NN L+  +  +   +T L  L L  N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 174 RLSGPVPDNGSFSQFT 189
           +L          +Q  
Sbjct: 359 QLKELSKIAEMTTQMK 374

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 23/179 (12%), Positives = 49/179 (27%), Gaps = 9/179 (5%)

Query: 6   LVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNP 65
           L  +   ++ +V       +  +D      + L+  N      DN               
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF-LSILAKLQT 218

Query: 66  EGSVTRVDLGNAALSGELAPELGQL---KNLELLELYGNNLSGHIPSALGNLI-----KL 117
              ++ + L N   +      + QL     +    +    L G +     +        L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278

Query: 118 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
               + S++F             +       +    +     + I+    LD SNN L+
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 23/111 (20%), Positives = 48/111 (43%), Gaps = 14/111 (12%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
            NS+    +     C+W         S+  +++ +  L+  +   L     +++L+L+ N
Sbjct: 383 QNSVSY--DEKKGDCSWT-------KSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431

Query: 102 NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSL 151
            +   IP  +  L  L+ L++ SN    ++PD     L  L+ + L+ N  
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 20/148 (13%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRL 357
           +++LG G   +V     L   +  AVK ++++       +   EV+++     HRN+L L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 412
             F        LV+  M  GS+ S + +R+            + +     + SA  L +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-------NELEASVVVQDVASA--LDFL 127

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQSS 440
           H      I HRD+K  NIL +     S 
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSP 152

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 25/160 (15%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 347
            D +     LG G F  V K R    GK  A K     RL   R      + + EV I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 402
              H N++ L+      T+ +L+   ++ G +   L E++S        T  +       
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-------LTEDEATQFLKQ 116

Query: 403 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
            L    G+ YLH     +I H D+K  NI+L +    + +
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 17/176 (9%)

Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK 328
            A      Q+G+   F +      +D +  K  LG+G F  V +      G   A K + 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 329 EERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 387
            ++ S  + Q  + E +I     H N++RL+      +   LV+  +T G +   +  R+
Sbjct: 64  TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123

Query: 388 SSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQS 439
                    +    A    +     ++Y H +    I+HR++K  N+LL   A  +
Sbjct: 124 FY-------SEAD-ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 37/149 (24%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHRNLLRLYG 359
           LG G FGKV         + VA+K +  +     ++  +   E+  + +  H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 360 FCTTVTEKLLVYPY---------MTNGSVASRLRERQSSLPPLDWPTRKK----IALGSA 406
             TT T+ ++V  Y         +       R+ E +          R+     I     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKK----RMTEDEG---------RRFFQQIIC---- 119

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
             + Y H H   KI+HRD+K  N+LLD++
Sbjct: 120 -AIEYCHRH---KIVHRDLKPENLLLDDN 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.4 bits (169), Expect = 8e-13
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  LK L+ L L  N +S  I + L +L +L+SL L +N    T    L+ L +L  L L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSL 160

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            +N +S +    L  +T L  L LS N +S
Sbjct: 161 EDNQISDI--VPLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 67.1 bits (163), Expect = 4e-12
 Identities = 22/108 (20%), Positives = 44/108 (40%), Gaps = 8/108 (7%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             + +L   +++        +L +++ +    +++   +   +  L  +  L L  N   
Sbjct: 23  TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 78

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              P  L NLK L +L L+ N +  L    L  +  L  L L +N +S
Sbjct: 79  DIKP--LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.3 bits (161), Expect = 7e-12
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 12/111 (10%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           S+ ++   N+ +   +   +  L N+  L L GN L+  I   L NL  L  L L  N  
Sbjct: 44  SIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN-- 97

Query: 128 NGTIPD--TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              I D  +L +LK+LK L L +N +S +    L  +  L  L L NN+++
Sbjct: 98  --KIKDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT 144

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 31/122 (25%), Positives = 50/122 (40%), Gaps = 6/122 (4%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  L  LE L L  N ++    + L  L KL +L L  N  +  I   LA L +L+ L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKK 206
           + N +S L    L  + +L++L+L +        ++ S           + +L  P    
Sbjct: 183 SKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

Query: 207 PC 208
             
Sbjct: 241 DD 242

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.4 bits (143), Expect = 1e-09
 Identities = 15/90 (16%), Positives = 32/90 (35%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
                      L   +++         L  +  +   ++    ++   +  L  +  L L
Sbjct: 17  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 72

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N N L+ + P  LT + +L  L L  N++ 
Sbjct: 73  NGNKLTDIKP--LTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 2/95 (2%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L  L+ L L  N++S     AL  L  L  L+L+S        +  +NL     +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV 179
           +  + SL      S         +       +  V
Sbjct: 227 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 40.9 bits (95), Expect = 7e-04
 Identities = 7/60 (11%), Positives = 19/60 (31%), Gaps = 4/60 (6%)

Query: 117 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           +      S       PD      +     L   S++  +      + S++ +  +N+ + 
Sbjct: 1   MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
            + +     LGRG FG V++    +  K    K +K       ++  + E+ I+++A HR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----G 408
           N+L L+    ++ E ++++ +++   +  R+      L   +        +         
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 443
           L +LH H    I H D++  NI+       + K I
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII 146

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 263 HEFFFDVPAED--DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-G 319
           HE+    P  D  DS      L+   L    V  + F    +LG+GGFG+V   ++   G
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209

Query: 320 KLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMT 375
           K+ A K+L+++R     GE     E +I+     R ++ L Y + T   + L LV   M 
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMN 267

Query: 376 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            G +   +                  A     GL  LH     +I++RD+K  NILLD+ 
Sbjct: 268 GGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 29/119 (24%), Positives = 51/119 (42%), Gaps = 3/119 (2%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
             T +DL N  +S     +   L++L  L L  N +S     A   L KL+ L +  N  
Sbjct: 55  DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
              IP  L     L  LR+++N +  +     + + ++N +++  N L     + G+F 
Sbjct: 115 V-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 10/119 (8%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L +   L  L L  N +      +L  L  L+ L L +N  +  +P  L +LK L+ + L
Sbjct: 213 LLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271

Query: 147 NNNSLSGLIPTS------LTTITSLNILDLSNNRLSGPVPDNGSFS---QFTPISFENN 196
           + N+++ +                 N + L NN +        +F        I F N 
Sbjct: 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 24/85 (28%), Positives = 35/85 (41%), Gaps = 3/85 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
            L  L +    L+  IP  L     L  L L  N       + L    +L  L L +N +
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
             +   SL+ + +L  L L NN+LS
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLS 254

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 11/94 (11%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT-------LANLKQLK 142
           L  L  L L  N LS  +P+ L +L  L+ + L++N     +                  
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297

Query: 143 YLRLNNNSLS--GLIPTSLTTITSLNILDLSNNR 174
            + L NN +    + P +   +T    +   N +
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 20/85 (23%), Positives = 35/85 (41%), Gaps = 3/85 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
           +L +++     L   +P  +        LDL +N  +    D    L+ L  L L NN +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
           S +   + + +  L  L +S N L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV 115

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 16/86 (18%), Positives = 32/86 (37%), Gaps = 11/86 (12%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-------ALGNLIKLKSLDLYSN 125
            L N  LS  +   L  LK L+++ L+ NN++  +                   + L++N
Sbjct: 247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNN 304

Query: 126 -LFNGTI-PDTLANLKQLKYLRLNNN 149
            +    + P T   +     ++  N 
Sbjct: 305 PVPYWEVQPATFRCVTDRLAIQFGNY 330

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 19/148 (12%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
             +LG+G FG+V K +     +  AVK + +      +      EV+++    H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 412
           +      +   +V    T G +   + +R+         +    A     + S   ++Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRF-------SEHDAARIIKQVFSG--ITYM 137

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQSS 440
           H+H    I+HRD+K  NILL+       
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCD 162

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 34/138 (24%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 303 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 357
           +GRGG G VY+    D      VA+K + E  +S    +   Q E +        +++ +
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
           + F     +  +    +    +A+ LR +     PL  P    I       L   H    
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 418 PKIIHRDVKAANILLDED 435
               HRDVK  NIL+  D
Sbjct: 154 -GATHRDVKPENILVSAD 170

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 18/142 (12%)

Query: 303 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 357
           LG GG  +V+  R  D +    VAVK L+ +          F+ E +  +   H  ++ +
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 358 Y--GFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           Y  G   T    L  +V  Y+   ++   +        P+      ++   + + L++ H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH 133

Query: 414 EHCDPKIIHRDVKAANILLDED 435
           ++    IIHRDVK ANI++   
Sbjct: 134 QN---GIIHRDVKPANIMISAT 152

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 30/183 (16%)

Query: 267 FDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK 325
           F    E D   +  Q K   L    +  + FS   I+GRGGFG+VY  R AD GK+ A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220

Query: 326 RLKEER--TSGGELQFQTEVKI---ISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGS 378
            L ++R     GE     E  +   +S      ++ + Y F T   +KL  +   M  G 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGD 278

Query: 379 VASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
           +   L +    S          +     I LG    L ++H      +++RD+K ANILL
Sbjct: 279 LHYHLSQHGVFSEA------DMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILL 325

Query: 433 DED 435
           DE 
Sbjct: 326 DEH 328

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  LK L+ L L  N +S  I + L +L +L+SL L +N    T    L+ L +L  L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSL 163

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            +N +S ++P  L  +T L  L LS N +S
Sbjct: 164 EDNQISDIVP--LAGLTKLQNLYLSKNHIS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 24/108 (22%), Positives = 47/108 (43%), Gaps = 8/108 (7%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             + +L   +++        +L +++ +    +++   +   +  L  +  L L  N   
Sbjct: 26  TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              P  LANLK L +L L+ N +  L  +SL  +  L  L L +N +S
Sbjct: 82  DIKP--LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 10/92 (10%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYL 144
           +  L N+  L L GN L+  I   L NL  L  L L  N     + D  +L +LK+LK L
Sbjct: 64  IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENK----VKDLSSLKDLKKLKSL 117

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L +N +S +    L  +  L  L L NN+++
Sbjct: 118 SLEHNGISDING--LVHLPQLESLYLGNNKIT 147

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 27/102 (26%), Positives = 42/102 (41%), Gaps = 6/102 (5%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L +L  L+ L L  N +S  I   L  L KL++L L  N  + +    LA LK L  L L
Sbjct: 152 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN--HISDLRALAGLKNLDVLEL 207

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFS 186
            +           + +   N +  ++  L  P    D+G + 
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 249

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
                      L   +++         L  +  +   ++    ++   +  L  +  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N N L+ + P  L  + +L  L L  N++ 
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVK 103

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 8/68 (11%), Positives = 24/68 (35%), Gaps = 4/68 (5%)

Query: 109 SALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL 168
            +     +    +L        +      L  +  +  NN+ +  +    +  + ++  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKL 73

Query: 169 DLSNNRLS 176
            L+ N+L+
Sbjct: 74  FLNGNKLT 81

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 4/108 (3%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             L  L  L+ L L  N++S  +  AL  L  L  L+L+S        +  +NL     +
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
           +  + SL      S         +       +  V  +  F Q   I 
Sbjct: 230 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV--SFIFYQPVTIG 275

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 17/146 (11%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
              LG+G F  V +   +  G+  A   +  ++ S  + Q  + E +I  +  H N++RL
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLH 413
           +   +      L++  +T G +   +  R+         +    A    +     + + H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYY-------SEAD-ASHCIQQILEAVLHCH 127

Query: 414 EHCDPKIIHRDVKAANILLDEDADQS 439
           +     ++HR++K  N+LL      +
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGA 150

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 25/160 (15%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 347
            D +     LG G F  V K R  + G   A K     R K  R        + EV I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 402
              H N++ L+      T+ +L+   +  G +   L E++S        T ++       
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------LTEEEATEFLKQ 122

Query: 403 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
            L    G+ YLH     +I H D+K  NI+L +      +
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 24/155 (15%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H 351
           TDG+  K  +G G +    +    A     AVK + + +    E     E++I+     H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQH 75

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSA 406
            N++ L           +V   M  G +  ++  ++         + ++ +     +   
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-------SEREASAVLFTITKT 128

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
             + YLH      ++HRD+K +NIL  +++     
Sbjct: 129 --VEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 36/163 (22%), Positives = 55/163 (33%), Gaps = 25/163 (15%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL 96
           KL   NN L S   LP  L                + +    L+  L     +LK L + 
Sbjct: 205 KLWAYNNRLTSLPALPSGL--------------KELIVSGNRLT-SLPVLPSELKELMV- 248

Query: 97  ELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 156
              GN L+  +P     L    SL +Y N     +P++L +L     + L  N LS    
Sbjct: 249 --SGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301

Query: 157 TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
            +L  ITS      S   +   +    +  +   +       L
Sbjct: 302 QALREITSAP--GYSGPIIRFDMAGASAPRETRALHLAAADWL 342

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 24/121 (19%), Positives = 47/121 (38%), Gaps = 23/121 (19%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG 129
             +++G + L+  L   L    ++  L +  NNL+  +P+    L   ++L++  N    
Sbjct: 43  AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPEL---RTLEVSGNQLT- 94

Query: 130 TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT--------------ITSLNILDLSNNRL 175
           ++P     L +L         L  L P+ L                   L  L +S+N+L
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPAL-PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQL 153

Query: 176 S 176
           +
Sbjct: 154 A 154

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 30/160 (18%)

Query: 37  KLQDPNNSLQSWDNLPGNLCT----WFHITCNPE--GSVTRVDLGNAALSGELAPELGQL 90
           +L   +N L     LP  LC        +T  P     +  + + +  L+  L     +L
Sbjct: 105 ELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSEL 163

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
             L       N L+  +P     L   + L +  N    ++P   + L +L        S
Sbjct: 164 CKLWAY---NNQLT-SLPMLPSGL---QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS 215

Query: 151 LSGLIPTSLTT--------------ITSLNILDLSNNRLS 176
           L  L P+ L                 + L  L +S NRL+
Sbjct: 216 LPAL-PSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT 254

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 33/155 (21%), Positives = 55/155 (35%), Gaps = 38/155 (24%)

Query: 36  SKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLEL 95
           + L  P+N+L S   LP  L                +++    L+  L      L  L +
Sbjct: 64  TTLVIPDNNLTSLPALPPEL--------------RTLEVSGNQLT-SLPVLPPGLLELSI 108

Query: 96  LELYGNNLSGHIPSALGNLI--------------KLKSLDLYSNLFNGTIPDTLANLKQL 141
                 +L   +PS L  L                L+ L +  N    ++P   + L +L
Sbjct: 109 FSNPLTHLPA-LPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKL 166

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
                 NN L+ L P      + L  L +S+N+L+
Sbjct: 167 W---AYNNQLTSL-PML---PSGLQELSVSDNQLA 194

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 17/93 (18%), Positives = 35/93 (37%), Gaps = 9/93 (9%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
                +L +  + L+  +P  L     + +L +  N    ++P       +L+ L ++ N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN 182
            L+ L P     +  L+I       L   +P  
Sbjct: 92  QLTSL-PVLPPGLLELSIFSNPLTHLP-ALPSG 122

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 29/114 (25%), Positives = 44/114 (38%), Gaps = 4/114 (3%)

Query: 63  CNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLD 121
           C P GS + +          L   L   +NL  L +       H+    L  L +L++L 
Sbjct: 5   CCPHGS-SGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 122 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
           +  +      PD      +L  L L+ N+L  L   ++    SL  L LS N L
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 1e-08
 Identities = 15/77 (19%), Positives = 28/77 (36%), Gaps = 1/77 (1%)

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGLIPTSL 159
            + +      L     L  L + +      +    L  L +L+ L +  + L  + P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 160 TTITSLNILDLSNNRLS 176
                L+ L+LS N L 
Sbjct: 77  HFTPRLSRLNLSFNALE 93

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 14/151 (9%)

Query: 294 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVH 351
            D F  + + G+G FG V  G+    G  VA+K+ +++ R    ELQ    ++ +++  H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78

Query: 352 RNLLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 404
            N+++L  +  T+ E+        +V  Y+   ++    R              K     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             R +  LH      + HRD+K  N+L++E 
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEA 167

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 29/143 (20%), Positives = 43/143 (30%), Gaps = 14/143 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGN 101
           N S  + D     L  W          +  + +  A        ++     L  L+L  N
Sbjct: 130 NVSWATRDAWLAELQQWLK------PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183

Query: 102 NLSGHIP----SALGNLIKLKSLDLYSNLFN---GTIPDTLANLKQLKYLRLNNNSLSGL 154
              G               L+ L L +       G      A   QL+ L L++NSL   
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243

Query: 155 IPTSLTTI-TSLNILDLSNNRLS 176
                    + LN L+LS   L 
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 32/116 (27%), Positives = 42/116 (36%), Gaps = 6/116 (5%)

Query: 74  LGNAALSGELAP-ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
           LG   L   L P +   L+ L L        SG   +     ++L+ LDL  N       
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 133 DTL-ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
                   QL  L L+   L  + P  L     L++LDLS NRL    P      Q
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQV-PKGLP--AKLSVLDLSYNRLDR-NPSPDELPQ 297

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 27/130 (20%), Positives = 42/130 (32%), Gaps = 12/130 (9%)

Query: 68  SVTRVDLGNAALSGELA--PELGQL--KNLELLELYGNNLSGHIPSALGNLIKLKSLDLY 123
            +  ++L N + +   A   EL Q     L++L +   +        +     L +LDL 
Sbjct: 122 DLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 124 SNLFNGTI-------PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            N   G         P     L+ L        + SG+          L  LDLS+N L 
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

Query: 177 GPVPDNGSFS 186
                  S  
Sbjct: 242 D-AAGAPSCD 250

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 26/137 (18%), Positives = 42/137 (30%), Gaps = 6/137 (4%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSA-LGNLIKLKSL 120
           +CN              L        G  ++LE L    +  +       +   + LK L
Sbjct: 14  SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73

Query: 121 DLYSNLFNGTIPDTLA---NLKQLKYLRLNNNSLSGLIPTSLT--TITSLNILDLSNNRL 175
            + +      I         +  L+ L L N  ++G  P  L   T   LNIL+L N   
Sbjct: 74  TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133

Query: 176 SGPVPDNGSFSQFTPIS 192
           +          Q+    
Sbjct: 134 ATRDAWLAELQQWLKPG 150

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 18/97 (18%), Positives = 40/97 (41%), Gaps = 3/97 (3%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRL-NNN 149
           + + L+L   +L      A  NL  +  + +  ++    +   +  NL ++ ++ + N  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFS 186
           +L+ + P +L  +  L  L + N  L    PD     
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVY 127

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 23/112 (20%), Positives = 45/112 (40%), Gaps = 4/112 (3%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLN 147
           L N+  + +  +     + S +  NL K+  +++ +      I  D L  L  LK+L + 
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 148 NNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
           N  L      T + +     IL++++N     +P N +F      +    L 
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN-AFQGLCNETLTLKLY 164

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 7/117 (5%)

Query: 87  LGQLKNLELLELYGNNLSGHIPS-ALGNLIK-LKSLDLYSNLFNGTIPDTLANLKQLKYL 144
           +       +LE+  N     IP  A   L     +L LY+N F  ++     N  +L  +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 145 RL-NNNSLSGLIPTSLTTITS-LNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
            L  N  L+ +   +   + S  ++LD+S   ++  +P  G       +   N   L
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKG-LEHLKELIARNTWTL 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 18/89 (20%), Positives = 37/89 (41%), Gaps = 6/89 (6%)

Query: 90  LKNLELLELYGNNLSGHIP--SALGNLIKLKSLDLYSNLFNGTIP-DTLANL-KQLKYLR 145
           L  L+ L ++   L    P  + + +      L++  N +  +IP +    L  +   L+
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNR 174
           L NN  +  +       T L+ + L+ N+
Sbjct: 163 LYNNGFTS-VQGYAFNGTKLDAVYLNKNK 190

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 33/170 (19%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK------------EERTSGGELQFQ 340
            + +     LG G +G+V   +        A+K +K             +       +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 341 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLD 394
            E+ ++    H N+++L+          LV  +   G +  ++       E  ++     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----- 149

Query: 395 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 443
                 I      G+ YLH+H    I+HRD+K  NILL+      + K +
Sbjct: 150 -----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)

Query: 300 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR 352
              LGRG FG+V +         A  + VAVK LKE  T        +E+KI+     H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 353 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL 393
           N++ L G CT     L+V   +   G++++ LR +++   P 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 64.5 bits (158), Expect = 9e-12
 Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 21/148 (14%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           +N +GRG +G+V            A K++ +      + +F+ E++I+    H N++RLY
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72

Query: 359 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
                 T+  LV    T G            RE  ++         K +       ++Y 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDV----LSAVAYC 122

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQSS 440
           H+     + HRD+K  N L   D+  S 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSP 147

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTE 342
            L+E+++  D F    ++GRG F +V   ++   G++ A+K + K +    GE+  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 343 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
             ++     R + +L + F       L LV  Y   G + + L  +     P +   R  
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFY 167

Query: 401 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +A +  A  +  +H       +HRD+K  NILLD  
Sbjct: 168 LAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC 198

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 21/101 (20%), Positives = 39/101 (38%), Gaps = 3/101 (2%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
              L++L+L    +   I   A  +L  L +L L  N          + L  L+ L    
Sbjct: 51  FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
            +L+ L    +  + +L  L++++N +         FS  T
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 5/93 (5%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLRLN 147
            L +L+ L     NL+      +G+L  LK L++  N + +  +P+  +NL  L++L L+
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 148 NNSLSGLIPTSLTTITSLNI----LDLSNNRLS 176
           +N +  +  T L  +  + +    LDLS N ++
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 2/86 (2%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNS 150
           + + L+L  N L      +  +  +L+ LDL       TI D    +L  L  L L  N 
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 151 LSGLIPTSLTTITSLNILDLSNNRLS 176
           +  L   + + ++SL  L      L+
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLA 113

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 28/90 (31%), Positives = 38/90 (42%), Gaps = 7/90 (7%)

Query: 89  QLKNLELLELYGNNLSGHIPS-ALGNLIKLK----SLDLYSNLFNGTIPDTLANLKQLKY 143
            L NLE L+L  N +   I    L  L ++     SLDL  N  N   P     + +LK 
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKE 204

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
           L L+ N L  +       +TSL  + L  N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 342
            ++++++  + F    ++GRG FG+V   +L +  K+ A+K L K E     E   F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 343 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
             ++     + +  L Y F       L LV  Y   G + + L + +  LP  +   R  
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPE-EM-ARFY 180

Query: 401 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           +A +  A  +  +H+      +HRD+K  NIL+D +
Sbjct: 181 LAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN 211

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 54/188 (28%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG- 359
            +GRGGFG V++ +   D    A+KR++         +   EVK ++   H  ++R +  
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 360 -------------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
                            + ++   +P  +   + +   + +   P     T  ++   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 407 RGLSYLH-EHCDP--------------------------------------KIIHRDVKA 427
           +   Y+  + C                                         ++HRD+K 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 428 ANILLDED 435
           +NI    D
Sbjct: 193 SNIFFTMD 200

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 4/89 (4%)

Query: 91  KNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRL-N 147
           +N   L      L   I   A      L+ +++  N     I  D  +NL +L  +R+  
Sbjct: 30  RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            N+L  + P +   + +L  L +SN  + 
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIK 117

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 3/111 (2%)

Query: 90  LKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDL-YSNLFNGTIPDTLANLKQLKYLRLN 147
             +LE +E+  N++   I +    NL KL  + +  +N      P+   NL  L+YL ++
Sbjct: 53  FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN 198
           N  +  L            +LD+ +N     +  N SF   +  S    LN
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN-SFVGLSFESVILWLN 162

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 21/113 (18%), Positives = 35/113 (30%), Gaps = 4/113 (3%)

Query: 89  QLKNLELLELYGNNLSGHIPS-ALGNL-IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
                 LL++  N     I   +   L  +   L L  N             +  +    
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNL 199
           +NN+L  L        +   ILD+S  R+   +P  G       +   +  NL
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.9 bits (127), Expect = 7e-08
 Identities = 15/109 (13%), Positives = 26/109 (23%), Gaps = 3/109 (2%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
              +L L  N +     SA       +     +N       D          L ++   +
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
             L    L  +  L      N +    +P           S     + C
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLKK---LPTLEKLVALMEASLTYPSHCC 260

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 34/195 (17%), Positives = 74/195 (37%), Gaps = 20/195 (10%)

Query: 42  NNSLQSWDNLPGNL----CTWFHITCNPE--GSVTRVDLGNAALSGELAPELGQLKNLEL 95
           +N L +   LP +L         +T  PE    +  ++  N  L+  L        +LE+
Sbjct: 109 DNRLSTLPELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLT-MLPELPT---SLEV 164

Query: 96  LELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLK----YLRLNNNSL 151
           L +  N L+  +P    +L   ++LD+ +NL   ++P         +    + R   N +
Sbjct: 165 LSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGS 211
           + + P ++ ++     + L +N LS  + ++ S     P      +     + ++     
Sbjct: 220 THI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHR 278

Query: 212 PPFSPPPPFGPTSSP 226
           P       + P +  
Sbjct: 279 PLADAVTAWFPENKQ 293

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 17/110 (15%)

Query: 73  DLGNAALSGEL------APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL 126
                AL GE         +   +     L+L   NLS  +P  L    ++  L++  N 
Sbjct: 35  KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNA 91

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              ++P+  A+   L+YL   +N LS L P       SL  LD+ NN+L+
Sbjct: 92  L-ISLPELPAS---LEYLDACDNRLSTL-PEL---PASLKHLDVDNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 26/109 (23%), Positives = 37/109 (33%), Gaps = 23/109 (21%)

Query: 88  GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN---GTIPDTLANLKQLKYL 144
               +L     Y N +SG          K +   L     N     + + L  + Q   L
Sbjct: 8   NNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSEL 64

Query: 145 RLNNNSLSGL---IPTSLTT--------------ITSLNILDLSNNRLS 176
           +LN  +LS L   +P  +T                 SL  LD  +NRLS
Sbjct: 65  QLNRLNLSSLPDNLPPQITVLEITQNALISLPELPASLEYLDACDNRLS 113

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 27/149 (18%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR-NLLRLYG 359
           LGRG F  V +    + G+  A K LK+ R           E+ ++ +A     ++ L+ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 360 FCTTVTEKLLVYPYMTNG--------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
                +E +L+  Y   G         +A  + E             K+I      G+ Y
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQI----LEGVYY 146

Query: 412 LHEHCDPKIIHRDVKAANILL---DEDAD 437
           LH++    I+H D+K  NILL       D
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGD 172

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 25/127 (19%), Positives = 48/127 (37%), Gaps = 5/127 (3%)

Query: 68  SVTRVDLGNAALSGELAPE--LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
               + L N   +  L       +L  L  +    N ++     A      +  + L SN
Sbjct: 33  YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
                       L+ LK L L +N ++ +   S   ++S+ +L L +N+++  V   G+F
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP-GAF 149

Query: 186 SQFTPIS 192
                +S
Sbjct: 150 DTLHSLS 156

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 22/85 (25%), Positives = 36/85 (42%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
               +  + L  N L          L  LK+L L SN       D+   L  ++ L L +
Sbjct: 79  GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138

Query: 149 NSLSGLIPTSLTTITSLNILDLSNN 173
           N ++ + P +  T+ SL+ L+L  N
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLAN 163

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 34/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
             +LG G F +V+  +    GKL A+K +K +  +  +   + E+ ++    H N++ L 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 359 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
               + T   LV   ++ G             E+ +SL        +++       + YL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQV----LSAVKYL 122

Query: 413 HEHCDPKIIHRDVKAANILLDEDADQSS 440
           HE+    I+HRD+K  N+L     + S 
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSK 147

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 62.1 bits (151), Expect = 5e-11
 Identities = 16/138 (11%), Positives = 37/138 (26%), Gaps = 16/138 (11%)

Query: 303 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 357
            G     + ++    D  L   VA+  +  +     ++     +    +S      + R+
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                T    L+V  ++  GS+            P       +     A      H    
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSP---VGAIRAMQSLAAAADAAHRA-- 148

Query: 418 PKIIHRDVKAANILLDED 435
             +       + + +  D
Sbjct: 149 -GVALSIDHPSRVRVSID 165

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 29/119 (24%), Positives = 50/119 (42%), Gaps = 15/119 (12%)

Query: 86  ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
              +  ++ +L L   +L+  +   L  L+ +  LDL  N     +P  LA L+ L+ L+
Sbjct: 436 LKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL---NLCG 201
            ++N+L  +    +  +  L  L L NNRL          +   P+     L   NL G
Sbjct: 493 ASDNALENV--DGVANLPRLQELLLCNNRLQ-------QSAAIQPLVSCPRLVLLNLQG 542

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 51.7 bits (123), Expect = 3e-07
 Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 8/100 (8%)

Query: 82  ELAPELGQLKNLELLELYG-----NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLA 136
           E       LK ++ +         +               ++ L L       T+   L 
Sbjct: 403 ETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLE 460

Query: 137 NLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            L  + +L L++N L   +P +L  +  L +L  S+N L 
Sbjct: 461 QLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 7/90 (7%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  L  LE L +  N L     + + +   L  L L +N       D+L +LK L+ L +
Sbjct: 81  LKDLTKLEELSVNRNRLK--NLNGIPSA-CLSRLFLDNN--ELRDTDSLIHLKNLEILSI 135

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            NN L  +    L  ++ L +LDL  N ++
Sbjct: 136 RNNKLKSI--VMLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 19/90 (21%), Positives = 37/90 (41%), Gaps = 6/90 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
              L N     L   +++  +  +   L  +++ +  ++         +     LK L L
Sbjct: 15  DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           ++N +S L P  L  +T L  L ++ NRL 
Sbjct: 71  SHNQISDLSP--LKDLTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           +  + +LG  +++ +L     +L  ++      +N+   + + +     LK L L  N  
Sbjct: 20  NAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN-- 73

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             +    L +L +L+ L +N N L  L          L+ L L NN L 
Sbjct: 74  QISDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNELR 119

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.8 bits (135), Expect = 5e-09
 Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 7/115 (6%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  LKNLE+L +  N L   I   LG L KL+ LDL+ N    T    L  LK++ ++ L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGN--EITNTGGLTRLKKVNWIDL 179

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP--DNGSFSQFTPISFENNLNL 199
                          +   N +   + R   P    + GS+     + +E  +  
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC-VLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 4/68 (5%)

Query: 109 SALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL 168
                L      +L     + T   +   L  ++    +N+++  L    +   T+L  L
Sbjct: 13  FPDPGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKEL 68

Query: 169 DLSNNRLS 176
            LS+N++S
Sbjct: 69  HLSHNQIS 76

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 4/108 (3%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
             LG L  LE+L+L+GN ++ +    L  L K+  +DL               L     +
Sbjct: 144 VMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
           +  +     + P  ++   S     +           +  FS++  + 
Sbjct: 202 KDPDGRW--ISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVG 247

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 23/85 (27%), Positives = 39/85 (45%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
            L++L  L LYGN ++    S    L  L+ L L +N  N    D   +L  L  L L +
Sbjct: 78  GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137

Query: 149 NSLSGLIPTSLTTITSLNILDLSNN 173
           N L  +   + + + ++  + L+ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 2/103 (1%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
            K L  ++L  N +S   P A   L  L SL LY N            L  L+ L LN N
Sbjct: 55  YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN 114

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS 192
            ++ L   +   + +LN+L L +N+L   +   G+FS    I 
Sbjct: 115 KINCLRVDAFQDLHNLNLLSLYDNKLQT-IAK-GTFSPLRAIQ 155

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 6e-10
 Identities = 22/85 (25%), Positives = 39/85 (45%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
            +  + L  N +    P A     KL+ +DL +N  +   PD    L+ L  L L  N +
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92

Query: 152 SGLIPTSLTTITSLNILDLSNNRLS 176
           + L  +    + SL +L L+ N+++
Sbjct: 93  TELPKSLFEGLFSLQLLLLNANKIN 117

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 11/109 (10%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
           ++T +D  N++++      + +L  L  L    NN++  +   L     L  L   SN  
Sbjct: 43  TLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKL 97

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              +   +  L +L YL  + N L+ L  +       L  L+ + N L+
Sbjct: 98  T-NLD--VTPLTKLTYLNCDTNKLTKLDVSQN---PLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 11/112 (9%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL 144
            ++     L  L+   N ++  +   +     L  L+  +N     +   L    QL +L
Sbjct: 164 LDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFL 217

Query: 145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
             ++N L+ +    +T +T L   D S N L+    D  + S+ T +     
Sbjct: 218 DCSSNKLTEI---DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQT 264

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 8/90 (8%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           + Q   L  L    N L+  I   + +  +L  LD + N         +    QL  L  
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDC 177

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           + N ++ L    ++    LN L+   N ++
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNIT 204

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 28/165 (16%), Positives = 49/165 (29%), Gaps = 23/165 (13%)

Query: 86  ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
           +L     L   +  G      +   + +  +L  LD  +      +   L+   +L YL 
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG----------SFSQFTPISFE- 194
           LNN  L+ L    ++  T L  L   N  +       G          +  Q   +  E 
Sbjct: 325 LNNTELTEL---DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKET 380

Query: 195 ---NNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 236
              N+L +          G+P    P   G         +   + 
Sbjct: 381 LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS 425

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 29/166 (17%), Positives = 49/166 (29%), Gaps = 20/166 (12%)

Query: 41  PNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYG 100
           P   L + D    N  T   ++ N    + R++     ++     +L Q   L  L+   
Sbjct: 168 PQTQLTTLD-CSFNKITELDVSQNK--LLNRLNCDTNNIT---KLDLNQNIQLTFLDCSS 221

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 160
           N L+  I   +  L +L   D   N     +  +   L +L  L      L  +  T  T
Sbjct: 222 NKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEIDLTHNT 275

Query: 161 TITSLNILDLSNNRLSGPVPDNG-------SFSQFTPISFENNLNL 199
            +                V  N          +  T +    N  L
Sbjct: 276 QLIYFQAEGC-RKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKL 320

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 21/117 (17%), Positives = 39/117 (33%), Gaps = 13/117 (11%)

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
            N          +      +   L  L SLD +++    T    +  L  L  L   +N+
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN 75

Query: 151 LSGLIPTSLTTITSLNILDLSNNRLSG-PVPDNG-------SFSQFTPISFENNLNL 199
           ++ L  +     T+L  L   +N+L+   V             ++ T +    N  L
Sbjct: 76  ITTLDLSQN---TNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 17/110 (15%), Positives = 36/110 (32%), Gaps = 13/110 (11%)

Query: 101 NNLSGHIPSALGNLIK---LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT 157
           N L      +  +        S    +     T   +   L  L  L  +N+S++ +  T
Sbjct: 1   NTLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--T 58

Query: 158 SLTTITSLNILDLSNNRLSG-PVPDNG-------SFSQFTPISFENNLNL 199
            +  +T L  L  ++N ++   +  N          ++ T +       L
Sbjct: 59  GIEKLTGLTKLICTSNNITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKL 108

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 342
            +R+L++  + +    ++GRG FG+V   R     K+ A+K L K E     +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 343 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
             I++ A    +++L Y F       L +V  YM  G + + +                 
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMS-------------NYD 164

Query: 401 IALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 435
           +    AR         L  +H       IHRDVK  N+LLD+ 
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 26/148 (17%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRL 357
              LG G F    K       +  AVK + +      E   Q E+  +     H N+++L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 412
           +          LV   +  G +  R+++++         +  + +     L SA  +S++
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHF-------SETEASYIMRKLVSA--VSHM 122

Query: 413 HEHCDPKIIHRDVKAANILL---DEDAD 437
           H+     ++HRD+K  N+L    +++ +
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLE 147

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 29/153 (18%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLR 356
           K +LG G  GKV +      G+  A+K L    +        + EV     A    +++ 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVC 86

Query: 357 LYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSAR 407
           +      +       L++   M  G + SR++ER          T ++ A     +G+A 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-----AFTEREAAEIMRDIGTA- 140

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
            + +LH H    I HRDVK  N+L       + 
Sbjct: 141 -IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 3/90 (3%)

Query: 96  LELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLI 155
           L L GN  +  +P  L N   L  +DL +N  +     + +N+ QL  L L+ N L  + 
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 156 PTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
           P +   + SL +L L  N +S  VP+ G+F
Sbjct: 95  PRTFDGLKSLRLLSLHGNDISV-VPE-GAF 122

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 23/59 (38%), Positives = 30/59 (50%), Gaps = 1/59 (1%)

Query: 118 KSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             L L  N F   +P  L+N K L  + L+NN +S L   S + +T L  L LS NRL 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 59.9 bits (146), Expect = 4e-10
 Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 20/174 (11%)

Query: 270 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRL- 327
            AE        Q  +   +  +   + F    ILG G F  V   R  A  +  A+K L 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 328 KEERTSGGELQF-QTEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 385
           K       ++ +   E  ++S   H   ++LY       EKL     Y  NG +   +R+
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRK 123

Query: 386 RQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             S     D    +    +I       L YLH      IIHRD+K  NILL+ED
Sbjct: 124 IGS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNED 166

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 4e-10
 Identities = 33/196 (16%), Positives = 53/196 (27%), Gaps = 45/196 (22%)

Query: 280 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGEL 337
            Q          + T+       +G G FG+V++   AD   VA+K   ++      G  
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63

Query: 338 Q-----FQTEVKI---------ISMAVHRNLLRLYGF--CTTVTEKLLVYPYM----TNG 377
           Q        E+ I                  + L            LL+  +     T G
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 378 SVASRLRERQSSLPPL-------------------DWPTRKKIALGSARGLSYLHEHCDP 418
           S   R    +     +                      T K I       L+        
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181

Query: 419 KIIHRDVKAANILLDE 434
           +  HRD+   N+LL +
Sbjct: 182 RFEHRDLHWGNVLLKK 197

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.4 bits (139), Expect = 5e-10
 Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 3/95 (3%)

Query: 82  ELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL 141
           E A +         L+L G  +   I +    L +  ++D   N     + D    L++L
Sbjct: 10  EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRL 66

Query: 142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           K L +NNN +  +       +  L  L L+NN L 
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 7e-06
 Identities = 21/85 (24%), Positives = 32/85 (37%), Gaps = 3/85 (3%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L   + ++   N +          L +LK+L + +N            L  L  L L NN
Sbjct: 41  LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98

Query: 150 SLSGL-IPTSLTTITSLNILDLSNN 173
           SL  L     L ++ SL  L +  N
Sbjct: 99  SLVELGDLDPLASLKSLTYLCILRN 123

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 29/195 (14%)

Query: 258 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-L 316
               PH      P       Q        +++  +  D      +LG G  GKV +    
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 317 ADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK----LLV 370
              +  A+K L    +        + EV++   A    +++R+      +       L+V
Sbjct: 85  RTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYLHEHCDPKIIHRDV 425
              +  G + SR+++R          T ++ +     +G A  + YLH      I HRDV
Sbjct: 138 MECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA--IQYLHSI---NIAHRDV 187

Query: 426 KAANILLDEDADQSS 440
           K  N+L       + 
Sbjct: 188 KPENLLYTSKRPNAI 202

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 33/156 (21%), Positives = 58/156 (37%), Gaps = 7/156 (4%)

Query: 25  NAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITC-NPEGSVTRVDLGNAALSGEL 83
           + +       K  L      +     L  +   + H+ C     S T ++      +  +
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMN-IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369

Query: 84  APELGQLKNLELLELYGNNLS--GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL-KQ 140
                 LK L+ L L  N L     +     N+  L++LD+  N  N    D      + 
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429

Query: 141 LKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           +  L L++N L+G +   L     + +LDL NNR+ 
Sbjct: 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 24/98 (24%), Positives = 38/98 (38%), Gaps = 4/98 (4%)

Query: 92  NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL 151
             + L L  N++S      +  L +L+ L L  N             + L+YL +++N L
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL 112

Query: 152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
             +    +    SL  LDLS N     +P    F   T
Sbjct: 113 QNISCCPM---ASLRHLDLSFNDFDV-LPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 7/99 (7%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT--LANLKQLKYLRL 146
             ++LE L++  N L  +I      +  L+ LDL  N F+  +P      NL +L +L L
Sbjct: 98  FNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
           +      L    +  +  L+ + L          +  S 
Sbjct: 154 SAAKFRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESL 191

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 29/104 (27%), Positives = 54/104 (51%), Gaps = 6/104 (5%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSAL-GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR 145
              + +LE L++  N+L+ H           +  L+L SN+  G++   L    ++K L 
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLD 456

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFT 189
           L+NN +  + P  +T + +L  L++++N+L   VPD G F + T
Sbjct: 457 LHNNRIMSI-PKDVTHLQALQELNVASNQLKS-VPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 21/115 (18%), Positives = 34/115 (29%), Gaps = 4/115 (3%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L  L +L L  N +             L+ LD+  N     I      +  L++L L+ N
Sbjct: 75  LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFN 131

Query: 150 SLSGLIPTSL-TTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 203
               L        +T L  L LS  +         +    + I  +         
Sbjct: 132 DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGG 186

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 28/133 (21%), Positives = 56/133 (42%), Gaps = 12/133 (9%)

Query: 42  NNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQL-KNLELLELYG 100
            N L+++  +         +           D+   +L+           +++ +L L  
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETL--------DVSLNSLNSHAYDRTCAWAESILVLNLSS 437

Query: 101 NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLT 160
           N L+G +   L    K+K LDL++N    +IP  + +L+ L+ L + +N L  +      
Sbjct: 438 NMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD 494

Query: 161 TITSLNILDLSNN 173
            +TSL  + L +N
Sbjct: 495 RLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 2/96 (2%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
               + +  L  ++          +      L+   N+F  ++    + LK+L+ L L  
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386

Query: 149 NSLSGLIPTS--LTTITSLNILDLSNNRLSGPVPDN 182
           N L      +     ++SL  LD+S N L+    D 
Sbjct: 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 17/158 (10%), Positives = 51/158 (32%), Gaps = 9/158 (5%)

Query: 48  WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQL---KNLELLELYGNNLS 104
            ++        F        ++  V L +   + + + +L Q    + +E L +Y   ++
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 105 GHIPSALGNLIK-----LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSL 159
             I        +     L    + + +F  +     +   ++    L+ +    +     
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 160 TTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN 196
            + +S   L+ + N  +  V     +  +   +  + N
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 358
           ++ LGRG    VY+ +     K  A+K LK    +  +   +TE+ ++    H N+++L 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHE 414
               T TE  LV   +T G +  R+ E+          + +  A  + +     ++YLHE
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYY-------SERD-AADAVKQILEAVAYLHE 166

Query: 415 HCDPKIIHRDVKAANILLDEDADQSS 440
           +    I+HRD+K  N+L    A  + 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAP 189

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 58.3 bits (142), Expect = 1e-09
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 28/146 (19%)

Query: 303 LGRGGFGKVY----KGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRL 357
           LG+G FGKV+           +L A+K LK+        ++ + E  I+    H  +++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 358 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGL 409
            Y F T    KL L+  ++  G + +RL +E   +          K     +AL     L
Sbjct: 92  HYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALA----L 139

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            +LH      II+RD+K  NILLDE+
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEE 162

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  LK  + L L  NN+   I S+L  +  L+ L L  NL    I +  A    L+ L +
Sbjct: 44  LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100

Query: 147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           + N ++ L  + +  + +L +L +SNN+++
Sbjct: 101 SYNQIASL--SGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 21/93 (22%), Positives = 39/93 (41%), Gaps = 6/93 (6%)

Query: 86  ELGQLKNLELLELYG--NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY 143
           +       E +EL+G    +   + + L  L   K L L +N     I  +L+ ++ L+ 
Sbjct: 18  KSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRI 74

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           L L  N +   I        +L  L +S N+++
Sbjct: 75  LSLGRNLIKK-IENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.2 bits (110), Expect = 5e-06
 Identities = 23/102 (22%), Positives = 43/102 (42%), Gaps = 4/102 (3%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL 146
           L  ++NL +L L  N +   I +       L+ L +  N    ++   +  L  L+ L +
Sbjct: 66  LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYM 122

Query: 147 NNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
           +NN ++       L  +  L  L L+ N L     +N + S+
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 27/152 (17%)

Query: 300 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRL 357
             +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76

Query: 358 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARG 408
                 +       L+V   +  G + SR+++R          T ++ +     +G A  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA-- 129

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS 440
           + YLH      I HRDVK  N+L       + 
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 27/89 (30%), Positives = 35/89 (39%), Gaps = 2/89 (2%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLN 147
           +L  L LL L  N L          L  L++L +  N     +P      L  L  LRL+
Sbjct: 59  RLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLD 117

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            N L  L P    ++T L  L L  N L 
Sbjct: 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 31/89 (34%), Positives = 39/89 (43%), Gaps = 2/89 (2%)

Query: 89  QLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 147
           +LKNLE L +  N L   +P      L+ L  L L  N      P    +L +L YL L 
Sbjct: 83  ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            N L  L       +TSL  L L NN+L 
Sbjct: 142 YNELQSLPKGVFDKLTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 32/89 (35%), Positives = 40/89 (44%), Gaps = 2/89 (2%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLN 147
           QL NL  L L  N L    P    +L KL  L L  N    ++P  +   L  LK LRL 
Sbjct: 107 QLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLY 165

Query: 148 NNSLSGLIPTSLTTITSLNILDLSNNRLS 176
           NN L  +   +   +T L  L L NN+L 
Sbjct: 166 NNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 18/60 (30%), Positives = 28/60 (46%)

Query: 117 LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
            K LDL SN  +         L +L+ L LN+N L  L       + +L  L +++N+L 
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 20/61 (32%), Positives = 30/61 (49%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           +L +L+ L LY N L      A   L +LK+L L +N           +L++LK L+L  
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 149 N 149
           N
Sbjct: 215 N 215

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 18/140 (12%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQF-QTEVKIISMAVHRNLLRL-Y 358
           +G+G FGKV   +  D  K+ A+K + K++     E++    E++I+    H  L+ L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIA-LGSARGLSYLHEH 415
            F     E + +V   +  G +   L +             +  I  L  A  L YL   
Sbjct: 83  SFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMA--LDYLQNQ 134

Query: 416 CDPKIIHRDVKAANILLDED 435
              +IIHRD+K  NILLDE 
Sbjct: 135 ---RIIHRDMKPDNILLDEH 151

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 39/151 (25%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 351
           +G+G FGKV   R  A+    AVK L+         E+          +E  ++   V H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI-------MSERNVLLKNVKH 98

Query: 352 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 404
             L+ L+ F     +KL  V  Y+  G +   L RER    P      R +     IA  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 151

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               L YLH      I++RD+K  NILLD  
Sbjct: 152 ----LGYLHSL---NIVYRDLKPENILLDSQ 175

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 6e-09
 Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 3/88 (3%)

Query: 90  LKNLELLELYGN-NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
             +++ L L  + +  G +        +L+ L   +     +I + L  L +LK L L++
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRLS 176
           N +SG +        +L  L+LS N++ 
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.3 bits (136), Expect = 7e-09
 Identities = 29/188 (15%), Positives = 64/188 (34%), Gaps = 48/188 (25%)

Query: 290 LQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIIS 347
           L+ ++  +S    LG G FG V +    + GK  A+K++ ++       +++  E+ I+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--------- 398
           +  H N+++L  +  T  ++    P   +       +    +                  
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 399 ---------KKIALGSA-------------------RGLSYLHEHCDPKIIHRDVKAANI 430
                     K+                        R + ++H      I HRD+K  N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 431 LLDEDADQ 438
           L++   + 
Sbjct: 173 LVNSKDNT 180

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 53/226 (23%)

Query: 250 PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN-------- 301
            +I    W       F  + P E +      Q     L++   A   F + +        
Sbjct: 73  FIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAE 132

Query: 302 ----------------------ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ 338
                                 +LG+G FGKV   +    G+  A+K LK+E     +  
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV 192

Query: 339 FQT--EVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLD 394
             T  E +++  + H  L  L  +     ++L  V  Y   G +   L RER  S     
Sbjct: 193 AHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED--- 248

Query: 395 WPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              R +     I       L YLH   +  +++RD+K  N++LD+D
Sbjct: 249 ---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKD 285

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 40/163 (24%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKE---------ERTSGGELQFQ 340
           +V  + F    +LG+G FGKV   R  A G+  A+K L++           T        
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53

Query: 341 TEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPT 397
           TE +++    H  L  L Y F T   ++L  V  Y   G +   L RER  +        
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEE------ 105

Query: 398 RKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           R +     I       L YLH      +++RD+K  N++LD+D
Sbjct: 106 RARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKD 141

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 18/148 (12%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 351
           D F     LG G FG+V   +  + G   A+K L K++     +++    E +I+     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----KIALGSAR 407
             L++L       +   +V  Y+  G + S LR           P  +    +I L    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT--- 153

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
              YLH      +I+RD+K  N+L+D+ 
Sbjct: 154 -FEYLHSL---DLIYRDLKPENLLIDQQ 177

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 55.6 bits (135), Expect = 1e-08
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 44/155 (28%)

Query: 303 LGRGGFGKVYKGRLA----DGKLVAVKRLKE----------ERTSGGELQFQTEVKIISM 348
           LG+GG+GKV++ R       GK+ A+K LK+            T       + E  I+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-------KAERNILEE 77

Query: 349 AVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK----- 400
             H  ++ L Y F T    KL L+  Y++ G +  +L RE                    
Sbjct: 78  VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAE 129

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           I++     L +LH+     II+RD+K  NI+L+  
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQ 157

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK---------EERTSGGELQFQ 340
           + +   F     LG G FG+V+  R    G+  A+K LK          E T        
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54

Query: 341 TEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
            E  ++S+  H  ++R++G      +++ ++  Y+  G + S LR+ Q        P  K
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQR----FPNPVAK 109

Query: 400 ----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               ++ L     L YLH      II+RD+K  NILLD++
Sbjct: 110 FYAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKN 142

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 31/123 (25%), Positives = 52/123 (42%), Gaps = 14/123 (11%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LKNLELLELYGNNLS----GHIPSALGNLIKLKSLDL 122
            +  +D+    LS     EL   L+  +++ L    L+      I SAL     L  L+L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 123 YSNLFNG----TIPDTLANLK-QLKYLRLNNNSLS----GLIPTSLTTITSLNILDLSNN 173
            SN         +   L     +++ L L N  L+    G++ ++L T+ +L  L LS+N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 174 RLS 176
            L 
Sbjct: 124 LLG 126

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 18/127 (14%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LKN----LELLELYGNNLS----GHIPSALGNLIKLK 118
           ++  ++L +  L       + Q L+     ++ L L    L+    G + S L  L  L+
Sbjct: 57  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116

Query: 119 SLDLYSNLFNGTIPDTLANLKQ-----LKYLRLNNNSLS----GLIPTSLTTITSLNILD 169
            L L  NL        L          L+ L+L   SLS      + + L        L 
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176

Query: 170 LSNNRLS 176
           +SNN ++
Sbjct: 177 VSNNDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 24/127 (18%), Positives = 48/127 (37%), Gaps = 18/127 (14%)

Query: 68  SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSG----HIPSALG-NLIKLK 118
            + ++ L   +LS      LA  L    + + L +  N+++      +   L  +  +L+
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 119 SLDLYSNLFN----GTIPDTLANLKQLKYLRLNNNSLSG-----LIPTSLTTITSLNILD 169
           +L L S          +   +A+   L+ L L +N L       L P  L   + L  L 
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262

Query: 170 LSNNRLS 176
           +    ++
Sbjct: 263 IWECGIT 269

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 30/127 (23%), Positives = 43/127 (33%), Gaps = 18/127 (14%)

Query: 68  SVTRVDLGNAALSGELAPELGQL-----KNLELLELYGNNLSG----HIPSALGNLIKLK 118
           S+  + L    L  E A  L +        LE L +   + +     H  S L     L 
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344

Query: 119 SLDLYSNLFNGTIPDTLA-----NLKQLKYLRLNNNSLS----GLIPTSLTTITSLNILD 169
            L + +N         L          L+ L L +  +S      +  +L    SL  LD
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404

Query: 170 LSNNRLS 176
           LSNN L 
Sbjct: 405 LSNNCLG 411

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 41/152 (26%)

Query: 303 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 351
           LG+G FGKV+        +  A+K LK          E T         E +++S+A  H
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-------MVEKRVLSLAWEH 77

Query: 352 RNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IAL 403
             L  +   F T   E L  V  Y+  G +   +    +  L       R       I L
Sbjct: 78  PFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIIL 129

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           G    L +LH      I++RD+K  NILLD+D
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKD 154

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 13/110 (11%)

Query: 78  ALSGELAPELGQLKNLEL----------LELYGNNLS-GHIPSALGNLIKLKSLDLYSNL 126
             SG    ++ +  +LEL          L L     + G I       + L+ L L +  
Sbjct: 1   GSSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG 60

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
              ++ + L  L +LK L L+ N + G +      + +L  L+LS N+L 
Sbjct: 61  LI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 25/145 (17%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 357
           +LG+G FGKV         +L AVK LK++      +++    E +++++      L +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 358 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 410
           +  C    ++L  V  Y+  G +   + +  +   P              IA+G    L 
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG----LF 456

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           +L       II+RD+K  N++LD +
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE 478

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.8 bits (128), Expect = 4e-08
 Identities = 21/125 (16%), Positives = 42/125 (33%), Gaps = 18/125 (14%)

Query: 70  TRVDLGNAALSGELAPELG--QLKNLELLELY-------GNNLSGHIPSAL--GNLIKLK 118
             +++ +  L   +  ++    L NLE L LY        +                 LK
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255

Query: 119 SLDLYSNLFNGTIPDTLAN---LKQLKYLRLNNNSLSG----LIPTSLTTITSLNILDLS 171
            L +        + +       L QL+ + ++   L+     L+   +  I  L  +++ 
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315

Query: 172 NNRLS 176
            N LS
Sbjct: 316 YNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 2e-04
 Identities = 17/109 (15%), Positives = 42/109 (38%), Gaps = 10/109 (9%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGN---LIKLKSLDLYSNLFNG 129
           D          +    +  NL+ L +        +         L +L+++D+ + +   
Sbjct: 236 DGDMNVFRPLFSK--DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293

Query: 130 T----IPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 174
                + D +  +K LK++ +  N LS  +   L     +  +D+S+++
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDSQ 341

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 44/204 (21%), Positives = 77/204 (37%), Gaps = 51/204 (25%)

Query: 262 PHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN------------ILGRGGFG 309
            H   +D+P  ++   Q          +  + T      +            ++GRG + 
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66

Query: 310 KVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-HRNLLRLY 358
           KV   RL    ++ A++ +K+         +         QTE  +   A  H  L+ L+
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-------QTEKHVFEQASNHPFLVGLH 119

Query: 359 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSY 411
             C     +L  V  Y+  G +   + R+R+            +     I+L     L+Y
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LNY 168

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LHE     II+RD+K  N+LLD +
Sbjct: 169 LHER---GIIYRDLKLDNVLLDSE 189

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 53.0 bits (128), Expect = 7e-08
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 39/151 (25%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 351
           LG+G FGKV         +L AVK LK+         E T         E +++++    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-------MVEKRVLALPGKP 80

Query: 352 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 404
             L +L+  C    ++L  V  Y+  G +   + +  +   P              IA+G
Sbjct: 81  PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG 133

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               L +L       II+RD+K  N++LD +
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSE 157

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 52.6 bits (127), Expect = 9e-08
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 39/151 (25%)

Query: 303 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 351
           LG+G FGKV   R+ + G L AVK LK+         E T        TE +I+S+A  H
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-------MTEKRILSLARNH 83

Query: 352 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 404
             L +L+  C    ++L  V  ++  G +   + + R+          R +     I   
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISA 136

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               L +LH+     II+RD+K  N+LLD +
Sbjct: 137 ----LMFLHDK---GIIYRDLKLDNVLLDHE 160

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 45/156 (28%)

Query: 303 LGRGGFGKVY---KGRLAD-GKLVAVKRLK----------EERTSGGELQFQTEVKIISM 348
           LG G +GKV+   K    D GKL A+K LK           E T       +TE +++  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-------RTERQVLEH 114

Query: 349 AVHRN-LLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK---- 400
                 L+ L Y F T    KL L+  Y+  G + + L +  + +          +    
Sbjct: 115 IRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVG 166

Query: 401 -IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
            I L     L +LH+     II+RD+K  NILLD +
Sbjct: 167 EIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 302 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 357
           ++GRG + KV   RL    ++ A+K +K+E      ++ + QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 358 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 410
           +  C     +L  V  Y+  G +   + R+R+            +     I+L     L+
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LN 124

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YLHE     II+RD+K  N+LLD +
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE 146

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 24/82 (29%), Positives = 34/82 (41%)

Query: 94  ELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG 153
           E L+L    L+    +    L KL  L+L  N           +L +L  L L NN L+ 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 154 LIPTSLTTITSLNILDLSNNRL 175
           L       +T L+ L L  N+L
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 35/134 (26%), Positives = 51/134 (38%), Gaps = 13/134 (9%)

Query: 70  TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN---- 125
            ++DL +  L+         L  L  L L  N L         +L +L +L L +N    
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
           L  G + D L  L     L L  N L  L       +T L  L L+ N+L   +P  G+F
Sbjct: 98  LPLG-VFDHLTQLD---KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPA-GAF 151

Query: 186 ---SQFTPISFENN 196
              +    +S   N
Sbjct: 152 DKLTNLQTLSLSTN 165

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 31/109 (28%), Positives = 42/109 (38%), Gaps = 1/109 (0%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
            L  L  L L  N L+        +L +L  L L  N            L +LK LRLN 
Sbjct: 81  DLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRL-SGPVPDNGSFSQFTPISFENN 196
           N L  +   +   +T+L  L LS N+L S P        +   I+   N
Sbjct: 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 42/169 (24%)

Query: 294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT---------EV 343
              ++ +  +  G +G V  G  ++G  VA+KR+    + G  +              E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 344 KIISMAVHRNLLRLYG-FCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPP------ 392
           ++++   H N+L L   F       +    LV   M    +A  + +++  + P      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 393 ----LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
               L              GL  LH   +  ++HRD+   NILL ++ D
Sbjct: 140 MYHIL-------------LGLHVLH---EAGVVHRDLHPGNILLADNND 172

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 12/116 (10%)

Query: 64  NPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALG---NLIKLKSL 120
           N   S+ ++   N+ +       +  L N+  L L GN L       +     L  L  L
Sbjct: 38  NELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYL 90

Query: 121 DLYSNLFNGTIPDTL-ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
            L  N    ++P+ +   L  LK L L  N L  L       +T+L  L+L++N+L
Sbjct: 91  ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL 145

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 30/87 (34%), Positives = 35/87 (40%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           +L NL  L L GN L          L  LK L L  N            L  L YL L +
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAH 142

Query: 149 NSLSGLIPTSLTTITSLNILDLSNNRL 175
           N L  L       +T+L  LDLS N+L
Sbjct: 143 NQLQSLPKGVFDKLTNLTELDLSYNQL 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 41/184 (22%), Positives = 59/184 (32%), Gaps = 24/184 (13%)

Query: 16  LVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLG 75
           + ++  I     V  L +  +KL      + +   L                ++T + L 
Sbjct: 53  IKSVQGIQYLPNVRYLALGGNKLH----DISALKELT---------------NLTYLILT 93

Query: 76  NAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTL 135
              L         +L NL+ L L  N L          L  L  L+L  N          
Sbjct: 94  GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF 153

Query: 136 ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF---SQFTPIS 192
             L  L  L L+ N L  L       +T L  L L  N+L   VPD G F   +    I 
Sbjct: 154 DKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS-VPD-GVFDRLTSLQYIW 211

Query: 193 FENN 196
             +N
Sbjct: 212 LHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 21/114 (18%), Positives = 40/114 (35%), Gaps = 18/114 (15%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-- 125
              + +L   +++   A    +L +++ +    +++       +  L  ++ L L  N  
Sbjct: 20  ETIKANLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL 75

Query: 126 ----LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
                           L  L YL L  N L  L       +T+L  L L  N+L
Sbjct: 76  HDISALKE--------LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 22/131 (16%), Positives = 45/131 (34%), Gaps = 22/131 (16%)

Query: 68  SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKS 119
           S+    L   A++ E    +   L +  +++ + L GN +       +   + +   L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 120 LDLYSNLFN----------GTIPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSL 165
            +                   +   L    +L  +RL++N+        +   L+  T L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 166 NILDLSNNRLS 176
             L L NN L 
Sbjct: 125 EHLYLHNNGLG 135

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 29/139 (20%), Positives = 45/139 (32%), Gaps = 31/139 (22%)

Query: 68  SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLS----------GHIPSALGN 113
           SV  + L    +  E    L+  +   K+LE+ E                   +  AL  
Sbjct: 33  SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLK 92

Query: 114 LIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLS-------------GLIP 156
             KL ++ L  N F  T    + D L+    L++L L+NN L                + 
Sbjct: 93  CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 152

Query: 157 TSLTTITSLNILDLSNNRL 175
                   L  +    NRL
Sbjct: 153 KKAKNAPPLRSIICGRNRL 171

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 24/128 (18%), Positives = 42/128 (32%), Gaps = 19/128 (14%)

Query: 68  SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNL-----SGHIPSALGNLIKLK 118
            +  +  G   L        A      + L  +++  N +        +   L    +LK
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219

Query: 119 SLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTI--TSLNIL 168
            LDL  N F       +   L +   L+ L LN+  LS      +  + + +    L  L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279

Query: 169 DLSNNRLS 176
            L  N + 
Sbjct: 280 RLQYNEIE 287

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 33/158 (20%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NL 354
           ++G+G FG+V K       + VA+K ++ E+      Q   E++I+     +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 355 LRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGS 405
           + +          C    E L           +  L E  +++       P  +K A   
Sbjct: 162 IHMLENFTFRNHICM-TFELL-----------SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 443
            + L  LH++   +IIH D+K  NILL +      K I
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.2 bits (118), Expect = 4e-07
 Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 3/91 (3%)

Query: 96  LELYGNNLSGHIPSAL-GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGL 154
           L L  N L       L G L  L  L+L  N   G  P+       ++ L+L  N +  +
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93

Query: 155 IPTSLTTITSLNILDLSNNRLSGPVPDNGSF 185
                  +  L  L+L +N++S  V   GSF
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISC-VMP-GSF 122

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.4 bits (108), Expect = 8e-06
 Identities = 28/85 (32%), Positives = 42/85 (49%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
           +L +L  LEL  N L+G  P+A      ++ L L  N            L QLK L L +
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111

Query: 149 NSLSGLIPTSLTTITSLNILDLSNN 173
           N +S ++P S   + SL  L+L++N
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASN 136

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 31/168 (18%), Positives = 60/168 (35%), Gaps = 39/168 (23%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----------A 349
            LG G F  V+  + + +   VA+K ++ ++        + E+K++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83

Query: 350 VHRNLLRLY------GFCTT----VTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPT 397
              ++L+L       G        V E L              L    ++     +    
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-----------GENLLALIKKYEHRGIPLIY 132

Query: 398 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR 445
            K+I+     GL Y+H  C   IIH D+K  N+L++      +   ++
Sbjct: 133 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK 178

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 28/142 (19%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLK---EERTSGGELQFQTEVKII-SMAVHRNLLRL 357
           LGRG + +V++   + + + V VK LK   +++        + E+KI+ ++    N++ L
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENLRGGPNIITL 96

Query: 358 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSYLH 413
                    +   LV+ ++ N    +  ++   +L   D   R  +   L   + L Y H
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYD--IRFYMYEIL---KALDYCH 147

Query: 414 EHCDPKIIHRDVKAANILLDED 435
                 I+HRDVK  N+++D +
Sbjct: 148 SM---GIMHRDVKPHNVMIDHE 166

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 51/169 (30%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 343
            D +  ++++G G +G V +     + ++VA+K++           F+          E+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103

Query: 344 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 398
            I++   H +++++         +      +V                 S    L    R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------DSDFKKL---FR 148

Query: 399 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
             + L              G+ Y+H      I+HRD+K AN L+++D  
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS 194

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 31/159 (19%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 353
           +++G+G FG+V K     + + VA+K +K ++      Q Q EV+++ +       +   
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 354 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 404
           ++ L          C  V E L           +  L +  R ++   +     +K A  
Sbjct: 118 IVHLKRHFMFRNHLCL-VFEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 443
               L +L    +  IIH D+K  NILL      + K +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 36/153 (23%), Positives = 52/153 (33%), Gaps = 34/153 (22%)

Query: 303 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKI---------ISMAVHR 352
           +G GGFG +Y        +  A   +K E    G L    E+K          I   + R
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKKWIER 102

Query: 353 NLLRLYGF-----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK-------K 400
             L   G            K   Y +M    V  RL      L  +             +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM----VMERL---GIDLQKISGQNGTFKKSTVLQ 155

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
           + +     L Y+HE+     +H D+KAAN+LL 
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 39/132 (29%), Positives = 49/132 (37%), Gaps = 5/132 (3%)

Query: 68  SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF 127
             T +DL   +L         +L +L  L L GN L          L  L  L+L +N  
Sbjct: 29  QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF-- 185
                     L QLK L LN N L  L       +T L  L L  N+L   VPD G F  
Sbjct: 89  QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPD-GVFDR 146

Query: 186 -SQFTPISFENN 196
            +    I   +N
Sbjct: 147 LTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 31/101 (30%), Positives = 39/101 (38%), Gaps = 19/101 (18%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLN 147
           +L +L  L L  N L          L +LK L L +N    ++PD     L QLK LRL 
Sbjct: 74  KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132

Query: 148 NNSLSGLIP-------TSLTTITSLN---------ILDLSN 172
            N L   +P       TSL  I   +         I  LS 
Sbjct: 133 QNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSE 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 26/86 (30%), Positives = 38/86 (44%), Gaps = 8/86 (9%)

Query: 94  ELLELYGNNLSGHIPSALGNLIKLKSLDLYSN----LFNGTIPDTLANLKQLKYLRLNNN 149
           ++L L+ N ++   P    +LI LK L L SN    L  G + D+L  L     L L  N
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSLTQLTV---LDLGTN 98

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRL 175
            L+ L       +  L  L +  N+L
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKL 124

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 18/100 (18%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
            L  L +L+L  N L+    +    L+ LK L +  N     +P  +  L  L +L L+ 
Sbjct: 86  SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144

Query: 149 NSLSGLIP-------TSLTTITSLN---------ILDLSN 172
           N L   IP       +SLT               I+ L N
Sbjct: 145 NQLKS-IPHGAFDRLSSLTHAYLFGNPWDCECRDIMYLRN 183

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 18/146 (12%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 360
           +G G FG +++G  L + + VA+K    E       Q + E +   +      +  +Y F
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                  +LV   +  G     L +   R+ S+      T    A      +  +HE   
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEKS- 126

Query: 418 PKIIHRDVKAANILLDEDADQSSKTI 443
             +++RD+K  N L+     +++  I
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMI 150

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 2e-05
 Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 66/201 (32%)

Query: 254 FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNIL--GRGGFGK- 310
           FA +  +R   +           L+L    R +L EL+        KN+L  G  G GK 
Sbjct: 126 FAKYNVSRLQPY-----------LKL----RQALLELR------PAKNVLIDGVLGSGKT 164

Query: 311 VYKGRLADGKLVAVKRLKEERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTTV 364
                +A   L      K +     ++         +   ++ M     L +L       
Sbjct: 165 W----VA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-----LQKLL------ 206

Query: 365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 424
               +   + +    +S ++ R  S+         +  L   R L     + +  ++  +
Sbjct: 207 --YQIDPNWTSRSDHSSNIKLRIHSI---------QAEL---RRLLKSKPYENCLLVLLN 252

Query: 425 VKAANILLDEDA-DQSSKTIL 444
           V+ A      +A + S K +L
Sbjct: 253 VQNAKAW---NAFNLSCKILL 270

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 4e-05
 Identities = 82/597 (13%), Positives = 156/597 (26%), Gaps = 231/597 (38%)

Query: 1   MEKRVLVFYLVSTIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSW--DNLPGN---L 55
           M K +L    +  I+      +S +A    L +F + L      +Q +  + L  N   L
Sbjct: 41  MPKSILSKEEIDHII------MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL 94

Query: 56  CTWFHITCN-----------------------PEGSVTRVDLGNA---ALSGELAPELG- 88
            +                               + +V+R+        AL  EL P    
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL-ELRPAKNV 153

Query: 89  ----------------QLKNLELLELYGNN---LS-GHIPSALGNLIKLKSL--DLYSNL 126
                              + ++          L+  +  S    L  L+ L   +  N 
Sbjct: 154 LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 127 FNG-----TIPDTLANLKQ-LKYL---RLNNNSLSGLI-----------------PTSLT 160
            +       I   + +++  L+ L   +   N L  L+                    LT
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLT 271

Query: 161 TITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPF 220
           T        LS    +    D+ S +  TP   +   +L            P        
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMT-LTP---DEVKSLLLKYLDCRPQDLPR------- 320

Query: 221 GPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTR----------------PHE 264
                    +     P  +++ A  +    +  +  W+                   P E
Sbjct: 321 ---------EVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370

Query: 265 F---FFD---------VPA-----------EDDSELQLGQLKRFSLRELQVATDGFSNKN 301
           +   F           +P            + D  + + +L ++SL              
Sbjct: 371 YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL-------------- 416

Query: 302 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLY-- 358
                                  K+ KE   S   +  + +VK+ +  A+HR+++  Y  
Sbjct: 417 ---------------------VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNI 455

Query: 359 --GFCTTVTEKLLV--YPY------MTNGSVASRLRERQSSLPP----LDWPTRKKIALG 404
              F +       +  Y Y      + N        ER +          +  +K     
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKN----IEHPERMTLFRMVFLDFRFLEQKIRHDS 511

Query: 405 SARGLS---------------YLHEHCDPKIIHRDVKA---------ANILLDEDAD 437
           +A   S               Y+ ++ DPK   R V A          N++  +  D
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDN-DPK-YERLVNAILDFLPKIEENLICSKYTD 566

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 30/106 (28%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 94  ELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG 153
             LEL  N L          L +L  L L  N            L +L  L L+ N L  
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90

Query: 154 LIPTSLTTITSLNILDLSNNRLSGPVPDNGSF---SQFTPISFENN 196
           L       +T L  L L  N+L   VPD G F   +    I    N
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKS-VPD-GIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 30/113 (26%), Positives = 40/113 (35%), Gaps = 21/113 (18%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLN 147
           +L  L  L L  N +          L KL  L L+ N    ++P+     L QLK L L+
Sbjct: 50  KLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108

Query: 148 NNSLSGLIP-------TSLTTITSLN---------ILDLSN--NRLSGPVPDN 182
            N L   +P       TSL  I             I  LS   N+ S     +
Sbjct: 109 TNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGS 160

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 29/132 (21%), Positives = 43/132 (32%), Gaps = 9/132 (6%)

Query: 51  LPGNLCTWFHITCNPEGSVTRVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPS 109
            P +              V  +DL N+ +    L   L Q   L+ L L G  LS  I +
Sbjct: 77  CPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN 136

Query: 110 ALGNLIKLKSLDLY--SNLFNGTIPDTLANLKQLKYL------RLNNNSLSGLIPTSLTT 161
            L     L  L+L   S      +   L++  +L  L            +   +     T
Sbjct: 137 TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 196

Query: 162 ITSLNILDLSNN 173
           IT LN+     N
Sbjct: 197 ITQLNLSGYRKN 208

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 20/130 (15%), Positives = 48/130 (36%), Gaps = 21/130 (16%)

Query: 68  SVTRVDLGNAALSGELAPELGQL-----KNLELLELYGNNLS----GHIPSAL-GNLIKL 117
           +V  ++L    L+ +   EL +       ++  L+L  N L       +          +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227

Query: 118 KSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGL-------IPTSLTTITSLN 166
            SL+L  N  +G     +     +LK L+ + L+ + +  +       +  +   I  + 
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287

Query: 167 ILDLSNNRLS 176
           ++D +   + 
Sbjct: 288 LVDKNGKEIH 297

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 32/152 (21%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----AVHRNLL 355
            +G G FG+V   + + + K  AVK ++  +        + E  I+         + N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99

Query: 356 RLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSA 406
           + +G        C  + E L              L E   +++         K   +   
Sbjct: 100 KYHGKFMYYDHMCL-IFEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 438
           + L+YL +     + H D+K  NILLD+   +
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFE 176

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 37/156 (23%)

Query: 303 LGRGGFGKVYKGRLADGKLVAVKR---LKEERTSGGELQFQTEVKI---------ISMAV 350
           +G+GGFG +Y   +   + V       +K E +  G L    E+K          I   +
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQIQKWI 100

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR----ERQ-SSLPPL-DWPTRK----- 399
               L+  G           +    +       R    +R  S L  + +   ++     
Sbjct: 101 RTRKLKYLGVPK-------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 400 --KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 433
             +++L     L Y+HEH     +H D+KA+N+LL+
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 51/169 (30%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 343
            D +  K+++GRG +G VY        K VA+K++           F+          E+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76

Query: 344 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 398
            I++      ++RLY               +V                 S L  L    +
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------------DSDLKKL---FK 121

Query: 399 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
             I L              G +++HE     IIHRD+K AN LL++D  
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCS 167

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 24/126 (19%), Positives = 39/126 (30%), Gaps = 17/126 (13%)

Query: 68  SVTRVDLGNAALSGELAPELGQ-LK----NLELLELYGNNLSG----HIPSALGNLIKLK 118
              ++ L   +L  E   +L   L      +  L L  N L+      +   L     + 
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186

Query: 119 SLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLNILDL 170
            L L            +   L   +QL+ L +  N         +  +     SL +L L
Sbjct: 187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHL 246

Query: 171 SNNRLS 176
             N LS
Sbjct: 247 YFNELS 252

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 34/140 (24%), Positives = 49/140 (35%), Gaps = 12/140 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 360
           +G G FG +Y G  +A G+ VA+K    E       Q   E KI   M     +  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
                  ++V   +  G     L    S    L   T   +A      + Y+H       
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126

Query: 421 IHRDVKAANILLDEDADQSS 440
           IHRDVK  N L+      + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNL 146

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 34/155 (21%)

Query: 302 ILGRGGFGKVYKG--RLADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 353
            LG G FGKV +          VA+K ++           + E+ ++             
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKFL 83

Query: 354 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 404
            + +  +       C    E L                E  ++++  P   P  + +A  
Sbjct: 84  CVLMSDWFNFHGHMCI-AFELL-----------GKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 439
               L +LHE+   ++ H D+K  NIL      ++
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 360
           +G G FG++  G+ L   + VA+K    E       Q   E +          + ++Y F
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 361 CTTVTEKLLVYPYMTNG-SVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
                   +V   +  G S+     L +R  SL      T   IA+     + Y+H    
Sbjct: 74  GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEYVHSKN- 125

Query: 418 PKIIHRDVKAANILLDEDADQSSKTI 443
             +I+RDVK  N L+    +++ + I
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVI 149

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 38/162 (23%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 343
              + +   +G G +G V        G+ VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 344 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDW 395
            ++    H N++ L              +  LV P+M      + L++            
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL----KFSE 125

Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
              + +     +GL Y+H      ++HRD+K  N+ ++ED +
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 38/159 (23%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 346
           + N   +G G  G V         + VA+K+L           FQ          E+ ++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYRELVLM 78

Query: 347 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 398
               H+N++ L              +  +V   M      + L +  +      LD    
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQM----ELDHERM 129

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
             +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 26/129 (20%), Positives = 46/129 (35%), Gaps = 19/129 (14%)

Query: 68  SVTRVDLGNAALSGE-----LAPELGQLKNLELLELYGNNLSGHIPSALGNLIK----LK 118
            +  V+L N            A  L     ++   + G   +  +  AL  ++K    LK
Sbjct: 37  DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLK 96

Query: 119 SLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLS------GLIPTSLTTITSLNIL 168
           SL++ SN  +G+    + + L +   L  LR++N S          I   L   T+L   
Sbjct: 97  SLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKF 156

Query: 169 DLSNNRLSG 177
                +   
Sbjct: 157 GYHFTQQGP 165

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 36/161 (22%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 343
              + N   +G G  G V         + VA+K+L           FQ          E+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112

Query: 344 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWP 396
            ++    H+N++ L              +  LV   M  N     ++         LD  
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHE 164

Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
               +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 38/153 (24%)

Query: 302 ILGRGGFGKVYKG--RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM------AVH 351
            LG G FGKV +     A G+ VAVK  +  +          ++E++++           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AARSEIQVLEHLNTTDPNST 76

Query: 352 RNLLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 402
              +++  +       C  V E L                +  +++   P      +K+A
Sbjct: 77  FRCVQMLEWFEHHGHICI-VFELL-----------GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               + +++LH +   K+ H D+K  NIL  + 
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQS 154

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 33/157 (21%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 346
           + +   +G G +G V        G  VA+K+L           FQ+         E++++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLL 78

Query: 347 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 400
               H N++ L             T+  LV P+M  G+   +L + +     L     + 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----KLGEDRIQF 132

Query: 401 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
           +     +GL Y+H      IIHRD+K  N+ ++ED +
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 166

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 12/139 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 360
           +G G FG++Y G  +   + VA+K    E       Q   E KI   +     +  +  F
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
                  +LV   +  G     L    S    L   T   +A      + ++H       
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 421 IHRDVKAANILLDEDADQS 439
           +HRD+K  N L+      +
Sbjct: 125 LHRDIKPDNFLMGLGRRAN 143

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 20/41 (48%), Positives = 23/41 (56%), Gaps = 2/41 (4%)

Query: 392 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 432
            L  P  KKI     +GL YLH  C  +IIH D+K  NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	447
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.98
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.97
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.93
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.93
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.93
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.93
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.93
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.93
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.93
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.93
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.92
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.92
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.92
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.92
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.92
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.91
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.91
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.91
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.91
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.91
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.91
3bhy_A	283	Death-associated protein kinase 3; death associate	99.91
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.91
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.91
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.91
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.91
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.91
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.91
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.91
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.91
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.91
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.91
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.91
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.91
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.91
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.9
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.9
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.9
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.9
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.9
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.9
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.9
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.9
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.9
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.9
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.9
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.9
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.9
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.9
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.89
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.89
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.89
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.89
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.89
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.89
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.89
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.89
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.88
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.88
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.88
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.88
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.88
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.87
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.87
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.86
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.85
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.83
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.82
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.75
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.75
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.74
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.72
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.69
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.66
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.65
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.64
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.63
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.62
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.61
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.6
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.6
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.6
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.59
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.58
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.58
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.57
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.57
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.57
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.56
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.56
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.56
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.55
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.53
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.53
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.53
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.52
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.52
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.52
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.51
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.5
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.5
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.5
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.5
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.5
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.5
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.49
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.49
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.48
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.48
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.47
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.47
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.46
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.46
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.46
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.46
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.45
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.45
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.44
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.44
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.44
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.44
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.44
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.43
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.42
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.4
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.4
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.39
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.39
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.39
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.39
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.39
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.39
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.37
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.37
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.36
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.36
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.35
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.34
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.34
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.34
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.33
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.33
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.31
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.31
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.3
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.29
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.28
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.27
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.26
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.22
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.18
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.13
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.02
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.01
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.92
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.92
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.88
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.85
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.83
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.79
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.72
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.57
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.48
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.35
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.29
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.29
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.11
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.07
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.02
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.0
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.97
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.93
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.83
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.72
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.48
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.46
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.44
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.42
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.06
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.05
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.03
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.98
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.83
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.82
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.81
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.79
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.42
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.39
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.3
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	95.86
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	95.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.55
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	95.18
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	94.93
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	94.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.65
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	94.48
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.86
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.94
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.7
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.87
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.51
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.71
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	81.17
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	80.64

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.7e-34  Score=273.65  Aligned_cols=146  Identities=25%  Similarity=0.405  Sum_probs=127.5

Q ss_pred             CCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +++..+.||+|+||+||+|++.      +++.||||+++.........+|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3445688999999999999863      4678999999766555556689999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          370 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      |||||++|+|.++|+....            ....++|..+..|+.|||+||+|||++   +||||||||+|||||+++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            9999999999999975421            123589999999999999999999999   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +||+||-
T Consensus       184 ~Ki~DFG  190 (308)
T 4gt4_A          184 VKISDLG  190 (308)
T ss_dssp             EEECCSC
T ss_pred             EEECCcc
Confidence            9999995

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.7e-34  Score=272.52  Aligned_cols=146  Identities=28%  Similarity=0.464  Sum_probs=126.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++... .....+|.+|+++|++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45667789999999999999863      47789999997542 233457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccC---------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          369 LVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      +|||||++|+|.++|+...         .....++|.++..|+.|||+||+|||++   +||||||||+|||+|+++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999998642         1234599999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       169 i~DFG  173 (299)
T 4asz_A          169 IGDFG  173 (299)
T ss_dssp             ECCCS
T ss_pred             ECCcc
Confidence            99995

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=272.40  Aligned_cols=146  Identities=31%  Similarity=0.479  Sum_probs=128.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|...+.||+|+||+||+|+++      +++.||||+++... .....+|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34556688999999999999864      47889999997542 333457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCC-----------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          369 LVYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      +|||||++|+|.++++....           ...+++|.++..|+.|||+||+|||++   +||||||||+|||||+++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986432           123589999999999999999999998   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +||+||-
T Consensus       197 ~Ki~DFG  203 (329)
T 4aoj_A          197 VKIGDFG  203 (329)
T ss_dssp             EEECCCC
T ss_pred             EEEcccc
Confidence            9999995

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-33  Score=271.25  Aligned_cols=145  Identities=21%  Similarity=0.316  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++++.++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57888999999999999999964 6999999999654322 234469999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++|+|.+++...+.  ..+++..+..|+.||+.||+|||++   +||||||||+||||++++.+||+||-
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTT
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccc
Confidence            9999999999976532  2478889999999999999999999   99999999999999999999999995

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-33  Score=265.83  Aligned_cols=142  Identities=30%  Similarity=0.420  Sum_probs=124.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .+++...+.||+|+||+||+|++.  ..||||+++.... .....+|.+|++++++++|||||+++|++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356677889999999999999975  3699999975432 2234579999999999999999999998865 56899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++|+|.++|+....   .++|..+..|+.|||+||+|||++   +||||||||+|||||+++.+||+||-
T Consensus       112 y~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             CCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             cCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            9999999999976532   489999999999999999999998   99999999999999999999999995

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.3e-33  Score=266.79  Aligned_cols=143  Identities=26%  Similarity=0.337  Sum_probs=129.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  .......+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46888999999999999999964 69999999996432  2233457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||++|+|.++++..+    .+++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+||-
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            9999999999998754    389999999999999999999999   99999999999999999999999995

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.98  E-value=8.9e-33  Score=266.66  Aligned_cols=141  Identities=25%  Similarity=0.353  Sum_probs=127.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+++|+.++|||||++++++.+.+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            35777889999999999999965 699999999965432 3344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++|+|.+++...     .+++..+..++.|++.||+|||++   +||||||||+||||++++.+||+||-
T Consensus       153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCc
Confidence            9999999999753     289999999999999999999999   99999999999999999999999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=2.6e-32  Score=261.11  Aligned_cols=141  Identities=28%  Similarity=0.389  Sum_probs=120.3

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~  371 (447)
                      +|...+.||+|+||+||+|++ +|+.||||+++...  .....++.|+..+..++|||||+++|+|.+++    ..++||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            355668899999999999998 58999999996432  11223455666677899999999999998654    579999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC-----CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||++|+|.++|+..     .++|..+.+++.|+++||+|||++     +.++||||||||+|||||+++++||+||-
T Consensus        81 Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999764     389999999999999999999986     35689999999999999999999999995

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.97  E-value=4.1e-32  Score=254.60  Aligned_cols=142  Identities=24%  Similarity=0.408  Sum_probs=123.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++....  ......+.+|+++++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            67999999999999999999964 699999999965432  223456999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+ +|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecC
Confidence            999 689999998754    389999999999999999999999   99999999999999999999999995

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.97  E-value=4.9e-32  Score=267.92  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45888899999999999999965 69999999996543 23344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++|+|.+++...     .+++..+..|+.||++||+|||++   +||||||||+||||+.++.+||+||-
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCc
Confidence            9999999999754     289999999999999999999999   99999999999999999999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=3.1e-32  Score=259.58  Aligned_cols=146  Identities=21%  Similarity=0.319  Sum_probs=123.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC--------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  365 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  365 (447)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++..........+.+|+++|+.++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888899999999999999964 689999999965443334457999999999999999999999987544        


Q ss_pred             ----ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          366 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       366 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                          ..++|||||++|+|.+++..... ....++..+..|+.|+++||+|||++   +||||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999986532 22356677889999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       161 DFG  163 (299)
T 4g31_A          161 DFG  163 (299)
T ss_dssp             CCC
T ss_pred             cCc
Confidence            995

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.97  E-value=6.8e-32  Score=255.26  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=121.7

Q ss_pred             CCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEe
Q 013258          298 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVY  371 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  371 (447)
                      ...+.||+|+||+||+|+.. +++.||||.+...... .....|.+|+++++.++|||||++++++.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            44567999999999999965 5899999999654322 234469999999999999999999999865    34579999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      |||++|+|.++++...    .+++..+..++.||++||+|||++ .++||||||||+||||+. ++.+||+||-
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFG  177 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCc
Confidence            9999999999998754    389999999999999999999998 234999999999999984 7899999995

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.97  E-value=4.3e-32  Score=261.12  Aligned_cols=137  Identities=24%  Similarity=0.289  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|...+.||+|+||+||+|+.+ +|+.||||+++....      ..+|+.+++.++|||||++++++.+.+..|+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45667788999999999999964 699999999965321      24799999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      |++|+|.++++..+    .+++..+..|+.|++.||+|||++   +||||||||+||||+.++ .+||+||-
T Consensus       132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCC
Confidence            99999999998754    389999999999999999999999   999999999999999998 59999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.97  E-value=1.2e-32  Score=261.69  Aligned_cols=143  Identities=27%  Similarity=0.317  Sum_probs=122.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++.... .....++.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46888999999999999999852    478999999965432 2223468899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||||++|+|.+++....    .+++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+||-
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccc
Confidence            999999999999998754    389999999999999999999999   99999999999999999999999995

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=4.6e-32  Score=263.72  Aligned_cols=157  Identities=27%  Similarity=0.380  Sum_probs=133.7

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccce
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRL  357 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l  357 (447)
                      ++..+.++..++|++.+.||+|+||+||+|++..      ++.||||.++.........+|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445556677889999999999999999998532      368999999765544445679999999999965 899999


Q ss_pred             eeEEecC-CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecC
Q 013258          358 YGFCTTV-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  424 (447)
Q Consensus       358 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  424 (447)
                      +|+|.+. +..++|||||++|+|.++|+....            ....++|.++..++.|||+||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999976421            123589999999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 013258          425 VKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       425 lkp~NILl~~~~~~~i~df~  444 (447)
                      |||+|||+++++.+||+||-
T Consensus       211 LK~~NILl~~~~~vKi~DFG  230 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFG  230 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCG
T ss_pred             cCccceeeCCCCCEEECcch
Confidence            99999999999999999995

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=9e-30  Score=246.11  Aligned_cols=175  Identities=81%  Similarity=1.241  Sum_probs=149.2

Q ss_pred             CCCCccccccCccccccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcC
Q 013258          270 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA  349 (447)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l  349 (447)
                      +...++....+..+.+++.++....++|+..+.||+|+||.||+|+..+++.||||+++..........+.+|+++++.+
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A            5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            34444455566778899999999999999999999999999999998789999999997655444444799999999999


Q ss_pred             CCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       350 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      +||||+++++++...+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+.++|+||||||+|
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            99999999999999999999999999999999998876555669999999999999999999999877899999999999


Q ss_pred             eeeCCCCceeecccc
Q 013258          430 ILLDEDADQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~~~~i~df~  444 (447)
                      ||+++++.+||+||-
T Consensus       165 il~~~~~~~kl~Dfg  179 (326)
T 3uim_A          165 ILLDEEFEAVVGDFG  179 (326)
T ss_dssp             EEECTTCCEEECCCS
T ss_pred             EEECCCCCEEeccCc
Confidence            999999999999995

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=251.09  Aligned_cols=142  Identities=23%  Similarity=0.401  Sum_probs=124.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec------CCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  366 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            46888899999999999999964 6999999999654322 223468899999999999999999998764      357


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .|+|||||+ |+|.+++...+    .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+||.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 78999997653    489999999999999999999999   99999999999999999999999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=5.4e-29  Score=257.28  Aligned_cols=144  Identities=28%  Similarity=0.370  Sum_probs=125.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHH---HHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|++.++||+|+||+||+|+.. +|+.||||+++....  ......+.   .++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            367999999999999999999965 699999999964321  12222233   346677788999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|||||+||+|.++|....    .+++..+..|+.||+.||+|||++   +||||||||+|||||++|.+||+||-
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccc
Confidence            99999999999999998754    389999999999999999999999   99999999999999999999999995

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=6.8e-29  Score=242.72  Aligned_cols=139  Identities=20%  Similarity=0.345  Sum_probs=124.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      ..+.|++.+.||+|+||+||+|+.+    +++.||||.+...   ....++.+|++++..+ +|||||++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999752    4678999998543   2345688999999988 699999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      ++||||+++|+|.+++..       +++.++..++.|++.||+|||++   +||||||||+|||++.+ +.+||+||-
T Consensus        96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            999999999999999842       78999999999999999999999   99999999999999987 799999995

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=5.8e-28  Score=250.04  Aligned_cols=143  Identities=20%  Similarity=0.332  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|+++... ......+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            67889999999999999999964 69999999986532 22344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC--Cceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~~i~df~  444 (447)
                      |++|+|.+++.....   .+++..+..++.||++||+|||++   +|+||||||+|||++.+  +.+||+||-
T Consensus       236 ~~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          236 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             CCCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             cCCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            999999999965432   489999999999999999999999   99999999999999865  799999995

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=1.7e-27  Score=229.64  Aligned_cols=152  Identities=43%  Similarity=0.720  Sum_probs=135.8

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       289 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++...+++|+..+.||+|+||.||+|+.++++.||||.+.... ......+.+|+++++.++||||+++++++...+..+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3344668899999999999999999998889999999986543 234457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.+++.........++|..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999976544444589999999999999999999999   99999999999999999999999995

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=2.7e-27  Score=237.36  Aligned_cols=153  Identities=20%  Similarity=0.281  Sum_probs=134.0

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEe
Q 013258          286 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  362 (447)
Q Consensus       286 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  362 (447)
                      .+.+++...++|+..++||+|+||+||+|+.. +++.||||+++....  ......+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34556667789999999999999999999976 488999999964321  112234889999999999999999999999


Q ss_pred             cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          363 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       363 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      +.+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +||||||||+|||+|.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            99999999999999999999986422   389999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       219 FG  220 (437)
T 4aw2_A          219 FG  220 (437)
T ss_dssp             CT
T ss_pred             hh
Confidence            96

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.94  E-value=6.6e-27  Score=230.46  Aligned_cols=145  Identities=31%  Similarity=0.436  Sum_probs=128.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|++.+.||+|+||.||+|+..    ++..||||.++.........+|.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357888999999999999999864    4678999999765433345579999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.++++...   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCc
Confidence            999999999999997643   2489999999999999999999999   99999999999999999999999995

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.94  E-value=9.2e-27  Score=229.22  Aligned_cols=148  Identities=28%  Similarity=0.441  Sum_probs=129.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      .++|.+.+.||+|+||.||+|+..        ++..||||.++.........++.+|+++++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            356778899999999999999852        35679999997654333445799999999999 899999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..++||||+++|+|.+++.....            ....+++..+..++.|+++||+|||++   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999987532            123478999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.+||+||-
T Consensus       237 ~~~~~~kl~DFG  248 (370)
T 2psq_A          237 TENNVMKIADFG  248 (370)
T ss_dssp             CTTCCEEECCCS
T ss_pred             CCCCCEEEcccc
Confidence            999999999995

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=9.5e-27  Score=225.26  Aligned_cols=144  Identities=24%  Similarity=0.390  Sum_probs=129.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...... ....++.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35788889999999999999996 57999999999654322 23446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....    +++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        94 e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence            99999999999977543    88999999999999999999999   99999999999999999999999995

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=9.4e-27  Score=225.08  Aligned_cols=144  Identities=29%  Similarity=0.407  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|.+.+.||+|+||.||+|+..    .+..||||.++..........+.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45777899999999999999974    34569999997654444455799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.++++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       129 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             EECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             eeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCC
Confidence            999999999999976432   489999999999999999999999   99999999999999999999999995

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=1.4e-26  Score=223.84  Aligned_cols=147  Identities=21%  Similarity=0.315  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC-------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-------  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------  365 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356888899999999999999976 699999999975544444567999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEeecCCCCChhhHhhccCCCCCCCCh
Q 013258          366 --------------------------------------------------EKLLVYPYMTNGSVASRLRERQSSLPPLDW  395 (447)
Q Consensus       366 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  395 (447)
                                                                        ..++||||+++|+|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              27999999999999999987532 233567


Q ss_pred             HHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       396 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  209 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG  209 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecC
Confidence            77899999999999999999   99999999999999999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=5.4e-27  Score=233.41  Aligned_cols=150  Identities=23%  Similarity=0.314  Sum_probs=132.0

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEec
Q 013258          287 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  363 (447)
Q Consensus       287 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  363 (447)
                      +.+++...++|+..+.||+|+||+||+|+.. +++.||+|+++...  .......+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556788999999999999999999975 58999999986432  12223358899999999999999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      .+..++||||+++|+|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999764     278999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       213 G  213 (410)
T 3v8s_A          213 G  213 (410)
T ss_dssp             T
T ss_pred             c
Confidence            5

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=1.6e-26  Score=224.41  Aligned_cols=143  Identities=24%  Similarity=0.330  Sum_probs=128.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|+++...  .......+.+|+.++..++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56888899999999999999965 68999999996542  2234456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeecc
Confidence            9999999999997653    388999999999999999999999   99999999999999999999999995

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=6.5e-27  Score=233.00  Aligned_cols=154  Identities=21%  Similarity=0.272  Sum_probs=134.5

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEE
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFC  361 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~  361 (447)
                      +.+++.....++|+..+.||+|+||+||+|+.+ +|+.||||+++....  ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345555666789999999999999999999975 699999999964321  11223488999999999999999999999


Q ss_pred             ecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       362 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      .+.+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+|.++.+||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999999986532   388999999999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       205 DFG  207 (412)
T 2vd5_A          205 DFG  207 (412)
T ss_dssp             CCT
T ss_pred             ech
Confidence            995

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=4.1e-26  Score=217.73  Aligned_cols=142  Identities=22%  Similarity=0.350  Sum_probs=128.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||+||+|+. .+++.||||.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            35799999999999999999995 4689999999865432 334568999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCC
Confidence            99999999999764     288999999999999999999999   99999999999999999999999995

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=6.1e-27  Score=231.12  Aligned_cols=145  Identities=30%  Similarity=0.454  Sum_probs=129.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|...+.||+|+||.||+|+.. +++.||||.++.........+|.+|+++++.++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456777899999999999999976 6899999999754333333468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.++++....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       193 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence            9999999999986432   378999999999999999999999   99999999999999999999999995

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.93  E-value=3e-26  Score=219.82  Aligned_cols=143  Identities=25%  Similarity=0.440  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||+||+|+.. +++.||+|.+... .......+.+|++++..++||||+++++++.+.+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46777899999999999999965 5899999988543 223345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....   .++|..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  153 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFG  153 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCT
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecc
Confidence            999999999987432   389999999999999999999999   99999999999999999999999995

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=1.2e-26  Score=224.26  Aligned_cols=143  Identities=25%  Similarity=0.379  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||+||+|+.. +++.||||++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888899999999999999965 68999999986544333345689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEee
Confidence            99999999987543    389999999999999999999999   99999999999999999999999995

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.93  E-value=1.2e-26  Score=225.65  Aligned_cols=152  Identities=30%  Similarity=0.478  Sum_probs=132.7

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  363 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  363 (447)
                      +....++|...+.||+|+||.||+|+..      +++.||||.++..........+.+|+.+++.++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999864      3488999999765443345579999999999999999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCC--------------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeec
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSS--------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHR  423 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  423 (447)
                      .+..++||||+++|+|.+++......                    ...+++..+..++.|+++||+|||++   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            99999999999999999999874311                    14589999999999999999999999   99999


Q ss_pred             CCCCCceeeCCCCceeecccc
Q 013258          424 DVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       424 Dlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+|||+++++.+||+||-
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg  219 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFG  219 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCS
T ss_pred             CCCcceEEECCCCeEEEeecC
Confidence            999999999999999999995

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.93  E-value=1e-25  Score=215.70  Aligned_cols=159  Identities=42%  Similarity=0.692  Sum_probs=140.2

Q ss_pred             ccccccHHHHHHHhcCCCCC------CccccCCCceEEEEEeCCCcEEEEEEcccccc---cccHHHHHHHHHHHhcCCC
Q 013258          281 QLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH  351 (447)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H  351 (447)
                      ....|++.++..++++|...      +.||+|+||.||+|+. +++.||||.+.....   ......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568999999999999877      8999999999999997 588999999864321   2234569999999999999


Q ss_pred             CCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       352 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                      |||+++++++...+..++||||+++|+|.+++..... ...++|..+..++.|+++||+|||+.   +|+||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999975422 23589999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      +++++.+||+||-
T Consensus       166 i~~~~~~kl~Dfg  178 (307)
T 2nru_A          166 LDEAFTAKISDFG  178 (307)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             EcCCCcEEEeecc
Confidence            9999999999995

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.93  E-value=1.9e-26  Score=225.29  Aligned_cols=146  Identities=29%  Similarity=0.419  Sum_probs=128.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCce
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  367 (447)
                      ...++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+.+|.+++..+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34578999999999999999999965 58999999996532  122344688999999988 799999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....    +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccc
Confidence            999999999999999987543    89999999999999999999999   99999999999999999999999995

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.93  E-value=6.3e-26  Score=218.88  Aligned_cols=153  Identities=22%  Similarity=0.292  Sum_probs=133.9

Q ss_pred             ccccHHHHHHHhcC----------CCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCC
Q 013258          283 KRFSLRELQVATDG----------FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH  351 (447)
Q Consensus       283 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H  351 (447)
                      ..++.+++..+++.          |+..+.||+|+||.||+|+.. +|+.||||+++... ......+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence            34677777776654          555678999999999999976 69999999986543 3345578999999999999


Q ss_pred             CCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       352 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                      |||+++++++...+..++||||+++|+|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+|||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            99999999999999999999999999999998643     389999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      ++.++.+||+||-
T Consensus       174 l~~~~~~kl~Dfg  186 (321)
T 2c30_A          174 LTLDGRVKLSDFG  186 (321)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             ECCCCcEEEeeee
Confidence            9999999999995

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.93  E-value=3.6e-26  Score=220.20  Aligned_cols=143  Identities=29%  Similarity=0.422  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|+++...  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56888899999999999999965 68999999996542  1223456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecC
Confidence            9999999999998653    388999999999999999999999   99999999999999999999999995

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=4.4e-26  Score=214.07  Aligned_cols=142  Identities=27%  Similarity=0.437  Sum_probs=128.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|+..+.||+|+||.||+|+..+++.||+|+++...  ....++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            5677789999999999999998888999999997543  23457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+||-
T Consensus        88 ~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  151 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  151 (269)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred             CCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccc
Confidence            99999999976432   488999999999999999999999   99999999999999999999999995

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=3e-26  Score=225.36  Aligned_cols=147  Identities=31%  Similarity=0.411  Sum_probs=128.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.........++.+|+.+++.++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56777899999999999999843      467899999976544444557999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCC---CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecc
Q 013258          369 LVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKT  442 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~d  442 (447)
                      +||||+++|+|.+++.....   ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999987532   223488999999999999999999999   999999999999999655   499999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       228 FG  229 (367)
T 3l9p_A          228 FG  229 (367)
T ss_dssp             CH
T ss_pred             Cc
Confidence            94

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.93  E-value=3.6e-26  Score=225.50  Aligned_cols=143  Identities=25%  Similarity=0.349  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+++.. +++.||+|.++...  .......+.+|+.++..++|||||++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888899999999999999965 58999999986432  2233457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+.+|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccc
Confidence            9999999999997643    389999999999999999999999   99999999999999999999999995

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=3.2e-26  Score=222.96  Aligned_cols=147  Identities=25%  Similarity=0.410  Sum_probs=128.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      ....++|...+.||+|+||+||+|+.+ +++.||||+++...  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999975 58999999996542  123344678899998876 99999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence            999999999999999998753    389999999999999999999999   99999999999999999999999995

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.93  E-value=3.8e-26  Score=226.18  Aligned_cols=144  Identities=26%  Similarity=0.349  Sum_probs=127.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|+..+.||+|+||+||+|+.+ +++.||||+++.....  .....+.+|..++..+ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457888999999999999999965 5889999999754322  1223578899998876 89999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecc
Confidence            999999999999998754    389999999999999999999999   99999999999999999999999995

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=5.7e-26  Score=216.39  Aligned_cols=143  Identities=22%  Similarity=0.296  Sum_probs=128.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+.......  ....+.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            56888899999999999999964 68999999985432222  2346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        91 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999998754    389999999999999999999999   99999999999999999999999995

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.93  E-value=7.6e-26  Score=221.67  Aligned_cols=144  Identities=24%  Similarity=0.327  Sum_probs=128.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|.++......     ....+.+|+.++..++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457888899999999999999965 58999999996543221     245789999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeeccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  443 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df  443 (447)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997643    389999999999999999999999   999999999999999887    7999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       164 G  164 (361)
T 2yab_A          164 G  164 (361)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.93  E-value=8.4e-26  Score=217.56  Aligned_cols=147  Identities=27%  Similarity=0.437  Sum_probs=115.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++..........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888999999999999999864 5899999999755444444578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccC--CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++ |+|.+++....  .....+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCc
Confidence            998 69999887642  1123488999999999999999999999   99999999999999999999999995

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.93  E-value=6.1e-26  Score=221.56  Aligned_cols=143  Identities=24%  Similarity=0.310  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++...  .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            56788899999999999999965 68999999986432  2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccc
Confidence            9999999999998753    388999999999999999999999   99999999999999999999999995

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=7.8e-26  Score=213.87  Aligned_cols=143  Identities=27%  Similarity=0.420  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|...++..||||+++...  ....++.+|++++..++||||+++++++...+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            45677789999999999999999888899999997543  2345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+||-
T Consensus       101 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A          101 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             CTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             cCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence            999999999976432   389999999999999999999999   99999999999999999999999995

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=6.8e-26  Score=212.55  Aligned_cols=143  Identities=28%  Similarity=0.424  Sum_probs=129.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|+..++..||||.++...  ....++.+|++++..++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45678889999999999999998888899999997543  2345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+||-
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  149 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFG  149 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTT
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCc
Confidence            999999999977532   388999999999999999999999   99999999999999999999999995

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.93  E-value=7e-26  Score=220.73  Aligned_cols=143  Identities=27%  Similarity=0.357  Sum_probs=127.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++......  ....+.+|..++..+ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46788899999999999999975 58999999997543222  233578899999887 899999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999998653    389999999999999999999999   99999999999999999999999995

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=1.4e-26  Score=226.61  Aligned_cols=157  Identities=28%  Similarity=0.396  Sum_probs=133.9

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccce
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  357 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l  357 (447)
                      +...+.....++|++.+.||+|+||.||+|++      .+++.||||+++..........+.+|++++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44555666778899999999999999999973      246899999997654444445799999999999 79999999


Q ss_pred             eeEEecCCc-eEEEeecCCCCChhhHhhccCCC-----------------------------------------------
Q 013258          358 YGFCTTVTE-KLLVYPYMTNGSVASRLRERQSS-----------------------------------------------  389 (447)
Q Consensus       358 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  389 (447)
                      ++++...+. .++||||+++|+|.++++.....                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 89999999999999999875321                                               


Q ss_pred             ---------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          390 ---------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       390 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                                     ...+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  238 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG  238 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEecc
Confidence                           11288999999999999999999999   99999999999999999999999995

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=7.4e-26  Score=217.37  Aligned_cols=144  Identities=24%  Similarity=0.393  Sum_probs=125.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||+||+|+..+++.||+|+++...... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            35688889999999999999998889999999996543322 23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |++ |+|.+.+.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       100 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A          100 FME-KDLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CCS-EEHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CCC-CCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            998 488888876432   388999999999999999999999   99999999999999999999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.93  E-value=5.1e-26  Score=220.10  Aligned_cols=144  Identities=25%  Similarity=0.333  Sum_probs=123.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      .++|+..+.||+|+||.||+++.    .+++.||+|+++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35688889999999999999986    4689999999975431   1223457899999999999999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence            999999999999999997653    378899999999999999999999   99999999999999999999999995

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=4.2e-26  Score=222.91  Aligned_cols=148  Identities=20%  Similarity=0.261  Sum_probs=127.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc----ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      .+.|++.+.||+|+||.||+|+.. +++.||||+++...    .......+.+|+.++..++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356888899999999999999864 68999999985432    1123457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~df~  444 (447)
                      +||||+++|+|.+.+.........+++..+..++.|+++||+|||++   +|+||||||+|||++.+++   +||+||-
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988876433333488999999999999999999999   9999999999999987765   9999995

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.93  E-value=1.1e-25  Score=216.39  Aligned_cols=174  Identities=33%  Similarity=0.610  Sum_probs=156.6

Q ss_pred             cCchHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCc--cceeEeCCC---CCEEEEEcCCCCccc--cccccccCCCCCC
Q 013258           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCT--WFHITCNPE---GSVTRVDLGNAALSG--ELAPELGQLKNLE   94 (447)
Q Consensus        22 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~v~~l~L~~~~l~g--~~~~~l~~l~~L~   94 (447)
                      .|.+.|..||+.||+++.+|. .+.+|.. +.+||.  |.||.|+..   ++|+.|+|++|.+.|  .+|+.+.++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence            477889999999999998886 7899975 468998  999999854   799999999999999  9999999999999


Q ss_pred             EEECCC-CccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccc
Q 013258           95 LLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  173 (447)
Q Consensus        95 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N  173 (447)
                      +|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+..+++|+.|++++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 9999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-CCCC-ccccccccccc
Q 013258          174 RLSGPVPDN-GSFS-QFTPISFENNL  197 (447)
Q Consensus       174 ~l~g~~p~~-~~~~-~~~~~~~~~n~  197 (447)
                      .++|.+|.. +.+. .++.+.+.+|.
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~  185 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNR  185 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCe
Confidence            999988864 2333 55556666654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=5.4e-26  Score=218.07  Aligned_cols=148  Identities=30%  Similarity=0.434  Sum_probs=129.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|.+.+.||+|+||.||+|+.      .+++.||||.++..........+.+|+++++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            45677889999999999999985      235789999997654434445789999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCC--------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCC
Q 013258          368 LLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  427 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp  427 (447)
                      ++||||+++|+|.+++.....                    ....+++..+..++.|+++||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999987532                    112378899999999999999999999   999999999


Q ss_pred             CceeeCCCCceeecccc
Q 013258          428 ANILLDEDADQSSKTIL  444 (447)
Q Consensus       428 ~NILl~~~~~~~i~df~  444 (447)
                      +|||+++++.+||+||-
T Consensus       179 ~NIli~~~~~~kl~Dfg  195 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFG  195 (314)
T ss_dssp             GGEEEETTTEEEECCCT
T ss_pred             heEEEcCCCCEEEcccc
Confidence            99999999999999995

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=1.2e-25  Score=222.84  Aligned_cols=146  Identities=22%  Similarity=0.294  Sum_probs=129.4

Q ss_pred             hcCCCCCCccccC--CCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|++.+.||+|  +||.||+|+.. +++.||||+++...... ....+.+|+.+++.++|||||++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3567888999999  99999999975 69999999996543322 23468889999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccc
Confidence            9999999999999987532  2389999999999999999999999   99999999999999999999999994

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.4e-25  Score=216.42  Aligned_cols=143  Identities=21%  Similarity=0.312  Sum_probs=127.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.++...  .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            357888899999999999999965 58899999986432  234468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--CCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~~i~df~  444 (447)
                      |+++|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||++.  ++.+||+||-
T Consensus        82 ~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           82 FISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             CCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             eCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            999999999997643   2488999999999999999999999   9999999999999997  7899999995

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.93  E-value=9.9e-26  Score=213.94  Aligned_cols=143  Identities=24%  Similarity=0.438  Sum_probs=126.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|+..+++.||+|+++..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            467788999999999999999878999999998654322 2235688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++ +|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||.
T Consensus        82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECc
Confidence            985 99998876432   388999999999999999999999   99999999999999999999999995

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.93  E-value=8.3e-26  Score=223.38  Aligned_cols=148  Identities=29%  Similarity=0.410  Sum_probs=129.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      .++|.+.+.||+|+||.||+|+..        ++..||||+++.........++.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            356777899999999999999852        23579999997654444445799999999999 999999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..++||||+++|+|.+++......            ...+++..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            9999999999999999999875421            23489999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.+||+||-
T Consensus       225 ~~~~~~kL~DFG  236 (382)
T 3tt0_A          225 TEDNVMKIADFG  236 (382)
T ss_dssp             CTTCCEEECSCS
T ss_pred             cCCCcEEEcccC
Confidence            999999999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=7.9e-26  Score=220.88  Aligned_cols=145  Identities=24%  Similarity=0.316  Sum_probs=128.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC-CcEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  368 (447)
                      ..++|+..+.||+|+||+||+|+... ++.||||+++...  .......+..|..++..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45678889999999999999999764 8899999996542  223345688999999887 8999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            9999999999999998653    389999999999999999999999   99999999999999999999999995

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.93  E-value=8.9e-26  Score=213.96  Aligned_cols=147  Identities=20%  Similarity=0.310  Sum_probs=129.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||+|+.. ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46788899999999999999964 58999999997665555566899999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      +++|+|.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||+   +.++.+||+||-
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            999999999865422223489999999999999999999999   99999999999999   456789999995

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.93  E-value=6.3e-26  Score=217.67  Aligned_cols=149  Identities=28%  Similarity=0.404  Sum_probs=129.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ....++|++.+.||+|+||.||+|+. +++.||||++...... ....++.+|++++++++||||+++++++...+..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34456788889999999999999987 5889999998654322 223468999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC--eeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++..... ...+++..+..++.|+++||+|||+.   +  |+||||||+|||+++++.+||+||-
T Consensus       112 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             EEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            9999999999999976421 12378999999999999999999998   7  9999999999999999999999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.93  E-value=1.2e-25  Score=213.30  Aligned_cols=140  Identities=10%  Similarity=-0.024  Sum_probs=123.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||||.++......  ....+.+|+..+..++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888899999999999999975 48999999997654322  2356899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      ||+++++|.++++..      ....++..++.|++.||+|||++   +|+||||||+|||+++++.+||+++
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            999999999998542      34557889999999999999999   9999999999999999999999865

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.4e-25  Score=216.00  Aligned_cols=146  Identities=23%  Similarity=0.316  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            45778899999999999999975 489999999976554445567899999999999999999999988755  679999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee----CCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++..... ...+++..+..++.|+++||+|||+.   +|+||||||+|||+    +.++.+||+||-
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            99999999999987532 22389999999999999999999999   99999999999999    888889999995

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=1e-25  Score=230.16  Aligned_cols=144  Identities=28%  Similarity=0.402  Sum_probs=129.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|...+.||+|+||.||+|++.. +..||||.++...  ....+|.+|+.++++++||||++++++|...+..++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4557778999999999999999764 8899999997543  235679999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       297 ~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             CCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             ccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence            9999999999986432  2488999999999999999999999   99999999999999999999999995

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.92  E-value=1.9e-25  Score=216.07  Aligned_cols=143  Identities=26%  Similarity=0.322  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      +.|...+.||+|+||.||+|+.. +++.||+|.++.....     .....+.+|+.++..++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45788899999999999999965 5899999998654321     13457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df~  444 (447)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++    .+||+||-
T Consensus        91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999997543    389999999999999999999999   999999999999999888    79999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.1e-25  Score=214.64  Aligned_cols=142  Identities=25%  Similarity=0.374  Sum_probs=120.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-------------------------ccHHHHHHHHHHHhc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-------------------------GGELQFQTEVKIISM  348 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~  348 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++.....                         .....+.+|+++++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57888899999999999999964 5899999998643211                         112468899999999


Q ss_pred             CCCCCccceeeEEec--CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCC
Q 013258          349 AVHRNLLRLYGFCTT--VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  426 (447)
Q Consensus       349 l~H~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  426 (447)
                      ++||||+++++++..  .+..++||||+++|+|.+++..     ..+++..+..++.|+++||+|||++   +|+|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            999999999999986  5678999999999999886543     2489999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceeecccc
Q 013258          427 AANILLDEDADQSSKTIL  444 (447)
Q Consensus       427 p~NILl~~~~~~~i~df~  444 (447)
                      |+|||++.++.+||+||-
T Consensus       165 p~Nil~~~~~~~kl~Dfg  182 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFG  182 (298)
T ss_dssp             GGGEEECTTSCEEECCCT
T ss_pred             HHHEEECCCCCEEEecCC
Confidence            999999999999999995

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.92  E-value=1.9e-25  Score=212.35  Aligned_cols=143  Identities=20%  Similarity=0.371  Sum_probs=124.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46788899999999999999965 58999999996544332 23568899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++ ++.+.+....   ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence            9975 6666665432   2389999999999999999999999   99999999999999999999999995

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=9.1e-26  Score=217.83  Aligned_cols=143  Identities=30%  Similarity=0.424  Sum_probs=124.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  369 (447)
                      .++|+..+.||+|+||+||+|+.. ++.||||+++...  .....+.+|+.++..++||||+++++++....    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            456888899999999999999975 7899999986432  22345677999999999999999999998754    3699


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC-------CCCCeeecCCCCCceeeCCCCceeecc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                      ||||+++|+|.++++..     .++|..+..++.|+++||+|||+.       +.++|+||||||+|||+++++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999764     289999999999999999999986       234899999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       175 Fg  176 (322)
T 3soc_A          175 FG  176 (322)
T ss_dssp             CT
T ss_pred             CC
Confidence            95

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=9.5e-26  Score=228.05  Aligned_cols=144  Identities=23%  Similarity=0.364  Sum_probs=127.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..++|+..+.||+|+||+||+|++.++..||||.++...  .....|.+|+.+++.++||||+++++++. .+..++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            345677789999999999999999888999999997543  34567999999999999999999999986 567899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       263 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             CCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             ecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999975421  1378899999999999999999999   99999999999999999999999995

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.92  E-value=2.1e-25  Score=218.83  Aligned_cols=142  Identities=24%  Similarity=0.274  Sum_probs=127.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|+..+.||+|+||.||+++.. +++.||||++.....  ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            356888899999999999999965 689999999965432  23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc--eeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.  +||+||-
T Consensus        97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            999999999997654    389999999999999999999999   9999999999999998776  9999995

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.92  E-value=1e-25  Score=218.66  Aligned_cols=142  Identities=25%  Similarity=0.424  Sum_probs=126.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+. .+++.||||+++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5688889999999999999996 568999999986432  1223347899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+ +|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEec
Confidence            999 789999987654    389999999999999999999999   99999999999999999999999995

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=1.7e-25  Score=213.44  Aligned_cols=144  Identities=26%  Similarity=0.434  Sum_probs=124.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--Cce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~  367 (447)
                      +.|+..+.||+|+||.||+|++     .+++.||||+++..........+.+|++++..++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3467779999999999999984     358899999997655445556799999999999999999999999876  668


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence            999999999999999966432   388999999999999999999999   99999999999999999999999995

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.4e-25  Score=218.22  Aligned_cols=151  Identities=26%  Similarity=0.406  Sum_probs=127.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      ...++|...+.||+|+||.||+|+.      .++..||||.++..........+.+|+.++..+ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3456788889999999999999985      235689999997554444455799999999999 899999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCCC-------------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCC
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  425 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  425 (447)
                      +..++||||+++|+|.+++......                   ...+++..+..++.|++.||+|||+.   +|+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            9999999999999999999865321                   12378999999999999999999999   9999999


Q ss_pred             CCCceeeCCCCceeeccccc
Q 013258          426 KAANILLDEDADQSSKTILR  445 (447)
Q Consensus       426 kp~NILl~~~~~~~i~df~~  445 (447)
                      ||+|||++.++.+||+||--
T Consensus       199 kp~NIll~~~~~~kL~Dfg~  218 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGL  218 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGG
T ss_pred             ChhhEEEcCCCcEEeCCCcc
Confidence            99999999999999999953

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=2.2e-25  Score=216.15  Aligned_cols=149  Identities=28%  Similarity=0.444  Sum_probs=128.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      ..++|...+.||+|+||.||+|+..        ++..||||+++.........++.+|++++..+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3467888899999999999999863        46789999997654333445789999999999 89999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCcee
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  431 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NIL  431 (447)
                      .+..++||||+++|+|.+++......            ...+++..+..++.|+++||+|||+.   +|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            99999999999999999999865321            12378999999999999999999999   9999999999999


Q ss_pred             eCCCCceeecccc
Q 013258          432 LDEDADQSSKTIL  444 (447)
Q Consensus       432 l~~~~~~~i~df~  444 (447)
                      ++.++.+||+||-
T Consensus       190 l~~~~~~kL~Dfg  202 (334)
T 2pvf_A          190 VTENNVMKIADFG  202 (334)
T ss_dssp             ECTTCCEEECCCT
T ss_pred             EcCCCCEEEcccc
Confidence            9999999999995

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=2.2e-25  Score=225.04  Aligned_cols=143  Identities=28%  Similarity=0.434  Sum_probs=127.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC-ceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lv~  371 (447)
                      ..++|+..+.||+|+||.||+|.+. ++.||||.++...   ....|.+|+.++++++||||+++++++...+ ..++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            3456778899999999999999985 7899999997543   3457999999999999999999999987665 789999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       267 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  334 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  334 (450)
T ss_dssp             ECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence            99999999999987532  2368899999999999999999999   99999999999999999999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.92  E-value=2e-25  Score=218.94  Aligned_cols=145  Identities=22%  Similarity=0.300  Sum_probs=127.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..++|+..+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467888999999999999999965 5899999999654322 2234688999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~  444 (447)
                      |||+++|+|.+.+....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++   .+||+||-
T Consensus       107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            99999999999987643    388999999999999999999999   999999999999998764   59999995

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=2.1e-25  Score=225.97  Aligned_cols=143  Identities=25%  Similarity=0.434  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||+++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56788899999999999999965 699999999964321  223456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG  161 (476)
T 2y94_A           96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  161 (476)
T ss_dssp             ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEecc
Confidence            9999999999997543    389999999999999999999999   99999999999999999999999995

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=2.5e-25  Score=228.15  Aligned_cols=147  Identities=31%  Similarity=0.430  Sum_probs=130.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|...+.||+|+||+||+|+.. +|+.||+|+++....  ......+.+|++++..++||||+++++++...+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888899999999999999975 699999999965431  233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFG  334 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLG  334 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecc
Confidence            99999999999987543344689999999999999999999999   99999999999999999999999995

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.92  E-value=1.2e-25  Score=221.26  Aligned_cols=143  Identities=27%  Similarity=0.348  Sum_probs=118.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHH-HhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++.....  .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            46778899999999999999975 5889999999654322  223346677776 5778999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCc
Confidence            99999999999998753    378899999999999999999999   99999999999999999999999995

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=6.5e-26  Score=228.76  Aligned_cols=144  Identities=24%  Similarity=0.316  Sum_probs=120.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            356888899999999999999964 68999999996542  222334678999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++.+||+||-
T Consensus       227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCC
Confidence            99999999999997654    38999999999999999999998 7   89999999999999999999999995

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.92  E-value=1.8e-25  Score=211.34  Aligned_cols=144  Identities=23%  Similarity=0.315  Sum_probs=124.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|++.+.||+|+||.||+|+...    +..||+|.++..........+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4567788999999999999998642    45799999875443334457999999999999999999999974 567899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccc
Confidence            9999999999999986532   488999999999999999999999   99999999999999999999999995

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=219.79  Aligned_cols=145  Identities=16%  Similarity=0.236  Sum_probs=125.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEE------eCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeEEec
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTT  363 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~  363 (447)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||+++..    ...++.+|++++..++   |+||+++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34668888999999999999994      346889999998643    3446788888888877   9999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCC-CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--------
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------  434 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------  434 (447)
                      .+..++||||+++|+|.+++..... ....++|..+..|+.|+++||+|||++   +||||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999975321 223589999999999999999999999   9999999999999998        


Q ss_pred             ---CCceeecccc
Q 013258          435 ---DADQSSKTIL  444 (447)
Q Consensus       435 ---~~~~~i~df~  444 (447)
                         ++.+||+||-
T Consensus       216 ~~~~~~~kl~DFG  228 (365)
T 3e7e_A          216 DDLSAGLALIDLG  228 (365)
T ss_dssp             ---CTTEEECCCT
T ss_pred             ccccCCEEEeeCc
Confidence               8999999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.92  E-value=2.5e-25  Score=228.93  Aligned_cols=146  Identities=27%  Similarity=0.363  Sum_probs=129.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|...+.||+|+||+||+|+.. +|+.||||+++...  .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888899999999999999965 69999999986432  223345688999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++.....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFG  331 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLG  331 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecc
Confidence            999999999999976432  2489999999999999999999999   99999999999999999999999995

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.92  E-value=7.3e-26  Score=217.34  Aligned_cols=144  Identities=24%  Similarity=0.350  Sum_probs=126.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCc----
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  366 (447)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++......  ....+.+|+.++..++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35688889999999999999996 568999999997543222  23468899999999999999999999876544    


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.++++...    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence            399999999999999998654    389999999999999999999999   99999999999999999999999995

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.92  E-value=1.9e-25  Score=209.41  Aligned_cols=146  Identities=26%  Similarity=0.382  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|+.. ++.||||+++..... .....+.+|+.+++.++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56778899999999999999985 889999999754322 2334699999999999999999999999887  7789999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....  ..+++..+..++.|+++||+|||+. .++|+||||||+|||+++++.++++||-
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~  158 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMAD  158 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred             cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEecc
Confidence            99999999999986532  2489999999999999999999998 1229999999999999999999988663

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=1e-25  Score=217.19  Aligned_cols=153  Identities=27%  Similarity=0.426  Sum_probs=131.9

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEe
Q 013258          289 ELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT  362 (447)
Q Consensus       289 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  362 (447)
                      +.+...++|...+.||+|+||.||+|+..      +++.||||.++..........+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445677888999999999999999753      367899999975543334456899999999999999999999999


Q ss_pred             cCCceEEEeecCCCCChhhHhhccC------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          363 TVTEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       363 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      ..+..++||||+++|+|.+++....      .....+++..+..++.|++.||+|||++   +|+||||||+|||+++++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999997632      1123468999999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+||+||-
T Consensus       176 ~~kl~Dfg  183 (322)
T 1p4o_A          176 TVKIGDFG  183 (322)
T ss_dssp             CEEECCTT
T ss_pred             eEEECcCc
Confidence            99999995

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.92  E-value=3.3e-25  Score=208.64  Aligned_cols=144  Identities=25%  Similarity=0.376  Sum_probs=129.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|+.. +++.||||.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356888899999999999999975 6899999998655444445679999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|++||-
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            999999999986542    388999999999999999999999   99999999999999999999999995

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=1.8e-26  Score=224.00  Aligned_cols=142  Identities=20%  Similarity=0.237  Sum_probs=117.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccc-------cccHHHHHHHHHHHhcCC---------CCCccce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAV---------HRNLLRL  357 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------H~niv~l  357 (447)
                      .++|+..+.||+|+||+||+|+. +|+.||||+++....       ......+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35678889999999999999998 689999999975432       222357889999998886         6666666


Q ss_pred             eeEE-----------------ec-------------CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHH
Q 013258          358 YGFC-----------------TT-------------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR  407 (447)
Q Consensus       358 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~  407 (447)
                      .+.+                 .+             .+..++||||+++|++.+.+...     .+++..+..++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-----~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-----LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-----CCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-----CCCHHHHHHHHHHHHH
Confidence            6543                 32             67899999999999877776432     3789999999999999


Q ss_pred             HHhhhh-cCCCCCeeecCCCCCceeeCCCC--------------------ceeecccc
Q 013258          408 GLSYLH-EHCDPKIIHRDVKAANILLDEDA--------------------DQSSKTIL  444 (447)
Q Consensus       408 gL~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~~i~df~  444 (447)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+||-
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG  227 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT  227 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCT
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecc
Confidence            999999 88   999999999999999987                    89999995

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=1.7e-25  Score=214.54  Aligned_cols=148  Identities=29%  Similarity=0.391  Sum_probs=129.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      .++|...+.||+|+||.||+|+.      .+++.||||.++..........+.+|+.++..+ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45678889999999999999984      246799999997554333445799999999999 99999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCC--------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          367 KLLVYPYMTNGSVASRLRERQSS--------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      .++||||+++|+|.+++......              ...+++..+..++.|+++||+|||++   +|+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            99999999999999999875321              12488999999999999999999999   99999999999999


Q ss_pred             CCCCceeecccc
Q 013258          433 DEDADQSSKTIL  444 (447)
Q Consensus       433 ~~~~~~~i~df~  444 (447)
                      ++++.+||+||-
T Consensus       179 ~~~~~~kl~Dfg  190 (313)
T 1t46_A          179 THGRITKICDFG  190 (313)
T ss_dssp             ETTTEEEECCCG
T ss_pred             cCCCCEEEcccc
Confidence            999999999995

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=1.6e-25  Score=216.56  Aligned_cols=143  Identities=27%  Similarity=0.473  Sum_probs=120.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||+||+|++. +++    .||+|.++.........++.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46778899999999999999854 344    468888865544455668999999999999999999999998754 789


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg  162 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCc
Confidence            9999999999999987543   489999999999999999999999   99999999999999999999999995

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.92  E-value=9.9e-26  Score=214.55  Aligned_cols=144  Identities=25%  Similarity=0.435  Sum_probs=125.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~  366 (447)
                      .++|++.+.||+|+||.||+|++     .+++.||||+++... ......+.+|++++..++||||+++++++..  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            35677889999999999999984     258899999986432 2234578999999999999999999999865  355


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             eEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCc
Confidence            8999999999999999987532   388999999999999999999999   99999999999999999999999995

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=3.5e-25  Score=207.37  Aligned_cols=142  Identities=27%  Similarity=0.427  Sum_probs=128.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|+..+.||+|+||.||+|+..+++.||+|.++....  ...++.+|++++..++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            56777899999999999999988888999999975432  3457999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++++|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||-
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg  149 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  149 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccc
Confidence            99999999986532   478999999999999999999999   99999999999999999999999995

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.92  E-value=2.9e-25  Score=223.32  Aligned_cols=145  Identities=19%  Similarity=0.265  Sum_probs=126.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..++|+..+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567888999999999999999864 6899999998654322 2234689999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC---CCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~~i~df~  444 (447)
                      |||+++|+|.+.+....    .+++..+..++.|+++||+|||++   +|+||||||+|||++   +++.+||+||-
T Consensus        89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            99999999999998753    389999999999999999999999   999999999999999   46789999995

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=2.9e-25  Score=209.99  Aligned_cols=148  Identities=26%  Similarity=0.375  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||.++.... .....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            456888899999999999999975 699999999865432 22345688999999998 999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC--------------
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--------------  436 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--------------  436 (447)
                      |||+++|+|.+++.........+++..+..++.|+++||+|||++   +|+||||||+|||++.++              
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986532223489999999999999999999999   999999999999999544              


Q ss_pred             -----ceeecccc
Q 013258          437 -----DQSSKTIL  444 (447)
Q Consensus       437 -----~~~i~df~  444 (447)
                           .+|++||-
T Consensus       167 ~~~~~~~kl~Dfg  179 (289)
T 1x8b_A          167 ASNKVMFKIGDLG  179 (289)
T ss_dssp             ---CCCEEECCCT
T ss_pred             cCCceEEEEcccc
Confidence                 78999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.92  E-value=5.8e-26  Score=219.97  Aligned_cols=151  Identities=27%  Similarity=0.379  Sum_probs=130.0

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCC-C-----cEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      +...++|...+.||+|+||.||+|.... +     ..||+|.++..........+.+|+.++..+ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445778889999999999999998642 3     479999997654333455799999999999 89999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCC----------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  433 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~  433 (447)
                      .+..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            9999999999999999999975321          122478999999999999999999999   999999999999999


Q ss_pred             CCCceeecccc
Q 013258          434 EDADQSSKTIL  444 (447)
Q Consensus       434 ~~~~~~i~df~  444 (447)
                      +++.+||+||-
T Consensus       199 ~~~~~kl~Dfg  209 (333)
T 2i1m_A          199 NGHVAKIGDFG  209 (333)
T ss_dssp             GGGEEEBCCCG
T ss_pred             CCCeEEECccc
Confidence            99999999995

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=3e-25  Score=213.14  Aligned_cols=144  Identities=24%  Similarity=0.211  Sum_probs=122.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|+..+.||+|+||+||+|+.. +++.||||++...... ....++..|+..+..+ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            356888899999999999999976 6999999988543222 2233455666655555 899999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+ +++|.+++.....   .++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       136 ~e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             Eecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence            9999 6799998877542   489999999999999999999999   99999999999999999999999995

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.92  E-value=2.1e-25  Score=225.35  Aligned_cols=143  Identities=27%  Similarity=0.423  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|.+.++..||||.++...  ....+|.+|+++++.++||||+++++++.. +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            45577778999999999999999878889999997543  234579999999999999999999999876 678999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.++++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       260 ~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          260 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             CTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             hcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence            999999999975321  2388999999999999999999999   99999999999999999999999995

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.92  E-value=1.1e-24  Score=209.25  Aligned_cols=142  Identities=25%  Similarity=0.340  Sum_probs=125.1

Q ss_pred             cCCCCC-CccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +.|.+. +.||+|+||.||+|+. .+++.||||+++... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            456663 7899999999999995 468999999996543 33455789999999884 7999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.   +||+||-
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            9999999999998753    388999999999999999999999   9999999999999998876   9999994

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=3.5e-25  Score=209.04  Aligned_cols=144  Identities=32%  Similarity=0.474  Sum_probs=128.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            456888899999999999999865 578999999854321  22345689999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||-
T Consensus        88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg  154 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  154 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecc
Confidence            99999999999998753    388999999999999999999999   99999999999999999999999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.92  E-value=4.1e-25  Score=223.68  Aligned_cols=142  Identities=20%  Similarity=0.321  Sum_probs=115.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec-----CCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~  367 (447)
                      ++|++.+.||+|+||+||+|+.. +++.||||++...... ....++.+|++++..++|||||++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            57888999999999999999865 6899999998643222 223468999999999999999999999844     3568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+ +|+|.+++....    .+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+||+||-
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEecc-ccchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence            9999998 579999987643    389999999999999999999999   99999999999999999999999995

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=4.2e-25  Score=214.19  Aligned_cols=144  Identities=29%  Similarity=0.466  Sum_probs=126.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|...+.||+|+||.||+|+...     +..||||.++..........+.+|+.++..++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            345667899999999999998542     246999999765433344578999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       124 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999976432   489999999999999999999999   99999999999999999999999995

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=5.2e-25  Score=209.94  Aligned_cols=138  Identities=28%  Similarity=0.409  Sum_probs=119.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeEEec----CCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTT----VTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~  367 (447)
                      .++|+..+.||+|+||+||+|+. +++.||||+++..    ....+.+|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            45788899999999999999998 6899999998543    23455666666655  899999999998654    3457


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh--------cCCCCCeeecCCCCCceeeCCCCcee
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      ++||||+++|+|.++++..     .+++..+..++.|+++||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            9999999999999999643     3899999999999999999999        66   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       154 l~Dfg  158 (301)
T 3q4u_A          154 IADLG  158 (301)
T ss_dssp             ECCCT
T ss_pred             EeeCC
Confidence            99995

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.92  E-value=4.3e-25  Score=219.27  Aligned_cols=147  Identities=22%  Similarity=0.313  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC--ceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lv~  371 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            45778899999999999999975 489999999976554445567889999999999999999999988755  679999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee----CCCCceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~~i~df~~  445 (447)
                      ||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||--
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999976432 22389999999999999999999999   99999999999999    7788899999953

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=4.1e-25  Score=215.73  Aligned_cols=141  Identities=28%  Similarity=0.359  Sum_probs=120.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+|++++..++||||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            456888899999999999999975 58899999986542   23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.   ++.+||+||-
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg  196 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFG  196 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCc
Confidence            999999999997643    388999999999999999999999   9999999999999976   8899999995

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.92  E-value=3.8e-25  Score=213.29  Aligned_cols=150  Identities=27%  Similarity=0.395  Sum_probs=120.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCC-Cc---EEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLAD-GK---LVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      ...++|+..+.||+|+||.||+|+... +.   .||||.++.... .....++.+|+++++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345678889999999999999998653 32   799999975432 2334579999999999999999999999987665


Q ss_pred             e------EEEeecCCCCChhhHhhccCC--CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          367 K------LLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       367 ~------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      .      ++||||+++|+|.+++.....  ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      999999999999999975421  122488999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      ||+||-
T Consensus       177 kl~Dfg  182 (323)
T 3qup_A          177 CVADFG  182 (323)
T ss_dssp             EECCCC
T ss_pred             EEeecc
Confidence            999995

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=4.8e-25  Score=213.07  Aligned_cols=147  Identities=29%  Similarity=0.489  Sum_probs=125.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcE--EEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKL--VAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..+.||+|+||.||+|+.. ++..  +|+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56778899999999999999854 4654  4999987544444455799999999999 899999999999999999999


Q ss_pred             eecCCCCChhhHhhccC------------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          371 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      |||+++|+|.+++....            .....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999998653            1223589999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      ||+||-
T Consensus       182 kL~Dfg  187 (327)
T 1fvr_A          182 KIADFG  187 (327)
T ss_dssp             EECCTT
T ss_pred             EEcccC
Confidence            999995

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=2.6e-25  Score=214.92  Aligned_cols=143  Identities=25%  Similarity=0.421  Sum_probs=122.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcE----EEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||+||+|+.. +++.    ||+|.+...........+.+|+.+++.++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46777899999999999999864 4443    78888754433333446789999999999999999999886 466899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        92 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCC
Confidence            9999999999999976422   388999999999999999999999   99999999999999999999999995

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.92  E-value=8.3e-25  Score=210.67  Aligned_cols=140  Identities=29%  Similarity=0.431  Sum_probs=124.3

Q ss_pred             CCCCCccccCCCceEEEEEeC-----CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC--CceEE
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  369 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l  369 (447)
                      |+..+.||+|+||.||++.+.     +++.||||+++..........+.+|+++++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            377899999999999988642     57899999997654334455799999999999999999999999874  56899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++....     +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence            999999999999997642     88999999999999999999999   99999999999999999999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=6.6e-25  Score=210.37  Aligned_cols=143  Identities=23%  Similarity=0.347  Sum_probs=127.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....... ....+.+|++++..++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56888899999999999999975 58999999986543222 23468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            999999998886543    388999999999999999999999   99999999999999999999999995

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.2e-25  Score=218.11  Aligned_cols=143  Identities=27%  Similarity=0.331  Sum_probs=126.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe----CCCcEEEEEEcccccc---cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      ++|++.+.||+|+||.||+|+.    .+++.||||+++....   ......+.+|++++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5688889999999999999986    3689999999865421   12234577899999999 69999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            999999999999999998753    388999999999999999999999   99999999999999999999999995

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=3.1e-25  Score=215.29  Aligned_cols=145  Identities=26%  Similarity=0.302  Sum_probs=127.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTV  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  364 (447)
                      ..++|+..+.||+|+||.||+|+. .+++.||||+++......       ....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            346789999999999999999985 468999999986543211       223578899999999999999999999999


Q ss_pred             CceEEEeecCCCC-ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          365 TEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       365 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      +..++||||+.+| +|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999777 9999987653    389999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       175 g  175 (335)
T 3dls_A          175 G  175 (335)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=7.8e-25  Score=206.43  Aligned_cols=144  Identities=28%  Similarity=0.464  Sum_probs=128.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+.....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688889999999999999996 4689999999864321  222457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeec
Confidence            9999999999997643   2489999999999999999999999   99999999999999999999999995

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=3.9e-25  Score=209.64  Aligned_cols=144  Identities=26%  Similarity=0.397  Sum_probs=126.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC-C-------cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD-G-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      .++|...+.||+|+||.||+|+... +       ..||+|.++... ......+.+|+.+++.++||||+++++++...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3567778999999999999998543 3       479999986543 234457999999999999999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc--------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------  437 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------  437 (447)
                      ..++||||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999986532   378999999999999999999999   9999999999999999987        


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +|++||-
T Consensus       160 ~kl~Dfg  166 (289)
T 4fvq_A          160 IKLSDPG  166 (289)
T ss_dssp             EEECCCC
T ss_pred             eeeccCc
Confidence            9999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=4.4e-25  Score=216.29  Aligned_cols=144  Identities=26%  Similarity=0.349  Sum_probs=129.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++..........+.+|+.++..++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56888899999999999999965 68999999997654333445789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++.+||+||-
T Consensus       113 ~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECC
Confidence            99999999998754    2889999999999999999999831  79999999999999999999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=3.9e-25  Score=217.75  Aligned_cols=142  Identities=33%  Similarity=0.491  Sum_probs=122.0

Q ss_pred             CCCCCccccCCCceEEEEEeC--CC--cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEe
Q 013258          297 FSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVY  371 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~  371 (447)
                      |...+.||+|+||+||+|+..  ++  ..||||.++.........++.+|+.+++.++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            455688999999999999853  22  46899998754444445679999999999999999999998765 45789999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.++++....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       171 e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG  237 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  237 (373)
T ss_dssp             ECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             ECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence            99999999999976432   378899999999999999999999   99999999999999999999999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=7.6e-25  Score=211.17  Aligned_cols=144  Identities=24%  Similarity=0.333  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-----cHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|++.+.||+|+||.||+|+.. +|+.||||.++......     ...++.+|+.++..++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            356888899999999999999965 58999999986543221     245799999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeeccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  443 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df  443 (447)
                      ++||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++++++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999997643    388999999999999999999999   999999999999999988    7999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       164 g  164 (321)
T 2a2a_A          164 G  164 (321)
T ss_dssp             T
T ss_pred             c
Confidence            5

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.92  E-value=2.2e-25  Score=215.25  Aligned_cols=143  Identities=26%  Similarity=0.440  Sum_probs=123.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46788899999999999999975 68999999996544332223466899999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++ |+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCc
Confidence            97 599998876532   488999999999999999999999   99999999999999999999999995

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.91  E-value=9.5e-25  Score=215.83  Aligned_cols=144  Identities=20%  Similarity=0.308  Sum_probs=126.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..++||||+++++++......++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            357888899999999999999965 68999999986432 2233468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--CCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~~i~df~  444 (447)
                      |+++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+||-
T Consensus       129 ~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          129 FLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             CCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             cCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            999999999987543   2489999999999999999999999   9999999999999985  4679999995

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.91  E-value=2e-25  Score=214.38  Aligned_cols=157  Identities=28%  Similarity=0.397  Sum_probs=133.1

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccce
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  357 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l  357 (447)
                      +...+.....++|.+.+.||+|+||.||+|+.      .+++.||||+++..........+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44455556678899999999999999999974      246899999997654433445789999999999 79999999


Q ss_pred             eeEEecCC-ceEEEeecCCCCChhhHhhccCCC------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecC
Q 013258          358 YGFCTTVT-EKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  424 (447)
Q Consensus       358 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  424 (447)
                      ++++...+ ..++||||+++|+|.+++......            ...+++..+..++.|+++||+|||+.   +|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99988755 489999999999999999875421            12278899999999999999999999   999999


Q ss_pred             CCCCceeeCCCCceeecccc
Q 013258          425 VKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       425 lkp~NILl~~~~~~~i~df~  444 (447)
                      |||+||++++++.+||+||-
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg  193 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFG  193 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCG
T ss_pred             CccceEEECCCCCEEECCCc
Confidence            99999999999999999995

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=9.3e-25  Score=214.06  Aligned_cols=153  Identities=22%  Similarity=0.333  Sum_probs=132.4

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc----------HHHHHHHHHHHhcCCCCCc
Q 013258          285 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVHRNL  354 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~ni  354 (447)
                      ....++....++|...+.||+|+||.||+|...+|+.||||++........          ...+.+|++++..++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            346677888899999999999999999999988899999999865432211          2568999999999999999


Q ss_pred             cceeeEEec-----CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          355 LRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       355 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      +++++++..     ....++||||+. |+|.+.+....   ..+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            999999854     335799999998 68888887543   2489999999999999999999999   99999999999


Q ss_pred             eeeCCCCceeecccc
Q 013258          430 ILLDEDADQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~~~~i~df~  444 (447)
                      ||++.++.+||+||-
T Consensus       165 Il~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          165 ILLADNNDITICDFN  179 (362)
T ss_dssp             EEECTTCCEEECCTT
T ss_pred             EEEcCCCCEEEEecC
Confidence            999999999999995

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=1.8e-24  Score=204.91  Aligned_cols=142  Identities=31%  Similarity=0.592  Sum_probs=123.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccH------HHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+.........      ..+.+|+.++..++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            56777899999999999999964 6899999998654322221      56899999999999999999999987654  


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC--eeecCCCCCceeeCCCCc-----eee
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDAD-----QSS  440 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~-----~~i  440 (447)
                      ++||||+++|+|.+.+.....   .+++..+..++.|++.||+|||++   +  |+||||||+|||++.++.     +||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            799999999999998876432   489999999999999999999998   7  999999999999998887     999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||-
T Consensus       171 ~Dfg  174 (287)
T 4f0f_A          171 ADFG  174 (287)
T ss_dssp             CCCT
T ss_pred             CCCC
Confidence            9995

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.91  E-value=8.8e-25  Score=207.86  Aligned_cols=143  Identities=22%  Similarity=0.332  Sum_probs=127.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|...+.||+|+||.||+++.. +++.||+|.+......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45777899999999999999975 5889999998654322  23446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||-
T Consensus        95 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             ECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEecc
Confidence            9999999999987653    388999999999999999999999   99999999999999999999999995

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=5.4e-25  Score=211.57  Aligned_cols=147  Identities=26%  Similarity=0.371  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEe----cCCceE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT----TVTEKL  368 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~----~~~~~~  368 (447)
                      .++|+..+.||+|+||.||+++. .+++.||||++.... ......+.+|+++++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            45788889999999999999996 568999999985432 233456899999999999999999999987    334689


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            99999999999999987433334589999999999999999999999   99999999999999999999999996

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.91  E-value=2.8e-25  Score=228.96  Aligned_cols=144  Identities=27%  Similarity=0.420  Sum_probs=127.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ..++|++.+.||+|+||.||+|++.++..||||+++...  ....+|.+|+++|+.++||||+++++++.. +..++|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            445677889999999999999999888889999997543  234579999999999999999999999876 67899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.++++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       342 ~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             CCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             hhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            9999999999975321  2388999999999999999999999   99999999999999999999999995

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.91  E-value=2.3e-25  Score=210.17  Aligned_cols=143  Identities=29%  Similarity=0.421  Sum_probs=126.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||.||+|+..+++.||||.++...  .....+.+|+++++.++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            45677889999999999999998888899999986543  23457999999999999999999999876 4568999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||-
T Consensus        89 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           89 MENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             CTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCc
Confidence            999999999975321  1388999999999999999999999   99999999999999999999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.91  E-value=1.2e-24  Score=205.03  Aligned_cols=143  Identities=22%  Similarity=0.326  Sum_probs=128.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|+.. ++..||+|.+..... .....+.+|+++++.++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            356888899999999999999965 478999999865432 345579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      |+++++|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.++|+||-
T Consensus        87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            999999999987654    388999999999999999999999   99999999999999   788999999995

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=5.7e-25  Score=208.36  Aligned_cols=145  Identities=28%  Similarity=0.397  Sum_probs=129.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..++|+..+.||+|+||.||+|+.. ++..||+|.++...  .....+.+|+++++.++||||+++++++...+..++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3456788899999999999999975 48899999986532  33457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        89 e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             ECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence            99999999999987432  3488999999999999999999999   99999999999999999999999995

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.91  E-value=8.7e-25  Score=212.14  Aligned_cols=143  Identities=22%  Similarity=0.332  Sum_probs=127.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|...+.||+|+||.||+++.. +++.||+|++......  .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            45777899999999999999975 4889999998654322  23446889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       121 e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             CCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeecc
Confidence            9999999999987653    389999999999999999999999   99999999999999999999999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.91  E-value=6.9e-25  Score=229.42  Aligned_cols=136  Identities=24%  Similarity=0.353  Sum_probs=121.8

Q ss_pred             ccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          302 ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       302 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .||+|+||.||+|.+.   ++..||||+++.........+|.+|+++++.++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999863   4667999999766544456689999999999999999999999876 56899999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            999997543   2489999999999999999999999   99999999999999999999999995

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=8.1e-25  Score=208.45  Aligned_cols=144  Identities=33%  Similarity=0.451  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l  369 (447)
                      ..|+..+.||+|+||.||+|+..+    ...+|+|.++..........+.+|+.++++++||||+++++++.. .+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            356777999999999999998642    236899998764443444578999999999999999999998654 567899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccc
Confidence            999999999999997643   2478999999999999999999999   99999999999999999999999995

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.91  E-value=7.6e-25  Score=212.03  Aligned_cols=140  Identities=19%  Similarity=0.256  Sum_probs=124.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||+||+|+. .+++.||||.++....   ...+.+|+++++.+ +||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5688889999999999999995 5689999999864422   23588999999999 99999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc-----eeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~~i~df~  444 (447)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     +||+||-
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99 999999998642   2489999999999999999999999   9999999999999999987     9999995

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.91  E-value=1.3e-24  Score=207.51  Aligned_cols=142  Identities=31%  Similarity=0.462  Sum_probs=128.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+.++..++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45777899999999999999864 68999999997654444556799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||.
T Consensus       102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A          102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecc
Confidence            9999999998642     389999999999999999999999   99999999999999999999999995

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.91  E-value=1.3e-24  Score=205.33  Aligned_cols=143  Identities=27%  Similarity=0.349  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.....     .....+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46788899999999999999975 5899999998654321     12457999999999999999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df~  444 (447)
                      +||||+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||++++++    .+||+||-
T Consensus        85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999997653    389999999999999999999999   999999999999999887    79999995

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.91  E-value=1e-24  Score=205.38  Aligned_cols=143  Identities=24%  Similarity=0.405  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|.+.+.||+|+||.||+|+.. +++.||||.++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            56888899999999999999975 68999999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+|++||-
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence            9999999999997653    388999999999999999999999   99999999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=7e-25  Score=209.13  Aligned_cols=151  Identities=28%  Similarity=0.376  Sum_probs=115.4

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||.+..........++.+|+.++..++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            344578899999999999999999854 6899999998655433444578899999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhcc----CCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRER----QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++...    ......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||.
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999998742    11123489999999999999999999999   99999999999999999999999994

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.1e-24  Score=207.47  Aligned_cols=142  Identities=27%  Similarity=0.389  Sum_probs=122.8

Q ss_pred             CCCCCccccCCCceEEEEEeC-CC---cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce-EEEe
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-LLVY  371 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lv~  371 (447)
                      |...+.||+|+||.||+|+.. ++   ..||+|.++..........+.+|+.+++.++||||+++++++...+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            444588999999999999853 23   379999987544333445789999999999999999999999876665 9999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+.+|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       103 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             ecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            9999999999997643   2478999999999999999999999   99999999999999999999999995

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=1e-24  Score=218.14  Aligned_cols=144  Identities=24%  Similarity=0.336  Sum_probs=122.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-------ccHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-------GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  364 (447)
                      ..++|...+.||+|+||+||+|... +++.||||++......       .....+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999864 5899999998643211       112248899999999999999999999754 


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeec
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  441 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~  441 (447)
                      +..++||||+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            55899999999999999887543    389999999999999999999999   999999999999997654   49999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       285 DFG  287 (419)
T 3i6u_A          285 DFG  287 (419)
T ss_dssp             CSS
T ss_pred             ecc
Confidence            995

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=8.9e-25  Score=207.17  Aligned_cols=142  Identities=23%  Similarity=0.341  Sum_probs=123.5

Q ss_pred             CCCCCC-ccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKN-ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +|.+.+ .||+|+||.||+|...   ++..||||.++.........++.+|++++..++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            444444 8999999999999853   57889999997654334455799999999999999999999998 556789999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+||-
T Consensus        89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             ECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence            9999999999997542   2489999999999999999999999   99999999999999999999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.91  E-value=1.1e-24  Score=230.24  Aligned_cols=145  Identities=24%  Similarity=0.316  Sum_probs=128.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  368 (447)
                      ..++|+..+.||+|+||+||+|+.. +++.||||+++...  .......+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4567889999999999999999965 58899999996532  223344688899999887 7999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.++++...    .+++..+..++.|++.||+|||++   +||||||||+|||+|+++.+||+||-
T Consensus       419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecc
Confidence            9999999999999998754    389999999999999999999999   99999999999999999999999995

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=1.3e-24  Score=205.50  Aligned_cols=144  Identities=22%  Similarity=0.310  Sum_probs=127.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|++.+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888899999999999999965 5899999998654322 22346889999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~df~  444 (447)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||-
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999887653    388999999999999999999999   9999999999999987765   9999995

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=1.5e-24  Score=208.04  Aligned_cols=144  Identities=23%  Similarity=0.305  Sum_probs=129.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccccc--HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++.......  ...+.+|+.++..++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367888999999999999999965 689999999975433222  34689999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCc
Confidence            99999999999998753    388999999999999999999999   99999999999999999999999995

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=2.3e-24  Score=208.25  Aligned_cols=134  Identities=20%  Similarity=0.324  Sum_probs=119.6

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeecCCCC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      .+.||+|+||.||+|+.. +++.||||++...    ....+.+|+.++..+. ||||+++++++.+....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999975 5899999998543    3446889999999997 999999999999999999999999999


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecccc
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  444 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~  444 (447)
                      +|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++   .+||+||-
T Consensus        92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            9999998753    389999999999999999999999   999999999999998766   79999995

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=5e-25  Score=214.39  Aligned_cols=151  Identities=21%  Similarity=0.248  Sum_probs=126.1

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc----ccccHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      ....++|+..+.||+|+||.||+|+.. +++.||+|+++...    .......+.+|+++++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            344567899999999999999999964 58899999986432    2233457999999999999999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCC------------------------------------CCCCChHHHHHHHHHHHHHH
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSS------------------------------------LPPLDWPTRKKIALGSARGL  409 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~gL  409 (447)
                      ..++||||+++|+|.+++......                                    ...+++..+..++.|+++||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998631100                                    11134667788999999999


Q ss_pred             hhhhcCCCCCeeecCCCCCceeeCCCC--ceeecccc
Q 013258          410 SYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTIL  444 (447)
Q Consensus       410 ~yLH~~~~~~ivHrDlkp~NILl~~~~--~~~i~df~  444 (447)
                      +|||+.   +|+||||||+|||++.++  .+||+||-
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg  215 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFG  215 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCT
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeecc
Confidence            999999   999999999999998877  89999995

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.91  E-value=7.1e-25  Score=213.87  Aligned_cols=143  Identities=31%  Similarity=0.438  Sum_probs=124.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +.|+..+.||+|+||.||+|+. .+++.||||+++.....  ....++.+|+++++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3477788999999999999996 56899999998643222  12346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+. |+|.+.+.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       134 e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             ECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            9997 688888865432   489999999999999999999999   99999999999999999999999995

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=1.3e-24  Score=205.64  Aligned_cols=143  Identities=29%  Similarity=0.452  Sum_probs=127.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....  .......+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56888899999999999999965 57899999985432  1223457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999998753    388999999999999999999999   99999999999999999999999995

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.91  E-value=1.5e-24  Score=209.63  Aligned_cols=148  Identities=31%  Similarity=0.402  Sum_probs=125.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|...+.||+|+||.||+|+.      .+++.||||.++.........++.+|+.+++.++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46788889999999999999984      246789999997544444455799999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCC---CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC---Cceeec
Q 013258          368 LLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSK  441 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~~i~  441 (447)
                      ++||||+++|+|.+++......   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.+   ..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999875321   13488999999999999999999999   99999999999999954   459999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       186 Dfg  188 (327)
T 2yfx_A          186 DFG  188 (327)
T ss_dssp             CCH
T ss_pred             ccc
Confidence            985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.91  E-value=1.3e-24  Score=214.02  Aligned_cols=138  Identities=24%  Similarity=0.347  Sum_probs=117.2

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCCCC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            467999999999999864 689999999865432 234579999999999999999999999999999999999999999


Q ss_pred             hhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee--CCCCceeecccc
Q 013258          379 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--DEDADQSSKTIL  444 (447)
Q Consensus       379 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~~~~i~df~  444 (447)
                      |.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||+  ++++.+||+||-
T Consensus       173 L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          173 LFDRIIDESY---NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             EHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             HHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCC
Confidence            9998875432   388999999999999999999999   99999999999999  667899999995

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.91  E-value=7.5e-25  Score=206.57  Aligned_cols=147  Identities=24%  Similarity=0.342  Sum_probs=126.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEe--cCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lv  370 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+.+++.++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56788899999999999999965 6899999998654322 23446899999999999999999999874  35678999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC-----eeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-----IIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++.........+++..+..++.|++.||+|||+.   +     |+||||||+||++++++.+||+||-
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999986543334589999999999999999999998   6     9999999999999999999999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=5.9e-25  Score=215.28  Aligned_cols=154  Identities=19%  Similarity=0.260  Sum_probs=132.2

Q ss_pred             ccccHHHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-----CCCccc
Q 013258          283 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLR  356 (447)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~  356 (447)
                      ..+++++.....++|.+.+.||+|+||.||+|+.. +++.||||+++...  .....+..|+.++..++     ||||++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34555555566788999999999999999999964 68999999986422  22345788999999886     999999


Q ss_pred             eeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--
Q 013258          357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--  434 (447)
Q Consensus       357 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--  434 (447)
                      +++++...+..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            999999999999999999 9999999987542  2488999999999999999999999   9999999999999986  


Q ss_pred             -----------------------CCceeecccc
Q 013258          435 -----------------------DADQSSKTIL  444 (447)
Q Consensus       435 -----------------------~~~~~i~df~  444 (447)
                                             ++.+||+||-
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG  207 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG  207 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCT
T ss_pred             ccccccchhcccccccccccccCCCCEEEEecc
Confidence                                   7899999995

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.91  E-value=1.2e-24  Score=208.50  Aligned_cols=147  Identities=20%  Similarity=0.308  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|+. .+++.||||+++....  .....++.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4577889999999999999996 4689999999865322  222346899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.........+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg  181 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  181 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecc
Confidence            99999999999976332233588999999999999999999999   99999999999999999999999995

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.91  E-value=1.1e-24  Score=212.09  Aligned_cols=145  Identities=26%  Similarity=0.341  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccccc----------------HHHHHHHHHHHhcCCCCCccce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------------ELQFQTEVKIISMAVHRNLLRL  357 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~H~niv~l  357 (447)
                      .++|.+.+.||+|+||.||+|+. +++.||||.+........                ...+.+|+.++..++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35788889999999999999999 899999999864432211                1679999999999999999999


Q ss_pred             eeEEecCCceEEEeecCCCCChhhH------hhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCce
Q 013258          358 YGFCTTVTEKLLVYPYMTNGSVASR------LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANI  430 (447)
Q Consensus       358 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NI  430 (447)
                      ++++...+..++||||+++|+|.++      +...  ....+++..+..++.|++.||+|||+ .   +|+||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      5432  12458999999999999999999998 8   999999999999


Q ss_pred             eeCCCCceeecccc
Q 013258          431 LLDEDADQSSKTIL  444 (447)
Q Consensus       431 Ll~~~~~~~i~df~  444 (447)
                      +++.++.+||+||-
T Consensus       184 l~~~~~~~kl~dfg  197 (348)
T 2pml_X          184 LMDKNGRVKLSDFG  197 (348)
T ss_dssp             EECTTSCEEECCCT
T ss_pred             EEcCCCcEEEeccc
Confidence            99999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.91  E-value=1.4e-24  Score=218.08  Aligned_cols=143  Identities=25%  Similarity=0.336  Sum_probs=125.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  366 (447)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++..... ....++.+|+++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            357888999999999999999964 5889999999653222 2335689999999999999999999998765     56


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+. |+|.+++....    .+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999986 59999997643    389999999999999999999999   99999999999999999999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.91  E-value=2.2e-24  Score=220.89  Aligned_cols=144  Identities=22%  Similarity=0.361  Sum_probs=124.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc------------ccHHHHHHHHHHHhcCCCCCccceeeE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS------------GGELQFQTEVKIISMAVHRNLLRLYGF  360 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~H~niv~l~~~  360 (447)
                      .++|.+.+.||+|+||+||+|+.. +++.||||+++.....            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467888899999999999999965 5889999998654321            224568999999999999999999999


Q ss_pred             EecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---c
Q 013258          361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---D  437 (447)
Q Consensus       361 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~  437 (447)
                      +......++||||+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999997653    389999999999999999999999   999999999999999876   6


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +||+||-
T Consensus       188 ~kl~Dfg  194 (504)
T 3q5i_A          188 IKIVDFG  194 (504)
T ss_dssp             EEECCCT
T ss_pred             EEEEECC
Confidence            8999995

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=2.4e-24  Score=205.46  Aligned_cols=144  Identities=25%  Similarity=0.401  Sum_probs=126.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++..++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            356888899999999999999975 58999999986543 3345579999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999876432   388999999999999999999999   99999999999999999999999995

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.91  E-value=2.9e-24  Score=211.00  Aligned_cols=149  Identities=23%  Similarity=0.304  Sum_probs=130.7

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-------cHHHHHHHHHHHhcC-CCCCccceee
Q 013258          289 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------GELQFQTEVKIISMA-VHRNLLRLYG  359 (447)
Q Consensus       289 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l-~H~niv~l~~  359 (447)
                      ......++|++.+.||+|+||.||+|+.. +|+.||||+++......       ....+.+|+.++..+ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            33445677999999999999999999975 69999999986543211       123578999999999 7999999999


Q ss_pred             EEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       360 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      ++......++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            9999999999999999999999998653    389999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      ++||-
T Consensus       241 l~DfG  245 (365)
T 2y7j_A          241 LSDFG  245 (365)
T ss_dssp             ECCCT
T ss_pred             EEecC
Confidence            99995

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=1.2e-24  Score=210.35  Aligned_cols=143  Identities=27%  Similarity=0.473  Sum_probs=125.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||.||+|+.. +++    .||+|.++..........+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            56888899999999999999864 444    357887765544555668999999999999999999999998754 889


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        94 v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCc
Confidence            9999999999999987533   388999999999999999999999   99999999999999999999999995

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=1.8e-24  Score=202.99  Aligned_cols=144  Identities=29%  Similarity=0.442  Sum_probs=120.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc---ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|+..+.||+|+||.||+|+.. ++.||||+++.....   .....+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56778899999999999999974 889999998654322   22356899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--------CCceeeccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------DADQSSKTI  443 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------~~~~~i~df  443 (447)
                      ||+++++|.+++...     .+++..+..++.|+++||+|||++...+|+||||||+|||+++        ++.+|++||
T Consensus        86 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998643     3889999999999999999999982223999999999999996        677999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       161 g  161 (271)
T 3dtc_A          161 G  161 (271)
T ss_dssp             C
T ss_pred             C
Confidence            5

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=1.9e-24  Score=209.33  Aligned_cols=143  Identities=25%  Similarity=0.422  Sum_probs=126.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....... ....+.+|+.++..++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            46777899999999999999975 48999999985443222 23457899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A          105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            999999888766543    389999999999999999999999   99999999999999999999999995

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.91  E-value=9.3e-25  Score=209.62  Aligned_cols=152  Identities=26%  Similarity=0.430  Sum_probs=123.5

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC----CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC
Q 013258          290 LQVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  364 (447)
Q Consensus       290 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  364 (447)
                      +....++|...+.||+|+||.||+|+..    +++.||||.++..... .....+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3445567888899999999999999753    3458999999754322 2234689999999999999999999999875


Q ss_pred             Cc-----eEEEeecCCCCChhhHhhccC--CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc
Q 013258          365 TE-----KLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  437 (447)
Q Consensus       365 ~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  437 (447)
                      +.     .++||||+++|+|.+++....  .....+++..+..++.|+++||.|||++   +|+||||||+||++++++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            53     499999999999999985432  2234589999999999999999999999   9999999999999999999


Q ss_pred             eeecccc
Q 013258          438 QSSKTIL  444 (447)
Q Consensus       438 ~~i~df~  444 (447)
                      +||+||-
T Consensus       186 ~kl~Dfg  192 (313)
T 3brb_A          186 VCVADFG  192 (313)
T ss_dssp             EEECSCS
T ss_pred             EEEeecC
Confidence            9999995

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.91  E-value=3.8e-24  Score=204.96  Aligned_cols=146  Identities=29%  Similarity=0.440  Sum_probs=121.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc----cccHHHHHHHHHHHhcCC---CCCccceeeEEecC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT----SGGELQFQTEVKIISMAV---HRNLLRLYGFCTTV  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  364 (447)
                      ..++|++.+.||+|+||+||+|+. .+++.||||+++....    ......+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999995 4689999999864321    112345778888777665   99999999999875


Q ss_pred             C-----ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          365 T-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       365 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      .     ..++||||+. |+|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            5     4799999997 699999986533  2389999999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       161 l~Dfg  165 (308)
T 3g33_A          161 LADFG  165 (308)
T ss_dssp             ECSCS
T ss_pred             EeeCc
Confidence            99995

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.91  E-value=1.4e-24  Score=205.12  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=125.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|...+.||+|+||.||+|+..+    +..||||.++..........+.+|+.+++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4567788999999999999998532    346999999765433445679999999999999999999999765 45789


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++++|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+||-
T Consensus        90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccC
Confidence            9999999999999976532   388999999999999999999999   99999999999999999999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=2e-24  Score=210.57  Aligned_cols=145  Identities=28%  Similarity=0.419  Sum_probs=121.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc----cHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||.++......    ....+.+|+.++..++||||+++++++...+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4567999999999999999999964 58999999996432211    123688999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++ +|.+++....   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999999986 8888887543   2488899999999999999999999   99999999999999999999999995

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.91  E-value=1.4e-24  Score=210.14  Aligned_cols=144  Identities=22%  Similarity=0.351  Sum_probs=122.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..++|+..+.||+|+||+||+|+.. +++.||||+++...... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4467888999999999999999854 68999999996543222 234578999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-----CCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----EDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~~i~df~  444 (447)
                      |||++ |+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++     +++.+||+||-
T Consensus       112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99998 59999997654    388999999999999999999999   999999999999994     45569999995

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=3.1e-24  Score=212.47  Aligned_cols=143  Identities=24%  Similarity=0.390  Sum_probs=116.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCC-CCCccceeeEEecCC--ce
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EK  367 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~  367 (447)
                      ..++|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999864 689999999854322 223346889999999997 999999999997544  68


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||++ |+|.++++..     .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence            99999997 6899998763     388999999999999999999999   99999999999999999999999995

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.91  E-value=2.4e-24  Score=219.57  Aligned_cols=144  Identities=26%  Similarity=0.438  Sum_probs=128.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888899999999999999965 689999999854432  23455799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      |||+.+|+|.+.+....    .+++..+..++.|++.||+|||++   +|+||||||+|||+   +.++.+||+||-
T Consensus       105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            99999999999987653    389999999999999999999999   99999999999999   567899999995

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=1.4e-24  Score=209.76  Aligned_cols=143  Identities=26%  Similarity=0.394  Sum_probs=125.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEe--cCCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  367 (447)
                      ++|+..+.||+|+||.||+|++     .+++.||||+++... ......+.+|+++++.++||||+++++++.  .....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5677889999999999999984     358899999986542 223446899999999999999999999886  45568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccc
Confidence            999999999999999986432   389999999999999999999999   99999999999999999999999995

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.9e-24  Score=212.40  Aligned_cols=141  Identities=23%  Similarity=0.352  Sum_probs=117.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCC------c
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~  366 (447)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++...... ....++.+|+++++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            56788899999999999999964 6999999998543222 22346889999999999999999999997653      4


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence            59999999 88999998763     388999999999999999999999   99999999999999999999999995

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.91  E-value=2.7e-24  Score=219.78  Aligned_cols=143  Identities=24%  Similarity=0.385  Sum_probs=122.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      +.|+..+.||+|+||+||+|+.. ++..||||+++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45888899999999999999965 689999999865432 2234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC---Cceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~~i~df~  444 (447)
                      |+++|+|.+.+....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++.+   +.+||+||-
T Consensus       117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            999999999887653    388999999999999999999999   99999999999999874   459999995

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.91  E-value=9.8e-25  Score=207.31  Aligned_cols=143  Identities=24%  Similarity=0.339  Sum_probs=122.1

Q ss_pred             hcCCCCCC-ccccCCCceEEEEEe---CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          294 TDGFSNKN-ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       294 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||+++...... ...++.+|+++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            34566666 899999999999964   246889999997543222 245799999999999999999999998 567789


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||-
T Consensus        94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence            9999999999999998753    388999999999999999999999   99999999999999999999999995

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.91  E-value=2.5e-24  Score=209.51  Aligned_cols=140  Identities=19%  Similarity=0.289  Sum_probs=121.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..++|+..+.||+|+||+||+|+.. +++.||||+++....     ...+|++++.++ +||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3467888999999999999999965 589999999965422     245688888777 799999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-C---ceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-A---DQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~---~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||+.++ +   .+||+||-
T Consensus        95 ~E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            99999999999997653    389999999999999999999999   99999999999998543 3   49999995

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=1.8e-24  Score=204.25  Aligned_cols=141  Identities=25%  Similarity=0.433  Sum_probs=124.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec---------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  363 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||+|.++...     ..+.+|++++..++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            456888899999999999999975 68999999986432     257789999999999999999998854         


Q ss_pred             -------CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          364 -------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       364 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                             ....++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   3457999999999999999976422  2488999999999999999999999   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+||+||-
T Consensus       160 ~~kl~Dfg  167 (284)
T 2a19_B          160 QVKIGDFG  167 (284)
T ss_dssp             EEEECCCT
T ss_pred             CEEECcch
Confidence            99999995

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.90  E-value=2.9e-24  Score=207.12  Aligned_cols=143  Identities=24%  Similarity=0.347  Sum_probs=121.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-------cccHHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.++....       ......+.+|+++++.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            457888999999999999999965 588999999864321       111234889999999999999999999987654


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKT  442 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~d  442 (447)
                       .++||||+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             899999999999999987543    388999999999999999999999   9999999999999998765   99999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       161 fg  162 (322)
T 2ycf_A          161 FG  162 (322)
T ss_dssp             CT
T ss_pred             Cc
Confidence            95

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=4.6e-24  Score=203.23  Aligned_cols=144  Identities=22%  Similarity=0.443  Sum_probs=124.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||.++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            56788899999999999999975 6899999998654322 223568899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+. |+|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+||-
T Consensus        83 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg  148 (299)
T 2r3i_A           83 FLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  148 (299)
T ss_dssp             CCS-EEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTT
T ss_pred             ccc-CCHHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcch
Confidence            997 699999876532  2378899999999999999999999   99999999999999999999999995

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=2.7e-24  Score=206.06  Aligned_cols=143  Identities=29%  Similarity=0.470  Sum_probs=121.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|++.+.||+|+||.||+|+.. ++.||||.+...   .....+.+|++++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            45777899999999999999985 788999998643   23457999999999999999999999877  4589999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc-eeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-~~i~df~  444 (447)
                      ++|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+|||+++++. +||+||-
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence            9999999998643 2224678899999999999999999932228999999999999998886 7999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.90  E-value=2e-24  Score=205.77  Aligned_cols=143  Identities=24%  Similarity=0.403  Sum_probs=124.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec---------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------  363 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||.++..  ......+.+|+.+++.++||||+++++++..         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456888899999999999999964 6899999998543  2234568999999999999999999998865         


Q ss_pred             ----CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCcee
Q 013258          364 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       364 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                          .+..++||||+++|+|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                346799999999999999998643   2367889999999999999999999   999999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      ++||-
T Consensus       157 l~dfg  161 (303)
T 1zy4_A          157 IGDFG  161 (303)
T ss_dssp             ECCCC
T ss_pred             EeeCc
Confidence            99995

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.90  E-value=2.1e-24  Score=218.45  Aligned_cols=141  Identities=23%  Similarity=0.292  Sum_probs=121.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecC------C
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~  365 (447)
                      .++|+..+.||+|+||+||+|+.. +++.||||++.... ......++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            367888999999999999999864 58999999996442 222344688999999999999999999999654      3


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..++||||+++ ++.+.+..      .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            56999999976 56666643      278999999999999999999999   99999999999999999999999995

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.90  E-value=3.7e-24  Score=203.77  Aligned_cols=144  Identities=28%  Similarity=0.313  Sum_probs=127.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--------ccHHHHHHHHHHHhcCC-CCCccceeeEEec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--------GGELQFQTEVKIISMAV-HRNLLRLYGFCTT  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~  363 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++.....        .....+.+|++++.++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888899999999999999975 5899999998643211        11235789999999995 9999999999999


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                      .+..++||||+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998753    388999999999999999999999   9999999999999999999999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       169 g  169 (298)
T 1phk_A          169 G  169 (298)
T ss_dssp             T
T ss_pred             c
Confidence            5

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=3.1e-24  Score=225.11  Aligned_cols=136  Identities=26%  Similarity=0.366  Sum_probs=120.0

Q ss_pred             CccccCCCceEEEEEeC---CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|.+.   +++.||||+++..... ....++.+|++++..++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999652   4678999999765432 234579999999999999999999999864 568999999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.+++....    .+++..+..|+.||+.||+|||++   +||||||||+|||+++++.+||+||-
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcC
Confidence            99999997653    389999999999999999999999   99999999999999999999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.90  E-value=3.2e-24  Score=207.22  Aligned_cols=143  Identities=25%  Similarity=0.441  Sum_probs=124.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC--ce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~  367 (447)
                      ++|+..+.||+|+||.||+|++     .+++.||||+++... ......+.+|+++++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4577789999999999999984     358899999986532 233457999999999999999999999987644  68


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....   .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCc
Confidence            999999999999999987532   388999999999999999999999   99999999999999999999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.90  E-value=3.1e-24  Score=218.91  Aligned_cols=144  Identities=24%  Similarity=0.408  Sum_probs=127.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++... .......+.+|+++++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356888999999999999999965 68999999986433 2334557999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC---CCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~~i~df~  444 (447)
                      ||+++|+|.+.+....    .+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+||-
T Consensus       101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999987654    389999999999999999999999   999999999999995   45679999995

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1.9e-24  Score=213.69  Aligned_cols=145  Identities=21%  Similarity=0.294  Sum_probs=119.5

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC-----
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----  364 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----  364 (447)
                      ....++|+..+.||+|+||+||+|+. .+|+.||||++.....     ...+|+++++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34567889999999999999999986 4699999999864322     234799999999999999999998543     


Q ss_pred             ---------------------------------CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhh
Q 013258          365 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  411 (447)
Q Consensus       365 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~y  411 (447)
                                                       ...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             33789999998 58888876532233458999999999999999999


Q ss_pred             hhcCCCCCeeecCCCCCceeeC-CCCceeecccc
Q 013258          412 LHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  444 (447)
Q Consensus       412 LH~~~~~~ivHrDlkp~NILl~-~~~~~~i~df~  444 (447)
                      ||+.   +|+||||||+|||++ +++.+||+||-
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg  187 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG  187 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCT
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECC
Confidence            9999   999999999999998 68899999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.90  E-value=5.8e-24  Score=207.56  Aligned_cols=143  Identities=29%  Similarity=0.469  Sum_probs=123.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC--------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  364 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------  364 (447)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++...... .....+.+|++++..++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4678889999999999999997 46899999998654322 2244688999999999999999999998763        


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +..++||||+++ +|.+.+.....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999975 78777765432   389999999999999999999999   99999999999999999999999995

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.90  E-value=7.9e-24  Score=202.19  Aligned_cols=145  Identities=23%  Similarity=0.333  Sum_probs=123.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc---cccHHHHHHHHHHHhcCCCCCccceeeEEe--cCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~  367 (447)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++....   ......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367999999999999999999964 589999999965421   233457999999999999999999999984  45678


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||++++ |.+.+.....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+|++||-
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence            9999999876 7777765432  3488999999999999999999999   99999999999999999999999995

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.90  E-value=2.5e-24  Score=209.57  Aligned_cols=141  Identities=22%  Similarity=0.279  Sum_probs=124.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~  371 (447)
                      +.|++.+.||+|+||.||++...+++.||||+++..... .....+.+|+.++..++|  |||+++++++...+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            457888999999999999999888999999998654322 223468999999999987  99999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      | +.+|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++ ++.+||+||-
T Consensus        89 e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             C-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             e-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecc
Confidence            9 56889999998753    388999999999999999999999   999999999999997 6789999995

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.90  E-value=5.7e-25  Score=216.97  Aligned_cols=146  Identities=16%  Similarity=0.183  Sum_probs=118.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc--ccccHHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEV---KIISMAVHRNLLRLY-------GFC  361 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~  361 (447)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++...  .......+.+|+   +.++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5677789999999999999995 569999999996432  222345789999   555666899999998       655


Q ss_pred             ecCC-----------------ceEEEeecCCCCChhhHhhccCCC---CCCCChHHHHHHHHHHHHHHhhhhcCCCCCee
Q 013258          362 TTVT-----------------EKLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKII  421 (447)
Q Consensus       362 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  421 (447)
                      ...+                 ..++||||+ +|+|.+++.....-   ...++|..+..|+.|+++||+|||++   +|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            5443                 278999999 68999999864210   11234578889999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceeecccc
Q 013258          422 HRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       422 HrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||||+|||++.++.+||+||-
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG  251 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFE  251 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGG
T ss_pred             cCCCCHHHEEEcCCCCEEEEech
Confidence            99999999999999999999995

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=5.6e-24  Score=201.91  Aligned_cols=141  Identities=25%  Similarity=0.382  Sum_probs=122.3

Q ss_pred             CCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEE
Q 013258          297 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLV  370 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv  370 (447)
                      |...+.||+|+||.||+|... ++..||+|.++..... .....+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            566678999999999999864 5889999998654322 234468999999999999999999998865    3458999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC--eeecCCCCCceeeC-CCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLD-EDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~~i~df~  444 (447)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +  |+||||||+|||++ +++.+||+||-
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            99999999999998753    388999999999999999999998   6  99999999999998 78999999995

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=2.7e-24  Score=204.11  Aligned_cols=143  Identities=30%  Similarity=0.457  Sum_probs=122.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..++|++.+.||+|+||.||+|+..  ..||||+++..... .....+.+|+++++.++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3457888899999999999999864  35999998654322 2234689999999999999999999965 456689999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             EecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            9999999999996543   2488999999999999999999999   99999999999999999999999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=7e-24  Score=205.40  Aligned_cols=144  Identities=28%  Similarity=0.413  Sum_probs=122.6

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeEEecC----
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----  364 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----  364 (447)
                      ....++|++.+.||+|+||.||+|+.. ++.||||++...    ....+.+|.+++..  ++||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            334567999999999999999999985 899999998543    22345556666554  4899999999999876    


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC-----CCCeeecCCCCCceeeCCCCcee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQS  439 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~~  439 (447)
                      ...++||||+++|+|.++++..     .+++..+..++.|++.||+|||+.+     .++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999764     3899999999999999999999762     44899999999999999999999


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       183 l~Dfg  187 (337)
T 3mdy_A          183 IADLG  187 (337)
T ss_dssp             ECCCT
T ss_pred             EEeCC
Confidence            99996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.90  E-value=1.2e-23  Score=199.96  Aligned_cols=144  Identities=23%  Similarity=0.347  Sum_probs=124.3

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      +|.....||+|+||.||+|+. .+++.||||.++... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455557899999999999996 468899999986543 233457899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-CCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~~i~df~  444 (447)
                      ++++|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+||-
T Consensus       102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A          102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecc
Confidence            99999999986532 23467888999999999999999999   9999999999999998 8999999995

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.90  E-value=7.1e-24  Score=205.88  Aligned_cols=141  Identities=28%  Similarity=0.403  Sum_probs=125.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhc--CCCCCccceeeEEecCC---
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTVT---  365 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---  365 (447)
                      ....++|...+.||+|+||.||+|+. +++.||||+++..    ....+.+|++++..  ++||||+++++++....   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            44557899999999999999999998 5899999998543    23467888888876  79999999999998776   


Q ss_pred             -ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh--------cCCCCCeeecCCCCCceeeCCCC
Q 013258          366 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       366 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                       ..++||||+++|+|.+++...     .+++..+..++.|++.||+|||        +.   +|+||||||+|||+++++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             789999999999999999764     3899999999999999999999        66   999999999999999999


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+||+||-
T Consensus       185 ~~kL~Dfg  192 (342)
T 1b6c_B          185 TCCIADLG  192 (342)
T ss_dssp             CEEECCCT
T ss_pred             CEEEEECC
Confidence            99999995

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.90  E-value=3.3e-24  Score=213.09  Aligned_cols=139  Identities=23%  Similarity=0.303  Sum_probs=117.9

Q ss_pred             cCCCCC-CccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeEEec----CCce
Q 013258          295 DGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  367 (447)
Q Consensus       295 ~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~  367 (447)
                      ++|... +.||+|+||+||+|+.. +++.||||+++..      ..+.+|+.++ ...+||||+++++++..    ....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            345554 68999999999999965 5899999998532      3577888887 45589999999998865    5568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||-
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999986432  3489999999999999999999999   9999999999999998   7889999995

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=4e-24  Score=204.37  Aligned_cols=143  Identities=24%  Similarity=0.392  Sum_probs=125.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|...+.||+|+||.||+|+.. +|+.||+|.++.... .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            356888899999999999999965 689999999965432 233468899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+||++   ++++.+|++||-
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg  154 (304)
T 2jam_A           87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG  154 (304)
T ss_dssp             CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred             cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence            999999999987653    388999999999999999999999   99999999999999   788899999995

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.90  E-value=2.9e-24  Score=203.65  Aligned_cols=148  Identities=22%  Similarity=0.262  Sum_probs=121.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHH-HHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++.........+ +.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788889999999999999996 4689999999975533323333 445555688899999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.+||+||-
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            9997 5888887653223345899999999999999999999842  79999999999999999999999995

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.90  E-value=4.5e-24  Score=209.53  Aligned_cols=142  Identities=21%  Similarity=0.297  Sum_probs=124.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  367 (447)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|++++..++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357888899999999999999964 68899999997543333345789999999999999999999998764     368


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+. |+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence            99999997 5999998763     288999999999999999999999   99999999999999999999999995

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=8.5e-24  Score=202.91  Aligned_cols=143  Identities=29%  Similarity=0.450  Sum_probs=123.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||.++...   ....+.+|+.++..++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3467888999999999999999975 58999999986532   3457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+||.
T Consensus       104 e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             ECCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecc
Confidence            99999999999974322   388999999999999999999999   99999999999999999999999995

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.90  E-value=5.2e-24  Score=207.83  Aligned_cols=142  Identities=22%  Similarity=0.364  Sum_probs=124.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~  367 (447)
                      .++|+..+.||+|+||.||+|+.. +|+.||||.++.........++.+|+++++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            357888899999999999999965 68999999996543333345688999999999999999999987654     678


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+. |+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence            99999997 6999998763     388999999999999999999999   99999999999999999999999995

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.90  E-value=2.5e-24  Score=211.32  Aligned_cols=144  Identities=16%  Similarity=0.211  Sum_probs=118.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC------CcEEEEEEcccccccc----------cHHHHHHHHHHHhcCCCCCccce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRL  357 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l  357 (447)
                      .++|.+.+.||+|+||.||+|++.+      ++.||||++.......          ....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4578888999999999999998754      4789999985432110          01124456667788899999999


Q ss_pred             eeEEecC----CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC
Q 013258          358 YGFCTTV----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  433 (447)
Q Consensus       358 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~  433 (447)
                      ++++...    ...++||||+ +++|.+++....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4479999999 999999998743   2489999999999999999999999   999999999999999


Q ss_pred             --CCCceeecccc
Q 013258          434 --EDADQSSKTIL  444 (447)
Q Consensus       434 --~~~~~~i~df~  444 (447)
                        .++.+||+||-
T Consensus       187 ~~~~~~~kl~DFG  199 (364)
T 3op5_A          187 YKNPDQVYLVDYG  199 (364)
T ss_dssp             SSCTTCEEECCCT
T ss_pred             cCCCCeEEEEECC
Confidence              88999999995

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=2.6e-24  Score=202.86  Aligned_cols=142  Identities=28%  Similarity=0.435  Sum_probs=123.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC-CceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lv~e  372 (447)
                      .++|+..+.||+|+||.||+|+.. |+.||||.++...   ....+.+|++++..++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            356788899999999999999874 8899999986532   345789999999999999999999987654 47899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||-
T Consensus        96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence            9999999999976421  1268889999999999999999999   99999999999999999999999995

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=9.5e-24  Score=204.03  Aligned_cols=136  Identities=23%  Similarity=0.311  Sum_probs=121.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEec--CCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--VTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  370 (447)
                      ++|++.+.||+|+||.||+|+. .+++.||||+++..    ....+.+|+.++..++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            5678889999999999999985 46899999998642    3457899999999997 9999999999987  5678999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      |||+.+++|.+++..       +++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+||-
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            999999999998853       78889999999999999999999   999999999999999777 89999995

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=6e-24  Score=210.55  Aligned_cols=141  Identities=22%  Similarity=0.275  Sum_probs=123.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCC--CCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||.||+|...+++.||||+++..... .....+.+|+.++..++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            458888999999999999999878999999998654322 23356899999999996  599999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      | +.+++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+||-
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecC
Confidence            9 56889999998753    378899999999999999999999   999999999999996 5889999995

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.90  E-value=1.2e-23  Score=200.25  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=124.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++...   ....+.+|+..+..+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            35688889999999999999995 568999999985432   223578899999999 7999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc-----eeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~~i~df~  444 (447)
                      ||+ +++|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.     +||+||-
T Consensus        86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            999 9999999986532   389999999999999999999999   9999999999999988876     9999995

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.90  E-value=1.8e-24  Score=208.78  Aligned_cols=147  Identities=31%  Similarity=0.468  Sum_probs=128.4

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec-----
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT-----  363 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----  363 (447)
                      ....++|++.+.||+|+||.||+|+. .+++.||||++....  .....+.+|+.++..+ +||||+++++++..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34567788899999999999999996 468999999986432  2345789999999998 89999999999976     


Q ss_pred             -CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          364 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       364 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                       .+..++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence             4578999999999999999986422  2488899999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       173 fg  174 (326)
T 2x7f_A          173 FG  174 (326)
T ss_dssp             CT
T ss_pred             Cc
Confidence            95

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=6.2e-24  Score=205.88  Aligned_cols=141  Identities=33%  Similarity=0.513  Sum_probs=116.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHH--HhcCCCCCccceeeEEec-----CCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYGFCTT-----VTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~  366 (447)
                      .++|+..+.||+|+||.||+|+. +++.||||+++...    ...+..|.++  +..++||||+++++++..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            35788889999999999999987 68999999985432    2334444444  456899999999986542     235


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC------CCCeeecCCCCCceeeCCCCceee
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------DPKIIHRDVKAANILLDEDADQSS  440 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDlkp~NILl~~~~~~~i  440 (447)
                      .++||||+++|+|.+++....     .++..+..++.|+++||+|||+.+      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            689999999999999997643     588999999999999999999863      348999999999999999999999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||-
T Consensus       162 ~DFG  165 (336)
T 3g2f_A          162 SDFG  165 (336)
T ss_dssp             CCCT
T ss_pred             eecc
Confidence            9995

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.90  E-value=5.7e-24  Score=208.98  Aligned_cols=141  Identities=24%  Similarity=0.344  Sum_probs=113.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecC------Cc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~  366 (447)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++..... ......+.+|+++++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            6788889999999999999985 4689999999865322 22344688999999999999999999998654      56


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++|+||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             EEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence            79999999 78999888652     389999999999999999999999   99999999999999999999999995

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.90  E-value=8.7e-24  Score=204.35  Aligned_cols=149  Identities=22%  Similarity=0.281  Sum_probs=128.0

Q ss_pred             HHHhcCCCCC-CccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCC-CCCccceeeEEecCCc
Q 013258          291 QVATDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  366 (447)
Q Consensus       291 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~  366 (447)
                      +...+.|.+. +.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.++..++ ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445566666 88999999999999965 5899999998654332 23457899999999985 6999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeeccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  443 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df  443 (447)
                      .++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.   ++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999999865422  3489999999999999999999999   9999999999999998   789999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       179 g  179 (327)
T 3lm5_A          179 G  179 (327)
T ss_dssp             G
T ss_pred             c
Confidence            5

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.90  E-value=4.1e-24  Score=226.71  Aligned_cols=140  Identities=21%  Similarity=0.337  Sum_probs=120.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC--CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc-----e
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----K  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~  367 (447)
                      ++|++.+.||+|+||.||+|+..  +++.||||.+...........+.+|++++..++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            57888899999999999999975  5899999998654333334568999999999999999999999987665     6


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++++|.+++..      .++|..+..++.|+++||+|||++   +||||||||+|||++++ .+||+||-
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence            999999999999887654      389999999999999999999999   99999999999999986 89999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.90  E-value=8.2e-24  Score=222.76  Aligned_cols=145  Identities=23%  Similarity=0.312  Sum_probs=126.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ..++|+..+.||+|+||.||+|++..    +..||||.++..........+.+|+.+++.++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34667888999999999999998642    46799999875443333457999999999999999999999985 46689


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.++++....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       467 lv~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            99999999999999986532   388999999999999999999999   99999999999999999999999995

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=1.1e-23  Score=200.91  Aligned_cols=139  Identities=23%  Similarity=0.303  Sum_probs=120.4

Q ss_pred             cCCCCC-CccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHH-hcCCCCCccceeeEEec----CCce
Q 013258          295 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  367 (447)
Q Consensus       295 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~  367 (447)
                      ++|... +.||+|+||.||+|+. .+++.||+|+++.      ...+.+|+.++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            455555 7799999999999996 4689999999853      23577888887 66699999999999876    6678


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.+||+||-
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            999999999999999987532  2489999999999999999999999   9999999999999998   7889999995

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.90  E-value=2.1e-23  Score=197.72  Aligned_cols=145  Identities=23%  Similarity=0.388  Sum_probs=128.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467899999999999999999975 689999999865432 33455799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC---ceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~~i~df~  444 (447)
                      +||+++++|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   .+|++||-
T Consensus       100 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg  169 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG  169 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred             EEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence            99999999999887653    388999999999999999999999   999999999999997644   69999995

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.89  E-value=1.3e-23  Score=206.82  Aligned_cols=140  Identities=22%  Similarity=0.293  Sum_probs=121.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCC------c
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~  366 (447)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57888899999999999999864 5899999998643222 22346889999999999999999999997654      6


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+. |+|.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||-
T Consensus       105 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence            799999997 478888753      278999999999999999999999   99999999999999999999999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.89  E-value=8.5e-24  Score=200.49  Aligned_cols=143  Identities=34%  Similarity=0.434  Sum_probs=116.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC--CCc--EEEEEEcccccc--cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|+..+.||+|+||.||+|++.  +++  .||||+++....  ......+.+|++++..++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            56788899999999999999853  333  689999865432  223457899999999999999999999988754 89


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +|+||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+||-
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence            99999999999999986432   388999999999999999999999   99999999999999999999999995

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.89  E-value=2.2e-23  Score=224.12  Aligned_cols=175  Identities=30%  Similarity=0.385  Sum_probs=138.9

Q ss_pred             HhcccCchHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCccceeEeCCCCCEEEEEcCCCCcccc---cc----------
Q 013258           18 ALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGE---LA----------   84 (447)
Q Consensus        18 ~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~v~~l~L~~~~l~g~---~~----------   84 (447)
                      +++..+.+.|++||+.||+++.||. .+.+|+. +.+||.|.||+|+ .++|+.|||+++.+.|.   +|          
T Consensus         4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~   80 (768)
T 3rgz_A            4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE   80 (768)
T ss_dssp             ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred             CccccCCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence            4455667889999999999999998 8999973 5789999999999 78999999999999987   55          


Q ss_pred             -------------ccccCCCCCCEEECCCCccCCCCCh--hhcCCCCCcEEEccCCcccccCCccc-cCCCCCCeeeCcC
Q 013258           85 -------------PELGQLKNLELLELYGNNLSGHIPS--ALGNLIKLKSLDLYSNLFNGTIPDTL-ANLKQLKYLRLNN  148 (447)
Q Consensus        85 -------------~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~g~~p~~~-~~l~~L~~L~l~~  148 (447)
                                   +.++.+++|++|+|++|.++|.+|.  .++++++|++|+|++|.+.+.+|..+ .++++|++|+|++
T Consensus        81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  160 (768)
T 3rgz_A           81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA  160 (768)
T ss_dssp             EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred             ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence                         4677788899999999999988888  88999999999999999988888776 7888888888888


Q ss_pred             ccccccCchH---HhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          149 NSLSGLIPTS---LTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       149 N~l~~~~p~~---~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      |++++..|..   +..+++|+.|++++|.+++.+|. ..+..++.+++.+|
T Consensus       161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n  210 (768)
T 3rgz_A          161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSN  210 (768)
T ss_dssp             SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSS
T ss_pred             CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCC
Confidence            8888887776   56666677777777766665554 33444444444444

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.89  E-value=2.1e-23  Score=200.33  Aligned_cols=140  Identities=26%  Similarity=0.377  Sum_probs=115.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEe-----------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-----------  362 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-----------  362 (447)
                      ++|...+.||+|+||.||+|+.. +++.||||.+.... .....++.+|+++++.++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            56888899999999999999976 48999999986432 223456899999999999999999999874           


Q ss_pred             ---cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCCce
Q 013258          363 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  438 (447)
Q Consensus       363 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~  438 (447)
                         .....++||||++ |+|.+++...     .+++..+..++.|+++||+|||++   +|+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3467899999998 6999998642     388999999999999999999999   999999999999997 56799


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      ||+||-
T Consensus       161 kl~Dfg  166 (320)
T 2i6l_A          161 KIGDFG  166 (320)
T ss_dssp             EECCCT
T ss_pred             EEccCc
Confidence            999995

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.89  E-value=2e-23  Score=201.34  Aligned_cols=146  Identities=29%  Similarity=0.490  Sum_probs=123.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeEEe----
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCT----  362 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~----  362 (447)
                      ..++|++.+.||+|+||.||+|+.  .+++.||||+++...... ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346788899999999999999997  358899999986543221 223567788777666   8999999999987    


Q ss_pred             -cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          363 -TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       363 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                       .....++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             4567899999998 699999987532  2488999999999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       163 Dfg  165 (326)
T 1blx_A          163 DFG  165 (326)
T ss_dssp             SCC
T ss_pred             cCc
Confidence            995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.89  E-value=2.3e-23  Score=204.96  Aligned_cols=140  Identities=21%  Similarity=0.354  Sum_probs=122.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCce-----
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-----  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-----  367 (447)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++...... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            56778899999999999999864 68999999996543222 234688999999999999999999999876654     


Q ss_pred             -EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 -LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                       ++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||-
T Consensus       122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence             99999997 688887743      288999999999999999999999   99999999999999999999999995

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=7.2e-24  Score=206.49  Aligned_cols=142  Identities=18%  Similarity=0.184  Sum_probs=116.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeC----CCcEEEEEEccccccc----------ccHHHHHHHHHHHhcCCCCCccceeeE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS----------GGELQFQTEVKIISMAVHRNLLRLYGF  360 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~  360 (447)
                      ++|.+.+.||+|+||.||+|+..    ++..+|||.+......          .....+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            46778899999999999999975    5778999998643211          012246788899999999999999999


Q ss_pred             Eec----CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          361 CTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       361 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                      +..    ....++||||+ +++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            987    67889999999 999999997654    489999999999999999999999   999999999999999888


Q ss_pred             --ceeecccc
Q 013258          437 --DQSSKTIL  444 (447)
Q Consensus       437 --~~~i~df~  444 (447)
                        .+||+||-
T Consensus       189 ~~~~kL~Dfg  198 (345)
T 2v62_A          189 PDQVYLADYG  198 (345)
T ss_dssp             TTSEEECCCT
T ss_pred             CCcEEEEeCC
Confidence              99999995

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.89  E-value=3.3e-23  Score=202.74  Aligned_cols=151  Identities=21%  Similarity=0.275  Sum_probs=113.5

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc
Q 013258          288 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       288 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  366 (447)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||||++....  .....+.+|++.+..++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            344566789999999999999999999974 68999999885432  223357788888899999999999999865433


Q ss_pred             -------eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh--cCCCCCeeecCCCCCceeeCC-CC
Q 013258          367 -------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--EHCDPKIIHRDVKAANILLDE-DA  436 (447)
Q Consensus       367 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDlkp~NILl~~-~~  436 (447)
                             .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999986 555555432223335888999999999999999999  77   9999999999999997 89


Q ss_pred             ceeecccc
Q 013258          437 DQSSKTIL  444 (447)
Q Consensus       437 ~~~i~df~  444 (447)
                      .+||+||-
T Consensus       170 ~~kl~Dfg  177 (360)
T 3e3p_A          170 TLKLCDFG  177 (360)
T ss_dssp             EEEECCCT
T ss_pred             cEEEeeCC
Confidence            99999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.89  E-value=1.2e-23  Score=202.27  Aligned_cols=144  Identities=24%  Similarity=0.443  Sum_probs=124.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ...++|+..+.||+|+||.||+|+..+  .+|+|.++.... ......+.+|+.++..++||||+++++++...+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345678889999999999999999753  499999865432 22234578899999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++++|.+++....   ..+++..+..++.|+++||+|||++   +|+||||||+|||++ ++.+||+||-
T Consensus       108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             eecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            99999999999997643   2488999999999999999999999   999999999999998 6799999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=1.4e-23  Score=209.87  Aligned_cols=140  Identities=29%  Similarity=0.427  Sum_probs=114.8

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC----C--ceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV----T--EKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~--~~~  368 (447)
                      +|+..+.||+|+||.||+|+.. +++.||||++....     ..+.+|+++++.++|||||++++++...    +  ..+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4677789999999999999975 58999999985432     1234799999999999999999988542    2  367


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      +||||+++ ++.+.+.........+++..+..++.|+++||+|||++   +|+||||||+|||++.+ +.+||+||-
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            99999985 67666654222223589999999999999999999999   99999999999999965 568999995

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.89  E-value=3e-23  Score=202.68  Aligned_cols=140  Identities=21%  Similarity=0.349  Sum_probs=121.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCc------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------  366 (447)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+....... ....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            46777899999999999999964 68999999986543222 23468899999999999999999999987654      


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+. |+|.+++..      .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence            499999997 688877643      288999999999999999999999   99999999999999999999999995

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.89  E-value=1.2e-23  Score=207.01  Aligned_cols=141  Identities=11%  Similarity=0.009  Sum_probs=105.1

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc--ccHHHHHHHHH---HHhcCCCCCcccee-------eEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVK---IISMAVHRNLLRLY-------GFCT  362 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~H~niv~l~-------~~~~  362 (447)
                      +|...+.||+|+||.||+|+.. +++.||||+++.....  .....+.+|+.   .+.. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            4777899999999999999965 6899999999764321  22335777854   5555 799988754       4443


Q ss_pred             cC-----------------CceEEEeecCCCCChhhHhhccCCCCCCCChHHH------HHHHHHHHHHHhhhhcCCCCC
Q 013258          363 TV-----------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR------KKIALGSARGLSYLHEHCDPK  419 (447)
Q Consensus       363 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~  419 (447)
                      ..                 ...++||||++ |+|.+++.....   .+.+..+      ..++.|+++||+|||++   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            32                 33799999999 899999987422   2455666      78889999999999999   9


Q ss_pred             eeecCCCCCceeeCCCCceeecccc
Q 013258          420 IIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       420 ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+||||||+|||++.++.+||+||-
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG  239 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVS  239 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGG
T ss_pred             CccCcCCHHHEEECCCCCEEEEecc
Confidence            9999999999999999999999995

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.89  E-value=3.2e-23  Score=207.90  Aligned_cols=142  Identities=21%  Similarity=0.298  Sum_probs=122.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcC------CCCCccceeeEEecCCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA------VHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~  367 (447)
                      .+|++.+.||+|+||+||+|+.. +++.||||+++...  ....++.+|++++..+      +|+||+++++++...+..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            46888899999999999999865 58999999996532  2234677888888766      577999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc--eeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~~i~df~  444 (447)
                      ++||||+. ++|.+++.....  ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.  +||+||-
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999996 699999887543  2489999999999999999999999   9999999999999999987  9999995

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.89  E-value=7.6e-24  Score=203.14  Aligned_cols=147  Identities=23%  Similarity=0.355  Sum_probs=118.8

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-----cHHHHHHHHHHHhcC----CCCCccceeeE
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMA----VHRNLLRLYGF  360 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~H~niv~l~~~  360 (447)
                      ....++|++.+.||+|+||.||+|+. .+++.||||+++......     ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34457799999999999999999986 468999999996543211     122466789988888    89999999999


Q ss_pred             EecCCceEEEeec-CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCCce
Q 013258          361 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  438 (447)
Q Consensus       361 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~  438 (447)
                      +...+..++|+|| +.+++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+||+++ +++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 78999999998754    389999999999999999999999   999999999999999 88999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      ||+||-
T Consensus       180 kl~dfg  185 (312)
T 2iwi_A          180 KLIDFG  185 (312)
T ss_dssp             EECCCS
T ss_pred             EEEEcc
Confidence            999995

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.89  E-value=2.2e-23  Score=201.76  Aligned_cols=145  Identities=26%  Similarity=0.363  Sum_probs=122.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEe--------c
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCT--------T  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~  363 (447)
                      ..+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++..+. ||||+++++++.        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            346788899999999999999964 68999999985432 223446899999999996 999999999984        2


Q ss_pred             CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCC--eeecCCCCCceeeCCCCceeec
Q 013258          364 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       364 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      ....++||||+. |+|.+++..... ...+++..+..++.|++.||+|||+.   +  |+||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence            344789999996 799998875321 22489999999999999999999998   6  9999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       181 Dfg  183 (337)
T 3ll6_A          181 DFG  183 (337)
T ss_dssp             CCT
T ss_pred             cCc
Confidence            995

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.88  E-value=8.1e-24  Score=206.69  Aligned_cols=138  Identities=20%  Similarity=0.232  Sum_probs=119.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC---------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccc---------
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR---------  356 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  356 (447)
                      ++|.+.+.||+|+||.||+|+...         ++.||||.++..      ..+.+|++++..++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            568888999999999999999653         789999998543      25889999999999999988         


Q ss_pred             ------eeeEEec-CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          357 ------LYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       357 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                            +++++.. ....++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  5677765 67889999999 999999998642  12489999999999999999999999   99999999999


Q ss_pred             eeeCCCC--ceeecccc
Q 013258          430 ILLDEDA--DQSSKTIL  444 (447)
Q Consensus       430 ILl~~~~--~~~i~df~  444 (447)
                      ||++.++  .+||+||-
T Consensus       190 Il~~~~~~~~~kl~Dfg  206 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYG  206 (352)
T ss_dssp             EEEETTEEEEEEECCGG
T ss_pred             EEEcCCCCceEEEecCc
Confidence            9999998  89999995

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.88  E-value=2.4e-23  Score=206.49  Aligned_cols=141  Identities=25%  Similarity=0.379  Sum_probs=115.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCc------eE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------KL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~  368 (447)
                      .+|...+.||+|+||.||+|+...+..||+|++.....     ...+|+++++.++||||+++++++.....      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            35777899999999999999987777799998854321     12479999999999999999999865432      78


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~~i~df~  444 (447)
                      +||||++++ +.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ +++.+||+||-
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            999999864 4444332211223488999999999999999999999   999999999999999 79999999995

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=2.2e-23  Score=200.95  Aligned_cols=145  Identities=22%  Similarity=0.345  Sum_probs=125.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-----cHHHHHHHHHHHhcCC--CCCccceeeEEecC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTV  364 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~  364 (447)
                      ..++|++.+.||+|+||.||+|+. .+++.||||.++......     ....+.+|+.++..++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            446788889999999999999985 468999999996543221     1234778999999996  59999999999999


Q ss_pred             CceEEEeecCCC-CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCCceeecc
Q 013258          365 TEKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKT  442 (447)
Q Consensus       365 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~~i~d  442 (447)
                      +..++|+||+.+ ++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||++ +++.+||+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999986 89999998753    388999999999999999999999   999999999999999 788999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       194 fg  195 (320)
T 3a99_A          194 FG  195 (320)
T ss_dssp             CT
T ss_pred             Cc
Confidence            95

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=4.8e-23  Score=205.14  Aligned_cols=142  Identities=23%  Similarity=0.332  Sum_probs=112.6

Q ss_pred             CCCC-CCccccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEE
Q 013258          296 GFSN-KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLL  369 (447)
Q Consensus       296 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l  369 (447)
                      .|.+ .++||+|+||+||+|+..   +++.||||+++...   ....+.+|+.+++.++||||+++++++..  ....++
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3544 468999999999999965   47899999996432   23468899999999999999999999954  667899


Q ss_pred             EeecCCCCChhhHhhccC-----CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee----CCCCceee
Q 013258          370 VYPYMTNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSS  440 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~~i  440 (447)
                      ||||+. |+|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+|||+    ++++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999997 58888776421     1122488999999999999999999999   99999999999999    77889999


Q ss_pred             cccc
Q 013258          441 KTIL  444 (447)
Q Consensus       441 ~df~  444 (447)
                      +||-
T Consensus       174 ~Dfg  177 (405)
T 3rgf_A          174 ADMG  177 (405)
T ss_dssp             CCTT
T ss_pred             EECC
Confidence            9996

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.88  E-value=2.8e-23  Score=214.94  Aligned_cols=132  Identities=15%  Similarity=0.133  Sum_probs=104.1

Q ss_pred             cccCCCceEEEEE-eCCCcEEEEEEcccccc---------cccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEe
Q 013258          303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERT---------SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       303 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .+.|+.|.++.++ .-.|+.+|||++.....         .....+|.+|+++|+++ .|+||+++++++.+....||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666655544 22488899999864321         11234699999999999 7999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++||+|.+.|....    +++.   ..|+.||+.||+|+|++   +||||||||+|||+++++.+||+||-
T Consensus       322 Eyv~G~~L~d~i~~~~----~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE----EIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             ECCCSEEHHHHHHTTC----CCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCcHHHHHHhCC----CCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence            9999999999998653    2543   35899999999999999   99999999999999999999999995

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.88  E-value=1.2e-22  Score=192.82  Aligned_cols=142  Identities=22%  Similarity=0.269  Sum_probs=118.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEE-ecCCceEEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLV  370 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv  370 (447)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++.....   ..++.+|+.++..++|++++..++++ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            346799999999999999999996 5689999998754322   22578999999999998887777665 567778999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      |||+ +++|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+   ++++.+||+||-
T Consensus        84 ~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             EECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             EEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            9999 9999999975432   389999999999999999999999   99999999999999   788999999995

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.88  E-value=3.1e-23  Score=215.74  Aligned_cols=147  Identities=25%  Similarity=0.349  Sum_probs=125.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec------CCce
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTEK  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~  367 (447)
                      ++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++..++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999864 5899999998765444445579999999999999999999998765      6678


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCc---eeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~~i~df~  444 (447)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+||-
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            999999999999999987532 23488999999999999999999999   9999999999999998775   8999995


Q ss_pred             c
Q 013258          445 R  445 (447)
Q Consensus       445 ~  445 (447)
                      -
T Consensus       170 ~  170 (676)
T 3qa8_A          170 Y  170 (676)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=8.4e-23  Score=197.23  Aligned_cols=148  Identities=23%  Similarity=0.324  Sum_probs=122.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHH-HHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|...+.||+|+||.||+|... +++.||||+++.........++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            357888899999999999999974 689999999975433333345666665 778889999999999999999999999


Q ss_pred             ecCCCCChhhHhhccC-CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQ-SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++ +|.+++.... .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+||.
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            99985 8877776311 1123488999999999999999999984  279999999999999999999999995

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.88  E-value=1.6e-22  Score=192.21  Aligned_cols=141  Identities=22%  Similarity=0.268  Sum_probs=121.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEE-ecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lv~  371 (447)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....   ...++.+|+.++..++|++++..+.++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            35788889999999999999996 568999999985432   223689999999999998877766665 5567789999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      ||+ +++|.+++.....   .+++..+..++.|++.||+|||++   +|+||||||+|||+   ++++.+||+||-
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  153 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence            999 9999999975432   489999999999999999999999   99999999999999   488899999995

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=9.6e-23  Score=197.25  Aligned_cols=143  Identities=21%  Similarity=0.313  Sum_probs=123.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-C-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC------ccceeeEEecCC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-A-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN------LLRLYGFCTTVT  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~  365 (447)
                      .++|++.+.||+|+||.||+|.. . +++.||||+++...  .....+.+|++++..++|++      ++++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            35788889999999999999986 3 58899999986432  22346889999998887654      999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-----------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----------  434 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----------  434 (447)
                      ..++||||+ +++|.+++.....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 8999999987532  2478999999999999999999999   9999999999999998           


Q ss_pred             --------CCceeecccc
Q 013258          435 --------DADQSSKTIL  444 (447)
Q Consensus       435 --------~~~~~i~df~  444 (447)
                              ++.+||+||-
T Consensus       165 ~~~~~~~~~~~~kl~Dfg  182 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFG  182 (339)
T ss_dssp             -CEEEEESCCCEEECCCS
T ss_pred             ccccccccCCCceEeeCc
Confidence                    6679999995

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.88  E-value=7.8e-23  Score=196.25  Aligned_cols=143  Identities=21%  Similarity=0.263  Sum_probs=124.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCC--CCCccceeeEEecCCceEE
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~l  369 (447)
                      ..++|++.+.||+|+||.||+++..+++.||||.+...... .....+.+|++++..++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34568888999999999999999888999999998654322 23346899999999997  5999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||| +.+++|.+++....    .+++..+..++.|+++||+|||+.   +|+||||||+|||+++ +.+||+||-
T Consensus       106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence            999 56889999998653    388999999999999999999999   9999999999999964 889999994

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.88  E-value=1.5e-22  Score=196.41  Aligned_cols=141  Identities=23%  Similarity=0.281  Sum_probs=115.3

Q ss_pred             hcCCCCC-CccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec----CCce
Q 013258          294 TDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEK  367 (447)
Q Consensus       294 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~  367 (447)
                      .++|.+. ++||+|+||.||+|+.. +++.||||++...     .....+....+..++||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4567774 46999999999999975 6899999998542     1122233334567799999999999876    4457


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC---Cceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~~i~df~  444 (447)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.+   +.+||+||-
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            999999999999999986532  3489999999999999999999999   99999999999999874   459999995

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.87  E-value=3.1e-22  Score=203.08  Aligned_cols=141  Identities=20%  Similarity=0.239  Sum_probs=120.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC-CccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|.+.+.||+|+||.||+|+. .+++.||||+++....   ..++.+|++++..++|+ ++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            35788999999999999999996 4689999998754432   23588999999999874 5556666667788899999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee---CCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~~i~df~  444 (447)
                      ||+ +++|.+++.....   .+++..+..|+.|++.||+|||++   +||||||||+|||+   ++++.+||+||-
T Consensus        83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFG  151 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFG  151 (483)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred             ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCC
Confidence            999 9999999986432   389999999999999999999999   99999999999999   688999999995

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.87  E-value=9.9e-23  Score=219.35  Aligned_cols=171  Identities=21%  Similarity=0.303  Sum_probs=145.9

Q ss_pred             cCchHHHHHHHHHHHHCCCCCCCCCCCCCCC----CCC--Ccc------------ceeEeCCCCCEEEEEcCCCCccccc
Q 013258           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLP----GNL--CTW------------FHITCNPEGSVTRVDLGNAALSGEL   83 (447)
Q Consensus        22 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~v~~l~L~~~~l~g~~   83 (447)
                      .....|+.||+.||.++.+|     +|+...    .+|  |.|            .||.|+..++|+.|+|+++++.|.+
T Consensus       265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i  339 (876)
T 4ecn_A          265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV  339 (876)
T ss_dssp             CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred             ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence            34567999999999999887     787543    356  999            9999998899999999999999999


Q ss_pred             cccccCCCCCCEEEC-CCCccCCC--------------------------------------------------------
Q 013258           84 APELGQLKNLELLEL-YGNNLSGH--------------------------------------------------------  106 (447)
Q Consensus        84 ~~~l~~l~~L~~L~L-~~N~l~~~--------------------------------------------------------  106 (447)
                      |++|++|++|++|+| ++|.++|.                                                        
T Consensus       340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~  419 (876)
T 4ecn_A          340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK  419 (876)
T ss_dssp             CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred             chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence            999999999999999 77765444                                                        


Q ss_pred             --------------------CChhhcCCCCCcEEEccCCcccc-----------------cCCcccc--CCCCCCeeeCc
Q 013258          107 --------------------IPSALGNLIKLKSLDLYSNLFNG-----------------TIPDTLA--NLKQLKYLRLN  147 (447)
Q Consensus       107 --------------------~p~~~~~l~~L~~L~ls~N~l~g-----------------~~p~~~~--~l~~L~~L~l~  147 (447)
                                          +|..|+++++|+.|+|++|+++|                 .+|+.++  ++++|++|+|+
T Consensus       420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls  499 (876)
T 4ecn_A          420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY  499 (876)
T ss_dssp             CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred             ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence                                88999999999999999999998                 4999988  99999999999


Q ss_pred             CccccccCchHHhhccccccccccccc-ccc-cCCCC--------CCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNR-LSG-PVPDN--------GSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~-l~g-~~p~~--------~~~~~~~~~~~~~n~  197 (447)
                      +|++.+.+|..++++++|+.|++++|+ ++| .+|..        ..+..+..+.+.+|.
T Consensus       500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~  559 (876)
T 4ecn_A          500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN  559 (876)
T ss_dssp             SCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSC
T ss_pred             CCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCc
Confidence            999999999999999999999999998 888 66642        122355555555554

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.87  E-value=8.2e-23  Score=202.34  Aligned_cols=136  Identities=25%  Similarity=0.357  Sum_probs=113.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC--------CCCccceeeEEe--
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--------HRNLLRLYGFCT--  362 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~--  362 (447)
                      .++|.+.+.||+|+||+||+|+.. +++.||||+++...  .....+.+|++++..++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            367888999999999999999854 58899999996432  23446889999999885        788999999987  


Q ss_pred             --cCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC
Q 013258          363 --TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  436 (447)
Q Consensus       363 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  436 (447)
                        .....++||||+ ++++.+.+.....  ..+++..+..++.|+++||+|||+++  +|+||||||+|||++.++
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence              556789999999 6677777665422  24899999999999999999999853  799999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=1.8e-22  Score=193.78  Aligned_cols=144  Identities=24%  Similarity=0.368  Sum_probs=112.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHH-HHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      .++|+..+.||+|+||.||+|+.. +|+.||||.++.........+ +.++..++..++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356777899999999999999975 689999999965433222223 445556788889999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+ ++.+..+.....   ..+++..+..++.|+++||+|||+ .   +|+||||||+||+++.++.+||+||-
T Consensus       104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECC
Confidence            999 445555544322   238899999999999999999998 5   89999999999999999999999995

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=1.5e-22  Score=203.31  Aligned_cols=140  Identities=25%  Similarity=0.220  Sum_probs=112.8

Q ss_pred             CCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeecCC
Q 013258          297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMT  375 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~~~  375 (447)
                      |...+.||+|+||+||.+...+|+.||||++...    ....+.+|++++..+ +||||+++++++.+.+..++||||+.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            3445789999999998766667999999998543    234578999999876 89999999999999999999999995


Q ss_pred             CCChhhHhhccCCCCCC---CChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-------------Ccee
Q 013258          376 NGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------------ADQS  439 (447)
Q Consensus       376 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~~  439 (447)
                       |+|.+++.........   .++..+..++.|++.||+|||++   +|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             6999999865322111   13345678999999999999999   99999999999999754             4899


Q ss_pred             ecccc
Q 013258          440 SKTIL  444 (447)
Q Consensus       440 i~df~  444 (447)
                      |+||-
T Consensus       169 L~DFG  173 (434)
T 2rio_A          169 ISDFG  173 (434)
T ss_dssp             ECCCT
T ss_pred             Ecccc
Confidence            99995

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=4.5e-22  Score=188.06  Aligned_cols=140  Identities=13%  Similarity=0.069  Sum_probs=111.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccc-----------------cHHHHHHHHHHHhcC
Q 013258          287 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----------------GELQFQTEVKIISMA  349 (447)
Q Consensus       287 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~E~~~l~~l  349 (447)
                      +..+......|...+.||+|+||.||+|+..+|+.||||.++......                 ....+.+|+++++.+
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            334444455677779999999999999999779999999996432111                 234689999999999


Q ss_pred             CCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCc
Q 013258          350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  429 (447)
Q Consensus       350 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~N  429 (447)
                      +  | +++.+++.. +..++||||+++|+|.+ +..          .....++.|+++||+|||+.   +|+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            8  5 667775544 55699999999999988 421          12457999999999999999   99999999999


Q ss_pred             eeeCCCCceeeccccc
Q 013258          430 ILLDEDADQSSKTILR  445 (447)
Q Consensus       430 ILl~~~~~~~i~df~~  445 (447)
                      ||++ ++.+||+||-.
T Consensus       224 ILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EEEE-TTEEEECCCTT
T ss_pred             EEEE-CCcEEEEECCC
Confidence            9999 99999999963

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.86  E-value=3e-22  Score=200.82  Aligned_cols=139  Identities=22%  Similarity=0.272  Sum_probs=115.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .+|...++||+|+||+||.....+++.||||++.....    ..+.+|++++..+ +|||||++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            45777899999999996655555789999999864322    1356899999998 799999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-----Cceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-----ADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~~i~df~  444 (447)
                      +. |+|.+++.....   ...+..+..++.|+++||+|||+.   +|+||||||+|||++.+     ..+||+||-
T Consensus       100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            96 699999986543   244556789999999999999999   99999999999999532     357799995

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=8.3e-22  Score=194.63  Aligned_cols=146  Identities=23%  Similarity=0.298  Sum_probs=121.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CC-----CccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR-----NLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~  365 (447)
                      ..++|++.+.||+|+||+||+|+.. +++.||||+++...  ....++.+|+.++..++ |+     +|+++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3467888999999999999999965 58899999996432  22346778888888775 54     4999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC--CCCceeeccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTI  443 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~~i~df  443 (447)
                      ..++||||+. |+|.+++.....  ..+++..+..++.|++.||+|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999996 599999987532  2388999999999999999999953 23899999999999995  4778999999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      -
T Consensus       206 G  206 (382)
T 2vx3_A          206 G  206 (382)
T ss_dssp             T
T ss_pred             c
Confidence            5

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.86  E-value=2.3e-22  Score=211.64  Aligned_cols=172  Identities=25%  Similarity=0.345  Sum_probs=146.0

Q ss_pred             chHHHHHHHHHHHHCCCCCCC--------CCCCCCCCCCCCcc---ceeEeCCCCCEEEEEcCCCCccccccccccCCCC
Q 013258           24 ANAEVDALYIFKSKLQDPNNS--------LQSWDNLPGNLCTW---FHITCNPEGSVTRVDLGNAALSGELAPELGQLKN   92 (447)
Q Consensus        24 ~~~~~~~l~~~~~~~~~~~~~--------l~~w~~~~~~~c~w---~gv~c~~~~~v~~l~L~~~~l~g~~~~~l~~l~~   92 (447)
                      ...|+.||..++.++.++.-.        ..+|+. +.++|.|   .||+|+..++|+.|+|+++++.|.+|+++++|++
T Consensus        28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~  106 (636)
T 4eco_A           28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred             HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence            346899999999998765322        337975 4789999   9999997799999999999999999999999999


Q ss_pred             CCEEECCCCc----------------------------------------------------------------------
Q 013258           93 LELLELYGNN----------------------------------------------------------------------  102 (447)
Q Consensus        93 L~~L~L~~N~----------------------------------------------------------------------  102 (447)
                      |++|+|++|.                                                                      
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l  186 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT  186 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred             ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence            9999999984                                                                      


Q ss_pred             --------cCCCCChhhcCCCCCcEEEccCCccccc-----------------CCcccc--CCCCCCeeeCcCccccccC
Q 013258          103 --------LSGHIPSALGNLIKLKSLDLYSNLFNGT-----------------IPDTLA--NLKQLKYLRLNNNSLSGLI  155 (447)
Q Consensus       103 --------l~~~~p~~~~~l~~L~~L~ls~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~  155 (447)
                              ++| +|..++++++|++|+|++|+++|.                 +|+.++  ++++|++|+|++|++.|.+
T Consensus       187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~  265 (636)
T 4eco_A          187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL  265 (636)
T ss_dssp             TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred             hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence                    345 899999999999999999999986                 999999  9999999999999999999


Q ss_pred             chHHhhccccccccccccc-ccc-cCCCC-CCC------Cccccccccccc
Q 013258          156 PTSLTTITSLNILDLSNNR-LSG-PVPDN-GSF------SQFTPISFENNL  197 (447)
Q Consensus       156 p~~~~~l~~L~~l~ls~N~-l~g-~~p~~-~~~------~~~~~~~~~~n~  197 (447)
                      |..++++++|+.|++++|. ++| .+|.. +.+      ..++.+.+.+|.
T Consensus       266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence            9999999999999999998 988 67643 112      455556665554

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=5.8e-22  Score=193.08  Aligned_cols=143  Identities=19%  Similarity=0.299  Sum_probs=121.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CC-cEEEEEEcccccccccHHHHHHHHHHHhcCCCCC------ccceeeEEecCC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DG-KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN------LLRLYGFCTTVT  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~  365 (447)
                      .++|++.+.||+|+||+||+|+.. ++ +.||||+++...  .....+.+|+.++..++|++      ++.+.+++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            357888899999999999999864 34 789999996432  23446888999999887766      899999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee-------------
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-------------  432 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl-------------  432 (447)
                      ..++||||+ ++++.+.+.....  ..+++..+..++.|++.||+|||++   +|+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 6778777766432  2488999999999999999999999   99999999999999             


Q ss_pred             ------CCCCceeecccc
Q 013258          433 ------DEDADQSSKTIL  444 (447)
Q Consensus       433 ------~~~~~~~i~df~  444 (447)
                            +.++.+||+||-
T Consensus       170 ~~~~~~~~~~~~kl~Dfg  187 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFG  187 (355)
T ss_dssp             CCCEEEESCCCEEECCCT
T ss_pred             cccccccCCCcEEEeecC
Confidence                  567899999995

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=2.1e-21  Score=199.77  Aligned_cols=128  Identities=15%  Similarity=0.239  Sum_probs=102.3

Q ss_pred             CCCccccCCCceEEEEEeCCCcEEEEEEcccccccc-------cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          299 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..+.||+|+||+||+|.. .++.+++|.........       ...++.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            357899999999999965 47888999864322111       1234899999999999999997777777788889999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++..            +..++.|+++||+|||++   +|+||||||+|||+++  .+||+||-
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFG  474 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFG  474 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCT
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECc
Confidence            99999999999865            357999999999999999   9999999999999999  99999995

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.85  E-value=8.7e-22  Score=193.45  Aligned_cols=143  Identities=19%  Similarity=0.320  Sum_probs=120.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-----------CCCccceeeEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCT  362 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  362 (447)
                      ++|.+.+.||+|+||+||+|+. .+++.||||+++...  .....+.+|+.++.+++           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5688889999999999999996 468999999986432  22346888999998876           899999999987


Q ss_pred             cCC----ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-----
Q 013258          363 TVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----  433 (447)
Q Consensus       363 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-----  433 (447)
                      ..+    ..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+++  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            644    689999999 8999999987432  23889999999999999999999853  799999999999994     


Q ss_pred             -CCCceeecccc
Q 013258          434 -EDADQSSKTIL  444 (447)
Q Consensus       434 -~~~~~~i~df~  444 (447)
                       .++.+||+||-
T Consensus       172 ~~~~~~kl~Dfg  183 (373)
T 1q8y_A          172 ENLIQIKIADLG  183 (373)
T ss_dssp             TTEEEEEECCCT
T ss_pred             cCcceEEEcccc
Confidence             44589999995

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.83  E-value=5.3e-21  Score=205.62  Aligned_cols=139  Identities=37%  Similarity=0.641  Sum_probs=132.1

Q ss_pred             EEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccc
Q 013258           72 VDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSL  151 (447)
Q Consensus        72 l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  151 (447)
                      +++..+.+.|.+|+.+..+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|+.++++++|+.|||++|++
T Consensus       613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l  692 (768)
T 3rgz_A          613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL  692 (768)
T ss_dssp             SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             cccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence            45667889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccCCCCCCCCCCC
Q 013258          152 SGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGS  211 (447)
Q Consensus       152 ~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~C~~~  211 (447)
                      +|.+|..+..+++|+.||+|+|+++|.+|..+.+..+...+|.||+++||.+.. +|...
T Consensus       693 ~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~  751 (768)
T 3rgz_A          693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS  751 (768)
T ss_dssp             EECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred             cCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence            999999999999999999999999999999999999999999999999998765 78543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.82  E-value=5e-21  Score=191.00  Aligned_cols=146  Identities=16%  Similarity=0.172  Sum_probs=108.2

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCC-CCcccee---------eE--
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH-RNLLRLY---------GF--  360 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H-~niv~l~---------~~--  360 (447)
                      .|...+.||+|+||+||+|+. .+|+.||||+++.....  .....+.+|+.++..++| +|.....         ..  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            355568899999999999995 46999999998733222  224579999999999987 3221111         11  


Q ss_pred             ----------Eec-----CCceEEEeecCCCCChhhHhhcc---CCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeee
Q 013258          361 ----------CTT-----VTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  422 (447)
Q Consensus       361 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  422 (447)
                                +..     ....+++|+++ +++|.+++...   ......++|..+..++.|+++||+|||++   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                      111     22356677755 68999888521   11223478889999999999999999999   9999


Q ss_pred             cCCCCCceeeCCCCceeeccccc
Q 013258          423 RDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       423 rDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |||||+|||++.++.+||+||--
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGG
T ss_pred             CCcccceEEEecCCeEEEEeccc
Confidence            99999999999999999999953

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.80  E-value=4.5e-21  Score=185.39  Aligned_cols=172  Identities=16%  Similarity=0.285  Sum_probs=144.7

Q ss_pred             cCchHHHHHHHHHHHHC-CCCCCCCCCCC---CCCCCCCccceeEeC---------CCCCEEEEEcCCCCcccccccccc
Q 013258           22 ISANAEVDALYIFKSKL-QDPNNSLQSWD---NLPGNLCTWFHITCN---------PEGSVTRVDLGNAALSGELAPELG   88 (447)
Q Consensus        22 ~~~~~~~~~l~~~~~~~-~~~~~~l~~w~---~~~~~~c~w~gv~c~---------~~~~v~~l~L~~~~l~g~~~~~l~   88 (447)
                      .+..++..||+.||..+ .++.+.+.+|.   ....++|.|.|+.|.         ...+|+.|+|++|.+. .+|+.++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~  101 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF  101 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence            35567899999999988 57877888994   345789999999995         2368999999999998 7898999


Q ss_pred             CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhh-------
Q 013258           89 QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTT-------  161 (447)
Q Consensus        89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-------  161 (447)
                      ++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+..       
T Consensus       102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~  179 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH  179 (328)
T ss_dssp             GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred             hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence            9999999999999999 89999999999999999999998 78999999999999999999888888887765       


Q ss_pred             --cccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          162 --ITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       162 --l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                        +++|+.|++++|.++ .+|. .+.+..+..+.+.+|.
T Consensus       180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~  217 (328)
T 4fcg_A          180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP  217 (328)
T ss_dssp             EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSC
T ss_pred             ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCC
Confidence              888999999999988 5554 3345566666666664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.3e-19  Score=168.98  Aligned_cols=133  Identities=17%  Similarity=0.182  Sum_probs=102.0

Q ss_pred             CCCCCccccCCCceEEEEEe-CCCcE--EEEEEcccccccc-----------------------cHHHHHHHHHHHhcCC
Q 013258          297 FSNKNILGRGGFGKVYKGRL-ADGKL--VAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  350 (447)
Q Consensus       297 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~  350 (447)
                      |++.+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999997 67888  9999875431110                       0125789999999999


Q ss_pred             CCCc--cceeeEEecCCceEEEeecCCC-C----ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhh-cCCCCCeee
Q 013258          351 HRNL--LRLYGFCTTVTEKLLVYPYMTN-G----SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIH  422 (447)
Q Consensus       351 H~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH  422 (447)
                      |+++  ..++++    +..++||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8865  333332    357899999942 4    55555432       234567889999999999999 88   9999


Q ss_pred             cCCCCCceeeCCCCceeeccccc
Q 013258          423 RDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       423 rDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |||||+|||+++  .++|+||-.
T Consensus       195 rDlkp~NILl~~--~~~liDFG~  215 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQ  215 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTT
T ss_pred             CCCCHHHEEEcC--cEEEEECcc
Confidence            999999999998  999999963

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.4e-18  Score=159.12  Aligned_cols=149  Identities=22%  Similarity=0.234  Sum_probs=129.8

Q ss_pred             CCCCCccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEE
Q 013258           52 PGNLCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLD  121 (447)
Q Consensus        52 ~~~~c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  121 (447)
                      ....|+|.+|.|...          .+++.|+|++|.+++..|..+..+++|+.|+|++|.+++..+..|..+++|+.|+
T Consensus        15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~   94 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD   94 (229)
T ss_dssp             TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence            368899999999732          3689999999999998899999999999999999999876667789999999999


Q ss_pred             ccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCcccccccccccccc
Q 013258          122 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLC  200 (447)
Q Consensus       122 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~lc  200 (447)
                      |++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|++++..+. ...+..+..+.+.+|+..|
T Consensus        95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A           95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            9999999776677899999999999999998 6889999999999999999999976654 2346677778888887665


Q ss_pred             C
Q 013258          201 G  201 (447)
Q Consensus       201 ~  201 (447)
                      .
T Consensus       174 ~  174 (229)
T 3e6j_A          174 E  174 (229)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.76  E-value=2.2e-18  Score=156.69  Aligned_cols=146  Identities=23%  Similarity=0.351  Sum_probs=128.8

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |.|..|.|...          ..++.|+|++|.+.+..+..+..+++|+.|+|++|.+++..|..|.++++|++|+|++|
T Consensus        11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            57899999632          36899999999999887778999999999999999999988999999999999999999


Q ss_pred             cccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccccccC
Q 013258          126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       126 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +++...+..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+. ...+..+..+.+.+|+..|.
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            99965555678999999999999999999999999999999999999999987765 34466777888889987763

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=6.8e-19  Score=156.57  Aligned_cols=148  Identities=25%  Similarity=0.319  Sum_probs=121.3

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccc-cccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      |.|..+.|...          ..++.|+|++|.+++..+. .+..+++|++|+|++|.+++..|..|.++++|+.|+|++
T Consensus         8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A            8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            57888888632          2689999999999877665 489999999999999999998899999999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccCCC
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN  203 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~  203 (447)
                      |++++..|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|.+++..+.......+....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            9999888888999999999999999999999999999999999999999999876532111112222344455556543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.75  E-value=1.8e-18  Score=165.94  Aligned_cols=138  Identities=28%  Similarity=0.487  Sum_probs=108.7

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.|+|++|.++|.+|..+..+. |+.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|. +..+++|++|+|+
T Consensus       175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls  252 (313)
T 1ogq_A          175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR  252 (313)
T ss_dssp             TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred             cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence            455566666666666666565555 66666666666666666677777777777777777765554 7778899999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccCCCCCCCC
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC  208 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~C  208 (447)
                      +|++++.+|..+..+++|+.|++++|+++|.+|..+.+..+..+.+.+|+.+||.+.. .|
T Consensus       253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence            9999999999999999999999999999999999888899999999999999997543 45

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.75  E-value=6e-18  Score=152.26  Aligned_cols=147  Identities=25%  Similarity=0.304  Sum_probs=126.6

Q ss_pred             CCccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           55 LCTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        55 ~c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      .|.|.+|.|...          .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..|.++++|++|++++
T Consensus         6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A            6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            468999999742          2589999999999977667789999999999999999977677789999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccccccC
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~  201 (447)
                      |++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|.+++..+.. ..+..+..+.+.+|+..|.
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  163 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  163 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence            9999766667899999999999999999888878899999999999999999766643 4567788888888876554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.74  E-value=6.1e-18  Score=153.75  Aligned_cols=146  Identities=18%  Similarity=0.285  Sum_probs=127.5

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccc-cccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAP-ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      |.|..+.|...          ..++.|+|++|.+++..+. .+..+++|++|+|++|.+++..|..|.++++|+.|+|++
T Consensus        11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            57888888632          2578999999999988664 478999999999999999988888999999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccccccC
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~  201 (447)
                      |++++..|..|.++++|++|+|++|++++..|..+..+++|+.|++++|++++..|.. ..+..+..+.+.+|+..|.
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            9999887888999999999999999999999999999999999999999999987754 3466777788888877663

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=6.1e-19  Score=171.52  Aligned_cols=136  Identities=15%  Similarity=0.111  Sum_probs=96.0

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEccccccc-------------ccHHHH--------HHHHHHHhcCCCCCc
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-------------GGELQF--------QTEVKIISMAVHRNL  354 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~--------~~E~~~l~~l~H~ni  354 (447)
                      -|++.+.||+|+||.||+|...+|+.||||+++.....             ......        .+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            37888999999999999999888999999987643211             011122        234555555544333


Q ss_pred             cceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC
Q 013258          355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  434 (447)
Q Consensus       355 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~  434 (447)
                      ....-+..  ...++||||++++.|.++..          ......++.|++.+|.|||..   +||||||||.|||+++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence            21111111  22479999999888765432          123456889999999999998   9999999999999998


Q ss_pred             CCc----------eeecccccc
Q 013258          435 DAD----------QSSKTILRR  446 (447)
Q Consensus       435 ~~~----------~~i~df~~~  446 (447)
                      +++          +.|.||=+.
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTC
T ss_pred             CCCcccccccccceEEEEeCCc
Confidence            874          789998653

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.72  E-value=2.8e-18  Score=174.60  Aligned_cols=143  Identities=18%  Similarity=0.194  Sum_probs=100.0

Q ss_pred             CccceeEeCCCCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhc-CCCCCcEEEccCCcccccCCcc
Q 013258           56 CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALG-NLIKLKSLDLYSNLFNGTIPDT  134 (447)
Q Consensus        56 c~w~gv~c~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~  134 (447)
                      |.+.++.|....+++.|+|++|.+++..|..++.+++|+.|+|++|.+++.+|..+. .+++|+.|+|++|.+++. |. 
T Consensus       109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-  186 (487)
T 3oja_A          109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-  186 (487)
T ss_dssp             SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred             CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence            445555665445677777888877777777777778888888888888777777765 677888888888887754 32 


Q ss_pred             ccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccC
Q 013258          135 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +..+++|+.|+|++|.+++.+| .+..+++|+.|++++|.+++.++....+..+..+++.+|+..|+
T Consensus       187 ~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          187 QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence            3357778888888888876444 47777778888888888876444444556666667777765553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.69  E-value=5.1e-17  Score=150.69  Aligned_cols=130  Identities=23%  Similarity=0.288  Sum_probs=109.0

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..+..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            57889999999988888888899999999999999998888888899999999999999987666778889999999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      +|++++..+..+..+++|+.|++++|.+++..+. ...+..+..+++.+|.
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            9999877777788888999999999999876663 3455667777777764

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.69  E-value=4.1e-17  Score=142.92  Aligned_cols=126  Identities=27%  Similarity=0.332  Sum_probs=109.1

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |+|.++.|...          ..++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..+..+++|+.|++++|
T Consensus         7 C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            67999999632          36899999999999766667889999999999999999776777899999999999999


Q ss_pred             cccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC
Q 013258          126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       126 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++++..+..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            99977667788999999999999999977776778899999999999999987664

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.66  E-value=2.8e-16  Score=145.65  Aligned_cols=135  Identities=25%  Similarity=0.301  Sum_probs=120.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|++|+|
T Consensus        59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  138 (251)
T 3m19_A           59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL  138 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence            57999999999999988888999999999999999999887888999999999999999999766667899999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccccccC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~lc~  201 (447)
                      ++|++++..|..+..+++|+.|++++|++++..|. ...+..+..+.+.+|+..|.
T Consensus       139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            99999988777899999999999999999987764 34567778888888877664

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.65  E-value=3.2e-16  Score=146.88  Aligned_cols=144  Identities=24%  Similarity=0.309  Sum_probs=75.3

Q ss_pred             CCCCccceeEeCCCCC---------------------EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhh
Q 013258           53 GNLCTWFHITCNPEGS---------------------VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSAL  111 (447)
Q Consensus        53 ~~~c~w~gv~c~~~~~---------------------v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~  111 (447)
                      .+.|.|.|+.|.....                     ++.|+|++|.+.+..+..+..+++|++|+|++|.++...+..|
T Consensus         2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~   81 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIF   81 (270)
T ss_dssp             CCCBGGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTT
T ss_pred             CccCCCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhh
Confidence            4678888877753333                     4455555555554444445555555555555555554333334


Q ss_pred             cCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccc
Q 013258          112 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTP  190 (447)
Q Consensus       112 ~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~  190 (447)
                      .++++|++|++++|++++..+..+.++++|++|++++|++++..|..+..+++|+.|++++|.+++..+.. ..+..+..
T Consensus        82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  161 (270)
T 2o6q_A           82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE  161 (270)
T ss_dssp             SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccce
Confidence            55555555555555555433344455555555555555555555555555555555555555555433321 22334444


Q ss_pred             cccccc
Q 013258          191 ISFENN  196 (447)
Q Consensus       191 ~~~~~n  196 (447)
                      +.+.+|
T Consensus       162 L~L~~n  167 (270)
T 2o6q_A          162 LRLYNN  167 (270)
T ss_dssp             EECCSS
T ss_pred             eEecCC
Confidence            444443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.64  E-value=7.5e-16  Score=144.54  Aligned_cols=127  Identities=29%  Similarity=0.375  Sum_probs=64.9

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+.+.  +.+..+++|++|+|++|.+++..|..+.++++|++|++++|++++..|..++.+++|++|+++
T Consensus        64 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  141 (272)
T 3rfs_A           64 NVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA  141 (272)
T ss_dssp             TCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence            455555555555541  245555555555555555554444445555555555555555554444445555555555555


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                      +|++++..|..+..+++|+.|++++|++++..|.. ..+..+..+.+.+|
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            55555444444455555555555555555444332 23344444444444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=5.6e-16  Score=137.74  Aligned_cols=108  Identities=26%  Similarity=0.372  Sum_probs=51.5

Q ss_pred             CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccc
Q 013258           92 NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS  171 (447)
Q Consensus        92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls  171 (447)
                      +|+.|+|++|.++ .+|..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+++
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            4555555555554 344445555555555555555554444445555555555555555554444445555555555555


Q ss_pred             cccccccCCC-CCCCCcccccccccccccc
Q 013258          172 NNRLSGPVPD-NGSFSQFTPISFENNLNLC  200 (447)
Q Consensus       172 ~N~l~g~~p~-~~~~~~~~~~~~~~n~~lc  200 (447)
                      +|.+++..+. ...+..+..+.+.+|+..|
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            5555443332 1223344444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.63  E-value=7.4e-16  Score=136.85  Aligned_cols=129  Identities=22%  Similarity=0.362  Sum_probs=113.3

Q ss_pred             EEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCCh-hhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           70 TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        70 ~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      +.|++++++++ .+|..+..  +|+.|+|++|.+++..+. .+.++++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            57999999994 68877655  999999999999976664 489999999999999999998899999999999999999


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccccccC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~  201 (447)
                      |++++..|..+..+++|+.|++++|++++.+|.. ..+..+..+.+.+|+..|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            9999999988999999999999999999988764 3466777788888876553

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.62  E-value=7e-16  Score=140.08  Aligned_cols=114  Identities=20%  Similarity=0.267  Sum_probs=107.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus        57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  136 (220)
T 2v70_A           57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL  136 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred             CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence            47999999999999888889999999999999999999888888999999999999999999888999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  180 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  180 (447)
                      ++|++++..|..+..+++|+.|++++|.+++..+
T Consensus       137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            9999999989999999999999999999997654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.61  E-value=1e-15  Score=160.35  Aligned_cols=131  Identities=18%  Similarity=0.213  Sum_probs=113.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|||++|.+++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            36899999999999877888999999999999999999877888999999999999999999766678999999999999


Q ss_pred             cCccccccCchHHhhccccccccccccccccc-CCCC-CCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGP-VPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~-~p~~-~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..+..|+++++|+.|++++|.+++. +|.. +.+..++.+.+.+|.
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~  184 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  184 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence            99999988777899999999999999999763 4443 334556666666653

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.60  E-value=2.8e-15  Score=142.07  Aligned_cols=128  Identities=27%  Similarity=0.323  Sum_probs=77.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+ . ..+++|++|+|++|.++ .+|..+..+++|+.|++++|++++..|..|.++++|++|+|
T Consensus        55 ~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L  131 (290)
T 1p9a_G           55 TRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (290)
T ss_dssp             TTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence            456667777776665322 2 56666666666666666 45666666666666666666666554555666666666666


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..+..+..+++|+.|++++|++++..+.. ..+..+..+.+.+|.
T Consensus       132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCc
Confidence            666666655555666666666666666666443332 224455555555553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.60  E-value=4.2e-15  Score=132.05  Aligned_cols=123  Identities=25%  Similarity=0.362  Sum_probs=110.4

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |.|..+.|...          ..++.|+|++|.++ .+|..+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|
T Consensus        10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            45777777531          36899999999998 78889999999999999999999888889999999999999999


Q ss_pred             cccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccC
Q 013258          126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  179 (447)
Q Consensus       126 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~  179 (447)
                      ++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+....
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            999888888999999999999999999877778999999999999999998643

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.60  E-value=6.3e-16  Score=131.26  Aligned_cols=112  Identities=26%  Similarity=0.321  Sum_probs=101.5

Q ss_pred             CCEEEEEcCCCCcc-ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.++ +.+|..+..+++|+.|++++|.+++.  ..++++++|++|++++|.+++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            46899999999998 88999899999999999999999975  7789999999999999999987898888899999999


Q ss_pred             CcCcccccc-CchHHhhcccccccccccccccccCC
Q 013258          146 LNNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPVP  180 (447)
Q Consensus       146 l~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~g~~p  180 (447)
                      +++|++++. .|..+..+++|+.|++++|.+++..+
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            999999874 45789999999999999999997654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.59  E-value=2.4e-15  Score=151.48  Aligned_cols=136  Identities=23%  Similarity=0.278  Sum_probs=122.6

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+.+.+|..+..+++|++|+|++|.+++..|..|.++++|+.|+|++|.+++..|..+.++++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            46899999999999999999999999999999999999888989999999999999999999888899999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccccccCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCGP  202 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~~  202 (447)
                      ++|++++..|..+..+++|+.|++++|++++..+.. ..+..+..+.+.+|+..|..
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  411 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  411 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence            999999988999999999999999999999866544 45678888888899876653

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.59  E-value=2e-15  Score=147.66  Aligned_cols=141  Identities=24%  Similarity=0.250  Sum_probs=111.0

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCcccccccccc-CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELG-QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      |.|.-+.|...          ..++.|+|++|.+++..+..+. .+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            56777777531          2478899999999887777776 899999999999999987777899999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC----CCCCcccccccccc
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN----GSFSQFTPISFENN  196 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~----~~~~~~~~~~~~~n  196 (447)
                      |++++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|.+++..+..    ..+..+..+++.+|
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N  173 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSN  173 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSS
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCC
Confidence            9998776777888999999999999998888888888999999999999988644332    22444444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.59  E-value=9.5e-16  Score=132.91  Aligned_cols=129  Identities=26%  Similarity=0.267  Sum_probs=108.6

Q ss_pred             CCEEEEEcCCCCcc-ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      ..++.|+|++|.++ +.+|..+..+++|+.|+|++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            46899999999998 78888889999999999999999865  7788999999999999999987888888899999999


Q ss_pred             CcCccccccC-chHHhhcccccccccccccccccCC----CCCCCCccccccccccc
Q 013258          146 LNNNSLSGLI-PTSLTTITSLNILDLSNNRLSGPVP----DNGSFSQFTPISFENNL  197 (447)
Q Consensus       146 l~~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~g~~p----~~~~~~~~~~~~~~~n~  197 (447)
                      |++|++++.. +..+..+++|+.|++++|.+++..+    ....+..+..+++.+|.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence            9999998743 2788889999999999999997665    33445666666666654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.58  E-value=6.1e-15  Score=138.15  Aligned_cols=131  Identities=27%  Similarity=0.333  Sum_probs=95.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..+.++++|+.|++++|++++..|..+..+++|++|+|
T Consensus        61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  140 (270)
T 2o6q_A           61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL  140 (270)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence            46788888888887544444577888888888888888666666777888888888888887666666777888888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      ++|.+++..+..+..+++|+.|++++|.+++..+.. ..+..+..+.+.+|.
T Consensus       141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (270)
T 2o6q_A          141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ  192 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCc
Confidence            888887766666777788888888888877655532 334556666666664

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.58  E-value=2.6e-15  Score=151.17  Aligned_cols=144  Identities=22%  Similarity=0.299  Sum_probs=122.2

Q ss_pred             CCCccce--eEeCCC---------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCC-ChhhcCCCCCcEEE
Q 013258           54 NLCTWFH--ITCNPE---------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHI-PSALGNLIKLKSLD  121 (447)
Q Consensus        54 ~~c~w~g--v~c~~~---------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~  121 (447)
                      ..|.|.+  +.|...         .+++.|+|++|.+.+..|..+.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus         6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~   85 (455)
T 3v47_A            6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK   85 (455)
T ss_dssp             -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred             ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence            4565555  677532         46899999999999988999999999999999999998666 56789999999999


Q ss_pred             ccCCcccccCCccccCCCCCCeeeCcCccccccCchH--HhhcccccccccccccccccCCCC--CCCCccccccccccc
Q 013258          122 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS--LTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENNL  197 (447)
Q Consensus       122 ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n~  197 (447)
                      |++|++++..|..++++++|++|+|++|++++.+|..  +..+++|+.|++++|.+++..|..  ..+..+..+++.+|.
T Consensus        86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A           86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred             CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence            9999999888999999999999999999999866665  889999999999999999887763  456677777777764

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.58  E-value=2.8e-15  Score=141.47  Aligned_cols=131  Identities=24%  Similarity=0.268  Sum_probs=104.0

Q ss_pred             CCEEEEEcCCCC-ccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAA-LSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~-l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|. +.+..|..+..+++|++|++++|.+++..|..+.++++|++|++++|++++..+..++.+++|++|+
T Consensus        80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  159 (285)
T 1ozn_A           80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (285)
T ss_dssp             TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence            468888898887 6665577788888889999988888887788888888888888888888866666688888888888


Q ss_pred             CcCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      |++|++++..+..+..+++|+.|++++|.+++..|.. ..+..+..+++.+|.
T Consensus       160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  212 (285)
T 1ozn_A          160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (285)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence            8888888776667888888888888888888876643 335566666666664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.57  E-value=1.8e-15  Score=156.20  Aligned_cols=142  Identities=19%  Similarity=0.243  Sum_probs=114.7

Q ss_pred             CCccceeEeCCC------------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEc
Q 013258           55 LCTWFHITCNPE------------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDL  122 (447)
Q Consensus        55 ~c~w~gv~c~~~------------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  122 (447)
                      .|.|.|+ |+..            .+++.|+|++|.+++..|..+.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            4788887 7521            36899999999999888888999999999999999999888888999999999999


Q ss_pred             cCCcccccCCccccCCCCCCeeeCcCccccc-cCchHHhhcccccccccccccccccCCC--CCCCCccccccccccc
Q 013258          123 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSG-LIPTSLTTITSLNILDLSNNRLSGPVPD--NGSFSQFTPISFENNL  197 (447)
Q Consensus       123 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~ls~N~l~g~~p~--~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..|..++++++|++|++++|++++ .+|..++.+++|+.|++++|.+.+.+|.  ...+..+..+.+.+|.
T Consensus        82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A           82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            9999997777779999999999999999986 3567788888899999999886555553  2345555555555553

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.57  E-value=4.8e-15  Score=134.53  Aligned_cols=112  Identities=25%  Similarity=0.372  Sum_probs=104.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..|..+..+++|++|+|++|.++...+..|.++++|+.|+|++|++++..|..|..+++|++|+|
T Consensus        56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  135 (220)
T 2v9t_B           56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL  135 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence            47999999999999998999999999999999999999766666899999999999999999888999999999999999


Q ss_pred             cCccccccCchHHhhccccccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      ++|++++..+..+..+++|+.|++++|.++..
T Consensus       136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            99999998888899999999999999999863

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.57  E-value=3.2e-15  Score=144.17  Aligned_cols=130  Identities=20%  Similarity=0.270  Sum_probs=102.0

Q ss_pred             CCEEEEEcCCCCccccccccccC---------CCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQ---------LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLAN  137 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~---------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  137 (447)
                      .+++.|+|++|.+.+.+|..+..         +++|++|+|++|.++ .+|..++++++|+.|+|++|++++ +|+.++.
T Consensus       150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~  227 (328)
T 4fcg_A          150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHH  227 (328)
T ss_dssp             TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGG
T ss_pred             cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhcc
Confidence            46888888888888888877654         888888888888888 678888888888888888888874 6777888


Q ss_pred             CCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccccc
Q 013258          138 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLN  198 (447)
Q Consensus       138 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~  198 (447)
                      +++|++|+|++|++.+.+|..++.+++|+.|++++|++.+.+|.. ..+..+..+.+.+|..
T Consensus       228 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~  289 (328)
T 4fcg_A          228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN  289 (328)
T ss_dssp             CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred             CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence            888888888888888888888888888888888888888887754 3455566666666543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.56  E-value=7.6e-15  Score=138.51  Aligned_cols=142  Identities=25%  Similarity=0.300  Sum_probs=116.8

Q ss_pred             CccceeEeCC---CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCc-ccccC
Q 013258           56 CTWFHITCNP---EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL-FNGTI  131 (447)
Q Consensus        56 c~w~gv~c~~---~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~  131 (447)
                      |++.|++..+   ...++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+.++++|++|++++|. +....
T Consensus        18 c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~   97 (285)
T 1ozn_A           18 CPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD   97 (285)
T ss_dssp             CCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCC
T ss_pred             cCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccC
Confidence            4444444332   2468999999999998777889999999999999999998888899999999999999997 77666


Q ss_pred             CccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          132 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       132 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      |..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+++..+. ...+..+..+.+.+|.
T Consensus        98 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  164 (285)
T 1ozn_A           98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (285)
T ss_dssp             TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence            88899999999999999999988888899999999999999999876654 2346667777776663

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.56  E-value=7.7e-15  Score=127.59  Aligned_cols=109  Identities=27%  Similarity=0.363  Sum_probs=96.7

Q ss_pred             EEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCc
Q 013258           70 TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN  149 (447)
Q Consensus        70 ~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  149 (447)
                      +.|++++|.++. +|..+.  ++|++|+|++|.+++..|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            467788888874 777664  89999999999999988999999999999999999999766667899999999999999


Q ss_pred             cccccCchHHhhcccccccccccccccccCCC
Q 013258          150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       150 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++++..|..+..+++|+.|++++|.++...++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            99988777899999999999999999977654

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.56  E-value=1.3e-14  Score=136.09  Aligned_cols=135  Identities=23%  Similarity=0.232  Sum_probs=118.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+.++++|++|++++|++++..|..++.+++|+.|++
T Consensus        85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  164 (272)
T 3rfs_A           85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL  164 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence            57999999999999877777899999999999999999877777899999999999999999777777899999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccccccC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc~  201 (447)
                      ++|++++..|..+..+++|+.|++++|++++.+|.. ..+..+..+.+.+|+..|.
T Consensus       165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  220 (272)
T 3rfs_A          165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  220 (272)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence            999999888888899999999999999999877754 4577788888888876554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.56  E-value=7.2e-15  Score=140.12  Aligned_cols=131  Identities=21%  Similarity=0.341  Sum_probs=99.2

Q ss_pred             CCEEEEEcCCCCcccccc-ccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccc-cCCccccCCCCCCee
Q 013258           67 GSVTRVDLGNAALSGELA-PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYL  144 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L  144 (447)
                      .+++.|+|++|.+.+..+ ..+..+++|++|++++|.+++..|..+.++++|+.|++++|.+++ .+|..+..+++|++|
T Consensus       101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  180 (306)
T 2z66_A          101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  180 (306)
T ss_dssp             TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence            467788888888876554 567788888888888888887777778888888888888888876 567778888888888


Q ss_pred             eCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       145 ~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      ++++|++++..|..+..+++|+.|++++|.+++..+. ...+..+..+++.+|.
T Consensus       181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            8888888877777788888888888888888765542 2334566666666664

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.55  E-value=2.5e-14  Score=125.08  Aligned_cols=129  Identities=22%  Similarity=0.264  Sum_probs=109.2

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      .+.++++++++.. +|..+  .++|+.|++++|.+++..+..+.++++|++|++++|++++..+..+.++++|++|++++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            3678999999874 55544  37999999999999987777789999999999999999976666789999999999999


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC  200 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc  200 (447)
                      |++++..+..+..+++|+.|++++|.+++..+.. ..+..+..+.+.+|+..|
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            9999888888899999999999999999766654 346777778888887654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.55  E-value=1.4e-14  Score=130.16  Aligned_cols=115  Identities=28%  Similarity=0.334  Sum_probs=103.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..+.++++|++|++++|++++..+..+..+++|++|++
T Consensus        52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  131 (208)
T 2o6s_A           52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL  131 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence            47999999999999766666789999999999999999777777899999999999999999776667899999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++|++++..+..+..+++|+.|++++|.+.+..|.
T Consensus       132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  166 (208)
T 2o6s_A          132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  166 (208)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTT
T ss_pred             CCCccceeCHHHhccCCCccEEEecCCCeecCCCC
Confidence            99999987777789999999999999999987764

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=1.3e-14  Score=126.58  Aligned_cols=109  Identities=25%  Similarity=0.316  Sum_probs=97.1

Q ss_pred             EEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCc
Q 013258           70 TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN  149 (447)
Q Consensus        70 ~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N  149 (447)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            57899999995 6887775  89999999999999988999999999999999999999755556789999999999999


Q ss_pred             cccccCchHHhhcccccccccccccccccCCC
Q 013258          150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       150 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++++..+..+..+++|+.|++++|.++...++
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            99987777799999999999999999876543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.54  E-value=5.7e-15  Score=143.84  Aligned_cols=144  Identities=21%  Similarity=0.265  Sum_probs=116.5

Q ss_pred             CCCCccceeEeCC------------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEE
Q 013258           53 GNLCTWFHITCNP------------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSL  120 (447)
Q Consensus        53 ~~~c~w~gv~c~~------------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  120 (447)
                      ...|.|.|+ |+.            ..+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|
T Consensus        27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            467888887 541            1368999999999998777789999999999999999998888889999999999


Q ss_pred             EccCCcccccCCccccCCCCCCeeeCcCccccccCc-hHHhhccccccccccccc-ccccCCC-CCCCCccccccccccc
Q 013258          121 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP-TSLTTITSLNILDLSNNR-LSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       121 ~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~ls~N~-l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      ++++|++++..+..++++++|++|++++|++++..+ ..+..+++|+.|++++|+ +++..|. ...+..+..+.+.+|.
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~  185 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD  185 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence            999999996444458999999999999999986444 478889999999999995 6655443 3345667777777664

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.53  E-value=2.5e-15  Score=157.90  Aligned_cols=130  Identities=23%  Similarity=0.411  Sum_probs=116.1

Q ss_pred             CCEEEEEcCCCCcccc-----------------cccccc--CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCc-
Q 013258           67 GSVTRVDLGNAALSGE-----------------LAPELG--QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL-  126 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~-----------------~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-  126 (447)
                      .+++.|+|++|.++|.                 +|+.++  ++++|++|+|++|.+.|.+|..++++++|+.|++++|+ 
T Consensus       206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~  285 (636)
T 4eco_A          206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG  285 (636)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred             cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence            5799999999999996                 999999  99999999999999999999999999999999999998 


Q ss_pred             ccc-cCCccccCC------CCCCeeeCcCccccccCch--HHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          127 FNG-TIPDTLANL------KQLKYLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       127 l~g-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++| .+|..++++      ++|++|++++|+++ .+|.  .++.+++|+.|++++|.++|.+|..+.+..+..+.+.+|.
T Consensus       286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~  364 (636)
T 4eco_A          286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ  364 (636)
T ss_dssp             SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSE
T ss_pred             CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCc
Confidence            998 899998887      99999999999999 7888  8999999999999999999999954445555666665553

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.53  E-value=1.9e-14  Score=131.37  Aligned_cols=114  Identities=23%  Similarity=0.295  Sum_probs=103.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|+++ .+|..+..+++|++|+|
T Consensus        64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  142 (229)
T 3e6j_A           64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL  142 (229)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred             cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence            47999999999997655566799999999999999999877777899999999999999999 78999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++|++++..+..+..+++|+.|++++|.+++..++
T Consensus       143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  177 (229)
T 3e6j_A          143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD  177 (229)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred             CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence            99999988778899999999999999999987653

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.53  E-value=1.2e-14  Score=151.73  Aligned_cols=130  Identities=18%  Similarity=0.253  Sum_probs=99.0

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            46788888888888777778888888888888888888777777888888888888888888777888888888888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccc-cCCC-CCCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPD-NGSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g-~~p~-~~~~~~~~~~~~~~n  196 (447)
                      ++|.+++..|..++.+++|+.|++++|.+++ .+|. .+.+..++.+++.+|
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n  163 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN  163 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence            8888877666777778888888888888775 4454 233455555555554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.52  E-value=2e-14  Score=134.89  Aligned_cols=129  Identities=18%  Similarity=0.243  Sum_probs=101.6

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.|+|++|.+++..+..+.++++|++|+|++|.+++..+..+.++++|++|++++|.+++..|..+.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            58888998888887777788888889999998888887667788888888889998888887777788888888888888


Q ss_pred             CccccccCchHHhhcccccccccccccccc-cCCCC-CCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~-~~~~~~~~~~~~~n  196 (447)
                      +|++++..+..+..+++|+.|++++|.+++ .+|.. ..+..+..+.+.+|
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N  159 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence            888887766678888888888888888876 34532 23445555555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.52  E-value=2e-14  Score=148.60  Aligned_cols=110  Identities=30%  Similarity=0.329  Sum_probs=102.8

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.|+|++|.+++ +|. ++.|++|+.|+|++|.|+ .+|..++++++|+.|+|++|++++ +| .++++++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            47889999999997 665 999999999999999999 799999999999999999999996 77 89999999999999


Q ss_pred             CccccccC-chHHhhcccccccccccccccccCCCC
Q 013258          148 NNSLSGLI-PTSLTTITSLNILDLSNNRLSGPVPDN  182 (447)
Q Consensus       148 ~N~l~~~~-p~~~~~l~~L~~l~ls~N~l~g~~p~~  182 (447)
                      +|++++.+ |..++.+++|+.|++++|++++.+|..
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            99999887 999999999999999999999987754

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.52  E-value=1.2e-14  Score=151.94  Aligned_cols=108  Identities=22%  Similarity=0.281  Sum_probs=52.3

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCC-CCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG-HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      ++.|+|++|.+.+..|..+..+++|++|++++|.+++ .+|..++.+++|+.|++++|++++..|..+.++++|++|+|+
T Consensus       426 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  505 (606)
T 3vq2_A          426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMS  505 (606)
T ss_dssp             CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECC
Confidence            4444444444444444444444444444444444444 234444444455555555555444444444445555555555


Q ss_pred             CccccccCchHHhhccccccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      +|++++.+|..+..+++|+.|++++|+++
T Consensus       506 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          506 HNNLLFLDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             SSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred             CCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence            55554444444444455555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.51  E-value=2e-14  Score=137.02  Aligned_cols=141  Identities=25%  Similarity=0.313  Sum_probs=116.7

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccC--CCCChhhcCCCCCcEEEcc
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLS--GHIPSALGNLIKLKSLDLY  123 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls  123 (447)
                      |.|.+|.|...          ..++.|+|++|.++...+..+.++++|++|+|++|.++  +.+|..+..+++|++|+++
T Consensus         7 C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A            7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             eCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            78999999742          36999999999998544445789999999999999998  3447788889999999999


Q ss_pred             CCcccccCCccccCCCCCCeeeCcCccccccCc-hHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       124 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      +|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+++..|.. ..+..+..+.+.+|.
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  161 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS  161 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc
Confidence            99998 578889999999999999999987655 57888999999999999999877753 345666667776664

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.51  E-value=2.4e-14  Score=149.58  Aligned_cols=131  Identities=21%  Similarity=0.212  Sum_probs=117.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|||++|.+++..|..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..++++++|++|++
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            46899999999999988999999999999999999999988999999999999999999999888999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccc-cCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..|..+..+++|+.|++++|.+++ .+|....+..++.+.+.+|.
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~  164 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA  164 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence            9999998778889999999999999999998 45665556666666666653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.51  E-value=1.6e-14  Score=156.70  Aligned_cols=140  Identities=27%  Similarity=0.300  Sum_probs=100.7

Q ss_pred             CccceeEeCCCCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCC-ChhhcCCCCCcEEEccCCcccccCCcc
Q 013258           56 CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHI-PSALGNLIKLKSLDLYSNLFNGTIPDT  134 (447)
Q Consensus        56 c~w~gv~c~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~  134 (447)
                      |.|..|.+ -..+++.|||++|.+++..|..+.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..
T Consensus        14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~   92 (844)
T 3j0a_A           14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA   92 (844)
T ss_dssp             CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred             CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence            45666666 4467888888888888877777888888888888888666555 667788888888888888887777777


Q ss_pred             ccCCCCCCeeeCcCccccccCchH--HhhcccccccccccccccccCCC--CCCCCcccccccccc
Q 013258          135 LANLKQLKYLRLNNNSLSGLIPTS--LTTITSLNILDLSNNRLSGPVPD--NGSFSQFTPISFENN  196 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~ls~N~l~g~~p~--~~~~~~~~~~~~~~n  196 (447)
                      |+++++|++|+|++|.+++.+|..  +.++++|+.|++++|.+++..|.  .+.+.+++.+.+.+|
T Consensus        93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N  158 (844)
T 3j0a_A           93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN  158 (844)
T ss_dssp             SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred             ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence            888888888888888877766654  77777778888888777765442  233444444444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.50  E-value=3.8e-14  Score=143.68  Aligned_cols=140  Identities=22%  Similarity=0.285  Sum_probs=116.5

Q ss_pred             cceeEeCC----------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcc
Q 013258           58 WFHITCNP----------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF  127 (447)
Q Consensus        58 w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  127 (447)
                      |..|.|..          ...++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++
T Consensus        13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   92 (477)
T 2id5_A           13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL   92 (477)
T ss_dssp             TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence            56777752          13688999999999988888999999999999999999988899999999999999999999


Q ss_pred             cccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       128 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      ++..+..|.++++|++|+|++|++++..|..+..+++|+.|++++|.+++..|.. ..+..+..+.+.+|.
T Consensus        93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  163 (477)
T 2id5_A           93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN  163 (477)
T ss_dssp             CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred             CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence            8655566889999999999999999888889999999999999999998876643 334555556665553

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.50  E-value=4.1e-14  Score=133.97  Aligned_cols=129  Identities=25%  Similarity=0.223  Sum_probs=113.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+++..+..+..+++|++|+|++|.+++. |.. +.+++|+.|++++|+++ .+|..+..+++|++|+|
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l  107 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence            4689999999999998889999999999999999999964 433 78999999999999998 78999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLN  198 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~  198 (447)
                      ++|++++..|..|..+++|+.|++++|++++..+.. ..+..+..+.+.+|..
T Consensus       108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  160 (290)
T 1p9a_G          108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL  160 (290)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred             CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence            999999888889999999999999999999776654 3456777777777753

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.50  E-value=2.4e-14  Score=127.50  Aligned_cols=124  Identities=17%  Similarity=0.256  Sum_probs=60.2

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      ++.|+|++|.+. .+| .+..+++|++|++++|.++  .++.+..+++|++|++++|++++..|..++.+++|++|++++
T Consensus        46 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~  121 (197)
T 4ezg_A           46 LTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH  121 (197)
T ss_dssp             CCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred             ccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence            455555555554 333 3555555555555555433  223455555555555555555544455555555555555555


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      |++++..|..+..+++|+.|++++|.+.+.+|....+..+..+.+.+|
T Consensus       122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A          122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD  169 (197)
T ss_dssp             SBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTB
T ss_pred             CccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCC
Confidence            555544455555555555555555542223333333333444444333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.50  E-value=1.3e-14  Score=141.83  Aligned_cols=135  Identities=22%  Similarity=0.247  Sum_probs=111.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|
T Consensus        64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  143 (361)
T 2xot_A           64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL  143 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence            57999999999999888888999999999999999999877778999999999999999999888999999999999999


Q ss_pred             cCccccccCchHH---hhcccccccccccccccccCCCC-CCCCc--cccccccccccccC
Q 013258          147 NNNSLSGLIPTSL---TTITSLNILDLSNNRLSGPVPDN-GSFSQ--FTPISFENNLNLCG  201 (447)
Q Consensus       147 ~~N~l~~~~p~~~---~~l~~L~~l~ls~N~l~g~~p~~-~~~~~--~~~~~~~~n~~lc~  201 (447)
                      ++|++++..+..+   ..+++|+.|++++|+|++..+.. ..+..  +..+.+.+|+..|.
T Consensus       144 ~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             CSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             CCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence            9999997555555   67899999999999998644321 11221  24456777776664

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.50  E-value=2.9e-14  Score=148.76  Aligned_cols=129  Identities=22%  Similarity=0.221  Sum_probs=77.6

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .++.++++++.+.+..+..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..|+++++|++|+|+
T Consensus        52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  131 (597)
T 3oja_B           52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE  131 (597)
T ss_dssp             CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence            34556666666654444445566666666666666666555566666666666666666666555556666666666666


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCC-CCCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n  196 (447)
                      +|.+++.++..|+.+++|+.|++++|.+++.+|. ...+..+..+.+.+|
T Consensus       132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  181 (597)
T 3oja_B          132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN  181 (597)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred             CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence            6666654444456666666666666666665553 233444444444444

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.50  E-value=3.7e-14  Score=126.31  Aligned_cols=127  Identities=17%  Similarity=0.247  Sum_probs=109.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.  .++.+..+++|++|++++|.+++..|..++.+++|++|++++|++++..|..++.+++|++|++
T Consensus        66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  143 (197)
T 4ezg_A           66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL  143 (197)
T ss_dssp             TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred             CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence            47999999999654  4568999999999999999999888999999999999999999999888999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|.+.+.+| .+..+++|+.|++++|.+++. +....+..++.+.+.+|.
T Consensus       144 ~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             CSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-TTGGGCSSCCEEEECBC-
T ss_pred             cCCCCccccH-hhcCCCCCCEEECCCCCCcCh-HHhccCCCCCEEEeeCcc
Confidence            9998444566 689999999999999999873 444456677777777764

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.49  E-value=7.6e-14  Score=130.96  Aligned_cols=114  Identities=23%  Similarity=0.284  Sum_probs=82.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|..+.++++|+.|++++|++++..+..++.+++|++|++
T Consensus        52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  131 (276)
T 2z62_A           52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV  131 (276)
T ss_dssp             TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred             cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence            45777777777777666666777777777777777777666677777777777777777777655556777777777777


Q ss_pred             cCcccccc-CchHHhhcccccccccccccccccCC
Q 013258          147 NNNSLSGL-IPTSLTTITSLNILDLSNNRLSGPVP  180 (447)
Q Consensus       147 ~~N~l~~~-~p~~~~~l~~L~~l~ls~N~l~g~~p  180 (447)
                      ++|++++. +|..+..+++|+.|++++|++++..+
T Consensus       132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A          132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             cCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            77777653 57777777777777777777776543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.49  E-value=5e-14  Score=141.94  Aligned_cols=130  Identities=19%  Similarity=0.261  Sum_probs=106.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+++..+..+.++++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..+.++++|++|+|
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  154 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL  154 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence            36899999999999988999999999999999999999888899999999999999999999766677999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC--CCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n  196 (447)
                      ++|++++..+..+..+++|+.|++++|+..+.+|..  ..+..+..+.+.+|
T Consensus       155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n  206 (452)
T 3zyi_A          155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC  206 (452)
T ss_dssp             CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTS
T ss_pred             CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCC
Confidence            999999777777777778888888775444444432  23344444455444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.48  E-value=5.8e-14  Score=146.94  Aligned_cols=135  Identities=21%  Similarity=0.329  Sum_probs=119.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccC-CCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLS-GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      ..+..++++.|.+.+..+..+..++.|+.|+|++|.+. +.+|..|..+++|+.|+|++|++++..|..|.++++|++|+
T Consensus       445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~  524 (635)
T 4g8a_A          445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN  524 (635)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence            35778899999999888888999999999999999854 56788899999999999999999998899999999999999


Q ss_pred             CcCccccccCchHHhhcccccccccccccccccCCCCC-CC-CccccccccccccccC
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-SF-SQFTPISFENNLNLCG  201 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~-~~-~~~~~~~~~~n~~lc~  201 (447)
                      |++|++++..|..+..+++|+.||+++|++++.+|+.. .+ .+++.+++.+|+..|.
T Consensus       525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            99999999999999999999999999999999888753 23 5677788999998874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.48  E-value=1.7e-14  Score=155.45  Aligned_cols=130  Identities=22%  Similarity=0.339  Sum_probs=116.5

Q ss_pred             CCEEEEEcCCCCccc-----------------ccccccc--CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCc-
Q 013258           67 GSVTRVDLGNAALSG-----------------ELAPELG--QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL-  126 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g-----------------~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-  126 (447)
                      .+++.|+|++|.++|                 .+|+.++  +|++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ 
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~  527 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG  527 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence            579999999999999                 4999988  99999999999999999999999999999999999998 


Q ss_pred             ccc-cCCccccCCC-------CCCeeeCcCccccccCch--HHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          127 FNG-TIPDTLANLK-------QLKYLRLNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       127 l~g-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      ++| .+|..+++++       +|+.|+|++|+++ .+|.  .++.+++|+.|++++|.++ .+|..+.+..+..+.+.+|
T Consensus       528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N  605 (876)
T 4ecn_A          528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN  605 (876)
T ss_dssp             SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred             cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence            998 8998777666       9999999999999 7888  9999999999999999999 8886666677777777776


Q ss_pred             cc
Q 013258          197 LN  198 (447)
Q Consensus       197 ~~  198 (447)
                      ..
T Consensus       606 ~l  607 (876)
T 4ecn_A          606 QI  607 (876)
T ss_dssp             CC
T ss_pred             cc
Confidence            53

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.48  E-value=2.1e-14  Score=152.74  Aligned_cols=109  Identities=27%  Similarity=0.426  Sum_probs=66.2

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      ++.|+|++|.+. .+|+.+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|++
T Consensus       226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~  302 (727)
T 4b8c_D          226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD  302 (727)
T ss_dssp             CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS
T ss_pred             CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC
Confidence            445555665555 45555556666666666666666 55666666666666666666666 5566666666666666666


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      |.++ .+|..|+.+++|+.|+|++|.|++.+|.
T Consensus       303 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~  334 (727)
T 4b8c_D          303 NMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK  334 (727)
T ss_dssp             SCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred             CCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence            6664 4455566666666666666666655554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.47  E-value=2.5e-14  Score=155.23  Aligned_cols=130  Identities=28%  Similarity=0.348  Sum_probs=99.8

Q ss_pred             CEEEEEcCCCCccccccc-cccCCCCCCEEECCCCccC-----CCCChhhcCCCCCcEEEccCCcccccCCccccCCCCC
Q 013258           68 SVTRVDLGNAALSGELAP-ELGQLKNLELLELYGNNLS-----GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL  141 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~-~l~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L  141 (447)
                      +++.|+|++|.+++..+. .+..+++|+.|+|++|.++     +..|..|.++++|+.|+|++|++++..|..+.++++|
T Consensus       427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  506 (844)
T 3j0a_A          427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL  506 (844)
T ss_dssp             TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred             ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence            466666666666654332 2445677777777777776     3445567888899999999999988888888899999


Q ss_pred             CeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccC
Q 013258          142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       142 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +.|+|++|++++..|..+.  ++|+.|++++|++++.+|+.  +..+..+++.+|+..|.
T Consensus       507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE  562 (844)
T ss_dssp             SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred             heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence            9999999999887766655  78999999999999888864  56778888999988884

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=7.3e-14  Score=135.60  Aligned_cols=109  Identities=25%  Similarity=0.237  Sum_probs=95.3

Q ss_pred             CccceeEeCCCCCEEEEEcCCC-CccccccccccCCCCCCEEECCC-CccCCCCChhhcCCCCCcEEEccCCcccccCCc
Q 013258           56 CTWFHITCNPEGSVTRVDLGNA-ALSGELAPELGQLKNLELLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD  133 (447)
Q Consensus        56 c~w~gv~c~~~~~v~~l~L~~~-~l~g~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~  133 (447)
                      |.|..|.|.           ++ ++++ +|+ |..+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++..|.
T Consensus         8 C~~~~v~~~-----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCT-----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECC-----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcC-----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            777766664           44 6664 788 99999999999996 999988888999999999999999999998888


Q ss_pred             cccCCCCCCeeeCcCccccccCchHHhhccccccccccccccccc
Q 013258          134 TLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       134 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      .|.++++|+.|+|++|+|++..|..+..++ |+.|++++|++...
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            999999999999999999987776666665 99999999999864

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.47  E-value=1.7e-13  Score=132.21  Aligned_cols=139  Identities=22%  Similarity=0.282  Sum_probs=116.4

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |.|..+.|...          ..++.|+|++|.+.+..|..+.++++|++|+|++|.+++..|..|.++++|++|++++|
T Consensus        33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  112 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN  112 (332)
T ss_dssp             EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred             ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence            67999998632          36899999999999888889999999999999999999888999999999999999999


Q ss_pred             cccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccc--cCCCCCCCCccccccccccc
Q 013258          126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG--PVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       126 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g--~~p~~~~~~~~~~~~~~~n~  197 (447)
                      +++ .+|..+.  ++|++|++++|++++..+..+..+++|+.|++++|.++.  ..|.......+..+.+.+|.
T Consensus       113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~  183 (332)
T 2ft3_A          113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK  183 (332)
T ss_dssp             CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSB
T ss_pred             cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCC
Confidence            998 6787765  899999999999998777789999999999999999963  44443221155555565554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.47  E-value=2.9e-14  Score=151.77  Aligned_cols=110  Identities=21%  Similarity=0.269  Sum_probs=67.6

Q ss_pred             cccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcc
Q 013258           84 APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT  163 (447)
Q Consensus        84 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~  163 (447)
                      +..+..+.+|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..++.++
T Consensus       217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  293 (727)
T 4b8c_D          217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF  293 (727)
T ss_dssp             -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred             hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence            445666666777777777666 56666666677777777777766 66666666777777777777766 5566666666


Q ss_pred             cccccccccccccccCCC-CCCCCccccccccccc
Q 013258          164 SLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       164 ~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      +|+.|+|++|.|+ .+|. .+.+..+..+.+.+|.
T Consensus       294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~  327 (727)
T 4b8c_D          294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNP  327 (727)
T ss_dssp             TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSC
T ss_pred             CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCc
Confidence            7777777777665 3443 3344455555555543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.46  E-value=8.4e-14  Score=137.42  Aligned_cols=131  Identities=21%  Similarity=0.223  Sum_probs=100.6

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+++++.+....+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..|..++++++|++|+|
T Consensus        45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  124 (390)
T 3o6n_A           45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  124 (390)
T ss_dssp             CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence            35677888888877544444678888888888888888777778888888888888888888777777888888888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      ++|+++...+..+..+++|+.|++++|.+++..|.. ..+..++.+.+.+|.
T Consensus       125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~  176 (390)
T 3o6n_A          125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR  176 (390)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSC
T ss_pred             CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCc
Confidence            888888655555678888888888888888766642 345566666666654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.46  E-value=1e-13  Score=143.53  Aligned_cols=129  Identities=24%  Similarity=0.314  Sum_probs=66.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCC-hhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIP-SALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.+.+..+. +..+++|++|++++|.+.+..| ..+.++++|+.|++++|.+.+..|..+.++++|++|+
T Consensus       373 ~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  451 (570)
T 2z63_A          373 TSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK  451 (570)
T ss_dssp             SCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred             CccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence            3566666666666543332 5555555555555555554433 3445555555555555555555555555555555555


Q ss_pred             CcCcccc-ccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          146 LNNNSLS-GLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       146 l~~N~l~-~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                      +++|.++ +.+|..+..+++|+.|++++|++++..|.. ..+..+..+.+.+|
T Consensus       452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  504 (570)
T 2z63_A          452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN  504 (570)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence            5555554 344555555555555555555555544432 22334444444444

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.46  E-value=8.8e-14  Score=144.03  Aligned_cols=126  Identities=19%  Similarity=0.194  Sum_probs=108.3

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            57999999999999888889999999999999999999888999999999999999999998 67877  8999999999


Q ss_pred             cCccccc-cCchHHhhcccccccccccccccccCCCCCCCCcc--ccccccccc
Q 013258          147 NNNSLSG-LIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF--TPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~-~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~--~~~~~~~n~  197 (447)
                      ++|++++ .+|..++++++|+.|++++|.+++.  ....+..+  +.+.+.+|.
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~  180 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVS  180 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESS
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeeccc
Confidence            9999987 4578999999999999999999863  22223333  555555553

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.46  E-value=1.5e-13  Score=131.86  Aligned_cols=130  Identities=18%  Similarity=0.162  Sum_probs=75.0

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhc-CCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALG-NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .++.|+|++|.+++..+..+..+++|++|+|++|.+++..|..+. .+++|+.|+|++|.+++. |. ...+++|++|+|
T Consensus       121 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~L  198 (317)
T 3o53_A          121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDL  198 (317)
T ss_dssp             SCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEEC
T ss_pred             CCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEEC
Confidence            455666666666655555566666666666666666655555543 566666666666666543 22 223666666666


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC  200 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc  200 (447)
                      ++|++++. |..+..+++|+.|++++|++++..+....+..+..+.+.+|+..|
T Consensus       199 s~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~  251 (317)
T 3o53_A          199 SSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC  251 (317)
T ss_dssp             CSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBH
T ss_pred             CCCcCCcc-hhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccC
Confidence            66666643 334666666666666666666433333344455555555555443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.46  E-value=1.4e-13  Score=145.78  Aligned_cols=130  Identities=25%  Similarity=0.246  Sum_probs=106.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..++++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            46889999999998877778899999999999999999888888999999999999999998544446888999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                      ++|++++..|..++.+++|+.|++++|.+++..|.. ..+..++.+.+.+|
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  155 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN  155 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence            999998877788888999999999999988876653 23445555555444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.45  E-value=1e-13  Score=127.31  Aligned_cols=129  Identities=22%  Similarity=0.259  Sum_probs=108.6

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCc-cCCCCChhhcCCCCCcEEEccC-CcccccCCccccCCCCCCee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNN-LSGHIPSALGNLIKLKSLDLYS-NLFNGTIPDTLANLKQLKYL  144 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L  144 (447)
                      ..++.|+|++|++++..+..+..+++|++|++++|. +++..+..|.++++|++|++++ |++++..+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            478999999999998777789999999999999997 8866666899999999999998 99997667789999999999


Q ss_pred             eCcCccccccCchHHhhccccc---ccccccc-cccccCCCC-CCCCccc-cccccccc
Q 013258          145 RLNNNSLSGLIPTSLTTITSLN---ILDLSNN-RLSGPVPDN-GSFSQFT-PISFENNL  197 (447)
Q Consensus       145 ~l~~N~l~~~~p~~~~~l~~L~---~l~ls~N-~l~g~~p~~-~~~~~~~-~~~~~~n~  197 (447)
                      ++++|++++ +|. +..+++|+   .|++++| .+++..+.. ..+..+. .+.+.+|.
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~  167 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG  167 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence            999999987 666 88888888   9999999 888766542 3455666 66666653

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.45  E-value=1.1e-13  Score=117.20  Aligned_cols=104  Identities=25%  Similarity=0.282  Sum_probs=94.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccccc-CCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT-IPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.+++.  +.+..+++|++|+|++|.+++.+|..+..+++|+.|++++|.+++. .|..++.+++|++|+
T Consensus        42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~  119 (149)
T 2je0_A           42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD  119 (149)
T ss_dssp             TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred             CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence            5799999999999976  7899999999999999999988999888999999999999999863 458899999999999


Q ss_pred             CcCccccccCc---hHHhhccccccccccc
Q 013258          146 LNNNSLSGLIP---TSLTTITSLNILDLSN  172 (447)
Q Consensus       146 l~~N~l~~~~p---~~~~~l~~L~~l~ls~  172 (447)
                      +++|++++..+   ..+..+++|+.||+++
T Consensus       120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99999998766   5899999999999874

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.44  E-value=1.7e-13  Score=118.63  Aligned_cols=110  Identities=25%  Similarity=0.254  Sum_probs=98.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccccc-CCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT-IPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~-~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.+++.  +.+..+++|++|+|++|.+++.+|..+.++++|+.|++++|.+++. .+..+..+++|++|+
T Consensus        49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~  126 (168)
T 2ell_A           49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD  126 (168)
T ss_dssp             GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred             CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence            4689999999999876  7899999999999999999988999888899999999999999853 227899999999999


Q ss_pred             CcCccccccCc---hHHhhccccccccccccccccc
Q 013258          146 LNNNSLSGLIP---TSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       146 l~~N~l~~~~p---~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      +++|.+++..+   ..+..+++|+.|++++|.+...
T Consensus       127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             eeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            99999997665   5889999999999999998753

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.44  E-value=8.8e-14  Score=145.24  Aligned_cols=115  Identities=26%  Similarity=0.302  Sum_probs=78.5

Q ss_pred             CCEEEEEcCCCCcccccccc-ccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccccc---CCccccCCCCCC
Q 013258           67 GSVTRVDLGNAALSGELAPE-LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT---IPDTLANLKQLK  142 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~---~p~~~~~l~~L~  142 (447)
                      ..++.|+|++|.+.+..++. +..+++|+.|++++|.+++..|..+..+++|+.|++++|++++.   .+..+..+++|+
T Consensus       400 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~  479 (606)
T 3t6q_A          400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE  479 (606)
T ss_dssp             TTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCC
T ss_pred             ccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCcc
Confidence            35677777777777665544 66777777777777777766676777777777777777777652   234566677777


Q ss_pred             eeeCcCccccccCchHHhhcccccccccccccccccCCC
Q 013258          143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       143 ~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      +|++++|++++..|..+..+++|+.|++++|++++.+|+
T Consensus       480 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  518 (606)
T 3t6q_A          480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE  518 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGG
T ss_pred             EEECCCCccCccChhhhccccCCCEEECCCCccCcCChh
Confidence            777777777766666677777777777777777665553

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.44  E-value=1.8e-13  Score=142.83  Aligned_cols=112  Identities=22%  Similarity=0.207  Sum_probs=103.8

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+.+..|..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus        75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence            36899999999999988889999999999999999999988888999999999999999999655555799999999999


Q ss_pred             cCccccccCchHHhhccccccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      ++|.+++.+|..+..+++|+.|++++|.+++.
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            99999999999999999999999999999875

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.44  E-value=2.4e-13  Score=136.48  Aligned_cols=139  Identities=20%  Similarity=0.302  Sum_probs=108.7

Q ss_pred             cceeEeCC----------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcc
Q 013258           58 WFHITCNP----------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLF  127 (447)
Q Consensus        58 w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  127 (447)
                      |..|.|..          ...++.|+|++|.+.+..+..+.++++|++|+|++|.+++..|..|.++++|+.|+|++|++
T Consensus        45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l  124 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL  124 (440)
T ss_dssp             SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred             CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence            55677753          13578899999999988888899999999999999999987778899999999999999999


Q ss_pred             cccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC--CCCCcccccccccc
Q 013258          128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN--GSFSQFTPISFENN  196 (447)
Q Consensus       128 ~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n  196 (447)
                      ++..+..+..+++|++|+|++|+++...+..+..+++|+.|++++|+..+.+|..  ..+..+..+.+.+|
T Consensus       125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n  195 (440)
T 3zyj_A          125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC  195 (440)
T ss_dssp             SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTS
T ss_pred             CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCC
Confidence            8665667889999999999999998777777778888888888875544444432  23444555555544

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.44  E-value=3.1e-13  Score=130.19  Aligned_cols=140  Identities=22%  Similarity=0.373  Sum_probs=116.1

Q ss_pred             CCccceeEeCC----------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           55 LCTWFHITCNP----------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        55 ~c~w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      .|.|..+.|..          ...++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|++++
T Consensus        30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  109 (330)
T 1xku_A           30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK  109 (330)
T ss_dssp             EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence            35789898863          13688999999999988777899999999999999999988899999999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccc--cCCCC-CCCCccccccccccc
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG--PVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g--~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      |+++ .+|..+.  ++|++|++++|++++..+..+..+++|+.|++++|.++.  ..+.. ..+..+..+.+.+|.
T Consensus       110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            9998 6787664  789999999999998888889999999999999999964  33322 234455555555553

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.44  E-value=5.6e-14  Score=134.45  Aligned_cols=109  Identities=21%  Similarity=0.275  Sum_probs=72.9

Q ss_pred             CCEEEEEcCCCCccccccccc--cCCCCCCEEECCCCccCCCCChhhcCC-----CCCcEEEccCCcccccCCccccCCC
Q 013258           67 GSVTRVDLGNAALSGELAPEL--GQLKNLELLELYGNNLSGHIPSALGNL-----IKLKSLDLYSNLFNGTIPDTLANLK  139 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~ls~N~l~g~~p~~~~~l~  139 (447)
                      .+++.|+|++|.++|.+|..+  ..+++|++|+|++|.+++. |..++.+     ++|++|+|++|++++..|..++.++
T Consensus        95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~  173 (312)
T 1wwl_A           95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP  173 (312)
T ss_dssp             SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred             CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence            356777777777777777665  6677777777777777765 6666665     6777777777777666556677777


Q ss_pred             CCCeeeCcCcccccc--CchHH--hhccccccccccccccc
Q 013258          140 QLKYLRLNNNSLSGL--IPTSL--TTITSLNILDLSNNRLS  176 (447)
Q Consensus       140 ~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~l~ls~N~l~  176 (447)
                      +|++|+|++|++.+.  +|..+  ..+++|+.|++++|.++
T Consensus       174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  214 (312)
T 1wwl_A          174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME  214 (312)
T ss_dssp             SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred             CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence            777777777776554  23333  55666666666666666

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.43  E-value=1.2e-13  Score=120.62  Aligned_cols=124  Identities=20%  Similarity=0.212  Sum_probs=90.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCC-CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLK-NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      ..++.|+|++|.+.. +| .+..+. +|+.|+|++|.+++.  ..+..+++|++|++++|++++..|..+..+++|++|+
T Consensus        19 ~~L~~L~l~~n~l~~-i~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   94 (176)
T 1a9n_A           19 VRDRELDLRGYKIPV-IE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   94 (176)
T ss_dssp             TSCEEEECTTSCCCS-CC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CCceEEEeeCCCCch-hH-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence            367888888888884 44 455555 888999998888864  5788888899999999988854334458888889999


Q ss_pred             CcCccccccCch--HHhhcccccccccccccccccCCC-----CCCCCcccccccccc
Q 013258          146 LNNNSLSGLIPT--SLTTITSLNILDLSNNRLSGPVPD-----NGSFSQFTPISFENN  196 (447)
Q Consensus       146 l~~N~l~~~~p~--~~~~l~~L~~l~ls~N~l~g~~p~-----~~~~~~~~~~~~~~n  196 (447)
                      +++|+++ .+|.  .+..+++|+.|++++|.++.. |.     ...+..+..+++.+|
T Consensus        95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n  150 (176)
T 1a9n_A           95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKV  150 (176)
T ss_dssp             CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEEC
T ss_pred             CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcC
Confidence            9988885 4565  778888888889988888743 33     223444444444444

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.42  E-value=3.5e-13  Score=138.08  Aligned_cols=129  Identities=22%  Similarity=0.304  Sum_probs=99.0

Q ss_pred             CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCC--CCChhhcCCCCCcEEEccCCcccccCCcc-ccCCCCCC
Q 013258           66 EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG--HIPSALGNLIKLKSLDLYSNLFNGTIPDT-LANLKQLK  142 (447)
Q Consensus        66 ~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~  142 (447)
                      ...++.|+|++|.+++.+|..+..+++|+.|+|++|++++  .+|..+..+++|+.|++++|.+++.+|.. +..+++|+
T Consensus       323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            3568899999999998888888999999999999999986  56778888999999999999998767764 67778888


Q ss_pred             eeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       143 ~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      +|++++|++++.+|..+.  ++|+.|++++|+++ .+|. ...+..+..+.+.+|.
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~  455 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ  455 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCc
Confidence            888888888776665543  56777777777777 4443 3345556666666654

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.41  E-value=5e-13  Score=116.02  Aligned_cols=101  Identities=21%  Similarity=0.263  Sum_probs=89.1

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |+|..+.|...          ..++.|+|++|.+++..|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus         9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A            9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            56777877531          36889999999999988999999999999999999999877777899999999999999


Q ss_pred             cccccCCccccCCCCCCeeeCcCccccccCc
Q 013258          126 LFNGTIPDTLANLKQLKYLRLNNNSLSGLIP  156 (447)
Q Consensus       126 ~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p  156 (447)
                      ++++..|..+..+++|++|+|++|.++...+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            9997666679999999999999999987543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.41  E-value=2.5e-13  Score=140.57  Aligned_cols=129  Identities=18%  Similarity=0.243  Sum_probs=80.7

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  108 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence            56667777777766666666677777777777777666556666667777777777777665555666666666666666


Q ss_pred             CccccccCchHHhhcccccccccccccccc-cCCCC-CCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSG-PVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~-~~~~~~~~~~~~~n  196 (447)
                      +|++++..+..++.+++|+.|++++|.+++ .+|.. +.+..++.+++.+|
T Consensus       109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n  159 (570)
T 2z63_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (570)
T ss_dssp             TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTS
T ss_pred             ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCC
Confidence            666665444456666666666666666665 33432 22344444444444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.41  E-value=4.4e-13  Score=132.23  Aligned_cols=127  Identities=21%  Similarity=0.208  Sum_probs=109.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCcc-ccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDT-LANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.+.+..+..+..+++|++|+|++|.+++..|..++++++|++|++++|+++. +|.. +.++++|++|+
T Consensus        69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred             ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc-CCHHHhcCCCCCcEEE
Confidence            468999999999998888899999999999999999998888889999999999999999994 5554 68999999999


Q ss_pred             CcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      +++|++++..|..+..+++|+.|++++|.+++..  ...+..+..+.+.+|
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n  196 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYN  196 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSS
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccc
Confidence            9999999988888999999999999999998752  233455555555554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.40  E-value=2.3e-13  Score=137.97  Aligned_cols=130  Identities=19%  Similarity=0.210  Sum_probs=96.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..|..+.++++|++|+|++|.+++..+..|.++++|+.|+|++|++++..|..+..+++|++|+|
T Consensus        56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l  135 (477)
T 2id5_A           56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV  135 (477)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred             CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence            46888888888888877888888888888888888888655556788888888888888888777777888888888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCC-CCCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n  196 (447)
                      ++|.+++..|..+..+++|+.|++++|.+++..+. ...+..+..+.+.+|
T Consensus       136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n  186 (477)
T 2id5_A          136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL  186 (477)
T ss_dssp             CCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESC
T ss_pred             CCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCC
Confidence            88888777777777777788888888877754332 122334444444443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.40  E-value=1.3e-13  Score=132.01  Aligned_cols=108  Identities=21%  Similarity=0.277  Sum_probs=57.5

Q ss_pred             EEEEEcCCCCc-ccccccccc-------CCCCCCEEECCCCccCCCCChhh--cCCCCCcEEEccCCcccccCCccccCC
Q 013258           69 VTRVDLGNAAL-SGELAPELG-------QLKNLELLELYGNNLSGHIPSAL--GNLIKLKSLDLYSNLFNGTIPDTLANL  138 (447)
Q Consensus        69 v~~l~L~~~~l-~g~~~~~l~-------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~ls~N~l~g~~p~~~~~l  138 (447)
                      ++.|+|++|.+ .+.+|..+.       ++++|++|+|++|.+++.+|..+  ..+++|++|+|++|++++. |..++.+
T Consensus        65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l  143 (312)
T 1wwl_A           65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL  143 (312)
T ss_dssp             HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred             HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence            44555555555 234444443       45555555555555555555544  5555555555555555543 5444444


Q ss_pred             -----CCCCeeeCcCccccccCchHHhhcccccccccccccccc
Q 013258          139 -----KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       139 -----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                           ++|++|+|++|++++..|..++.+++|+.|++++|++.|
T Consensus       144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  187 (312)
T 1wwl_A          144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG  187 (312)
T ss_dssp             HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred             HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence                 555555555555555555555555555555555555544

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.39  E-value=8.9e-13  Score=132.27  Aligned_cols=130  Identities=22%  Similarity=0.264  Sum_probs=105.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|+++...+..+.++++|++|+|
T Consensus        88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l  167 (440)
T 3zyj_A           88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL  167 (440)
T ss_dssp             SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence            47899999999999888888999999999999999999766678999999999999999998766667888888999999


Q ss_pred             cCcc-ccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNS-LSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~-l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|+ +....+..+..+++|+.|++++|.++ .+|....+..+..+++.+|.
T Consensus       168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~  218 (440)
T 3zyj_A          168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNH  218 (440)
T ss_dssp             CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSC
T ss_pred             CCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCc
Confidence            8854 44444446788888888888888887 45665556666666666663

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.39  E-value=2e-13  Score=140.57  Aligned_cols=132  Identities=25%  Similarity=0.392  Sum_probs=94.0

Q ss_pred             CCCCCCCCCCC-----cccee-EeCCCCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcE
Q 013258           46 QSWDNLPGNLC-----TWFHI-TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKS  119 (447)
Q Consensus        46 ~~w~~~~~~~c-----~w~gv-~c~~~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  119 (447)
                      .+|.. ...+|     .|.|+ .|. .++++.|+|++|.+++ +|+.+.  ++|++|+|++|.|+ .+|   ..+++|+.
T Consensus        34 ~~W~~-~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~  104 (571)
T 3cvr_A           34 DKWEK-QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY  104 (571)
T ss_dssp             HHHHT-TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred             HHHhc-cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence            35754 45778     79999 686 3478999999999987 777663  77888888888888 577   45678888


Q ss_pred             EEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          120 LDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       120 L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      |+|++|++++ +|. +.+  +|++|+|++|++++ +|.   .+++|+.|++++|.+++ +|.  .+..+..+.+++|.
T Consensus       105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSC
T ss_pred             EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCC
Confidence            8888888875 676 554  77778888777776 554   46677777777777776 444  34455555555553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.39  E-value=7.9e-13  Score=133.12  Aligned_cols=130  Identities=19%  Similarity=0.234  Sum_probs=104.3

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+..+..+++|++|+|++|.+++..+..|.++++|+.|+|++|++++..+..+.++++|+.|++
T Consensus        99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  178 (452)
T 3zyi_A           99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL  178 (452)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence            46899999999999988889999999999999999999777777999999999999999999666667888888888888


Q ss_pred             cCc-cccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNN-SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N-~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++| .+....+..+..+++|+.|++++|++++ +|....+..+..+++.+|.
T Consensus       179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~  229 (452)
T 3zyi_A          179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH  229 (452)
T ss_dssp             CCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECTTSC
T ss_pred             CCCCCccccChhhccCCCCCCEEECCCCcccc-cccccccccccEEECcCCc
Confidence            884 4444444467778888888888888875 3555555566666555553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.39  E-value=3.1e-13  Score=138.49  Aligned_cols=127  Identities=19%  Similarity=0.231  Sum_probs=82.2

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccc--cCCccccCCCCCCeee
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG--TIPDTLANLKQLKYLR  145 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~  145 (447)
                      +++.|++++|.+.+...  ...+++|++|++++|.+++.+|..++++++|+.|++++|++++  .+|..++.+++|++|+
T Consensus       303 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~  380 (520)
T 2z7x_B          303 NIKNFTVSGTRMVHMLC--PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD  380 (520)
T ss_dssp             CCSEEEEESSCCCCCCC--CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred             ceeEEEcCCCccccccc--hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence            46677777776654321  1466777777777777777677777777777777777777765  4556677777777777


Q ss_pred             CcCccccccCch-HHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          146 LNNNSLSGLIPT-SLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       146 l~~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      +++|++++.+|. .+..+++|+.|++++|.+++.+|.... ..+..+++++|.
T Consensus       381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~  432 (520)
T 2z7x_B          381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNK  432 (520)
T ss_dssp             CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSC
T ss_pred             CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCCc
Confidence            777777764454 356666777777777777766554321 345555555553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.39  E-value=2.6e-13  Score=137.88  Aligned_cols=30  Identities=20%  Similarity=0.022  Sum_probs=26.1

Q ss_pred             HHHHHHHHHHHhcCCCCCccceeeEEecCC
Q 013258          336 ELQFQTEVKIISMAVHRNLLRLYGFCTTVT  365 (447)
Q Consensus       336 ~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  365 (447)
                      ..+|..|++.+++++|+|+|+++|||.+..
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            457999999999999999999999998764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.39  E-value=4.2e-13  Score=130.59  Aligned_cols=129  Identities=21%  Similarity=0.282  Sum_probs=110.6

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCc--cccCCCCCCee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYL  144 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L  144 (447)
                      .+++.|+|++|.+++..+..+.++++|++|+|++|.+++..+..+.++++|++|++++|+++ .+|.  .+.++++|++|
T Consensus        76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred             CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence            57999999999999988888999999999999999999755555999999999999999998 4665  78999999999


Q ss_pred             eCcCc-cccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          145 RLNNN-SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       145 ~l~~N-~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                      ++++| .+.+..|..+..+++|+.|++++|.+++..|.. ..+..+..+.+.+|
T Consensus       155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n  208 (353)
T 2z80_A          155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK  208 (353)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred             ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCC
Confidence            99999 477777888999999999999999999987754 34455666666555

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.39  E-value=2.8e-13  Score=124.28  Aligned_cols=129  Identities=18%  Similarity=0.232  Sum_probs=107.6

Q ss_pred             CCEEEEEcCCCC-ccccccccccCCCCCCEEECCC-CccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCC--
Q 013258           67 GSVTRVDLGNAA-LSGELAPELGQLKNLELLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLK--  142 (447)
Q Consensus        67 ~~v~~l~L~~~~-l~g~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~--  142 (447)
                      .+++.|+|++|. +++..+..+..+++|++|++++ |.+++..+..|.++++|+.|++++|++++ +|+ +..+++|+  
T Consensus        55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L  132 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF  132 (239)
T ss_dssp             TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred             CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence            479999999997 7766666899999999999998 99997777789999999999999999986 787 88888888  


Q ss_pred             -eeeCcCc-cccccCchHHhhccccc-ccccccccccccCCCCCCCCccccccccccc
Q 013258          143 -YLRLNNN-SLSGLIPTSLTTITSLN-ILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       143 -~L~l~~N-~l~~~~p~~~~~l~~L~-~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                       +|++++| .+++..+..+..+++|+ .|++++|.++...+.......+..+.+.+|.
T Consensus       133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred             cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence             9999999 99887777899999999 9999999998433333333456666676663

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.39  E-value=7e-13  Score=137.26  Aligned_cols=131  Identities=24%  Similarity=0.295  Sum_probs=105.5

Q ss_pred             CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCC--CCChhhcCCCCCcEEEccCCcccccCCcc-ccCCCCCC
Q 013258           66 EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG--HIPSALGNLIKLKSLDLYSNLFNGTIPDT-LANLKQLK  142 (447)
Q Consensus        66 ~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~l~~L~  142 (447)
                      ..+++.|+|++|.+++.+|..+..+++|+.|+|++|.+++  .+|..+.++++|+.|++++|++++.+|.. +..+++|+
T Consensus       352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~  431 (562)
T 3a79_B          352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL  431 (562)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred             CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence            3578999999999999899999999999999999999996  34567889999999999999999766654 77888899


Q ss_pred             eeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccc
Q 013258          143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  198 (447)
Q Consensus       143 ~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~  198 (447)
                      +|++++|++++.+|..+.  ++|+.|++++|+++...+....+..+..+.+.+|..
T Consensus       432 ~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l  485 (562)
T 3a79_B          432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL  485 (562)
T ss_dssp             EEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCC
T ss_pred             EEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCC
Confidence            999999998877776553  578888888888884333444566677777777653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.37  E-value=4.8e-13  Score=137.87  Aligned_cols=116  Identities=26%  Similarity=0.300  Sum_probs=105.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccc-cCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNG-TIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g-~~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.+++..|..+..+++|++|+|++|.+++..|..|+++++|++|++++|.+++ .+|..++++++|++|+
T Consensus        50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~  129 (549)
T 2z81_A           50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR  129 (549)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred             CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence            579999999999999888999999999999999999998777789999999999999999986 4678899999999999


Q ss_pred             CcCccccccCc-hHHhhcccccccccccccccccCCCC
Q 013258          146 LNNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDN  182 (447)
Q Consensus       146 l~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~  182 (447)
                      +++|++.+.+| ..+..+++|+.|++++|.+++.+|..
T Consensus       130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  167 (549)
T 2z81_A          130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS  167 (549)
T ss_dssp             EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT
T ss_pred             CCCCccccccCHhhhhcccccCeeeccCCcccccChhh
Confidence            99999555555 68999999999999999999987754

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.37  E-value=7.7e-13  Score=115.45  Aligned_cols=106  Identities=21%  Similarity=0.275  Sum_probs=94.3

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCc--cccCCCCCCeee
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD--TLANLKQLKYLR  145 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~--~~~~l~~L~~L~  145 (447)
                      +++.|+|++|.+++.  +.+..+++|++|+|++|.+++..|..+..+++|+.|++++|+++ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            799999999999975  68999999999999999999655555699999999999999996 6777  889999999999


Q ss_pred             CcCccccccCchH----Hhhcccccccccccccccc
Q 013258          146 LNNNSLSGLIPTS----LTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       146 l~~N~l~~~~p~~----~~~l~~L~~l~ls~N~l~g  177 (447)
                      +++|.++. +|..    +..+++|+.||+++|.+..
T Consensus       120 l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          120 ILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             CCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             ecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            99999985 5664    8999999999999998864

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.36  E-value=1.4e-12  Score=113.61  Aligned_cols=106  Identities=24%  Similarity=0.302  Sum_probs=92.1

Q ss_pred             CCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccccccc
Q 013258           93 LELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  172 (447)
Q Consensus        93 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~  172 (447)
                      -+.+++++|.++ .+|..+.  ++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            378999999997 6887775  8999999999999988899999999999999999999987777789999999999999


Q ss_pred             ccccccCCC-CCCCCccccccccccccccC
Q 013258          173 NRLSGPVPD-NGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       173 N~l~g~~p~-~~~~~~~~~~~~~~n~~lc~  201 (447)
                      |+|++..+. ...+..+..+.+.+|+..|.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            999987665 44567788888888876553

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.36  E-value=4.9e-13  Score=141.52  Aligned_cols=110  Identities=30%  Similarity=0.387  Sum_probs=57.6

Q ss_pred             CEEEEEcCCCCcc--ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccC----C----ccccC
Q 013258           68 SVTRVDLGNAALS--GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI----P----DTLAN  137 (447)
Q Consensus        68 ~v~~l~L~~~~l~--g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~----p----~~~~~  137 (447)
                      .++.|+|++|.+.  +.+|..+..+++|+.|+|++|.+++..|..+.++++|+.|++++|++++..    |    ..+.+
T Consensus       455 ~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~  534 (680)
T 1ziw_A          455 SLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG  534 (680)
T ss_dssp             TCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTT
T ss_pred             ccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcC
Confidence            4555666665554  345555556666666666666665544445555555555555555554321    1    12444


Q ss_pred             CCCCCeeeCcCccccccCchHHhhcccccccccccccccc
Q 013258          138 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       138 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      +++|+.|+|++|+++...+..|..+++|+.|++++|++++
T Consensus       535 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~  574 (680)
T 1ziw_A          535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT  574 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCc
Confidence            5555555555555553333344555555555555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.36  E-value=2.2e-13  Score=130.12  Aligned_cols=131  Identities=17%  Similarity=0.110  Sum_probs=94.9

Q ss_pred             CCEEEEEcCCCCcccccc----ccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccccc--CC--ccccCC
Q 013258           67 GSVTRVDLGNAALSGELA----PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT--IP--DTLANL  138 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~--~p--~~~~~l  138 (447)
                      .+++.|+|++|.+++..+    ..+..+++|++|+|++|.+++..|..++.+++|++|+|++|++.+.  ++  ..++.+
T Consensus       117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l  196 (310)
T 4glp_A          117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF  196 (310)
T ss_dssp             BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred             CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence            457888888888887554    3445788888888888888877778888888888888888887642  22  234678


Q ss_pred             CCCCeeeCcCccccccCch----HHhhcccccccccccccccccCCCC-CCC---Ccccccccccccc
Q 013258          139 KQLKYLRLNNNSLSGLIPT----SLTTITSLNILDLSNNRLSGPVPDN-GSF---SQFTPISFENNLN  198 (447)
Q Consensus       139 ~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~l~ls~N~l~g~~p~~-~~~---~~~~~~~~~~n~~  198 (447)
                      ++|++|+|++|+++. +|.    .+..+++|+.||+++|.+++..|.. ..+   ..+..+.+++|..
T Consensus       197 ~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l  263 (310)
T 4glp_A          197 PAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGL  263 (310)
T ss_dssp             CCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCC
T ss_pred             CCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCC
Confidence            888888888888863 233    2467788888888888888875533 333   4666666666643

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.35  E-value=2.2e-12  Score=122.02  Aligned_cols=122  Identities=34%  Similarity=0.454  Sum_probs=87.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+  +..+++|++|+|++|.+++ +| .+..+++|+.|++++|++++ + +.+..+++|+.|++
T Consensus        68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l  141 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL  141 (291)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred             CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence            467888888888876444  7788888888888888875 33 47778888888888888774 3 45777778888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++.  ..+..+++|+.|++++|.+++..| ...+..+..+.+.+|.
T Consensus       142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCc
Confidence            88887764  467777778888888887776554 4445556666665553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.34  E-value=2.4e-12  Score=121.77  Aligned_cols=101  Identities=31%  Similarity=0.429  Sum_probs=49.3

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      ++.|++++|.+.+.  +.+..+++|++|+|++|.+++..|  +.++++|+.|++++|.+++ +| .+..+++|++|++++
T Consensus        48 L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~  121 (291)
T 1h6t_A           48 IDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH  121 (291)
T ss_dssp             CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred             ccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCC
Confidence            44555555554432  224455555555555555553222  5555555555555555543 22 245555555555555


Q ss_pred             ccccccCchHHhhcccccccccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      |++++.  ..+..+++|+.|++++|.+++
T Consensus       122 n~i~~~--~~l~~l~~L~~L~l~~n~l~~  148 (291)
T 1h6t_A          122 NGISDI--NGLVHLPQLESLYLGNNKITD  148 (291)
T ss_dssp             SCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred             CcCCCC--hhhcCCCCCCEEEccCCcCCc
Confidence            555432  234455555555555555544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.34  E-value=5e-13  Score=127.64  Aligned_cols=128  Identities=20%  Similarity=0.194  Sum_probs=103.0

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCC--C--ChhhcCCCCCcEEEccCCcccccCCc----cccCC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGH--I--PSALGNLIKLKSLDLYSNLFNGTIPD----TLANL  138 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~ls~N~l~g~~p~----~~~~l  138 (447)
                      .+++.|+|++|.+.+..+..+..+++|++|+|++|++.+.  +  +..++.+++|++|+|++|+++ .+|.    .++++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence            4789999999999988888999999999999999998752  2  223468899999999999997 3343    25678


Q ss_pred             CCCCeeeCcCccccccCchHHhhc---ccccccccccccccccCCCCCCCCccccccccccc
Q 013258          139 KQLKYLRLNNNSLSGLIPTSLTTI---TSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       139 ~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++|+|++|++++..|..+..+   ++|+.|++++|+++ .+|... +..+..+++++|.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N~  283 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL-PAKLRVLDLSSNR  283 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC-CSCCSCEECCSCC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh-cCCCCEEECCCCc
Confidence            999999999999998878777776   58999999999998 566543 3677777777775

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.34  E-value=3.3e-12  Score=122.93  Aligned_cols=128  Identities=21%  Similarity=0.273  Sum_probs=88.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccC--CCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLS--GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYL  144 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L  144 (447)
                      ..++.|+|++|.+.+..+..+..+++|+.|++++|.++  +..+..+.++++|+.|++++|.++ .+|..+.  ++|++|
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L  197 (330)
T 1xku_A          121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL  197 (330)
T ss_dssp             TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred             ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence            46888888888888777777888888888888888885  366777788888888777777776 3555443  566777


Q ss_pred             eCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccc
Q 013258          145 RLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNL  197 (447)
Q Consensus       145 ~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~  197 (447)
                      ++++|++++..|..+..+++|+.|++++|.+++..+. ...+..+..+.+.+|.
T Consensus       198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~  251 (330)
T 1xku_A          198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK  251 (330)
T ss_dssp             ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred             ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCc
Confidence            7777777666666666666677777777766665542 2234445555555553

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.34  E-value=3.7e-12  Score=118.69  Aligned_cols=124  Identities=23%  Similarity=0.296  Sum_probs=96.3

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+  +..+++|+.|+|++|++++ +|.. .. ++|+.|++++|++++ +| .+..+++|+.|+|
T Consensus        63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L  135 (263)
T 1xeu_A           63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI  135 (263)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence            468888898888886544  8888889999999998885 4443 23 888899999998885 34 5888899999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC  200 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc  200 (447)
                      ++|++++. | .+..+++|+.|++++|++++. +....+..+..+.+.+|...+
T Consensus       136 s~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          136 RNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             TTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred             CCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence            99999864 4 688888999999999999876 445556677777777776443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.33  E-value=1.6e-14  Score=128.82  Aligned_cols=125  Identities=24%  Similarity=0.357  Sum_probs=85.3

Q ss_pred             CEEEEEcCCCCccccccc------cccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCC
Q 013258           68 SVTRVDLGNAALSGELAP------ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQL  141 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L  141 (447)
                      .++.++|+.+.+.|.+|+      .+..+++|++|+|++|.+++ +| .+.++++|+.|++++|+++ .+|..+..+++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            445555666666666555      77777778888888777775 66 7777778888888888777 567766667777


Q ss_pred             CeeeCcCccccccCchHHhhcccccccccccccccccC--CCCCCCCccccccccccc
Q 013258          142 KYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV--PDNGSFSQFTPISFENNL  197 (447)
Q Consensus       142 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~--p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++|++++ +| .+..+++|+.|++++|++++..  +....+..+..+.+.+|+
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~  151 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence            888888887775 34 5777777788888887776422  122344555556666554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.33  E-value=2.9e-12  Score=124.08  Aligned_cols=124  Identities=33%  Similarity=0.427  Sum_probs=89.6

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++..+  +..+++|++|++++|.+++ + +.+..+++|+.|++++|++++ + +.+..+++|+.|++
T Consensus       221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L  294 (347)
T 4fmz_A          221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFL  294 (347)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred             CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEEC
Confidence            356777777777765433  7777788888888887775 3 457777888888888888774 3 45777788888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..|..+..+++|+.|++++|++++..| ...+..+..+++.+|.
T Consensus       295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV  344 (347)
T ss_dssp             CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred             cCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence            8888887777778888888888888888877666 4445666666666654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=5.7e-12  Score=117.15  Aligned_cols=142  Identities=12%  Similarity=0.033  Sum_probs=109.3

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEE
Q 013258          292 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       292 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv  370 (447)
                      ...++|.....++.|+.+.||+.... ++.+++|..+.... .....+.+|+++++.+. |..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34467877778888888999999854 68899999865321 12235889999998884 67788999999888889999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC-----------------------------------
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----------------------------------  415 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------  415 (447)
                      |||++|.+|.+.+..         ......++.+++++|+.||+.                                   
T Consensus        89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            999999998776321         122347888999999999981                                   


Q ss_pred             ---------------------CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          416 ---------------------CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       416 ---------------------~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                                           ..+.++|+|++|.|||++++....|.||.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe  209 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG  209 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence                                 01358999999999999876666799985

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.31  E-value=9.2e-13  Score=126.24  Aligned_cols=119  Identities=18%  Similarity=0.143  Sum_probs=59.0

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+++..+  +..+++|++|+|++|.+++. |    ..++|+.|++++|++++..+.   .+++|++|+++
T Consensus        59 ~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~  128 (317)
T 3o53_A           59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLA  128 (317)
T ss_dssp             TCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECC
T ss_pred             cCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECC
Confidence            46666666666665443  56666666666666665531 1    113333333333333322111   23455555666


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCC--CCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG--SFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~--~~~~~~~~~~~~n  196 (447)
                      +|++++..|..+..+++|+.|++++|.+++..|...  .+..+..+.+.+|
T Consensus       129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  179 (317)
T 3o53_A          129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN  179 (317)
T ss_dssp             SSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred             CCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence            666655555555555666666666666655433321  2334444444444

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.31  E-value=2.9e-12  Score=123.50  Aligned_cols=126  Identities=18%  Similarity=0.303  Sum_probs=62.4

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccc--ccCCccccCC-------
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN--GTIPDTLANL-------  138 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--g~~p~~~~~l-------  138 (447)
                      +++.|+|++|.+. .+|+.+.  ++|++|++++|.+++..+..+.++++|+.|++++|.++  +..|..+..+       
T Consensus       103 ~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l  179 (332)
T 2ft3_A          103 KLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI  179 (332)
T ss_dssp             TCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBC
T ss_pred             CCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEEC
Confidence            4555555555554 3343332  44455555555444433333444444444444444442  1222222211       


Q ss_pred             -------------CCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCcccccccccc
Q 013258          139 -------------KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENN  196 (447)
Q Consensus       139 -------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n  196 (447)
                                   ++|++|++++|.+++..|..+..+++|+.|++++|.+++..|. ...+..+..+.+.+|
T Consensus       180 ~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  251 (332)
T 2ft3_A          180 SEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN  251 (332)
T ss_dssp             CSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred             cCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCC
Confidence                         3566666666666665556666666666666666666655442 223344444455444

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.31  E-value=4.1e-12  Score=121.19  Aligned_cols=122  Identities=25%  Similarity=0.450  Sum_probs=87.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+.  +.+..+++|++|+|++|.+++ +|. +..+++|+.|++++|++++. |. +..+++|+.|++
T Consensus        85 ~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l  158 (308)
T 1h6u_A           85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSI  158 (308)
T ss_dssp             CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEc
Confidence            4688888888888763  367888888888888888875 443 77888888888888888753 33 777788888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..+  +..+++|+.|++++|.+++..+ ...+..+..+.+.+|.
T Consensus       159 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          159 GNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSC
T ss_pred             cCCcCCCChh--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCc
Confidence            8888876433  7777778888888887776443 3344555555565554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.30  E-value=6e-12  Score=120.06  Aligned_cols=122  Identities=28%  Similarity=0.463  Sum_probs=97.0

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..+  +..+++|++|+|++|.+++ +| .+..+++|+.|++++|++++ +|. +..+++|++|++
T Consensus        63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l  136 (308)
T 1h6u_A           63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL  136 (308)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred             CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence            468899999998886444  8889999999999999885 34 68889999999999999985 444 888999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..+  +..+++|+.|++++|.+++..+ ...+..+..+.+.+|.
T Consensus       137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK  184 (308)
T ss_dssp             CSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             CCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence            9999986544  8888899999999999887544 4455666666666664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.29  E-value=6.3e-12  Score=130.68  Aligned_cols=103  Identities=37%  Similarity=0.473  Sum_probs=49.9

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+.+..+  +..|++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++ + +.+..+++|+.|+|+
T Consensus        66 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls  139 (605)
T 1m9s_A           66 NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLG  139 (605)
T ss_dssp             TCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECC
T ss_pred             CCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECC
Confidence            45566666666554333  5555555555555555553 22 34455555555555555543 2 234444444444444


Q ss_pred             CccccccCchHHhhccccccccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      +|.+++.  ..+..+++|+.|+|++|.+++.
T Consensus       140 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A          140 NNKITDI--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             SSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             CCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence            4444432  3344444444444444444443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.28  E-value=7.2e-12  Score=130.27  Aligned_cols=123  Identities=27%  Similarity=0.339  Sum_probs=107.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+  ++.+..|++|+.|+|++|.+++ + +.+..+++|+.|+|++|++++.  +.+..+++|+.|+|
T Consensus        87 ~~L~~L~Ls~N~l~~--l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~L  160 (605)
T 1m9s_A           87 KNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL  160 (605)
T ss_dssp             TTCCEEECCSSCCCC--CTTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEEC
T ss_pred             CCCCEEECcCCCCCC--ChhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEEC
Confidence            479999999999986  3479999999999999999996 3 4689999999999999999964  67899999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLN  198 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~  198 (447)
                      ++|++++..|  +..+++|+.|+|++|.|++. |....+..+..+.+.+|..
T Consensus       161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l  209 (605)
T 1m9s_A          161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC  209 (605)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred             cCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence            9999998766  89999999999999999974 6666677788888877754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.27  E-value=6.6e-12  Score=121.74  Aligned_cols=106  Identities=18%  Similarity=0.152  Sum_probs=91.9

Q ss_pred             CEEECCCC-ccCCCCChhhcCCCCCcEEEccC-CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccc
Q 013258           94 ELLELYGN-NLSGHIPSALGNLIKLKSLDLYS-NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS  171 (447)
Q Consensus        94 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls  171 (447)
                      ..++++++ +|++ +|. +..+++|+.|+|++ |+|++..|..|+++++|+.|+|++|+|++.+|..|..+++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35788888 8984 888 99999999999996 99998877899999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCccccccccccccccC
Q 013258          172 NNRLSGPVPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       172 ~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      +|+|++.++.......+..+.+.+|...|.
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCC
Confidence            999998776654433477777888877664

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.26  E-value=1e-11  Score=128.27  Aligned_cols=101  Identities=28%  Similarity=0.328  Sum_probs=90.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccC-CccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTI-PDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~-p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|.++ .+|..++.|++|+.|+|++|.|++ +| .++++++|+.|+|++|++++.. |..++.+++|+.|+
T Consensus       463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~  539 (567)
T 1dce_A          463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN  539 (567)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence            47999999999999 889999999999999999999997 77 8999999999999999999876 99999999999999


Q ss_pred             CcCccccccCch---HHhhccccccccc
Q 013258          146 LNNNSLSGLIPT---SLTTITSLNILDL  170 (447)
Q Consensus       146 l~~N~l~~~~p~---~~~~l~~L~~l~l  170 (447)
                      |++|++++.+|.   .+..+++|+.||+
T Consensus       540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          540 LQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            999999987653   2345788888763

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.26  E-value=1e-11  Score=115.61  Aligned_cols=121  Identities=27%  Similarity=0.350  Sum_probs=101.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.++. ++ .+..+++|+.|+|++|.+++. |+ +.++++|+.|+|++|++++ +|....  ++|+.|+|
T Consensus        41 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L  113 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL  113 (263)
T ss_dssp             TTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred             CcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence            468999999999984 55 789999999999999999974 44 9999999999999999985 555333  89999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++. | .+..+++|+.|++++|++++. |....+..+..+.+.+|.
T Consensus       114 ~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A          114 DNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             CSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSC
T ss_pred             cCCccCCC-h-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCc
Confidence            99999974 4 589999999999999999975 444456667777777765

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.22  E-value=1.8e-11  Score=123.61  Aligned_cols=122  Identities=31%  Similarity=0.439  Sum_probs=78.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+..+  +..+++|+.|++++|.+++..|  +..+++|+.|++++|++++..|  +..+++|+.|++
T Consensus       243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L  316 (466)
T 1o6v_A          243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL  316 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred             CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence            357777777777776544  6677777777777777775333  6677777777777777765332  666777777777


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..|  +..+++|+.|++++|.+++. +....+..+..+.+.+|.
T Consensus       317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSC
T ss_pred             cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCc
Confidence            7777766554  56666677777777766654 333344455555555543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.21  E-value=1.4e-13  Score=122.70  Aligned_cols=110  Identities=20%  Similarity=0.259  Sum_probs=98.8

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+.+ +| .+..+++|++|++++|.++ .+|..+..+++|+.|++++|++++ +| .+..+++|++|++
T Consensus        48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l  122 (198)
T 1ds9_A           48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM  122 (198)
T ss_dssp             TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred             CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence            478999999999987 66 8999999999999999999 688888889999999999999996 56 6889999999999


Q ss_pred             cCccccccCc-hHHhhcccccccccccccccccCCC
Q 013258          147 NNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       147 ~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      ++|++++..+ ..+..+++|+.|++++|.+++.+|.
T Consensus       123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A          123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             CCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            9999986433 5788999999999999999988775

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.19  E-value=3.1e-11  Score=121.91  Aligned_cols=122  Identities=31%  Similarity=0.432  Sum_probs=103.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+.+.  +.+..+++|+.|++++|.+++..|  +..+++|+.|++++|.+++. |. +..+++|+.|++
T Consensus       221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L  294 (466)
T 1o6v_A          221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLEL  294 (466)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEc
Confidence            4689999999999863  468899999999999999997555  88999999999999999864 44 889999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|++++..|  +..+++|+.|++++|++++..| ...+..+..+.+.+|.
T Consensus       295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSC
T ss_pred             CCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCc
Confidence            9999997654  7889999999999999998776 4456777777777764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.19  E-value=3e-11  Score=116.88  Aligned_cols=104  Identities=25%  Similarity=0.412  Sum_probs=92.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++.  +.+..+++|++|++++|.+++.  +.+..+++|+.|++++|.+++..|..+..+++|++|++
T Consensus       243 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  318 (347)
T 4fmz_A          243 SQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL  318 (347)
T ss_dssp             TTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred             CCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence            5799999999999874  5689999999999999999964  46899999999999999999888999999999999999


Q ss_pred             cCccccccCchHHhhccccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      ++|++++..|  +..+++|+.|++++|.++
T Consensus       319 ~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          319 SQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             cCCccccccC--hhhhhccceeehhhhccc
Confidence            9999998766  889999999999999986

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.18  E-value=4.5e-11  Score=120.40  Aligned_cols=103  Identities=22%  Similarity=0.220  Sum_probs=78.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|...+.+  .+..+++|+.|++++|.+++ +|  ++.+++|+.|++++|++++.   .++.+++|+.|++
T Consensus       148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~L  219 (457)
T 3bz5_A          148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDC  219 (457)
T ss_dssp             TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEEC
T ss_pred             CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEEC
Confidence            46788888888666666  36778888888888888886 55  77788888888888888753   3777788888888


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  180 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  180 (447)
                      ++|++++ +|  +..+++|+.|++++|++++..+
T Consensus       220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             CSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             cCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            8888876 55  6777788888888888877543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.18  E-value=2.6e-11  Score=124.88  Aligned_cols=94  Identities=30%  Similarity=0.390  Sum_probs=61.2

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.+++ +|. +..  +|++|+|++|.|++ +|.   .+++|+.|+|++|++++ +|.   .+++|+.|+|
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  167 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSV  167 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEEC
Confidence            467778888887776 665 554  77777777777775 555   46667777777777764 554   3556666666


Q ss_pred             cCccccccCchHHhhccccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      ++|++++ +|. +.  ++|+.|++++|.|+
T Consensus       168 s~N~L~~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          168 RNNQLTF-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             CSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred             CCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence            6666665 444 43  55666666666665

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.17  E-value=5.7e-11  Score=119.63  Aligned_cols=116  Identities=22%  Similarity=0.307  Sum_probs=67.9

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+++. | .+..+++|++|+|++|.+++ +|  ++.+++|++|++++|++++ +|  ++++++|++|+++
T Consensus        43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~  114 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCD  114 (457)
T ss_dssp             TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECC
Confidence            466666666666653 3 56666666666666666665 33  5666666666666666664 23  5666666666666


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      +|++++ +|  ++.+++|+.|++++|++++. | .+.+..+..+.+.+|
T Consensus       115 ~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~-l~~l~~L~~L~l~~n  158 (457)
T 3bz5_A          115 TNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D-VSHNTQLTELDCHLN  158 (457)
T ss_dssp             SSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C-CTTCTTCCEEECTTC
T ss_pred             CCcCCe-ec--CCCCCcCCEEECCCCcccee-c-cccCCcCCEEECCCC
Confidence            666665 33  55666666666666666652 2 233344444444433

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.16  E-value=7e-11  Score=109.29  Aligned_cols=126  Identities=14%  Similarity=0.048  Sum_probs=93.2

Q ss_pred             ccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccceeeEEecCCceEEEeecCCCCChhh
Q 013258          304 GRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGSVAS  381 (447)
Q Consensus       304 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~  381 (447)
                      +.|..+.||+....+|+.+++|.....    ....+.+|+++++.+.+.+  +.+++++....+..++||||++|.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            455669999998777888999987543    1235788999998886545  456888888777889999999998873 


Q ss_pred             HhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC---------------------------------------------
Q 013258          382 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------------  416 (447)
Q Consensus       382 ~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------  416 (447)
                       ...       .+   ...++.++++.|..||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   2356777778888888641                                             


Q ss_pred             ----------CCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          417 ----------DPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       417 ----------~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                                .+.++|+|++|.|||++++....+.||.-
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~  211 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGR  211 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTT
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchh
Confidence                      11399999999999998876677999853

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.13  E-value=1e-10  Score=117.64  Aligned_cols=79  Identities=30%  Similarity=0.439  Sum_probs=37.4

Q ss_pred             CCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccccc
Q 013258           91 KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  170 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  170 (447)
                      ++|++|++++|.+++ +| .++++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .++.+++|+.|++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            345555555555553 44 35555555555555555543 34322   244455555554443 33 2444444444444


Q ss_pred             ccccccc
Q 013258          171 SNNRLSG  177 (447)
Q Consensus       171 s~N~l~g  177 (447)
                      ++|.+++
T Consensus       203 ~~N~l~~  209 (454)
T 1jl5_A          203 DNNSLKK  209 (454)
T ss_dssp             CSSCCSS
T ss_pred             CCCcCCc
Confidence            4444443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.13  E-value=8.8e-12  Score=120.07  Aligned_cols=110  Identities=21%  Similarity=0.194  Sum_probs=75.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCC-CChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGH-IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      ..++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|+.|++++|.+++..|..++.+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            3466677777766665444 55677777777777777654 666677777777777777777766677777777777777


Q ss_pred             CcCc-cccc-cCchHHhhcccccccccccc-cccc
Q 013258          146 LNNN-SLSG-LIPTSLTTITSLNILDLSNN-RLSG  177 (447)
Q Consensus       146 l~~N-~l~~-~~p~~~~~l~~L~~l~ls~N-~l~g  177 (447)
                      +++| .+++ .+|..+..+++|+.|++++| .+++
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~  183 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTE  183 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence            7777 5654 25666677777777777777 6664

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.12  E-value=1.4e-11  Score=121.34  Aligned_cols=132  Identities=20%  Similarity=0.259  Sum_probs=108.0

Q ss_pred             CCEEEEEcCCCCcc-cccc---ccccCCCCCCEEECCCCccC--C---CCChhhcCCCCCcEEEccCCccc----ccCCc
Q 013258           67 GSVTRVDLGNAALS-GELA---PELGQLKNLELLELYGNNLS--G---HIPSALGNLIKLKSLDLYSNLFN----GTIPD  133 (447)
Q Consensus        67 ~~v~~l~L~~~~l~-g~~~---~~l~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----g~~p~  133 (447)
                      .+++.|+|++|.++ +.++   ..+..+++|++|+|++|.++  |   .+|..+..+++|+.|+|++|.++    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            67999999999998 4455   56788999999999999998  3   35558889999999999999996    67889


Q ss_pred             cccCCCCCCeeeCcCcccccc----CchHHhh--cccccccccccccccc----cCCCCC--CCCcccccccccccc
Q 013258          134 TLANLKQLKYLRLNNNSLSGL----IPTSLTT--ITSLNILDLSNNRLSG----PVPDNG--SFSQFTPISFENNLN  198 (447)
Q Consensus       134 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~--l~~L~~l~ls~N~l~g----~~p~~~--~~~~~~~~~~~~n~~  198 (447)
                      .+..+++|++|+|++|.+++.    +|..+..  +++|+.|++++|.+++    .+|...  .+..+..+.+.+|..
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l  315 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF  315 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred             HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence            999999999999999999876    5666644  8899999999999998    455432  246677777777753

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.12  E-value=6e-12  Score=123.89  Aligned_cols=131  Identities=22%  Similarity=0.277  Sum_probs=107.4

Q ss_pred             CCEEEEEcCCCCccc----cccccccCC---------CCCCEEECCCCccC-CCCC---hhhcCCCCCcEEEccCCccc-
Q 013258           67 GSVTRVDLGNAALSG----ELAPELGQL---------KNLELLELYGNNLS-GHIP---SALGNLIKLKSLDLYSNLFN-  128 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g----~~~~~l~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~ls~N~l~-  128 (447)
                      .+++.|+|++|.+++    .++..+..+         ++|++|+|++|+++ +.+|   ..+..+++|+.|+|++|+++ 
T Consensus       122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~  201 (386)
T 2ca6_A          122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  201 (386)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence            579999999999974    356667777         89999999999998 4556   57788999999999999997 


Q ss_pred             -c---cCCccccCCCCCCeeeCcCcccc----ccCchHHhhccccccccccccccccc----CCCC---CCCCccccccc
Q 013258          129 -G---TIPDTLANLKQLKYLRLNNNSLS----GLIPTSLTTITSLNILDLSNNRLSGP----VPDN---GSFSQFTPISF  193 (447)
Q Consensus       129 -g---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~l~ls~N~l~g~----~p~~---~~~~~~~~~~~  193 (447)
                       |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|++++|.+++.    +|..   +.+..+..+.+
T Consensus       202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L  281 (386)
T 2ca6_A          202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  281 (386)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence             3   45558899999999999999996    67888999999999999999999865    3332   23556666777


Q ss_pred             cccc
Q 013258          194 ENNL  197 (447)
Q Consensus       194 ~~n~  197 (447)
                      .+|.
T Consensus       282 ~~n~  285 (386)
T 2ca6_A          282 QYNE  285 (386)
T ss_dssp             CSSC
T ss_pred             cCCc
Confidence            6664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2.1e-10  Score=111.73  Aligned_cols=138  Identities=12%  Similarity=0.192  Sum_probs=101.1

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcc--cccccccHHHHHHHHHHHhcCC--CCCccceeeEEecC---CceEEEee
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTV---TEKLLVYP  372 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lv~e  372 (447)
                      .+.++.|.++.||+.... +..+++|+..  ..........+.+|.++++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467889999999998875 4678888775  3322122346888999999887  45578888888766   34899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC------------------------------------
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------------------------------------  416 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------  416 (447)
                      |++|..+.+..      ...++...+..++.++++.|+.||+..                                    
T Consensus       122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99988774321      112667788899999999999999731                                    


Q ss_pred             -------------------CCCeeecCCCCCceeeCCCCc--eeecccc
Q 013258          417 -------------------DPKIIHRDVKAANILLDEDAD--QSSKTIL  444 (447)
Q Consensus       417 -------------------~~~ivHrDlkp~NILl~~~~~--~~i~df~  444 (447)
                                         .+.++|+|+++.|||+++++.  ..|.||.
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe  244 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWE  244 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCT
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcc
Confidence                               246999999999999998764  5888985

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.11  E-value=1e-11  Score=119.59  Aligned_cols=131  Identities=21%  Similarity=0.267  Sum_probs=97.6

Q ss_pred             CCEEEEEcCCCCcccc-ccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC-ccccc-CCccccCCCCCCe
Q 013258           67 GSVTRVDLGNAALSGE-LAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-LFNGT-IPDTLANLKQLKY  143 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~g~-~p~~~~~l~~L~~  143 (447)
                      .+++.|+|++|.+++. ++..+..+++|++|+|++|.+++..|..++.+++|+.|++++| .+++. +|..+.++++|++
T Consensus        93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~  172 (336)
T 2ast_B           93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  172 (336)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence            4688889998888876 7777888888999999888888778888888888888888888 67653 6777788888888


Q ss_pred             eeCcCc-ccccc-CchHHhhcc-cccccccccc--ccc-ccCCCC-CCCCccccccccccc
Q 013258          144 LRLNNN-SLSGL-IPTSLTTIT-SLNILDLSNN--RLS-GPVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       144 L~l~~N-~l~~~-~p~~~~~l~-~L~~l~ls~N--~l~-g~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      |++++| .+++. ++..+..++ +|+.|++++|  .++ +.+|.. ..+..+..+.+.+|.
T Consensus       173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~  233 (336)
T 2ast_B          173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV  233 (336)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred             EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence            888888 88754 577778888 8888888888  444 223321 123445555555553

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.09  E-value=7.7e-11  Score=114.41  Aligned_cols=117  Identities=20%  Similarity=0.235  Sum_probs=84.3

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCCh-hhcCCCCCcE-EEcc
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKS-LDLY  123 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~ls  123 (447)
                      |+|..|.|...          .+++.|+|++|+++...+..|.+|++|++|+|++|.+.+.+|. .|.++++++. ++++
T Consensus         9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X            9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            57888888521          3578888888888854445678888888888888888766654 5677877664 5666


Q ss_pred             CCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccccccc
Q 013258          124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  172 (447)
Q Consensus       124 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~  172 (447)
                      +|+++...|..|..+++|++|++++|++++..+..+....++..+++++
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~  137 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD  137 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence            7888876677888888888888888888766555554444555555544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.07  E-value=7.5e-11  Score=115.06  Aligned_cols=112  Identities=23%  Similarity=0.265  Sum_probs=89.6

Q ss_pred             CCEEEEEcCCCCcccccc----ccccCCC-CCCEEECCCCccCCCCChhhcCC-----CCCcEEEccCCcccccCCcccc
Q 013258           67 GSVTRVDLGNAALSGELA----PELGQLK-NLELLELYGNNLSGHIPSALGNL-----IKLKSLDLYSNLFNGTIPDTLA  136 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~ls~N~l~g~~p~~~~  136 (447)
                      .+++.|||++|.+++..+    ..+..++ +|++|+|++|.+++..+..+..+     ++|+.|+|++|.+++..+..+.
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            358899999999887766    6677888 89999999999988777777775     8899999999999876666444


Q ss_pred             ----CC-CCCCeeeCcCccccccCchHHhhc-----cccccccccccccccc
Q 013258          137 ----NL-KQLKYLRLNNNSLSGLIPTSLTTI-----TSLNILDLSNNRLSGP  178 (447)
Q Consensus       137 ----~l-~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~l~ls~N~l~g~  178 (447)
                          .+ ++|++|+|++|++++..+..+...     ++|+.|++++|.+++.
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~  153 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK  153 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred             HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence                34 789999999999987776665542     5899999999998853

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.07  E-value=5.9e-11  Score=115.79  Aligned_cols=113  Identities=29%  Similarity=0.309  Sum_probs=74.7

Q ss_pred             CEEEEEcCCCCccccccccccCC-----CCCCEEECCCCccCCCCChhhcC----C-CCCcEEEccCCcccccCCcccc-
Q 013258           68 SVTRVDLGNAALSGELAPELGQL-----KNLELLELYGNNLSGHIPSALGN----L-IKLKSLDLYSNLFNGTIPDTLA-  136 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~ls~N~l~g~~p~~~~-  136 (447)
                      +++.|+|++|.+++..+..+..+     ++|++|+|++|.+++..+..+..    + ++|+.|+|++|++++..+..+. 
T Consensus        52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~  131 (362)
T 3goz_A           52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ  131 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence            57778888887777666666554     77788888888777665554433    3 6778888888877755444433 


Q ss_pred             ---C-CCCCCeeeCcCccccccCc----hHHhhcc-cccccccccccccccCC
Q 013258          137 ---N-LKQLKYLRLNNNSLSGLIP----TSLTTIT-SLNILDLSNNRLSGPVP  180 (447)
Q Consensus       137 ---~-l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~l~ls~N~l~g~~p  180 (447)
                         . .++|++|+|++|.+++..+    ..+..++ +|+.|++++|.+++..+
T Consensus       132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~  184 (362)
T 3goz_A          132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC  184 (362)
T ss_dssp             HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence               2 2577788888887775333    3334444 77788888887776543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.02  E-value=2.4e-10  Score=115.01  Aligned_cols=102  Identities=25%  Similarity=0.381  Sum_probs=59.3

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCC--CCChhhc-------------CC-CCCcEEEccCCcccccC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG--HIPSALG-------------NL-IKLKSLDLYSNLFNGTI  131 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~-------------~l-~~L~~L~ls~N~l~g~~  131 (447)
                      +++.|+|++|.+.+ +|..   +++|+.|++++|.+++  .+|..+.             .+ ++|+.|++++|++++ +
T Consensus       258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-l  332 (454)
T 1jl5_A          258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-L  332 (454)
T ss_dssp             TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-C
T ss_pred             ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-c
Confidence            45555555555554 3322   2445555555555543  2222211             12 467777777777774 5


Q ss_pred             CccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccc--cCCC
Q 013258          132 PDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSG--PVPD  181 (447)
Q Consensus       132 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g--~~p~  181 (447)
                      |..   +++|++|++++|++++ +|.   .+++|+.|++++|++++  .+|.
T Consensus       333 p~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~  377 (454)
T 1jl5_A          333 PAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPE  377 (454)
T ss_dssp             CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred             ccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChH
Confidence            554   4677777777777774 554   35677777777777777  5554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.01  E-value=3.1e-10  Score=118.18  Aligned_cols=81  Identities=28%  Similarity=0.339  Sum_probs=43.9

Q ss_pred             CCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccccc
Q 013258           91 KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  170 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  170 (447)
                      ++|+.|+|++|.+++ +|   ..+++|+.|+|++|+++ .+|.   .+++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            445555555555553 33   23455555555555555 3444   3455666666666665 44555666666666666


Q ss_pred             ccccccccCC
Q 013258          171 SNNRLSGPVP  180 (447)
Q Consensus       171 s~N~l~g~~p  180 (447)
                      ++|++++.+|
T Consensus       292 ~~N~l~~~~~  301 (622)
T 3g06_A          292 EGNPLSERTL  301 (622)
T ss_dssp             CSCCCCHHHH
T ss_pred             cCCCCCCcCH
Confidence            6666655544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.92  E-value=8e-10  Score=107.20  Aligned_cols=108  Identities=18%  Similarity=0.159  Sum_probs=91.5

Q ss_pred             EEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCc-cccCCCCCCe-eeCcC
Q 013258           71 RVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKY-LRLNN  148 (447)
Q Consensus        71 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~-L~l~~  148 (447)
                      .++-++++++ .+|..+  .+++++|+|++|+|+...+..|.++++|+.|+|++|++.+.+|. .|.+++++.. ++++.
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            5778888888 678766  36899999999999965556799999999999999998777765 6788988875 66778


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      |++++..|..|..+++|+.|++++|.+++..+.
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~  122 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV  122 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC
T ss_pred             CcccccCchhhhhccccccccccccccccCCch
Confidence            999988899999999999999999999876543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.92  E-value=1.5e-09  Score=113.11  Aligned_cols=74  Identities=27%  Similarity=0.346  Sum_probs=37.0

Q ss_pred             CCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccc
Q 013258          115 IKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISF  193 (447)
Q Consensus       115 ~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~  193 (447)
                      ++|+.|+|++|++++ +|   ..+++|+.|+|++|+++. +|.   .+++|+.|++++|+++ .+|. ...+..+..+.+
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            344555555555542 33   233455555666665553 333   3455666666666666 3343 223344444555


Q ss_pred             cccc
Q 013258          194 ENNL  197 (447)
Q Consensus       194 ~~n~  197 (447)
                      .+|+
T Consensus       292 ~~N~  295 (622)
T 3g06_A          292 EGNP  295 (622)
T ss_dssp             CSCC
T ss_pred             cCCC
Confidence            5553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.88  E-value=8.2e-11  Score=108.91  Aligned_cols=84  Identities=26%  Similarity=0.293  Sum_probs=60.6

Q ss_pred             EECCCCccC---CCCChhhcCCCCCcEEEccCCcccc--cCCccccCCCCCCeeeCcCccccccCchHHhhcc--ccccc
Q 013258           96 LELYGNNLS---GHIPSALGNLIKLKSLDLYSNLFNG--TIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTIT--SLNIL  168 (447)
Q Consensus        96 L~L~~N~l~---~~~p~~~~~l~~L~~L~ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~l  168 (447)
                      ++++.|...   +.++....++++|+.|+|++|++++  .+|..+..+++|+.|+|++|++++.  ..+..+.  +|+.|
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            455666332   2222223567889999999999987  5567777889999999999999865  3455555  78899


Q ss_pred             ccccccccccCCC
Q 013258          169 DLSNNRLSGPVPD  181 (447)
Q Consensus       169 ~ls~N~l~g~~p~  181 (447)
                      ++++|.+++.+|+
T Consensus       226 ~L~~Npl~~~~~~  238 (267)
T 3rw6_A          226 WLDGNSLCDTFRD  238 (267)
T ss_dssp             ECTTSTTGGGCSS
T ss_pred             EccCCcCccccCc
Confidence            9999999887764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.85  E-value=3.6e-10  Score=113.59  Aligned_cols=131  Identities=21%  Similarity=0.213  Sum_probs=96.2

Q ss_pred             CCEEEEEcCCCCcccc----ccccccCCCCCCEEECCCCccCCCCChhhcC-----CCCCcEEEccCCccccc----CCc
Q 013258           67 GSVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSGHIPSALGN-----LIKLKSLDLYSNLFNGT----IPD  133 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~g~----~p~  133 (447)
                      ..++.|+|++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|+.|++++|.+++.    +|.
T Consensus       256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~  335 (461)
T 1z7x_W          256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS  335 (461)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence            5789999999998875    6777888899999999999887544444443     26889999999988765    566


Q ss_pred             cccCCCCCCeeeCcCccccccCchHHhh-----cccccccccccccccc----cCCCC-CCCCccccccccccc
Q 013258          134 TLANLKQLKYLRLNNNSLSGLIPTSLTT-----ITSLNILDLSNNRLSG----PVPDN-GSFSQFTPISFENNL  197 (447)
Q Consensus       134 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~ls~N~l~g----~~p~~-~~~~~~~~~~~~~n~  197 (447)
                      .+..+++|++|++++|.+++..+..+..     .++|+.|++++|.+++    .+|.. ..+..+..+++.+|.
T Consensus       336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC  409 (461)
T ss_dssp             HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred             HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence            7777888999999999887765655554     5688889999988875    44432 124455666666664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.83  E-value=1.5e-10  Score=116.29  Aligned_cols=131  Identities=21%  Similarity=0.179  Sum_probs=100.0

Q ss_pred             CCEEEEEcCCCCccccc----cccc-cCCCCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCcccccCCccccC
Q 013258           67 GSVTRVDLGNAALSGEL----APEL-GQLKNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFNGTIPDTLAN  137 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~----~~~l-~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~  137 (447)
                      .+++.|+|++|.+++..    .+.+ ..+++|++|++++|.+++.    ++..+.++++|+.|++++|.+++..+..+..
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            57999999999998753    2332 3689999999999999864    6888888999999999999997654444433


Q ss_pred             -----CCCCCeeeCcCcccccc----CchHHhhcccccccccccccccccCCCCC------CCCccccccccccc
Q 013258          138 -----LKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSGPVPDNG------SFSQFTPISFENNL  197 (447)
Q Consensus       138 -----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g~~p~~~------~~~~~~~~~~~~n~  197 (447)
                           .++|++|++++|.+++.    +|..+..+++|+.|++++|.+++..+...      ....+..+.+.+|.
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence                 36999999999999876    56777788999999999999986432210      13355566666653

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.79  E-value=1.8e-09  Score=105.62  Aligned_cols=111  Identities=19%  Similarity=0.182  Sum_probs=72.2

Q ss_pred             CCEEEEEcCCCCcccccccccc-CCCCCCEEECCCCccCCCCChhh-----cCCCCCcEEEccCCcccc----cCCcccc
Q 013258           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLELYGNNLSGHIPSAL-----GNLIKLKSLDLYSNLFNG----TIPDTLA  136 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~ls~N~l~g----~~p~~~~  136 (447)
                      ..++.|+|++|.+++.....+. .+.+|+.|+|++|.++......+     ...++|+.|+|++|.++.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4688888888887654333332 35567788888887764333333     235678888888887753    2445556


Q ss_pred             CCCCCCeeeCcCcccccc----CchHHhhcccccccccccccccc
Q 013258          137 NLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       137 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      .+++|++|+|++|.++..    ++..+...++|+.|++++|.++.
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence            677788888888877642    24455566677888888887764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.72  E-value=6.2e-09  Score=96.24  Aligned_cols=80  Identities=28%  Similarity=0.304  Sum_probs=67.1

Q ss_pred             cCCCCCCEEECCCCccCC--CCChhhcCCCCCcEEEccCCcccccCCccccCCC--CCCeeeCcCccccccCch------
Q 013258           88 GQLKNLELLELYGNNLSG--HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLK--QLKYLRLNNNSLSGLIPT------  157 (447)
Q Consensus        88 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------  157 (447)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|++++.  ..+..+.  +|++|+|++|.+.+.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            468899999999999998  5678888999999999999999864  3445555  899999999999987762      


Q ss_pred             -HHhhcccccccc
Q 013258          158 -SLTTITSLNILD  169 (447)
Q Consensus       158 -~~~~l~~L~~l~  169 (447)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             467788888876

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.64  E-value=3.5e-09  Score=103.47  Aligned_cols=86  Identities=22%  Similarity=0.261  Sum_probs=35.8

Q ss_pred             CCCCEEECCCCccCC----CCChhhcCCCCCcEEEccCCccccc----CCccccCCCCCCeeeCcCcccccc----CchH
Q 013258           91 KNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGL----IPTS  158 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~  158 (447)
                      .+|++|+|++|.++.    .++..+..+++|++|+|++|.++..    ++..+...++|+.|+|++|.++..    ++..
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            444444444444432    1233334444444444444444321    233333444444444444444321    1222


Q ss_pred             Hhhccccccccccccccc
Q 013258          159 LTTITSLNILDLSNNRLS  176 (447)
Q Consensus       159 ~~~l~~L~~l~ls~N~l~  176 (447)
                      +...++|+.||+++|.|+
T Consensus       235 L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          235 AREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHCSSCCEEECTTSSCC
T ss_pred             HHhCCCCCEEeccCCCCC
Confidence            233344444444444443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.57  E-value=1.7e-08  Score=88.53  Aligned_cols=111  Identities=21%  Similarity=0.253  Sum_probs=88.8

Q ss_pred             CCCEEEEEcCCC-Ccccc----ccccccCCCCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCccccc----CC
Q 013258           66 EGSVTRVDLGNA-ALSGE----LAPELGQLKNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IP  132 (447)
Q Consensus        66 ~~~v~~l~L~~~-~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p  132 (447)
                      ...++.|+|++| .++..    +...+...++|++|+|++|.+...    +...+...++|++|+|++|.++..    +.
T Consensus        35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~  114 (185)
T 1io0_A           35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV  114 (185)
T ss_dssp             CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence            357999999999 88753    456677789999999999999742    455666678999999999999743    56


Q ss_pred             ccccCCCCCCeeeC--cCcccccc----CchHHhhccccccccccccccc
Q 013258          133 DTLANLKQLKYLRL--NNNSLSGL----IPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       133 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      ..+...++|++|+|  ++|.+...    +...+...++|+.|++++|.+.
T Consensus       115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            67788889999999  88999754    3344555688999999999886

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.48  E-value=2e-07  Score=88.27  Aligned_cols=132  Identities=20%  Similarity=0.146  Sum_probs=90.8

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCC--ccceeeEEecCC---ceEEEeec
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRN--LLRLYGFCTTVT---EKLLVYPY  373 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lv~e~  373 (447)
                      .+.++.|.+..||+..    ..+++|+.+..   .....+.+|.+++..+. +..  +.+.+......+   ..|+||||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568899999999853    45788876432   22346889999998873 333  344444433332   34889999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC--------------------------------------
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------------  415 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------  415 (447)
                      ++|..+.+....      .++..++..++.++++.|+.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999887654322      155666777777777777777751                                      


Q ss_pred             -----------------CCCCeeecCCCCCceeeCC--CCceeecccc
Q 013258          416 -----------------CDPKIIHRDVKAANILLDE--DADQSSKTIL  444 (447)
Q Consensus       416 -----------------~~~~ivHrDlkp~NILl~~--~~~~~i~df~  444 (447)
                                       ..+.++|+|++|.||++++  +....+.||.
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~  219 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFG  219 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCT
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCC
Confidence                             1245899999999999998  4557889985

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.38  E-value=5.1e-08  Score=101.07  Aligned_cols=110  Identities=15%  Similarity=0.144  Sum_probs=63.8

Q ss_pred             CEEEEEcCCCCccccccccccC-CCCCCEEECC----CCccCCC-----CChhhcCCCCCcEEEccCC--cccccCCccc
Q 013258           68 SVTRVDLGNAALSGELAPELGQ-LKNLELLELY----GNNLSGH-----IPSALGNLIKLKSLDLYSN--LFNGTIPDTL  135 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~ls~N--~l~g~~p~~~  135 (447)
                      +++.|+|..+.+++..+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|+++++  .+++..+..+
T Consensus       379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~  458 (592)
T 3ogk_B          379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI  458 (592)
T ss_dssp             TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred             cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence            5677777777777666666654 7777777774    5666642     3333555666666666532  2444433333


Q ss_pred             c-CCCCCCeeeCcCccccc-cCchHHhhcccccccccccccccc
Q 013258          136 A-NLKQLKYLRLNNNSLSG-LIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       136 ~-~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      . .+++|++|++++|++++ .++..+..+++|+.|++++|.+++
T Consensus       459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  502 (592)
T 3ogk_B          459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE  502 (592)
T ss_dssp             HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred             HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence            3 25566666666666654 233444555666666666666543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.35  E-value=2e-06  Score=79.67  Aligned_cols=132  Identities=17%  Similarity=0.102  Sum_probs=90.8

Q ss_pred             CccccCCCc-eEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFG-KVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.+..|..| .||+.... ++..+.+|+-+..    ....+.+|...|+.+. +--+.++++++...+..++|||++++.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            345556555 58987754 4667888976432    2346888999888774 334678888888888999999999998


Q ss_pred             ChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC------------------------------------------
Q 013258          378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH------------------------------------------  415 (447)
Q Consensus       378 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------  415 (447)
                      ++.+.....        ......+..+++..|.-||+.                                          
T Consensus       106 ~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          106 TAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             cccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            776654321        112334555555556655532                                          


Q ss_pred             -------------CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          416 -------------CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       416 -------------~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                                   ..+.++|+|+.+.|||+++++..-|.||.
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe  219 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG  219 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence                         11237999999999999988777788875

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.29  E-value=1.8e-07  Score=96.89  Aligned_cols=104  Identities=11%  Similarity=0.175  Sum_probs=68.4

Q ss_pred             CEEEEEcCCCC-ccc-cccccccCCCCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCccc----ccCCccccC
Q 013258           68 SVTRVDLGNAA-LSG-ELAPELGQLKNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFN----GTIPDTLAN  137 (447)
Q Consensus        68 ~v~~l~L~~~~-l~g-~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~----g~~p~~~~~  137 (447)
                      +++.|+|+++. ++. .++.....+++|++|+|++|.+++.    ++..+.++++|+.|++++|.++    +.++..+.+
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            37778887765 221 1223334677788888888877654    4444566777888888877776    334555566


Q ss_pred             CCCCCeeeCcCccccccCchHHhhccccccccccc
Q 013258          138 LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN  172 (447)
Q Consensus       138 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~  172 (447)
                      +++|+.|++++|.+.+ +|..+..+++|+.|+++.
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            7777888887777765 566677777777777764

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.29  E-value=7.2e-07  Score=85.42  Aligned_cols=89  Identities=15%  Similarity=0.119  Sum_probs=66.6

Q ss_pred             CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCC-eeeCcCccccccCchHHhhcccccc
Q 013258           89 QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLK-YLRLNNNSLSGLIPTSLTTITSLNI  167 (447)
Q Consensus        89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~  167 (447)
                      .+++|+.|+|++|+++...+..|.++++|+.|+|++| +...-+.+|.++++|+ .+++.+ +++..-+.+|.++++|+.
T Consensus       224 ~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~  301 (329)
T 3sb4_A          224 YMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY  301 (329)
T ss_dssp             HCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred             hcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence            3778888888888887555566888888888888887 6644455678888888 888877 666566677888888888


Q ss_pred             cccccccccccC
Q 013258          168 LDLSNNRLSGPV  179 (447)
Q Consensus       168 l~ls~N~l~g~~  179 (447)
                      +++++|.++...
T Consensus       302 l~l~~n~i~~I~  313 (329)
T 3sb4_A          302 VLATGDKITTLG  313 (329)
T ss_dssp             EEECSSCCCEEC
T ss_pred             EEeCCCccCccc
Confidence            888888776543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.25  E-value=4.1e-06  Score=79.34  Aligned_cols=131  Identities=15%  Similarity=0.132  Sum_probs=84.9

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC---CccceeeEEe-cCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCT-TVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lv~e~~~~  376 (447)
                      +.++.|....||+.    ++.+++|+-+.   ......+.+|.+++..+.+.   .+.+.+.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            55778888889987    45678887432   12234688999999998753   3556666664 34567899999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC-----------------------------------------
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----------------------------------------  415 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------------  415 (447)
                      ..+.+..-..      ++......++.++++.|+.||+.                                         
T Consensus        98 ~~l~~~~~~~------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMAV------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHTT------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhhh------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            8776532110      22333334444444444444321                                         


Q ss_pred             ----------------CCCCeeecCCCCCceeeCC---CCc-eeecccc
Q 013258          416 ----------------CDPKIIHRDVKAANILLDE---DAD-QSSKTIL  444 (447)
Q Consensus       416 ----------------~~~~ivHrDlkp~NILl~~---~~~-~~i~df~  444 (447)
                                      ..+.++|+|++|.|||+++   ++. ..|.||.
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~  220 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFG  220 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCT
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehh
Confidence                            2346799999999999998   455 4788985

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.11  E-value=4.2e-06  Score=80.92  Aligned_cols=80  Identities=8%  Similarity=-0.019  Sum_probs=54.2

Q ss_pred             Ccc-ccCCCceEEEEEeC-------CCcEEEEEEcccccc--cccHHHHHHHHHHHhcCC-C--CCccceeeEEecC---
Q 013258          301 NIL-GRGGFGKVYKGRLA-------DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTV---  364 (447)
Q Consensus       301 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~---  364 (447)
                      +.| +.|....+|+....       +++.+++|+......  ......+.+|.+++..+. +  -.+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988754       256788887654320  101235778888888774 2  3567788877654   


Q ss_pred             CceEEEeecCCCCChh
Q 013258          365 TEKLLVYPYMTNGSVA  380 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~  380 (447)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999987654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.07  E-value=4.8e-07  Score=93.67  Aligned_cols=130  Identities=12%  Similarity=0.115  Sum_probs=86.4

Q ss_pred             CCEEEEEcCCCCcccccccccc-CCCCCCEEECC--C----CccCCC-----CChhhcCCCCCcEEEccCCcccccCCcc
Q 013258           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLELY--G----NNLSGH-----IPSALGNLIKLKSLDLYSNLFNGTIPDT  134 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~g~~p~~  134 (447)
                      .+++.|++..+.+++.....+. .+++|+.|+|+  +    |.+++.     ++..+.++++|+.|++++ .+++..+..
T Consensus       372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~  450 (594)
T 2p1m_B          372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY  450 (594)
T ss_dssp             TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred             hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence            3577788888888877666665 58888888888  3    555521     222356778888888876 565555555


Q ss_pred             ccC-CCCCCeeeCcCccccccCchHH-hhcccccccccccccccccCCC--CCCCCccccccccccc
Q 013258          135 LAN-LKQLKYLRLNNNSLSGLIPTSL-TTITSLNILDLSNNRLSGPVPD--NGSFSQFTPISFENNL  197 (447)
Q Consensus       135 ~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~ls~N~l~g~~p~--~~~~~~~~~~~~~~n~  197 (447)
                      +.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++..+.  ...+..++.+.+.+|.
T Consensus       451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred             HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence            554 7888888888888876555444 5678888888888888543221  1224555555565553

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.02  E-value=2.7e-06  Score=81.38  Aligned_cols=101  Identities=14%  Similarity=0.116  Sum_probs=81.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCc-EEEccCCcccccCCccccCCCCCCeee
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLK-SLDLYSNLFNGTIPDTLANLKQLKYLR  145 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~ls~N~l~g~~p~~~~~l~~L~~L~  145 (447)
                      .+++.|+|++|++...-+..|.++.+|+.|+|++| +...-+..|.++++|+ .+++++ +++..-+.+|.++++|+.++
T Consensus       226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            36888899988887655566888999999999887 7766667788899998 999988 66645567888899999999


Q ss_pred             CcCccccccCchHHhhcccccccc
Q 013258          146 LNNNSLSGLIPTSLTTITSLNILD  169 (447)
Q Consensus       146 l~~N~l~~~~p~~~~~l~~L~~l~  169 (447)
                      ++.|+++...+.+|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            988988877777888888888765

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.00  E-value=1.8e-06  Score=75.43  Aligned_cols=96  Identities=23%  Similarity=0.225  Sum_probs=75.9

Q ss_pred             cccccccCCCCCCEEECCCC-ccCCC----CChhhcCCCCCcEEEccCCccccc----CCccccCCCCCCeeeCcCcccc
Q 013258           82 ELAPELGQLKNLELLELYGN-NLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLS  152 (447)
Q Consensus        82 ~~~~~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~  152 (447)
                      .+...+...++|++|+|++| .+...    +...+...++|++|+|++|.+...    +...+...++|++|+|++|.+.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            45556788999999999999 88742    455677789999999999999642    4455666789999999999997


Q ss_pred             cc----CchHHhhccccccccc--ccccccc
Q 013258          153 GL----IPTSLTTITSLNILDL--SNNRLSG  177 (447)
Q Consensus       153 ~~----~p~~~~~l~~L~~l~l--s~N~l~g  177 (447)
                      ..    +...+...++|+.|++  ++|.+..
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence            54    3455666678999999  8899864

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.00  E-value=1.8e-06  Score=83.71  Aligned_cols=127  Identities=16%  Similarity=0.245  Sum_probs=78.1

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhc--CCCCCcEEEccC--Cccccc-----CCccc--
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALG--NLIKLKSLDLYS--NLFNGT-----IPDTL--  135 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~g~-----~p~~~--  135 (447)
                      .+++.|+|+++.- -.+++ + .+.+|++|+|..+.++...-..+.  .+++|+.|+|+.  |...|.     +...+  
T Consensus       172 P~L~~L~L~g~~~-l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~  248 (362)
T 2ra8_A          172 PLLNNLKIKGTNN-LSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK  248 (362)
T ss_dssp             TTCCEEEEECCBT-CBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred             CCCcEEEEeCCCC-ceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence            4788899887621 13333 3 378899999888877643333343  688888888863  222211     11122  


Q ss_pred             cCCCCCCeeeCcCccccccCchHHh---hccccccccccccccccc----CCCC-CCCCcccccccccc
Q 013258          136 ANLKQLKYLRLNNNSLSGLIPTSLT---TITSLNILDLSNNRLSGP----VPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       136 ~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~l~ls~N~l~g~----~p~~-~~~~~~~~~~~~~n  196 (447)
                      ..+++|++|+|++|.+....+..+.   .+++|+.|+++.|.+++.    ++.. ..+.++..+.+..|
T Consensus       249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n  317 (362)
T 2ra8_A          249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN  317 (362)
T ss_dssp             TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred             CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence            2468888999988888765555554   367888899988888753    2222 12344555555444

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=3.2e-05  Score=73.97  Aligned_cols=138  Identities=16%  Similarity=0.221  Sum_probs=75.7

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-----CCCcccee-e--EEecCCceEEEee
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLRLY-G--FCTTVTEKLLVYP  372 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lv~e  372 (447)
                      +.|+.|..+.||+....+| .+++|+....     ..++..|..++..+.     .|.++.-. |  +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3455677889999987554 5889988542     123344555554442     24433311 1  1123566789999


Q ss_pred             cCCCCChh--------------hHhhccCCCC----------CCCChHHHH-----------------------------
Q 013258          373 YMTNGSVA--------------SRLRERQSSL----------PPLDWPTRK-----------------------------  399 (447)
Q Consensus       373 ~~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~-----------------------------  399 (447)
                      |++|..+.              ..++......          ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1122110000          012342210                             


Q ss_pred             --HHHHHHHHHHhhhhc----------CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          400 --KIALGSARGLSYLHE----------HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       400 --~i~~~ia~gL~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                        .+..++..++++|+.          ...+.++|+|+++.|||++.++.+.+.||.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe  248 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLD  248 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCT
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehh
Confidence              111123445666653          123589999999999999888889999985

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.97  E-value=2.3e-06  Score=88.47  Aligned_cols=107  Identities=18%  Similarity=0.199  Sum_probs=77.8

Q ss_pred             CCEEEEEcCCCCcccccccccc-CCCCCCEEECCCC-ccCCC-CChhhcCCCCCcEEEccCCcccccCCcccc----CCC
Q 013258           67 GSVTRVDLGNAALSGELAPELG-QLKNLELLELYGN-NLSGH-IPSALGNLIKLKSLDLYSNLFNGTIPDTLA----NLK  139 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~----~l~  139 (447)
                      .+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .++
T Consensus       105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~  184 (594)
T 2p1m_B          105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT  184 (594)
T ss_dssp             TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred             CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence            3688999999998887777775 6889999999988 55432 455556789999999999988765444443    567


Q ss_pred             CCCeeeCcCcc--ccc-cCchHHhhcccccccccccc
Q 013258          140 QLKYLRLNNNS--LSG-LIPTSLTTITSLNILDLSNN  173 (447)
Q Consensus       140 ~L~~L~l~~N~--l~~-~~p~~~~~l~~L~~l~ls~N  173 (447)
                      +|+.|++++|.  +.. .++..+..+++|+.|++++|
T Consensus       185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~  221 (594)
T 2p1m_B          185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA  221 (594)
T ss_dssp             CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred             cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence            89999998887  221 12222345588899998887

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.93  E-value=4.2e-05  Score=75.06  Aligned_cols=76  Identities=9%  Similarity=0.022  Sum_probs=49.2

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEcccccc------cccHHHHHHHHHHHhcCCC--CC-ccceeeEEecCCceEE
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT------SGGELQFQTEVKIISMAVH--RN-LLRLYGFCTTVTEKLL  369 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~l  369 (447)
                      .+.+|.|.++.||++... +++.++||.......      .....++..|.+++..+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999754 468899998643211      1122356788888887642  33 4455543  3455789


Q ss_pred             EeecCCCC
Q 013258          370 VYPYMTNG  377 (447)
Q Consensus       370 v~e~~~~g  377 (447)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.85  E-value=7.6e-05  Score=70.61  Aligned_cols=138  Identities=16%  Similarity=0.171  Sum_probs=90.2

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC---CCCccceeeEEecCCceEEEeecCCC
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      .+.|+.|.+..+|+... +++.+.+|+....    ....+.+|.+.|+.+.   ...+.+++.++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            35688999999999886 4677888976432    2446889998888774   35678888888877889999999998


Q ss_pred             CChhh-----------HhhccCC-CC-----------------CCCChHHHH---HHHHH----------------HHHH
Q 013258          377 GSVAS-----------RLRERQS-SL-----------------PPLDWPTRK---KIALG----------------SARG  408 (447)
Q Consensus       377 gsL~~-----------~l~~~~~-~~-----------------~~l~~~~~~---~i~~~----------------ia~g  408 (447)
                      ..+..           .|+.... ..                 ..-+|....   ++..+                +...
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76421           2232211 00                 012454321   11111                1111


Q ss_pred             -Hhhhhc-CCCCCeeecCCCCCceeeCCCCceeeccc
Q 013258          409 -LSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  443 (447)
Q Consensus       409 -L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df  443 (447)
                       ...|.. ...|.++|+|+.+.|++++.++ +.|.|+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~  231 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP  231 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence             123321 2357899999999999999887 888886

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.83  E-value=0.00014  Score=67.90  Aligned_cols=76  Identities=17%  Similarity=0.235  Sum_probs=54.1

Q ss_pred             CCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC---CccceeeEEecCCceEEEeecC
Q 013258          298 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ...+.+|.|..+.||+.+..+|+.|.||+-.... ......|.+|.+.|+.+.-.   -+.+.+++    +..++||||+
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l   92 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence            3346789999999999999999999999875432 22233588999998877422   24445543    2357999999


Q ss_pred             CCCC
Q 013258          375 TNGS  378 (447)
Q Consensus       375 ~~gs  378 (447)
                      +++.
T Consensus        93 ~~~~   96 (288)
T 3f7w_A           93 DERP   96 (288)
T ss_dssp             CCCC
T ss_pred             cccC
Confidence            8765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.72  E-value=1.1e-05  Score=78.06  Aligned_cols=126  Identities=17%  Similarity=0.201  Sum_probs=67.2

Q ss_pred             CEEEEEcCCCCc---------cccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCcccc--
Q 013258           68 SVTRVDLGNAAL---------SGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLA--  136 (447)
Q Consensus        68 ~v~~l~L~~~~l---------~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~--  136 (447)
                      +++.|.|..+..         .+.+.+.+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..+.++...-..+.  
T Consensus       140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~  216 (362)
T 2ra8_A          140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGS  216 (362)
T ss_dssp             TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred             hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHc
Confidence            566676655432         1224455566777888888776311 2333 3 267788888877766543333333  


Q ss_pred             CCCCCCeeeCcC--ccccccC-----chHH--hhcccccccccccccccccCC----CCCCCCcccccccccc
Q 013258          137 NLKQLKYLRLNN--NSLSGLI-----PTSL--TTITSLNILDLSNNRLSGPVP----DNGSFSQFTPISFENN  196 (447)
Q Consensus       137 ~l~~L~~L~l~~--N~l~~~~-----p~~~--~~l~~L~~l~ls~N~l~g~~p----~~~~~~~~~~~~~~~n  196 (447)
                      .+++|+.|+|+.  |...+..     ...+  ..+++|+.|++++|.+....+    ..+.+.+++.++++.|
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n  289 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG  289 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC
Confidence            577788777753  2222110     1111  235678888887777764221    1123445555555444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.48  E-value=6e-05  Score=65.88  Aligned_cols=110  Identities=15%  Similarity=0.202  Sum_probs=73.9

Q ss_pred             CCCEEEEEcCCC-Cccc----cccccccCCCCCCEEECCCCccCC----CCChhhcCCCCCcEEEccCCccccc----CC
Q 013258           66 EGSVTRVDLGNA-ALSG----ELAPELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGT----IP  132 (447)
Q Consensus        66 ~~~v~~l~L~~~-~l~g----~~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p  132 (447)
                      ...++.|+|+++ .+..    .+...+..-+.|+.|+|++|.+..    .+...+..-+.|+.|+|++|.++..    +-
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala  119 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL  119 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence            346888889875 7764    245566777888999999998873    3445555667889999999988632    33


Q ss_pred             ccccCCCCCCeeeCcCc---ccccc----CchHHhhcccccccccccccc
Q 013258          133 DTLANLKQLKYLRLNNN---SLSGL----IPTSLTTITSLNILDLSNNRL  175 (447)
Q Consensus       133 ~~~~~l~~L~~L~l~~N---~l~~~----~p~~~~~l~~L~~l~ls~N~l  175 (447)
                      +++..-+.|++|+|++|   .+...    +-..+..-++|+.|+++.|.+
T Consensus       120 ~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          120 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            45555677888998865   33321    333445556788888776654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.46  E-value=0.00045  Score=68.23  Aligned_cols=74  Identities=14%  Similarity=0.110  Sum_probs=45.6

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEccccc-----c---cccHHHHHHHHHHHh-cCCCCCccceeeEEecCCceEEE
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER-----T---SGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .+.+|.|..+.||+... +++.++||......     .   ......++.|+..+. ...+..+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            36689999999999964 46789999432210     0   112223444544332 22234566777665  5667999


Q ss_pred             eecC-CC
Q 013258          371 YPYM-TN  376 (447)
Q Consensus       371 ~e~~-~~  376 (447)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.44  E-value=4.7e-05  Score=65.32  Aligned_cols=84  Identities=15%  Similarity=0.175  Sum_probs=59.0

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCc-cCCCCChhhcCC----CCCcEEEccCCc-ccccCCccccCCCC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNN-LSGHIPSALGNL----IKLKSLDLYSNL-FNGTIPDTLANLKQ  140 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~g~~p~~~~~l~~  140 (447)
                      -.++.|||+++.++..--..+..+++|++|+|+++. ++..-=..++.+    ++|+.|+|+++. ++..-=..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            368999999988877655667888899999998874 553222234443    368888888874 65332234667888


Q ss_pred             CCeeeCcCcc
Q 013258          141 LKYLRLNNNS  150 (447)
Q Consensus       141 L~~L~l~~N~  150 (447)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888888875

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.42  E-value=3.9e-05  Score=65.84  Aligned_cols=84  Identities=12%  Similarity=0.099  Sum_probs=63.2

Q ss_pred             CCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCc-ccccCCccccCC----CCCCeeeCcCcc-ccccCchHHhhccc
Q 013258           91 KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNL-FNGTIPDTLANL----KQLKYLRLNNNS-LSGLIPTSLTTITS  164 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~  164 (447)
                      .+|+.|||+++.++..-=..+.++++|+.|+|+++. ++..-=..++.+    ++|++|+|++|. ++..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            479999999999885444557889999999999985 654322345543    479999999985 76543456778889


Q ss_pred             cccccccccc
Q 013258          165 LNILDLSNNR  174 (447)
Q Consensus       165 L~~l~ls~N~  174 (447)
                      |+.|++++..
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            9999998864

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.23  E-value=0.00033  Score=68.80  Aligned_cols=102  Identities=16%  Similarity=0.178  Sum_probs=75.4

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccc-----ccCCccccCCCCCC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN-----GTIPDTLANLKQLK  142 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----g~~p~~~~~l~~L~  142 (447)
                      .++.++|+++ +...-...+.+ .+|+.+.| .|.++..-+..|.++++|+.+++.+|.+.     ..-+.+|.++++|+
T Consensus       227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~  303 (401)
T 4fdw_A          227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA  303 (401)
T ss_dssp             TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred             CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence            5777888764 33222334445 78999999 55566555778889999999999988764     23456788899999


Q ss_pred             eeeCcCccccccCchHHhhcccccccccccc
Q 013258          143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNN  173 (447)
Q Consensus       143 ~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N  173 (447)
                      .++|. |.++..-..+|.++++|+.+++.+|
T Consensus       304 ~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          304 RFEIP-ESIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             EECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred             eEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence            99998 4577666778888899999998665

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.06  E-value=0.0018  Score=61.62  Aligned_cols=76  Identities=12%  Similarity=0.037  Sum_probs=38.4

Q ss_pred             CccccCCCce-EEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEeecCCCC
Q 013258          301 NILGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       301 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~g  377 (447)
                      +.|+.|.... +|+....+++.+.+|.......    ..+..|+.++..+..  -.+.+++.+....  -+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            4455554444 6677654467777776543210    124456666665532  2355666653332  37899999776


Q ss_pred             ChhhH
Q 013258          378 SVASR  382 (447)
Q Consensus       378 sL~~~  382 (447)
                      .+.+.
T Consensus        98 ~l~~~  102 (333)
T 3csv_A           98 LFTEV  102 (333)
T ss_dssp             BHHHH
T ss_pred             chHHH
Confidence            65443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.05  E-value=0.00061  Score=55.44  Aligned_cols=57  Identities=23%  Similarity=0.316  Sum_probs=40.4

Q ss_pred             CEEECCCCccC-CCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCcccc
Q 013258           94 ELLELYGNNLS-GHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS  152 (447)
Q Consensus        94 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  152 (447)
                      ..++-+++.|+ ..+|..+.  .+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            46778888876 34665443  46788888888887544556677888888888888775

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.03  E-value=0.0022  Score=62.90  Aligned_cols=79  Identities=13%  Similarity=0.161  Sum_probs=45.3

Q ss_pred             CCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccc
Q 013258           92 NLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS  171 (447)
Q Consensus        92 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls  171 (447)
                      +|+.+.+.+ .+...-+..|.++++|+.++|++|+++ .+|...-...+|+.+.|.+| ++..-..+|.++++|+.+++.
T Consensus       158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~  234 (401)
T 4fdw_A          158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP  234 (401)
T ss_dssp             CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred             CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence            466666653 444444456666666666666666666 33333222466666666633 544445566666666666665


Q ss_pred             cc
Q 013258          172 NN  173 (447)
Q Consensus       172 ~N  173 (447)
                      +|
T Consensus       235 ~~  236 (401)
T 4fdw_A          235 EN  236 (401)
T ss_dssp             TT
T ss_pred             CC
Confidence            54

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.98  E-value=0.0012  Score=53.73  Aligned_cols=56  Identities=30%  Similarity=0.382  Sum_probs=38.8

Q ss_pred             EEEcCCCCcc-ccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccc
Q 013258           71 RVDLGNAALS-GELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN  128 (447)
Q Consensus        71 ~l~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  128 (447)
                      .++.++++++ ..+|..+.  .+|++|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5666777775 35564433  35788888888888655566777888888888888664

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.83  E-value=0.022  Score=53.75  Aligned_cols=75  Identities=19%  Similarity=0.117  Sum_probs=47.7

Q ss_pred             CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCC--CccceeeE-----EecCCceEEEeec
Q 013258          301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGF-----CTTVTEKLLVYPY  373 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lv~e~  373 (447)
                      +.++ |....||+....+|+.+++|..+...  .....+..|..++..+...  .+++++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4466 77789999877667789999886332  1234567788877766422  24444443     1123456789999


Q ss_pred             CCCCC
Q 013258          374 MTNGS  378 (447)
Q Consensus       374 ~~~gs  378 (447)
                      ++|..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.82  E-value=0.0045  Score=58.34  Aligned_cols=156  Identities=7%  Similarity=0.032  Sum_probs=82.3

Q ss_pred             ccHHHHHHHhcCCCCC-----CccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC--ccce
Q 013258          285 FSLRELQVATDGFSNK-----NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRL  357 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l  357 (447)
                      ++.+++......|...     +.|+.|....+|+....+| .+++|......   ...++..|..++..+....  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4455555555556542     3456677788999887555 57789875421   1224566777776654222  2333


Q ss_pred             eeE------EecCCceEEEeecCCCCChhh--------------HhhccCCC--CC------CCChHHHHH---------
Q 013258          358 YGF------CTTVTEKLLVYPYMTNGSVAS--------------RLRERQSS--LP------PLDWPTRKK---------  400 (447)
Q Consensus       358 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~--~~------~l~~~~~~~---------  400 (447)
                      +..      ....+..+++++|++|..+..              .++.....  ..      ...|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      112345689999998865321              12211100  00      012322110         


Q ss_pred             ---HHHHHHHHHhhhhc----CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          401 ---IALGSARGLSYLHE----HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       401 ---i~~~ia~gL~yLH~----~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                         +...+...+++++.    .....++|+|+.+.|||++++....+.||-
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~  213 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFY  213 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCT
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecch
Confidence               00113344445442    123479999999999999987666899984

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.81  E-value=0.0028  Score=59.35  Aligned_cols=71  Identities=8%  Similarity=0.028  Sum_probs=43.0

Q ss_pred             CCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEeecC-CCC
Q 013258          300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYM-TNG  377 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~-~~g  377 (447)
                      .+.|+.|....+|+.     +.+.+|+.......  .....+|..++..+....+ .+++++  ..+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            577888999999998     45778877543211  1123567777766643333 355543  344467899999 554


Q ss_pred             Ch
Q 013258          378 SV  379 (447)
Q Consensus       378 sL  379 (447)
                      .+
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.79  E-value=0.0027  Score=62.81  Aligned_cols=71  Identities=18%  Similarity=0.260  Sum_probs=47.5

Q ss_pred             CccccCCCceEEEEEeCC--------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEe
Q 013258          301 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  371 (447)
                      +.|+.|-...+|+....+        ++.+.+|+....   .....+.+|..++..+...++ .++++.+..    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            457778888999998653        478888887331   111356678888887753344 566765542    3899


Q ss_pred             ecCCCCC
Q 013258          372 PYMTNGS  378 (447)
Q Consensus       372 e~~~~gs  378 (447)
                      ||++|..
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.64  E-value=0.0068  Score=58.75  Aligned_cols=138  Identities=13%  Similarity=0.142  Sum_probs=77.2

Q ss_pred             CccccCCCceEEEEEeC--------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEEe
Q 013258          301 NILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~  371 (447)
                      +.+..|-...+|+....        +++.+.+|+....  ........+|.++++.+.-.+ ..++++++..    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45666778889998864        2478889886332  123345678999888774323 3566666543    3999


Q ss_pred             ecCCCCChhh--------------H---hhccCCC-CCCCC--hHHHHHHHHHHHH-------------------HHhhh
Q 013258          372 PYMTNGSVAS--------------R---LRERQSS-LPPLD--WPTRKKIALGSAR-------------------GLSYL  412 (447)
Q Consensus       372 e~~~~gsL~~--------------~---l~~~~~~-~~~l~--~~~~~~i~~~ia~-------------------gL~yL  412 (447)
                      ||++|..+..              .   |+..... .....  |.+..++..++..                   .+++|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998755431              1   1111100 11112  3344444433322                   12222


Q ss_pred             h----c-CCCCCeeecCCCCCceeeCCC----Cceeecccc
Q 013258          413 H----E-HCDPKIIHRDVKAANILLDED----ADQSSKTIL  444 (447)
Q Consensus       413 H----~-~~~~~ivHrDlkp~NILl~~~----~~~~i~df~  444 (447)
                      .    . .....++|+|+.+.|||++++    +.+.+.||.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE  250 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFE  250 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCT
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecc
Confidence            2    1 123368999999999999887    678999985

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.42  E-value=0.017  Score=57.49  Aligned_cols=73  Identities=15%  Similarity=0.172  Sum_probs=46.3

Q ss_pred             CccccCCCceEEEEEeCC-CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEeecCCCCC
Q 013258          301 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      +.|+.|-...+|+....+ +..+.+|+......  ....-.+|..++..+...++ .++++++.  +  .+||||++|..
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            557778888999998765 47788887643221  11122578888888865555 56777663  2  35999998744


Q ss_pred             h
Q 013258          379 V  379 (447)
Q Consensus       379 L  379 (447)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.39  E-value=0.0011  Score=57.82  Aligned_cols=90  Identities=13%  Similarity=0.137  Sum_probs=65.2

Q ss_pred             cccccCCCCCCEEECCCC-ccCC----CCChhhcCCCCCcEEEccCCccccc----CCccccCCCCCCeeeCcCcccccc
Q 013258           84 APELGQLKNLELLELYGN-NLSG----HIPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGL  154 (447)
Q Consensus        84 ~~~l~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~  154 (447)
                      ..-+.+-+.|+.|+|++| .+..    .+-..+..-+.|+.|+|++|++...    +-+.+..-++|++|+|++|.+...
T Consensus        34 ~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~  113 (197)
T 1pgv_A           34 NRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPE  113 (197)
T ss_dssp             HHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHH
T ss_pred             HHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHH
Confidence            334566788999999986 7763    2455677778999999999999632    344555668999999999999743


Q ss_pred             Cch----HHhhcccccccccccc
Q 013258          155 IPT----SLTTITSLNILDLSNN  173 (447)
Q Consensus       155 ~p~----~~~~l~~L~~l~ls~N  173 (447)
                      --.    ++..-+.|+.|++++|
T Consensus       114 Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          114 LLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHHHHhhCCceeEEECCCC
Confidence            222    3333456999999865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.30  E-value=0.0074  Score=58.22  Aligned_cols=72  Identities=7%  Similarity=0.029  Sum_probs=42.3

Q ss_pred             CccccCCCceEEEEEeCC---------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEE
Q 013258          301 NILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv  370 (447)
                      +.++.|....+|+....+         ++.+.+|+.......  ..+...|.+++..+...+ ..++++..    .-++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            456778888999988654         267888876543211  112356777777764333 34666543    23789


Q ss_pred             eecCCCCC
Q 013258          371 YPYMTNGS  378 (447)
Q Consensus       371 ~e~~~~gs  378 (447)
                      |||++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=95.86  E-value=0.016  Score=55.93  Aligned_cols=85  Identities=18%  Similarity=0.224  Sum_probs=45.2

Q ss_pred             cccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccc
Q 013258           86 ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL  165 (447)
Q Consensus        86 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  165 (447)
                      .+.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|+.+++.++.++..-..+|.++.+|
T Consensus       235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L  312 (379)
T 4h09_A          235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL  312 (379)
T ss_dssp             TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred             cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence            3455666666666544 33333345555666666666443 322223345556666666666555554445556666666


Q ss_pred             ccccccc
Q 013258          166 NILDLSN  172 (447)
Q Consensus       166 ~~l~ls~  172 (447)
                      +.+++..
T Consensus       313 ~~i~lp~  319 (379)
T 4h09_A          313 SSVTLPT  319 (379)
T ss_dssp             CEEECCT
T ss_pred             CEEEcCc
Confidence            6665543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=95.73  E-value=0.025  Score=54.99  Aligned_cols=82  Identities=20%  Similarity=0.327  Sum_probs=34.1

Q ss_pred             CCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccc
Q 013258           89 QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNIL  168 (447)
Q Consensus        89 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l  168 (447)
                      ++.+|+.+.+. +.++..-...|.++.+|+.++|..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.++++|+.+
T Consensus       286 ~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i  362 (394)
T 4gt6_A          286 NCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNI  362 (394)
T ss_dssp             TCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred             cccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence            34444444442 2233222334444455555555433 22122234444555555555332 332223444445555555


Q ss_pred             ccccc
Q 013258          169 DLSNN  173 (447)
Q Consensus       169 ~ls~N  173 (447)
                      ++++|
T Consensus       363 ~~~~~  367 (394)
T 4gt6_A          363 EYSGS  367 (394)
T ss_dssp             EESSC
T ss_pred             EECCc
Confidence            44444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.55  E-value=0.08  Score=50.29  Aligned_cols=27  Identities=19%  Similarity=0.217  Sum_probs=24.4

Q ss_pred             CCeeecCCCCCceeeCCCCceeecccc
Q 013258          418 PKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       418 ~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ..++|+|+.+.||++++++.+.+.||.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e  232 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWD  232 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCS
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECC
Confidence            479999999999999988889999985

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=95.18  E-value=0.026  Score=54.87  Aligned_cols=87  Identities=10%  Similarity=0.170  Sum_probs=58.7

Q ss_pred             ccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccc
Q 013258           85 PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS  164 (447)
Q Consensus        85 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  164 (447)
                      ..+.++.+|+.+.|..+ ++..-..+|.++.+|+.+.+..+ ++..-..+|.++++|+.+++.+|....   ..+....+
T Consensus       305 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~  379 (394)
T 4gt6_A          305 SVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSG  379 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCC
T ss_pred             eeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCC
Confidence            45678999999999765 66445678999999999999866 553335689999999999999886542   34556677


Q ss_pred             cccccccccccc
Q 013258          165 LNILDLSNNRLS  176 (447)
Q Consensus       165 L~~l~ls~N~l~  176 (447)
                      |+.+.+..|.+.
T Consensus       380 L~~i~i~~~~~~  391 (394)
T 4gt6_A          380 LQNLPVAPGSID  391 (394)
T ss_dssp             C-----------
T ss_pred             CCEEEeCCCCEE
Confidence            888877666543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=94.93  E-value=0.025  Score=55.01  Aligned_cols=82  Identities=11%  Similarity=0.044  Sum_probs=38.3

Q ss_pred             ccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccc
Q 013258           87 LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN  166 (447)
Q Consensus        87 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  166 (447)
                      +..+..++.+.+..+.+.   ...+..+.+|+.+.+.++ +...-..+|.++++|+.++|.++ ++..-..+|.++++|+
T Consensus       272 F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~  346 (394)
T 4fs7_A          272 FYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLS  346 (394)
T ss_dssp             TTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCC
T ss_pred             cccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCC
Confidence            344555555555443321   123445555555555443 33222334555555555555433 3333344555555555


Q ss_pred             ccccccc
Q 013258          167 ILDLSNN  173 (447)
Q Consensus       167 ~l~ls~N  173 (447)
                      .+++..|
T Consensus       347 ~i~lp~~  353 (394)
T 4fs7_A          347 NINFPLS  353 (394)
T ss_dssp             EECCCTT
T ss_pred             EEEECcc
Confidence            5555443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=94.81  E-value=0.033  Score=54.14  Aligned_cols=85  Identities=13%  Similarity=0.090  Sum_probs=67.2

Q ss_pred             cccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccc
Q 013258           86 ELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL  165 (447)
Q Consensus        86 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L  165 (447)
                      .+..+.+|+.+.+..+ ++..-..+|.++++|+.+++.++ ++-.-..+|.++++|+.+++..| ++..-..+|.++++|
T Consensus       292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L  368 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL  368 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred             cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence            4667899999999765 66445667899999999999765 65344568899999999999877 665566789999999


Q ss_pred             cccccccc
Q 013258          166 NILDLSNN  173 (447)
Q Consensus       166 ~~l~ls~N  173 (447)
                      +.+++..+
T Consensus       369 ~~i~lp~~  376 (394)
T 4fs7_A          369 KKVELPKR  376 (394)
T ss_dssp             CEEEEEGG
T ss_pred             CEEEECCC
Confidence            99988765

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=94.48  E-value=0.16  Score=48.80  Aligned_cols=82  Identities=12%  Similarity=0.152  Sum_probs=41.7

Q ss_pred             ccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccc
Q 013258           87 LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN  166 (447)
Q Consensus        87 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  166 (447)
                      +.++.+|+.+.+..+ +...-...|.++++|+.+.+.++.++..-..+|.++.+|+.++|.++ ++..-..+|.++++|+
T Consensus       259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  336 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS  336 (379)
T ss_dssp             TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence            444555666555432 33222334555666666666555554333345555666666666433 3333344555555555


Q ss_pred             cccc
Q 013258          167 ILDL  170 (447)
Q Consensus       167 ~l~l  170 (447)
                      .+.+
T Consensus       337 ~i~i  340 (379)
T 4h09_A          337 TISY  340 (379)
T ss_dssp             CCCC
T ss_pred             EEEE
Confidence            5544

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.86  E-value=0.05  Score=34.43  Aligned_cols=32  Identities=22%  Similarity=0.174  Sum_probs=19.2

Q ss_pred             CCcccchhhhhhHHHHHhhhhhhheeehhcCC
Q 013258          231 SNAAIPVGVALGAALLFAVPVIGFAYWRRTRP  262 (447)
Q Consensus       231 ~~~~i~i~v~~g~~~lv~~~vi~~~~~~~~~~  262 (447)
                      ....|+.+++.|.+.++++.+..++++|||+.
T Consensus         9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B            9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             CcceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            34456667776666665555555666666554

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.98  E-value=0.05  Score=34.31  Aligned_cols=33  Identities=27%  Similarity=0.263  Sum_probs=19.5

Q ss_pred             CCcccchhhhhhHHHHHhhhhhhheeehhcCCC
Q 013258          231 SNAAIPVGVALGAALLFAVPVIGFAYWRRTRPH  263 (447)
Q Consensus       231 ~~~~i~i~v~~g~~~lv~~~vi~~~~~~~~~~~  263 (447)
                      ....|+.+++.|.+.++++....++++|||+.+
T Consensus         8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            345566666666666655555556666665543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.94  E-value=0.35  Score=47.36  Aligned_cols=73  Identities=4%  Similarity=0.017  Sum_probs=46.0

Q ss_pred             CccccCCCceEEEEEeCC--------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCC-ccceeeEEecCCceEEEe
Q 013258          301 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lv~  371 (447)
                      +.+..|-...+|+....+        ++.+.+|+......  ...+..+|.++++.+.-.+ ..++++.+.    -++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            456667788899988753        57888888643321  1112457788777764323 345555332    37899


Q ss_pred             ecCCCCCh
Q 013258          372 PYMTNGSV  379 (447)
Q Consensus       372 e~~~~gsL  379 (447)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.70  E-value=0.038  Score=55.06  Aligned_cols=61  Identities=7%  Similarity=0.009  Sum_probs=17.9

Q ss_pred             CCccccCCCceEEEEEeCC-CcEEEE------EEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec
Q 013258          300 KNILGRGGFGKVYKGRLAD-GKLVAV------KRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT  363 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  363 (447)
                      .+.+|   ||+||+|.+.. ..+|||      |..+..... .....|.+|..++...+|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45666   99999999754 467888      766543322 223358889999999999999999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.87  E-value=1.3  Score=38.79  Aligned_cols=81  Identities=7%  Similarity=0.012  Sum_probs=58.4

Q ss_pred             CCCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCC
Q 013258          349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  428 (447)
Q Consensus       349 l~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~  428 (447)
                      ..||+.+.. .+-.+.+...+.|+.-+.+-=+..++.       .+...+++++..++.--+++++.     +|--+.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            368888866 455556666666654433222222332       66788999999999888888765     78899999


Q ss_pred             ceeeCCCCceeecc
Q 013258          429 NILLDEDADQSSKT  442 (447)
Q Consensus       429 NILl~~~~~~~i~d  442 (447)
                      ||.+|.++.|++..
T Consensus       109 NL~f~~~~~p~i~~  122 (215)
T 4ann_A          109 ELFFTRDGLPIAKT  122 (215)
T ss_dssp             GEEECTTSCEEESC
T ss_pred             eEEEcCCCCEEEEE
Confidence            99999999999875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.51  E-value=2.3  Score=37.32  Aligned_cols=79  Identities=10%  Similarity=0.016  Sum_probs=57.9

Q ss_pred             CCCCccceeeEEecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHh-hhhcCCCCCeeecCCCCC
Q 013258          350 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS-YLHEHCDPKIIHRDVKAA  428 (447)
Q Consensus       350 ~H~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivHrDlkp~  428 (447)
                      .||++  -...-.+.+...+.|+.-+++-=+..++.       ++...+++++..++.-.. ++++.     +|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence            58887  33344566777777765544443444432       677889999999988888 77765     78889999


Q ss_pred             ceeeCCCCceeecc
Q 013258          429 NILLDEDADQSSKT  442 (447)
Q Consensus       429 NILl~~~~~~~i~d  442 (447)
                      ||.+|.++.|++..
T Consensus       114 NL~f~~~~~p~i~h  127 (219)
T 4ano_A          114 NLMFNRALEPFFLH  127 (219)
T ss_dssp             GEEECTTCCEEESC
T ss_pred             eEEEeCCCcEEEEE
Confidence            99999999999874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.71  E-value=0.34  Score=47.02  Aligned_cols=25  Identities=28%  Similarity=0.329  Sum_probs=20.9

Q ss_pred             eeecCCCCCceee------CCCCceeecccc
Q 013258          420 IIHRDVKAANILL------DEDADQSSKTIL  444 (447)
Q Consensus       420 ivHrDlkp~NILl------~~~~~~~i~df~  444 (447)
                      ++|+|+.+.|||+      +++..+.+.||.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwE  276 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFE  276 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCT
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechH
Confidence            5799999999999      445678899985

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=81.17  E-value=0.94  Score=28.05  Aligned_cols=28  Identities=39%  Similarity=0.600  Sum_probs=13.0

Q ss_pred             cccchhhhhhHHHHHhhhhhhheeehhc
Q 013258          233 AAIPVGVALGAALLFAVPVIGFAYWRRT  260 (447)
Q Consensus       233 ~~i~i~v~~g~~~lv~~~vi~~~~~~~~  260 (447)
                      ..++.+++.|.++++++....++++|||
T Consensus        13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rRr   40 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLLVLAGVGFFIHRRR   40 (41)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHSSSSSC
T ss_pred             EEEEeehhHHHHHHHHHHHHheeEeeec
Confidence            4445555555554332334444555543

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=80.64  E-value=0.73  Score=28.96  Aligned_cols=26  Identities=15%  Similarity=0.236  Sum_probs=11.6

Q ss_pred             hhhhhhHHHHHhhhhhhheeehhcCC
Q 013258          237 VGVALGAALLFAVPVIGFAYWRRTRP  262 (447)
Q Consensus       237 i~v~~g~~~lv~~~vi~~~~~~~~~~  262 (447)
                      ++.++|.++++.+.+..++++|||+.
T Consensus        15 a~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           15 ISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHHHHHHHhheehhhh
Confidence            44444444444444444445555443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	447
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-37
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-36
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-36
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-34
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-34
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-34
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-34
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-33
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-33
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-33
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-31
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-31
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-30
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-29
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-27
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-22
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-39
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 290 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++  YG   +  E  +   +M  GS+   L++       +      K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           L+YL E    KI+HRDVK +NIL++  
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSR 141

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 19/164 (11%)

Query: 285 FSLRELQVATDGFSNK---------NILGRGGFGKVYKGRLA----DGKLVAVKRLKEER 331
           F+  +   A   F+ +          ++G G FG+V  G L         VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 332 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 391
           T      F +E  I+    H N++ L G  T  T  +++  +M NGS+ S LR+      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123

Query: 392 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                    +  G A G+ YL +      +HRD+ A NIL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 8e-37
 Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           +       LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           +RLY   T      ++  YM NGS+   L+        L       +A   A G++++ E
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 415 HCDPKIIHRDVKAANILLDE 434
                 IHRD++AANIL+ +
Sbjct: 128 RN---YIHRDLRAANILVSD 144

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-36
 Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 11/152 (7%)

Query: 288 RELQVATDGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEV 343
           ++L +  D     +I LG G FG V +G          VA+K LK+        +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 344 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 403
           +I+    +  ++RL G C      +LV      G +   L  ++  +P        ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIP---VSNVAELLH 116

Query: 404 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
             + G+ YL E      +HRD+ A N+LL   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNR 145

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 6e-36
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 10/140 (7%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLL 355
            +    +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
              G+ T   +  +V  +    S+   L   ++     +      IA  +A+G+ YLH  
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 416 CDPKIIHRDVKAANILLDED 435
               IIHRD+K+ NI L ED
Sbjct: 124 S---IIHRDLKSNNIFLHED 140

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 7e-36
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIIS- 347
           +  S    LG G FGKV +              VAVK LK            +E+K++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--------------PL 393
           +  H N++ L G CT     L++  Y   G + + LR ++ S                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 394 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           D       +   A+G+++L        IHRD+ A NILL   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 8e-36
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
                 +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQ 64

Query: 357 LYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
           L G        L +V  YM  GS+   LR R  S   L      K +L     + YL  +
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 416 CDPKIIHRDVKAANILLDED 435
                +HRD+ A N+L+ ED
Sbjct: 123 ---NFVHRDLAARNVLVSED 139

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR 352
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 353 NLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           N++R Y      T   L  V  Y   G +AS + +       LD     ++       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 411 YLHEH--CDPKIIHRDVKAANILLDED 435
             H        ++HRD+K AN+ LD  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK 150

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 4e-35
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 29/176 (16%)

Query: 286 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQF 339
            L  L+   +       +G G FG+V++ R           +VAVK LKEE ++  +  F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL--------- 390
           Q E  +++   + N+++L G C       L++ YM  G +   LR               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 391 -----------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                      PPL    +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 6e-35
 Identities = 36/142 (25%), Positives = 58/142 (40%), Gaps = 8/142 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           + +     LG G +G+V         + VAVK +  +R        + E+ I  M  H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           +++ YG       + L   Y + G +  R+         +  P  ++       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120

Query: 414 EHCDPKIIHRDVKAANILLDED 435
                 I HRD+K  N+LLDE 
Sbjct: 121 GIG---ITHRDIKPENLLLDER 139

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 29/160 (18%)

Query: 302 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL 354
           +LG G FGKV                VAVK LKE+  S       +E+K+++    H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-------------------PLDW 395
           + L G CT      L++ Y   G + + LR ++                        L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 396 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                 A   A+G+ +L        +HRD+ A N+L+   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 200

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV 350
              FS+   +G G FG VY  R + + ++VA+K++        E       EV+ +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H N ++  G         LV  Y    +       ++    PL       +  G+ +GL+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           YLH H    +IHRDVKA NILL E 
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEP 151

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            +    +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQ 64

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG C       LV+ +M +G ++  LR ++         T   + L    G++YL E C
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 417 DPKIIHRDVKAANILLDED 435
              +IHRD+ A N L+ E+
Sbjct: 122 ---VIHRDLAARNCLVGEN 137

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 17/145 (11%)

Query: 300 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 359
           +  +G+G FG+V++G+   G+ VAVK              + E+    M  H N+L    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64

Query: 360 FCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
                  T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119

Query: 416 C-----DPKIIHRDVKAANILLDED 435
                  P I HRD+K+ NIL+ ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN 144

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 8/139 (5%)

Query: 297 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 356
            +    LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQ 63

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG CT      ++  YM NG + + LRE +            ++       + YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 417 DPKIIHRDVKAANILLDED 435
               +HRD+ A N L+++ 
Sbjct: 121 ---FLHRDLAARNCLVNDQ 136

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 8/154 (5%)

Query: 283 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT 341
              +  + ++     + K+ LG G +G+VY+G        VAVK LKE+     E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 401
           E  ++    H NL++L G CT      ++  +MT G++   LRE       +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A   +  + YL +      IHRD+ A N L+ E+
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 300 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 357
              +GRG F  VYKG   +    VA   L++ + +  E Q F+ E +++    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 358 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           Y    +  +     +LV   MT+G++ + L+  +     +     +       +GL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 414 EHCDPKIIHRDVKAANILLDED 435
               P IIHRD+K  NI +   
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGP 150

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-33
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 283 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQF 339
           ++++L + ++          LG+G FG VY  R      ++A+K L + +   +G E Q 
Sbjct: 1   RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 340 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 399
           + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++        D     
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTA 109

Query: 400 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                 A  LSY H     ++IHRD+K  N+LL   
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSA 142

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 8/143 (5%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
            D +     LG G FGKVYK +      L A K +  +     E  +  E+ I++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L           ++  +   G+V + + E +    PL     + +   +   L+YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H++   KIIHRD+KA NIL   D
Sbjct: 127 HDN---KIIHRDLKAGNILFTLD 146

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAV 350
           +    ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTR 398
           H N++ L G C       L   Y  +G++   LR+ +            S+   L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 399 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              A   ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-33
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKI 345
           ++     + + ++G G FG+VYKG L          VA+K LK   T    + F  E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 346 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 405
           +    H N++RL G  +     +++  YM NG++   LRE+              +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGI 119

Query: 406 ARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A G+ YL        +HRD+ A NIL++ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSN 146

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-32
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 8/141 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 354
           +    +  LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
           ++LY   +      +V  YM+ GS+   L+        L  P    +A   A G++Y+  
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER 131

Query: 415 HCDPKIIHRDVKAANILLDED 435
                 +HRD++AANIL+ E+
Sbjct: 132 MN---YVHRDLRAANILVGEN 149

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 5e-32
 Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 12/139 (8%)

Query: 301 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLR 356
             LG G FG V KG        K VAVK LK E        +   E  ++    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           + G C      +LV      G +   L++ +     +      ++    + G+ YL E  
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 417 DPKIIHRDVKAANILLDED 435
               +HRD+ A N+LL   
Sbjct: 127 --NFVHRDLAARNVLLVTQ 143

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 8e-32
 Identities = 45/141 (31%), Positives = 59/141 (41%), Gaps = 11/141 (7%)

Query: 300 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
             ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 356 RLYGFCTTV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 414
            L G C       L+V PYM +G + + +R                  L  A+G   +  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKG---MKF 145

Query: 415 HCDPKIIHRDVKAANILLDED 435
               K +HRD+ A N +LDE 
Sbjct: 146 LASKKFVHRDLAARNCMLDEK 166

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTE 342
           E +VA +  +    LG+G FG VY+G             VA+K + E  +    ++F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 343 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 396
             ++      +++RL G  +     L++   MT G + S LR           L P    
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 397 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
              ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  120 bits (301), Expect = 4e-31
 Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 8/144 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +     LG G FG V++    A G   A K +     S  E   + E++ +S+  H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           L+ L+       E +++Y +M+ G +  ++ +  +    +      +      +GL ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141

Query: 414 EHCDPKIIHRDVKAANILLDEDAD 437
           E+     +H D+K  NI+      
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRS 162

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  120 bits (301), Expect = 5e-31
 Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 8/150 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 353
           D +     LG G FG V++    A G++   K +            + E+ I++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           L+ L+       E +L+  +++ G +  R+         +           +  GL ++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144

Query: 414 EHCDPKIIHRDVKAANILLDEDADQSSKTI 443
           EH    I+H D+K  NI+ +     S K I
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKII 171

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
              ++    +G+G  G VY    +A G+ VA++++  ++    E     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N++          E  +V  Y+  GS+   + E       +D      +     + L +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFL 132

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H +   ++IHRD+K+ NILL  D
Sbjct: 133 HSN---QVIHRDIKSDNILLGMD 152

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-30
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 295 DGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKII 346
           D       LG G FG+V                  VAVK LK + T        +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 347 SMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPL 393
            M   H+N++ L G CT      ++  Y + G++   L+ R             +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 394 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                   A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 6e-30
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 11/137 (8%)

Query: 302 ILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 357
            +G G FG V++G           VA+K  K   +     +F  E   +    H ++++L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 358 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 417
            G  T      ++    T G + S L+ R+     LD  +    A   +  L+YL     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK-- 127

Query: 418 PKIIHRDVKAANILLDE 434
            + +HRD+ A N+L+  
Sbjct: 128 -RFVHRDIAARNVLVSS 143

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  117 bits (293), Expect = 6e-30
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 295 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGE-----LQFQTEVKIISM 348
           + FS   I+GRGGFG+VY  R AD GK+ A+K L ++R    +     L  +  + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
                ++ +     T  +   +   M  G +   L +             +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDE 434
           L ++H      +++RD+K ANILLDE
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDE 142

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 48/139 (34%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 303 LGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 356
           LG G FG V +G           VAVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 357 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 416
           LYG   T     +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR 131

Query: 417 DPKIIHRDVKAANILLDED 435
               IHRD+ A N+LL   
Sbjct: 132 ---FIHRDLAARNLLLATR 147

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  113 bits (284), Expect = 2e-29
 Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--------EERTSGGELQFQTEVKI 345
           + +  K ILGRG    V +       K  AVK +          E           EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 346 IS-MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 404
           +  ++ H N+++L     T T   LV+  M  G +   L E+      L     +KI   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118

Query: 405 SARGLSYLHEHCDPKIIHRDVKAANILLDED 435
               +  LH+     I+HRD+K  NILLD+D
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDD 146

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-29
 Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 352
              ++N + +G G +G V       +   VA+K++          +   E+KI+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N++ +       T + +   Y+    + + L +   +   L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 125

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H      ++HRD+K +N+LL+  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTT 145

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 39/144 (27%), Positives = 54/144 (37%), Gaps = 10/144 (6%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH 351
           + F    ILG G F  V   R LA  +  A+K L++              E  ++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
              ++LY       +      Y  NG     L +    +   D    +         L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 412 LHEHCDPKIIHRDVKAANILLDED 435
           LH      IIHRD+K  NILL+ED
Sbjct: 124 LHGKG---IIHRDLKPENILLNED 144

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 6e-29
 Identities = 33/142 (23%), Positives = 64/142 (45%), Gaps = 9/142 (6%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LGRG FG V++    +  K    K +K + T   ++  + E+ I+++A HRN+L L+   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70

Query: 362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 421
            ++ E ++++ +++   +  R+         L+              L +LH H    I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 422 HRDVKAANILLDEDADQSSKTI 443
           H D++  NI+       + K I
Sbjct: 125 HFDIRPENIIYQTRRSSTIKII 146

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 7e-29
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 295 DGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 348
           D       LGRG FG+V +         A  + VAVK LKE  T        +E+KI+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 349 AVHR-NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPP------------LD 394
             H  N++ L G CT     L ++  +   G++++ LR +++   P            L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 395 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 31/151 (20%), Positives = 64/151 (42%), Gaps = 8/151 (5%)

Query: 288 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII 346
           ++ +   D +  +++LG G F +V         KLVA+K + ++   G E   + E+ ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 347 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
               H N++ L     +     L+   ++ G +  R+ E+             ++     
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 437
             + YLH+     I+HRD+K  N+L     +
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDE 145

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-28
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 293 ATDGFSNKNILGRGGFGKVYKGR-LADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 347
            T+ F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++
Sbjct: 8   ETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
              + ++ RL G C T +   L+   M  G +   +RE +     +         +  A+
Sbjct: 67  SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAK 122

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
           G++YL +    +++HRD+ A N+L+   
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTP 147

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-28
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 297 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 355
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76

Query: 356 RLYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
           RL  F  +  EK       LV  Y+         R    +   L     K       R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
           +Y+H      I HRD+K  N+LLD D
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPD 158

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 9e-28
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 301 NILGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV---HRNL 354
             +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 355 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYL 412
           +RL+  CT           +    V   L     +   P +   T K +     RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H H   +++HRD+K  NIL+   
Sbjct: 133 HSH---RVVHRDLKPQNILVTSS 152

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  107 bits (268), Expect = 5e-27
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYG 359
             +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 360 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 419
              T    +LV+ ++                  L+  T K   L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 420 IIHRDVKAANILLDED 435
           ++HRD+K  N+L++ +
Sbjct: 121 VLHRDLKPQNLLINRE 136

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 285 FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQT 341
           +SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E     +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 342 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 401
           E  ++S+  H  ++R++G      +  ++  Y+        L            P  K  
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109

Query: 402 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           A      L YLH      II+RD+K  NILLD++
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKN 140

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 1e-26
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 17/144 (11%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG 359
           +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72

Query: 360 FCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
               +       L+V   +  G + SR+++R             +I       + YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130

Query: 416 CDPKIIHRDVKAANILLDEDADQS 439
               I HRDVK  N+L       +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNA 151

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-26
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 8/143 (5%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 352
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 353 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 412
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 413 HEHCDPKIIHRDVKAANILLDED 435
           H H    ++HRD+K  N+L++ +
Sbjct: 119 HSHR---VLHRDLKPQNLLINTE 138

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  105 bits (262), Expect = 3e-26
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 14/148 (9%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 350
           +D +    ILG GG  +V+  R L   + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 351 HRNLLRLYGFCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           H  ++ +Y      T       +V  Y+   +    LR+   +  P+      ++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 121

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDE 434
           + L++ H++    IIHRDVK ANI++  
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISA 146

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 5e-26
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 11/145 (7%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV- 350
           + F    +LG+G FGKV+        +  A+K LK++     +       E +++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 351 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           H  L  ++    T      V  Y+  G +   ++         D       A     GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           +LH      I++RD+K  NILLD+D
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKD 139

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (264), Expect = 5e-26
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 272 EDDSELQLGQLKRFSLRELQVAT-DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 329
           E  ++ +   LK++       A  D F     LG G FG+V   +    G   A+K L +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 330 ERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 387
           ++    +       E +I+       L++L       +   +V  Y+  G + S LR   
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 388 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                   P  +  A        YLH      +I+RD+K  N+L+D+ 
Sbjct: 137 ----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLL 355
           + LG G F  VYK R     ++VA+K++K     E   G       E+K++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 356 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 415
            L       +   LV+ +M            + +   L     K   L + +GL YLH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 416 CDPKIIHRDVKAANILLDED 435
               I+HRD+K  N+LLDE+
Sbjct: 120 W---ILHRDLKPNNLLLDEN 136

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 6e-25
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)

Query: 285 FSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-Q 338
           F  +E+                +G G +G V        G  VA+K+L     S     +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 339 FQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPP 392
              E++++    H N++ L    T        T+  LV P+M  G+   +L + +     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----K 117

Query: 393 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
           L     + +     +GL Y+H      IIHRD+K  N+ ++ED
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 157

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (251), Expect = 1e-24
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 11/148 (7%)

Query: 289 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 347
           EL+V  + +     +G G FG +Y G  +A G+ VA+K    +       Q   E KI  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57

Query: 348 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 407
           M      +    +C    +  ++   +   S+                 T   +A     
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 408 GLSYLHEHCDPKIIHRDVKAANILLDED 435
            + Y+H       IHRDVK  N L+   
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLG 139

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 8e-24
 Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 13/153 (8%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-----QFQTEVKIISM 348
           D +     LG G F  V K R  + G   A K +K+ RT            + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H N++ L+      T+ +L+   +  G     L +  +    L      +       G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 441
           + YLH      I H D+K  NI+L +      +
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 96.8 bits (240), Expect = 4e-23
 Identities = 26/143 (18%), Positives = 51/143 (35%), Gaps = 12/143 (8%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGF 360
           +G G FG +++G  L + + VA+K       +    Q + E +   +      +  +Y F
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 361 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 420
                  +LV   +      S               T    A      +  +HE     +
Sbjct: 70  GQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SL 122

Query: 421 IHRDVKAANILLDEDADQSSKTI 443
           ++RD+K  N L+     +++  I
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMI 145

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 4e-23
 Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 10/147 (6%)

Query: 292 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISM 348
           V  + F    +LG+G FGKV   R  A G+  A+K L++E     +      TE +++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 349 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 408
             H  L  L     T      V  Y   G +   L   +           +      A  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYG---AEI 114

Query: 409 LSYLHEHCDPKIIHRDVKAANILLDED 435
           +S L       +++RD+K  N++LD+D
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD 141

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 5e-23
 Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 14/142 (9%)

Query: 302 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----LQFQTEVKIISM--AVHRN 353
           +LG GGFG VY G  ++D   VA+K ++++R S         +   EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 354 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 413
           ++RL  +       +L+                +     L     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH 127

Query: 414 EHCDPKIIHRDVKAANILLDED 435
                 ++HRD+K  NIL+D +
Sbjct: 128 NC---GVLHRDIKDENILIDLN 146

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.1 bits (238), Expect = 1e-22
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 295 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHR 352
           D +     LGRG + +V++   + + + V VK LK  +      + + E+KI+  +    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90

Query: 353 NLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 410
           N++ L         +   LV+ ++ N       +        L     +       + L 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143

Query: 411 YLHEHCDPKIIHRDVKAANILLDED 435
           Y H      I+HRDVK  N+++D +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHE 165

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 17/149 (11%)

Query: 297 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNL 354
           +     +G+G FG+V+K R    G+ VA+K++  E    G  +    E+KI+ +  H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 355 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 406
           + L   C T             LV+ +  +           + L        K++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVM---Q 124

Query: 407 RGLSYLHEHCDPKIIHRDVKAANILLDED 435
             L+ L+     KI+HRD+KAAN+L+  D
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRD 153

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 7e-22
 Identities = 24/143 (16%), Positives = 41/143 (28%), Gaps = 19/143 (13%)

Query: 301 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMAVH 351
            ++G G    V+           VK  K   TS          G+L F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
           R L +L G             Y   G+           L  +      ++       ++ 
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 412 LHEHCDPKIIHRDVKAANILLDE 434
            +      I+H D+   N+L+ E
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE 138

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.9 bits (227), Expect = 2e-21
 Identities = 29/137 (21%), Positives = 60/137 (43%), Gaps = 9/137 (6%)

Query: 301 NILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLY 358
             +G G +G V+K +     ++VA+KR++ ++   G       E+ ++    H+N++RL+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 359 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 418
               +  +  LV+ +          +   S    LD    K       + L  L      
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSR 120

Query: 419 KIIHRDVKAANILLDED 435
            ++HRD+K  N+L++ +
Sbjct: 121 NVLHRDLKPQNLLINRN 137

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 4e-21
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 15/153 (9%)

Query: 291 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGEL---QFQTEV 343
           +V  + F    +LG G +GKV+  R       GKL A+K LK+             +TE 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 344 KIISMAVHR-NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 402
           +++        L+ L+    T T+  L+  Y+  G + + L +R+            +I 
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138

Query: 403 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                 +  L       II+RD+K  NILLD +
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSN 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 5e-20
 Identities = 31/143 (21%), Positives = 53/143 (37%), Gaps = 5/143 (3%)

Query: 294 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 351
            + + N + +G G +G V        G  VAVK+L     S     +   E++++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 352 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 411
            N++ L    T                +             L     + +     RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 412 LHEHCDPKIIHRDVKAANILLDE 434
           +H      IIHRD+K +N+ ++E
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNE 156

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.6 bits (208), Expect = 1e-18
 Identities = 35/178 (19%), Positives = 60/178 (33%), Gaps = 33/178 (18%)

Query: 266 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAV 324
           F+ V   +  +     LKR+   +             +G G  G V         + VA+
Sbjct: 3   FYSV---EVGDSTFTVLKRYQNLKP------------IGSGAQGIVCAAYDAVLDRNVAI 47

Query: 325 KRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNG 377
           K+L     +     +   E+ ++    H+N++ L    T         +  LV   M   
Sbjct: 48  KKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN 107

Query: 378 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 435
                  E        D      +      G+ +LH      IIHRD+K +NI++  D
Sbjct: 108 LCQVIQMEL-------DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD 155

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.8 bits (198), Expect = 2e-17
 Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 17/146 (11%)

Query: 303 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 361
           LG G F  V+  + + +   VA+K ++ ++        + E+K++      +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 362 TTVTEKLLVYPY------------MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 409
                KLL +                          ++     +     K+I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 410 SYLHEHCDPKIIHRDVKAANILLDED 435
            Y+H  C   IIH D+K  N+L++  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIV 162

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 76.3 bits (186), Expect = 6e-16
 Identities = 22/64 (34%), Positives = 34/64 (53%), Gaps = 1/64 (1%)

Query: 146 LNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK 205
           L NN + G +P  LT +  L+ L++S N L G +P  G+  +F   ++ NN  LCG    
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-PL 309

Query: 206 KPCS 209
             C+
Sbjct: 310 PACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 2e-15
 Identities = 56/193 (29%), Positives = 83/193 (43%), Gaps = 13/193 (6%)

Query: 27  EVDALYIFKSKLQDPNNSLQSWDNLPGNLC--TWFHITCNPEGSVTRV---DLGNAALSG 81
           +  AL   K  L +P   L SW     + C  TW  + C+ +    RV   DL    L  
Sbjct: 7   DKQALLQIKKDLGNPTT-LSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 82  --ELAPELGQLKNLELLELYGN-NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
              +   L  L  L  L + G  NL G IP A+  L +L  L +     +G IPD L+ +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSF---SQFTPISFEN 195
           K L  L  + N+LSG +P S++++ +L  +    NR+SG +PD+         +     N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184

Query: 196 NLNLCGPNTKKPC 208
            L    P T    
Sbjct: 185 RLTGKIPPTFANL 197

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.4 bits (155), Expect = 4e-12
 Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 3/62 (4%)

Query: 121 DLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL--SGP 178
           DL +N   GT+P  L  LK L  L ++ N+L G IP     +   ++   +NN+     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

Query: 179 VP 180
           +P
Sbjct: 309 LP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.2 bits (152), Expect = 1e-11
 Identities = 23/64 (35%), Positives = 30/64 (46%), Gaps = 2/64 (3%)

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL-NNN 149
           KNL  L+L  N + G +P  L  L  L SL++  N   G IP    NL++       NN 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302

Query: 150 SLSG 153
            L G
Sbjct: 303 CLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.0 bits (141), Expect = 2e-10
 Identities = 22/77 (28%), Positives = 30/77 (38%), Gaps = 1/77 (1%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLI 115
             +         ++  +DL N  + G L   L QLK L  L +  NNL G IP   GNL 
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQ 291

Query: 116 KLKSLDLYSNLFNGTIP 132
           +       +N      P
Sbjct: 292 RFDVSAYANNKCLCGSP 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.8 bits (185), Expect = 2e-15
 Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 6/85 (7%)

Query: 89  QLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN 148
            LKNL  L LY NN+S   P  + +L KL+ L   +N    +   +LANL  + +L   +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGH 360

Query: 149 NSLSGLIPTSLTTITSLNILDLSNN 173
           N +S L P  L  +T +  L L++ 
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 66.2 bits (160), Expect = 2e-12
 Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 28/167 (16%)

Query: 50  NLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIP- 108
           +L GN         +   ++T +DL N  +S      L  L  L  L+L  N +S   P 
Sbjct: 225 SLNGNQLKDIGTLASLT-NLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISPL 281

Query: 109 -------------------SALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
                              S + NL  L  L LY N  +   P  +++L +L+ L   NN
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339

Query: 150 SLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN 196
            +S    +SL  +T++N L   +N++S   P   + ++ T +   + 
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTPL-ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.9 bits (123), Expect = 6e-08
 Identities = 34/126 (26%), Positives = 49/126 (38%), Gaps = 25/126 (19%)

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
            NL+ L L GN L       L +L  L  LDL +N  +   P  L+ L +L  L+L  N 
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 151 LSGLIPTSLTTITS--------------------LNILDLSNNRLSGPVPDNGSFSQFTP 190
           +S + P +  T  +                    L  L L  N +S   P   S ++   
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQR 333

Query: 191 ISFENN 196
           + F NN
Sbjct: 334 LFFANN 339

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 4/68 (5%)

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
            L +     L       T+  +  +L Q+  L+ +   +  +    +  + +L  ++ SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 173 NRLSGPVP 180
           N+L+   P
Sbjct: 76  NQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 17/84 (20%), Positives = 33/84 (39%), Gaps = 6/84 (7%)

Query: 90  LKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
           L       L   N++  +     +L ++ +L            D +  L  L  +  +NN
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNN 76

Query: 150 SLSGLIPTSLTTITSLNILDLSNN 173
            L+ + P  L  +T L  + ++NN
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNN 98

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 7e-05
 Identities = 15/81 (18%), Positives = 30/81 (37%), Gaps = 6/81 (7%)

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
             +  LG   ++  ++     L  +  L+     +       +  L  L  ++  +N   
Sbjct: 24  KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 79

Query: 129 GTIPDTLANLKQLKYLRLNNN 149
              P  L NL +L  + +NNN
Sbjct: 80  DITP--LKNLTKLVDILMNNN 98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 62.0 bits (149), Expect = 3e-11
 Identities = 21/85 (24%), Positives = 36/85 (42%)

Query: 91  KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
            +  LL+L  N ++        NL  L +L L +N  +   P   A L +L+ L L+ N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 151 LSGLIPTSLTTITSLNILDLSNNRL 175
           L  L      T+  L + +    ++
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKV 115

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.8 bits (133), Expect = 3e-09
 Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 13/150 (8%)

Query: 56  CTWFHITCN-------PEG---SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSG 105
           C    + C+       P+        +DL N  ++     +   LKNL  L L  N +S 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 106 HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL 165
             P A   L+KL+ L L  N     +P+ +    Q   LR++ N ++ +  +    +  +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQM 126

Query: 166 NILDLSNNRLSGPVPDNGSFSQFTPISFEN 195
            +++L  N L     +NG+F     +S+  
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIR 156

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 50.0 bits (118), Expect = 2e-07
 Identities = 38/184 (20%), Positives = 69/184 (37%), Gaps = 10/184 (5%)

Query: 12  STIVLVALPMISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLCTWFHITCNPEG---S 68
           + +       ++    V+            N + Q    L        +IT  P+G   S
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS 172

Query: 69  VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFN 128
           +T + L    ++   A  L  L NL  L L  N++S     +L N   L+ L   +N   
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNKL 231

Query: 129 GTIPDTLANLKQLKYLRLNNNSLSGLIPTS------LTTITSLNILDLSNNRLSGPVPDN 182
             +P  LA+ K ++ + L+NN++S +           T   S + + L +N +       
Sbjct: 232 VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291

Query: 183 GSFS 186
            +F 
Sbjct: 292 STFR 295

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.2 bits (108), Expect = 3e-06
 Identities = 30/164 (18%), Positives = 48/164 (29%), Gaps = 14/164 (8%)

Query: 37  KLQDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELL 96
           +L    N L+              +  N    V +           +            L
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-----------EL 131

Query: 97  ELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIP 156
                  SG    A   + KL  + +       TIP  L     L  L L+ N ++ +  
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDA 188

Query: 157 TSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
            SL  + +L  L LS N +S     + + +        NN  L 
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 2e-09
 Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 5/99 (5%)

Query: 115 IKLKSLDLYSNLFNGT-IPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLNILD 169
           + ++SLD+     +     + L  L+Q + +RL++  L+      I ++L    +L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 170 LSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPC 208
           L +N L             TP      L+L         
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 4e-09
 Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 10/92 (10%)

Query: 92  NLELLELYGNNLS-GHIPSALGNLIKLKSLDLYSNLFNG----TIPDTLANLKQLKYLRL 146
           +++ L++    LS       L  L + + + L            I   L     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 147 NNNSLSGLIPTSL-----TTITSLNILDLSNN 173
            +N L  +    +     T    +  L L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 4e-09
 Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 5/91 (5%)

Query: 68  SVTRVDLGNAALSGELAPEL-GQLKNLELLELYGNNLSG----HIPSALGNLIKLKSLDL 122
            +  +D+    LS     EL   L+  +++ L    L+      I SAL     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 123 YSNLFNGTIPDTLANLKQLKYLRLNNNSLSG 153
            SN         +    Q    ++   SL  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 5e-09
 Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 9/96 (9%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSGHIPSAL 111
                    P   +  + L +  +S      LA  L    +L  L+L  N L       L
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417

Query: 112 GNLIK-----LKSLDLYSNLFNGTIPDTLANLKQLK 142
              ++     L+ L LY   ++  + D L  L++ K
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 9e-09
 Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 13/91 (14%)

Query: 91  KNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGTIPDTLA-----NLKQL 141
             L +L L   ++S      + + L     L+ LDL +N         L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 142 KYLRLNNNSLSGLIPTSLTTI----TSLNIL 168
           + L L +   S  +   L  +     SL ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 3e-07
 Identities = 17/85 (20%), Positives = 25/85 (29%), Gaps = 9/85 (10%)

Query: 106 HIPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLIPTSLTT 161
                      L+ L L     + +    +  TL     L+ L L+NN L       L  
Sbjct: 360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

Query: 162 I-----TSLNILDLSNNRLSGPVPD 181
                   L  L L +   S  + D
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMED 444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 3e-09
 Identities = 21/112 (18%), Positives = 35/112 (31%), Gaps = 9/112 (8%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLI 115
                   +    +        A S E+        +LE L +  N L   +P+      
Sbjct: 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR-- 305

Query: 116 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNI 167
            L+ L    N     +P+   N   LK L +  N L    P    ++  L +
Sbjct: 306 -LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREF-PDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 6e-07
 Identities = 19/84 (22%), Positives = 30/84 (35%), Gaps = 9/84 (10%)

Query: 98  LYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT 157
            Y N  S  I S       L+ L++ +N     +P     L+    L  + N L+ +   
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEVPEL 322

Query: 158 SLTTITSLNILDLSNNRLSGPVPD 181
                 +L  L +  N L    PD
Sbjct: 323 ----PQNLKQLHVEYNPLRE-FPD 341

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 9e-09
 Identities = 31/106 (29%), Positives = 43/106 (40%), Gaps = 6/106 (5%)

Query: 73  DLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP 132
            L +  L+      L QL  +  L+L  N L    P+ L  L  L+ L    N       
Sbjct: 4   HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--NV 58

Query: 133 DTLANLKQLKYLRLNNNSLSGL-IPTSLTTITSLNILDLSNNRLSG 177
           D +ANL +L+ L L NN L        L +   L +L+L  N L  
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 6e-08
 Identities = 22/67 (32%), Positives = 33/67 (49%), Gaps = 4/67 (5%)

Query: 106 HIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSL 165
              + L NL KL +L    N  +   P  LA+L  L  + L NN +S + P  L   ++L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 166 NILDLSN 172
            I+ L+N
Sbjct: 220 FIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 6e-05
 Identities = 13/41 (31%), Positives = 17/41 (41%), Gaps = 3/41 (7%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
             L  L NL  + L  N +S   P  L N   L  + L +N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 10/63 (15%), Positives = 25/63 (39%), Gaps = 4/63 (6%)

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
            L     +    +    T+  T A+L  +  L      ++ +    +  + +L  L+L +
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 173 NRL 175
           N++
Sbjct: 73  NQI 75

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 16/54 (29%), Positives = 29/54 (53%), Gaps = 2/54 (3%)

Query: 127 FNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP 180
              +    LANL +L  L+ ++N +S + P  L ++ +L  + L NN++S   P
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 7/82 (8%), Positives = 23/82 (28%), Gaps = 5/82 (6%)

Query: 128 NGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQ 187
           N   PD    L     +    ++++  +  +   +  +  L      ++  +      + 
Sbjct: 10  NVIFPD--PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IEGVQYLNN 64

Query: 188 FTPISFENNLNLCGPNTKKPCS 209
              +  ++N        K    
Sbjct: 65  LIGLELKDNQITDLAPLKNLTK 86

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (116), Expect = 3e-07
 Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 2/162 (1%)

Query: 39  QDPNNSLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLEL 98
                +LQ        L      T    G++T + L    +S         L +L+ L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 99  YGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTS 158
           + N ++   P A  +L +L +L L++N  +    + LA L+ L+YLRLN+N        +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-A 243

Query: 159 LTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
                 L     S++ +   +P   +      ++  N+L  C
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLA-ANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (115), Expect = 5e-07
 Identities = 31/122 (25%), Positives = 46/122 (37%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLI 115
                       ++  + L + AL          L NL  L L+GN +S     A   L 
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177

Query: 116 KLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
            L  L L+ N      P    +L +L  L L  N+LS L   +L  + +L  L L++N  
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

Query: 176 SG 177
             
Sbjct: 238 VC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 32/139 (23%), Positives = 49/139 (35%), Gaps = 1/139 (0%)

Query: 44  SLQSWDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELAP-ELGQLKNLELLELYGNN 102
           +L         L             + ++DL + A    + P     L  L  L L    
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 103 LSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI 162
           L    P     L  L+ L L  N       DT  +L  L +L L+ N +S +   +   +
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176

Query: 163 TSLNILDLSNNRLSGPVPD 181
            SL+ L L  NR++   P 
Sbjct: 177 HSLDRLLLHQNRVAHVHPH 195

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (110), Expect = 7e-07
 Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 3/106 (2%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT--IPDTLANLKQLK 142
           P+L       +L    ++++  +     N+ +L SL+L +N       +   +     LK
Sbjct: 36  PDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94

Query: 143 YLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQF 188
            L L+ N L             L  L L  N LS    D  ++   
Sbjct: 95  ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA 140

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.001
 Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 7/97 (7%)

Query: 90  LKNLELLELYGNNLSGH--IPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN 147
           +  L  L L  N L     + S +     LK L+L  N              +L+ L L+
Sbjct: 64  IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLD 123

Query: 148 NNSLSGLIPTSLTTITSL-----NILDLSNNRLSGPV 179
            NSLS       T I+++      +L L  + L  P+
Sbjct: 124 GNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 4e-06
 Identities = 8/53 (15%), Positives = 14/53 (26%), Gaps = 1/53 (1%)

Query: 123 YSNLFNGTIP-DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNR 174
             N     +P D          L ++   +  L    L  +  L      N +
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 7e-06
 Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 1/47 (2%)

Query: 105 GHIP-SALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS 150
             +P            LD+     +      L NLK+L+     N  
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 1e-05
 Identities = 7/39 (17%), Positives = 14/39 (35%)

Query: 87  LGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN 125
                   +L++    +       L NL KL++   Y+ 
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 4e-06
 Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 3/64 (4%)

Query: 62  TCNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLD 121
             +   S   V+     L+  L P+L   K+  +L L  N L     + L    +L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 122 LYSN 125
           L   
Sbjct: 62  LDRA 65

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 12/63 (19%), Positives = 19/63 (30%), Gaps = 3/63 (4%)

Query: 112 GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLS 171
             +     ++         +P  L   K    L L+ N L      +L   T L  L+L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 172 NNR 174
              
Sbjct: 64  RAE 66

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (100), Expect = 1e-05
 Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 3/102 (2%)

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
           N ++ + LDL        I +  A L Q   +  ++N +  L       +  L  L ++N
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72

Query: 173 NRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPF 214
           NR+                    N +L       P +     
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 114

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 2e-04
 Identities = 25/101 (24%), Positives = 40/101 (39%), Gaps = 6/101 (5%)

Query: 79  LSGEL---APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTL 135
           L+ EL   A +         L+L G  +   I +    L +  ++D   N       D  
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGF 59

Query: 136 ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLS 176
             L++LK L +NNN +  +       +  L  L L+NN L 
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 19/109 (17%), Positives = 43/109 (39%), Gaps = 8/109 (7%)

Query: 96  LELYGNNLSGHIPSALGNLIK--LKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSG 153
           L+L G NL    P   G L+   + +     +  +  + +  +  + ++++ L+N+ +  
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60

Query: 154 -LIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC 200
             +   L+  + L  L L   RLS P+ +     S    ++        
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 3e-05
 Identities = 17/89 (19%), Positives = 38/89 (42%), Gaps = 4/89 (4%)

Query: 80  SGELAPELGQLKNLELLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANL 138
             +   E  QL  L+ L L    ++       LG +  LK+L ++  + +GT+       
Sbjct: 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---K 245

Query: 139 KQLKYLRLNNNSLSGLIPTSLTTITSLNI 167
           + L +L++N +  + +   ++    +  I
Sbjct: 246 EALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 3e-05
 Identities = 19/120 (15%), Positives = 33/120 (27%), Gaps = 2/120 (1%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKY 143
           P+         L    +         L     L  L + +      +    L  L +L+ 
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 144 LRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN 203
           L +  + L  + P +      L+ L+LS N L               +    N   C   
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.001
 Identities = 22/112 (19%), Positives = 42/112 (37%), Gaps = 3/112 (2%)

Query: 63  CNPEGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPS-ALGNLIKLKSLD 121
           C P GS + +         +    L   +NL  L +       H+    L  L +L++L 
Sbjct: 5   CCPHGS-SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 122 LYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN 173
           +  +      PD      +L  L L+ N+L  L   ++  ++   ++   N 
Sbjct: 63  IVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNP 114

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 7e-05
 Identities = 13/92 (14%), Positives = 31/92 (33%), Gaps = 6/92 (6%)

Query: 115 IKLKSLDLYSNLFNG--TIPDTLANLKQLKYLRLNNNSLSG----LIPTSLTTITSLNIL 168
           I+ KSL L +       ++   L     +K + L+ N++       +  ++ +   L I 
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 169 DLSNNRLSGPVPDNGSFSQFTPISFENNLNLC 200
           + S+        +     +    +      L 
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 1e-04
 Identities = 9/74 (12%), Positives = 23/74 (31%), Gaps = 4/74 (5%)

Query: 82  ELAPELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGTIPDTLAN 137
            +   L +  +++ + L GN +       +   + +   L+  +           +    
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 138 LKQLKYLRLNNNSL 151
           L+ L    L    L
Sbjct: 82  LRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.8 bits (96), Expect = 1e-04
 Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 12/79 (15%)

Query: 98  LYGNNLSGHIPSALGN------LIKLKSLDLYSNLFNGTIPDTLA-----NLKQLKYLRL 146
           L    LS    +A+ +       I L++L L  N        TL       +  L +L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 147 NNNSLSGLIPTSLTTITSL 165
           N N  S      +  I  +
Sbjct: 310 NGNRFSEE-DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 4e-04
 Identities = 17/105 (16%), Positives = 34/105 (32%), Gaps = 12/105 (11%)

Query: 56  CTWFHITCNPEGSVTRVDLGNAALSGE----LAPELGQLKNLELLELY--GNNLSGHIPS 109
            +   I      ++  + L +  LS      +     +L+N+ L  L    N +      
Sbjct: 232 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291

Query: 110 AL-----GNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNN 149
            L       +  L  L+L  N F     D +  ++++   R    
Sbjct: 292 TLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 11/66 (16%)

Query: 122 LYSNLFNGTIPDTLAN------LKQLKYLRLNNNSLSGLIPTSLTTI-----TSLNILDL 170
           L   L +      + +         L+ LRL  N +      +L T+       L  L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 171 SNNRLS 176
           + NR S
Sbjct: 310 NGNRFS 315

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 9e-05
 Identities = 9/65 (13%), Positives = 24/65 (36%), Gaps = 4/65 (6%)

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
              +    +L        +  T   L  +  +  NN+ +  +    +  + ++  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 173 NRLSG 177
           N+L+ 
Sbjct: 78  NKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 14/40 (35%), Positives = 19/40 (47%), Gaps = 2/40 (5%)

Query: 85  PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS 124
             L  L  L+ L L  N++S     AL  L  L  L+L+S
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 5e-04
 Identities = 13/38 (34%), Positives = 24/38 (63%), Gaps = 2/38 (5%)

Query: 135 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
           LA L +L+ L L+ N +S L   +L  + +L++L+L +
Sbjct: 174 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 38.6 bits (88), Expect = 6e-04
 Identities = 17/100 (17%), Positives = 31/100 (31%), Gaps = 26/100 (26%)

Query: 99  YGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKY--------------- 143
             N +          L +LK+L+LY N  +  +P +  +L  L                 
Sbjct: 86  GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145

Query: 144 --------LRLNNNSLSGLIPTSLTTITSLNILDLSNNRL 175
                     LN  +     P+ +     + I DL ++  
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.001
 Identities = 18/75 (24%), Positives = 26/75 (34%), Gaps = 4/75 (5%)

Query: 48  WDNLPGNLCTWFHITCNPEGSVTRVDLGNAALSGELA--PELGQLKNLELLELYGNNLSG 105
             NL     +   I+     S           S ++     L  L  LE L++  N +S 
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186

Query: 106 HIPSALGNLIKLKSL 120
              S L  L  L+SL
Sbjct: 187 --ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.002
 Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 4/65 (6%)

Query: 113 NLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSN 172
            L +     L       T+  +  +L Q+  L+ +   +  +    +  + +L  ++ SN
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 173 NRLSG 177
           N+L+ 
Sbjct: 72  NQLTD 76

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 15/65 (23%), Positives = 25/65 (38%), Gaps = 8/65 (12%)

Query: 86  ELGQLKNLELLELYGNNLSGHIP------SALGNLIKLKSLDLYSNLFNGTIPDTLANLK 139
              + K++   E     L G IP      + L  L   K L L +N        +L+ ++
Sbjct: 13  IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI--EKISSLSGME 70

Query: 140 QLKYL 144
            L+ L
Sbjct: 71  NLRIL 75

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	447
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.98
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.96
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.96
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.96
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.96
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.94
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.94
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.92
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.69
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.58
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.45
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.45
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.43
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.41
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.35
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.33
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.31
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.25
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.21
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.17
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.08
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.07
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.03
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.03
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.99
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.98
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.94
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.84
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.66
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.62
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.47
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.24
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.17
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.14
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.13
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.98
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.97
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.89
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.65
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.11
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.05
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.76
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.57
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.09

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.7e-33  Score=260.09  Aligned_cols=144  Identities=25%  Similarity=0.376  Sum_probs=127.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||+++.........++.+|++++++++|||||++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            356888899999999999999964 6899999999654433334468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG  148 (271)
T d1nvra_          84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  148 (271)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccch
Confidence            999999999997543    389999999999999999999999   99999999999999999999999995

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.9e-33  Score=262.47  Aligned_cols=145  Identities=28%  Similarity=0.397  Sum_probs=130.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..++|+..+.||+|+||+||+|++. +++.||||+++...  ....+|.+|+++++.++|||||+++++|.+.+..++||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            3456777899999999999999975 58899999997543  34557999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....  ..++|..+..|+.|+++||+|||++   +|+||||||+|||+|+++.+||+||-
T Consensus        93 E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          93 EFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             ECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             ecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence            99999999999976532  3589999999999999999999999   99999999999999999999999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-32  Score=254.64  Aligned_cols=142  Identities=27%  Similarity=0.437  Sum_probs=129.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|+..+.||+|+||+||+|++.+++.||||+++...  ....+|.+|++++++++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4677788999999999999999888899999997543  34567999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....   .++|..+..++.|+|+||+|||++   +|+||||||+|||+|+++.+||+||-
T Consensus        83 ~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  146 (263)
T d1sm2a_          83 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFG  146 (263)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred             CCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccc
Confidence            99999999876432   488999999999999999999999   99999999999999999999999995

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.8e-32  Score=259.43  Aligned_cols=144  Identities=29%  Similarity=0.435  Sum_probs=126.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-C---cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..+.||+|+||+||+|+++. +   ..||||.+..........+|.+|+++|++++|||||+++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            446667899999999999999753 3   368999987654444456799999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||++|+|.+++.....   .++|.++..++.|+++||+|||++   +|+||||||+|||+|+++.+||+||-
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  173 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFG  173 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcc
Confidence            999999999998876432   489999999999999999999999   99999999999999999999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.7e-33  Score=264.91  Aligned_cols=145  Identities=26%  Similarity=0.362  Sum_probs=131.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ..++|++.+.||+|+||+||+|+.. +|+.||+|+++.........++.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3567889999999999999999964 689999999976544444567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....    +++..+..++.|+++||+|||+ +   +|+||||||+|||+++++.+||+||-
T Consensus        84 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             ECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            99999999999987543    8999999999999999999997 5   79999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=251.81  Aligned_cols=141  Identities=22%  Similarity=0.352  Sum_probs=128.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+++++.++|||||++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4699999999999999999996 4699999999865432 3345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++...     .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+||-
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccch
Confidence            9999999988653     389999999999999999999999   99999999999999999999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.6e-32  Score=250.51  Aligned_cols=144  Identities=32%  Similarity=0.478  Sum_probs=129.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++....  .......+.+|+++++.++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56888899999999999999975 68999999986432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ||+++|+|.+++.....    +++..+..++.|+++||+|||++   +||||||||+|||+++++.+||+||.-
T Consensus        86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccce
Confidence            99999999999987543    89999999999999999999999   999999999999999999999999963

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.4e-32  Score=252.73  Aligned_cols=143  Identities=29%  Similarity=0.425  Sum_probs=126.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      .++|+..+.||+|+||+||+|++++++.||||+++...  ....+|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            35677789999999999999999888999999996543  345579999999999999999999998754 567999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....  ..++|..+..|+.||++||+|||++   +|+||||||+|||+|+++.+||+||.
T Consensus        89 ~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          89 MENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             CTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeecccc
Confidence            999999998765422  2389999999999999999999999   99999999999999999999999996

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-31  Score=250.11  Aligned_cols=142  Identities=30%  Similarity=0.436  Sum_probs=125.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .++|++.+.||+|+||+||+|+++  ..||||+++.... ......|.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467888999999999999999864  3699999965432 3334579999999999999999999998755 56899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+++|+|.+++.....   .++|..+..|+.|+++||+|||++   +||||||||+|||+|+++.+||+||-
T Consensus        84 y~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             cCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            9999999999976432   489999999999999999999999   99999999999999999999999995

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-31  Score=246.45  Aligned_cols=142  Identities=27%  Similarity=0.423  Sum_probs=130.1

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|+..+.||+|+||+||+|++++++.||||.++...  ....+|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788999999999999999999888899999997543  34567999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....   .+++..+.+++.|+++||+|||+.   +|+||||||+|||+++++.+||+||-
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG  145 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG  145 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcch
Confidence            99999999766433   388999999999999999999999   99999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.3e-32  Score=253.22  Aligned_cols=143  Identities=28%  Similarity=0.411  Sum_probs=128.6

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      +.|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++++.++|||||++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45788899999999999999964 68999999986542 23345789999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++++||+||-
T Consensus        91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEech
Confidence            999999999876432   389999999999999999999999   99999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-32  Score=253.08  Aligned_cols=150  Identities=23%  Similarity=0.327  Sum_probs=120.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec--CCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lv  370 (447)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||.++..... .....+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57888999999999999999864 6899999998654322 223468999999999999999999999864  4568999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCC--CCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.+++.........+++..+..++.|+++||+|||++.  ..+||||||||+|||+++++.+||+||-
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            9999999999998764323345899999999999999999999862  1249999999999999999999999994

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.6e-31  Score=249.62  Aligned_cols=143  Identities=27%  Similarity=0.341  Sum_probs=129.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  .......+.+|++++++++|||||++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56888899999999999999964 68999999986432  2233457999999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++...+.    +++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+||.
T Consensus        88 Ey~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            99999999999887643    89999999999999999999999   99999999999999999999999995

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-31  Score=249.79  Aligned_cols=142  Identities=24%  Similarity=0.360  Sum_probs=123.0

Q ss_pred             CCCCCCc-cccCCCceEEEEEeC---CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          296 GFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       296 ~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      +|...+. ||+|+||+||+|.++   ++..||||.++.........+|.+|++++++++|||||+++|++.. +..++||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            4444554 999999999999864   3557999999765444445679999999999999999999999865 5689999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        88 E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             ECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             EeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccch
Confidence            99999999999865432   489999999999999999999999   99999999999999999999999995

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=248.49  Aligned_cols=144  Identities=29%  Similarity=0.469  Sum_probs=127.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeCC-C----cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLAD-G----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      +.|+..++||+|+||+||+|++++ +    ..||||.++.........+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            346677899999999999998653 2    47999999765444445579999999999999999999999999999999


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+.+|++.+.+.....   .++|..+..++.|++.||+|||++   +|+||||||+|||+|+++.+||+||-
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence            9999999999998876532   489999999999999999999999   99999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=3.6e-31  Score=251.19  Aligned_cols=142  Identities=29%  Similarity=0.401  Sum_probs=126.1

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc--ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .|+..+.||+|+||+||+|+. .+++.||||+++.....  .....+.+|++++++++|||||++++++.+.+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            477889999999999999996 46899999998654322  223468999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||++|+|..++....    .+++..+..++.|+++||+|||++   +||||||||+|||+++++.+||+||.
T Consensus        96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence            999999987765543    389999999999999999999999   99999999999999999999999995

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=6.3e-31  Score=249.44  Aligned_cols=144  Identities=23%  Similarity=0.368  Sum_probs=123.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      .+.|++.+.||+|+||+||+|+.. +++.||||++...........+.+|+.+++.++|||||++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356888899999999999999965 6899999999755444444568899999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC---CCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~~i~df~  444 (447)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++   +++.+||+||.
T Consensus        88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccc
Confidence            999999999997643    389999999999999999999999   999999999999995   57889999995

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5e-31  Score=247.33  Aligned_cols=142  Identities=27%  Similarity=0.426  Sum_probs=126.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      ++|++.+.||+|+||+||+|++++++.||||+++...  .....|.+|+.++++++|||||+++|++.+ ++.++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            5688889999999999999999888899999997543  334579999999999999999999999854 5689999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|..++.....  ..++|.++..|+.||+.||+|||++   +|+||||||+|||+|+++++||+||-
T Consensus        94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG  158 (285)
T d1fmka3          94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG  158 (285)
T ss_dssp             TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             CCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccc
Confidence            99999998876422  2389999999999999999999999   99999999999999999999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=244.34  Aligned_cols=136  Identities=26%  Similarity=0.361  Sum_probs=117.8

Q ss_pred             CccccCCCceEEEEEeC---CCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecCCC
Q 013258          301 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  376 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~~~  376 (447)
                      +.||+|+||+||+|.++   +++.||||+++...... ...+|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            56999999999999864   25689999996543322 24579999999999999999999999865 467899999999


Q ss_pred             CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          377 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       377 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+|.++++...    .++|..+..++.||++||+|||++   +||||||||+|||++.++.+|++||-
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFG  152 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  152 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchh
Confidence            99999998754    389999999999999999999999   99999999999999999999999995

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=250.67  Aligned_cols=145  Identities=25%  Similarity=0.327  Sum_probs=130.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...  .......+.+|+.+|+.++|||||++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35788899999999999999996 469999999996532  233445789999999999999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      ||||++|+|.+++.....    +++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+||--
T Consensus        84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccc
Confidence            999999999999987643    88899999999999999999999   999999999999999999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.2e-30  Score=244.54  Aligned_cols=144  Identities=26%  Similarity=0.320  Sum_probs=128.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .+.|++.+.||+|+||+||+|+.+ +|+.||||+++.....     .....+.+|+.++++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357888999999999999999964 6999999998643221     2245799999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC----ceeeccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  443 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~~i~df  443 (447)
                      ++|||||++|+|.+++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++    .+|++||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999998754    389999999999999999999999   999999999999999887    4899999


Q ss_pred             c
Q 013258          444 L  444 (447)
Q Consensus       444 ~  444 (447)
                      .
T Consensus       162 G  162 (293)
T d1jksa_         162 G  162 (293)
T ss_dssp             T
T ss_pred             h
Confidence            5

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.96  E-value=1.3e-30  Score=243.52  Aligned_cols=144  Identities=28%  Similarity=0.314  Sum_probs=128.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc--------cHHHHHHHHHHHhcCC-CCCccceeeEEecC
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--------GELQFQTEVKIISMAV-HRNLLRLYGFCTTV  364 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  364 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++......        ....+.+|+.++++++ |||||++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999996 468999999986543211        1225889999999997 99999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +..++||||+++|+|.++++...    .+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||-
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999998754    389999999999999999999999   99999999999999999999999995


Q ss_pred             c
Q 013258          445 R  445 (447)
Q Consensus       445 ~  445 (447)
                      -
T Consensus       156 ~  156 (277)
T d1phka_         156 F  156 (277)
T ss_dssp             T
T ss_pred             h
Confidence            3

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1e-30  Score=250.39  Aligned_cols=149  Identities=27%  Similarity=0.417  Sum_probs=125.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCC-C-----cEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCC
Q 013258          293 ATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  365 (447)
Q Consensus       293 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  365 (447)
                      ..++|++.+.||+|+||+||+|++.. +     ..||||.+...........+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34678888999999999999998532 2     369999987654444556799999999988 8999999999999999


Q ss_pred             ceEEEeecCCCCChhhHhhccCCC-------------------CCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCC
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  426 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlk  426 (447)
                      ..++||||+++|+|.++++.....                   ...++|..+..|+.|+++||+|||++   +|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence            999999999999999999865321                   23489999999999999999999999   99999999


Q ss_pred             CCceeeCCCCceeecccc
Q 013258          427 AANILLDEDADQSSKTIL  444 (447)
Q Consensus       427 p~NILl~~~~~~~i~df~  444 (447)
                      |+|||++.++.+||+||-
T Consensus       192 p~Nill~~~~~~Kl~DFG  209 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFG  209 (325)
T ss_dssp             GGGEEEETTTEEEECCCG
T ss_pred             hhccccccCCeEEEeecc
Confidence            999999999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=7.2e-31  Score=248.82  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=134.3

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEE
Q 013258          288 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC  361 (447)
Q Consensus       288 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~  361 (447)
                      .+++...++|+..+.||+|+||+||+|+++      +++.||||+++.........+|.+|+++++.++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556778999999999999999999863      35789999997655444456799999999999999999999999


Q ss_pred             ecCCceEEEeecCCCCChhhHhhccCC--------------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCee
Q 013258          362 TTVTEKLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKII  421 (447)
Q Consensus       362 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  421 (447)
                      ...+..+++|||+++|+|.++++....                    ....++|..+..|+.|++.||+|||++   +||
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence            999999999999999999999975321                    123488999999999999999999999   999


Q ss_pred             ecCCCCCceeeCCCCceeecccc
Q 013258          422 HRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       422 HrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||||+|||+|.++.+||+||-
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFG  185 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFG  185 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCS
T ss_pred             eeEEcccceEECCCCcEEEccch
Confidence            99999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=241.76  Aligned_cols=142  Identities=25%  Similarity=0.387  Sum_probs=121.0

Q ss_pred             CCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEec----CCceEEEe
Q 013258          298 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVY  371 (447)
Q Consensus       298 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lv~  371 (447)
                      +..+.||+|+||+||+|+.. +++.||+|.+..... ......|.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            34467999999999999965 588999999865432 2234468999999999999999999999865    34579999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC-CCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~~i~df~  444 (447)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+||-
T Consensus        92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence            9999999999998754    389999999999999999999998 22399999999999997 57899999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=1.8e-30  Score=247.25  Aligned_cols=143  Identities=29%  Similarity=0.423  Sum_probs=128.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  .......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56888899999999999999964 69999999996432  2233457899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+++|+|...+.....    +++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+||.
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence            99999999999887543    78889999999999999999999   99999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=3.1e-30  Score=249.09  Aligned_cols=143  Identities=21%  Similarity=0.323  Sum_probs=127.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|++++++++|||||++++++.+.+..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5688899999999999999996 4699999999865432 2344688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeC--CCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~~i~df~  444 (447)
                      |++|+|.+.+....   ..+++..+..|+.||+.||+|||++   +||||||||+|||++  .++.+||+||-
T Consensus       108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG  174 (352)
T d1koba_         108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  174 (352)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence            99999998876543   2489999999999999999999999   999999999999998  57899999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.96  E-value=3.7e-30  Score=248.37  Aligned_cols=143  Identities=20%  Similarity=0.331  Sum_probs=127.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++|||||++++++.+.+..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57888999999999999999964 699999999965432 2344689999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC--CCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~~i~df~  444 (447)
                      |++|+|.+++.....   .+++..+..|+.||+.||+|||++   +||||||||+|||++.  ++.+||+||.
T Consensus       105 ~~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         105 MSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             CCSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             CCCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            999999999865432   489999999999999999999999   9999999999999964  5789999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=244.23  Aligned_cols=143  Identities=21%  Similarity=0.316  Sum_probs=126.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||.++...  .....+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            56888899999999999999965 68999999996542  2334688999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC--ceeeccccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTILR  445 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--~~~i~df~~  445 (447)
                      |++|+|.+++.....   .+++.++..++.|+++||+|||++   +|+||||||+|||++.++  .+|++||.-
T Consensus        83 ~~gg~L~~~i~~~~~---~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          83 ISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             CCCCBHHHHHTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccch
Confidence            999999999976532   389999999999999999999999   999999999999998654  789999953

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.4e-29  Score=239.68  Aligned_cols=181  Identities=31%  Similarity=0.561  Sum_probs=158.3

Q ss_pred             cCchHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC--ccceeEeCCCC---CEEEEEcCCCCccc--cccccccCCCCCC
Q 013258           22 ISANAEVDALYIFKSKLQDPNNSLQSWDNLPGNLC--TWFHITCNPEG---SVTRVDLGNAALSG--ELAPELGQLKNLE   94 (447)
Q Consensus        22 ~~~~~~~~~l~~~~~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~~---~v~~l~L~~~~l~g--~~~~~l~~l~~L~   94 (447)
                      .|.++|++||++||+.+.+|. .+.+|.. ++|||  .|.||+|+..+   +|+.|||+++.++|  .+|+++++|++|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~   79 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence            478999999999999999885 6899974 57999  59999998543   79999999999998  5899999999999


Q ss_pred             EEECCC-CccCCCCChhhcCCCCCcEEEccCCcccccC------------------------------------------
Q 013258           95 LLELYG-NNLSGHIPSALGNLIKLKSLDLYSNLFNGTI------------------------------------------  131 (447)
Q Consensus        95 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~------------------------------------------  131 (447)
                      +|+|++ |+++|.+|..|+++++|++|+|++|++.+..                                          
T Consensus        80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            999986 8999999999999999999999888665321                                          


Q ss_pred             -----------------------------------------------------------------------------Ccc
Q 013258          132 -----------------------------------------------------------------------------PDT  134 (447)
Q Consensus       132 -----------------------------------------------------------------------------p~~  134 (447)
                                                                                                   ++.
T Consensus       160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~  239 (313)
T d1ogqa_         160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK  239 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                                                                                         122


Q ss_pred             ccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccccccccccCCCC
Q 013258          135 LANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT  204 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~~~~  204 (447)
                      ++.+++|+.|+|++|+++|.+|..++++++|+.|++++|+|+|.+|+.+.+..+..+++.+|+.+||.|.
T Consensus       240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence            3445678889999999999999999999999999999999999999988889999999999999999754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.5e-30  Score=242.59  Aligned_cols=147  Identities=29%  Similarity=0.485  Sum_probs=125.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc--EEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|+..++||+|+||+||+|+++ ++.  .||||.++..........|.+|+++++++ +|||||+++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56777899999999999999865 344  57888886554444455799999999998 799999999999999999999


Q ss_pred             eecCCCCChhhHhhccC------------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCce
Q 013258          371 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  438 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  438 (447)
                      |||+++|+|.++++...            .....++|..+..++.|||+||.|+|++   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997541            2234589999999999999999999999   99999999999999999999


Q ss_pred             eecccc
Q 013258          439 SSKTIL  444 (447)
Q Consensus       439 ~i~df~  444 (447)
                      ||+||-
T Consensus       167 kl~DfG  172 (309)
T d1fvra_         167 KIADFG  172 (309)
T ss_dssp             EECCTT
T ss_pred             EEcccc
Confidence            999995

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=1.4e-29  Score=244.28  Aligned_cols=143  Identities=24%  Similarity=0.312  Sum_probs=129.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEe
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~  371 (447)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++...  .......+.+|+++++.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            56888899999999999999964 69999999986432  2233456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||+.+|+|.+++.....    +++..+..++.|++.||.|||++   +||||||||+|||++.++.+||+||-
T Consensus       121 e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            99999999999987643    89999999999999999999999   99999999999999999999999995

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=240.31  Aligned_cols=144  Identities=22%  Similarity=0.445  Sum_probs=122.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      |+|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788899999999999999996 56999999999654322 234578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |+.+ ++.+.+.....  ..+++..+..++.|++.||+|||++   +||||||||+|||++.++..|++||-
T Consensus        82 ~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             CCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCC
Confidence            9975 44455443322  2489999999999999999999999   99999999999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=1.1e-29  Score=238.96  Aligned_cols=143  Identities=23%  Similarity=0.392  Sum_probs=127.5

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||+||+|+.++|+.||||+++.... .....++.+|+.++++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            57888899999999999999998899999999965432 22345799999999999999999999999999999999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +.++.+..+.+...    .+++..+..++.|+++||+|||+.   +||||||||+|||++.++.+|++||-
T Consensus        82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTT
T ss_pred             ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccc
Confidence            98877766655432    389999999999999999999999   99999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=1e-29  Score=237.99  Aligned_cols=143  Identities=24%  Similarity=0.329  Sum_probs=126.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCc----e
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----K  367 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~  367 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++......  ....+.+|+++++.++|||||++++++...+.    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5688899999999999999996 469999999997544322  23468999999999999999999999876543    7


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||||+++|+|.+++....    .+++.++..++.|+++||+|||++   +|+||||||+|||++.++..+++||.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            89999999999999987764    389999999999999999999999   99999999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=237.26  Aligned_cols=144  Identities=23%  Similarity=0.315  Sum_probs=124.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC----CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      .++|++.+.||+|+||+||+|++..    +..||||.++..........|.+|+.++++++|||||+++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4568888999999999999998642    35789999865544444557999999999999999999999986 467899


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ||||+++|+|.+++.....   .+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+||-
T Consensus        85 v~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccch
Confidence            9999999999998876432   489999999999999999999999   99999999999999999999999995

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=241.20  Aligned_cols=143  Identities=26%  Similarity=0.467  Sum_probs=122.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCc----EEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l  369 (447)
                      ++|+..+.||+|+||+||+|++. +|+    .||||.++.........+|.+|++++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            45888899999999999999864 344    68999887655555567899999999999999999999999864 5788


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++||+.+|+|.+.+.....   .++|..+..++.||++||+|||++   +||||||||+|||++.++.+||+||-
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccc
Confidence            8999999999998876533   489999999999999999999999   99999999999999999999999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-29  Score=240.81  Aligned_cols=143  Identities=25%  Similarity=0.396  Sum_probs=126.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccc--ccccHHHHHHHHHHHh-cCCCCCccceeeEEecCCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lv  370 (447)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++...  .......+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999965 69999999996432  2233345677777665 68999999999999999999999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||+++|+|.++++....    +++..+..++.||+.||+|||++   +|+||||||+|||+++++.+|++||-
T Consensus        82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccc
Confidence            999999999999987643    88999999999999999999999   99999999999999999999999995

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=237.01  Aligned_cols=141  Identities=28%  Similarity=0.443  Sum_probs=122.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEeec
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPY  373 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~  373 (447)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++..   ....+|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45677789999999999999984 788999999653   234579999999999999999999999865 4568999999


Q ss_pred             CCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          374 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       374 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+|.+++.....  ..++|..++.++.||+.||+|||+.   +|+||||||+|||++.++.+|++||-
T Consensus        83 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg  148 (262)
T d1byga_          83 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  148 (262)
T ss_dssp             CTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccc
Confidence            999999999976422  2379999999999999999999999   99999999999999999999999985

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=1.8e-29  Score=244.94  Aligned_cols=143  Identities=28%  Similarity=0.376  Sum_probs=124.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccc--cccHHHHH---HHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.....  ......+.   +|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57888999999999999999965 699999999854321  12222344   4467778889999999999999999999


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|+|.+++.....    +++..+..++.||+.||+|||++   +||||||||+|||+++++.+||+||.
T Consensus        84 ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeec
Confidence            99999999999999987543    78899999999999999999999   99999999999999999999999995

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=240.24  Aligned_cols=148  Identities=26%  Similarity=0.417  Sum_probs=128.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCCce
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  367 (447)
                      .++|+..+.||+|+||+||+|++.      +++.||||+++..........|.+|+.++++++|||||++++++...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            456777899999999999999863      25789999997554444445699999999999999999999999999999


Q ss_pred             EEEeecCCCCChhhHhhccC------CCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          368 LLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                      ++||||+++|+|.+++....      .....++|..+..++.|+|+||.|||++   +|+||||||+|||+|+++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999999987531      2223478999999999999999999999   99999999999999999999999


Q ss_pred             ccc
Q 013258          442 TIL  444 (447)
Q Consensus       442 df~  444 (447)
                      ||-
T Consensus       176 DFG  178 (308)
T d1p4oa_         176 DFG  178 (308)
T ss_dssp             CTT
T ss_pred             ecc
Confidence            995

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.3e-29  Score=237.25  Aligned_cols=139  Identities=33%  Similarity=0.494  Sum_probs=120.9

Q ss_pred             CCccccCCCceEEEEEeCCC----cEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEec-CCceEEEeecC
Q 013258          300 KNILGRGGFGKVYKGRLADG----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYM  374 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lv~e~~  374 (447)
                      .++||+|+||+||+|++.++    ..||||+++.........+|.+|++++++++|||||+++|++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            36899999999999996432    36899999754444444679999999999999999999999876 45789999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      ++|+|.+++.....   ..++..+..++.|+++||.|+|+.   +|+||||||+|||+|+++.+||+||-
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEeccc
Confidence            99999999876533   377889999999999999999999   99999999999999999999999995

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-29  Score=239.65  Aligned_cols=149  Identities=28%  Similarity=0.380  Sum_probs=129.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecCCc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  366 (447)
                      .++|+..+.||+|+||.||+|++      .+++.||||+++.........+|.+|+.++..+ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            45677789999999999999985      246789999997655444455799999999998 69999999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCC--------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          367 KLLVYPYMTNGSVASRLRERQS--------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      .++||||+++|+|.++++....              ....+++..+..++.||++||+|||++   +||||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            9999999999999999986432              123588999999999999999999999   99999999999999


Q ss_pred             CCCCceeeccccc
Q 013258          433 DEDADQSSKTILR  445 (447)
Q Consensus       433 ~~~~~~~i~df~~  445 (447)
                      +.++.+|++||.-
T Consensus       179 ~~~~~~ki~DfG~  191 (311)
T d1t46a_         179 THGRITKICDFGL  191 (311)
T ss_dssp             ETTTEEEECCCGG
T ss_pred             cccCcccccccch
Confidence            9999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.8e-29  Score=236.58  Aligned_cols=149  Identities=29%  Similarity=0.403  Sum_probs=124.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCC--------CcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEecC
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  364 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  364 (447)
                      .++|.+.+.||+|+||.||+|+...        +..||||.++.........++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4567778999999999999998522        2479999997665444456788999999888 899999999999999


Q ss_pred             CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceee
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  432 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl  432 (447)
                      +..++||||+++|+|.++++....            ....+++.++..++.|++.||+|||++   +||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999976532            123589999999999999999999999   99999999999999


Q ss_pred             CCCCceeeccccc
Q 013258          433 DEDADQSSKTILR  445 (447)
Q Consensus       433 ~~~~~~~i~df~~  445 (447)
                      +.++.+||+||.-
T Consensus       169 ~~~~~~kl~dfg~  181 (299)
T d1fgka_         169 TEDNVMKIADFGL  181 (299)
T ss_dssp             CTTCCEEECSTTC
T ss_pred             cCCCCeEeccchh
Confidence            9999999999953

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.3e-29  Score=237.14  Aligned_cols=139  Identities=29%  Similarity=0.389  Sum_probs=118.2

Q ss_pred             CCccccCCCceEEEEEeC-CCcEEEEEEccccccccc----HHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEeecC
Q 013258          300 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG----ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  374 (447)
Q Consensus       300 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e~~  374 (447)
                      .++||+|+||+||+|+.+ +|+.||||+++.......    ...+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999964 699999999965432211    236889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          375 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       375 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .++++.......    ..+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+||+||--
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~  146 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  146 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcc
Confidence            988776665433    2388899999999999999999999   999999999999999999999999963

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-29  Score=238.58  Aligned_cols=151  Identities=28%  Similarity=0.387  Sum_probs=122.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeC------CCcEEEEEEcccccccccHHHHHHHHHHHhcC-CCCCccceeeEEec
Q 013258          291 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  363 (447)
Q Consensus       291 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  363 (447)
                      ++..++|++.+.||+|+||+||+|++.      +++.||||.++..........+.+|...+.++ +|+|||++++++.+
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            344567888999999999999999853      24689999997655444455688888888776 68999999998876


Q ss_pred             C-CceEEEeecCCCCChhhHhhccCC------------CCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCce
Q 013258          364 V-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  430 (447)
Q Consensus       364 ~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NI  430 (447)
                      . ...++|||||++|+|.++++....            ....++|..+..++.|+++||+|||++   +||||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence            5 468999999999999999976421            123488999999999999999999999   999999999999


Q ss_pred             eeCCCCceeecccc
Q 013258          431 LLDEDADQSSKTIL  444 (447)
Q Consensus       431 Ll~~~~~~~i~df~  444 (447)
                      |+++++.+||+||-
T Consensus       166 Ll~~~~~~Kl~DFG  179 (299)
T d1ywna1         166 LLSEKNVVKICDFG  179 (299)
T ss_dssp             EECGGGCEEECC--
T ss_pred             eECCCCcEEEccCc
Confidence            99999999999995

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.2e-29  Score=233.71  Aligned_cols=143  Identities=34%  Similarity=0.429  Sum_probs=115.7

Q ss_pred             cCCCCCCccccCCCceEEEEEeC--CC--cEEEEEEcccccccc--cHHHHHHHHHHHhcCCCCCccceeeEEecCCceE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  368 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  368 (447)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||.++......  ...+|.+|+.++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45778899999999999999853  23  378999986543222  23479999999999999999999999976 4678


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +||||+++|++.+.+.....   .+++..+..++.|+|.||+|||++   +|+||||||+|||++.++.+|++||-
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence            99999999999998876532   389999999999999999999999   99999999999999999999999994

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.4e-29  Score=234.88  Aligned_cols=141  Identities=28%  Similarity=0.389  Sum_probs=117.6

Q ss_pred             CCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEEEe
Q 013258          296 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVY  371 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lv~  371 (447)
                      +|...+.||+|+||.||+|++ +|+.||||.++...  .....++.|+..+..++|||||+++++|.+.+    ..++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            355568899999999999997 58899999986432  11122344555566789999999999998654    578999


Q ss_pred             ecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC-----CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          372 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH-----CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       372 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      |||++|+|.+++++.     .++|..+..++.|+|.||+|+|+.     ..++||||||||+|||+|+++.+||+||-
T Consensus        81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999864     389999999999999999999973     23589999999999999999999999994

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-28  Score=235.89  Aligned_cols=142  Identities=20%  Similarity=0.300  Sum_probs=120.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecCC----ceEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  369 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l  369 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.........++.+|+++|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4688889999999999999985 5799999999975443333457899999999999999999999987643    2355


Q ss_pred             EeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          370 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       370 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +++|+.+|+|.+++...     .+++..+..++.|+++||+|||++   +||||||||+|||+++++.+||+||.
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccC
Confidence            55677799999999754     289999999999999999999999   99999999999999999999999995

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.3e-28  Score=228.53  Aligned_cols=144  Identities=19%  Similarity=0.328  Sum_probs=128.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-cHHHHHHHHHHHhcCCCCCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++...... ...++.+|+.+++.++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4688889999999999999996 468999999996544332 34578999999999999999999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      |+.++++..+++..+    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+|++||--
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            999999988876543    378899999999999999999999   999999999999999999999999953

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.3e-28  Score=232.55  Aligned_cols=139  Identities=23%  Similarity=0.293  Sum_probs=119.0

Q ss_pred             cCCCCC-CccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhc-CCCCCccceeeEEec----CCce
Q 013258          295 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTT----VTEK  367 (447)
Q Consensus       295 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~  367 (447)
                      ++|.+. ++||+|+||+||+|+. .+++.||||+++.      ...+.+|++++.+ .+|||||++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            567765 4699999999999996 5689999999853      2357889998755 589999999999865    4568


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeecccc
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  444 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df~  444 (447)
                      ++|||||++|+|.+++.....  ..+++..+..|+.|++.||+|||++   +|+||||||+|||+++   ++.+||+||-
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            999999999999999986432  3489999999999999999999999   9999999999999986   4569999995

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.7e-28  Score=227.65  Aligned_cols=144  Identities=22%  Similarity=0.347  Sum_probs=123.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccc-----cHHHHHHHHHHHhcCC--CCCccceeeEEecCCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTVTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~  366 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++......     ...++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4688889999999999999996 468999999986543211     1224678999999886  8999999999999999


Q ss_pred             eEEEeecCCC-CChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCC-Cceeecccc
Q 013258          367 KLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~~i~df~  444 (447)
                      .++||||+.+ +++.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.+ +.+||+||-
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999976 67888877653    389999999999999999999999   99999999999999955 789999996


Q ss_pred             c
Q 013258          445 R  445 (447)
Q Consensus       445 ~  445 (447)
                      -
T Consensus       157 ~  157 (273)
T d1xwsa_         157 S  157 (273)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-27  Score=230.38  Aligned_cols=140  Identities=28%  Similarity=0.411  Sum_probs=114.9

Q ss_pred             CCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCccceeeEEecC------CceE
Q 013258          296 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKL  368 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~  368 (447)
                      +|+..++||+|+||+||+|+.. +|+.||||+++....     ...+|+++|++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4666789999999999999965 699999999965432     234799999999999999999998543      3478


Q ss_pred             EEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeecccc
Q 013258          369 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  444 (447)
Q Consensus       369 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~  444 (447)
                      +||||++++. .+.+.........+++..+..++.|+++||+|||++   +|+||||||+|||++.++ .+||+||-
T Consensus        96 lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          96 LVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             EEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             EEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence            9999998654 334332212233589999999999999999999999   999999999999999875 89999995

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-27  Score=229.11  Aligned_cols=143  Identities=23%  Similarity=0.342  Sum_probs=117.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecCC------
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  365 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------  365 (447)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357888899999999999999964 6999999999754322 22346889999999999999999999997654      


Q ss_pred             ceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          366 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       366 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      +.++||||+ +.+|..+.+..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..|++||.-
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            469999999 56777776543     389999999999999999999999   999999999999999999999999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=3.8e-27  Score=225.79  Aligned_cols=137  Identities=23%  Similarity=0.303  Sum_probs=119.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEec--CCceEEE
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--VTEKLLV  370 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lv  370 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..    ...++.+|+++|..++ ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5788999999999999999996 46999999998643    3457899999999995 9999999999874  3568999


Q ss_pred             eecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCC-ceeeccccc
Q 013258          371 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTILR  445 (447)
Q Consensus       371 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~~i~df~~  445 (447)
                      |||+.+|+|....+       .+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+|++||--
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            99999999876642       288999999999999999999999   999999999999999765 589999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.2e-27  Score=228.24  Aligned_cols=144  Identities=22%  Similarity=0.322  Sum_probs=123.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEecC-----Cc
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  366 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~  366 (447)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++..... ....++.+|+++++.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46788899999999999999995 46999999999754322 2234688999999999999999999998643     34


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeeccccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  445 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~~  445 (447)
                      .++++||+.+|+|.++++..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..|++||.-
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            56777888999999998643     389999999999999999999999   999999999999999999999999853

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.1e-27  Score=226.59  Aligned_cols=143  Identities=27%  Similarity=0.334  Sum_probs=126.3

Q ss_pred             cCCCCCCccccCCCceEEEEEeC----CCcEEEEEEcccccc---cccHHHHHHHHHHHhcCCC-CCccceeeEEecCCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~  366 (447)
                      ++|++.+.||+|+||+||+|+..    +|+.||||.++....   ......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56888999999999999999852    478999999865421   2233468899999999977 799999999999999


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .+++|||+.+|+|.+++.....    +.......++.|++.||+|+|++   +|+||||||+|||+|.++.+||+||-
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence            9999999999999999987643    67888999999999999999999   99999999999999999999999995

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.2e-27  Score=223.34  Aligned_cols=143  Identities=27%  Similarity=0.431  Sum_probs=119.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccc-cccHHHHHHHHHHHhcCCCCCccceeeEEec--------C
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT--------V  364 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~  364 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..... .....++.+|+.+|+.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5688889999999999999996 4699999999864432 2334578999999999999999999998865        3


Q ss_pred             CceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          365 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       365 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      +..++||||+.++.+.......    ..++......++.|+++||+|||++   +|+||||||+|||+++++.+|++||-
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4579999999887766554332    2378889999999999999999999   99999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.5e-27  Score=222.37  Aligned_cols=145  Identities=28%  Similarity=0.466  Sum_probs=118.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CC-CcEEEEEEcccccccc-cHHHHHHHHHHHhcC---CCCCccceeeEEec----
Q 013258          294 TDGFSNKNILGRGGFGKVYKGRL-AD-GKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT----  363 (447)
Q Consensus       294 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----  363 (447)
                      .++|++.+.||+|+||+||+|+. .+ ++.||||+++...... ....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46788999999999999999996 34 6779999996543222 223467787777655   79999999999853    


Q ss_pred             -CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecc
Q 013258          364 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  442 (447)
Q Consensus       364 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~d  442 (447)
                       ....+++|||+.++++........   ..+++..+..++.|++.||+|||++   +||||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             346799999999877655444322   2488999999999999999999999   999999999999999999999999


Q ss_pred             cc
Q 013258          443 IL  444 (447)
Q Consensus       443 f~  444 (447)
                      |-
T Consensus       160 fg  161 (305)
T d1blxa_         160 FG  161 (305)
T ss_dssp             CC
T ss_pred             hh
Confidence            85

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.5e-26  Score=221.34  Aligned_cols=140  Identities=23%  Similarity=0.300  Sum_probs=118.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcCCCCCccceeeEEec------CCc
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTE  366 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~  366 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+.+++.++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56888899999999999999965 6999999999654322 223468899999999999999999999864      367


Q ss_pred             eEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          367 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       367 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                      .++||||+.++ +.+.+..      .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..|++||-
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            89999999765 4444432      278999999999999999999999   99999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.92  E-value=2.2e-25  Score=209.86  Aligned_cols=141  Identities=18%  Similarity=0.217  Sum_probs=121.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-CCcEEEEEEcccccccccHHHHHHHHHHHhcCCC-CCccceeeEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++....   ..++.+|++.+..++| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            56888899999999999999964 689999998854432   2247788899988875 899999999999999999999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC-----CCceeeccccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----DADQSSKTILR  445 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~~i~df~~  445 (447)
                      |+ +|+|.++++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.     ++.+|++||--
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence            99 6899999876543   388999999999999999999999   9999999999999975     56799999963

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=1.4e-24  Score=205.03  Aligned_cols=140  Identities=21%  Similarity=0.215  Sum_probs=114.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCcccee-eEEecCCceEEEee
Q 013258          295 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY-GFCTTVTEKLLVYP  372 (447)
Q Consensus       295 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-~~~~~~~~~~lv~e  372 (447)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....   ..++.+|+++++.++|+|+|..+ ++..+.+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4688889999999999999996 4689999998865322   23578999999999887766554 55567788899999


Q ss_pred             cCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCC---CCceeecccc
Q 013258          373 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTIL  444 (447)
Q Consensus       373 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~~i~df~  444 (447)
                      |+ +|++...+.....   .+++..+..++.|++.||+|||++   +||||||||+|||++.   +..+|++||-
T Consensus        84 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             Ec-CCchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99 5577666655332   489999999999999999999999   9999999999998764   4579999995

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=8.3e-22  Score=173.22  Aligned_cols=128  Identities=13%  Similarity=0.103  Sum_probs=100.3

Q ss_pred             CCCccccCCCceEEEEEeCCCcEEEEEEccccccc-----------------ccHHHHHHHHHHHhcCCCCCccceeeEE
Q 013258          299 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-----------------GGELQFQTEVKIISMAVHRNLLRLYGFC  361 (447)
Q Consensus       299 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~H~niv~l~~~~  361 (447)
                      +.+.||+|+||+||+|+..+|+.||||+++.....                 .......+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45789999999999999888999999987532110                 0012355688899999999999887653


Q ss_pred             ecCCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcCCCCCeeecCCCCCceeeCCCCceeec
Q 013258          362 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  441 (447)
Q Consensus       362 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~~i~  441 (447)
                          ..+++|||+++..+.+           +++.....++.|+++|++|||++   +|+||||||+|||+++++ ++++
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEEC
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEE
Confidence                2479999998765432           33445678999999999999999   999999999999999654 8899


Q ss_pred             cccc
Q 013258          442 TILR  445 (447)
Q Consensus       442 df~~  445 (447)
                      ||-.
T Consensus       145 DFG~  148 (191)
T d1zara2         145 DFPQ  148 (191)
T ss_dssp             CCTT
T ss_pred             ECCC
Confidence            9964

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=3.2e-21  Score=186.62  Aligned_cols=144  Identities=19%  Similarity=0.245  Sum_probs=111.6

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-----------CCCccceeeEEec
Q 013258          296 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCTT  363 (447)
Q Consensus       296 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  363 (447)
                      +|++.+.||+|+||+||+|+. .+|+.||||+++...  .....+.+|+.+++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            488889999999999999996 469999999997542  12345788888887765           5789999988764


Q ss_pred             --CCceEEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhc-CCCCCeeecCCCCCceeeCCCCc---
Q 013258          364 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD---  437 (447)
Q Consensus       364 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~---  437 (447)
                        ....+++++++..+.......... ....+++..+..++.|+++||+|||+ .   +|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              455667777765554333332221 22347889999999999999999998 5   8999999999999987654   


Q ss_pred             ---eeeccccc
Q 013258          438 ---QSSKTILR  445 (447)
Q Consensus       438 ---~~i~df~~  445 (447)
                         ++++||..
T Consensus       168 ~~~~kl~dfg~  178 (362)
T d1q8ya_         168 LIQIKIADLGN  178 (362)
T ss_dssp             EEEEEECCCTT
T ss_pred             cceeeEeeccc
Confidence               89999865

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.69  E-value=8.3e-18  Score=147.38  Aligned_cols=124  Identities=27%  Similarity=0.369  Sum_probs=109.6

Q ss_pred             CccceeEeCCC----------CCEEEEEcCCCCccccc-cccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccC
Q 013258           56 CTWFHITCNPE----------GSVTRVDLGNAALSGEL-APELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYS  124 (447)
Q Consensus        56 c~w~gv~c~~~----------~~v~~l~L~~~~l~g~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  124 (447)
                      |+|..|.|...          ..++.|+|++|.+++.+ +..+..+++|++|+|++|.+.+..+..+..+++|+.|+|++
T Consensus         8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_           8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            56888888621          36899999999998766 45578899999999999999998999999999999999999


Q ss_pred             CcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccC
Q 013258          125 NLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPV  179 (447)
Q Consensus       125 N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~  179 (447)
                      |++++..|..|.++++|++|+|++|+|++..|..|..+++|+.+++++|.+....
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence            9999877888999999999999999999988889999999999999999998654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.58  E-value=2.9e-15  Score=130.84  Aligned_cols=128  Identities=23%  Similarity=0.359  Sum_probs=111.4

Q ss_pred             EEEEcCCCCccccccccccCCCCCCEEECCCCccCCCC-ChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           70 TRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHI-PSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        70 ~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      +.++.++++++ .+|+.+.  +++++|+|++|.|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            46899999998 6888774  68999999999998754 56779999999999999999988899999999999999999


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccccccc
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC  200 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc  200 (447)
                      |++++..|.+|.++++|+.|++++|+|++..|+. ..+..+..+.+.+|+..|
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            9999988999999999999999999999987764 245667777777776554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=2.9e-14  Score=114.97  Aligned_cols=103  Identities=31%  Similarity=0.370  Sum_probs=90.6

Q ss_pred             EEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCcc
Q 013258           71 RVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNS  150 (447)
Q Consensus        71 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  150 (447)
                      .|||++|+++ .++ .+..+++|++|++++|.++ .+|+.++.+++|+.|++++|.+++ +| .+..+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            5899999998 444 5899999999999999998 588899999999999999999984 55 58999999999999999


Q ss_pred             ccccC-chHHhhccccccccccccccccc
Q 013258          151 LSGLI-PTSLTTITSLNILDLSNNRLSGP  178 (447)
Q Consensus       151 l~~~~-p~~~~~l~~L~~l~ls~N~l~g~  178 (447)
                      ++... ...+..+++|+.+++++|+++..
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            98643 25788999999999999999853

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.45  E-value=4.8e-14  Score=132.60  Aligned_cols=111  Identities=32%  Similarity=0.463  Sum_probs=99.5

Q ss_pred             EEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcC
Q 013258           69 VTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        69 v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~  148 (447)
                      ...+++.++...|.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|+.++++++|++|||++
T Consensus       199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~  277 (313)
T d1ogqa_         199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF  277 (313)
T ss_dssp             CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence            3468888888888899999999999999999999998665 688999999999999999999999999999999999999


Q ss_pred             ccccccCchHHhhccccccccccccc-cccc-CCC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNR-LSGP-VPD  181 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~-l~g~-~p~  181 (447)
                      |+++|.+|+ ++++++|+.+++++|+ +.|. +|.
T Consensus       278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp~  311 (313)
T d1ogqa_         278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA  311 (313)
T ss_dssp             SEEEEECCC-STTGGGSCGGGTCSSSEEESTTSSC
T ss_pred             CcccccCCC-cccCCCCCHHHhCCCccccCCCCCC
Confidence            999999995 6889999999999997 5664 453

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=1.5e-13  Score=126.11  Aligned_cols=131  Identities=28%  Similarity=0.307  Sum_probs=76.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC---------------------
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN---------------------  125 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N---------------------  125 (447)
                      .+++.|+|++|.++. ++ .++.+++|++|+|++|++++ +|..+.++++|+.|++++|                     
T Consensus        55 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l  131 (266)
T d1p9ag_          55 TRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (266)
T ss_dssp             TTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             ccccccccccccccc-cc-cccccccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccc
Confidence            346666666666652 32 23455666666666666553 3444555555555555554                     


Q ss_pred             ---cccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCC-CCCCCccccccccccccccC
Q 013258          126 ---LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD-NGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       126 ---~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~lc~  201 (447)
                         .++...+..+..+++|+.+++++|++++..+..+..+++|+.|++++|+|+ .+|. ...+..++.+.+.+|+..|.
T Consensus       132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence               444333444555666777777777777666666677777777777777777 4443 33445566666667766553

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=8.3e-14  Score=129.13  Aligned_cols=133  Identities=20%  Similarity=0.237  Sum_probs=98.5

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+.+..+..+..+.+|+.+++++|.+++..+..|..+++|+.|++++|++++..|..+.++++|+.++++
T Consensus       106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~  185 (284)
T d1ozna_         106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (284)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence            57777787777776666667777778888888888876556677777788888888888876667777778888888888


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLC  200 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc  200 (447)
                      +|++++..|..|..+++|+.||+++|.+++..|.. ..+..+..+.+.+|+..|
T Consensus       186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence            88888777777887888888888888887765532 234556666777776655

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=4.7e-14  Score=130.79  Aligned_cols=114  Identities=27%  Similarity=0.277  Sum_probs=106.5

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..+..+++++|.+++..+..+..+++|+.|++++|++++..|..|.++++|+.+++++|++++..|..|.++++|++||+
T Consensus       129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l  208 (284)
T d1ozna_         129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL  208 (284)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence            46899999999999777778889999999999999999888889999999999999999999999999999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCC
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVP  180 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p  180 (447)
                      ++|++.+..|..+..+++|+.|++++|++.+..+
T Consensus       209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             cccccccccccccccccccCEEEecCCCCCCCcc
Confidence            9999999999999999999999999999997654

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=7e-13  Score=112.00  Aligned_cols=107  Identities=21%  Similarity=0.218  Sum_probs=85.1

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      .+..|||++|+++. ++..+..+++|++|+|++|.++. ++ .+..+++|+.|++++|+++...+..+..+++|+.|+++
T Consensus        19 ~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~   95 (162)
T d1a9na_          19 RDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   95 (162)
T ss_dssp             SCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             cCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence            57889999999875 45556778999999999999884 44 47888999999999999985444455678999999999


Q ss_pred             CccccccCc-hHHhhcccccccccccccccc
Q 013258          148 NNSLSGLIP-TSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       148 ~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      +|+++.... ..+..+++|+.+++++|+++.
T Consensus        96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~  126 (162)
T d1a9na_          96 NNSLVELGDLDPLASLKSLTYLCILRNPVTN  126 (162)
T ss_dssp             SCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             cccccccccccccccccccchhhcCCCcccc
Confidence            999875321 467788899999999998864

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.6e-12  Score=119.15  Aligned_cols=128  Identities=25%  Similarity=0.229  Sum_probs=101.9

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+|++|.+++..+..|.++++|++|+|++|+|+. +| .++.+++|+.|+|++|+++ .+|..+.++++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence            368999999999997766788999999999999999984 55 3578999999999999998 46778888999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCC-CCCccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNG-SFSQFTPISFENNL  197 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~-~~~~~~~~~~~~n~  197 (447)
                      ++|.+.+..+..+..+.+++.|++++|.++...+... .+..+..+.+.+|.
T Consensus       108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_         108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             cccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            9999888777777888888888888888876554432 23455555555553

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.31  E-value=4.2e-12  Score=118.53  Aligned_cols=140  Identities=26%  Similarity=0.373  Sum_probs=100.0

Q ss_pred             CccceeEeCC----------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC
Q 013258           56 CTWFHITCNP----------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN  125 (447)
Q Consensus        56 c~w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  125 (447)
                      |.|.+|.|..          ...++.|+|++|+++...+..+.++++|++|++++|.+....|..|.++++|+.|++++|
T Consensus        10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n   89 (305)
T d1xkua_          10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN   89 (305)
T ss_dssp             EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence            6799999963          146899999999998655567999999999999999999877889999999999999998


Q ss_pred             cccccCC------------------------------------------------ccccC--------------------
Q 013258          126 LFNGTIP------------------------------------------------DTLAN--------------------  137 (447)
Q Consensus       126 ~l~g~~p------------------------------------------------~~~~~--------------------  137 (447)
                      +++. +|                                                ..+..                    
T Consensus        90 ~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~  168 (305)
T d1xkua_          90 QLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG  168 (305)
T ss_dssp             CCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred             ccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence            7652 11                                                11111                    


Q ss_pred             -CCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCC-CCCCcccccccccc
Q 013258          138 -LKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-GSFSQFTPISFENN  196 (447)
Q Consensus       138 -l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n  196 (447)
                       +++|+.|++++|..++..+..+..++.++.|++++|.+++..|.. ..+..+..+.+++|
T Consensus       169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N  229 (305)
T d1xkua_         169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN  229 (305)
T ss_dssp             CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred             cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccc
Confidence             234555555555555556666666777777777777777665543 22345555556555

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.27  E-value=3.4e-12  Score=102.58  Aligned_cols=100  Identities=26%  Similarity=0.377  Sum_probs=83.2

Q ss_pred             CEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhcccccccccccc
Q 013258           94 ELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNN  173 (447)
Q Consensus        94 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N  173 (447)
                      +.|+|++|+++ .+| .+..+++|++|++++|+++ .+|+.++.+++|+.|++++|++++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57999999999 455 4899999999999999998 689899999999999999999986 45 4899999999999999


Q ss_pred             cccccCC--CCCCCCcccccccccccc
Q 013258          174 RLSGPVP--DNGSFSQFTPISFENNLN  198 (447)
Q Consensus       174 ~l~g~~p--~~~~~~~~~~~~~~~n~~  198 (447)
                      +++....  ....+..+..+++.+|+.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence            9985422  223445666777777763

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=5.7e-12  Score=105.55  Aligned_cols=101  Identities=24%  Similarity=0.170  Sum_probs=82.8

Q ss_pred             cCCCCccccccccccCCCCCCEEECCCC-ccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCcccc
Q 013258           74 LGNAALSGELAPELGQLKNLELLELYGN-NLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLS  152 (447)
Q Consensus        74 L~~~~l~g~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  152 (447)
                      .+++++. .+|..+..+++|+.|++++| .++...+..|.++++|+.|+|++|+++...|.+|..+++|++|+|++|+++
T Consensus        15 c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          15 CTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             CCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             ecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc
Confidence            3444444 45777888999999999766 488666678999999999999999999777888999999999999999999


Q ss_pred             ccCchHHhhccccccccccccccc
Q 013258          153 GLIPTSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       153 ~~~p~~~~~l~~L~~l~ls~N~l~  176 (447)
                      ...+..+. ..+|+.|++++|.+.
T Consensus        94 ~l~~~~~~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          94 SLSWKTVQ-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCCSTTTC-SCCCCEEECCSSCCC
T ss_pred             ccChhhhc-cccccccccCCCccc
Confidence            65555554 447999999999986

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=3.5e-12  Score=107.58  Aligned_cols=110  Identities=21%  Similarity=0.213  Sum_probs=88.8

Q ss_pred             ccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccc
Q 013258           85 PELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITS  164 (447)
Q Consensus        85 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  164 (447)
                      +.+.+..+|+.|+|++|+++. +|..+..+++|+.|+|++|+++ .++ .+..+++|++|++++|+++...+..+..+++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence            446788899999999999994 6777788999999999999998 454 5889999999999999999877777788999


Q ss_pred             cccccccccccccc--CCCCCCCCccccccccccc
Q 013258          165 LNILDLSNNRLSGP--VPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       165 L~~l~ls~N~l~g~--~p~~~~~~~~~~~~~~~n~  197 (447)
                      |+.|++++|+++..  +.....+..+..+.+.+|+
T Consensus        89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred             cccceeccccccccccccccccccccchhhcCCCc
Confidence            99999999999742  1112234555666666664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=1.9e-11  Score=102.29  Aligned_cols=113  Identities=16%  Similarity=0.079  Sum_probs=93.7

Q ss_pred             cCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCC-cccccCCccccCCCCCCeeeCcCccccccCchHHhhccccc
Q 013258           88 GQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSN-LFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLN  166 (447)
Q Consensus        88 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~  166 (447)
                      ..+...+.++.+++.+. .+|..+..+++|+.|++++| .++..-++.|.++++|+.|+|++|+++...|.+|..+++|+
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            44455677899998888 57888999999999999876 48866667899999999999999999998899999999999


Q ss_pred             ccccccccccccCCCCCCCCccccccccccccccC
Q 013258          167 ILDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG  201 (447)
Q Consensus       167 ~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lc~  201 (447)
                      .|++++|+|+...+.......+..+.+.+|+..|.
T Consensus        84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             ceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence            99999999996555544444677788888887663

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.17  E-value=2e-11  Score=113.79  Aligned_cols=129  Identities=23%  Similarity=0.307  Sum_probs=104.0

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.+++++|.+.. +|..+  +++|+.|++++|..++..+..+.+++.++.|++++|.+++..|..+.++++|++|+|
T Consensus       150 ~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L  226 (305)
T d1xkua_         150 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL  226 (305)
T ss_dssp             TTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred             cccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence            357889999998873 55443  678999999999999888999999999999999999999888888999999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCC-------CCCCccccccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDN-------GSFSQFTPISFENNLNL  199 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-------~~~~~~~~~~~~~n~~l  199 (447)
                      ++|+++ .+|..+..+++|+.|++++|+|+..-...       ....++..+++.+|+..
T Consensus       227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            999998 46888999999999999999998532211       11234555667777643

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.08  E-value=1.6e-10  Score=100.74  Aligned_cols=120  Identities=28%  Similarity=0.455  Sum_probs=65.6

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+++..+  +.++++|++|++++|.+.. +| .+.++++|+.|++++|.+..  .+.+..+++|+.|+++
T Consensus        63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~  136 (199)
T d2omxa2          63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELS  136 (199)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECC
T ss_pred             CcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccccccccccc--ccccchhhhhHHhhhh
Confidence            45666666666654322  5566666666666666552 33 25566666666666665543  1235556666666666


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      +|++.. + +.+..+++|+.|++++|++++. +....+..++.+++.+|
T Consensus       137 ~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N  182 (199)
T d2omxa2         137 SNTISD-I-SALSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSN  182 (199)
T ss_dssp             SSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred             hhhhcc-c-ccccccccccccccccccccCC-ccccCCCCCCEEECCCC
Confidence            666653 2 2355566666666666666543 22333444555555444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.07  E-value=2.1e-10  Score=99.87  Aligned_cols=121  Identities=28%  Similarity=0.428  Sum_probs=96.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+++++.+.. + +.+..+++|++|++++|++++. ++ ++++++|+.|++++|.+. .+| .+.++++|+.|++
T Consensus        40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l  113 (199)
T d2omxa2          40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL  113 (199)
T ss_dssp             TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred             cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence            368899999999874 3 3588899999999999999964 33 899999999999999987 455 4889999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      ++|.....  ..+..+++|+.|++++|++.. +|....+..+..+.+.+|
T Consensus       114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n  160 (199)
T d2omxa2         114 FNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSN  160 (199)
T ss_dssp             CSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSS
T ss_pred             cccccccc--cccchhhhhHHhhhhhhhhcc-cccccccccccccccccc
Confidence            99998754  347889999999999999874 343344555555555555

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.03  E-value=2.4e-10  Score=109.44  Aligned_cols=58  Identities=33%  Similarity=0.496  Sum_probs=25.9

Q ss_pred             cCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          136 ANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       136 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      ..+++++.|++++|++++..|  +..+++|+.|++++|++++ +|....+..++.+++.+|
T Consensus       304 ~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N  361 (384)
T d2omza2         304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN  361 (384)
T ss_dssp             GGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSS
T ss_pred             chhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCC
Confidence            334455555555555554321  4445555555555555543 222223334444444443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.03  E-value=4.3e-10  Score=98.76  Aligned_cols=120  Identities=33%  Similarity=0.421  Sum_probs=77.6

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|+|++|.+++. + .++.+++|+.|++++|++++ +| .+..+++|+.|++++|.+. .+ +.+..++.++.++++
T Consensus        69 ~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~  142 (210)
T d1h6ta2          69 NVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG  142 (210)
T ss_dssp             TCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred             CCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence            577777777777653 2 25677777777777777774 44 4677777777777777765 22 346666777777777


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      +|.+++  +..+..+++|+.+++++|++++. +....+..+..+.+.+|
T Consensus       143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N  188 (210)
T d1h6ta2         143 NNKITD--ITVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKN  188 (210)
T ss_dssp             SSCCCC--CGGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred             cccccc--ccccccccccccccccccccccc-ccccCCCCCCEEECCCC
Confidence            777664  23456667777777777777653 33334555555555555

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.99  E-value=4.2e-12  Score=110.85  Aligned_cols=110  Identities=24%  Similarity=0.362  Sum_probs=62.7

Q ss_pred             ccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhc
Q 013258           83 LAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTI  162 (447)
Q Consensus        83 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l  162 (447)
                      ++.++..|++|++|+|++|+++. ++ .+.++++|+.|+|++|.++ .+|.....+++|+.|++++|+++..  +.+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            34456666666666666666663 43 3666666666666666665 4554444455666666666666542  235566


Q ss_pred             cccccccccccccccc--CCCCCCCCccccccccccc
Q 013258          163 TSLNILDLSNNRLSGP--VPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       163 ~~L~~l~ls~N~l~g~--~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|+.|++++|+++..  +.....+..+..+.+.+|+
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~  151 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCc
Confidence            6666666666666532  1112334455555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.98  E-value=9.7e-12  Score=108.48  Aligned_cols=111  Identities=21%  Similarity=0.268  Sum_probs=93.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|+|++|.++. ++ .+..|++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. + +.+..+++|+.|++
T Consensus        48 ~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L  122 (198)
T d1m9la_          48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYM  122 (198)
T ss_dssp             TTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEE
T ss_pred             cccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccccccc
Confidence            468999999999984 54 5899999999999999998 577766777889999999999984 4 35788999999999


Q ss_pred             cCccccccCc-hHHhhcccccccccccccccccCCCC
Q 013258          147 NNNSLSGLIP-TSLTTITSLNILDLSNNRLSGPVPDN  182 (447)
Q Consensus       147 ~~N~l~~~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~  182 (447)
                      ++|+++.... ..+..+++|+.|++++|+++...+..
T Consensus       123 ~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  159 (198)
T d1m9la_         123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN  159 (198)
T ss_dssp             SEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTT
T ss_pred             ccchhccccccccccCCCccceeecCCCccccCcccc
Confidence            9999985422 46889999999999999998766544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.97  E-value=8.4e-10  Score=96.81  Aligned_cols=117  Identities=28%  Similarity=0.356  Sum_probs=95.4

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      .+++.|++++|.+++ +| .+..+++|+.|++++|.+.. + +.+..++.++.+++++|.+++  +..+..+++|+.+++
T Consensus        90 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l  163 (210)
T d1h6ta2          90 KNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSL  163 (210)
T ss_dssp             TTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEEC
T ss_pred             ccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccccccccccc--ccccccccccccccc
Confidence            579999999999985 44 58999999999999999873 3 468899999999999999974  446788999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPIS  192 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~  192 (447)
                      ++|++++. + .+.++++|+.|++++|+++. +|....+..++.+.
T Consensus       164 ~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~  206 (210)
T d1h6ta2         164 EDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLE  206 (210)
T ss_dssp             CSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEE
T ss_pred             cccccccc-c-cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEE
Confidence            99999864 3 38899999999999999985 45433444444443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.94  E-value=6.1e-10  Score=106.48  Aligned_cols=121  Identities=29%  Similarity=0.429  Sum_probs=99.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.|+++++.+.+..  .+..+..++.+.++.|.+++  ...+..+++++.|++++|++++. + .+..+++|+.|++
T Consensus       263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L  336 (384)
T d2omza2         263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFF  336 (384)
T ss_dssp             TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEEC
T ss_pred             ccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEEC
Confidence            46899999999998643  37889999999999999985  34588899999999999999864 3 3788999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                      ++|++++ +| .+..+++|+.|++++|++++.+| ...++.++.+.+++|
T Consensus       337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            9999985 44 68999999999999999998665 445667777766665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.84  E-value=3.3e-09  Score=94.03  Aligned_cols=123  Identities=28%  Similarity=0.485  Sum_probs=79.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCC--------------
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP--------------  132 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p--------------  132 (447)
                      .+++.|+|++|.+.+..|  +..+.+|+.+++++|.++. ++ .+..+++|+.++++++...+..+              
T Consensus        63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~  138 (227)
T d1h6ua2          63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL  138 (227)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred             CCCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchh
Confidence            468888888888876443  7788888888888887763 43 46778888888888776553211              


Q ss_pred             ------ccccCCCCCCeeeCcCccccccCchHHhhcccccccccccccccccCCCCCCCCcccccccccc
Q 013258          133 ------DTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISFENN  196 (447)
Q Consensus       133 ------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n  196 (447)
                            ..+.++++|+.|++++|.+....  .+..+++|+.|++++|++++ +|....+..+..+.+.+|
T Consensus       139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N  205 (227)
T d1h6ua2         139 NQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNN  205 (227)
T ss_dssp             SCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTS
T ss_pred             hhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCC
Confidence                  12444566777777777765432  36667777777777777764 333334455555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.79  E-value=5.1e-09  Score=92.75  Aligned_cols=118  Identities=25%  Similarity=0.349  Sum_probs=88.7

Q ss_pred             CCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeC
Q 013258           67 GSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRL  146 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l  146 (447)
                      ..++.++++++...+.  ..+.....++.+.++++.+....  .+.++++|+.|++++|.+.+.  ..++++++|+.|+|
T Consensus       107 ~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~L  180 (227)
T d1h6ua2         107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKA  180 (227)
T ss_dssp             TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred             cccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc--hhhcccccceeccc
Confidence            3578889988877653  33667888999999998887533  367888999999999988743  33788999999999


Q ss_pred             cCccccccCchHHhhcccccccccccccccccCCCCCCCCccccccc
Q 013258          147 NNNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPDNGSFSQFTPISF  193 (447)
Q Consensus       147 ~~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~  193 (447)
                      ++|++++. | .+..+++|+.|++++|++++.. ....+..+..+++
T Consensus       181 s~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~-~l~~l~~L~~L~l  224 (227)
T d1h6ua2         181 DDNKISDI-S-PLASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTL  224 (227)
T ss_dssp             CSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEE
T ss_pred             CCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc-ccccCCCCCEEEe
Confidence            99999863 3 3788899999999999988643 3334455554444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=1.4e-08  Score=90.64  Aligned_cols=103  Identities=20%  Similarity=0.274  Sum_probs=70.0

Q ss_pred             EEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCC-ccccCCCCCCeeeCc-Cc
Q 013258           72 VDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIP-DTLANLKQLKYLRLN-NN  149 (447)
Q Consensus        72 l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p-~~~~~l~~L~~L~l~-~N  149 (447)
                      ++.++..++ .+|+++.  .++++|+|++|+++...+..|.++++|++|++++|.+...+| ..|.++++++++++. .|
T Consensus        13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            344445555 5665553  467788888888775444467778888888888887765443 356777777777765 35


Q ss_pred             cccccCchHHhhcccccccccccccccc
Q 013258          150 SLSGLIPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       150 ~l~~~~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      ++....+..+..+++|+.+++++|.++.
T Consensus        90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          90 NLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             TCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             cccccccccccccccccccccchhhhcc
Confidence            6766666777777788888888877764

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.62  E-value=2.3e-08  Score=89.09  Aligned_cols=122  Identities=18%  Similarity=0.248  Sum_probs=93.2

Q ss_pred             CccceeEeCC----------CCCEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCC-hhhcCCCCCcEEEcc-
Q 013258           56 CTWFHITCNP----------EGSVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIP-SALGNLIKLKSLDLY-  123 (447)
Q Consensus        56 c~w~gv~c~~----------~~~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls-  123 (447)
                      |.+..|.|..          ...+++|||++|.++...+..|.++++|++|++++|.+...+| ..|.+++.++.|++. 
T Consensus         8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1           8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            4566777752          1368999999999986555568999999999999999986554 468899999999986 


Q ss_pred             CCcccccCCccccCCCCCCeeeCcCccccccCch-HHhhcccccccccccccccc
Q 013258          124 SNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPT-SLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       124 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~ls~N~l~g  177 (447)
                      .|++....+..+.++++|+.+++++|.+....+. .+..+..+..+..+++.+..
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~  142 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT  142 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence            4778877788899999999999999999754332 23344555555666666654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.47  E-value=1.7e-07  Score=87.65  Aligned_cols=100  Identities=31%  Similarity=0.380  Sum_probs=80.5

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCc
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLN  147 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~  147 (447)
                      +++.|||+++.++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            5788999999997 57753   568999999999999 678654   57899999999997 55542   2469999999


Q ss_pred             CccccccCchHHhhcccccccccccccccccCCC
Q 013258          148 NNSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       148 ~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      +|.+.. +|. ++.+++|+.|++++|.++...+.
T Consensus       107 ~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~  138 (353)
T d1jl5a_         107 NNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDL  138 (353)
T ss_dssp             SSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred             cccccc-ccc-hhhhccceeeccccccccccccc
Confidence            999985 564 57889999999999998865543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=8.6e-07  Score=79.54  Aligned_cols=145  Identities=13%  Similarity=0.070  Sum_probs=93.0

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC-CCCccceeeEEecCCce
Q 013258          289 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK  367 (447)
Q Consensus       289 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  367 (447)
                      ++...-+.|+..+..+-++.+.||+... +++.+.+|+...... .....+.+|...+..+. +--+.+++.+...++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3444445565444433344568998875 456677887754322 12234678888877663 43467788888888889


Q ss_pred             EEEeecCCCCChhhHhhccCCCCCCCChHHHHHHHHHHHHHHhhhhcC--------------------------------
Q 013258          368 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------  415 (447)
Q Consensus       368 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------  415 (447)
                      ++||+++++..+.+.....         .....++.++++.++.||+.                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998776543221         11233445555555555532                                


Q ss_pred             ------------------------CCCCeeecCCCCCceeeCCCCceeecccc
Q 013258          416 ------------------------CDPKIIHRDVKAANILLDEDADQSSKTIL  444 (447)
Q Consensus       416 ------------------------~~~~ivHrDlkp~NILl~~~~~~~i~df~  444 (447)
                                              ..+.++|+|+.|.|||+++++..-+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe  209 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG  209 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeech
Confidence                                    01237899999999999987777788985

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.39  E-value=2e-08  Score=97.62  Aligned_cols=110  Identities=28%  Similarity=0.343  Sum_probs=86.3

Q ss_pred             CEEEEEcCCCCccccc-cccccCCCCCCEEECCCCccCC----CCChhhcCCCCCcEEEccCCccccc----CCcccc-C
Q 013258           68 SVTRVDLGNAALSGEL-APELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGT----IPDTLA-N  137 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~-~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~-~  137 (447)
                      +++.|||+.+++++.. ..-+..++++++|+|++|.++.    .++..+..+++|+.|||++|.++..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5899999999999743 3445678999999999999873    3566778899999999999998631    223332 2


Q ss_pred             CCCCCeeeCcCcccccc----CchHHhhcccccccccccccccc
Q 013258          138 LKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       138 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      ..+|++|+|++|+++..    ++..+..+++|+.|++++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            35799999999999754    45566778899999999999864

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=3.1e-08  Score=82.79  Aligned_cols=65  Identities=28%  Similarity=0.255  Sum_probs=31.8

Q ss_pred             CCCCCCEEECCCCccCCC--CChhhcCCCCCcEEEccCCcccccCCc-cccCCCCCCeeeCcCcccccc
Q 013258           89 QLKNLELLELYGNNLSGH--IPSALGNLIKLKSLDLYSNLFNGTIPD-TLANLKQLKYLRLNNNSLSGL  154 (447)
Q Consensus        89 ~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~~~  154 (447)
                      .+++|++|+|++|+++..  ++..+..+++|+.|+|++|.++. +++ ......+|+.|++++|.+...
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence            455555566666655532  22334455555555555555552 222 222233455555555555443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.17  E-value=2.7e-07  Score=76.87  Aligned_cols=106  Identities=23%  Similarity=0.176  Sum_probs=73.4

Q ss_pred             EEEcCCCCccccccccccCCCCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCccccc--CCccccCCCCCCeeeCcC
Q 013258           71 RVDLGNAALSGELAPELGQLKNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGT--IPDTLANLKQLKYLRLNN  148 (447)
Q Consensus        71 ~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~--~p~~~~~l~~L~~L~l~~  148 (447)
                      .||+++...    .+.+..+..+..+++.+|... .++.....+++|++|+|++|+++..  ++..+..+++|+.|+|++
T Consensus        26 ~Ldls~l~~----~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~  100 (162)
T d1koha1          26 ALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG  100 (162)
T ss_dssp             CBCCCCCSS----CTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTT
T ss_pred             eeecccCCC----CchhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccccc
Confidence            355555432    223445555555555555443 4555566799999999999999843  345577899999999999


Q ss_pred             ccccccCchHHhhcccccccccccccccccCCC
Q 013258          149 NSLSGLIPTSLTTITSLNILDLSNNRLSGPVPD  181 (447)
Q Consensus       149 N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~  181 (447)
                      |.++...+-......+|+.+++++|+++....+
T Consensus       101 N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~  133 (162)
T d1koha1         101 NELKSERELDKIKGLKLEELWLDGNSLSDTFRD  133 (162)
T ss_dssp             SCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSS
T ss_pred             CccccchhhhhhhccccceeecCCCCcCcCccc
Confidence            999865443344445799999999999876543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.14  E-value=2.3e-06  Score=79.68  Aligned_cols=94  Identities=31%  Similarity=0.388  Sum_probs=73.3

Q ss_pred             CCCCEEECCCCccCCCCChhhcCCCCCcEEEccCCcccccCCccccCCCCCCeeeCcCccccccCchHHhhccccccccc
Q 013258           91 KNLELLELYGNNLSGHIPSALGNLIKLKSLDLYSNLFNGTIPDTLANLKQLKYLRLNNNSLSGLIPTSLTTITSLNILDL  170 (447)
Q Consensus        91 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l  170 (447)
                      .+++.|+|++|.++ .+|+.   +++|++|+|++|+++ .+|+.+   .+|+.|++++|+++. ++. +  .+.|+.|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSD-L--PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCS-C--CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhh-h--ccccccccc
Confidence            47899999999998 58864   578999999999999 788764   578999999999974 442 1  246999999


Q ss_pred             ccccccccCCCCCCCCccccccccccc
Q 013258          171 SNNRLSGPVPDNGSFSQFTPISFENNL  197 (447)
Q Consensus       171 s~N~l~g~~p~~~~~~~~~~~~~~~n~  197 (447)
                      ++|.++. +|..+.+..++.+.+.++.
T Consensus       106 ~~n~l~~-lp~~~~l~~L~~L~l~~~~  131 (353)
T d1jl5a_         106 SNNQLEK-LPELQNSSFLKIIDVDNNS  131 (353)
T ss_dssp             CSSCCSS-CCCCTTCTTCCEEECCSSC
T ss_pred             ccccccc-ccchhhhccceeecccccc
Confidence            9999984 5666666677666665543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.13  E-value=4.1e-07  Score=85.31  Aligned_cols=109  Identities=22%  Similarity=0.265  Sum_probs=57.9

Q ss_pred             CEEEEEcCCCCcccc----ccccccCCCCCCEEECCCCccCCC-----CChhhcCCCCCcEEEccCCccccc----CCcc
Q 013258           68 SVTRVDLGNAALSGE----LAPELGQLKNLELLELYGNNLSGH-----IPSALGNLIKLKSLDLYSNLFNGT----IPDT  134 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~  134 (447)
                      .++.+++++|.++..    +...+.....|+.|+|++|.++..     +...+..+++|+.|+|++|.++..    +...
T Consensus       159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~  238 (344)
T d2ca6a1         159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA  238 (344)
T ss_dssp             CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred             ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence            455666666655422    233345556666666666665521     223345556666666666665421    3344


Q ss_pred             ccCCCCCCeeeCcCccccccCchHH----hh--ccccccccccccccc
Q 013258          135 LANLKQLKYLRLNNNSLSGLIPTSL----TT--ITSLNILDLSNNRLS  176 (447)
Q Consensus       135 ~~~l~~L~~L~l~~N~l~~~~p~~~----~~--l~~L~~l~ls~N~l~  176 (447)
                      +..+++|++|+|++|.+++.-...+    ..  ..+|+.||+++|+++
T Consensus       239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~  286 (344)
T d2ca6a1         239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  286 (344)
T ss_dssp             GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence            5556666666666666654322222    11  134666666666654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=4.9e-06  Score=74.00  Aligned_cols=74  Identities=12%  Similarity=0.027  Sum_probs=51.9

Q ss_pred             ccccCCC-ceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCC--CCccceeeEEecCCceEEEeecCCCCC
Q 013258          302 ILGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNGS  378 (447)
Q Consensus       302 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lv~e~~~~gs  378 (447)
                      .+..|.. +.||+....++..+.+|.-+...    ...+.+|.+.++.+..  -.+.+++.+..+++..++||||++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445543 57899988777778889765432    2246777777776643  335677888888888999999998765


Q ss_pred             h
Q 013258          379 V  379 (447)
Q Consensus       379 L  379 (447)
                      +
T Consensus        93 ~   93 (255)
T d1nd4a_          93 L   93 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=1.1e-06  Score=80.14  Aligned_cols=110  Identities=24%  Similarity=0.290  Sum_probs=48.3

Q ss_pred             CEEEEEcCCCCccccccccccCCCCCCEEECCCC-ccCC-CCChhhcCCCCCcEEEccCC-cccc-cCCccccC-CCCCC
Q 013258           68 SVTRVDLGNAALSGELAPELGQLKNLELLELYGN-NLSG-HIPSALGNLIKLKSLDLYSN-LFNG-TIPDTLAN-LKQLK  142 (447)
Q Consensus        68 ~v~~l~L~~~~l~g~~~~~l~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~ls~N-~l~g-~~p~~~~~-l~~L~  142 (447)
                      +++.|+|+++.+++..+..++.+++|++|+++++ .++. .+..-..++++|+.|+++++ .++. .++..+.. .++|+
T Consensus        72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~  151 (284)
T d2astb2          72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT  151 (284)
T ss_dssp             CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred             CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccc
Confidence            3455555555555444445555555555555552 3331 11112234455555555543 2221 01111111 23455


Q ss_pred             eeeCcCc--ccccc-CchHHhhcccccccccccc-cccc
Q 013258          143 YLRLNNN--SLSGL-IPTSLTTITSLNILDLSNN-RLSG  177 (447)
Q Consensus       143 ~L~l~~N--~l~~~-~p~~~~~l~~L~~l~ls~N-~l~g  177 (447)
                      .|+++++  .++.. +......+++|+.|++++| .+++
T Consensus       152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd  190 (284)
T d2astb2         152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN  190 (284)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG
T ss_pred             hhhhcccccccccccccccccccccccccccccccCCCc
Confidence            5555432  22211 2222345677888888775 3553

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.97  E-value=9.6e-07  Score=82.73  Aligned_cols=111  Identities=20%  Similarity=0.242  Sum_probs=75.6

Q ss_pred             CCEEEEEcCCCCcc--c--cc---------cccccCCCCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCcccc
Q 013258           67 GSVTRVDLGNAALS--G--EL---------APELGQLKNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFNG  129 (447)
Q Consensus        67 ~~v~~l~L~~~~l~--g--~~---------~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g  129 (447)
                      .+++.|+|++|.+.  |  .+         .........|+.|++++|.++..    +...+...+.|+.|+|++|+++.
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  200 (344)
T d2ca6a1         121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  200 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence            46888888888753  1  11         11124567788888888887632    34445667888888888888753


Q ss_pred             c-----CCccccCCCCCCeeeCcCcccccc----CchHHhhcccccccccccccccc
Q 013258          130 T-----IPDTLANLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       130 ~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      .     +...+..+++|+.|+|++|.++..    +...+...++|+.|++++|.+++
T Consensus       201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            2     334566778888888888887532    33455667788888888888764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.89  E-value=1.3e-06  Score=84.25  Aligned_cols=111  Identities=26%  Similarity=0.227  Sum_probs=78.9

Q ss_pred             CCEEEEEcCCCCcccccccc----c-cCCCCCCEEECCCCccCCCC----ChhhcCCCCCcEEEccCCccccc----CCc
Q 013258           67 GSVTRVDLGNAALSGELAPE----L-GQLKNLELLELYGNNLSGHI----PSALGNLIKLKSLDLYSNLFNGT----IPD  133 (447)
Q Consensus        67 ~~v~~l~L~~~~l~g~~~~~----l-~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~ls~N~l~g~----~p~  133 (447)
                      ..+..+++++|.+++.....    + .....|+.+++++|.++..-    ...+...++|+.|+|++|+++..    ++.
T Consensus       283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~  362 (460)
T d1z7xw1         283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ  362 (460)
T ss_dssp             TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence            46788899999887533322    2 23467899999999887543    23344567899999999988642    344


Q ss_pred             ccc-CCCCCCeeeCcCcccccc----CchHHhhcccccccccccccccc
Q 013258          134 TLA-NLKQLKYLRLNNNSLSGL----IPTSLTTITSLNILDLSNNRLSG  177 (447)
Q Consensus       134 ~~~-~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~ls~N~l~g  177 (447)
                      .+. ..+.|++|+|++|+++..    ++..+...++|++||+++|+++.
T Consensus       363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            443 456799999999998743    44556667889999999999864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.82  E-value=5e-06  Score=69.23  Aligned_cols=109  Identities=17%  Similarity=0.203  Sum_probs=78.2

Q ss_pred             CCEEEEEcCCC-Ccccc----ccccccCCCCCCEEECCCCccCC----CCChhhcCCCCCcEEEccCCccccc----CCc
Q 013258           67 GSVTRVDLGNA-ALSGE----LAPELGQLKNLELLELYGNNLSG----HIPSALGNLIKLKSLDLYSNLFNGT----IPD  133 (447)
Q Consensus        67 ~~v~~l~L~~~-~l~g~----~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~g~----~p~  133 (447)
                      ..++.|+|+++ .++..    +...+...++|++|+|++|.+..    .+...+...+.|+.|+|++|.++..    +-.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence            46899999874 46542    34567778899999999999873    2344566678999999999998643    233


Q ss_pred             cccCCCCCCeeeCcCcccccc-------CchHHhhcccccccccccccc
Q 013258          134 TLANLKQLKYLRLNNNSLSGL-------IPTSLTTITSLNILDLSNNRL  175 (447)
Q Consensus       134 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~l~ls~N~l  175 (447)
                      .+...++|++|++++|.+...       +...+..-++|+.|+++.+..
T Consensus        95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            566678899999999876532       234445567788888877654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=0.00012  Score=69.27  Aligned_cols=76  Identities=11%  Similarity=0.041  Sum_probs=47.4

Q ss_pred             CccccCCCceEEEEEeCC-CcEEEEEEccccc------ccccHHHHHHHHHHHhcCC-C--CCccceeeEEecCCceEEE
Q 013258          301 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEER------TSGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTVTEKLLV  370 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lv  370 (447)
                      +.||.|....||+....+ ++.+.||.-....      ......+...|.+.+..+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 6789999653211      1112224556777776552 2  345555544  45567899


Q ss_pred             eecCCCCC
Q 013258          371 YPYMTNGS  378 (447)
Q Consensus       371 ~e~~~~gs  378 (447)
                      |||+.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.65  E-value=2.9e-05  Score=70.36  Aligned_cols=107  Identities=17%  Similarity=0.228  Sum_probs=81.0

Q ss_pred             CCEEEEEcCCC-Cccc-cccccccC-CCCCCEEECCCC--ccCC-CCChhhcCCCCCcEEEccCC-cccccCCccccCCC
Q 013258           67 GSVTRVDLGNA-ALSG-ELAPELGQ-LKNLELLELYGN--NLSG-HIPSALGNLIKLKSLDLYSN-LFNGTIPDTLANLK  139 (447)
Q Consensus        67 ~~v~~l~L~~~-~l~g-~~~~~l~~-l~~L~~L~L~~N--~l~~-~~p~~~~~l~~L~~L~ls~N-~l~g~~p~~~~~l~  139 (447)
                      .+++.|+|+++ .+++ .+...+.. .++|+.|++++.  .++. .+.....++++|+.|++++| .+++..+..+..++
T Consensus       121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~  200 (284)
T d2astb2         121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  200 (284)
T ss_dssp             TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence            46999999985 4443 23333443 478999999875  3442 23444567899999999986 57777788899999


Q ss_pred             CCCeeeCcCc-cccccCchHHhhcccccccccccc
Q 013258          140 QLKYLRLNNN-SLSGLIPTSLTTITSLNILDLSNN  173 (447)
Q Consensus       140 ~L~~L~l~~N-~l~~~~p~~~~~l~~L~~l~ls~N  173 (447)
                      +|++|+|+++ .++......++++++|+.|+++++
T Consensus       201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            9999999994 677766677888999999999876

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.11  E-value=9.2e-05  Score=61.20  Aligned_cols=89  Identities=16%  Similarity=0.180  Sum_probs=64.4

Q ss_pred             cCCCCCCEEECCCC-ccCCC----CChhhcCCCCCcEEEccCCccccc----CCccccCCCCCCeeeCcCccccccCc--
Q 013258           88 GQLKNLELLELYGN-NLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLIP--  156 (447)
Q Consensus        88 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~p--  156 (447)
                      .+.++|+.|+|+++ .++..    +-..+...+.|+.|+|++|.+...    +...+...++|+.|+|++|.++..--  
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999974 56521    334566778999999999998632    23345567899999999999975322  


Q ss_pred             --hHHhhccccccccccccccc
Q 013258          157 --TSLTTITSLNILDLSNNRLS  176 (447)
Q Consensus       157 --~~~~~l~~L~~l~ls~N~l~  176 (447)
                        .++..-++|+.|++++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence              23444567999999988654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.05  E-value=0.00011  Score=60.66  Aligned_cols=109  Identities=21%  Similarity=0.249  Sum_probs=76.3

Q ss_pred             CCEEEEEcCC-CCcccc----ccccccCCCCCCEEECCCCccCCC----CChhhcCCCCCcEEEccCCccccc----CCc
Q 013258           67 GSVTRVDLGN-AALSGE----LAPELGQLKNLELLELYGNNLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IPD  133 (447)
Q Consensus        67 ~~v~~l~L~~-~~l~g~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~  133 (447)
                      ..++.|+|++ +.++..    +...+...++|++|+|++|.++..    +-..+...+.++.|++++|.++..    +-.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            4688899987 456532    445567888999999999988743    334566678999999999988532    334


Q ss_pred             cccCCCCCCeeeC--cCccccc----cCchHHhhcccccccccccccc
Q 013258          134 TLANLKQLKYLRL--NNNSLSG----LIPTSLTTITSLNILDLSNNRL  175 (447)
Q Consensus       134 ~~~~l~~L~~L~l--~~N~l~~----~~p~~~~~l~~L~~l~ls~N~l  175 (447)
                      .+...++|+.++|  +.|.+..    .+...+...++|+.|+++.|..
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            5667788887555  5667743    2344556677888888877654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.76  E-value=0.002  Score=58.92  Aligned_cols=67  Identities=18%  Similarity=0.142  Sum_probs=43.7

Q ss_pred             ceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc--cceee-----EEecCCceEEEeecCCCC
Q 013258          309 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL--LRLYG-----FCTTVTEKLLVYPYMTNG  377 (447)
Q Consensus       309 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lv~e~~~~g  377 (447)
                      -.||+.+..+|+.|++|+.+....  ...++..|...+..+....+  +..+.     ........+.++++++|.
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            369999998999999999865422  34467788888876643222  11111     123345678899998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.57  E-value=0.0025  Score=51.98  Aligned_cols=90  Identities=24%  Similarity=0.211  Sum_probs=62.3

Q ss_pred             ccCCCCCCEEECCC-CccCCC----CChhhcCCCCCcEEEccCCccccc----CCccccCCCCCCeeeCcCccccccC--
Q 013258           87 LGQLKNLELLELYG-NNLSGH----IPSALGNLIKLKSLDLYSNLFNGT----IPDTLANLKQLKYLRLNNNSLSGLI--  155 (447)
Q Consensus        87 l~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~~~~--  155 (447)
                      ..+.++|++|+|++ |.++..    +-..+...++|+.|++++|.++..    +-..+...++++.+++++|.+....  
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            45678999999997 556521    344566788999999999988643    2334566789999999999986432  


Q ss_pred             --chHHhhccccccc--cccccccc
Q 013258          156 --PTSLTTITSLNIL--DLSNNRLS  176 (447)
Q Consensus       156 --p~~~~~l~~L~~l--~ls~N~l~  176 (447)
                        -..+...++|+.+  ++++|.+.
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHhCccccEEeeccCCCcCc
Confidence              2334455667764  44566654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.28  E-value=0.048  Score=50.65  Aligned_cols=72  Identities=18%  Similarity=0.269  Sum_probs=46.3

Q ss_pred             CccccCCCceEEEEEeCC--------CcEEEEEEcccccccccHHHHHHHHHHHhcCCCCCc-cceeeEEecCCceEEEe
Q 013258          301 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  371 (447)
Q Consensus       301 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lv~  371 (447)
                      +.|+.|-.=.+|+...++        .+.|.+++.. .  ........+|..+++.+.-.++ .++++++..    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            457777777899988643        2456666553 2  1223356688888887753344 577777643    6899


Q ss_pred             ecCCCCCh
Q 013258          372 PYMTNGSV  379 (447)
Q Consensus       372 e~~~~gsL  379 (447)
                      ||+++..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.09  E-value=0.26  Score=43.71  Aligned_cols=62  Identities=5%  Similarity=0.021  Sum_probs=36.3

Q ss_pred             ccHHHHHHHhcCCCCCCccc-----cCCCceEEEEEeCCCcEEEEEEcccccccccHHHHHHHHHHHhcCC
Q 013258          285 FSLRELQVATDGFSNKNILG-----RGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV  350 (447)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~  350 (447)
                      .+.+|++....+|...++..     .|---+.|+.+..+|+ +++|+......   ..+...|++++..+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE---KNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhh
Confidence            45677777778887754443     4444668988876554 88898754321   124455666666554